chr1	898119	900565	Q6TDP4	0	+	898119	900565	255,102,0	1	2446	0	.	Interaction	with	F-actin.
chr1	900559	900568	Q6TDP4	0	+	900559	900568	255,102,0	1	9	0	.	Interaction	with	PDZK1.
chr1	949816	949831	P05161	0	+	949816	949831	255,102,0	1	15	0	.	Involved	in	the	ligation	of	specific	target	proteins.
chr1	1152894	1153056	Q9BRK5	0	-	1152894	1153056	255,102,0	1	162	0	.	Necessary	for	intracellular	retention	in	Golgi	apparatus	lumen.
chr1	1268890	1268920	Q7RTX0	0	+	1268890	1268920	255,102,0	1	30	0	.	Required	for	brazzein	responsiveness.
chr1	1322904	1323215	Q96S94	0	-	1322904	1323215	255,102,0	1	311	0	.	RS.
chr1	1325856	1330776	Q96S94	0	-	1325856	1330776	255,102,0	1	4920	0	.	Cyclin-like	2.
chr1	1330812	1334440	Q96S94	0	-	1330812	1334440	255,102,0	1	3628	0	.	Cyclin-like	1.
chr1	1447651	1447798	Q9NVI7	0	+	1447651	1447798	255,102,0	1	147	0	.	Required	for	interaction	with	the	inner	surface	of	the	mitochondrial	outer	membrane.
chr1	1458240	1458899	Q9NVI7	0	+	1458240	1458899	255,102,0	1	659	0	.	S100B-binding.
chr1	1987963	2075663	Q05513	0	+	1987963	2075663	255,102,0	1	87700	0	.	Interaction	with	SQSTM1.
chr1	2408027	2411366	O75038	0	+	2408027	2411366	255,102,0	1	3339	0	.	Necessary	for	plasma	membrane	localization.
chr1	3328795	3342619	Q9HAZ2	0	+	3328795	3342619	255,102,0	1	13824	0	.	Interaction	with	CTBP1,	CTBP2	and	ZNF516.
chr1	3328975	3350372	Q9HAZ2	0	+	3328975	3350372	255,102,0	1	21397	0	.	Mediates	interaction	with	SKI	and	regulation	of	TGF-beta	signaling.	Pubmed:19049980
chr1	3385461	3392596	Q5VV41	0	+	3385461	3392596	255,102,0	1	7135	0	.	Required	for	RHOG	activation	and	mediates	interaction	with	EPHA2.	Pubmed:20679435
chr1	3598929	3599696	O15350	0	+	3598929	3599696	255,102,0	1	767	0	.	Transactivation.
chr1	3624316	3644279	O15350	0	+	3624316	3644279	255,102,0	1	19963	0	.	DNA-binding.
chr1	3644739	3645956	O15350	0	+	3644739	3645956	255,102,0	1	1217	0	.	Interaction	with	HIPK2.	Pubmed:11925430
chr1	3644739	3645974	O15350	0	+	3644739	3645974	255,102,0	1	1235	0	.	Oligomerization.
chr1	3692449	3692482	B2RUZ4	0	+	3692449	3692482	255,102,0	1	33	0	.	Displays	the	Vel	antigen.	Pubmed:26452714
chr1	4829989	4834556	Q9UKB5	0	+	4829989	4834556	255,102,0	1	4567	0	.	Targeting	signals.
chr1	5923327	5947364	O75161	0	-	5923327	5947364	255,102,0	1	24037	0	.	Sufficient	for	basal	bodies	localization.	Pubmed:26644512
chr1	6203966	6209440	Q8TDI0	0	-	6203966	6209440	255,102,0	1	5474	0	.	Histone-binding.
chr1	6681514	6681538	Q86YI8	0	+	6681514	6681538	255,102,0	1	24	0	.	Interaction	with	trimethylated	histone	H3	(H3K4).
chr1	7880202	7887293	P56645	0	+	7880202	7887293	255,102,0	1	7091	0	.	CSNK1E	binding	domain.
chr1	7889926	7890196	P56645	0	+	7889926	7890196	255,102,0	1	270	0	.	5	X	18	AA	tandem	repeats	of	S-[HP]-[AP]-T-[AT]-[GST]-[ATV]-L-S-[MT]-G-[LS]-P-P-[MRS]-[EKR]-[NST]-P.
chr1	7896000	7902812	P56645	0	+	7896000	7902812	255,102,0	1	6812	0	.	CRY	binding	domain.
chr1	7980897	7993261	Q07011	0	-	7980897	7993261	255,102,0	1	12364	0	.	Interaction	with	LRR-1.
chr1	8073569	8073659	Q9UJM3	0	-	8073569	8073659	255,102,0	1	90	0	.	Interaction	with	EGFR	and	ERBB2	and	regulation	of	EGFR	activation.
chr1	8921421	8922968	P06733	0	-	8921421	8922968	255,102,0	1	1547	0	.	Required	for	interaction	with	PLG.
chr1	8923350	8923362	A0A024R4F1	0	-	8923350	8923362	255,102,0	1	12	0	.	Substrate	binding.
chr1	8923350	8923362	P06733	0	-	8923350	8923362	255,102,0	1	12	0	.	Substrate	binding.
chr1	8925497	8928068	P06733	0	-	8925497	8928068	255,102,0	1	2571	0	.	Required	for	repression	of	c-myc	promoter	activity.
chr1	8930561	8931965	P06733	0	-	8930561	8931965	255,102,0	1	1404	0	.	Epitope	recognized	by	CAR	antibodies.
chr1	8932016	8932040	P06733	0	-	8932016	8932040	255,102,0	1	24	0	.	Epitope	recognized	by	CAR	and	healthy	patient	antibodies.
chr1	9027803	9027809	P23280	0	+	9027803	9027809	255,102,0	1	6	0	.	Substrate	binding.
chr1	9074742	9074763	Q6PXP3	0	-	9074742	9074763	255,102,0	1	21	0	.	Monosaccharide	binding.
chr1	9097997	9098003	P22732	0	-	9097997	9098003	255,102,0	1	6	0	.	Fructose	binding.
chr1	9099712	9099721	P22732	0	-	9099712	9099721	255,102,0	1	9	0	.	Fructose	binding.
chr1	9305050	9324130	O95479	0	+	9305050	9324130	255,102,0	1	19080	0	.	Glucose	1-dehydrogenase.
chr1	9324130	9324172	O95479	0	+	9324130	9324172	255,102,0	1	42	0	.	Linker.
chr1	9324172	9324925	O95479	0	+	9324172	9324925	255,102,0	1	753	0	.	6-phosphogluconolactonase.
chr1	10035696	10035705	Q9HAN9	0	+	10035696	10035705	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:11959140
chr1	10035807	10035819	Q9HAN9	0	+	10035807	10035819	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:11788603,	Pubmed:11959140
chr1	10042420	10042426	Q9HAN9	0	+	10042420	10042426	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:11788603,	Pubmed:11959140
chr1	10332307	10338056	O60333	0	+	10332307	10338056	255,102,0	1	5749	0	.	Interaction	with	KBP.	Pubmed:16225668
chr1	10464271	10464280	P52209	0	+	10464271	10464280	255,102,0	1	9	0	.	Substrate	binding.
chr1	10471513	10471519	P52209	0	+	10471513	10471519	255,102,0	1	6	0	.	Substrate	binding.
chr1	11080587	11082708	Q13148	0	+	11080587	11082708	255,102,0	1	2121	0	.	Interaction	with	UBQLN2.	Pubmed:23541532
chr1	11116667	11116679	P19623	0	-	11116667	11116679	255,102,0	1	12	0	.	Putrescine	binding.
chr1	11116727	11116733	P19623	0	-	11116727	11116733	255,102,0	1	6	0	.	S-adenosylmethioninamine	binding.
chr1	11181347	11182074	P42345	0	-	11181347	11182074	255,102,0	1	727	0	.	Interaction	with	MLST8.
chr1	11186772	11187863	P42345	0	-	11186772	11187863	255,102,0	1	1091	0	.	Sufficient	for	interaction	with	the	FKBP1A/rapamycin	complex.
chr1	11298507	11319466	P42345	0	-	11298507	11319466	255,102,0	1	20959	0	.	Interaction	with	NBN.	Pubmed:23762398
chr1	11708804	11708810	Q9UK22	0	-	11708804	11708810	255,102,0	1	6	0	.	Carbohydrate	binding.
chr1	11709263	11709272	Q9UK22	0	-	11709263	11709272	255,102,0	1	9	0	.	Carbohydrate	binding.
chr1	11734834	11735768	Q9UI95	0	-	11734834	11735768	255,102,0	1	934	0	.	Mediates	interaction	with	ipaB.
chr1	11735750	11740508	Q9UI95	0	-	11735750	11740508	255,102,0	1	4758	0	.	Mediates	interaction	with	REV1	and	REV3L	and	homodimerization.
chr1	11808630	11810135	Q6RW13	0	+	11808630	11810135	255,102,0	1	1505	0	.	Interaction	with	AGTR1.
chr1	12089820	12089952	Q5JXC2	0	+	12089820	12089952	255,102,0	1	132	0	.	Interaction	with	IGFBP2.	Pubmed:14617774
chr1	14105169	14105238	Q13029	0	+	14105169	14105238	255,102,0	1	69	0	.	Retinoblastoma	protein	binding.
chr1	15361345	15386750	Q674X7	0	+	15361345	15386750	255,102,0	1	25405	0	.	Interaction	with	PPL.	Pubmed:15337775
chr1	15987590	15987599	Q92681	0	+	15987590	15987599	255,102,0	1	9	0	.	Involved	in	post-transcriptional	down-regulation	of	SLC5A1.
chr1	16011053	16052029	Q8IWE5	0	+	16011053	16052029	255,102,0	1	40976	0	.	Interaction	with	KIF5B.	Pubmed:15905402
chr1	16057101	16058874	Q8IWE5	0	+	16057101	16058874	255,102,0	1	1773	0	.	Interaction	with	sifA.
chr1	16091478	16091688	Q8WUP2	0	+	16091478	16091688	255,102,0	1	210	0	.	Filamin-binding.
chr1	16091478	16093875	Q8WUP2	0	+	16091478	16093875	255,102,0	1	2397	0	.	Intrinsically	disordered.
chr1	16101226	16111153	Q8WUP2	0	+	16101226	16111153	255,102,0	1	9927	0	.	FERMT2-binding.
chr1	16259122	16260127	Q96T58	0	+	16259122	16260127	255,102,0	1	1005	0	.	Interaction	with	MSX2.
chr1	16260859	16261345	Q96T58	0	+	16260859	16261345	255,102,0	1	486	0	.	Interaction	with	RBPSUH.
chr1	16268466	16269153	Q13105	0	-	16268466	16269153	255,102,0	1	687	0	.	Interaction	with	HCFC1.	Pubmed:12244100
chr1	16268721	16269153	Q13105	0	-	16268721	16269153	255,102,0	1	432	0	.	Interaction	with	MYC.
chr1	16271434	16271554	Q13105	0	-	16271434	16271554	255,102,0	1	120	0	.	Interaction	with	MYC.
chr1	16343688	16344458	Q9UBY9	0	-	16343688	16344458	255,102,0	1	770	0	.	Required	for	localization	to	SC35	splicing	speckles.
chr1	16451712	16456734	P29317	0	-	16451712	16456734	255,102,0	1	5022	0	.	Negatively	regulates	interaction	with	ARHGEF16.	Pubmed:20679435
chr1	16456035	16460024	P29317	0	-	16456035	16460024	255,102,0	1	3989	0	.	Mediates	interaction	with	ARHGEF16	and	ELMO2.	Pubmed:20679435
chr1	16475077	16482427	P29317	0	-	16475077	16482427	255,102,0	1	7350	0	.	Mediates	interaction	with	CLDN4.	Pubmed:16236711
chr1	16558545	16560224	Q9BU20	0	-	16558545	16560224	255,102,0	1	1679	0	.	Small	GTPase-like.
chr1	18958175	19018291	P23759	0	+	18958175	19018291	255,102,0	1	60116	0	.	Sufficient	to	mediate	interaction	with	PAXBP1.
chr1	20209213	20216884	Q5T2D3	0	+	20209213	20216884	255,102,0	1	7671	0	.	Cys-loop.
chr1	20220868	20220901	Q5T2D3	0	+	20220868	20220901	255,102,0	1	33	0	.	Variable-loop.
chr1	20224077	20224095	Q5T2D3	0	+	20224077	20224095	255,102,0	1	18	0	.	His-loop.
chr1	20810174	20811752	Q7Z7J9	0	-	20810174	20811752	255,102,0	1	1578	0	.	CAMK2	inhibitory	domain.
chr1	20931425	20931446	P32320	0	+	20931425	20931446	255,102,0	1	21	0	.	Substrate	binding.
chr1	21133814	21133859	O43432	0	-	21133814	21133859	255,102,0	1	45	0	.	Necessary	but	not	sufficient	for	MKNK1-binding.
chr1	21133814	21143935	O43432	0	-	21133814	21143935	255,102,0	1	10121	0	.	EIF4A-binding.
chr1	21186896	21212855	O43432	0	-	21186896	21212855	255,102,0	1	25959	0	.	eIF3/EIF4A-binding.
chr1	21221935	21221971	O43432	0	-	21221935	21221971	255,102,0	1	36	0	.	EIF4E-binding.
chr1	21296026	21299518	O43432	0	-	21296026	21299518	255,102,0	1	3492	0	.	PABPC1-binding.
chr1	22150208	22150618	P98160	0	-	22150208	22150618	255,102,0	1	410	0	.	Mediates	motor	neuron	attachment.
chr1	22154601	22154610	P98160	0	-	22154601	22154610	255,102,0	1	9	0	.	Mediates	motor	neuron	attachment.
chr1	22921808	22922611	P29322	0	+	22921808	22922611	255,102,0	1	803	0	.	Mediates	interaction	with	ANKS1A	and	ANKS1B.
chr1	22923803	22924170	P29322	0	+	22923803	22924170	255,102,0	1	367	0	.	Mediates	interaction	with	PIK3CG	and	required	for	endocytosis.
chr1	23382498	23409854	O60341	0	+	23382498	23409854	255,102,0	1	27356	0	.	Demethylase	activity.
chr1	23519758	23519773	P28221	0	-	23519758	23519773	255,102,0	1	15	0	.	Agonist	binding.
chr1	23520343	23520373	P28221	0	-	23520343	23520373	255,102,0	1	30	0	.	Agonist	binding.
chr1	23637147	23637510	O43390	0	-	23637147	23637510	255,102,0	1	363	0	.	RNA-binding	RGG-box.
chr1	23637357	23637465	O43390	0	-	23637357	23637465	255,102,0	1	108	0	.	3	X	11	AA	approximate	repeats	of	D-D-Y-Y-G-Y-D-Y-H-D-Y.
chr1	23644611	23644974	O43390	0	-	23644611	23644974	255,102,0	1	363	0	.	RNA-binding	RGG-box.
chr1	23644821	23644929	O43390	0	-	23644821	23644929	255,102,0	1	108	0	.	3	X	11	AA	approximate	repeats	of	D-D-Y-Y-G-Y-D-Y-H-D-Y.
chr1	23836374	23836611	Q14209	0	-	23836374	23836611	255,102,0	1	237	0	.	Transactivation.
chr1	23836404	23836458	Q14209	0	-	23836404	23836458	255,102,0	1	54	0	.	Retinoblastoma	protein	binding.
chr1	23843004	23847553	Q14209	0	-	23843004	23847553	255,102,0	1	4549	0	.	Dimerization.
chr1	23843838	23844075	Q14209	0	-	23843838	23844075	255,102,0	1	237	0	.	Transactivation.
chr1	23843868	23843922	Q14209	0	-	23843868	23843922	255,102,0	1	54	0	.	Retinoblastoma	protein	binding.
chr1	23848378	23848444	Q14209	0	-	23848378	23848444	255,102,0	1	66	0	.	Leucine-zipper.
chr1	23850468	23855017	Q14209	0	-	23850468	23855017	255,102,0	1	4549	0	.	Dimerization.
chr1	23850917	23857093	Q14209	0	-	23850917	23857093	255,102,0	1	6176	0	.	Cyclin	A/CDK2	binding.
chr1	23855842	23855908	Q14209	0	-	23855842	23855908	255,102,0	1	66	0	.	Leucine-zipper.
chr1	23858381	23864557	Q14209	0	-	23858381	23864557	255,102,0	1	6176	0	.	Cyclin	A/CDK2	binding.
chr1	24080615	24082834	Q14241	0	+	24080615	24082834	255,102,0	1	2219	0	.	Activation	domain.
chr1	24080699	24080729	Q14241	0	+	24080699	24080729	255,102,0	1	30	0	.	BC-box.
chr1	24122719	24122731	Q14376	0	-	24122719	24122731	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:11279032,	Pubmed:11279193
chr1	24123396	24123405	Q14376	0	-	24123396	24123405	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:10801319,	Pubmed:11279032,	Pubmed:11279193
chr1	24123541	24123550	Q14376	0	-	24123541	24123550	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:10801319,	Pubmed:11279032,	Pubmed:11279193
chr1	24123604	24123613	Q14376	0	-	24123604	24123613	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:11279032,	Pubmed:11279193
chr1	24124310	24124319	Q14376	0	-	24124310	24124319	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:15175331,	Pubmed:10801319
chr1	24657985	24662990	Q8TE85	0	+	24657985	24662990	255,102,0	1	5005	0	.	Transcription	activation.	Pubmed:12549979
chr1	24969817	24976509	Q8IYB3	0	+	24969817	24976509	255,102,0	1	6692	0	.	Necessary	for	DNA	and	RNA-binding.
chr1	24969817	24976524	Q8IYB3	0	+	24969817	24976524	255,102,0	1	6707	0	.	Necessary	for	mRNA	3'-end	cleavage	and	cytoplasmic	accumulation.
chr1	24979096	24995938	Q8IYB3	0	+	24979096	24995938	255,102,0	1	16842	0	.	Necessary	for	speckles	and	matrix	localization.
chr1	25072047	25140705	Q9Y696	0	+	25072047	25140705	255,102,0	1	68658	0	.	Required	for	insertion	into	the	membrane.
chr1	25890279	25893384	Q5SW96	0	+	25890279	25893384	255,102,0	1	3105	0	.	AP-2	complex	binding.	Pubmed:12221107
chr1	26161486	26161999	Q9H7T9	0	-	26161486	26161999	255,102,0	1	513	0	.	Interaction	with	AURKA.	Pubmed:20596670
chr1	26385057	26392871	Q969Q1	0	-	26385057	26392871	255,102,0	1	7814	0	.	Interaction	with	TTN.	Pubmed:11243782
chr1	26582221	26586251	Q6P2H3	0	+	26582221	26586251	255,102,0	1	4030	0	.	Mediates	interaction	with	NEK2	and	is	required	for	its	function	in	the	suppression	of	centrosome	disjunction.	Pubmed:26220856
chr1	26586251	26595060	Q6P2H3	0	+	26586251	26595060	255,102,0	1	8809	0	.	Required	for	centrosome	localization	and	for	its	function	in	the	suppression	of	centrosome	disjunction.	Pubmed:26220856
chr1	26608822	26608894	Q5T124	0	-	26608822	26608894	255,102,0	1	72	0	.	3	X	8	AA	tandem	repeats	of	P-G-P-G-P-G-P-S.
chr1	26751901	26751973	Q9H9Z2	0	+	26751901	26751973	255,102,0	1	72	0	.	Flexible	linker.
chr1	27238425	27240263	Q15466	0	-	27238425	27240263	255,102,0	1	1838	0	.	Ligand-binding.
chr1	27429192	27429743	P19634	0	-	27429192	27429743	255,102,0	1	551	0	.	Interaction	with	CHP2.
chr1	27695849	27695855	O75636	0	-	27695849	27695855	255,102,0	1	6	0	.	Carbohydrate	binding.	Pubmed:17215869
chr1	28157346	28167679	Q12972	0	+	28157346	28167679	255,102,0	1	10333	0	.	Interaction	with	CDC5L,	SF3B1	and	MELK.	Pubmed:10827081,	Pubmed:12105215,	Pubmed:14699119
chr1	28167679	28173573	Q12972	0	+	28167679	28173573	255,102,0	1	5894	0	.	Interaction	with	EED.	Pubmed:12788942
chr1	28169774	28169804	Q12972	0	+	28169774	28169804	255,102,0	1	30	0	.	Involved	in	PP-1	inhibition.
chr1	28169801	28169813	Q12972	0	+	28169801	28169813	255,102,0	1	12	0	.	Involved	in	PP-1	binding.
chr1	28176828	28176888	Q12972	0	+	28176828	28176888	255,102,0	1	60	0	.	Interaction	with	EED.	Pubmed:12788942
chr1	28176888	28176954	Q12972	0	+	28176888	28176954	255,102,0	1	66	0	.	RNA-binding.
chr1	28176891	28176912	Q12972	0	+	28176891	28176912	255,102,0	1	21	0	.	Involved	in	PP-1	inhibition.
chr1	28199082	28208549	Q5TEJ8	0	+	28199082	28208549	255,102,0	1	9467	0	.	CABIT	1.
chr1	28208549	28209377	Q5TEJ8	0	+	28208549	28209377	255,102,0	1	828	0	.	CABIT	2.
chr1	28218676	28220875	P15927	0	-	28218676	28220875	255,102,0	1	2199	0	.	Interaction	with	RAD52,	TIPIN,	UNG	and	XPA.	Pubmed:11081631
chr1	28562769	28562940	Q9UII2	0	+	28562769	28562940	255,102,0	1	171	0	.	N-terminal	inhibitory	region.
chr1	28564387	28564486	Q9UII2	0	+	28564387	28564486	255,102,0	1	99	0	.	Antiparallel	alpha-helical	coiled	coil	region.
chr1	28598223	28599271	P58004	0	+	28598223	28599271	255,102,0	1	1048	0	.	N-terminal	domain;	mediates	the	alkylhydroperoxide	reductase	activity.	Pubmed:26612684
chr1	28600570	28607310	P58004	0	+	28600570	28607310	255,102,0	1	6740	0	.	C-terminal	domain;	mediates	TORC1	regulation.	Pubmed:26612684
chr1	28601434	28601446	P58004	0	+	28601434	28601446	255,102,0	1	12	0	.	Leucine-binding.	Pubmed:26586190
chr1	29063635	29069934	Q9Y5A9	0	+	29063635	29069934	255,102,0	1	6299	0	.	Localization	to	mRNA	processing	bodies	(P-bodies).	Pubmed:24284625
chr1	29069934	29095461	Q9Y5A9	0	+	29069934	29095461	255,102,0	1	25527	0	.	Interaction	with	m6A-containing	mRNAs.	Pubmed:24284625
chr1	29070027	29070036	Q9Y5A9	0	+	29070027	29070036	255,102,0	1	9	0	.	N6-methyladenosine	binding.	Pubmed:25412658
chr1	29070075	29070081	Q9Y5A9	0	+	29070075	29070081	255,102,0	1	6	0	.	N6-methyladenosine	binding.	Pubmed:25412658
chr1	29365781	29379821	P11171	0	+	29365781	29379821	255,102,0	1	14040	0	.	Hydrophilic.
chr1	29379821	29391625	P11171	0	+	29379821	29391625	255,102,0	1	11804	0	.	Spectrin--actin-binding.
chr1	29391625	29442306	P11171	0	+	29391625	29442306	255,102,0	1	50681	0	.	C-terminal	(CTD).
chr1	29611373	29630521	Q92729	0	+	29611373	29630521	255,102,0	1	19148	0	.	Mediates	interaction	with	CTNNB1.
chr1	29639213	29641899	Q92729	0	+	29639213	29641899	255,102,0	1	2686	0	.	Substrate	binding.
chr1	31409540	31409555	Q14671	0	-	31409540	31409555	255,102,0	1	15	0	.	Uracil-nucleotide	binding	in	RNA	target.	Pubmed:21397187,	Pubmed:18328718
chr1	31409669	31413999	Q14671	0	-	31409669	31413999	255,102,0	1	4330	0	.	Guanine-nucleotide	binding	in	RNA	target.	Pubmed:21397187,	Pubmed:18328718
chr1	31414092	31414107	Q14671	0	-	31414092	31414107	255,102,0	1	15	0	.	Uracil-nucleotide	binding	in	RNA	target.	Pubmed:21397187,	Pubmed:18328718
chr1	31414925	31414940	Q14671	0	-	31414925	31414940	255,102,0	1	15	0	.	Adenine-nucleotide	binding	in	RNA	target.	Pubmed:18328718
chr1	31418255	31418270	Q14671	0	-	31418255	31418270	255,102,0	1	15	0	.	Non-specific-nucleotide	binding	in	RNA	target.	Pubmed:18328718
chr1	31423012	31423027	Q14671	0	-	31423012	31423027	255,102,0	1	15	0	.	Adenine-nucleotide	binding	in	RNA	target.	Pubmed:18328718
chr1	31425092	31425107	Q14671	0	-	31425092	31425107	255,102,0	1	15	0	.	Uracil-nucleotide	binding	in	RNA	target.	Pubmed:18328718
chr1	31425200	31426565	Q14671	0	-	31425200	31426565	255,102,0	1	1365	0	.	Adenine-nucleotide	binding	in	RNA	target.	Pubmed:18328718
chr1	32084868	32084916	O43613	0	+	32084868	32084916	255,102,0	1	48	0	.	Required	for	response	to	orexin-A.	Pubmed:26950369
chr1	32096216	32098111	Q9UBV8	0	-	32096216	32098111	255,102,0	1	1895	0	.	Required	for	interaction	with	PDCD6.
chr1	32098913	32101087	Q9UBV8	0	-	32098913	32101087	255,102,0	1	2174	0	.	9	X	9	AA	approximate	tandem	repeat	of	[AP]-P-G-G-P-Y-G-G-P-P.
chr1	32118254	32118332	Q07092	0	-	32118254	32118332	255,102,0	1	78	0	.	Nonhelical	region	1	(NC1).
chr1	32118332	32119585	Q07092	0	-	32118332	32119585	255,102,0	1	1253	0	.	Triple-helical	region	1	(COL1)	with	2	imperfections.
chr1	32119585	32120450	Q07092	0	-	32119585	32120450	255,102,0	1	865	0	.	Nonhelical	region	2	(NC2).
chr1	32120450	32138088	Q07092	0	-	32120450	32138088	255,102,0	1	17638	0	.	Triple-helical	region	2	(COL2)	with	2	imperfections.
chr1	32138088	32138336	Q07092	0	-	32138088	32138336	255,102,0	1	248	0	.	Nonhelical	region	3	(NC3).
chr1	32138336	32138381	Q07092	0	-	32138336	32138381	255,102,0	1	45	0	.	Triple-helical	region	3	(COL3).
chr1	32138381	32140867	Q07092	0	-	32138381	32140867	255,102,0	1	2486	0	.	Nonhelical	region	4	(NC4).
chr1	32140867	32145651	Q07092	0	-	32140867	32145651	255,102,0	1	4784	0	.	Triple-helical	region	4	(COL4)	with	2	imperfections.
chr1	32145651	32145684	Q07092	0	-	32145651	32145684	255,102,0	1	33	0	.	Nonhelical	region	5	(NC5).
chr1	32145684	32149778	Q07092	0	-	32145684	32149778	255,102,0	1	4094	0	.	Triple-helical	region	5	(COL5)	with	3	imperfections.
chr1	32149778	32149823	Q07092	0	-	32149778	32149823	255,102,0	1	45	0	.	Nonhelical	region	6	(NC6).
chr1	32149823	32151299	Q07092	0	-	32149823	32151299	255,102,0	1	1476	0	.	Triple-helical	region	6	(COL6)	with	1	imperfection.
chr1	32151299	32151362	Q07092	0	-	32151299	32151362	255,102,0	1	63	0	.	Nonhelical	region	7	(NC7).
chr1	32151362	32154512	Q07092	0	-	32151362	32154512	255,102,0	1	3150	0	.	Triple-helical	region	7	(COL7)	with	1	imperfection.
chr1	32154512	32154563	Q07092	0	-	32154512	32154563	255,102,0	1	51	0	.	Nonhelical	region	8	(NC8).
chr1	32154563	32155398	Q07092	0	-	32154563	32155398	255,102,0	1	835	0	.	Triple-helical	region	8	(COL8)	with	1	imperfection.
chr1	32155398	32155443	Q07092	0	-	32155398	32155443	255,102,0	1	45	0	.	Nonhelical	region	9	(NC9).
chr1	32155443	32158234	Q07092	0	-	32155443	32158234	255,102,0	1	2791	0	.	Triple-helical	region	9	(COL9)	with	3	imperfections.
chr1	32158234	32162865	Q07092	0	-	32158234	32162865	255,102,0	1	4631	0	.	Nonhelical	region	10	(NC10).
chr1	32377295	32377313	Q12974	0	-	32377295	32377313	255,102,0	1	18	0	.	Phosphate	binding.
chr1	32479893	32502519	Q07666	0	+	32479893	32502519	255,102,0	1	22626	0	.	Involved	in	homodimerization.	Pubmed:26758068
chr1	32503580	32508222	Q07666	0	+	32503580	32508222	255,102,0	1	4642	0	.	Interaction	with	HNRNPA1.	Pubmed:17371836
chr1	32625012	32627617	O60684	0	+	32625012	32627617	255,102,0	1	2605	0	.	NLS	binding	site	(major).
chr1	32628869	32632865	O60684	0	+	32628869	32632865	255,102,0	1	3996	0	.	NLS	binding	site	(minor).
chr1	32739933	32740622	P06239	0	+	32739933	32740622	255,102,0	1	689	0	.	Interactions	with	CD4	and	CD8.
chr1	32741251	32742032	P06239	0	+	32741251	32742032	255,102,0	1	781	0	.	Interaction	with	PTPRH.	Pubmed:12837766
chr1	32757794	32796493	Q13547	0	+	32757794	32796493	255,102,0	1	38699	0	.	Histone	deacetylase.
chr1	32800455	32800527	P49006	0	-	32800455	32800527	255,102,0	1	72	0	.	Effector	domain	involved	in	lipid-binding.
chr1	32800485	32800527	P49006	0	-	32800485	32800527	255,102,0	1	42	0	.	Calmodulin-binding	(PSD).
chr1	33147453	33149674	Q9H7C4	0	-	33147453	33149674	255,102,0	1	2221	0	.	Tail.
chr1	33149674	33160651	Q9H7C4	0	-	33149674	33160651	255,102,0	1	10977	0	.	Coil	2.
chr1	33160651	33160771	Q9H7C4	0	-	33160651	33160771	255,102,0	1	120	0	.	Linker	2.
chr1	33160771	33161005	Q9H7C4	0	-	33160771	33161005	255,102,0	1	234	0	.	Coil	1b.
chr1	33161005	33161086	Q9H7C4	0	-	33161005	33161086	255,102,0	1	81	0	.	Linker	1.
chr1	33161086	33161191	Q9H7C4	0	-	33161086	33161191	255,102,0	1	105	0	.	Coil	1A.
chr1	33161191	33161215	Q9H7C4	0	-	33161191	33161215	255,102,0	1	24	0	.	Rod.
chr1	33161215	33168261	Q9H7C4	0	-	33161215	33168261	255,102,0	1	7046	0	.	Head.
chr1	33478967	33486972	A0A140VK93	0	-	33478967	33486972	255,102,0	1	8005	0	.	LID.
chr1	33478967	33486972	F8W1A4	0	-	33478967	33486972	255,102,0	1	8005	0	.	LID.
chr1	33478967	33486972	P54819	0	-	33478967	33486972	255,102,0	1	8005	0	.	LID.
chr1	33487301	33490129	A0A140VK93	0	-	33487301	33490129	255,102,0	1	2828	0	.	NMPbind.
chr1	33487301	33490129	F8W1A4	0	-	33487301	33490129	255,102,0	1	2828	0	.	NMPbind.
chr1	33487301	33490129	P54819	0	-	33487301	33490129	255,102,0	1	2828	0	.	NMPbind.
chr1	33557719	33557791	Q96A70	0	+	33557719	33557791	255,102,0	1	72	0	.	Necessary	for	polyamine	uptake	stimulation.
chr1	35658569	35658626	P23246	0	-	35658569	35658626	255,102,0	1	57	0	.	3	X	3	AA	repeats	of	R-G-G.
chr1	36055603	36060199	Q6VUC0	0	+	36055603	36060199	255,102,0	1	4596	0	.	H-S-H	(helix-span-helix),	dimerization.
chr1	36360774	36360792	Q9UL18	0	+	36360774	36360792	255,102,0	1	18	0	.	Interaction	with	guide	RNA.
chr1	36372701	36379552	Q9UL18	0	+	36372701	36379552	255,102,0	1	6851	0	.	Interaction	with	guide	RNA.
chr1	36381122	36381140	Q9UL18	0	+	36381122	36381140	255,102,0	1	18	0	.	Impairs	access	of	bound	RNA	to	the	active	site.
chr1	36383286	36383301	Q9UL18	0	+	36383286	36383301	255,102,0	1	15	0	.	Interaction	with	guide	RNA.
chr1	36384009	36384667	Q9UL18	0	+	36384009	36384667	255,102,0	1	658	0	.	Interaction	with	guide	RNA.
chr1	36384751	36384829	Q9UL18	0	+	36384751	36384829	255,102,0	1	78	0	.	Interaction	with	guide	RNA.
chr1	36563172	36563673	P25067	0	-	36563172	36563673	255,102,0	1	501	0	.	Nonhelical	region	(NC1).
chr1	36563673	36565053	P25067	0	-	36563673	36565053	255,102,0	1	1380	0	.	Triple-helical	region.
chr1	36565053	36565759	P25067	0	-	36565053	36565759	255,102,0	1	706	0	.	Nonhelical	region	(NC2).
chr1	36748167	36752401	Q9Y2W1	0	+	36748167	36752401	255,102,0	1	4234	0	.	Required	for	mRNA	splicing	activation.
chr1	36754694	36769615	Q9Y2W1	0	+	36754694	36769615	255,102,0	1	14921	0	.	Required	for	mRNA	decay	activity.
chr1	37282675	37282684	Q13003	0	-	37282675	37282684	255,102,0	1	9	0	.	Glutamate	binding.
chr1	37941220	37941358	Q5D1E8	0	+	37941220	37941358	255,102,0	1	138	0	.	Ubiquitin	association	domain.
chr1	37941337	37945897	Q5D1E8	0	+	37941337	37945897	255,102,0	1	4560	0	.	Necessary	for	interaction	with	TANK.	Pubmed:25861989
chr1	37941430	37948107	Q5D1E8	0	+	37941430	37948107	255,102,0	1	6677	0	.	RNase.	Pubmed:22561375
chr1	37947257	37947278	Q5D1E8	0	+	37947257	37947278	255,102,0	1	21	0	.	RNA	binding.	Pubmed:22561375
chr1	37948116	37948783	Q5D1E8	0	+	37948116	37948783	255,102,0	1	667	0	.	Necessary	for	interaction	with	ZC3H12D.	Pubmed:26134560
chr1	38158362	38158656	Q53HL2	0	+	38158362	38158656	255,102,0	1	294	0	.	Required	for	interaction	with	INCENP.	Pubmed:17956729
chr1	38158362	38161622	Q53HL2	0	+	38158362	38161622	255,102,0	1	3260	0	.	Required	for	centromere	localization.
chr1	38158362	38166190	Q53HL2	0	+	38158362	38166190	255,102,0	1	7828	0	.	Required	for	interaction	with	SENP3.	Pubmed:18946085
chr1	38158389	38164639	Q53HL2	0	+	38158389	38164639	255,102,0	1	6250	0	.	Required	to	form	a	minimal	CPC	core	complex	that	localizes	to	the	central	spindle	and	midbody	and	properly	executes	the	role	of	the	CPC	during	cytokinesis.
chr1	38158419	38161592	Q53HL2	0	+	38158419	38161592	255,102,0	1	3173	0	.	Required	for	interaction	with	INCENP	and	BIRC5.	Pubmed:17956729
chr1	38338682	38341301	P32019	0	-	38338682	38341301	255,102,0	1	2619	0	.	ASH.
chr1	38341301	38355242	P32019	0	-	38341301	38355242	255,102,0	1	13941	0	.	5-phosphatase.
chr1	38343982	38343991	P32019	0	-	38343982	38343991	255,102,0	1	9	0	.	Substrate	binding.
chr1	38345788	38345794	P32019	0	-	38345788	38345794	255,102,0	1	6	0	.	Substrate	binding.
chr1	38351488	38351494	P32019	0	-	38351488	38351494	255,102,0	1	6	0	.	Substrate	binding.
chr1	39927682	39951463	Q9UPN3	0	+	39927682	39951463	255,102,0	1	23781	0	.	C-terminal	tail.
chr1	39951235	39951283	Q9UPN3	0	+	39951235	39951283	255,102,0	1	48	0	.	4	X	4	AA	tandem	repeats	of	[GS]-S-R-[AR].
chr1	40092832	40098344	Q9NQ87	0	-	40092832	40098344	255,102,0	1	5512	0	.	Transcriptional	repression	and	interaction	with	NCOR1	and	SIN3A.
chr1	40312904	40312961	Q9H3H1	0	-	40312904	40312961	255,102,0	1	57	0	.	Interaction	with	substrate	tRNA.
chr1	40312907	40312931	Q9H3H1	0	-	40312907	40312931	255,102,0	1	24	0	.	Interaction	with	substrate	tRNA.
chr1	40313298	40313307	Q9H3H1	0	-	40313298	40313307	255,102,0	1	9	0	.	Interaction	with	substrate	tRNA.
chr1	40313707	40315797	Q9H3H1	0	-	40313707	40315797	255,102,0	1	2090	0	.	Interaction	with	isopentenylpyrophosphate	transferase.
chr1	40318401	40318416	Q9H3H1	0	-	40318401	40318416	255,102,0	1	15	0	.	Interaction	with	substrate	tRNA.
chr1	40348989	40349001	Q9H3H1	0	-	40348989	40349001	255,102,0	1	12	0	.	Interaction	with	substrate	tRNA.
chr1	40349052	40349070	Q9H3H1	0	-	40349052	40349070	255,102,0	1	18	0	.	Substrate	binding.
chr1	40363055	40363142	P12524	0	-	40363055	40363142	255,102,0	1	87	0	.	Leucine-zipper.
chr1	40766856	40766931	Q14055	0	-	40766856	40766931	255,102,0	1	75	0	.	Nonhelical	region	1	(NC1).
chr1	40766931	40767021	Q14055	0	-	40766931	40767021	255,102,0	1	90	0	.	Triple-helical	region	1	(COL1).
chr1	40767021	40767027	Q14055	0	-	40767021	40767027	255,102,0	1	6	0	.	Nonhelical	region	2	(NC2).
chr1	40767027	40768437	Q14055	0	-	40767027	40768437	255,102,0	1	1410	0	.	Triple-helical	region	2	(COL2).
chr1	40768437	40768848	Q14055	0	-	40768437	40768848	255,102,0	1	411	0	.	Nonhelical	region	3	(NC3).
chr1	40768848	40776937	Q14055	0	-	40768848	40776937	255,102,0	1	8089	0	.	Triple-helical	region	3	(COL3).
chr1	40776937	40777201	Q14055	0	-	40776937	40777201	255,102,0	1	264	0	.	Nonhelical	region	4	(NC4).
chr1	40777201	40781333	Q14055	0	-	40777201	40781333	255,102,0	1	4132	0	.	Triple-helical	region	4	(COL4).
chr1	40878771	40881862	Q8WU79	0	+	40878771	40881862	255,102,0	1	3091	0	.	Interaction	with	clathrin	heavy	chains.
chr1	40882621	40887770	Q8WU79	0	+	40882621	40887770	255,102,0	1	5149	0	.	Interaction	with	PICALM.
chr1	41300660	41304057	P56696	0	+	41300660	41304057	255,102,0	1	3397	0	.	A-domain	(Tetramerization).
chr1	41948147	41948195	P20800	0	-	41948147	41948195	255,102,0	1	48	0	.	Endothelin-like.
chr1	41976898	41978735	Q5T1R4	0	-	41976898	41978735	255,102,0	1	1837	0	.	6	X	4	AA	tandem	repeats	of	S-P-X-[RK].
chr1	41979275	41984094	Q5T1R4	0	-	41979275	41984094	255,102,0	1	4819	0	.	Acidic	3.
chr1	41984124	41990529	Q5T1R4	0	-	41984124	41990529	255,102,0	1	6405	0	.	ZAS2.
chr1	42047246	42049838	Q5T1R4	0	-	42047246	42049838	255,102,0	1	2592	0	.	No	DNA	binding	activity	or	transactivation	activity,	but	complete	prevention	of	TRAF-dependent	NF-Kappa-B	activation;	associates	with	TRAF2	and	JUN.
chr1	42047819	42047885	Q5T1R4	0	-	42047819	42047885	255,102,0	1	66	0	.	Acidic	2.
chr1	42049607	42049679	Q5T1R4	0	-	42049607	42049679	255,102,0	1	72	0	.	Acidic	1.
chr1	42049742	42049895	Q5T1R4	0	-	42049742	42049895	255,102,0	1	153	0	.	ZAS1.
chr1	43148278	43149120	P67809	0	+	43148278	43149120	255,102,0	1	842	0	.	Interaction	with	ss-DNA.
chr1	43395266	43395287	P11166	0	-	43395266	43395287	255,102,0	1	21	0	.	Monosaccharide	binding.
chr1	43852299	43852329	Q96G25	0	-	43852299	43852329	255,102,0	1	30	0	.	Interaction	with	the	Elongin	BC	complex.
chr1	44019272	44019302	P10586	0	+	44019272	44019302	255,102,0	1	30	0	.	Heparin-binding.
chr1	44084868	44084974	P10586	0	+	44084868	44084974	255,102,0	1	106	0	.	Substrate	binding.
chr1	44149408	44154643	O75164	0	+	44149408	44154643	255,102,0	1	5235	0	.	Interaction	with	NCOR1.	Pubmed:16024779
chr1	44447494	44447509	O60909	0	+	44447494	44447509	255,102,0	1	15	0	.	UDP-alpha-D-galactose	binding.
chr1	44450551	44450560	O60909	0	+	44450551	44450560	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr1	44450635	44450641	O60909	0	+	44450635	44450641	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr1	44451046	44451058	O60909	0	+	44451046	44451058	255,102,0	1	12	0	.	N-acetyl-D-glucosamine	binding.
chr1	44451255	44451264	O60909	0	+	44451255	44451264	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr1	45115426	45115566	Q5VTB9	0	+	45115426	45115566	255,102,0	1	140	0	.	Required	for	targeting	to	the	cytoplasm.
chr1	45205607	45221603	Q99661	0	+	45205607	45221603	255,102,0	1	15996	0	.	Globular.
chr1	45219460	45220472	Q99661	0	+	45219460	45220472	255,102,0	1	1012	0	.	Negative	regulator	of	microtubule-binding.
chr1	45478666	45478681	P06132	0	+	45478666	45478681	255,102,0	1	15	0	.	Substrate	binding.
chr1	45973949	45973961	Q9Y4U1	0	+	45973949	45973961	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:21697092,	Pubmed:22642810
chr1	45973991	45974000	Q9Y4U1	0	+	45973991	45974000	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:21697092,	Pubmed:22642810
chr1	46072199	46072235	P49321	0	+	46072199	46072235	255,102,0	1	36	0	.	Histone-binding.	Pubmed:8724350
chr1	46073213	46073315	P49321	0	+	46073213	46073315	255,102,0	1	102	0	.	Histone-binding.	Pubmed:8724350
chr1	46073987	46079797	P49321	0	+	46073987	46079797	255,102,0	1	5810	0	.	Histone-binding.	Pubmed:8724350
chr1	46714183	46714207	Q92698	0	+	46714183	46714207	255,102,0	1	24	0	.	Required	for	chromatin	remodeling,	strand	pairing	activities	and	coupling	of	ATPase	activity.
chr1	46768832	46768862	Q15345	0	-	46768832	46768862	255,102,0	1	30	0	.	Interaction	with	Elongin	BC	complex.
chr1	46812695	46812716	Q96CB9	0	+	46812695	46812716	255,102,0	1	21	0	.	S-adenosyl-L-methionine	binding.
chr1	46871392	46871404	O00519	0	+	46871392	46871404	255,102,0	1	12	0	.	Substrate	binding.
chr1	46972682	46976726	Q8NFW5	0	+	46972682	46976726	255,102,0	1	4044	0	.	Interaction	with	OTX2	and	is	required	for	repressor	activity.
chr1	47725983	47775991	Q15468	0	-	47725983	47775991	255,102,0	1	50008	0	.	Interaction	with	RBM14.	Pubmed:25385835
chr1	47737787	47765587	Q15468	0	-	47737787	47765587	255,102,0	1	27800	0	.	Interaction	with	CENPJ.	Pubmed:22020124,	Pubmed:25385835
chr1	47737793	47746380	Q15468	0	-	47737793	47746380	255,102,0	1	8587	0	.	PIN1-binding.
chr1	47834161	47834254	B2R6S5	0	+	47834161	47834254	255,102,0	1	93	0	.	NMPbind.
chr1	47840601	47840634	B2R6S5	0	+	47840601	47840634	255,102,0	1	33	0	.	LID.
chr1	51826905	51868194	P42566	0	-	51826905	51868194	255,102,0	1	41289	0	.	15	X	3	AA	repeats	of	D-P-F.
chr1	51906068	51984900	P42566	0	-	51906068	51984900	255,102,0	1	78832	0	.	Interaction	with	DAB2.
chr1	52732346	52734148	O95405	0	+	52732346	52734148	255,102,0	1	1802	0	.	SBD.
chr1	52838855	52850915	Q13415	0	-	52838855	52850915	255,102,0	1	12060	0	.	Necessary	and	sufficient	for	ORC	complex	assembly.
chr1	53676699	53676738	P23786	0	+	53676699	53676738	255,102,0	1	39	0	.	Coenzyme	A	binding.
chr1	53722951	53723128	Q14114	0	-	53722951	53723128	255,102,0	1	177	0	.	Clustered	O-linked	oligosaccharides.
chr1	55051536	55051545	Q8WXI4	0	+	55051536	55051545	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr1	55058264	55058273	Q8WXI4	0	+	55058264	55058273	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr1	55065014	55065023	Q8WXI4	0	+	55065014	55065023	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr1	55523875	55529254	Q8NBP7	0	+	55523875	55529254	255,102,0	1	5379	0	.	C-terminal	domain.
chr1	57169725	57169983	P54646	0	+	57169725	57169983	255,102,0	1	258	0	.	AIS.
chr1	59247818	59247905	P05412	0	-	59247818	59247905	255,102,0	1	87	0	.	Leucine-zipper.
chr1	59247905	59247989	P05412	0	-	59247905	59247989	255,102,0	1	84	0	.	Basic	motif.
chr1	60280789	60330838	Q9UJC3	0	+	60280789	60330838	255,102,0	1	50049	0	.	Sufficient	for	interaction	with	microtubules.
chr1	60336734	60338634	Q9UJC3	0	+	60336734	60338634	255,102,0	1	1900	0	.	Sufficient	for	interaction	with	AKTIP	and	VPS18.	Pubmed:18799622
chr1	63063285	63063732	Q9Y5C1	0	+	63063285	63063732	255,102,0	1	447	0	.	Sufficient	to	inhibit	LPL	lipase	activity.	Pubmed:12909640
chr1	63063285	63066767	Q9Y5C1	0	+	63063285	63066767	255,102,0	1	3482	0	.	Sufficient	to	inhibit	LIPG/EL	phospholipase	activity.	Pubmed:17110602
chr1	63063330	63063405	Q9Y5C1	0	+	63063330	63063405	255,102,0	1	75	0	.	Required	for	inhibition	of	LPL	lipase	activity.	Pubmed:19318355
chr1	63955787	63955880	Q13352	0	-	63955787	63955880	255,102,0	1	93	0	.	DD1.
chr1	64095197	64095203	P36871	0	+	64095197	64095203	255,102,0	1	6	0	.	Substrate	binding.
chr1	64101904	64101910	P36871	0	+	64101904	64101910	255,102,0	1	6	0	.	Substrate	binding.
chr1	64104452	64104461	P36871	0	+	64104452	64104461	255,102,0	1	9	0	.	Substrate	binding.
chr1	65614192	65656439	P27144	0	+	65614192	65656439	255,102,0	1	42247	0	.	NMPbind.	Pubmed:19073142
chr1	65684543	65690482	P27144	0	+	65684543	65690482	255,102,0	1	5939	0	.	LID.	Pubmed:19073142
chr1	65830400	65830436	O75061	0	+	65830400	65830436	255,102,0	1	36	0	.	3	X	4	AA	approximate	tandem	repeats.
chr1	66067638	66070769	P48357	0	+	66067638	66070769	255,102,0	1	3131	0	.	Leptin-binding.	Pubmed:22405007
chr1	66101876	66101894	P48357	0	+	66101876	66101894	255,102,0	1	18	0	.	Required	for	JAK2	activation.
chr1	66101891	66101918	P48357	0	+	66101891	66101918	255,102,0	1	27	0	.	Required	for	STAT3	phosphorylation.
chr1	67185026	67185047	Q9BQI5	0	+	67185026	67185047	255,102,0	1	21	0	.	Interaction	with	DPF	motifs-containing	proteins.	Pubmed:26822536
chr1	67194980	67194989	Q9BQI5	0	+	67194980	67194989	255,102,0	1	9	0	.	Interaction	with	DPF	motifs-containing	proteins.	Pubmed:26822536
chr1	67199476	67208775	Q9BQI5	0	+	67199476	67208775	255,102,0	1	9299	0	.	Necessary	and	sufficient	to	mediate	interaction	with	CANX.
chr1	67199530	67199542	Q9BQI5	0	+	67199530	67199542	255,102,0	1	12	0	.	Interaction	with	DPF	motifs-containing	proteins.	Pubmed:26822536
chr1	67207091	67207109	Q9BQI5	0	+	67207091	67207109	255,102,0	1	18	0	.	Interaction	with	DPF	motifs-containing	proteins.	Pubmed:26822536
chr1	67425423	67438584	Q8N108	0	+	67425423	67438584	255,102,0	1	13161	0	.	Interaction	with	HDAC1.	Pubmed:12482978
chr1	67861568	67861586	Q99665	0	+	67861568	67861586	255,102,0	1	18	0	.	Required	for	STAT4	binding.
chr1	68151177	68151711	P24522	0	+	68151177	68151711	255,102,0	1	534	0	.	Intrinsically	disordered.
chr1	68152198	68152240	P24522	0	+	68152198	68152240	255,102,0	1	42	0	.	Intrinsically	disordered.
chr1	68619306	68659716	Q5T9L3	0	-	68619306	68659716	255,102,0	1	40410	0	.	Interaction	with	Wnt	proteins.
chr1	68944979	68947266	Q5TB30	0	-	68944979	68947266	255,102,0	1	2287	0	.	Interaction	with	ZNF224.	Pubmed:20587513
chr1	70705141	70715671	Q05519	0	+	70705141	70715671	255,102,0	1	10530	0	.	10	X	8	AA	approximate	repeats	of	R-R-S-R-S-R-S-R.
chr1	71530777	71537866	O95218	0	-	71530777	71537866	255,102,0	1	7089	0	.	Required	for	nuclear	targeting.
chr1	76215226	76215238	P11310	0	+	76215226	76215238	255,102,0	1	12	0	.	Substrate	binding.
chr1	76257244	76257253	P53611	0	+	76257244	76257253	255,102,0	1	9	0	.	Geranylgeranyl	diphosphate	binding.
chr1	76257979	76259795	P53611	0	+	76257979	76259795	255,102,0	1	1816	0	.	Geranylgeranyl	diphosphate	binding.
chr1	77620156	77620189	Q92643	0	-	77620156	77620189	255,102,0	1	33	0	.	Essential	for	GPI	attachment.
chr1	77759626	77876722	Q9Y6K8	0	+	77759626	77876722	255,102,0	1	117096	0	.	Adenylate	kinase	1.	Pubmed:19647735
chr1	77763311	77763407	Q9Y6K8	0	+	77763311	77763407	255,102,0	1	96	0	.	NMPbind	1.
chr1	77806127	77806160	Q9Y6K8	0	+	77806127	77806160	255,102,0	1	33	0	.	LID	1.
chr1	77952018	78024343	Q9Y6K8	0	+	77952018	78024343	255,102,0	1	72325	0	.	Adenylate	kinase	2.	Pubmed:19647735
chr1	77984316	77984406	Q9Y6K8	0	+	77984316	77984406	255,102,0	1	90	0	.	NMPbind	2.
chr1	78001597	78001630	Q9Y6K8	0	+	78001597	78001630	255,102,0	1	33	0	.	LID	2.
chr1	84386783	84387058	Q6ZT98	0	-	84386783	84387058	255,102,0	1	275	0	.	c-MTBD	region.	Pubmed:25959773
chr1	84961951	84962005	Q9H9Y2	0	+	84961951	84962005	255,102,0	1	54	0	.	RNA-binding.
chr1	85930491	85930497	O94760	0	-	85930491	85930497	255,102,0	1	6	0	.	Substrate	binding.
chr1	86048298	86048524	O00622	0	+	86048298	86048524	255,102,0	1	226	0	.	Heparin-binding.
chr1	86890089	86898082	Q9UQC9	0	+	86890089	86898082	255,102,0	1	7993	0	.	Metalloprotease	domain.
chr1	86934789	86947927	A8K7I4	0	+	86934789	86947927	255,102,0	1	13138	0	.	Metalloprotease	domain.	Pubmed:23112050
chr1	87012934	87030996	Q14CN2	0	+	87012934	87030996	255,102,0	1	18062	0	.	Metalloprotease	domain.
chr1	87170582	87181424	Q9Y371	0	+	87170582	87181424	255,102,0	1	10842	0	.	Membrane-binding	amphipathic	helix.
chr1	87170582	87181445	Q9Y371	0	+	87170582	87181445	255,102,0	1	10863	0	.	Required	for	membrane	binding.	Pubmed:21068542
chr1	89250479	89270181	Q16513	0	+	89250479	89270181	255,102,0	1	19702	0	.	Necessary	to	rescue	apical	junction	formation.
chr1	89298837	89299107	Q16513	0	+	89298837	89299107	255,102,0	1	270	0	.	Necessary	for	the	catalytic	activity.
chr1	89299107	89299128	Q16513	0	+	89299107	89299128	255,102,0	1	21	0	.	Negatively	regulates	the	responsiveness	of	the	catalytic	activity	by	cardiolipin	and	is	required	for	optimal	activation	by	the	GTP-bound	RhoA.
chr1	89477651	89486404	Q9H0R5	0	-	89477651	89486404	255,102,0	1	8753	0	.	GTPase	domain	(Globular).
chr1	89522758	89528917	P32455	0	-	89522758	89528917	255,102,0	1	6159	0	.	GTPase	domain	(Globular).
chr1	89579920	89587649	P32456	0	-	89579920	89587649	255,102,0	1	7729	0	.	GTPase	domain	(Globular).
chr1	89615196	89637618	Q8N8V2	0	-	89615196	89637618	255,102,0	1	22422	0	.	GTPase	domain	(Globular).
chr1	89655942	89664517	Q96PP9	0	-	89655942	89664517	255,102,0	1	8575	0	.	GTPase	domain	(Globular).
chr1	89726389	89727965	Q96PP8	0	-	89726389	89727965	255,102,0	1	1576	0	.	Required	for	tetramerization,	but	not	for	dimerization.	Pubmed:22461501
chr1	89730590	89735238	Q96PP8	0	-	89730590	89735238	255,102,0	1	4648	0	.	GTPase	domain	(Globular).
chr1	89730599	89735238	Q96PP8	0	-	89730599	89735238	255,102,0	1	4639	0	.	NLRP3-binding.	Pubmed:22461501
chr1	89834110	89847311	Q6ZN66	0	+	89834110	89847311	255,102,0	1	13201	0	.	GTPase	domain	(Globular).
chr1	90460816	90473066	Q5BKZ1	0	+	90460816	90473066	255,102,0	1	12250	0	.	Mediates	transcriptional	activation.
chr1	92174253	92174298	Q03167	0	-	92174253	92174298	255,102,0	1	45	0	.	Interaction	with	TGF-beta	ligand.
chr1	92946172	92946526	Q99684	0	-	92946172	92946526	255,102,0	1	354	0	.	Required	for	interaction	with	RELA.	Pubmed:20547752
chr1	92948984	92949044	Q99684	0	-	92948984	92949044	255,102,0	1	60	0	.	SNAG	domain.
chr1	92979215	93101779	O60447	0	-	92979215	93101779	255,102,0	1	122564	0	.	Interaction	with	AURKB	and	INCENP.	Pubmed:16764853
chr1	92979215	93159858	O60447	0	-	92979215	93159858	255,102,0	1	180643	0	.	Targeting	to	the	centrosomes.
chr1	93029237	93170201	O60447	0	-	93029237	93170201	255,102,0	1	140964	0	.	Dimerization.
chr1	93101788	93257951	O60447	0	-	93101788	93257951	255,102,0	1	156163	0	.	Interaction	with	alpha-tubulin,	gamma-tubulin,	BIRC5	and	FBXO5.	Pubmed:16439210,	Pubmed:16764853
chr1	93998571	94014937	Q5T0N5	0	+	93998571	94014937	255,102,0	1	16366	0	.	Interaction	with	CDC42.
chr1	94014895	94017970	Q5T0N5	0	+	94014895	94017970	255,102,0	1	3075	0	.	Interaction	with	DNM1.	Pubmed:16326391
chr1	94014952	94016643	Q5T0N5	0	+	94014952	94016643	255,102,0	1	1691	0	.	Interaction	with	DNM2	and	WASL.	Pubmed:16418535
chr1	94014952	94017970	Q5T0N5	0	+	94014952	94017970	255,102,0	1	3018	0	.	Interaction	with	DAAM1,	DIAPH1	and	DIAPH2.	Pubmed:16630611
chr1	94338761	94341849	Q5QJE6	0	-	94338761	94341849	255,102,0	1	3088	0	.	TdBR	region;	mediates	interaction	with	DNTT.
chr1	94639427	94639439	Q52LW3	0	-	94639427	94639439	255,102,0	1	12	0	.	Interaction	with	PTPN13/PTPL1.	Pubmed:9305890
chr1	94884037	94939358	P28288	0	+	94884037	94939358	255,102,0	1	55321	0	.	Targeting	to	peroxisomes.
chr1	94884037	94941263	P28288	0	+	94884037	94941263	255,102,0	1	57226	0	.	Interaction	with	PEX19.
chr1	95699822	95699831	Q9Y3V2	0	+	95699822	95699831	255,102,0	1	9	0	.	Interaction	with	UBE2I/UBC9.	Pubmed:25918163
chr1	95709978	95709987	Q9Y3V2	0	+	95709978	95709987	255,102,0	1	9	0	.	Interaction	with	UBE2I/UBC9.	Pubmed:25918163
chr1	97770902	97770908	Q12882	0	-	97770902	97770908	255,102,0	1	6	0	.	Substrate	binding.
chr1	97839164	97839173	Q12882	0	-	97839164	97839173	255,102,0	1	9	0	.	Substrate	binding.
chr1	100818528	100908519	Q9UNH5	0	+	100818528	100908519	255,102,0	1	89991	0	.	A.
chr1	100908519	100920969	Q9UNH5	0	+	100908519	100920969	255,102,0	1	12450	0	.	Linker.
chr1	100920969	100949899	Q9UNH5	0	+	100920969	100949899	255,102,0	1	28930	0	.	B.
chr1	101339611	101339653	Q9UBQ6	0	-	101339611	101339653	255,102,0	1	42	0	.	Substrate	binding.
chr1	101339755	101339770	Q9UBQ6	0	-	101339755	101339770	255,102,0	1	15	0	.	Substrate	binding.
chr1	101342397	101342406	Q9UBQ6	0	-	101342397	101342406	255,102,0	1	9	0	.	Substrate	binding.
chr1	101343062	101343080	Q9UBQ6	0	-	101343062	101343080	255,102,0	1	18	0	.	Substrate	binding.
chr1	101377763	101379361	Q8NEW0	0	+	101377763	101379361	255,102,0	1	1598	0	.	His-rich	loop.
chr1	101479295	101479301	Q9H2P9	0	-	101479295	101479301	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr1	101704897	101704903	P21453	0	+	101704897	101704903	255,102,0	1	6	0	.	Sphingosine	1-phosphate	binding.
chr1	101705332	101705347	P21453	0	+	101705332	101705347	255,102,0	1	15	0	.	Sphingosine	1-phosphate	binding.
chr1	103352531	103352594	P12107	0	-	103352531	103352594	255,102,0	1	63	0	.	Nonhelical	region	(C-terminal).
chr1	103352594	103478013	P12107	0	-	103352594	103478013	255,102,0	1	125419	0	.	Triple-helical	region.
chr1	103478013	103480105	P12107	0	-	103478013	103480105	255,102,0	1	2092	0	.	Telopeptide.
chr1	103480105	103480114	P12107	0	-	103480105	103480114	255,102,0	1	9	0	.	Short	nonhelical	segment.
chr1	103480114	103487313	P12107	0	-	103480114	103487313	255,102,0	1	7199	0	.	Triple-helical	region	(interrupted).
chr1	103487313	103496764	P12107	0	-	103487313	103496764	255,102,0	1	9451	0	.	Nonhelical	region.
chr1	104068692	104083975	Q96LT9	0	+	104068692	104083975	255,102,0	1	15283	0	.	Necessary	for	interaction	with	PDCD7.	Pubmed:16096647
chr1	104079969	104087657	Q96LT9	0	+	104079969	104087657	255,102,0	1	7688	0	.	Necessary	for	binding	to	m(7)G-capped	U12	snRNA.
chr1	107691452	107866930	Q9Y2I2	0	+	107691452	107866930	255,102,0	1	175478	0	.	NGL	discriminant	loop	I.
chr1	107867278	107867299	Q9Y2I2	0	+	107867278	107867299	255,102,0	1	21	0	.	NGL	discriminant	loop	II.
chr1	107867473	107867482	Q9Y2I2	0	+	107867473	107867482	255,102,0	1	9	0	.	NGL	discriminant	loop	III.
chr1	108115955	108247199	Q9UKW4	0	-	108115955	108247199	255,102,0	1	131244	0	.	Sufficient	for	interaction	with	ROS1.	Pubmed:11094073
chr1	109289359	109321988	O00186	0	+	109289359	109321988	255,102,0	1	32629	0	.	Mediates	interaction	with	DOC2B.
chr1	109439492	109446755	P81274	0	+	109439492	109446755	255,102,0	1	7263	0	.	Important	for	interaction	with	NUMA1;	INSC	and	FRMPD1.
chr1	109777894	109777903	P49591	0	+	109777894	109777903	255,102,0	1	9	0	.	Serine	binding.
chr1	109823654	109824453	Q6PGN9	0	-	109823654	109824453	255,102,0	1	799	0	.	4	X	4	AA	repeats	of	P-X-X-P.
chr1	109856667	109857316	Q99523	0	-	109856667	109857316	255,102,0	1	649	0	.	Golgi	to	endosome	transport	and	interactions	with	GGA1	and	GGA2.
chr1	109857382	109865744	Q99523	0	-	109857382	109865744	255,102,0	1	8362	0	.	Interactions	with	LRPAP1	and	NGFB.
chr1	109940331	109940367	Q99523	0	-	109940331	109940367	255,102,0	1	36	0	.	Intrachain	binding	of	the	propeptide	and	the	extracellular	domain.
chr1	110171012	110171030	Q01433	0	+	110171012	110171030	255,102,0	1	18	0	.	Substrate	binding.
chr1	110173001	110173013	Q01433	0	+	110173001	110173013	255,102,0	1	12	0	.	Substrate	binding.
chr1	110199029	110199035	Q03013	0	+	110199029	110199035	255,102,0	1	6	0	.	Glutathione	binding.
chr1	110199859	110199874	Q03013	0	+	110199859	110199874	255,102,0	1	15	0	.	Glutathione	binding.
chr1	110199898	110200214	Q03013	0	+	110199898	110200214	255,102,0	1	316	0	.	Glutathione	binding.
chr1	110200247	110200253	Q03013	0	+	110200247	110200253	255,102,0	1	6	0	.	Glutathione	binding.
chr1	110210755	110210761	P28161	0	+	110210755	110210761	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:16549767,	Pubmed:19808963
chr1	110211560	110211572	P28161	0	+	110211560	110211572	255,102,0	1	12	0	.	Glutathione	binding.	Pubmed:16549767,	Pubmed:19808963
chr1	110211608	110211914	P28161	0	+	110211608	110211914	255,102,0	1	306	0	.	Glutathione	binding.	Pubmed:16549767,	Pubmed:19808963
chr1	110211947	110211953	P28161	0	+	110211947	110211953	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:16549767,	Pubmed:19808963
chr1	110230513	110230519	P09488	0	+	110230513	110230519	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:16548513
chr1	110231308	110231320	P09488	0	+	110231308	110231320	255,102,0	1	12	0	.	Glutathione	binding.	Pubmed:16548513
chr1	110231356	110231672	P09488	0	+	110231356	110231672	255,102,0	1	316	0	.	Glutathione	binding.	Pubmed:16548513
chr1	110231705	110231711	P09488	0	+	110231705	110231711	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:16548513
chr1	110254952	110254958	P46439	0	+	110254952	110254958	255,102,0	1	6	0	.	Glutathione	binding.
chr1	110255763	110255778	P46439	0	+	110255763	110255778	255,102,0	1	15	0	.	Glutathione	binding.
chr1	110255802	110256108	P46439	0	+	110255802	110256108	255,102,0	1	306	0	.	Glutathione	binding.
chr1	110256141	110256147	P46439	0	+	110256141	110256147	255,102,0	1	6	0	.	Glutathione	binding.
chr1	110280946	110280952	P21266	0	-	110280946	110280952	255,102,0	1	6	0	.	Glutathione	binding.
chr1	110280985	110282053	P21266	0	-	110280985	110282053	255,102,0	1	1068	0	.	Glutathione	binding.
chr1	110282077	110282092	P21266	0	-	110282077	110282092	255,102,0	1	15	0	.	Glutathione	binding.
chr1	110282873	110282879	P21266	0	-	110282873	110282879	255,102,0	1	6	0	.	Glutathione	binding.
chr1	110466458	110466521	P09603	0	+	110466458	110466521	255,102,0	1	63	0	.	O-glycosylated	at	one	site.
chr1	110551727	110553879	O43865	0	+	110551727	110553879	255,102,0	1	2152	0	.	PEST.	Pubmed:25237103
chr1	110559023	110561699	O43865	0	+	110559023	110561699	255,102,0	1	2676	0	.	NAD	binding.
chr1	110563444	110564299	O43865	0	+	110563444	110564299	255,102,0	1	855	0	.	PDZ-binding.
chr1	110754121	110754205	Q03721	0	+	110754121	110754205	255,102,0	1	84	0	.	Inactivation	gate.
chr1	111146429	111146471	P16389	0	-	111146429	111146471	255,102,0	1	42	0	.	S4-S5	linker.
chr1	111147029	111147404	P16389	0	-	111147029	111147404	255,102,0	1	375	0	.	Tetramerization	domain.
chr1	111854963	111854969	Q9BZP6	0	+	111854963	111854969	255,102,0	1	6	0	.	Chitooligosaccharide	binding.
chr1	111857192	111857204	Q9BZP6	0	+	111857192	111857204	255,102,0	1	12	0	.	Chitooligosaccharide	binding.
chr1	111860629	111860641	Q9BZP6	0	+	111860629	111860641	255,102,0	1	12	0	.	Chitooligosaccharide	binding.
chr1	112269943	112270075	Q9NTI7	0	-	112269943	112270075	255,102,0	1	132	0	.	Inka	box.
chr1	112308411	112308690	Q9UHI6	0	+	112308411	112308690	255,102,0	1	279	0	.	SMN	interacting.
chr1	112322846	112322894	Q9UK17	0	-	112322846	112322894	255,102,0	1	48	0	.	Mediates	dendritic	targeting.
chr1	112525288	112525345	Q9UK17	0	-	112525288	112525345	255,102,0	1	57	0	.	Interaction	with	KCNIP2.
chr1	113242566	113242937	Q9HCE1	0	+	113242566	113242937	255,102,0	1	371	0	.	Interaction	with	AGO2	and	APOBEC3G.	Pubmed:22791714
chr1	114511151	114515780	Q86Z02	0	+	114511151	114515780	255,102,0	1	4629	0	.	Interaction	with	TP53.	Pubmed:12702766
chr1	114511169	114512800	Q86Z02	0	+	114511169	114512800	255,102,0	1	1631	0	.	Required	for	localization	to	nuclear	speckles.
chr1	114511202	114512584	Q86Z02	0	+	114511202	114512584	255,102,0	1	1382	0	.	SUMO	interaction	motifs	(SIM);	required	for	nuclear	localization	and	kinase	activity.
chr1	114636410	114640420	Q5T7P8	0	-	114636410	114640420	255,102,0	1	4010	0	.	Necessary	for	cell	membrane	association	(isoform	2).
chr1	114696280	114696361	Q5T7P8	0	-	114696280	114696361	255,102,0	1	81	0	.	Cysteine	motif.
chr1	114970468	115005754	Q9UPN9	0	-	114970468	115005754	255,102,0	1	35286	0	.	Necessary	for	oligomerization.
chr1	115053256	115053697	Q9UPN9	0	-	115053256	115053697	255,102,0	1	441	0	.	Necessary	for	E3	ubiquitin-protein	ligase	activity	and	repression	of	SMAD4	signaling	and	transcriptional	repression.
chr1	115216544	115216556	P23109	0	-	115216544	115216556	255,102,0	1	12	0	.	Substrate	binding.
chr1	115220617	115220635	P23109	0	-	115220617	115220635	255,102,0	1	18	0	.	Substrate	binding.
chr1	115251170	115251230	P01111	0	-	115251170	115251230	255,102,0	1	60	0	.	Hypervariable	region.
chr1	116929969	116929978	P05023	0	+	116929969	116929978	255,102,0	1	9	0	.	Phosphoinositide-3	kinase	binding.
chr1	117297371	117297416	P06729	0	+	117297371	117297416	255,102,0	1	45	0	.	LFA-3	(CD58)	binding	region	1.
chr1	117297506	117297551	P06729	0	+	117297506	117297551	255,102,0	1	45	0	.	LFA-3	(CD58)	binding	region	2.
chr1	120337306	120341126	Q9BYZ8	0	-	120337306	120341126	255,102,0	1	3820	0	.	Carbohydrate-binding.
chr1	120341219	120342359	Q9BYZ8	0	-	120341219	120342359	255,102,0	1	1140	0	.	Carbohydrate-binding.
chr1	120436631	120436766	Q9UKF2	0	-	120436631	120436766	255,102,0	1	135	0	.	5	X	9	AA	approximate	repeats.
chr1	120465040	120468166	Q04721	0	-	120465040	120468166	255,102,0	1	3126	0	.	Negative	regulatory	region	(NRR).
chr1	145584196	145584229	Q9Y6X2	0	+	145584196	145584229	255,102,0	1	33	0	.	SUMO1-binding.
chr1	145522769	145522916	O96011	0	+	145522769	145522916	255,102,0	1	147	0	.	Interaction	with	PEX19,	PEX11G	and	FIS1	and	peroxisome	targeting.	Pubmed:10704444,	Pubmed:20826455
chr1	147086383	147087657	O00512	0	+	147086383	147087657	255,102,0	1	1273	0	.	Interaction	with	PYGO1.
chr1	147091032	147091083	O00512	0	+	147091032	147091083	255,102,0	1	51	0	.	Interaction	with	CTNNB1.	Pubmed:17052462
chr1	149762881	149762944	P12314	0	+	149762881	149762944	255,102,0	1	63	0	.	Interaction	with	EPB41L2.	Pubmed:18023480
chr1	149885221	149885392	Q7L0J3	0	-	149885221	149885392	255,102,0	1	171	0	.	Interaction	with	SYT1.
chr1	149937726	149937747	Q6GQQ9	0	-	149937726	149937747	255,102,0	1	21	0	.	Regulatory	loop.	Pubmed:27732584
chr1	150129182	150131067	Q53GL0	0	+	150129182	150131067	255,102,0	1	1884	0	.	Interaction	with	capping	proteins	(CPs).
chr1	150129191	150131412	Q53GL0	0	+	150129191	150131412	255,102,0	1	2220	0	.	Interaction	with	ATM,	CKIP,	IFP35	and	NMI.	Pubmed:17197158,	Pubmed:16325375
chr1	150131409	150131715	Q53GL0	0	+	150131409	150131715	255,102,0	1	306	0	.	Negative	regulator	of	AP-1	activity.
chr1	150235526	150235532	Q9ULX7	0	+	150235526	150235532	255,102,0	1	6	0	.	Substrate	binding.
chr1	150312916	150318503	O43395	0	+	150312916	150318503	255,102,0	1	5587	0	.	Mediates	interaction	with	SART3.	Pubmed:15314151
chr1	150483413	150484959	Q16610	0	+	150483413	150484959	255,102,0	1	1546	0	.	2	X	approximate	repeats.
chr1	150551481	150551697	Q07820	0	-	150551481	150551697	255,102,0	1	216	0	.	PEST-like.
chr1	150621093	150621129	Q9H4A5	0	-	150621093	150621129	255,102,0	1	36	0	.	Beta-hairpin	required	for	oligomerization.
chr1	150931759	150931768	Q15047	0	+	150931759	150931768	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr1	150936214	150936473	Q15047	0	+	150936214	150936473	255,102,0	1	259	0	.	S-adenosyl-L-methionine	binding.
chr1	150970150	150970569	Q8N5J2	0	-	150970150	150970569	255,102,0	1	419	0	.	Ubiquitin-binding	domain	(UBD).	Pubmed:27292798
chr1	151006524	151006608	Q86TP1	0	+	151006524	151006608	255,102,0	1	84	0	.	Essential	for	homodimerization.
chr1	151027584	151027602	Q9NRR8	0	-	151027584	151027602	255,102,0	1	18	0	.	Mediates	phosphoinositide-binding.
chr1	151140782	151141558	Q9BWG6	0	+	151140782	151141558	255,102,0	1	776	0	.	Required	for	interaction	with	LUC7L2.
chr1	151238019	151238806	P55036	0	+	151238019	151238806	255,102,0	1	787	0	.	Interaction	with	UBQLN1.	Pubmed:15147878
chr1	151238076	151238485	P55036	0	+	151238076	151238485	255,102,0	1	409	0	.	Essential	for	ubiquitin-binding.
chr1	151238878	151238893	P55036	0	+	151238878	151238893	255,102,0	1	15	0	.	Essential	for	ubiquitin-binding.
chr1	151317286	151318724	P48382	0	-	151317286	151318724	255,102,0	1	1438	0	.	N-terminal	domain.
chr1	151317616	151317631	P48382	0	-	151317616	151317631	255,102,0	1	15	0	.	Leucine-rich	region;	critical	for	dimer	formation	and	for	interaction	with	RFXAP.
chr1	151379102	151379715	Q7Z3K3	0	-	151379102	151379715	255,102,0	1	613	0	.	Required	for	interaction	with	CBX5.
chr1	151634656	151641048	Q96L92	0	+	151634656	151641048	255,102,0	1	6392	0	.	FERM-like	region	F1.
chr1	151641078	151664934	Q96L92	0	+	151641078	151664934	255,102,0	1	23856	0	.	FERM-like	region	F2.
chr1	151664943	151665956	Q96L92	0	+	151664943	151665956	255,102,0	1	1013	0	.	FERM-like	region	F3.
chr1	151779950	151787395	P51449	0	-	151779950	151787395	255,102,0	1	7445	0	.	Ligand-binding.
chr1	151787395	151789149	P51449	0	-	151787395	151789149	255,102,0	1	1754	0	.	Hinge.
chr1	151789736	151804240	P51449	0	-	151789736	151804240	255,102,0	1	14504	0	.	Modulating.
chr1	151849537	151849543	Q5T1C6	0	-	151849537	151849543	255,102,0	1	6	0	.	Substrate	binding.
chr1	151955719	151955755	P60903	0	-	151955719	151955755	255,102,0	1	36	0	.	Ancestral	calcium	site.
chr1	152080010	152081819	Q07283	0	-	152080010	152081819	255,102,0	1	1809	0	.	23	X	26	AA	approximate	tandem	repeats.
chr1	152082080	152082977	Q07283	0	-	152082080	152082977	255,102,0	1	897	0	.	10	X	30	AA	tandem	repeats.
chr1	152083643	152084420	Q07283	0	-	152083643	152084420	255,102,0	1	777	0	.	9	X	28	AA	approximate	tandem	repeats.
chr1	152084417	152084561	Q07283	0	-	152084417	152084561	255,102,0	1	144	0	.	8	X	6	AA	tandem	repeats	of	R-R-E-Q-Q-L.
chr1	152084561	152084753	Q07283	0	-	152084561	152084753	255,102,0	1	192	0	.	5	X	13	AA	tandem	repeats	of	R-R-E-Q-E-E-E-R-R-E-Q-Q-L.
chr1	152085419	152086556	Q07283	0	-	152085419	152086556	255,102,0	1	1137	0	.	S-100-like.
chr1	152129301	152130365	Q6XPR3	0	-	152129301	152130365	255,102,0	1	1064	0	.	S-100-like.
chr1	152193861	152195729	Q86YZ3	0	-	152193861	152195729	255,102,0	1	1868	0	.	S-100-like.
chr1	152330018	152331360	Q5D862	0	-	152330018	152331360	255,102,0	1	1342	0	.	S-100-like.
chr1	152856913	152857102	P49901	0	+	152856913	152857102	255,102,0	1	189	0	.	7	X	7	(OR	8)	AA	approximate	repeats.
chr1	152882729	152883899	P07476	0	+	152882729	152883899	255,102,0	1	1170	0	.	39	X	10	AA	approximate	tandem	repeats	of	[LP]-[EKG]-[LHVYQEK]-[PLSQE]-[EQDV]-[QHEKRGA]-Q-[EMVQLP]-[GKLE]-[QHVNLD].
chr1	152957712	152957793	P35321	0	+	152957712	152957793	255,102,0	1	81	0	.	2	X	12	AA	approximate	repeats.
chr1	152957796	152957940	P35321	0	+	152957796	152957940	255,102,0	1	144	0	.	6	X	8	AA	approximate	tandem	repeats.
chr1	152975622	152975958	Q9UBC9	0	+	152975622	152975958	255,102,0	1	336	0	.	14	X	8	AA	approximate	tandem	repeats.
chr1	153004827	153004908	P22528	0	+	153004827	153004908	255,102,0	1	81	0	.	2	X	12	AA	approximate	repeats.
chr1	153004911	153005055	P22528	0	+	153004911	153005055	255,102,0	1	144	0	.	6	X	8	AA	approximate	tandem	repeats.
chr1	153012681	153012762	P22532	0	-	153012681	153012762	255,102,0	1	81	0	.	3	X	9	AA	tandem	repeats	of	P-K-C-P-[EQ]-P-C-P-[PS].
chr1	153029070	153029151	P35326	0	-	153029070	153029151	255,102,0	1	81	0	.	3	X	9	AA	tandem	repeats	of	P-K-C-P-[EQ]-P-C-P-P.
chr1	153043174	153043255	P35325	0	-	153043174	153043255	255,102,0	1	81	0	.	3	X	9	AA	tandem	repeats	of	P-K-C-P-[EQ]-P-C-P-P.
chr1	153066086	153066167	P22531	0	-	153066086	153066167	255,102,0	1	81	0	.	3	X	9	AA	tandem	repeats	of	P-K-C-P-[EQ]-P-C-P-P.
chr1	153085068	153085149	Q96RM1	0	-	153085068	153085149	255,102,0	1	81	0	.	3	X	9	AA	tandem	repeats	of	[PS]-K-C-P-[EQ]-[PS]-C-P-P.
chr1	153122445	153122526	Q9BYE4	0	-	153122445	153122526	255,102,0	1	81	0	.	3	X	9	AA	approximate	tandem	repeats.
chr1	153271628	153271646	Q96LB9	0	-	153271628	153271646	255,102,0	1	18	0	.	Interaction	with	murein.
chr1	153303302	153303308	Q96LB8	0	-	153303302	153303308	255,102,0	1	6	0	.	Interaction	with	murein.
chr1	153309693	153309723	Q96LB8	0	-	153309693	153309723	255,102,0	1	30	0	.	Interaction	with	murein.
chr1	153346422	153346957	P80511	0	-	153346422	153346957	255,102,0	1	535	0	.	Hinge	domain.
chr1	153615755	153617616	Q9Y3Y2	0	+	153615755	153617616	255,102,0	1	1861	0	.	Interaction	with	PRMT1.
chr1	153631979	153633774	O95295	0	+	153631979	153633774	255,102,0	1	1795	0	.	Interaction	with	TOR1A.
chr1	153784587	153788947	Q8WXI9	0	-	153784587	153788947	255,102,0	1	4360	0	.	CR2;	histone	tail-binding.
chr1	153791278	153791371	Q8WXI9	0	-	153791278	153791371	255,102,0	1	93	0	.	CR1;	MBD2-	and	MBD3-binding.
chr1	153801818	153806178	Q8WXI9	0	-	153801818	153806178	255,102,0	1	4360	0	.	CR2;	histone	tail-binding.
chr1	153808509	153808602	Q8WXI9	0	-	153808509	153808602	255,102,0	1	93	0	.	CR1;	MBD2-	and	MBD3-binding.
chr1	153932975	153932981	Q9NY26	0	-	153932975	153932981	255,102,0	1	6	0	.	Heavy	metals	binding.
chr1	153945465	153945555	Q8TEY5	0	+	153945465	153945555	255,102,0	1	90	0	.	Basic	motif.
chr1	153945701	153945883	Q8TEY5	0	+	153945701	153945883	255,102,0	1	182	0	.	Leucine-zipper.
chr1	154245202	154245881	O00165	0	+	154245202	154245881	255,102,0	1	679	0	.	Required	for	localization	in	mitochondria.
chr1	154246272	154248174	O00165	0	+	154246272	154248174	255,102,0	1	1902	0	.	Involved	in	HCLS1	binding.
chr1	154247443	154247691	O00165	0	+	154247443	154247691	255,102,0	1	248	0	.	Involved	in	CASP9	binding.
chr1	154247446	154247946	O00165	0	+	154247446	154247946	255,102,0	1	500	0	.	Involved	in	GNA13	binding.
chr1	154247467	154248174	O00165	0	+	154247467	154248174	255,102,0	1	707	0	.	Required	for	localization	in	sarcoplasmic	reticulum.
chr1	154247470	154248174	O00165	0	+	154247470	154248174	255,102,0	1	704	0	.	Involved	in	PKD2	binding.
chr1	154247679	154247880	O00165	0	+	154247679	154247880	255,102,0	1	201	0	.	Involved	in	PLN	binding.
chr1	154247679	154247940	O00165	0	+	154247679	154247940	255,102,0	1	261	0	.	Involved	in	ATP2A2	binding.
chr1	154248144	154248174	O00165	0	+	154248144	154248174	255,102,0	1	30	0	.	Required	for	ITGB6	binding.
chr1	154938180	154938959	P29353	0	-	154938180	154938959	255,102,0	1	779	0	.	CH1.
chr1	154956509	154960823	Q8NFF5	0	+	154956509	154960823	255,102,0	1	4314	0	.	Molybdenum	cofactor	biosynthesis	protein-like.
chr1	154962109	154965414	Q8NFF5	0	+	154962109	154965414	255,102,0	1	3305	0	.	FAD	synthase.
chr1	155110454	155110754	Q9BRV3	0	+	155110454	155110754	255,102,0	1	300	0	.	Mediates	interaction	with	TRPV2.
chr1	155247516	155247654	Q9P1Z3	0	+	155247516	155247654	255,102,0	1	138	0	.	Involved	in	subunit	assembly.
chr1	155260395	155260413	P30613	0	-	155260395	155260413	255,102,0	1	18	0	.	Allosteric	activator	binding.	Pubmed:11960989
chr1	155261724	155262981	P30613	0	-	155261724	155262981	255,102,0	1	1257	0	.	Allosteric	activator	binding.	Pubmed:11960989
chr1	155262920	155263058	Q9P1Z3	0	+	155262920	155263058	255,102,0	1	138	0	.	Involved	in	subunit	assembly.
chr1	155275799	155275817	P30613	0	-	155275799	155275817	255,102,0	1	18	0	.	Allosteric	activator	binding.	Pubmed:11960989
chr1	155277128	155278385	P30613	0	-	155277128	155278385	255,102,0	1	1257	0	.	Allosteric	activator	binding.	Pubmed:11960989
chr1	155294685	155295464	Q9BVN2	0	+	155294685	155295464	255,102,0	1	779	0	.	Interaction	with	TRAF6.	Pubmed:19365808
chr1	155295655	155296525	Q9BVN2	0	+	155295655	155296525	255,102,0	1	870	0	.	Interaction	with	IKBKG.	Pubmed:19365808
chr1	155327486	155348327	Q9NR48	0	-	155327486	155348327	255,102,0	1	20841	0	.	Catalytic	domain.
chr1	155735246	155753871	Q3T8J9	0	-	155735246	155753871	255,102,0	1	18625	0	.	Required	for	interaction	with	YY1,	SIN3A	AND	HDAC1,	and	transcriptional	repression	activity.
chr1	155935190	155935501	Q92974	0	-	155935190	155935501	255,102,0	1	311	0	.	Interaction	with	DYNLT1.
chr1	156025153	156025195	Q9Y2Q5	0	+	156025153	156025195	255,102,0	1	42	0	.	Required	for	location	at	endosomes.
chr1	156084709	156084808	P02545	0	+	156084709	156084808	255,102,0	1	99	0	.	Head.
chr1	156084709	156100441	P02545	0	+	156084709	156100441	255,102,0	1	15732	0	.	Interaction	with	MLIP.	Pubmed:21498514
chr1	156084808	156084919	P02545	0	+	156084808	156084919	255,102,0	1	111	0	.	Coil	1A.
chr1	156084808	156105904	P02545	0	+	156084808	156105904	255,102,0	1	21096	0	.	Rod.
chr1	156084919	156084949	P02545	0	+	156084919	156084949	255,102,0	1	30	0	.	Linker	1.
chr1	156084949	156104610	P02545	0	+	156084949	156104610	255,102,0	1	19661	0	.	Coil	1B.
chr1	156104610	156104682	P02545	0	+	156104610	156104682	255,102,0	1	72	0	.	Linker	2.
chr1	156104682	156105904	P02545	0	+	156104682	156105904	255,102,0	1	1222	0	.	Coil	2.
chr1	156105904	156108894	P02545	0	+	156105904	156108894	255,102,0	1	2990	0	.	Tail.
chr1	156268575	156268821	Q6RSH7	0	-	156268575	156268821	255,102,0	1	246	0	.	Beta-domain.
chr1	156446285	156446306	Q14814	0	-	156446285	156446306	255,102,0	1	21	0	.	Beta	domain.
chr1	156562219	156562234	Q8NCW5	0	+	156562219	156562234	255,102,0	1	15	0	.	NAD(P)HX.
chr1	156563247	156563268	Q8NCW5	0	+	156563247	156563268	255,102,0	1	21	0	.	NAD(P)HX.
chr1	156622299	156622332	Q96GW7	0	+	156622299	156622332	255,102,0	1	33	0	.	O-glycosylated	at	two	sites.
chr1	156622359	156622377	Q96GW7	0	+	156622359	156622377	255,102,0	1	18	0	.	O-glycosylated	at	two	sites.
chr1	156622446	156622467	Q96GW7	0	+	156622446	156622467	255,102,0	1	21	0	.	O-glycosylated	at	one	site.
chr1	156639116	156643288	P48681	0	-	156639116	156643288	255,102,0	1	4172	0	.	Tail.
chr1	156643288	156646471	P48681	0	-	156643288	156646471	255,102,0	1	3183	0	.	Coil	2B.
chr1	156643288	156647035	P48681	0	-	156643288	156647035	255,102,0	1	3747	0	.	Rod.
chr1	156646471	156646480	P48681	0	-	156646471	156646480	255,102,0	1	9	0	.	Linker	2.
chr1	156646480	156646537	P48681	0	-	156646480	156646537	255,102,0	1	57	0	.	Coil	2A.
chr1	156646537	156646603	P48681	0	-	156646537	156646603	255,102,0	1	66	0	.	Linker	12.
chr1	156646603	156646891	P48681	0	-	156646603	156646891	255,102,0	1	288	0	.	Coil	1B.
chr1	156646891	156646927	P48681	0	-	156646891	156646927	255,102,0	1	36	0	.	Linker	1.
chr1	156646927	156647035	P48681	0	-	156646927	156647035	255,102,0	1	108	0	.	Coil	1A.
chr1	156647035	156647056	P48681	0	-	156647035	156647056	255,102,0	1	21	0	.	Head.
chr1	156669829	156669838	P29373	0	-	156669829	156669838	255,102,0	1	9	0	.	Retinoic	acid	binding.
chr1	156737563	156737863	Q92733	0	+	156737563	156737863	255,102,0	1	300	0	.	Mediates	interaction	with	MAD2L2.	Pubmed:11717438
chr1	156845361	156845427	P04629	0	+	156845361	156845427	255,102,0	1	66	0	.	Interaction	with	SQSTM1.
chr1	158151997	158152009	P15813	0	+	158151997	158152009	255,102,0	1	12	0	.	Glycolipid	binding.	Pubmed:16007090,	Pubmed:17581592
chr1	158225082	158225097	P06126	0	+	158225082	158225097	255,102,0	1	15	0	.	Glycolipid	binding.	Pubmed:12833155
chr1	158988042	159002331	Q16666	0	+	158988042	159002331	255,102,0	1	14289	0	.	Interaction	with	TP53	C-terminus.
chr1	159021513	159024631	Q16666	0	+	159021513	159024631	255,102,0	1	3118	0	.	Interaction	with	TP53	core	domain.
chr1	160093062	160093071	P50993	0	+	160093062	160093071	255,102,0	1	9	0	.	Interaction	with	phosphoinositide-3	kinase.
chr1	160124894	160124903	Q13733	0	+	160124894	160124903	255,102,0	1	9	0	.	Interaction	with	phosphoinositide-3	kinase.
chr1	160183018	160183048	Q15121	0	+	160183018	160183048	255,102,0	1	30	0	.	Microtubule-binding.
chr1	160183246	160183270	Q15121	0	+	160183246	160183270	255,102,0	1	24	0	.	Microtubule-binding.
chr1	160252806	160254911	P40855	0	-	160252806	160254911	255,102,0	1	2105	0	.	Necessary	for	PEX19	function	on	peroxisome	biogenesis.
chr1	160253331	160254911	P40855	0	-	160253331	160254911	255,102,0	1	1580	0	.	Docking	to	the	peroxisome	membrane	and	binding	to	PEX3.
chr1	160721196	160721990	Q9NQ25	0	+	160721196	160721990	255,102,0	1	794	0	.	Interaction	with	FYN	when	phosphorylated	at	Tyr-284.
chr1	160849100	160849106	Q8WWA0	0	-	160849100	160849106	255,102,0	1	6	0	.	Carbohydrate	binding.	Pubmed:26148048
chr1	160917718	160917724	Q8WWU7	0	-	160917718	160917724	255,102,0	1	6	0	.	Carbohydrate	binding.
chr1	161009766	161010024	P22415	0	-	161009766	161010024	255,102,0	1	258	0	.	Leucine-zipper.
chr1	161142045	161142054	O60512	0	-	161142045	161142054	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr1	161143408	161143420	O60512	0	-	161143408	161143420	255,102,0	1	12	0	.	N-acetyl-D-glucosamine	binding.
chr1	161143737	161143743	O60512	0	-	161143737	161143743	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr1	161143815	161143824	O60512	0	-	161143815	161143824	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr1	161144869	161144884	O60512	0	-	161144869	161144884	255,102,0	1	15	0	.	UDP-alpha-D-galactose	binding.
chr1	161160930	161161886	O75173	0	-	161160930	161161886	255,102,0	1	956	0	.	Spacer.
chr1	161192763	161192799	P02652	0	-	161192763	161192799	255,102,0	1	36	0	.	O-glycosylated	at	one	site.
chr1	161198798	161198882	Q969M1	0	+	161198798	161198882	255,102,0	1	84	0	.	Required	for	mitochondrial	targeting.
chr1	161494454	161495612	P17066	0	+	161494454	161495612	255,102,0	1	1158	0	.	Nucleotide-binding	domain	(NBD).
chr1	161495633	161495981	P17066	0	+	161495633	161495981	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr1	161721458	161721476	Q9UNI6	0	+	161721458	161721476	255,102,0	1	18	0	.	Substrate	binding.	Pubmed:24531476
chr1	161736150	161761293	P18850	0	+	161736150	161761293	255,102,0	1	25143	0	.	Transcription	activation.
chr1	161789434	161789530	P18850	0	+	161789434	161789530	255,102,0	1	96	0	.	Basic	motif.
chr1	161789554	161789578	P18850	0	+	161789554	161789578	255,102,0	1	24	0	.	Leucine-zipper.
chr1	161821593	161882133	P18850	0	+	161821593	161882133	255,102,0	1	60540	0	.	Interaction	with	THBS4.	Pubmed:22682248
chr1	162337215	162337254	O75052	0	+	162337215	162337254	255,102,0	1	39	0	.	Interaction	with	NOS1.
chr1	162546607	162546619	Q16222	0	+	162546607	162546619	255,102,0	1	12	0	.	UTP	binding.
chr1	163295841	163318765	Q9BZD4	0	+	163295841	163318765	255,102,0	1	22924	0	.	Interaction	with	the	N-terminus	of	NDC80.
chr1	163318765	163325256	Q9BZD4	0	+	163318765	163325256	255,102,0	1	6491	0	.	Interaction	with	the	C-terminus	of	NDC80	and	the	SPBC24-SPBC25	subcomplex.
chr1	165370502	165380188	P48443	0	-	165370502	165380188	255,102,0	1	9686	0	.	Ligand-binding.
chr1	165380188	165386287	P48443	0	-	165380188	165386287	255,102,0	1	6099	0	.	Hinge.
chr1	165389134	165414130	P48443	0	-	165389134	165414130	255,102,0	1	24996	0	.	Modulating.
chr1	168165784	168169281	O75663	0	+	168165784	168169281	255,102,0	1	3497	0	.	Interaction	with	PPP2CA.
chr1	168665834	168698205	Q07507	0	-	168665834	168698205	255,102,0	1	32371	0	.	3	X	6	AA	repeats	of	D-R-[EQ]-W-[NQK]-[FY].
chr1	168665834	168698337	Q07507	0	-	168665834	168698337	255,102,0	1	32503	0	.	2	X	53-55	AA	tandem	repeats.
chr1	169099250	169100790	P05026	0	+	169099250	169100790	255,102,0	1	1540	0	.	immunoglobulin-like.
chr1	169356396	169356417	Q9H2G9	0	+	169356396	169356417	255,102,0	1	21	0	.	Essential	for	interaction	with	GORASP2.	Pubmed:11739401
chr1	169509608	169512254	P12259	0	-	169509608	169512254	255,102,0	1	2646	0	.	B.
chr1	169509824	169510775	P12259	0	-	169509824	169510775	255,102,0	1	951	0	.	35	X	9	AA	approximate	tandem	repeats	of	[TNP]-L-S-P-D-L-S-Q-T.
chr1	169511543	169511645	P12259	0	-	169511543	169511645	255,102,0	1	102	0	.	2	X	17	AA	tandem	repeats.
chr1	169822856	169823938	Q8IZE3	0	-	169822856	169823938	255,102,0	1	1082	0	.	Interaction	with	EZR.	Pubmed:12651155
chr1	170135831	170135837	Q5VVY1	0	+	170135831	170135837	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr1	170513885	170521600	Q5T7V8	0	+	170513885	170521600	255,102,0	1	7715	0	.	Necessary	for	interaction	with	RCHY1.	Pubmed:15781263
chr1	173499187	173503673	Q5TAH2	0	-	173499187	173503673	255,102,0	1	4486	0	.	Ion	transport-like.
chr1	173806143	173806155	Q6PI48	0	+	173806143	173806155	255,102,0	1	12	0	.	Aspartate.
chr1	173951936	173952607	Q5TC82	0	-	173951936	173952607	255,102,0	1	671	0	.	ROQ.
chr1	174969319	174975885	Q9HB71	0	+	174969319	174975885	255,102,0	1	6566	0	.	Interaction	with	SIAH1.
chr1	174973950	174979212	Q9HB71	0	+	174973950	174979212	255,102,0	1	5262	0	.	Interaction	with	SKP1.	Pubmed:11389839
chr1	174977771	174979212	Q9HB71	0	+	174977771	174979212	255,102,0	1	1441	0	.	Interaction	with	S100A6.
chr1	175957460	175957469	Q8NHY2	0	-	175957460	175957469	255,102,0	1	9	0	.	Interaction	with	TRIB1.	Pubmed:27041596
chr1	176564063	176659397	Q9BXP8	0	+	176564063	176659397	255,102,0	1	95334	0	.	Metalloprotease.
chr1	177930839	177937017	Q96JE7	0	-	177930839	177937017	255,102,0	1	6178	0	.	Required	for	endoplasmic	reticulum	localization.
chr1	178863102	178885491	Q86X27	0	+	178863102	178885491	255,102,0	1	22389	0	.	Required	for	stimulation	of	nucleotide	exchange	by	RALA.
chr1	179076855	179077344	P42684	0	-	179076855	179077344	255,102,0	1	489	0	.	F-actin-binding.
chr1	179077611	179078322	P42684	0	-	179077611	179078322	255,102,0	1	711	0	.	F-actin-binding.
chr1	179100518	179198529	P42684	0	-	179100518	179198529	255,102,0	1	98011	0	.	CAP.
chr1	179815208	179815913	Q8NFQ8	0	-	179815208	179815913	255,102,0	1	705	0	.	Interaction	with	TOR1A.	Pubmed:23569223
chr1	179886687	179887371	Q5JTV8	0	+	179886687	179887371	255,102,0	1	684	0	.	Interaction	with	TOR1A.
chr1	180471182	180471197	Q9BR61	0	-	180471182	180471197	255,102,0	1	15	0	.	Acyl-CoA	binding.
chr1	180775221	180775245	Q9UBH6	0	+	180775221	180775245	255,102,0	1	24	0	.	Important	for	inositol	polyphosphate	binding.
chr1	181018186	181018447	Q95460	0	+	181018186	181018447	255,102,0	1	261	0	.	Alpha-1.
chr1	181018186	181019421	Q95460	0	+	181018186	181019421	255,102,0	1	1235	0	.	Ligand-binding.
chr1	181019145	181019421	Q95460	0	+	181019145	181019421	255,102,0	1	276	0	.	Alpha-2.
chr1	181021369	181021645	Q95460	0	+	181021369	181021645	255,102,0	1	276	0	.	Alpha-3.
chr1	181022707	181022734	Q95460	0	+	181022707	181022734	255,102,0	1	27	0	.	Connecting	peptide.
chr1	181680153	181684475	Q15878	0	+	181680153	181684475	255,102,0	1	4322	0	.	Binding	to	the	beta	subunit.
chr1	182555116	182555185	Q05823	0	-	182555116	182555185	255,102,0	1	69	0	.	2-5A	binding	(P-loop)	2.
chr1	182555215	182555257	Q05823	0	-	182555215	182555257	255,102,0	1	42	0	.	2-5A	binding	(P-loop)	1.
chr1	182775287	182775293	Q9BXD5	0	+	182775287	182775293	255,102,0	1	6	0	.	Substrate	binding.
chr1	182811701	182827315	Q08211	0	+	182811701	182827315	255,102,0	1	15614	0	.	Interaction	with	CREBBP.	Pubmed:9323138
chr1	182827252	182827942	Q08211	0	+	182827252	182827942	255,102,0	1	690	0	.	Interaction	with	BRCA1.	Pubmed:9662397
chr1	182827957	182828252	Q08211	0	+	182827957	182828252	255,102,0	1	295	0	.	MTAD.
chr1	182853937	182856536	Q08211	0	+	182853937	182856536	255,102,0	1	2599	0	.	NTD.
chr1	183096503	183111922	P11047	0	+	183096503	183111922	255,102,0	1	15419	0	.	Domain	II	and	I.
chr1	183200187	183212532	Q13753	0	+	183200187	183212532	255,102,0	1	12345	0	.	Domain	II	and	I.
chr1	183247699	183247705	Q9BZQ4	0	-	183247699	183247705	255,102,0	1	6	0	.	Substrate	binding.
chr1	183259298	183259310	Q9BZQ4	0	-	183259298	183259310	255,102,0	1	12	0	.	Substrate	binding.
chr1	183262842	183262851	Q9BZQ4	0	-	183262842	183262851	255,102,0	1	9	0	.	Substrate	binding.
chr1	185056688	185067276	Q99496	0	+	185056688	185067276	255,102,0	1	10588	0	.	Interaction	with	HIP2.	Pubmed:11513855
chr1	185270119	185276662	Q9Y6Y0	0	-	185270119	185276662	255,102,0	1	6543	0	.	Sufficient	for	AHR	interaction	and	signaling.
chr1	186301329	186302275	P12270	0	-	186301329	186302275	255,102,0	1	946	0	.	Sufficient	and	essential	for	mediating	its	nuclear	import.
chr1	186310219	186312556	P12270	0	-	186310219	186312556	255,102,0	1	2337	0	.	Necessary	for	interaction	with	HSF1.	Pubmed:17897941
chr1	186326713	186329011	P12270	0	-	186326713	186329011	255,102,0	1	2298	0	.	Necessary	for	association	to	the	NPC.
chr1	186337093	186344121	P12270	0	-	186337093	186344121	255,102,0	1	7028	0	.	Necessary	for	interaction	with	HSF1.	Pubmed:17897941
chr1	186344121	186344154	P12270	0	-	186344121	186344154	255,102,0	1	33	0	.	Sufficient	for	interaction	with	TPR.
chr1	186413113	186413521	P20941	0	-	186413113	186413521	255,102,0	1	408	0	.	Thioredoxin	fold.
chr1	186823486	186880497	P47712	0	+	186823486	186880497	255,102,0	1	57011	0	.	Phospholipid	binding.
chr1	192778294	192779383	P41220	0	+	192778294	192779383	255,102,0	1	1089	0	.	Necessary	for	membrane	association.	Pubmed:11278586
chr1	192779521	192780184	P41220	0	+	192779521	192780184	255,102,0	1	663	0	.	Necessary	to	inhibit	protein	synthesis.	Pubmed:19736320
chr1	192985483	192990235	Q9Y5K5	0	-	192985483	192990235	255,102,0	1	4752	0	.	Interaction	with	ADRM1.
chr1	193038541	193045681	P10155	0	+	193038541	193045681	255,102,0	1	7140	0	.	RNA-binding.
chr1	193046174	193053858	P10155	0	+	193046174	193053858	255,102,0	1	7684	0	.	VWFA-like	domain.
chr1	193111064	193117017	Q6P1J9	0	+	193111064	193117017	255,102,0	1	5953	0	.	Interaction	with	CTNNB1.	Pubmed:16630820
chr1	193111064	193219839	Q6P1J9	0	+	193111064	193219839	255,102,0	1	108775	0	.	Interaction	with	POLR2A	and	PAF1.
chr1	198222169	198222211	Q8TDX7	0	+	198222169	198222211	255,102,0	1	42	0	.	NTE	motif.
chr1	200017859	200080389	O00482	0	+	200017859	200080389	255,102,0	1	62530	0	.	Ligand-binding.
chr1	200089959	200089977	O00482	0	+	200089959	200089977	255,102,0	1	18	0	.	Lipid	binding.
chr1	200522518	200561320	Q15058	0	-	200522518	200561320	255,102,0	1	38802	0	.	Required	for	CIT-binding.
chr1	200569572	200586786	Q15058	0	-	200569572	200586786	255,102,0	1	17214	0	.	Required	for	microtubule-binding	with	high	affinity.
chr1	200586783	200587851	Q15058	0	-	200586783	200587851	255,102,0	1	1068	0	.	Required	for	PRC1-binding.
chr1	200957894	200972728	O75037	0	-	200957894	200972728	255,102,0	1	14834	0	.	Interaction	with	TRIM3.
chr1	201019548	201020216	Q13698	0	-	201019548	201020216	255,102,0	1	668	0	.	Dihydropyridine	binding.
chr1	201019581	201020180	Q13698	0	-	201019581	201020180	255,102,0	1	599	0	.	Phenylalkylamine	binding.
chr1	201030418	201031163	Q13698	0	-	201030418	201031163	255,102,0	1	745	0	.	Dihydropyridine	binding.
chr1	201054591	201054645	Q13698	0	-	201054591	201054645	255,102,0	1	54	0	.	Binding	to	the	beta	subunit.
chr1	201355675	201355882	O00515	0	-	201355675	201355882	255,102,0	1	207	0	.	8	X	SEK	repeats.
chr1	201380586	201380652	P19237	0	-	201380586	201380652	255,102,0	1	66	0	.	Involved	in	binding	TNC	and	actin.
chr1	201383690	201386918	P19237	0	-	201383690	201386918	255,102,0	1	3228	0	.	Involved	in	binding	TNC.
chr1	201868559	201868619	P29536	0	-	201868559	201868619	255,102,0	1	60	0	.	5	X	4	AA	approximate	tandem	repeats.
chr1	201869261	201869648	P29536	0	-	201869261	201869648	255,102,0	1	387	0	.	8	X	approximate	tandem	repeats.
chr1	201966483	201966498	Q9H4A4	0	+	201966483	201966498	255,102,0	1	15	0	.	Substrate	binding.
chr1	202119536	202121674	A0A024R963	0	-	202119536	202121674	255,102,0	1	2138	0	.	Substrate	binding.
chr1	202119536	202121674	A0A024R9A7	0	-	202119536	202121674	255,102,0	1	2138	0	.	Substrate	binding.
chr1	202119536	202121674	J3KR55	0	-	202119536	202121674	255,102,0	1	2138	0	.	Substrate	binding.
chr1	202119536	202121674	P35236	0	-	202119536	202121674	255,102,0	1	2138	0	.	Substrate	binding.
chr1	202127398	202128419	P35236	0	-	202127398	202128419	255,102,0	1	1021	0	.	Interaction	with	MAP	kinases.
chr1	202566007	202572195	Q8N9I0	0	-	202566007	202572195	255,102,0	1	6188	0	.	Phospholipid	binding.
chr1	202861663	202863800	Q53G59	0	-	202861663	202863800	255,102,0	1	2137	0	.	Interaction	with	DVL3.	Pubmed:16547521
chr1	203148710	203148930	P36222	0	-	203148710	203148930	255,102,0	1	220	0	.	Important	for	AKT1	activation	and	IL8	production.
chr1	203150379	203150391	P36222	0	-	203150379	203150391	255,102,0	1	12	0	.	Chitooligosaccharide	binding.
chr1	203153717	203153729	P36222	0	-	203153717	203153729	255,102,0	1	12	0	.	Chitooligosaccharide	binding.
chr1	203154355	203154361	P36222	0	-	203154355	203154361	255,102,0	1	6	0	.	Chitooligosaccharide	binding.
chr1	203191419	203191431	Q13231	0	-	203191419	203191431	255,102,0	1	12	0	.	Chitooligosaccharide	binding.
chr1	203194189	203194201	Q13231	0	-	203194189	203194201	255,102,0	1	12	0	.	Chitooligosaccharide	binding.
chr1	203194840	203194846	Q13231	0	-	203194840	203194846	255,102,0	1	6	0	.	Chitooligosaccharide	binding.
chr1	203769245	203769494	P86452	0	+	203769245	203769494	255,102,0	1	249	0	.	HATC	(Hobo-Ac-Tam3)	domain.
chr1	204159665	204159695	Q15726	0	-	204159665	204159695	255,102,0	1	30	0	.	Essential	for	receptor	binding	and	receptor	activation.
chr1	204438036	204438927	O00750	0	-	204438036	204438927	255,102,0	1	891	0	.	Interaction	with	GRB2.	Pubmed:11533253
chr1	204513725	204518333	O15151	0	+	204513725	204518333	255,102,0	1	4608	0	.	Region	II.
chr1	204518513	204518807	O15151	0	+	204518513	204518807	255,102,0	1	294	0	.	Necessary	for	interaction	with	USP2.	Pubmed:19838211
chr1	206653421	206653820	Q14164	0	+	206653421	206653820	255,102,0	1	399	0	.	Leucine-zipper.
chr1	206902189	206902383	P49137	0	+	206902189	206902383	255,102,0	1	194	0	.	Staurosporine	binding.
chr1	206905186	206905952	P49137	0	+	206905186	206905952	255,102,0	1	766	0	.	Autoinhibitory	helix.
chr1	206905955	206906030	P49137	0	+	206905955	206906030	255,102,0	1	75	0	.	p38	MAPK-binding	site.
chr1	207222523	207222541	Q5VVQ6	0	-	207222523	207222541	255,102,0	1	18	0	.	S2	site.	Pubmed:23827681
chr1	207222610	207222625	Q5VVQ6	0	-	207222610	207222625	255,102,0	1	15	0	.	His-loop.	Pubmed:23827681
chr1	207222742	207222775	Q5VVQ6	0	-	207222742	207222775	255,102,0	1	33	0	.	Variable-loop.	Pubmed:23827681
chr1	207222931	207222952	Q5VVQ6	0	-	207222931	207222952	255,102,0	1	21	0	.	Cys-loop.	Pubmed:23827681
chr1	207223027	207224228	Q5VVQ6	0	-	207223027	207224228	255,102,0	1	1201	0	.	UBX-like.	Pubmed:23827681
chr1	207228065	207240955	O60825	0	+	207228065	207240955	255,102,0	1	12890	0	.	6-phosphofructo-2-kinase.
chr1	207240955	207245713	O60825	0	+	207240955	207245713	255,102,0	1	4758	0	.	Fructose-2,6-bisphosphatase.
chr1	209784810	209785172	Q96NX5	0	+	209784810	209785172	255,102,0	1	362	0	.	Autoinhibitory	domain.
chr1	209784870	209785175	Q96NX5	0	+	209784870	209785175	255,102,0	1	305	0	.	Calmodulin-binding.
chr1	209788624	209796434	Q13751	0	-	209788624	209796434	255,102,0	1	7810	0	.	Domain	I.
chr1	209796434	209796852	Q13751	0	-	209796434	209796852	255,102,0	1	418	0	.	Domain	alpha.
chr1	209796852	209799234	Q13751	0	-	209796852	209799234	255,102,0	1	2382	0	.	Domain	II.
chr1	210796965	210796989	Q5VTY9	0	+	210796965	210796989	255,102,0	1	24	0	.	GTP-binding.	Pubmed:11160356
chr1	210856700	210856823	O95259	0	-	210856700	210856823	255,102,0	1	123	0	.	CAD	(involved	in	subunit	assembly).
chr1	210857282	210948785	O95259	0	-	210857282	210948785	255,102,0	1	91503	0	.	Calmodulin-binding.	Pubmed:10880439
chr1	210948698	210948707	O95259	0	-	210948698	210948707	255,102,0	1	9	0	.	Interaction	with	cyclic	nucleotide-binding	pocket.
chr1	211256193	211256229	O95259	0	-	211256193	211256229	255,102,0	1	36	0	.	Required	for	phosphatidylinositol	bisphosphate	binding.	Pubmed:27005320
chr1	211544745	211546041	O00463	0	+	211544745	211546041	255,102,0	1	1296	0	.	Interaction	with	EIF2AK2/PKR.	Pubmed:15121867
chr1	211751480	211751519	Q9Y6M5	0	-	211751480	211751519	255,102,0	1	39	0	.	6	X	2	AA	approximate	repeats	of	H-G.
chr1	211836770	211840574	P51955	0	-	211836770	211840574	255,102,0	1	3804	0	.	Necessary	for	interaction	with	MAD1L1.	Pubmed:14978040
chr1	211836770	211842539	P51955	0	-	211836770	211842539	255,102,0	1	5769	0	.	Intearction	with	CEP85.	Pubmed:26220856
chr1	211836770	211842650	P51955	0	-	211836770	211842650	255,102,0	1	5880	0	.	Interaction	with	PCNT.	Pubmed:20599736
chr1	211836788	211836899	P51955	0	-	211836788	211836899	255,102,0	1	111	0	.	Interaction	with	SAV1	and	STK3/MST2.	Pubmed:21076410
chr1	211840448	211840562	P51955	0	-	211840448	211840562	255,102,0	1	114	0	.	Required	for	microtubule	binding	and	for	localization	to	the	centrosomes.
chr1	211840556	211842524	P51955	0	-	211840556	211842524	255,102,0	1	1968	0	.	Leucine-zipper.
chr1	212791489	212791558	P18847	0	+	212791489	212791558	255,102,0	1	69	0	.	Basic	motif.
chr1	212791567	212792777	P18847	0	+	212791567	212792777	255,102,0	1	1210	0	.	Leucine-zipper.
chr1	212860243	212870311	Q9NR55	0	-	212860243	212870311	255,102,0	1	10068	0	.	Leucine-zipper.
chr1	212870311	212870389	Q9NR55	0	-	212870311	212870389	255,102,0	1	78	0	.	Basic	motif.
chr1	214169878	214169962	Q92786	0	+	214169878	214169962	255,102,0	1	84	0	.	Interaction	with	RORG.
chr1	214178510	214209168	Q92786	0	+	214178510	214209168	255,102,0	1	30658	0	.	Homeo-Prospero.
chr1	214209129	214209150	Q92786	0	+	214209129	214209150	255,102,0	1	21	0	.	Essential	for	nuclear	localization,	interaction	with	RORG,	repression	of	RORG	transcriptional	activator	activity.
chr1	214454645	214454654	Q9NRG4	0	+	214454645	214454654	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr1	214497995	214498004	Q9NRG4	0	+	214497995	214498004	255,102,0	1	9	0	.	Peptide	substrate	binding.
chr1	214500977	214500983	Q9NRG4	0	+	214500977	214500983	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr1	214503576	214503585	Q9NRG4	0	+	214503576	214503585	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr1	214537908	214537929	Q15678	0	-	214537908	214537929	255,102,0	1	21	0	.	Substrate	binding.
chr1	215408266	215408485	O95069	0	+	215408266	215408485	255,102,0	1	219	0	.	Required	for	basal	channel	activity.
chr1	215408338	215408485	O95069	0	+	215408338	215408485	255,102,0	1	147	0	.	Essential	for	chloroform	and	halothane	sensitivity.
chr1	220142150	220160503	P07814	0	-	220142150	220160503	255,102,0	1	18353	0	.	Proline--tRNA	ligase.
chr1	220160548	220160647	P07814	0	-	220160548	220160647	255,102,0	1	99	0	.	Charged.
chr1	220160653	220170588	P07814	0	-	220160653	220170588	255,102,0	1	9935	0	.	3	X	57	AA	approximate	repeats.
chr1	220170588	220205767	P07814	0	-	220170588	220205767	255,102,0	1	35179	0	.	Glutamate--tRNA	ligase.
chr1	220236176	220236188	O95861	0	-	220236176	220236188	255,102,0	1	12	0	.	Substrate	binding.
chr1	220242741	220242753	O95861	0	-	220242741	220242753	255,102,0	1	12	0	.	Substrate	binding.
chr1	221912441	221912492	Q9Y6W6	0	-	221912441	221912492	255,102,0	1	51	0	.	Interaction	with	MAP	kinases.
chr1	222823632	222833323	Q5JRA6	0	+	222823632	222833323	255,102,0	1	9691	0	.	Mediates	interaction	with	CTAGE5.	Pubmed:21525241
chr1	222835662	222838958	Q5JRA6	0	+	222835662	222838958	255,102,0	1	3296	0	.	Proline-rich	domain	(PRD);	mediates	interaction	with	COPII	coat	subunits.	Pubmed:19269366
chr1	222846697	222849561	Q96BJ3	0	-	222846697	222849561	255,102,0	1	2864	0	.	Axin-binding.
chr1	223803845	223807064	A6NHC0	0	-	223803845	223807064	255,102,0	1	3219	0	.	Domain	III.
chr1	223940555	223949295	P17655	0	+	223940555	223949295	255,102,0	1	8740	0	.	Domain	III.
chr1	223949295	223949908	P17655	0	+	223949295	223949908	255,102,0	1	613	0	.	Linker.
chr1	223949908	223962556	P17655	0	+	223949908	223962556	255,102,0	1	12648	0	.	Domain	IV.
chr1	224492823	224517829	O15381	0	-	224492823	224517829	255,102,0	1	25006	0	.	Interaction	with	RPL5.	Pubmed:15469983
chr1	225685488	225688714	Q8N8S7	0	-	225685488	225688714	255,102,0	1	3226	0	.	EVH2	block	C.
chr1	225685488	225702345	Q8N8S7	0	-	225685488	225702345	255,102,0	1	16857	0	.	EVH2.
chr1	225700403	225700613	Q8N8S7	0	-	225700403	225700613	255,102,0	1	210	0	.	EVH2	block	B.
chr1	225700703	225702345	Q8N8S7	0	-	225700703	225702345	255,102,0	1	1642	0	.	EVH2	block	A.
chr1	225707101	225707236	Q8N8S7	0	-	225707101	225707236	255,102,0	1	135	0	.	9	X	5	AA	tandem	repeats	of	[LMQ]-E-[QR]-E-[QR].
chr1	226567313	226570779	P09874	0	-	226567313	226570779	255,102,0	1	3466	0	.	Automodification	domain.
chr1	226829672	226829696	P27987	0	-	226829672	226829696	255,102,0	1	24	0	.	Substrate	binding.
chr1	226829744	226829771	P27987	0	-	226829744	226829771	255,102,0	1	27	0	.	Calmodulin-binding.
chr1	230371787	230379164	Q10471	0	+	230371787	230379164	255,102,0	1	7377	0	.	Catalytic	subdomain	A.
chr1	230385009	230391040	Q10471	0	+	230385009	230391040	255,102,0	1	6031	0	.	Catalytic	subdomain	B.
chr1	230914776	230923312	O14815	0	+	230914776	230923312	255,102,0	1	8536	0	.	Domain	III.
chr1	230923312	230937339	O14815	0	+	230923312	230937339	255,102,0	1	14027	0	.	Domain	IV.
chr1	231556881	231556914	Q9GZT9	0	-	231556881	231556914	255,102,0	1	33	0	.	Beta(2)beta(3)	'finger-like'	loop.	Pubmed:18063574
chr1	231557574	231557619	Q9GZT9	0	-	231557574	231557619	255,102,0	1	45	0	.	Required	for	nuclear	export.
chr1	231673053	231700402	Q99598	0	+	231673053	231700402	255,102,0	1	27349	0	.	Interaction	with	C1D.	Pubmed:11801738
chr1	233490718	233497825	Q5TCX8	0	+	233490718	233497825	255,102,0	1	7107	0	.	Leucine-zipper	1.
chr1	233497864	233497930	Q5TCX8	0	+	233497864	233497930	255,102,0	1	66	0	.	Leucine-zipper	2.
chr1	233750265	233802351	O00180	0	+	233750265	233802351	255,102,0	1	52086	0	.	Selectivity	filter	1.	Pubmed:21653227,	Pubmed:22282804
chr1	233802657	233802675	O00180	0	+	233802657	233802675	255,102,0	1	18	0	.	Selectivity	filter	2.	Pubmed:22282804
chr1	233807141	233807162	O00180	0	+	233807141	233807162	255,102,0	1	21	0	.	Important	for	intracellular	retention	in	recycling	endosomes.	Pubmed:19959478
chr1	234527403	234527433	Q13395	0	-	234527403	234527433	255,102,0	1	30	0	.	S-adenosyl-L-methionine	binding.	Pubmed:18412263
chr1	234528223	234528232	Q13395	0	-	234528223	234528232	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.	Pubmed:18412263
chr1	234742996	234743131	Q7Z5L9	0	-	234742996	234743131	255,102,0	1	135	0	.	Cys-rich.
chr1	235341151	235341175	Q4LE39	0	-	235341151	235341175	255,102,0	1	24	0	.	Antigenic	epitope.
chr1	235383271	235383631	Q4LE39	0	-	235383271	235383631	255,102,0	1	360	0	.	Antigenic	epitope.
chr1	236708155	236708176	O00214	0	+	236708155	236708176	255,102,0	1	21	0	.	Beta-galactoside	binding.
chr1	237038129	237038135	Q99707	0	+	237038129	237038135	255,102,0	1	6	0	.	Cobalamin-binding.
chr1	237060385	237060391	Q99707	0	+	237060385	237060391	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr1	237167489	237167585	P0DM35	0	-	237167489	237167585	255,102,0	1	96	0	.	Alpha.
chr1	237167585	237167672	P0DM35	0	-	237167585	237167672	255,102,0	1	87	0	.	Beta.
chr1	237666748	237838091	Q92736	0	+	237666748	237838091	255,102,0	1	171343	0	.	4	X	approximate	repeats.
chr1	237890401	237890491	Q92736	0	+	237890401	237890491	255,102,0	1	90	0	.	Interaction	with	CALM.	Pubmed:18650434
chr1	240071192	240071207	P20309	0	+	240071192	240071207	255,102,0	1	15	0	.	Agonist	binding.
chr1	240072269	240072341	P20309	0	+	240072269	240072341	255,102,0	1	72	0	.	Agonist	binding.
chr1	240637427	240637451	Q9NZ56	0	+	240637427	240637451	255,102,0	1	24	0	.	Important	for	interaction	with	SPIRE1.
chr1	241672076	241672085	P07954	0	-	241672076	241672085	255,102,0	1	9	0	.	Substrate	binding.
chr1	241675284	241675296	P07954	0	-	241675284	241675296	255,102,0	1	12	0	.	B	site.
chr1	242013727	242016675	Q9UQ84	0	+	242013727	242016675	255,102,0	1	2948	0	.	N-domain.
chr1	242016762	242030251	Q9UQ84	0	+	242016762	242030251	255,102,0	1	13489	0	.	Interaction	with	MSH3.	Pubmed:11427529
chr1	242020652	242021951	Q9UQ84	0	+	242020652	242021951	255,102,0	1	1299	0	.	I-domain.
chr1	242030251	242035536	Q9UQ84	0	+	242030251	242035536	255,102,0	1	5285	0	.	Interaction	with	MLH1.
chr1	242042333	242052899	Q9UQ84	0	+	242042333	242052899	255,102,0	1	10566	0	.	Interaction	with	MSH2.
chr1	242048762	242052899	Q9UQ84	0	+	242048762	242052899	255,102,0	1	4137	0	.	Interaction	with	MLH1.
chr1	243289753	243327925	Q5SW79	0	-	243289753	243327925	255,102,0	1	38172	0	.	Targeting	to	centrosomes.
chr1	243289753	243328705	Q5SW79	0	-	243289753	243328705	255,102,0	1	38952	0	.	Targeting	to	microtubules.
chr1	243456491	243663084	Q86SQ7	0	+	243456491	243663084	255,102,0	1	206593	0	.	Sufficient	for	homodimerization.
chr1	243542145	243663084	Q86SQ7	0	+	243542145	243663084	255,102,0	1	120939	0	.	Mediates	interaction	with	OFD1.	Pubmed:20835237
chr1	244218030	244218384	Q99592	0	+	244218030	244218384	255,102,0	1	354	0	.	Interaction	with	DNMT3A.	Pubmed:11350943
chr1	244580991	244581012	A0A024R5Q7	0	-	244580991	244581012	255,102,0	1	21	0	.	Substrate	binding.
chr1	244580991	244581012	P30520	0	-	244580991	244581012	255,102,0	1	21	0	.	Substrate	binding.
chr1	244601049	244601061	A0A024R5Q7	0	-	244601049	244601061	255,102,0	1	12	0	.	IMP	binding.
chr1	244601049	244601061	P30520	0	-	244601049	244601061	255,102,0	1	12	0	.	IMP	binding.
chr1	244614990	244615002	A0A024R5Q7	0	-	244614990	244615002	255,102,0	1	12	0	.	IMP	binding.
chr1	244614990	244615002	P30520	0	-	244614990	244615002	255,102,0	1	12	0	.	IMP	binding.
chr1	245018860	245019233	Q00839	0	-	245018860	245019233	255,102,0	1	373	0	.	RNA-binding	RGG-box.	Pubmed:1628625
chr1	245912867	246027188	Q9H7B4	0	-	245912867	246027188	255,102,0	1	114321	0	.	C-terminal	domain;	essential	for	histone	methyltransferase	activity,	nuclear	localization	and	mediates	interaction	with	HSP90AA1.	Pubmed:25738358
chr1	246091316	246091322	Q9H7B4	0	-	246091316	246091322	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr1	246670471	246670480	Q9H7B4	0	-	246670471	246670480	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr10	294401	298317	Q15326	0	+	294401	298317	255,102,0	1	3916	0	.	Interaction	with	human	adenovirus	E1A.
chr10	3109787	3155353	Q01813	0	+	3109787	3155353	255,102,0	1	45566	0	.	N-terminal	catalytic	PFK	domain	1.
chr10	3146032	3146041	Q01813	0	+	3146032	3146041	255,102,0	1	9	0	.	Substrate	binding.
chr10	3147334	3147343	Q01813	0	+	3147334	3147343	255,102,0	1	9	0	.	Substrate	binding.
chr10	3150940	3150952	Q01813	0	+	3150940	3150952	255,102,0	1	12	0	.	Substrate	binding.
chr10	3155353	3155572	Q01813	0	+	3155353	3155572	255,102,0	1	219	0	.	Interdomain	linker.
chr10	3155572	3178768	Q01813	0	+	3155572	3178768	255,102,0	1	23196	0	.	C-terminal	regulatory	PFK	domain	2.
chr10	3162164	3162179	Q01813	0	+	3162164	3162179	255,102,0	1	15	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr10	3172073	3172082	Q01813	0	+	3172073	3172082	255,102,0	1	9	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr10	3175494	3175506	Q01813	0	+	3175494	3175506	255,102,0	1	12	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr10	5454655	5471159	Q7Z628	0	+	5454655	5471159	255,102,0	1	16504	0	.	Necessary	for	nuclear	localization.
chr10	6245223	6262732	Q16875	0	+	6245223	6262732	255,102,0	1	17509	0	.	6-phosphofructo-2-kinase.
chr10	6262732	6274902	Q16875	0	+	6262732	6274902	255,102,0	1	12170	0	.	Fructose-2,6-bisphosphatase.
chr10	7780618	7780663	P19823	0	+	7780618	7780663	255,102,0	1	45	0	.	O-glycosylated	at	three	sites.
chr10	7798051	7801954	O60870	0	-	7798051	7801954	255,102,0	1	3903	0	.	C-terminal	subdomain	B.	Pubmed:17045609
chr10	7804435	7805754	O60870	0	-	7804435	7805754	255,102,0	1	1319	0	.	C-terminal	subdomain	A.	Pubmed:17045609
chr10	7820878	7825102	O60870	0	-	7820878	7825102	255,102,0	1	4224	0	.	Winged	helix-turn-helix	(wHTH).
chr10	8106041	8111462	P23771	0	+	8106041	8111462	255,102,0	1	5421	0	.	Flexible	linker.
chr10	11047350	11330409	O95319	0	+	11047350	11330409	255,102,0	1	283059	0	.	Necessary	for	RNA-binding,	TNNT2	exon	5	and	NMDA	R1	exon	21	inclusion.
chr10	11356214	11371013	O95319	0	+	11356214	11371013	255,102,0	1	14799	0	.	Necessary	for	RNA-binding,	TNNT2	exon	5	and	NMDA	R1	exon	21	inclusion.
chr10	11963299	11985092	Q9HAU5	0	-	11963299	11985092	255,102,0	1	21793	0	.	Sufficient	for	interaction	with	UPF1	C-terminus.
chr10	11963299	12001271	Q9HAU5	0	-	11963299	12001271	255,102,0	1	37972	0	.	Sufficient	for	interaction	with	EIF4A1	and	EIF1.	Pubmed:11073994
chr10	11973706	11978591	Q9HAU5	0	-	11973706	11978591	255,102,0	1	4885	0	.	Interaction	with	UPF1.
chr10	11973733	11984729	Q9HAU5	0	-	11973733	11984729	255,102,0	1	10996	0	.	Necessary	for	interaction	with	UPF1.
chr10	11978702	11984729	Q9HAU5	0	-	11978702	11984729	255,102,0	1	6027	0	.	Interaction	with	UPF1.
chr10	11997296	12006061	Q9HAU5	0	-	11997296	12006061	255,102,0	1	8765	0	.	Sufficient	for	interaction	with	UPF3A	and	UPF3B.
chr10	11997503	11998378	Q9HAU5	0	-	11997503	11998378	255,102,0	1	875	0	.	Binds	to	UPF3B.
chr10	12071489	12077143	Q9HAU5	0	-	12071489	12077143	255,102,0	1	5654	0	.	Sufficient	for	interaction	with	UPF1.
chr10	12221121	12221127	Q9UKK9	0	-	12221121	12221127	255,102,0	1	6	0	.	Substrate	binding;	shared	with	dimeric	partner.	Pubmed:21768126,	Pubmed:18462755,	Pubmed:17052728
chr10	12866464	12867607	Q8IU85	0	+	12866464	12867607	255,102,0	1	1143	0	.	Autoinhibitory	domain.
chr10	12866524	12867610	Q8IU85	0	+	12866524	12867610	255,102,0	1	1086	0	.	Calmodulin-binding.
chr10	13206202	13214638	Q7L590	0	+	13206202	13214638	255,102,0	1	8436	0	.	N-terminal	domain.
chr10	13217625	13228229	Q7L590	0	+	13217625	13228229	255,102,0	1	10604	0	.	OB-fold	domain.
chr10	13228229	13230907	Q7L590	0	+	13228229	13230907	255,102,0	1	2678	0	.	Zinc	finger-like	1.
chr10	13243525	13246269	Q7L590	0	+	13243525	13246269	255,102,0	1	2744	0	.	Zinc	finger-like	2.
chr10	13246308	13251097	Q7L590	0	+	13246308	13251097	255,102,0	1	4789	0	.	Zinc	finger-like	3.
chr10	13330506	13330515	O14832	0	-	13330506	13330515	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.
chr10	14939447	14939456	Q9H5I1	0	+	14939447	14939456	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.	Pubmed:20084102
chr10	14941675	14941681	Q9H5I1	0	+	14941675	14941681	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:20084102
chr10	15120949	15120964	Q8N6N7	0	-	15120949	15120964	255,102,0	1	15	0	.	Acyl-CoA	binding.
chr10	15172244	15172259	O60551	0	-	15172244	15172259	255,102,0	1	15	0	.	Myristoyl-CoA	binding.	Pubmed:25255805
chr10	15172274	15172283	O60551	0	-	15172274	15172283	255,102,0	1	9	0	.	Myristoyl-CoA	binding.	Pubmed:25255805
chr10	15177297	15177306	O60551	0	-	15177297	15177306	255,102,0	1	9	0	.	Myristoyl-CoA	binding.	Pubmed:25255805
chr10	17216549	17216555	O14717	0	-	17216549	17216555	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine	binding.	Pubmed:11139614
chr10	17243588	17243597	O14717	0	-	17243588	17243597	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine	binding.	Pubmed:11139614
chr10	17271424	17271706	P08670	0	+	17271424	17271706	255,102,0	1	282	0	.	Head.
chr10	17271706	17271814	P08670	0	+	17271706	17271814	255,102,0	1	108	0	.	Coil	1A.
chr10	17271706	17277380	P08670	0	+	17271706	17277380	255,102,0	1	5674	0	.	Rod.
chr10	17271814	17271880	P08670	0	+	17271814	17271880	255,102,0	1	66	0	.	Linker	1.
chr10	17271880	17275783	P08670	0	+	17271880	17275783	255,102,0	1	3903	0	.	Coil	1B.
chr10	17275783	17275852	P08670	0	+	17275783	17275852	255,102,0	1	69	0	.	Linker	12.
chr10	17275852	17277380	P08670	0	+	17275852	17277380	255,102,0	1	1528	0	.	Coil	2.
chr10	17277380	17279267	P08670	0	+	17277380	17279267	255,102,0	1	1887	0	.	Tail.
chr10	17363101	17363110	P61647	0	-	17363101	17363110	255,102,0	1	9	0	.	Substrate	binding.
chr10	17365077	17365086	P61647	0	-	17365077	17365086	255,102,0	1	9	0	.	Substrate	binding.
chr10	18885169	18885190	Q8TEA1	0	-	18885169	18885190	255,102,0	1	21	0	.	S-adenosyl-L-methionine	binding.
chr10	21076139	21101710	O76041	0	-	21076139	21101710	255,102,0	1	25571	0	.	Linker.
chr10	21827838	21959443	P55197	0	+	21827838	21959443	255,102,0	1	131605	0	.	Self-association.
chr10	21901291	21906136	P55197	0	+	21901291	21906136	255,102,0	1	4845	0	.	Interaction	with	FSTL3.	Pubmed:17868029
chr10	21959512	22016816	P55197	0	+	21959512	22016816	255,102,0	1	57304	0	.	DNA-binding.
chr10	22019871	22021961	P55197	0	+	22019871	22021961	255,102,0	1	2090	0	.	Transactivation	domain;	required	for	DOT1L-binding.
chr10	22021856	22021943	P55197	0	+	22021856	22021943	255,102,0	1	87	0	.	Leucine-zipper.
chr10	22617546	22618174	P35226	0	+	22617546	22618174	255,102,0	1	628	0	.	Interaction	with	E4F1.	Pubmed:16882984
chr10	23729325	23729346	Q5VV17	0	+	23729325	23729346	255,102,0	1	21	0	.	Cys-loop.
chr10	23729490	23729523	Q5VV17	0	+	23729490	23729523	255,102,0	1	33	0	.	His-loop.
chr10	23729661	23729679	Q5VV17	0	+	23729661	23729679	255,102,0	1	18	0	.	Variable-loop.
chr10	26512835	26512844	Q05329	0	+	26512835	26512844	255,102,0	1	9	0	.	Substrate	binding.
chr10	27112114	27149741	Q8IZP0	0	-	27112114	27149741	255,102,0	1	37627	0	.	Required	for	binding	to	WASF1.
chr10	27524088	27524103	B7Z2R7	0	-	27524088	27524103	255,102,0	1	15	0	.	Acyl-CoA	binding.
chr10	27524088	27524103	Q5T8D3	0	-	27524088	27524103	255,102,0	1	15	0	.	Acyl-CoA	binding.
chr10	27524133	27529269	B7Z2R7	0	-	27524133	27529269	255,102,0	1	5136	0	.	Acyl-CoA	binding.
chr10	27524133	27529269	Q5T8D3	0	-	27524133	27529269	255,102,0	1	5136	0	.	Acyl-CoA	binding.
chr10	29770551	29777623	O95425	0	-	29770551	29777623	255,102,0	1	7072	0	.	Interaction	with	NEB.	Pubmed:18639526
chr10	29839830	29843987	O95425	0	-	29839830	29843987	255,102,0	1	4157	0	.	Interaction	with	MYLK.
chr10	32304459	32306089	P33176	0	-	32304459	32306089	255,102,0	1	1630	0	.	Globular.
chr10	33190518	33190542	P05556	0	-	33190518	33190542	255,102,0	1	24	0	.	Interaction	with	ITGB1BP1.
chr10	33197325	33197343	P05556	0	-	33197325	33197343	255,102,0	1	18	0	.	Signal	for	sorting	from	recycling	endosomes;	interaction	with	ACAP1.
chr10	33200401	33208886	P05556	0	-	33200401	33208886	255,102,0	1	8485	0	.	Cysteine-rich	tandem	repeats.
chr10	33212512	33212572	P05556	0	-	33212512	33212572	255,102,0	1	60	0	.	CX3CL1-binding.	Pubmed:24789099
chr10	33214945	33214966	P05556	0	-	33214945	33214966	255,102,0	1	21	0	.	CX3CL1-binding.	Pubmed:23125415
chr10	34620078	34636977	Q8TEW0	0	-	34620078	34636977	255,102,0	1	16899	0	.	Interaction	with	PRKCI	and	PRKCZ.
chr10	35929901	35929919	Q9H461	0	-	35929901	35929919	255,102,0	1	18	0	.	Wnt-binding.
chr10	35930057	35930075	Q9H461	0	-	35930057	35930075	255,102,0	1	18	0	.	Wnt-binding.
chr10	35930123	35930147	Q9H461	0	-	35930123	35930147	255,102,0	1	24	0	.	Palmitate-binding	groove.
chr10	43614998	43615007	P07949	0	+	43614998	43615007	255,102,0	1	9	0	.	Inhibitors	binding.
chr10	43882252	43882270	P52597	0	-	43882252	43882270	255,102,0	1	18	0	.	Interaction	with	RNA.
chr10	43882780	43882798	P52597	0	-	43882780	43882798	255,102,0	1	18	0	.	Interaction	with	RNA.
chr10	43883074	43883092	P52597	0	-	43883074	43883092	255,102,0	1	18	0	.	Interaction	with	RNA.
chr10	44874140	44876212	P48061	0	-	44874140	44876212	255,102,0	1	2072	0	.	Receptor	binding.
chr10	44876236	44876269	P48061	0	-	44876236	44876269	255,102,0	1	33	0	.	Heparin	binding.
chr10	44876239	44876248	P48061	0	-	44876239	44876248	255,102,0	1	9	0	.	Receptor	binding.
chr10	44876266	44876275	P48061	0	-	44876266	44876275	255,102,0	1	9	0	.	Receptor	binding.
chr10	44876290	44876305	P48061	0	-	44876290	44876305	255,102,0	1	15	0	.	Receptor	and	heparin	binding.
chr10	48751863	48751884	Q4JDL3	0	-	48751863	48751884	255,102,0	1	21	0	.	Substrate	binding.
chr10	48381958	48390826	P10745	0	-	48381958	48390826	255,102,0	1	8868	0	.	4	X	approximate	tandem	repeats.
chr10	50667058	50667145	Q03468	0	-	50667058	50667145	255,102,0	1	87	0	.	Ubiquitin-binding	domain	(UBD).
chr10	50820196	50820382	Q16572	0	+	50820196	50820382	255,102,0	1	186	0	.	Mediates	interaction	with	SEC14L1.
chr10	50859975	50860014	P28329	0	+	50859975	50860014	255,102,0	1	39	0	.	Coenzyme	A	binding.
chr10	51040873	51040891	Q86W56	0	-	51040873	51040891	255,102,0	1	18	0	.	Substrate	binding.
chr10	51051646	51093251	Q86W56	0	-	51051646	51093251	255,102,0	1	41605	0	.	Catalytic.
chr10	51069657	51069663	Q86W56	0	-	51069657	51069663	255,102,0	1	6	0	.	Substrate	binding.
chr10	51827765	51845294	Q641Q2	0	+	51827765	51845294	255,102,0	1	17529	0	.	Sufficient	for	interaction	with	WASHC3,	WASHC4	and	WASHC5;	required	for	interaction	with	WASHC1.
chr10	51853089	51866156	Q641Q2	0	+	51853089	51866156	255,102,0	1	13067	0	.	Sufficient	for	interaction	with	CCDC93.
chr10	51853092	51892702	Q641Q2	0	+	51853092	51892702	255,102,0	1	39610	0	.	Interaction	with	VPS35.
chr10	51885936	51892702	Q641Q2	0	+	51885936	51892702	255,102,0	1	6766	0	.	Interaction	with	phospholipids.
chr10	51887552	51889232	Q641Q2	0	+	51887552	51889232	255,102,0	1	1680	0	.	Required	for	interaction	with	F-actin-capping	protein	subunit	alpha	(CAPZA1	or	CAPZA2	or	CAPZA3).
chr10	51947077	51947110	Q9NR71	0	-	51947077	51947110	255,102,0	1	33	0	.	Required	for	correct	folding	and	localization.
chr10	52573736	52575829	Q9NQ94	0	-	52573736	52575829	255,102,0	1	2093	0	.	Required	for	nuclear	localization.	Pubmed:12896982
chr10	52751141	52912963	Q13976	0	+	52751141	52912963	255,102,0	1	161822	0	.	Required	for	dimerization.
chr10	52751162	52751270	Q13976	0	+	52751162	52751270	255,102,0	1	108	0	.	Leucine-zipper.
chr10	52751285	52751363	Q13976	0	+	52751285	52751363	255,102,0	1	78	0	.	Autoinhibitory	domain.
chr10	52912963	53667273	Q13976	0	+	52912963	53667273	255,102,0	1	754310	0	.	cGMP-binding,	high	affinity.
chr10	53457662	53457797	Q9H0L4	0	-	53457662	53457797	255,102,0	1	135	0	.	9	X	5	AA	tandem	repeats	of	G-[AT]-G-[MI]-Q.
chr10	53457923	53458058	Q9H0L4	0	-	53457923	53458058	255,102,0	1	135	0	.	9	X	5	AA	tandem	repeats	of	M-E-T-R-[AG].
chr10	53667273	53921715	Q13976	0	+	53667273	53921715	255,102,0	1	254442	0	.	cGMP-binding,	low	affinity.
chr10	54074691	54076062	O94907	0	+	54074691	54076062	255,102,0	1	1371	0	.	DKK-type	Cys-1.
chr10	54076330	54076555	O94907	0	+	54076330	54076555	255,102,0	1	225	0	.	DKK-type	Cys-2.
chr10	58119251	58119797	O95229	0	-	58119251	58119797	255,102,0	1	546	0	.	Interaction	with	NDC80	and	ZW10.
chr10	59976007	59976034	Q8NFU5	0	-	59976007	59976034	255,102,0	1	27	0	.	Substrate	binding.
chr10	61572534	61612448	Q16204	0	-	61572534	61612448	255,102,0	1	39914	0	.	5	X	29	AA	tandem	repeats.
chr10	61842474	61844943	Q12955	0	-	61842474	61844943	255,102,0	1	2469	0	.	UPA	domain.
chr10	62648795	62671300	O94844	0	-	62648795	62671300	255,102,0	1	22505	0	.	Rho-like.
chr10	69644482	69644896	Q96EB6	0	+	69644482	69644896	255,102,0	1	414	0	.	Interaction	with	CLOCK.
chr10	69644482	69651174	Q96EB6	0	+	69644482	69651174	255,102,0	1	6692	0	.	Interaction	with	HIST1H1E.
chr10	69648857	69648869	Q96EB6	0	+	69648857	69648869	255,102,0	1	12	0	.	Required	for	interaction	with	the	sumoylated	form	of	CCAR2.	Pubmed:25406032
chr10	69672484	69672493	Q96EB6	0	+	69672484	69672493	255,102,0	1	9	0	.	Phosphorylated	at	one	of	three	serine	residues.
chr10	69881195	69925541	Q86TC9	0	+	69881195	69925541	255,102,0	1	44346	0	.	Interaction	with	CARP.	Pubmed:11309420
chr10	69926394	69933880	Q86TC9	0	+	69926394	69933880	255,102,0	1	7486	0	.	Interaction	with	NEB.	Pubmed:11309420
chr10	69948790	69970209	Q86TC9	0	+	69948790	69970209	255,102,0	1	21419	0	.	Interaction	with	ACTN.
chr10	70174798	70196856	P51530	0	-	70174798	70196856	255,102,0	1	22058	0	.	Helicase	activity.
chr10	70196856	70229754	P51530	0	-	70196856	70229754	255,102,0	1	32898	0	.	Nuclease	activity.
chr10	70333676	70404508	Q8NFU7	0	+	70333676	70404508	255,102,0	1	70832	0	.	Sufficient	for	binding	to	genomic	CpG	islands.
chr10	70432715	70432757	Q8NFU7	0	+	70432715	70432757	255,102,0	1	42	0	.	Interaction	with	DNA.
chr10	70451286	70451295	Q8NFU7	0	+	70451286	70451295	255,102,0	1	9	0	.	2-oxoglutarate	binding.
chr10	70451304	70451313	Q8NFU7	0	+	70451304	70451313	255,102,0	1	9	0	.	Substrate	binding.
chr10	70482261	70507244	Q8IX12	0	+	70482261	70507244	255,102,0	1	24983	0	.	Interaction	with	AR.	Pubmed:23887938
chr10	70507005	70520823	Q8IX12	0	+	70507005	70520823	255,102,0	1	13818	0	.	Interaction	with	GATA2.	Pubmed:23887938
chr10	70520769	70551020	Q8IX12	0	+	70520769	70551020	255,102,0	1	30251	0	.	Interaction	with	GATA1.	Pubmed:24245781
chr10	70742385	70742460	Q9NR30	0	+	70742385	70742460	255,102,0	1	75	0	.	3	X	5	AA	repeats.
chr10	70863678	70863732	P10124	0	+	70863678	70863732	255,102,0	1	54	0	.	9	X	2	AA	tandem	repeats	of	[SF]-G.
chr10	70968377	70968788	Q8IYB8	0	+	70968377	70968788	255,102,0	1	411	0	.	Interaction	with	LAMTOR5,	important	for	protein	stability.
chr10	70987115	71000437	Q2TB90	0	+	70987115	71000437	255,102,0	1	13322	0	.	Hexokinase	small	subdomain	1.
chr10	70992838	70998827	Q2TB90	0	+	70992838	70998827	255,102,0	1	5989	0	.	Glucose-binding.
chr10	71000437	71008255	Q2TB90	0	+	71000437	71008255	255,102,0	1	7818	0	.	Hexokinase	large	subdomain	1.
chr10	71008474	71017112	Q2TB90	0	+	71008474	71017112	255,102,0	1	8638	0	.	Hexokinase	small	subdomain	2.
chr10	71010357	71016821	Q2TB90	0	+	71010357	71016821	255,102,0	1	6464	0	.	Glucose-binding.
chr10	71017112	71026441	Q2TB90	0	+	71017112	71026441	255,102,0	1	9329	0	.	Hexokinase	large	subdomain	2.
chr10	71078703	71078739	P19367	0	+	71078703	71078739	255,102,0	1	36	0	.	Hydrophobic.
chr10	71078739	71142402	P19367	0	+	71078739	71142402	255,102,0	1	63663	0	.	Regulatory.
chr10	71103735	71129022	P19367	0	+	71103735	71129022	255,102,0	1	25287	0	.	Hexokinase	small	subdomain	1.
chr10	71119675	71119690	P19367	0	+	71119675	71119690	255,102,0	1	15	0	.	Glucose-6-phosphate	1	binding.
chr10	71128309	71128315	P19367	0	+	71128309	71128315	255,102,0	1	6	0	.	Substrate	1	binding.
chr10	71129022	71129028	P19367	0	+	71129022	71129028	255,102,0	1	6	0	.	Substrate	1	binding.
chr10	71129022	71142318	P19367	0	+	71129022	71142318	255,102,0	1	13296	0	.	Hexokinase	large	subdomain	1.
chr10	71129375	71136696	P19367	0	+	71129375	71136696	255,102,0	1	7321	0	.	Substrate	1	binding.
chr10	71139822	71139831	P19367	0	+	71139822	71139831	255,102,0	1	9	0	.	Glucose-6-phosphate	1	binding.
chr10	71142402	71160888	P19367	0	+	71142402	71160888	255,102,0	1	18486	0	.	Catalytic.
chr10	71142537	71148982	P19367	0	+	71142537	71148982	255,102,0	1	6445	0	.	Hexokinase	small	subdomain	2.
chr10	71144111	71144126	P19367	0	+	71144111	71144126	255,102,0	1	15	0	.	Glucose-6-phosphate	2	binding.
chr10	71144638	71144644	P19367	0	+	71144638	71144644	255,102,0	1	6	0	.	Substrate	2	binding.
chr10	71146096	71146102	P19367	0	+	71146096	71146102	255,102,0	1	6	0	.	Substrate	2	binding.
chr10	71148982	71148988	P19367	0	+	71148982	71148988	255,102,0	1	6	0	.	Substrate	2	binding.
chr10	71148982	71160822	P19367	0	+	71148982	71160822	255,102,0	1	11840	0	.	Hexokinase	large	subdomain	2.
chr10	71151888	71151894	P19367	0	+	71151888	71151894	255,102,0	1	6	0	.	Substrate	2	binding.
chr10	71158555	71158564	P19367	0	+	71158555	71158564	255,102,0	1	9	0	.	Glucose-6-phosphate	2	binding.
chr10	71562179	71582193	Q5TAT6	0	+	71562179	71582193	255,102,0	1	20014	0	.	Nonhelical	region	1	(NC1).
chr10	71627552	71655323	Q5TAT6	0	+	71627552	71655323	255,102,0	1	27771	0	.	Triple-helical	region	1	(COL1).
chr10	71655323	71662530	Q5TAT6	0	+	71655323	71662530	255,102,0	1	7207	0	.	Nonhelical	region	2	(NC2).
chr10	71662530	71685586	Q5TAT6	0	+	71662530	71685586	255,102,0	1	23056	0	.	Triple-helical	region	2	(COL2).
chr10	71685586	71686866	Q5TAT6	0	+	71685586	71686866	255,102,0	1	1280	0	.	Nonhelical	region	3	(NC3).
chr10	71688692	71712709	Q5TAT6	0	+	71688692	71712709	255,102,0	1	24017	0	.	Triple-helical	region	3	(COL3).
chr10	71712709	71716798	Q5TAT6	0	+	71712709	71716798	255,102,0	1	4089	0	.	Nonhelical	region	4	(NC4).
chr10	71899787	71905388	Q2T9J0	0	-	71899787	71905388	255,102,0	1	5601	0	.	Serine	protease.
chr10	72504986	72511344	Q8WXS8	0	+	72504986	72511344	255,102,0	1	6358	0	.	Spacer.
chr10	72643778	72643790	P61457	0	-	72643778	72643790	255,102,0	1	12	0	.	Substrate	binding.
chr10	72644935	72644944	P61457	0	-	72644935	72644944	255,102,0	1	9	0	.	Substrate	binding.
chr10	73053579	73057689	Q8IZJ1	0	+	73053579	73057689	255,102,0	1	4110	0	.	UPA	domain.
chr10	73053633	73053690	Q8IZJ1	0	+	73053633	73053690	255,102,0	1	57	0	.	Interaction	with	DCC.
chr10	74127988	74128021	Q9BPX6	0	-	74127988	74128021	255,102,0	1	33	0	.	C-helix	region.	Pubmed:24514027
chr10	74322652	74322688	Q9BPX6	0	-	74322652	74322688	255,102,0	1	36	0	.	Polybasic	region.	Pubmed:27099988
chr10	74618936	74620284	Q8NE86	0	+	74618936	74620284	255,102,0	1	1348	0	.	N-terminal	MCU	domain.	Pubmed:26341627
chr10	74628609	74631179	Q8NE86	0	+	74628609	74631179	255,102,0	1	2570	0	.	Outer	juxtamembrane	helix	(OJMH).
chr10	74631323	74644038	Q8NE86	0	+	74631323	74644038	255,102,0	1	12715	0	.	Inner	juxtamembrane	helix	(IJMH).
chr10	74894343	74899173	O95905	0	-	74894343	74899173	255,102,0	1	4830	0	.	Transcription	activation.	Pubmed:19919181
chr10	74896569	74896662	O95905	0	-	74896569	74896662	255,102,0	1	93	0	.	Acidic	region	required	for	transactivation	activity.	Pubmed:19919181
chr10	74896674	74897809	O95905	0	-	74896674	74897809	255,102,0	1	1135	0	.	Involved	in	nuclear	export.	Pubmed:19919181
chr10	75156282	75160614	P20073	0	-	75156282	75160614	255,102,0	1	4332	0	.	Repeat-rich	region.
chr10	75158137	75160602	P20073	0	-	75158137	75160602	255,102,0	1	2465	0	.	3	X	5	AA	tandem	repeats	of	G-Y-P-P-X.
chr10	75198086	75198155	P16298	0	-	75198086	75198155	255,102,0	1	69	0	.	Inhibitory	domain.
chr10	75206248	75206317	P16298	0	-	75206248	75206317	255,102,0	1	69	0	.	Calmodulin-binding.
chr10	75230496	75230514	P16298	0	-	75230496	75230514	255,102,0	1	18	0	.	Calcineurin	B	binding-site	2.
chr10	75230496	75255644	P16298	0	-	75230496	75255644	255,102,0	1	25148	0	.	Catalytic.
chr10	75230850	75230871	P16298	0	-	75230850	75230871	255,102,0	1	21	0	.	Calcineurin	B	binding-site	1.
chr10	75525253	75525331	P53992	0	+	75525253	75525331	255,102,0	1	78	0	.	Zinc	finger-like.
chr10	75562211	75564582	P52849	0	-	75562211	75564582	255,102,0	1	2371	0	.	Heparan	sulfate	N-sulfotransferase	2.
chr10	75564582	75568026	P52849	0	-	75564582	75568026	255,102,0	1	3444	0	.	Heparan	sulfate	N-deacetylase	2.
chr10	75757968	75867058	P18206	0	+	75757968	75867058	255,102,0	1	109090	0	.	N-terminal	globular	head.	Pubmed:20484056
chr10	75832489	75834502	P18206	0	+	75832489	75834502	255,102,0	1	2013	0	.	Talin-interaction.
chr10	75834652	75856985	P18206	0	+	75834652	75856985	255,102,0	1	22333	0	.	3	X	112	AA	tandem	repeats.
chr10	75864897	75864969	P18206	0	+	75864897	75864969	255,102,0	1	72	0	.	Interaction	with	ACTN4.	Pubmed:15988023
chr10	75867058	75868803	P18206	0	+	75867058	75868803	255,102,0	1	1745	0	.	Linker	(Pro-rich).	Pubmed:20484056
chr10	75868803	75877924	P18206	0	+	75868803	75877924	255,102,0	1	9121	0	.	C-terminal	tail.	Pubmed:20484056
chr10	75873998	75874130	P18206	0	+	75873998	75874130	255,102,0	1	132	0	.	Facilitates	phospholipid	membrane	insertion.
chr10	75877879	75877924	P18206	0	+	75877879	75877924	255,102,0	1	45	0	.	Facilitates	phospholipid	membrane	insertion.
chr10	76735175	76739017	Q8WYB5	0	+	76735175	76739017	255,102,0	1	3842	0	.	Negatively	regulates	HAT	activity.
chr10	76739017	76781641	Q8WYB5	0	+	76739017	76781641	255,102,0	1	42624	0	.	Catalytic.
chr10	76741566	76781641	Q8WYB5	0	+	76741566	76781641	255,102,0	1	40075	0	.	Interaction	with	BRPF1.	Pubmed:18794358
chr10	76748806	76748821	Q8WYB5	0	+	76748806	76748821	255,102,0	1	15	0	.	Acetyl-CoA	binding.
chr10	76748833	76748854	Q8WYB5	0	+	76748833	76748854	255,102,0	1	21	0	.	Acetyl-CoA	binding.
chr10	76789259	76790801	Q8WYB5	0	+	76789259	76790801	255,102,0	1	1542	0	.	Interaction	with	RUNX1	and	RUNX2.	Pubmed:11965546
chr10	76797797	76797821	Q68J44	0	-	76797797	76797821	255,102,0	1	24	0	.	Substrate	binding.
chr10	76994931	76994937	Q86VU5	0	-	76994931	76994937	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr10	78651468	78669777	Q12791	0	-	78651468	78669777	255,102,0	1	18309	0	.	Segment	S10.
chr10	78709037	78709100	Q12791	0	-	78709037	78709100	255,102,0	1	63	0	.	Segment	S9.
chr10	78771773	78771788	Q12791	0	-	78771773	78771788	255,102,0	1	15	0	.	Heme-binding	motif.
chr10	78787609	78799308	Q12791	0	-	78787609	78799308	255,102,0	1	11699	0	.	Segment	S8.
chr10	78832875	78832938	Q12791	0	-	78832875	78832938	255,102,0	1	63	0	.	Segment	S7.
chr10	79759786	79759825	O14802	0	-	79759786	79759825	255,102,0	1	39	0	.	Bridging	helix.
chr10	80961389	81037017	Q9ULJ6	0	+	80961389	81037017	255,102,0	1	75628	0	.	Sufficient	for	transactivation	activity;	sufficient	for	interaction	with	NOTCH1.	Pubmed:26522984
chr10	81065941	81072503	Q9ULJ6	0	+	81065941	81072503	255,102,0	1	6562	0	.	Transactivation	domain.	Pubmed:26522984
chr10	82040465	82040504	Q00266	0	-	82040465	82040504	255,102,0	1	39	0	.	Flexible	loop.
chr10	82180262	82185687	Q9BRX8	0	+	82180262	82185687	255,102,0	1	5425	0	.	Thioredoxin	fold.
chr10	82269116	82276034	Q8NG11	0	+	82269116	82276034	255,102,0	1	6918	0	.	Necessary	and	sufficient	for	interaction	with	ADAM10.	Pubmed:26668317
chr10	88232017	88277826	Q7Z5K2	0	-	88232017	88277826	255,102,0	1	45809	0	.	Mediates	interaction	with	the	cohesin	complex.
chr10	88651971	88651980	P36894	0	+	88651971	88651980	255,102,0	1	9	0	.	Mediates	specificity	for	BMP	ligand.
chr10	88718511	88719795	O76070	0	+	88718511	88719795	255,102,0	1	1284	0	.	4	X	11	AA	tandem	repeats	of	[EGSA]-K-T-K-[EQ]-[GQ]-V-X(4).
chr10	89419738	89474747	O95340	0	+	89419738	89474747	255,102,0	1	55009	0	.	Adenylyl-sulfate	kinase.
chr10	89472920	89472932	O95340	0	+	89472920	89472932	255,102,0	1	12	0	.	Adenylyl	sulfate	binding.
chr10	89472971	89472983	O95340	0	+	89472971	89472983	255,102,0	1	12	0	.	Adenylyl	sulfate	binding.
chr10	89473049	89473055	O95340	0	+	89473049	89473055	255,102,0	1	6	0	.	Adenylyl	sulfate	binding.
chr10	89474500	89474506	O95340	0	+	89474500	89474506	255,102,0	1	6	0	.	Adenylyl	sulfate	binding.
chr10	89474771	89505724	O95340	0	+	89474771	89505724	255,102,0	1	30953	0	.	Sulfate	adenylyltransferase.
chr10	89725217	89725226	P60484	0	+	89725217	89725226	255,102,0	1	9	0	.	PDZ	domain-binding.
chr10	90341996	90342002	Q5VYX0	0	-	90341996	90342002	255,102,0	1	6	0	.	FAD-binding.
chr10	90771820	90774150	P25445	0	+	90771820	90774150	255,102,0	1	2330	0	.	Interaction	with	HIPK3.
chr10	90773886	90773961	P25445	0	+	90773886	90773961	255,102,0	1	75	0	.	Interaction	with	CALM.	Pubmed:24914971
chr10	91162797	91162818	P09914	0	+	91162797	91162818	255,102,0	1	21	0	.	Interaction	with	the	5'-triphosphate	group	of	PPP-RNA.
chr10	91177715	91177736	Q13325	0	+	91177715	91177736	255,102,0	1	21	0	.	Interaction	with	the	5'-triphosphate	group	of	PPP-RNA.
chr10	91497745	91497919	Q96Q89	0	+	91497745	91497919	255,102,0	1	174	0	.	Necessary	and	sufficient	for	interaction	with	SHTN1.
chr10	91518636	91533802	Q96Q89	0	+	91518636	91533802	255,102,0	1	15166	0	.	Interaction	with	PIN1.	Pubmed:11470801
chr10	93389848	93390217	Q9UQK1	0	-	93389848	93390217	255,102,0	1	369	0	.	Interaction	with	EPM2A.	Pubmed:14532330
chr10	93600422	93600449	Q9H2K2	0	+	93600422	93600449	255,102,0	1	27	0	.	HIF1AN-binding.
chr10	94267933	94267948	P14735	0	-	94267933	94267948	255,102,0	1	15	0	.	Substrate	binding.
chr10	94268518	94268539	P14735	0	-	94268518	94268539	255,102,0	1	21	0	.	Substrate	binding	exosite.
chr10	95163779	95169374	Q9NZM1	0	-	95163779	95169374	255,102,0	1	5595	0	.	Necessary	for	interaction	with	EHD2.	Pubmed:18502764
chr10	95266753	95276720	Q53EZ4	0	+	95266753	95276720	255,102,0	1	9967	0	.	Interaction	with	TSG101.
chr10	95266762	95275275	Q53EZ4	0	+	95266762	95275275	255,102,0	1	8513	0	.	Interaction	with	PDCD6IP.
chr10	95278702	95287907	Q53EZ4	0	+	95278702	95287907	255,102,0	1	9205	0	.	Required	for	localization	to	the	interphase	centrosome	and	to	the	midbody	during	cytokinesis.
chr10	96053284	96058260	Q9P212	0	+	96053284	96058260	255,102,0	1	4976	0	.	Required	for	activation	by	RHOA,	RHOB,	GNA12,	GNA13	and	G-beta	gamma.
chr10	97366521	97386528	P54886	0	-	97366521	97386528	255,102,0	1	20007	0	.	Gamma-glutamyl	phosphate	reductase.
chr10	97386528	97413134	P54886	0	-	97386528	97413134	255,102,0	1	26606	0	.	Glutamate	5-kinase.
chr10	98079090	98097978	P04053	0	+	98079090	98097978	255,102,0	1	18888	0	.	Mediates	interaction	with	DNTTIP2.	Pubmed:12786946
chr10	98084043	98084058	P04053	0	+	98084043	98084058	255,102,0	1	15	0	.	Involved	in	DNA	binding.
chr10	98087346	98088488	P04053	0	+	98087346	98088488	255,102,0	1	1142	0	.	Deoxynucleoside	triphosphate	binding.
chr10	98088497	98088509	P04053	0	+	98088497	98088509	255,102,0	1	12	0	.	Deoxynucleoside	triphosphate	binding.
chr10	98092335	98092341	P04053	0	+	98092335	98092341	255,102,0	1	6	0	.	Deoxynucleoside	triphosphate	binding.
chr10	98170229	98192636	Q9Y6L7	0	-	98170229	98192636	255,102,0	1	22407	0	.	Metalloprotease.
chr10	98416689	98469726	Q6ZUJ8	0	-	98416689	98469726	255,102,0	1	53037	0	.	Necessary	and	sufficient	to	mediate	inhibition	of	NF-kappa-B	downstream	of	activated	TLRs;	may	mediate	interaction	with	MYD88	and	TIRAP.
chr10	99079801	99079870	Q92837	0	+	99079801	99079870	255,102,0	1	69	0	.	Involved	in	GSK-3	binding.
chr10	99093741	99093810	O75474	0	-	99093741	99093810	255,102,0	1	69	0	.	Involved	in	GSK-3	binding.
chr10	99186091	99186115	P18669	0	+	99186091	99186115	255,102,0	1	24	0	.	Substrate	binding.	Pubmed:23653202,	Pubmed:15883004
chr10	99186130	99186136	P18669	0	+	99186130	99186136	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:23653202,	Pubmed:15883004
chr10	99190260	99190272	P18669	0	+	99190260	99190272	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:15883004
chr10	99190341	99190347	P18669	0	+	99190341	99190347	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:15883004
chr10	99190855	99190861	P18669	0	+	99190855	99190861	255,102,0	1	6	0	.	Substrate	binding.
chr10	99332476	99338086	Q9GZV1	0	+	99332476	99338086	255,102,0	1	5610	0	.	May	mediate	interaction	with	PML,	p53/TP53	and	YBX1.	Pubmed:15136035
chr10	99358548	99358554	Q86XE5	0	+	99358548	99358554	255,102,0	1	6	0	.	Substrate	binding.
chr10	99410730	99410739	Q9BTU6	0	+	99410730	99410739	255,102,0	1	9	0	.	Important	for	substrate	binding.	Pubmed:24675427
chr10	99410754	99410796	Q9BTU6	0	+	99410754	99410796	255,102,0	1	42	0	.	Important	for	interaction	with	membranes.	Pubmed:25168678,	Pubmed:24675427
chr10	99416610	99416637	Q9BTU6	0	+	99416610	99416637	255,102,0	1	27	0	.	Important	for	interaction	with	membranes.	Pubmed:24675427
chr10	99424731	99426214	Q9BTU6	0	+	99424731	99426214	255,102,0	1	1483	0	.	Important	for	interaction	with	membranes.	Pubmed:24675427
chr10	99498234	99504493	Q5T4F4	0	+	99498234	99504493	255,102,0	1	6259	0	.	Sufficient	for	homooligomerization.	Pubmed:23969831
chr10	99498234	99509294	Q5T4F4	0	+	99498234	99509294	255,102,0	1	11060	0	.	Sufficient	for	localization	to	endoplasmic	reticulum	tubular	network	and	for	interactions	with	REEP1,	REEP5,	ATL1,	ATL2,	ATL3	and	SPAST.	Pubmed:23969831,	Pubmed:24668814
chr10	99498384	99498426	Q5T4F4	0	+	99498384	99498426	255,102,0	1	42	0	.	Necessary	for	interaction	with	RAB11A	and	function	in	neurite	outgrowth.	Pubmed:17082457
chr10	99511153	99517062	Q5T4F4	0	+	99511153	99517062	255,102,0	1	5909	0	.	Necessary	for	interaction	with	KIF5A.	Pubmed:21976701
chr10	99511198	99511219	Q5T4F4	0	+	99511198	99511219	255,102,0	1	21	0	.	Necessary	for	interaction	with	VAPA	and	function	in	cell	projections	formation.
chr10	100008740	100013548	Q96JB6	0	-	100008740	100013548	255,102,0	1	4808	0	.	Lysyl-oxidase	like.
chr10	101814194	101841322	P15169	0	-	101814194	101841322	255,102,0	1	27128	0	.	Catalytic.
chr10	101949363	101949381	O15111	0	-	101949363	101949381	255,102,0	1	18	0	.	NEMO-binding.
chr10	101964341	101964407	O15111	0	-	101964341	101964407	255,102,0	1	66	0	.	Leucine-zipper.
chr10	102048774	102050174	Q9P0L9	0	-	102048774	102050174	255,102,0	1	1400	0	.	Required	for	protein	homotrimerization.
chr10	102295718	102296365	Q9NWT6	0	+	102295718	102296365	255,102,0	1	647	0	.	Interaction	with	VHL.	Pubmed:11641274
chr10	102300502	102300511	Q9NWT6	0	+	102300502	102300511	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:21177872
chr10	102304730	102304739	Q9NWT6	0	+	102304730	102304739	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:21177872
chr10	102304841	102304847	Q9NWT6	0	+	102304841	102304847	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:21177872
chr10	102762295	102763851	Q9BRK4	0	+	102762295	102763851	255,102,0	1	1556	0	.	Required	for	centrosomal	localization.
chr10	102766253	102766922	Q9BRK4	0	+	102766253	102766922	255,102,0	1	669	0	.	Sufficient	for	interaction	with	CTNNB1.	Pubmed:17000760
chr10	102766262	102766922	Q9BRK4	0	+	102766262	102766922	255,102,0	1	660	0	.	Sufficient	for	interaction	with	KATNB1	and	for	inhibition	of	katanin-mediated	microtubule	severing.
chr10	103281452	103281602	Q9Y297	0	+	103281452	103281602	255,102,0	1	150	0	.	Homodimerization	domain	D.
chr10	103285780	103285897	Q9Y297	0	+	103285780	103285897	255,102,0	1	117	0	.	Required	for	down-regulation	of	SNAI1.
chr10	103339422	103339542	Q9UGP5	0	-	103339422	103339542	255,102,0	1	120	0	.	DNA	binding.	Pubmed:14992725
chr10	103340080	103340110	Q9UGP5	0	-	103340080	103340110	255,102,0	1	30	0	.	Involved	in	primer	binding.
chr10	103343285	103343297	Q9UGP5	0	-	103343285	103343297	255,102,0	1	12	0	.	DNA	binding.	Pubmed:14992725
chr10	103344412	103344457	Q9UGP5	0	-	103344412	103344457	255,102,0	1	45	0	.	DNA	binding.	Pubmed:14992725
chr10	103563687	103563696	O60502	0	-	103563687	103563696	255,102,0	1	9	0	.	Substrate	binding.
chr10	103587112	103587154	Q9NS61	0	-	103587112	103587154	255,102,0	1	42	0	.	Interaction	with	KCND2.
chr10	103867963	103868080	Q86U70	0	-	103867963	103868080	255,102,0	1	117	0	.	LIM-binding	domain	(LID).
chr10	103899561	103899666	Q5VV67	0	+	103899561	103899666	255,102,0	1	105	0	.	Necessary	for	interaction	with	CREB1	and	NRF1	and	for	transcriptional	coactivation.	Pubmed:16908542
chr10	103906883	103907099	Q5VV67	0	+	103906883	103907099	255,102,0	1	216	0	.	Necessary	for	interaction	with	CREB1	and	NRF1.	Pubmed:16908542
chr10	103917018	103920807	Q14978	0	+	103917018	103920807	255,102,0	1	3789	0	.	11	X	12	AA	approximate	repeats	of	an	acidic	serine	cluster.
chr10	103918951	103920255	Q14978	0	+	103918951	103920255	255,102,0	1	1304	0	.	Interaction	with	RPA194.
chr10	104018695	104113405	Q92538	0	+	104018695	104113405	255,102,0	1	94710	0	.	DCB;	DCB:DCB	domain	and	DCB:HUS	domain	interaction.
chr10	104018695	104119155	Q92538	0	+	104018695	104119155	255,102,0	1	100460	0	.	Interaction	with	RAB1B.	Pubmed:17429068
chr10	104121573	104121636	Q92538	0	+	104121573	104121636	255,102,0	1	63	0	.	HUS;	DCB:HUS	domain	interaction.
chr10	104127990	104136382	Q92538	0	+	104127990	104136382	255,102,0	1	8392	0	.	Phosphatidylinositol-phosphate	binding;	required	for	translocation	to	the	leading	edge	and	for	ARF1	activation	upon	GPCR	signaling.	Pubmed:22573891
chr10	104158539	104159058	Q00653	0	+	104158539	104159058	255,102,0	1	519	0	.	GRR.
chr10	104181672	104182654	Q9H469	0	+	104181672	104182654	255,102,0	1	982	0	.	Interaction	with	SMURF1.	Pubmed:21572392
chr10	104356974	104375082	Q9UMX1	0	+	104356974	104375082	255,102,0	1	18108	0	.	Intrinsically	disordered.	Pubmed:24311597
chr10	104859685	104859712	P49902	0	-	104859685	104859712	255,102,0	1	27	0	.	Substrate	binding.
chr10	105006188	105006200	Q2QD12	0	+	105006188	105006200	255,102,0	1	12	0	.	Substrate	binding.
chr10	105006341	105006347	Q2QD12	0	+	105006341	105006347	255,102,0	1	6	0	.	Substrate	binding.
chr10	105036968	105037229	Q16352	0	+	105036968	105037229	255,102,0	1	261	0	.	Head.
chr10	105037229	105037355	Q16352	0	+	105037229	105037355	255,102,0	1	126	0	.	Coil	1A.
chr10	105037229	105048150	Q16352	0	+	105037229	105048150	255,102,0	1	10921	0	.	Rod.
chr10	105037355	105037394	Q16352	0	+	105037355	105037394	255,102,0	1	39	0	.	Linker	1.
chr10	105037394	105037682	Q16352	0	+	105037394	105037682	255,102,0	1	288	0	.	Coil	1B.
chr10	105037682	105037754	Q16352	0	+	105037682	105037754	255,102,0	1	72	0	.	Linker	2.
chr10	105037754	105048150	Q16352	0	+	105037754	105048150	255,102,0	1	10396	0	.	Coil	2.
chr10	105048150	105048423	Q16352	0	+	105048150	105048423	255,102,0	1	273	0	.	Tail.
chr10	105642444	105648893	Q9H668	0	-	105642444	105648893	255,102,0	1	6449	0	.	Winged	helix-turn-helix	(wHTH)	2.
chr10	105648893	105658645	Q9H668	0	-	105648893	105658645	255,102,0	1	9752	0	.	Winged	helix-turn-helix	(wHTH)	1.
chr10	105658660	105677352	Q9H668	0	-	105658660	105677352	255,102,0	1	18692	0	.	Interaction	with	CTC1.	Pubmed:23851344
chr10	105791995	105792040	Q9UMD9	0	-	105791995	105792040	255,102,0	1	45	0	.	Nonhelical	region	(NC1).
chr10	105792040	105815148	Q9UMD9	0	-	105792040	105815148	255,102,0	1	23108	0	.	Triple-helical	region.
chr10	105815148	105840431	Q9UMD9	0	-	105815148	105840431	255,102,0	1	25283	0	.	Nonhelical	region	(NC16).
chr10	105824271	105831820	Q9UMD9	0	-	105824271	105831820	255,102,0	1	7549	0	.	Necessary	for	interaction	with	DST	and	for	the	recruitment	of	DST	to	hemidesmosome.	Pubmed:12482924
chr10	106019442	106019448	P78417	0	+	106019442	106019448	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:10783391,	Pubmed:21106529
chr10	106037760	106037766	Q9H4Y5	0	+	106037760	106037766	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:22522127
chr10	111893304	111893358	Q9UEY8	0	+	111893304	111893358	255,102,0	1	54	0	.	Interaction	with	calmodulin.
chr10	112350172	112356193	Q9UQE7	0	+	112350172	112356193	255,102,0	1	6021	0	.	Flexible	hinge.
chr10	114710515	114710674	Q9NQB0	0	+	114710515	114710674	255,102,0	1	159	0	.	CTNNB1-binding.
chr10	114900990	114912115	Q9NQB0	0	+	114900990	114912115	255,102,0	1	11125	0	.	Mediates	interaction	with	MAD2L2.	Pubmed:19443654
chr10	114919683	114925386	Q9NQB0	0	+	114919683	114925386	255,102,0	1	5703	0	.	Promoter-specific	activation	domain.
chr10	115609021	115609678	Q6PJP8	0	-	115609021	115609678	255,102,0	1	657	0	.	Nuclear	focus	formation.
chr10	115610293	115612941	Q6PJP8	0	-	115610293	115612941	255,102,0	1	2648	0	.	Nuclear	localization	region.
chr10	118969252	118969270	Q7Z418	0	+	118969252	118969270	255,102,0	1	18	0	.	Interaction	with	calcineurin.
chr10	118969399	118969417	Q7Z418	0	+	118969399	118969417	255,102,0	1	18	0	.	Interaction	with	YWHAH.
chr10	119768511	119768655	Q7L804	0	-	119768511	119768655	255,102,0	1	144	0	.	Necessary	for	interaction	with	AP2A1,	RAB11A,	subcellular	location,	endocytosis	activity	and	homooligomerization.	Pubmed:12364336
chr10	119805368	119805632	Q7L804	0	-	119805368	119805632	255,102,0	1	264	0	.	Necessary	for	its	cellular	translocation	to	the	plasma	membrane.
chr10	120353646	120353664	P49683	0	-	120353646	120353664	255,102,0	1	18	0	.	Required	for	interaction	with	GRIP1,	GRIP2	and	PICK1.	Pubmed:11641419
chr10	120789430	120789481	Q8WY41	0	+	120789430	120789481	255,102,0	1	51	0	.	Essential	for	its	translational	repressor	activity.
chr10	120801515	120802259	Q14152	0	-	120801515	120802259	255,102,0	1	744	0	.	25	X	10	AA	approximate	tandem	repeats	of	[DE]-[DE]-[DE]-R-[SEVGFPILV]-[HPSN]-[RSW]-[RL]-[DRGTIHN]-[EPMANLGDT].
chr10	120809465	120816540	Q14152	0	-	120809465	120816540	255,102,0	1	7075	0	.	Interaction	with	EIF3B.
chr10	120967429	121189908	P34947	0	+	120967429	121189908	255,102,0	1	222479	0	.	N-terminal.
chr10	121086032	121086092	P34947	0	+	121086032	121086092	255,102,0	1	60	0	.	Interaction	with	calmodulin.
chr10	121212749	121214501	P34947	0	+	121212749	121214501	255,102,0	1	1752	0	.	Sufficient	for	membrane	localization.
chr10	121652294	121663789	Q9Y6Y8	0	+	121652294	121663789	255,102,0	1	11495	0	.	Interaction	with	SEC23A.	Pubmed:10400679
chr10	122278391	122280492	Q5VZY2	0	+	122278391	122280492	255,102,0	1	2101	0	.	Phosphatase	sequence	motif	I.
chr10	122280588	122280600	Q5VZY2	0	+	122280588	122280600	255,102,0	1	12	0	.	Phosphatase	sequence	motif	II.
chr10	122334779	122334812	Q5VZY2	0	+	122334779	122334812	255,102,0	1	33	0	.	Phosphatase	sequence	motif	III.
chr10	123310893	123310947	P21802	0	-	123310893	123310947	255,102,0	1	54	0	.	Heparin-binding.
chr10	124248974	124268258	Q92743	0	+	124248974	124268258	255,102,0	1	19284	0	.	Serine	protease.
chr10	124802564	124802570	P45954	0	+	124802564	124802570	255,102,0	1	6	0	.	Substrate	binding.
chr10	124803971	124803983	P45954	0	+	124803971	124803983	255,102,0	1	12	0	.	Substrate	binding.
chr10	126150479	126150488	Q9H008	0	+	126150479	126150488	255,102,0	1	9	0	.	Substrate	binding.
chr10	126172741	126172747	Q9H008	0	+	126172741	126172747	255,102,0	1	6	0	.	Substrate	binding.
chr10	126490413	126515244	Q15018	0	+	126490413	126515244	255,102,0	1	24831	0	.	MPN-like.
chr10	126518025	126519920	Q15018	0	+	126518025	126519920	255,102,0	1	1895	0	.	Important	for	interaction	with	SHMT2.	Pubmed:24075985
chr10	126518040	126519977	Q15018	0	+	126518040	126519977	255,102,0	1	1937	0	.	Important	for	interaction	with	BBRC36	and	other	subunits	of	the	BRISC	complex.	Pubmed:26344097
chr10	126662230	126673357	Q9UGI0	0	+	126662230	126673357	255,102,0	1	11127	0	.	TRAF-binding.
chr10	127515168	127520078	Q9P287	0	+	127515168	127520078	255,102,0	1	4910	0	.	Interaction	with	BRCA2.
chr10	127520057	127524675	Q9P287	0	+	127520057	127524675	255,102,0	1	4618	0	.	Interaction	with	CDKN1A.
chr10	128114435	128149978	Q96M02	0	-	128114435	128149978	255,102,0	1	35543	0	.	ALMS	motif.
chr10	128193096	128193423	Q96M02	0	-	128193096	128193423	255,102,0	1	327	0	.	Required	for	interaction	with	HDAC1.
chr10	129237351	129237378	Q14185	0	+	129237351	129237378	255,102,0	1	27	0	.	Phosphoinositide-binding.
chr10	129245683	129245764	Q14185	0	+	129245683	129245764	255,102,0	1	81	0	.	Interaction	with	NCK2	second	and	third	SH3	domain	(minor).
chr10	129245764	129249601	Q14185	0	+	129245764	129249601	255,102,0	1	3837	0	.	Interaction	with	NCK2	third	SH3	domain	(major).
chr10	129249601	129249649	Q14185	0	+	129249601	129249649	255,102,0	1	48	0	.	Interaction	with	NCK2	(minor).
chr10	129866545	129867971	P23469	0	+	129866545	129867971	255,102,0	1	1426	0	.	Substrate	binding.
chr10	129901319	129907106	P46013	0	-	129901319	129907106	255,102,0	1	5787	0	.	16	X	122	AA	approximate	repeats.	Pubmed:8227122
chr10	131671779	131671791	Q9H4W6	0	-	131671779	131671791	255,102,0	1	12	0	.	Interaction	with	DNA.
chr10	131676055	131676079	Q9H4W6	0	-	131676055	131676079	255,102,0	1	24	0	.	Interaction	with	DNA.
chr10	131761723	131761735	Q9H4W6	0	-	131761723	131761735	255,102,0	1	12	0	.	Interaction	with	DNA.
chr10	135044754	135044850	Q5T230	0	+	135044754	135044850	255,102,0	1	96	0	.	Leucine-zipper.
chr10	135183518	135183530	P30084	0	-	135183518	135183530	255,102,0	1	12	0	.	Substrate	binding.
chr10	135347325	135347343	P05181	0	+	135347325	135347343	255,102,0	1	18	0	.	Substrate	binding.
chr11	314984	315110	P13164	0	+	314984	315110	255,102,0	1	126	0	.	Interaction	with	CAV1.	Pubmed:19499152
chr11	319840	319918	Q01628	0	-	319840	319918	255,102,0	1	78	0	.	Interaction	with	VAPA.	Pubmed:23601107
chr11	319960	320636	Q01628	0	-	319960	320636	255,102,0	1	676	0	.	Interaction	with	SPP1.	Pubmed:19901966
chr11	502129	502159	P13489	0	-	502129	502159	255,102,0	1	30	0	.	2	X	5	AA	tandem	repeats	of	S-L-D-I-Q.
chr11	532650	532710	P01112	0	-	532650	532710	255,102,0	1	60	0	.	Hypervariable	region.
chr11	617353	618001	Q9HBB8	0	-	617353	618001	255,102,0	1	648	0	.	Mediates	interaction	with	USH1C	and	MYO7B	and	is	required	for	proper	localization	to	microvilli	tips	and	function	in	microvilli	organization.	Pubmed:24725409
chr11	618623	618941	Q9HBB8	0	-	618623	618941	255,102,0	1	318	0	.	4	X	31	AA	approximate	tandem	repeats.
chr11	674604	678742	O75398	0	-	674604	678742	255,102,0	1	4138	0	.	Interaction	with	LMO4.
chr11	798177	798270	I0J062	0	+	798177	798270	255,102,0	1	93	0	.	Necessary	for	nucleolar	localization.	Pubmed:22094112
chr11	800344	801013	Q9HB75	0	-	800344	801013	255,102,0	1	669	0	.	UPA	domain.
chr11	926033	970272	O94973	0	+	926033	970272	255,102,0	1	44239	0	.	Lipid-binding.
chr11	1016941	1017982	Q6W4X9	0	-	1016941	1017982	255,102,0	1	1041	0	.	Approximate	repeats.
chr11	1262106	1270794	Q9HC84	0	+	1262106	1270794	255,102,0	1	8688	0	.	7	X	Cys-rich	subdomain	repeats.
chr11	1263777	1264707	Q9HC84	0	+	1263777	1264707	255,102,0	1	930	0	.	11	X	approximate	tandem	repeats,	Ser/Thr-rich.
chr11	1265364	1266378	Q9HC84	0	+	1265364	1266378	255,102,0	1	1014	0	.	11	X	approximate	tandem	repeats,	Ser/Thr-rich.
chr11	1267035	1268478	Q9HC84	0	+	1267035	1268478	255,102,0	1	1443	0	.	17	X	approximate	tandem	repeats,	Ser/Thr-rich.
chr11	1269135	1270149	Q9HC84	0	+	1269135	1270149	255,102,0	1	1014	0	.	11	X	approximate	tandem	repeats,	Ser/Thr-rich.
chr11	1270806	1272747	Q9HC84	0	+	1270806	1272747	255,102,0	1	1941	0	.	23	X	approximate	tandem	repeats,	Ser/Thr-rich.
chr11	1605666	1606356	Q6L8H4	0	-	1605666	1606356	255,102,0	1	690	0	.	8	X	4	AA	repeats	of	C-C-X-P.
chr11	1605676	1606366	Q6L8H4	0	-	1605676	1606366	255,102,0	1	690	0	.	8	X	4	AA	repeats	of	C-C-X-P.
chr11	1611376	1612066	Q6L8H4	0	-	1611376	1612066	255,102,0	1	690	0	.	8	X	4	AA	repeats	of	C-C-X-P.
chr11	1618970	1619297	Q701N4	0	-	1618970	1619297	255,102,0	1	327	0	.	6	X	4	AA	repeats	of	C-C-X-P.
chr11	1618986	1619313	Q701N4	0	-	1618986	1619313	255,102,0	1	327	0	.	6	X	4	AA	repeats	of	C-C-X-P.
chr11	1624680	1625007	Q701N4	0	-	1624680	1625007	255,102,0	1	327	0	.	6	X	4	AA	repeats	of	C-C-X-P.
chr11	1628922	1629513	Q6L8H2	0	-	1628922	1629513	255,102,0	1	591	0	.	11	X	4	AA	repeats	of	C-C-X-P.
chr11	1628948	1629539	Q6L8H2	0	-	1628948	1629539	255,102,0	1	591	0	.	11	X	4	AA	repeats	of	C-C-X-P.
chr11	1634632	1635223	Q6L8H2	0	-	1634632	1635223	255,102,0	1	591	0	.	11	X	4	AA	repeats	of	C-C-X-P.
chr11	1642688	1643387	Q6L8H1	0	-	1642688	1643387	255,102,0	1	699	0	.	9	X	4	AA	repeats	of	C-C-X-P.
chr11	1651253	1651760	Q701N2	0	+	1651253	1651760	255,102,0	1	507	0	.	8	X	4	AA	repeats	of	C-C-X-P.
chr11	1656963	1657470	Q701N2	0	+	1656963	1657470	255,102,0	1	507	0	.	8	X	4	AA	repeats	of	C-C-X-P.
chr11	1715775	1716030	Q6L8G9	0	+	1715775	1716030	255,102,0	1	255	0	.	6	X	4	AA	repeats	of	C-C-X-P.
chr11	1718556	1718811	Q6L8G9	0	+	1718556	1718811	255,102,0	1	255	0	.	6	X	4	AA	repeats	of	C-C-X-P.
chr11	1860929	1861844	P48788	0	+	1860929	1861844	255,102,0	1	915	0	.	Involved	in	binding	TNC.
chr11	1862272	1862335	P48788	0	+	1862272	1862335	255,102,0	1	63	0	.	Involved	in	binding	TNC	and	actin.
chr11	2154779	2154797	P01344	0	-	2154779	2154797	255,102,0	1	18	0	.	D.
chr11	2154797	2154860	P01344	0	-	2154797	2154860	255,102,0	1	63	0	.	A.
chr11	2154860	2154896	P01344	0	-	2154860	2154896	255,102,0	1	36	0	.	C.
chr11	2156597	2156681	P01344	0	-	2156597	2156681	255,102,0	1	84	0	.	B.
chr11	2797201	2798246	P51787	0	+	2797201	2798246	255,102,0	1	1045	0	.	Interaction	with	KCNE1	C-terminus.	Pubmed:25037568
chr11	2799234	2869050	P51787	0	+	2799234	2869050	255,102,0	1	69816	0	.	Interaction	with	AKAP9.	Pubmed:11799244
chr11	2799237	2869062	P51787	0	+	2799237	2869062	255,102,0	1	69825	0	.	C-terminal	assembly	domain.	Pubmed:10654932
chr11	2906080	2906254	P49918	0	-	2906080	2906254	255,102,0	1	174	0	.	9	X	4	AA	repeats	of	P-A-P-A.
chr11	3122917	3122923	Q9H0X9	0	-	3122917	3122923	255,102,0	1	6	0	.	Phosphatidylinositol	4-phosphate	binding.
chr11	3123490	3123502	Q9H0X9	0	-	3123490	3123502	255,102,0	1	12	0	.	Phosphatidylinositol	4-phosphate	binding.
chr11	3125499	3125517	Q9H0X9	0	-	3125499	3125517	255,102,0	1	18	0	.	Phosphatidylinositol	4-phosphate	binding.
chr11	3125499	3125517	Q9H0X9	0	-	3125499	3125517	255,102,0	1	18	0	.	Phosphatidylserine	binding.
chr11	3381508	3383120	O14628	0	-	3381508	3383120	255,102,0	1	1612	0	.	Spacer.
chr11	3765757	3793122	P52948	0	-	3765757	3793122	255,102,0	1	27365	0	.	FG	repeats	2.
chr11	3793122	3797138	P52948	0	-	3793122	3797138	255,102,0	1	4016	0	.	GLEBS;	interaction	with	RAE1.	Pubmed:10209021
chr11	3797138	3803347	P52948	0	-	3797138	3803347	255,102,0	1	6209	0	.	FG	repeats	1.
chr11	4103443	4104586	Q13586	0	+	4103443	4104586	255,102,0	1	1143	0	.	SOAR/CAD.
chr11	4123233	4123254	P23921	0	+	4123233	4123254	255,102,0	1	21	0	.	Allosteric	activator	binding.
chr11	4133290	4139553	P23921	0	+	4133290	4139553	255,102,0	1	6263	0	.	Substrate	binding.
chr11	4141134	4141146	P23921	0	+	4141134	4141146	255,102,0	1	12	0	.	Allosteric	effector	binding,	determines	substrate	specificity.
chr11	4144572	4144587	P23921	0	+	4144572	4144587	255,102,0	1	15	0	.	Substrate	binding.
chr11	4153552	4153567	P23921	0	+	4153552	4153567	255,102,0	1	15	0	.	Substrate	binding.
chr11	5699583	5699625	Q9C035	0	-	5699583	5699625	255,102,0	1	42	0	.	Required	for	interaction	with	GABARAP	and	for	autophagy.
chr11	6461923	6461956	P02790	0	-	6461923	6461956	255,102,0	1	33	0	.	O-glycosylated	at	one	site.
chr11	6478085	6486922	O75382	0	-	6478085	6486922	255,102,0	1	8837	0	.	Interaction	with	KIF21B.
chr11	6629282	6629989	Q13418	0	+	6629282	6629989	255,102,0	1	707	0	.	Interaction	with	LIMS1.	Pubmed:12167643
chr11	6630306	6630547	Q13418	0	+	6630306	6630547	255,102,0	1	241	0	.	PH-like;	mediates	interaction	with	TGFB1I1.
chr11	7273441	7273510	Q86SS6	0	+	7273441	7273510	255,102,0	1	69	0	.	Cysteine	motif.
chr11	8751495	8751636	P78524	0	-	8751495	8751636	255,102,0	1	141	0	.	Interaction	with	ABL1.	Pubmed:9632734
chr11	9806853	9810700	Q86WG5	0	-	9806853	9810700	255,102,0	1	3847	0	.	Interaction	with	MTMR2.	Pubmed:15998640
chr11	10516472	10516490	Q01432	0	+	10516472	10516490	255,102,0	1	18	0	.	Substrate	binding.
chr11	10524414	10524426	Q01432	0	+	10524414	10524426	255,102,0	1	12	0	.	Substrate	binding.
chr11	11362488	11398736	Q6P9A2	0	-	11362488	11398736	255,102,0	1	36248	0	.	Catalytic	subdomain	B.
chr11	11398904	11454306	Q6P9A2	0	-	11398904	11454306	255,102,0	1	55402	0	.	Catalytic	subdomain	A.
chr11	11986211	11988552	Q9UBP4	0	-	11986211	11988552	255,102,0	1	2341	0	.	DKK-type	Cys-2.
chr11	11988588	11990031	Q9UBP4	0	-	11988588	11990031	255,102,0	1	1443	0	.	DKK-type	Cys-1.
chr11	12029991	12030045	Q9UBP4	0	-	12029991	12030045	255,102,0	1	54	0	.	O-glycosylated	at	one	site.
chr11	12183705	12244990	O94851	0	+	12183705	12244990	255,102,0	1	61285	0	.	Monooxygenase	domain.
chr11	12315161	12315281	Q6ZW33	0	+	12315161	12315281	255,102,0	1	120	0	.	Interaction	with	MAPK1.
chr11	12371404	12379987	Q6ZW33	0	+	12371404	12379987	255,102,0	1	8583	0	.	RAB-binding	domain	(RBD).	Pubmed:27552051
chr11	13399990	13408186	O00327	0	+	13399990	13408186	255,102,0	1	8196	0	.	Interaction	with	CIART.
chr11	13410380	13441155	Q9BSF8	0	-	13410380	13441155	255,102,0	1	30775	0	.	Interaction	with	AKT	family	members.
chr11	13514092	13514149	P01270	0	-	13514092	13514149	255,102,0	1	57	0	.	Important	for	receptor	binding.
chr11	14665621	14665696	Q13370	0	+	14665621	14665696	255,102,0	1	75	0	.	Interaction	with	RAPGEF3.	Pubmed:21393242
chr11	14810678	14810753	Q13370	0	+	14810678	14810753	255,102,0	1	75	0	.	Interaction	with	PIK3R6.	Pubmed:21393242
chr11	14854309	14891083	Q13370	0	+	14854309	14891083	255,102,0	1	36774	0	.	Catalytic.
chr11	15197308	15197356	Q1MX18	0	+	15197308	15197356	255,102,0	1	48	0	.	Important	for	interaction	with	GPSM2.	Pubmed:22074847
chr11	16824587	16838601	Q6IQ23	0	-	16824587	16838601	255,102,0	1	14014	0	.	Interaction	with	CTNND1.	Pubmed:19041755
chr11	17113795	17113813	O00443	0	-	17113795	17113813	255,102,0	1	18	0	.	Interaction	with	PtdIns(4,5)P2-containing	membranes.
chr11	17190862	17191285	O00443	0	-	17190862	17191285	255,102,0	1	423	0	.	Interaction	with	clathrin;	sufficient	to	induce	clathrin	assemby.
chr11	17378301	17378313	Q68D85	0	+	17378301	17378313	255,102,0	1	12	0	.	Interaction	with	NCR3.	Pubmed:19528259
chr11	17378505	17378517	Q68D85	0	+	17378505	17378517	255,102,0	1	12	0	.	Interaction	with	NCR3.	Pubmed:19528259
chr11	17393564	17393981	Q68D85	0	+	17393564	17393981	255,102,0	1	417	0	.	Retroviral-Gag-like.
chr11	17515913	17547988	Q9Y6N9	0	-	17515913	17547988	255,102,0	1	32075	0	.	Mediates	interaction	with	MYO7B.	Pubmed:26812017,	Pubmed:26812018
chr11	17552829	17565854	Q9Y6N9	0	-	17552829	17565854	255,102,0	1	13025	0	.	N-terminal	domain.	Pubmed:20142502
chr11	18528465	18531098	Q99816	0	-	18528465	18531098	255,102,0	1	2633	0	.	Interaction	with	CEP55.
chr11	18631410	18634036	Q68D10	0	-	18631410	18634036	255,102,0	1	2626	0	.	Important	for	interaction	with	histones.	Pubmed:23378026
chr11	18636110	18655804	Q68D10	0	-	18636110	18655804	255,102,0	1	19694	0	.	Important	for	interaction	with	DNA.	Pubmed:23378026
chr11	18751097	18751209	A8MXF1	0	-	18751097	18751209	255,102,0	1	112	0	.	Substrate	binding.
chr11	18751097	18751209	E9PLZ4	0	-	18751097	18751209	255,102,0	1	112	0	.	Substrate	binding.
chr11	18751097	18751209	P54829	0	-	18751097	18751209	255,102,0	1	112	0	.	Substrate	binding.
chr11	19207861	19209684	P50461	0	-	19207861	19209684	255,102,0	1	1823	0	.	Interaction	with	CLF2	and	isoform	2.	Pubmed:24860983,	Pubmed:19752190
chr11	19213980	19213995	P50461	0	-	19213980	19213995	255,102,0	1	15	0	.	Interaction	with	TCAP.	Pubmed:12507422
chr11	22849375	22849414	Q8NHG7	0	-	22849375	22849414	255,102,0	1	39	0	.	VCP/p97-interacting	motif	(VIM).	Pubmed:21896481
chr11	24936051	24998190	Q86TE4	0	+	24936051	24998190	255,102,0	1	62139	0	.	Leucine-zipper.
chr11	28232635	28232644	A6NJ78	0	+	28232635	28232644	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr11	30032800	30032842	P22459	0	-	30032800	30032842	255,102,0	1	42	0	.	S4-S5	linker.
chr11	32623849	32623942	Q7L2H7	0	+	32623849	32623942	255,102,0	1	93	0	.	Interaction	with	HSV-1	and	HSV-2.
chr11	33369551	33373178	Q9H422	0	+	33369551	33373178	255,102,0	1	3627	0	.	Interaction	with	AR.
chr11	33370083	33370699	Q9H422	0	+	33370083	33370699	255,102,0	1	616	0	.	Interaction	with	FAS.
chr11	33370260	33373379	Q9H422	0	+	33370260	33373379	255,102,0	1	3119	0	.	Required	for	localization	to	nuclear	speckles.
chr11	33370293	33370780	Q9H422	0	+	33370293	33370780	255,102,0	1	487	0	.	SUMO	interaction	motifs	(SIM);	required	for	nuclear	localization	and	kinase	activity.
chr11	33370305	33370338	Q9H422	0	+	33370305	33370338	255,102,0	1	33	0	.	Interaction	with	UBL1.
chr11	34107721	34107872	Q14444	0	+	34107721	34107872	255,102,0	1	151	0	.	G3BP1-binding.
chr11	34156106	34156115	A0A087WV29	0	+	34156106	34156115	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr11	34156106	34156115	Q9H0A0	0	+	34156106	34156115	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr11	34156127	34156736	A0A087WV29	0	+	34156127	34156736	255,102,0	1	609	0	.	Acetyl-CoA	binding.
chr11	34156127	34156736	Q9H0A0	0	+	34156127	34156736	255,102,0	1	609	0	.	Acetyl-CoA	binding.
chr11	34158263	34167736	Q9H0A0	0	+	34158263	34167736	255,102,0	1	9473	0	.	Required	for	localization	to	the	nucleolus	and	midbody.	Pubmed:19303003
chr11	35218294	35243202	P16070	0	+	35218294	35243202	255,102,0	1	24908	0	.	Stem.
chr11	36511390	36511894	Q9Y4K3	0	-	36511390	36511894	255,102,0	1	504	0	.	Interaction	with	TANK.	Pubmed:25861989
chr11	36511894	36523065	Q9Y4K3	0	-	36511894	36523065	255,102,0	1	11171	0	.	Interaction	with	TAX1BP1.	Pubmed:10920205
chr11	36594854	36595718	P15918	0	+	36594854	36595718	255,102,0	1	864	0	.	Interaction	with	importin	alpha-1.
chr11	43333680	43350396	Q9BZZ5	0	+	43333680	43350396	255,102,0	1	16716	0	.	ARM-like	and	Heat-like	helical	repeats.
chr11	43350423	43351560	Q9BZZ5	0	+	43350423	43351560	255,102,0	1	1137	0	.	Leucine-zipper.
chr11	43913640	43913649	Q96Q83	0	+	43913640	43913649	255,102,0	1	9	0	.	Substrate	binding.
chr11	43923140	43923149	Q96Q83	0	+	43923140	43923149	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.	Pubmed:16858410
chr11	43941503	43941524	Q96Q83	0	+	43941503	43941524	255,102,0	1	21	0	.	Alpha-ketoglutarate	binding.	Pubmed:16858410
chr11	44228395	44228413	Q93063	0	+	44228395	44228413	255,102,0	1	18	0	.	Substrate	binding.
chr11	44228458	44228467	Q93063	0	+	44228458	44228467	255,102,0	1	9	0	.	Substrate	binding.
chr11	44255727	44255742	Q93063	0	+	44255727	44255742	255,102,0	1	15	0	.	Substrate	binding.
chr11	44257890	44257926	Q93063	0	+	44257890	44257926	255,102,0	1	36	0	.	Substrate	binding.
chr11	45891341	45892001	Q49AN0	0	+	45891341	45892001	255,102,0	1	660	0	.	Required	for	inhibition	of	CLOCK-ARNTL-mediated	transcription.
chr11	45921859	45924173	Q9UQF2	0	+	45921859	45924173	255,102,0	1	2314	0	.	JNK-binding	domain	(JBD).
chr11	45921949	45923536	Q9UQF2	0	+	45921949	45923536	255,102,0	1	1587	0	.	Minimal	inhibitory	domain	(MID).
chr11	45924164	45924731	Q9UQF2	0	+	45924164	45924731	255,102,0	1	567	0	.	Interaction	with	MAP3K7.	Pubmed:17709393
chr11	45924728	45926717	Q9UQF2	0	+	45924728	45926717	255,102,0	1	1989	0	.	Interaction	with	VRK2.	Pubmed:18286207
chr11	45931807	45935900	Q9Y5Y5	0	-	45931807	45935900	255,102,0	1	4093	0	.	Interaction	with	PEX19.
chr11	45937369	45937807	Q9Y5Y5	0	-	45937369	45937807	255,102,0	1	438	0	.	Required	for	peroxisomal	location.
chr11	45945026	45948100	Q8N3Y3	0	+	45945026	45948100	255,102,0	1	3074	0	.	Xylosyltransferase	activity.
chr11	45948100	45950375	Q8N3Y3	0	+	45948100	45950375	255,102,0	1	2275	0	.	Glucuronyltransferase	activity.
chr11	45955521	45959857	Q96BD5	0	-	45955521	45959857	255,102,0	1	4336	0	.	Required	for	transcriptional	repression.
chr11	46299662	46321563	Q96BA8	0	+	46299662	46321563	255,102,0	1	21901	0	.	Required	for	transcriptional	activation.
chr11	46333995	46334222	Q96BA8	0	+	46333995	46334222	255,102,0	1	227	0	.	Basic	motif.
chr11	46334432	46337864	Q96BA8	0	+	46334432	46337864	255,102,0	1	3432	0	.	Leucine-zipper.
chr11	46393271	46393316	Q13574	0	+	46393271	46393316	255,102,0	1	45	0	.	MARCKS	homology.
chr11	46393627	46394576	Q13574	0	+	46393627	46394576	255,102,0	1	949	0	.	Mediates	interaction	with	RASGRP1.
chr11	46671787	46671811	O75143	0	+	46671787	46671811	255,102,0	1	24	0	.	Important	for	interaction	with	ATG101.	Pubmed:26299944
chr11	46751107	46760662	P00734	0	+	46751107	46760662	255,102,0	1	9555	0	.	High	affinity	receptor-binding	region	which	is	also	known	as	the	TP508	peptide.
chr11	46765800	46766038	Q14008	0	-	46765800	46766038	255,102,0	1	238	0	.	Interaction	with	TACC3.	Pubmed:25596274
chr11	46782271	46785141	Q14008	0	-	46782271	46785141	255,102,0	1	2870	0	.	TOG	5.	Pubmed:24966168
chr11	46791591	46800026	Q14008	0	-	46791591	46800026	255,102,0	1	8435	0	.	TOG	4.	Pubmed:24966168
chr11	46800131	46812022	Q14008	0	-	46800131	46812022	255,102,0	1	11891	0	.	TOG	3.	Pubmed:24966168
chr11	46817287	46831012	Q14008	0	-	46817287	46831012	255,102,0	1	13725	0	.	TOG	2.	Pubmed:24966168
chr11	46831385	46842782	Q14008	0	-	46831385	46842782	255,102,0	1	11396	0	.	TOG	1.	Pubmed:24966168
chr11	47187035	47196840	Q8N6H7	0	-	47187035	47196840	255,102,0	1	9805	0	.	Required	for	interaction	with	coatomer.
chr11	47237960	47237996	Q92466	0	+	47237960	47237996	255,102,0	1	36	0	.	Required	for	interaction	with	DDB1.
chr11	47238017	47238438	Q92466	0	+	47238017	47238438	255,102,0	1	421	0	.	Required	for	interaction	with	DDB1.
chr11	47256939	47256948	Q92466	0	+	47256939	47256948	255,102,0	1	9	0	.	Photolesion	recognition.
chr11	47280767	47282015	Q13133	0	+	47280767	47282015	255,102,0	1	1248	0	.	Transactivation	AF-1;	required	for	ligand-independent	transactivation	function.	Pubmed:25661920
chr11	47282904	47290244	Q13133	0	+	47282904	47290244	255,102,0	1	7340	0	.	Transactivation	AF-2;	required	for	ligand-dependent	transactivation	function;	mediates	interaction	with	CCAR2.	Pubmed:25661920
chr11	47282934	47290205	Q13133	0	+	47282934	47290205	255,102,0	1	7271	0	.	Ligand-binding.
chr11	48185165	48185947	Q12913	0	+	48185165	48185947	255,102,0	1	782	0	.	Substrate	binding.
chr11	49168460	49168466	Q04609	0	-	49168460	49168466	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17372356,	Pubmed:17567119
chr11	49175906	49207227	Q04609	0	-	49175906	49207227	255,102,0	1	31321	0	.	NAALADase.
chr11	49176008	49176014	Q04609	0	-	49176008	49176014	255,102,0	1	6	0	.	Substrate	binding.
chr11	49178283	49178292	Q04609	0	-	49178283	49178292	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:18234225,	Pubmed:19053759
chr11	49178337	49178343	Q04609	0	-	49178337	49178343	255,102,0	1	6	0	.	Substrate	binding.
chr11	57069665	57087653	Q9C0C2	0	-	57069665	57087653	255,102,0	1	17988	0	.	Acidic.
chr11	57069989	57070268	Q9C0C2	0	-	57069989	57070268	255,102,0	1	279	0	.	Tankyrase-binding.
chr11	57244063	57244102	Q86UN3	0	+	57244063	57244102	255,102,0	1	39	0	.	Important	for	interaction	with	MAG.
chr11	57317525	57317582	A8MU46	0	+	57317525	57317582	255,102,0	1	57	0	.	Calmodulin-binding.
chr11	57367552	57367657	P05155	0	+	57367552	57367657	255,102,0	1	105	0	.	7	X	4	AA	tandem	repeats	of	[QE]-P-T-[TQ].
chr11	58381725	58384190	Q96JP5	0	+	58381725	58384190	255,102,0	1	2465	0	.	Interaction	with	MAP3K14/NIK.	Pubmed:20682767
chr11	58920146	58920974	Q96PZ2	0	+	58920146	58920974	255,102,0	1	828	0	.	Interaction	with	SV40	large	T	antigen.
chr11	59361185	59361191	P22059	0	-	59361185	59361191	255,102,0	1	6	0	.	Phosphatidylinositol	4-phosphate	binding.
chr11	59361551	59361563	P22059	0	-	59361551	59361563	255,102,0	1	12	0	.	Phosphatidylinositol	4-phosphate	binding.
chr11	59361668	59368064	P22059	0	-	59361668	59368064	255,102,0	1	6396	0	.	Sterol	binding.
chr11	59378058	59382789	P22059	0	-	59378058	59382789	255,102,0	1	4731	0	.	Phosphatidylinositol	4-phosphate	binding.
chr11	59405865	59420018	Q86TB9	0	-	59405865	59420018	255,102,0	1	14153	0	.	Region	C.
chr11	59405865	59420421	Q86TB9	0	-	59405865	59420421	255,102,0	1	14556	0	.	Involved	in	nuclear	spleckles	localization.
chr11	59420018	59420448	Q86TB9	0	-	59420018	59420448	255,102,0	1	430	0	.	Region	H.
chr11	59420421	59424028	Q86TB9	0	-	59420421	59424028	255,102,0	1	3607	0	.	Involved	in	RNA-binding.
chr11	59420421	59436368	Q86TB9	0	-	59420421	59436368	255,102,0	1	15947	0	.	Involved	in	nuclear	foci	localization.
chr11	59420448	59426817	Q86TB9	0	-	59420448	59426817	255,102,0	1	6369	0	.	Region	N;	interaction	with	decapping	machinery.
chr11	59426817	59436368	Q86TB9	0	-	59426817	59436368	255,102,0	1	9551	0	.	Region	A;	interaction	with	DDX6/RCK.
chr11	59599157	59599187	P27352	0	-	59599157	59599187	255,102,0	1	30	0	.	Cobalamin	binding.
chr11	59599232	59599250	P27352	0	-	59599232	59599250	255,102,0	1	18	0	.	Cobalamin	binding.
chr11	59620450	59622249	P20061	0	-	59620450	59622249	255,102,0	1	1799	0	.	Globular	C-terminal	beta	domain.
chr11	59620703	59620712	P20061	0	-	59620703	59620712	255,102,0	1	9	0	.	Cobalamin	binding.
chr11	59622249	59623348	P20061	0	-	59622249	59623348	255,102,0	1	1099	0	.	Flexible	linker.
chr11	59623348	59633874	P20061	0	-	59623348	59633874	255,102,0	1	10526	0	.	Globular	N-terminal	alpha	domain.
chr11	59626738	59629012	P20061	0	-	59626738	59629012	255,102,0	1	2274	0	.	Cobalamin	binding.
chr11	59629117	59629132	P20061	0	-	59629117	59629132	255,102,0	1	15	0	.	Cobalamin	binding.
chr11	60230534	60230555	P11836	0	+	60230534	60230555	255,102,0	1	21	0	.	Epitope	1.
chr11	60233492	60233537	P11836	0	+	60233492	60233537	255,102,0	1	45	0	.	Epitope	2.
chr11	60233558	60233582	P11836	0	+	60233558	60233582	255,102,0	1	24	0	.	Epitope	3	(recognized	by	antibodies,	including	Rituximab).
chr11	60668374	60670975	Q9UMS4	0	-	60668374	60670975	255,102,0	1	2601	0	.	May	mediate	interaction	with	PSMC5.
chr11	60702230	60704055	Q24JP5	0	+	60702230	60704055	255,102,0	1	1825	0	.	Binds	to	HSPA5/GRP78.
chr11	60702897	60704376	Q24JP5	0	+	60702897	60704376	255,102,0	1	1479	0	.	Confers	cellular	localization	similar	to	full-length	form.
chr11	61067610	61077857	Q16531	0	-	61067610	61077857	255,102,0	1	10247	0	.	Interaction	with	CDT1	and	CUL4A.	Pubmed:15448697
chr11	61069814	61079501	Q16531	0	-	61069814	61079501	255,102,0	1	9687	0	.	WD	repeat	beta-propeller	C.
chr11	61077863	61100437	Q16531	0	-	61077863	61100437	255,102,0	1	22574	0	.	Interaction	with	CDT1.	Pubmed:15448697
chr11	61079501	61089118	Q16531	0	-	61079501	61089118	255,102,0	1	9617	0	.	WD	repeat	beta-propeller	B;	Interaction	with	CUL4A.
chr11	61089821	61100404	Q16531	0	-	61089821	61100404	255,102,0	1	10583	0	.	WD	repeat	beta-propeller	A.
chr11	61105574	61105586	Q3LXA3	0	+	61105574	61105586	255,102,0	1	12	0	.	Dihydroxyacetone	binding.
chr11	61562833	61563145	P39748	0	+	61562833	61563145	255,102,0	1	312	0	.	N-domain.
chr11	61562833	61563145	Q6FHX6	0	+	61562833	61563145	255,102,0	1	312	0	.	N-domain.
chr11	61563196	61563592	P39748	0	+	61563196	61563592	255,102,0	1	396	0	.	I-domain.
chr11	61563196	61563592	Q6FHX6	0	+	61563196	61563592	255,102,0	1	396	0	.	I-domain.
chr11	61563838	61563865	P39748	0	+	61563838	61563865	255,102,0	1	27	0	.	Interaction	with	PCNA.	Pubmed:9305916
chr11	61563838	61563865	Q6FHX6	0	+	61563838	61563865	255,102,0	1	27	0	.	Interaction	with	PCNA.
chr11	61897368	61897743	Q9NQS7	0	+	61897368	61897743	255,102,0	1	375	0	.	Interaction	with	CBX5.	Pubmed:21346195
chr11	61908513	61916222	Q9NQS7	0	+	61908513	61916222	255,102,0	1	7709	0	.	SAH.
chr11	61917600	61919382	Q9NQS7	0	+	61917600	61919382	255,102,0	1	1782	0	.	Interaction	with	AURKC.	Pubmed:27332895
chr11	61917612	61919391	Q9NQS7	0	+	61917612	61919391	255,102,0	1	1779	0	.	IN	box.
chr11	62156698	62156710	Q7L266	0	+	62156698	62156710	255,102,0	1	12	0	.	Substrate	binding.
chr11	62159037	62159049	Q7L266	0	+	62159037	62159049	255,102,0	1	12	0	.	Substrate	binding.
chr11	62384130	62384160	O94766	0	-	62384130	62384160	255,102,0	1	30	0	.	Interaction	with	galactose	moiety	of	substrate	glycoprotein.
chr11	62439283	62439544	Q6UW78	0	+	62439283	62439544	255,102,0	1	261	0	.	Mediates	lipid-binding.	Pubmed:25605331
chr11	62444064	62446060	Q04323	0	-	62444064	62446060	255,102,0	1	1996	0	.	Interaction	with	BRCA1.	Pubmed:20351172
chr11	62569255	62572825	Q9UBU9	0	-	62569255	62572825	255,102,0	1	3570	0	.	Interaction	with	ALYREF/THOC4	and	LUZP4.	Pubmed:25662211
chr11	62570905	62571298	Q9UBU9	0	-	62570905	62571298	255,102,0	1	393	0	.	Major	non-specific	RNA-binding.
chr11	62570905	62572825	Q9UBU9	0	-	62570905	62572825	255,102,0	1	1920	0	.	RNA-binding	(RBD).
chr11	62571298	62572825	Q9UBU9	0	-	62571298	62572825	255,102,0	1	1527	0	.	Minor	non-specific	RNA-binding.
chr11	63521144	63525670	O95197	0	+	63521144	63525670	255,102,0	1	4526	0	.	Interaction	with	FADD.	Pubmed:17031492
chr11	63523586	63523595	O95197	0	+	63523586	63523595	255,102,0	1	9	0	.	Interaction	with	BACE1.
chr11	63720005	63720014	Q86UY6	0	+	63720005	63720014	255,102,0	1	9	0	.	Sustrate	binding.	Pubmed:25619998
chr11	63720234	63720243	Q86UY6	0	+	63720234	63720243	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:25619998
chr11	63720258	63720276	Q86UY6	0	+	63720258	63720276	255,102,0	1	18	0	.	Acetyl-CoA	binding.	Pubmed:25619998
chr11	63764377	63764404	Q96FW1	0	+	63764377	63764404	255,102,0	1	27	0	.	Ubiquitin-conjugating	enzyme	E2	binding.	Pubmed:22325355
chr11	63764602	63764629	Q96FW1	0	+	63764602	63764629	255,102,0	1	27	0	.	Ubiquitin-conjugating	enzyme	E2	binding.	Pubmed:22325355
chr11	63764662	63764683	Q96FW1	0	+	63764662	63764683	255,102,0	1	21	0	.	Free	ubiquitin	binding.	Pubmed:22367539,	Pubmed:22325355
chr11	63764713	63764841	Q96FW1	0	+	63764713	63764841	255,102,0	1	128	0	.	Ubiquitin-conjugating	enzyme	E2	binding.	Pubmed:22367539,	Pubmed:22325355
chr11	63764841	63764865	Q96FW1	0	+	63764841	63764865	255,102,0	1	24	0	.	Free	ubiquitin	binding.	Pubmed:22367539,	Pubmed:22325355
chr11	63764934	63764955	Q96FW1	0	+	63764934	63764955	255,102,0	1	21	0	.	Free	ubiquitin	binding.	Pubmed:22367539,	Pubmed:22325355
chr11	63766874	63767020	Q9BQ69	0	-	63766874	63767020	255,102,0	1	146	0	.	Substrate	binding.
chr11	63767810	63782736	Q9BQ69	0	-	63767810	63782736	255,102,0	1	14926	0	.	Substrate	binding.
chr11	63782748	63918714	Q9BQ69	0	-	63782748	63918714	255,102,0	1	135966	0	.	Substrate	binding.
chr11	63918744	63918753	Q9BQ69	0	-	63918744	63918753	255,102,0	1	9	0	.	Substrate	binding.
chr11	64035013	64035025	Q01970	0	+	64035013	64035025	255,102,0	1	12	0	.	Interaction	with	SHANK2.
chr11	64064466	64064601	Q9NYG8	0	+	64064466	64064601	255,102,0	1	135	0	.	Selectivity	filter	1.	Pubmed:23341632,	Pubmed:25500157
chr11	64065097	64065115	Q9NYG8	0	+	64065097	64065115	255,102,0	1	18	0	.	Selectivity	filter	2.	Pubmed:23341632,	Pubmed:25500157
chr11	64074651	64074879	P11474	0	+	64074651	64074879	255,102,0	1	228	0	.	Repressor	domain.
chr11	64082256	64083372	P11474	0	+	64082256	64083372	255,102,0	1	1116	0	.	Ligand	binding	domain.
chr11	64083372	64083435	P11474	0	+	64083372	64083435	255,102,0	1	63	0	.	AF-2	domain.
chr11	64138805	64138949	O75676	0	+	64138805	64138949	255,102,0	1	144	0	.	Required	for	nuclear	targeting	and	association	with	MAPK14.
chr11	64564596	64564810	Q12851	0	-	64564596	64564810	255,102,0	1	214	0	.	PEST3.
chr11	64566282	64566916	Q12851	0	-	64566282	64566916	255,102,0	1	634	0	.	PEST2.
chr11	64567128	64567616	Q12851	0	-	64567128	64567616	255,102,0	1	488	0	.	PEST1.
chr11	64573121	64575377	O00255	0	-	64573121	64575377	255,102,0	1	2256	0	.	Interaction	with	FANCD2.	Pubmed:12874027
chr11	64757227	64761928	Q8N1L9	0	-	64757227	64761928	255,102,0	1	4701	0	.	Leucine-zipper.
chr11	64761937	64762003	Q8N1L9	0	-	64761937	64762003	255,102,0	1	66	0	.	Basic	motif.
chr11	64813778	64822027	Q9UQQ1	0	-	64813778	64822027	255,102,0	1	8249	0	.	NAALADase.
chr11	64898616	64898797	Q86TM6	0	-	64898616	64898797	255,102,0	1	181	0	.	Interaction	with	p53/TP53.	Pubmed:17170702
chr11	64900946	64901012	Q86TM6	0	-	64900946	64901012	255,102,0	1	66	0	.	Interaction	with	SEL1L.
chr11	64938936	64940202	Q5MJ68	0	+	64938936	64940202	255,102,0	1	1266	0	.	Speedy/Ringo	box;	Required	for	CDK-binding.
chr11	64956114	64974263	P07384	0	+	64956114	64974263	255,102,0	1	18149	0	.	Domain	III.
chr11	64974263	64975546	P07384	0	+	64974263	64975546	255,102,0	1	1283	0	.	Linker.
chr11	64975546	64978751	P07384	0	+	64975546	64978751	255,102,0	1	3205	0	.	Domain	IV.
chr11	65305986	65306034	Q96KG9	0	+	65305986	65306034	255,102,0	1	48	0	.	Interaction	with	COPB1.
chr11	65357572	65359704	Q8N3D4	0	+	65357572	65359704	255,102,0	1	2132	0	.	RAB-binding	domain	(RBD).	Pubmed:27552051
chr11	65374852	65374918	Q16584	0	-	65374852	65374918	255,102,0	1	66	0	.	Leucine-zipper	2.
chr11	65374957	65375150	Q16584	0	-	65374957	65375150	255,102,0	1	193	0	.	Leucine-zipper	1.
chr11	65422127	65422262	Q04206	0	-	65422127	65422262	255,102,0	1	135	0	.	Activation	domain.
chr11	65484389	65486649	Q92993	0	+	65484389	65486649	255,102,0	1	2260	0	.	Interaction	with	ATF2.	Pubmed:18397884
chr11	65484395	65484404	Q92993	0	+	65484395	65484404	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr11	65484416	65484437	Q92993	0	+	65484416	65484437	255,102,0	1	21	0	.	Acetyl-CoA	binding.
chr11	65629438	65630662	Q96NY9	0	+	65629438	65630662	255,102,0	1	1224	0	.	Interaction	with	BLM.	Pubmed:15805243
chr11	65660689	65661493	P15407	0	-	65660689	65661493	255,102,0	1	804	0	.	Leucine-zipper.
chr11	65661508	65661571	P15407	0	-	65661508	65661571	255,102,0	1	63	0	.	Basic	motif.
chr11	65977889	65977913	Q6VY07	0	+	65977889	65977913	255,102,0	1	24	0	.	Involved	in	binding	to	AP-1.
chr11	66039841	66039901	Q9H0U4	0	+	66039841	66039901	255,102,0	1	60	0	.	Switch	2	region;	required	for	interaction	with	REP1/CHM.
chr11	66099917	66102390	Q13671	0	-	66099917	66102390	255,102,0	1	2473	0	.	Ras	and	14-3-3	protein	binding	region.
chr11	66188650	66188689	Q8IUM7	0	+	66188650	66188689	255,102,0	1	39	0	.	Basic	motif;	degenerate.
chr11	66188689	66188809	Q8IUM7	0	+	66188689	66188809	255,102,0	1	120	0	.	Helix-loop-helix	motif.
chr11	66366940	66373203	O14618	0	+	66366940	66373203	255,102,0	1	6263	0	.	Superoxide	dismutase-like.
chr11	66392265	66392409	Q96PK6	0	+	66392265	66392409	255,102,0	1	144	0	.	TRBP-interacting	domain;	interaction	with	STIL.	Pubmed:25385835
chr11	66411093	66411600	Q9BWF3	0	+	66411093	66411600	255,102,0	1	507	0	.	Interaction	with	TNPO3.	Pubmed:12628928
chr11	66436097	66436589	Q9BQ04	0	-	66436097	66436589	255,102,0	1	492	0	.	Interaction	with	TNPO3.
chr11	66620009	66620024	P11498	0	-	66620009	66620024	255,102,0	1	15	0	.	Substrate	binding.
chr11	67034170	67048578	P25098	0	+	67034170	67048578	255,102,0	1	14408	0	.	N-terminal.
chr11	67160169	67161005	Q99638	0	+	67160169	67161005	255,102,0	1	836	0	.	Possesses	3'-5'	exonuclease	activity.
chr11	67163794	67165027	Q99638	0	+	67163794	67165027	255,102,0	1	1233	0	.	Sufficient	for	interaction	with	ABL1.	Pubmed:11971963
chr11	67177099	67177222	Q8IV04	0	+	67177099	67177222	255,102,0	1	123	0	.	Interaction	with	calcineurin.
chr11	67352164	67352170	P09211	0	+	67352164	67352170	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:19396894,	Pubmed:9012673,	Pubmed:9351803
chr11	67352203	67352209	P09211	0	+	67352203	67352209	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:19396894,	Pubmed:9012673,	Pubmed:9351803
chr11	67410200	67412519	Q96HD9	0	-	67410200	67412519	255,102,0	1	2319	0	.	Shielding	domain.
chr11	67412519	67414514	Q96HD9	0	-	67412519	67414514	255,102,0	1	1995	0	.	Hydrolytic	domain.
chr11	67414301	67414307	Q96HD9	0	-	67414301	67414307	255,102,0	1	6	0	.	Substrate	binding.
chr11	67864584	67864593	P35790	0	-	67864584	67864593	255,102,0	1	9	0	.	Substrate	binding.
chr11	68115316	68131392	O75197	0	+	68115316	68131392	255,102,0	1	16076	0	.	Beta-propeller	1.
chr11	68153788	68173996	O75197	0	+	68153788	68173996	255,102,0	1	20208	0	.	Beta-propeller	2.
chr11	68174119	68181362	O75197	0	+	68174119	68181362	255,102,0	1	7243	0	.	Beta-propeller	3.
chr11	68183800	68193654	O75197	0	+	68183800	68193654	255,102,0	1	9854	0	.	Beta-propeller	4.
chr11	68540771	68540810	P50416	0	-	68540771	68540810	255,102,0	1	39	0	.	Coenzyme	A	binding.
chr11	68703859	68704303	P38935	0	+	68703859	68704303	255,102,0	1	444	0	.	SS	DNA-binding.
chr11	71191899	71212395	Q6IA69	0	+	71191899	71212395	255,102,0	1	20496	0	.	Ligase.
chr11	71238448	71238820	Q6L8G8	0	+	71238448	71238820	255,102,0	1	372	0	.	7	X	4	AA	repeats	of	C-C-X-P.
chr11	71249182	71249641	O75690	0	+	71249182	71249641	255,102,0	1	459	0	.	9	X	4	AA	repeats	of	C-C-X-P.
chr11	71259805	71260189	P26371	0	+	71259805	71260189	255,102,0	1	384	0	.	8	X	4	AA	repeats	of	C-C-X-P.
chr11	71276774	71277218	Q6L8G5	0	+	71276774	71277218	255,102,0	1	444	0	.	7	X	4	AA	repeats	of	C-C-X-P.
chr11	71293436	71293781	Q6L8G4	0	-	71293436	71293781	255,102,0	1	345	0	.	6	X	4	AA	repeats	of	C-C-X-P.
chr11	71714575	71719852	Q14980	0	-	71714575	71719852	255,102,0	1	5277	0	.	Tail	(Globular).
chr11	71716299	71717177	Q14980	0	-	71716299	71717177	255,102,0	1	878	0	.	Interaction	with	microtubules.	Pubmed:11956313
chr11	71716347	71716404	Q14980	0	-	71716347	71716404	255,102,0	1	57	0	.	Interaction	with	GPSM2.	Pubmed:21816348
chr11	71729974	71746989	Q14980	0	-	71729974	71746989	255,102,0	1	17015	0	.	Head	(Globular).
chr11	71808870	71809367	Q6IAA8	0	-	71808870	71809367	255,102,0	1	497	0	.	Interaction	with	LAMTOR2	and	LAMTOR3.
chr11	71819024	71819030	Q8WZ04	0	+	71819024	71819030	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr11	71906667	71906682	P15328	0	+	71906667	71906682	255,102,0	1	15	0	.	Folate	binding.	Pubmed:23851396
chr11	71906766	71906784	P15328	0	+	71906766	71906784	255,102,0	1	18	0	.	Folate	binding.	Pubmed:23851396
chr11	71932231	71932246	P14207	0	+	71932231	71932246	255,102,0	1	15	0	.	Folate	binding.
chr11	71932330	71932348	P14207	0	+	71932330	71932348	255,102,0	1	18	0	.	Folate	binding.
chr11	72288580	72292946	O00408	0	-	72288580	72292946	255,102,0	1	4366	0	.	Catalytic.
chr11	72292465	72292480	O00408	0	-	72292465	72292480	255,102,0	1	15	0	.	Substrate	binding.
chr11	73686087	73686156	P55851	0	-	73686087	73686156	255,102,0	1	69	0	.	Purine	nucleotide	binding.
chr11	73712492	73712561	P55916	0	-	73712492	73712561	255,102,0	1	69	0	.	Purine	nucleotide	binding.
chr11	74054371	74054380	Q6PCE3	0	-	74054371	74054380	255,102,0	1	9	0	.	Substrate	binding.
chr11	74057802	74057808	Q6PCE3	0	-	74057802	74057808	255,102,0	1	6	0	.	Substrate	binding.
chr11	74079563	74079569	Q6PCE3	0	-	74079563	74079569	255,102,0	1	6	0	.	Substrate	binding.
chr11	74203368	74203377	A6NK58	0	-	74203368	74203377	255,102,0	1	9	0	.	Substrate	binding.
chr11	74203407	74204289	A6NK58	0	-	74203407	74204289	255,102,0	1	882	0	.	Substrate	binding.
chr11	74204472	74204496	A6NK58	0	-	74204472	74204496	255,102,0	1	24	0	.	Substrate	binding.
chr11	74351775	74351808	Q15054	0	+	74351775	74351808	255,102,0	1	33	0	.	Interaction	with	PCNA.	Pubmed:11595739,	Pubmed:22148433
chr11	74977209	74983985	P49407	0	-	74977209	74983985	255,102,0	1	6776	0	.	Interaction	with	TRAF6.	Pubmed:16378096
chr11	74989781	75062651	P49407	0	-	74989781	75062651	255,102,0	1	72870	0	.	Interaction	with	SRC.
chr11	74994426	74995303	P49407	0	-	74994426	74995303	255,102,0	1	877	0	.	Interaction	with	CHRM2.
chr11	75316974	75317019	Q96JE9	0	-	75316974	75317019	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75319159	75319204	Q96JE9	0	-	75319159	75319204	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75319309	75378523	Q96JE9	0	-	75319309	75378523	255,102,0	1	59214	0	.	Mn	3.
chr11	75319312	75319357	Q96JE9	0	-	75319312	75319357	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75378805	75378850	Q96JE9	0	-	75378805	75378850	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75378886	75378931	Q96JE9	0	-	75378886	75378931	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75378886	75378958	Q96JE9	0	-	75378886	75378958	255,102,0	1	72	0	.	Mn	2.
chr11	75378991	75379063	Q96JE9	0	-	75378991	75379063	255,102,0	1	72	0	.	Mn	1.
chr11	75378994	75379039	Q96JE9	0	-	75378994	75379039	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75672491	75694538	Q9P2Y5	0	+	75672491	75694538	255,102,0	1	22047	0	.	Sufficient	for	interaction	with	STX7;	VTI1B	AND	STX8.	Pubmed:24550300
chr11	75694538	75826988	Q9P2Y5	0	+	75694538	75826988	255,102,0	1	132450	0	.	Sufficient	for	interaction	with	VPS16,	required	for	interaction	with	CEP63.	Pubmed:22542840,	Pubmed:18552835
chr11	75826988	75852454	Q9P2Y5	0	+	75826988	75852454	255,102,0	1	25466	0	.	Required	for	interaction	with	PRKDC,	XRCC6	and	XRCC5.	Pubmed:22542840
chr11	76157982	76224500	Q7Z589	0	+	76157982	76224500	255,102,0	1	66518	0	.	Interaction	with	BRCA2.	Pubmed:14651845
chr11	76169290	76169305	Q7Z589	0	+	76169290	76169305	255,102,0	1	15	0	.	Interaction	with	ZMYND11.
chr11	76829260	76831956	O15484	0	+	76829260	76831956	255,102,0	1	2696	0	.	Domain	III.
chr11	76883889	76883913	Q13402	0	+	76883889	76883913	255,102,0	1	24	0	.	Actin-binding.
chr11	76890984	76892536	Q13402	0	+	76890984	76892536	255,102,0	1	1552	0	.	SAH.	Pubmed:25122759
chr11	77064606	77090331	Q13153	0	-	77064606	77090331	255,102,0	1	25725	0	.	Interaction	with	CRIPAK.	Pubmed:16278681
chr11	77090304	77091022	Q13153	0	-	77090304	77091022	255,102,0	1	718	0	.	Autoregulatory	region.
chr11	77090409	77091007	Q13153	0	-	77090409	77091007	255,102,0	1	598	0	.	GTPase-binding.
chr11	77553557	77583358	Q9H7C9	0	+	77553557	77583358	255,102,0	1	29801	0	.	MTH138-like	domain.
chr11	82550386	82561379	P42785	0	-	82550386	82561379	255,102,0	1	10993	0	.	SKS	domain.
chr11	85372473	85372581	Q9NS37	0	-	85372473	85372581	255,102,0	1	108	0	.	Leucine-zipper.
chr11	85372596	85372620	Q9NS37	0	-	85372596	85372620	255,102,0	1	24	0	.	Basic	motif.
chr11	85375118	85375226	Q9NS37	0	-	85375118	85375226	255,102,0	1	108	0	.	Leucine-zipper.
chr11	85375241	85375265	Q9NS37	0	-	85375241	85375265	255,102,0	1	24	0	.	Basic	motif.
chr11	85714419	85722177	Q13492	0	-	85714419	85722177	255,102,0	1	7758	0	.	Interaction	with	FAM64A.	Pubmed:16491119
chr11	85961463	85989564	O75530	0	+	85961463	85989564	255,102,0	1	28101	0	.	Interaction	with	EZH2.
chr11	85967446	85979546	O75530	0	+	85967446	85979546	255,102,0	1	12100	0	.	Required	for	interaction	with	the	matrix	protein	MA	of	HIV-1.
chr11	85979537	85989564	O75530	0	+	85979537	85989564	255,102,0	1	10027	0	.	Required	for	interaction	with	the	matrix	protein	MA	of	HIV-1.
chr11	88300423	88300438	P41594	0	-	88300423	88300438	255,102,0	1	15	0	.	Allosteric	effector	binding.
chr11	88780515	88780524	P41594	0	-	88780515	88780524	255,102,0	1	9	0	.	Glutamate	binding.
chr11	89059935	89135598	Q9NPH5	0	-	89059935	89135598	255,102,0	1	75663	0	.	Mediates	interaction	with	TLR4.	Pubmed:15356101
chr11	89885645	89911158	Q9Y3Q0	0	+	89885645	89911158	255,102,0	1	25513	0	.	NAALADase.
chr11	89909155	89909161	Q9Y3Q0	0	+	89909155	89909161	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:19678840
chr11	89909206	89909215	Q9Y3Q0	0	+	89909206	89909215	255,102,0	1	9	0	.	Substrate	binding.
chr11	89911050	89911056	Q9Y3Q0	0	+	89911050	89911056	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:19678840
chr11	89924756	89924762	Q9Y3Q0	0	+	89924756	89924762	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:19678840
chr11	89935623	89947322	Q9UHD1	0	-	89935623	89947322	255,102,0	1	11699	0	.	Interaction	with	HSP90AA1	and	HSP90AB1.
chr11	89947283	89956119	Q9UHD1	0	-	89947283	89956119	255,102,0	1	8836	0	.	Interaction	with	PPP5C.
chr11	93462811	93463432	Q9C0D2	0	+	93462811	93463432	255,102,0	1	621	0	.	ALMS	motif.
chr11	94039723	94039783	A6ND01	0	+	94039723	94039783	255,102,0	1	60	0	.	Important	for	interaction	with	IZUMO1.	Pubmed:27309808,	Pubmed:27309818
chr11	94906421	94917593	P58005	0	-	94906421	94917593	255,102,0	1	11172	0	.	C-terminal	domain;	mediates	TORC1	regulation.
chr11	94910962	94910974	P58005	0	-	94910962	94910974	255,102,0	1	12	0	.	Leucine-binding.
chr11	95532521	95555052	Q86XR8	0	+	95532521	95555052	255,102,0	1	22531	0	.	centrosome	localization	domain	(CLD).
chr11	95555683	95564390	Q86XR8	0	+	95555683	95564390	255,102,0	1	8707	0	.	Mediates	interaction	with	microtubules.
chr11	95578233	95578254	Q13614	0	-	95578233	95578254	255,102,0	1	21	0	.	Substrate	binding.	Pubmed:14690594
chr11	95580988	95580994	Q13614	0	-	95580988	95580994	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:14690594
chr11	95581057	95582843	Q13614	0	-	95581057	95582843	255,102,0	1	1786	0	.	Substrate	binding.	Pubmed:14690594
chr11	100909849	100933331	P06401	0	-	100909849	100933331	255,102,0	1	23482	0	.	AF2;	mediates	transcriptional	activation.	Pubmed:1587864
chr11	100909849	100933349	P06401	0	-	100909849	100933349	255,102,0	1	23500	0	.	Steroid-binding.
chr11	100996828	100999801	P06401	0	-	100996828	100999801	255,102,0	1	2973	0	.	Modulating,	Pro-Rich.
chr11	100998163	100998436	P06401	0	-	100998163	100998436	255,102,0	1	273	0	.	AF1;	mediates	transcriptional	activation.	Pubmed:1587864
chr11	100998886	100999309	P06401	0	-	100998886	100999309	255,102,0	1	423	0	.	Mediates	transcriptional	transrepression	(in	isoform	A).	Pubmed:9407067
chr11	100999309	100999801	P06401	0	-	100999309	100999801	255,102,0	1	492	0	.	AF3;	mediates	transcriptional	activation	(in	isoform	B).	Pubmed:11546784
chr11	102076691	102100668	P46937	0	+	102076691	102100668	255,102,0	1	23977	0	.	Transactivation	domain.
chr11	102562499	102562643	Q9H306	0	-	102562499	102562643	255,102,0	1	144	0	.	Required	for	retention	in	the	endoplasmic	reticulum.	Pubmed:24548619
chr11	102665975	102668045	P03956	0	-	102665975	102668045	255,102,0	1	2070	0	.	Metalloprotease.
chr11	102814997	102820954	P45452	0	-	102814997	102820954	255,102,0	1	5957	0	.	Interaction	with	collagen.
chr11	102822801	102824996	P45452	0	-	102822801	102824996	255,102,0	1	2195	0	.	Interaction	with	TIMP2.
chr11	102980303	103039671	Q8NCM8	0	+	102980303	103039671	255,102,0	1	59368	0	.	Stem.
chr11	103039671	103044850	Q8NCM8	0	+	103039671	103044850	255,102,0	1	5179	0	.	AAA	1.
chr11	103047100	103055630	Q8NCM8	0	+	103047100	103055630	255,102,0	1	8530	0	.	AAA	2.
chr11	103057087	103062323	Q8NCM8	0	+	103057087	103062323	255,102,0	1	5236	0	.	AAA	3.
chr11	103069965	103082567	Q8NCM8	0	+	103069965	103082567	255,102,0	1	12602	0	.	AAA	4.
chr11	103082618	103104829	Q8NCM8	0	+	103082618	103104829	255,102,0	1	22211	0	.	Stalk.
chr11	103107178	103126927	Q8NCM8	0	+	103107178	103126927	255,102,0	1	19749	0	.	AAA	5.
chr11	103158306	103187339	Q8NCM8	0	+	103158306	103187339	255,102,0	1	29033	0	.	AAA	6.
chr11	104825558	104839252	P49662	0	-	104825558	104839252	255,102,0	1	13694	0	.	Required	for	LPS-binding.
chr11	105795145	105795154	P48058	0	+	105795145	105795154	255,102,0	1	9	0	.	Glutamate	binding.
chr11	105797644	105797650	P48058	0	+	105797644	105797650	255,102,0	1	6	0	.	Glutamate	binding.
chr11	105950265	105950283	Q9NRN7	0	+	105950265	105950283	255,102,0	1	18	0	.	Coenzyme	A	binding.
chr11	105950331	105950343	Q9NRN7	0	+	105950331	105950343	255,102,0	1	12	0	.	Coenzyme	A	binding.
chr11	105962051	105962066	Q9NRN7	0	+	105962051	105962066	255,102,0	1	15	0	.	Coenzyme	A	binding.
chr11	107375386	107393081	Q96BT7	0	-	107375386	107393081	255,102,0	1	17695	0	.	Methyltransferase	domain.
chr11	107422546	107422555	Q96BT7	0	-	107422546	107422555	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.	Pubmed:22065580
chr11	108012372	108012381	A0A140VJX1	0	+	108012372	108012381	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr11	108012372	108012381	P24752	0	+	108012372	108012381	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr11	108031765	108031840	Q14207	0	-	108031765	108031840	255,102,0	1	75	0	.	Required	for	acceleration	of	G1	phase.
chr11	108032056	108032131	Q14207	0	-	108032056	108032131	255,102,0	1	75	0	.	Required	for	acceleration	of	G1	phase.
chr11	108032650	108032698	Q14207	0	-	108032650	108032698	255,102,0	1	48	0	.	Required	for	acceleration	of	G1	phase.
chr11	108043151	108043229	Q14207	0	-	108043151	108043229	255,102,0	1	78	0	.	Required	for	acceleration	of	G1	phase.
chr11	108043751	108043826	Q14207	0	-	108043751	108043826	255,102,0	1	75	0	.	Required	for	acceleration	of	G1	phase.
chr11	108047090	108056164	Q14207	0	-	108047090	108056164	255,102,0	1	9074	0	.	Mediates	transcriptional	activation.
chr11	108047769	108093263	Q14207	0	-	108047769	108093263	255,102,0	1	45494	0	.	Interaction	with	MIZF.	Pubmed:15988025
chr11	108059953	108060028	Q14207	0	-	108059953	108060028	255,102,0	1	75	0	.	Required	for	activation	of	histone	gene	transcription	and	interaction	with	MIZF.	Pubmed:15988025
chr11	108068109	108093251	Q14207	0	-	108068109	108093251	255,102,0	1	25142	0	.	Required	for	activation	of	histone	gene	transcription	and	interaction	with	MIZF.	Pubmed:15988025
chr11	108159710	108159740	Q13315	0	+	108159710	108159740	255,102,0	1	30	0	.	Interaction	with	ABL1.	Pubmed:9168117
chr11	110135506	110135518	P35241	0	-	110135506	110135518	255,102,0	1	12	0	.	Phosphatidylinositol	binding.
chr11	111431021	111431156	Q6UX15	0	+	111431021	111431156	255,102,0	1	135	0	.	Interaction	with	NF2.
chr11	111431042	111431180	Q6UX15	0	+	111431042	111431180	255,102,0	1	138	0	.	Interaction	with	TLN1.
chr11	111431051	111431159	Q6UX15	0	+	111431051	111431159	255,102,0	1	108	0	.	3	X	5	AA	repeats	of	E-S-G-X-V.
chr11	111431099	111431174	Q6UX15	0	+	111431099	111431174	255,102,0	1	75	0	.	2	X	4	AA	repeats	of	N-X-I-Y.
chr11	111915912	111933256	P10515	0	+	111915912	111933256	255,102,0	1	17344	0	.	Catalytic.
chr11	113281598	113281625	P14416	0	-	113281598	113281625	255,102,0	1	27	0	.	Agonist	binding.
chr11	113283296	113286235	P14416	0	-	113283296	113286235	255,102,0	1	2939	0	.	Interaction	with	PPP1R9B.
chr11	113286274	113286298	P14416	0	-	113286274	113286298	255,102,0	1	24	0	.	Agonist	binding.
chr11	113619116	113644385	O43264	0	-	113619116	113644385	255,102,0	1	25269	0	.	Interaction	with	RINT1.
chr11	113631637	113644385	O43264	0	-	113631637	113644385	255,102,0	1	12748	0	.	Interaction	with	ZWINT.
chr11	113816673	113816772	O95264	0	+	113816673	113816772	255,102,0	1	99	0	.	HA-stretch.
chr11	113860287	113860398	P46098	0	+	113860287	113860398	255,102,0	1	111	0	.	HA-stretch.
chr11	114168704	114168710	P40261	0	+	114168704	114168710	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr11	114168704	114168710	Q6FH49	0	+	114168704	114168710	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr11	114182827	114182833	P40261	0	+	114182827	114182833	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr11	114182827	114182833	Q6FH49	0	+	114182827	114182833	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr11	116703501	116703597	P02656	0	+	116703501	116703597	255,102,0	1	96	0	.	Lipid-binding.
chr11	116706526	116707126	P02647	0	-	116706526	116707126	255,102,0	1	600	0	.	10	X	approximate	tandem	repeats.
chr11	117209302	117233149	Q9UPV0	0	+	117209302	117233149	255,102,0	1	23847	0	.	Interaction	with	ATRIP.	Pubmed:18283122
chr11	118392692	118392698	Q03164	0	+	118392692	118392698	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr11	118531617	118531870	O43280	0	-	118531617	118531870	255,102,0	1	253	0	.	Substrate	binding.
chr11	118532166	118532175	O43280	0	-	118532166	118532175	255,102,0	1	9	0	.	Substrate	binding.
chr11	118532434	118532600	O43280	0	-	118532434	118532600	255,102,0	1	166	0	.	Substrate	binding.
chr11	118772852	118773542	Q86UU0	0	-	118772852	118773542	255,102,0	1	690	0	.	Necessary	for	interaction	with	CTNNB1.
chr11	119003906	119005205	Q9BQA5	0	+	119003906	119005205	255,102,0	1	1299	0	.	Interaction	with	NPAT.	Pubmed:15988025
chr11	119003909	119004875	Q9BQA5	0	+	119003909	119004875	255,102,0	1	966	0	.	Required	for	activation	of	histone	H4	transcription	and	contributes	to	DNA-binding.
chr11	119043691	119045980	Q86UT6	0	+	119043691	119045980	255,102,0	1	2289	0	.	Required	for	interaction	with	MAVS.	Pubmed:18200010
chr11	119045977	119054142	Q86UT6	0	+	119045977	119054142	255,102,0	1	8165	0	.	Required	for	the	repression	of	MAVS-induced	interferon	signaling.
chr11	119077127	119148530	P22681	0	+	119077127	119148530	255,102,0	1	71403	0	.	Sufficient	for	interaction	with	EPHB1.	Pubmed:18034775
chr11	119077265	119142526	P22681	0	+	119077265	119142526	255,102,0	1	65261	0	.	4H.
chr11	119142526	119144731	P22681	0	+	119142526	119144731	255,102,0	1	2205	0	.	EF-hand-like.
chr11	119144731	119148512	P22681	0	+	119144731	119148512	255,102,0	1	3781	0	.	SH2-like.
chr11	119148512	119148920	P22681	0	+	119148512	119148920	255,102,0	1	408	0	.	Linker.
chr11	119158561	119170488	P22681	0	+	119158561	119170488	255,102,0	1	11927	0	.	Interaction	with	CD2AP.	Pubmed:11067845
chr11	119228292	119229513	O75604	0	-	119228292	119229513	255,102,0	1	1221	0	.	Necessary	for	interaction	with	MDM4.	Pubmed:19838211
chr11	119243590	119244190	O75604	0	-	119243590	119244190	255,102,0	1	600	0	.	Necessary	for	interaction	with	MDM4.	Pubmed:19838211
chr11	119545974	119547819	Q15223	0	-	119545974	119547819	255,102,0	1	1845	0	.	Interaction	with	FGFR.
chr11	122666887	122680591	Q8TF42	0	+	122666887	122680591	255,102,0	1	13704	0	.	Protein	tyrosine	phosphatase.
chr11	122929187	122929910	P11142	0	-	122929187	122929910	255,102,0	1	723	0	.	Substrate-binding	domain	(SBD).	Pubmed:27474739
chr11	122929931	122932029	P11142	0	-	122929931	122932029	255,102,0	1	2098	0	.	Nucleotide-binding	domain	(NBD).	Pubmed:27474739
chr11	122929958	122930832	P11142	0	-	122929958	122930832	255,102,0	1	874	0	.	Interaction	with	BAG1.
chr11	125496663	125507420	O14757	0	+	125496663	125507420	255,102,0	1	10757	0	.	Interaction	with	CLSPN.
chr11	125514475	125525212	O14757	0	+	125514475	125525212	255,102,0	1	10737	0	.	Autoinhibitory	region.
chr11	125547722	125547917	P26436	0	-	125547722	125547917	255,102,0	1	195	0	.	9	X	5	AA	repeats	of	[SV]-G-E-Q-[PSA].
chr11	125547740	125547992	P26436	0	-	125547740	125547992	255,102,0	1	252	0	.	4	X	4	AA	repeats	of	S-G-E-H.
chr11	125547959	125548049	P26436	0	-	125547959	125548049	255,102,0	1	90	0	.	3	X	5	AA	repeats	of	S-E-H-[GA]-S.
chr11	126215295	126215331	Q96C86	0	+	126215295	126215331	255,102,0	1	36	0	.	Substrate	binding.
chr11	128354718	128359200	P14921	0	-	128354718	128359200	255,102,0	1	4482	0	.	Activation	domain;	required	for	transcription	activation.
chr11	128838804	128840013	A7KAX9	0	-	128838804	128840013	255,102,0	1	1209	0	.	Interaction	with	FYN.	Pubmed:12788081
chr11	128839932	128840895	A7KAX9	0	-	128839932	128840895	255,102,0	1	963	0	.	Interaction	with	GAB2.	Pubmed:12819203
chr11	129748229	129752064	Q6P4R8	0	-	129748229	129752064	255,102,0	1	3835	0	.	Winged-helix	like	domain.
chr11	130013295	130013340	Q06481	0	+	130013295	130013340	255,102,0	1	45	0	.	Interaction	with	DAB2.
chr11	130275629	130278390	Q9UP79	0	-	130275629	130278390	255,102,0	1	2761	0	.	Spacer.
chr11	130342963	130343377	Q8TE58	0	+	130342963	130343377	255,102,0	1	414	0	.	Spacer.
chr11	134131051	134131063	Q9UKU7	0	+	134131051	134131063	255,102,0	1	12	0	.	Substrate	binding.
chr11	134252759	134252789	Q9P2W7	0	-	134252759	134252789	255,102,0	1	30	0	.	Interaction	with	galactose	moiety	of	substrate	glycoprotein.
chr11	134257538	134257547	Q9P2W7	0	-	134257538	134257547	255,102,0	1	9	0	.	Essential	for	transport	from	endoplasmic	reticulum	to	Golgi	apparatus	and	interaction	with	SAR1A.
chr12	394624	394828	P29375	0	-	394624	394828	255,102,0	1	204	0	.	Interaction	with	LMO2.	Pubmed:9129143
chr12	1025534	1025869	P43351	0	-	1025534	1025869	255,102,0	1	335	0	.	Mediates	interaction	with	RPA2.	Pubmed:8702565
chr12	1703088	1703229	Q8N1E6	0	-	1703088	1703229	255,102,0	1	141	0	.	Required	for	down-regulation	of	SNAI1.
chr12	2909240	2910450	Q02790	0	+	2909240	2910450	255,102,0	1	1210	0	.	Interaction	with	tubulin.
chr12	3018719	3030039	O75386	0	+	3018719	3030039	255,102,0	1	11320	0	.	Required	for	association	with	the	IFT	complex	A	(IFT-A).
chr12	4668036	4668156	Q96B01	0	+	4668036	4668156	255,102,0	1	120	0	.	Interaction	with	RAD51.
chr12	4737656	4737698	O75969	0	-	4737656	4737698	255,102,0	1	42	0	.	PKA-RII	subunit	binding	domain.
chr12	4848356	4854616	Q9NY28	0	+	4848356	4854616	255,102,0	1	6260	0	.	Catalytic	subdomain	A.
chr12	4854784	4870186	Q9NY28	0	+	4854784	4870186	255,102,0	1	15402	0	.	Catalytic	subdomain	B.
chr12	4920284	4920326	P17658	0	+	4920284	4920326	255,102,0	1	42	0	.	S4-S5	linker.
chr12	4961846	4961888	P17658	0	+	4961846	4961888	255,102,0	1	42	0	.	S4-S5	linker.
chr12	5020544	5020928	Q09470	0	+	5020544	5020928	255,102,0	1	384	0	.	Tetramerization	domain.
chr12	5021471	5021513	Q09470	0	+	5021471	5021513	255,102,0	1	42	0	.	S4-S5	linker.
chr12	5153493	5153559	P22460	0	+	5153493	5153559	255,102,0	1	66	0	.	2	X	11	AA	tandem	repeat	of	D-[SP]-G-V-R-P-L-P-P-L-P.
chr12	5154564	5154606	P22460	0	+	5154564	5154606	255,102,0	1	42	0	.	S4-S5	linker.
chr12	6100999	6101137	P04275	0	-	6100999	6101137	255,102,0	1	138	0	.	E2.
chr12	6143979	6145624	P04275	0	-	6143979	6145624	255,102,0	1	1645	0	.	CX.
chr12	6145600	6153537	P04275	0	-	6145600	6153537	255,102,0	1	7937	0	.	E1.
chr12	6153537	6153609	P04275	0	-	6153537	6153609	255,102,0	1	72	0	.	Amino-terminal.
chr12	6438956	6438989	P19438	0	-	6438956	6438989	255,102,0	1	33	0	.	N-SMase	activation	domain	(NSD).
chr12	6604264	6631058	Q15021	0	+	6604264	6631058	255,102,0	1	26794	0	.	Interactions	with	SMC2	and	SMC4.
chr12	6644001	6646383	P04406	0	+	6644001	6646383	255,102,0	1	2382	0	.	Interaction	with	WARS.	Pubmed:15628863
chr12	6646481	6646490	P04406	0	+	6646481	6646490	255,102,0	1	9	0	.	Glyceraldehyde	3-phosphate	binding.
chr12	6646854	6646860	P04406	0	+	6646854	6646860	255,102,0	1	6	0	.	Glyceraldehyde	3-phosphate	binding.
chr12	6670842	6670863	P46087	0	-	6670842	6670863	255,102,0	1	21	0	.	S-adenosyl-L-methionine	binding.
chr12	6679844	6690507	Q14839	0	-	6679844	6690507	255,102,0	1	10663	0	.	Required	for	interaction	with	PCNT.	Pubmed:17626165
chr12	6887478	6887550	P18627	0	+	6887478	6887550	255,102,0	1	72	0	.	12	X	2	AA	tandem	repeats	of	E-X.
chr12	6928012	6928483	P01730	0	+	6928012	6928483	255,102,0	1	471	0	.	HIV-1	Vpu-susceptibility	domain.
chr12	6958912	6959002	Q99618	0	-	6958912	6959002	255,102,0	1	90	0	.	F-box-like.
chr12	6965946	6965958	A0A140VJZ1	0	+	6965946	6965958	255,102,0	1	12	0	.	Substrate	binding.
chr12	6965946	6965958	P45974	0	+	6965946	6965958	255,102,0	1	12	0	.	Substrate	binding.
chr12	7031258	7031270	P09104	0	+	7031258	7031270	255,102,0	1	12	0	.	Substrate	binding.
chr12	7031258	7031270	Q6FHV6	0	+	7031258	7031270	255,102,0	1	12	0	.	Substrate	binding.
chr12	7045978	7046131	P54259	0	+	7045978	7046131	255,102,0	1	153	0	.	Involved	in	binding	BAIAP2.
chr12	7047760	7047808	P54259	0	+	7047760	7047808	255,102,0	1	48	0	.	Required	for	interaction	with	FAT1.	Pubmed:19131340
chr12	7067231	7069105	P29350	0	+	7067231	7069105	255,102,0	1	1874	0	.	Substrate	binding.
chr12	7077139	7077603	Q99623	0	-	7077139	7077603	255,102,0	1	464	0	.	Necessary	for	transcriptional	repression.	Pubmed:10359819
chr12	7079423	7079652	Q99623	0	-	7079423	7079652	255,102,0	1	229	0	.	Necessary	for	transcriptional	repression.	Pubmed:10359819
chr12	7084890	7084908	Q92979	0	+	7084890	7084908	255,102,0	1	18	0	.	S-adenosyl-L-methionine	binding.
chr12	7947358	7947493	Q9H9S0	0	+	7947358	7947493	255,102,0	1	135	0	.	8	X	repeats	starting	with	a	Trp	in	each	unit.
chr12	7947358	7947493	Q9H9S0	0	+	7947358	7947493	255,102,0	1	135	0	.	Sufficient	for	transactivation	activity.
chr12	7947493	7947688	Q9H9S0	0	+	7947493	7947688	255,102,0	1	195	0	.	Sufficient	for	strong	transactivation	activity.
chr12	7980093	7980114	Q8TDB8	0	-	7980093	7980114	255,102,0	1	21	0	.	Monosaccharide	binding.
chr12	8082282	8082303	P11169	0	-	8082282	8082303	255,102,0	1	21	0	.	Monosaccharide	binding.	Pubmed:26176916
chr12	8082303	8082312	P11169	0	-	8082303	8082312	255,102,0	1	9	0	.	Important	for	selectivity	against	fructose.	Pubmed:26176916
chr12	8757889	8757976	Q9GZX7	0	-	8757889	8757976	255,102,0	1	87	0	.	Required	for	interaction	with	RNF126.	Pubmed:23277564
chr12	8759490	8759502	Q9GZX7	0	-	8759490	8759502	255,102,0	1	12	0	.	Important	for	interaction	with	CTNNBL1.	Pubmed:18722174
chr12	8759538	8765360	Q9GZX7	0	-	8759538	8765360	255,102,0	1	5822	0	.	Interaction	with	SUPT6H.	Pubmed:21518874
chr12	9002318	9002814	A8K2U0	0	+	9002318	9002814	255,102,0	1	496	0	.	Bait	region.
chr12	9246095	9246113	P01023	0	-	9246095	9246113	255,102,0	1	18	0	.	Inhibitory.
chr12	9246116	9247626	P01023	0	-	9246116	9247626	255,102,0	1	1510	0	.	Bait	region.
chr12	9246131	9246146	P01023	0	-	9246131	9246146	255,102,0	1	15	0	.	Inhibitory.
chr12	9246173	9247584	P01023	0	-	9246173	9247584	255,102,0	1	1411	0	.	Inhibitory.
chr12	9318700	9321519	P20742	0	-	9318700	9321519	255,102,0	1	2819	0	.	Bait	region.
chr12	10313498	10321679	P78380	0	-	10313498	10321679	255,102,0	1	8181	0	.	Neck.
chr12	10365728	10365794	Q9H0R8	0	+	10365728	10365794	255,102,0	1	66	0	.	Interaction	with	beta-tubulin.
chr12	10370676	10373073	Q9H0R8	0	+	10370676	10373073	255,102,0	1	2397	0	.	Interaction	with	GABRG2.
chr12	10658642	10658666	Q2VIR3	0	+	10658642	10658666	255,102,0	1	24	0	.	G1.
chr12	10658726	10658741	Q2VIR3	0	+	10658726	10658741	255,102,0	1	15	0	.	G2.
chr12	10658900	10658912	Q2VIR3	0	+	10658900	10658912	255,102,0	1	12	0	.	G3.
chr12	10659068	10659080	Q2VIR3	0	+	10659068	10659080	255,102,0	1	12	0	.	G4.
chr12	10659173	10659182	Q2VIR3	0	+	10659173	10659182	255,102,0	1	9	0	.	G5.
chr12	12291259	12303967	O75581	0	-	12291259	12303967	255,102,0	1	12708	0	.	Beta-propeller	4.
chr12	12311883	12317368	O75581	0	-	12311883	12317368	255,102,0	1	5485	0	.	Beta-propeller	3.
chr12	12317491	12334368	O75581	0	-	12317491	12334368	255,102,0	1	16877	0	.	Beta-propeller	2.
chr12	12339875	12397587	O75581	0	-	12339875	12397587	255,102,0	1	57712	0	.	Beta-propeller	1.
chr12	12788779	12788875	O60519	0	+	12788779	12788875	255,102,0	1	96	0	.	Basic	motif.
chr12	12788878	12788902	O60519	0	+	12788878	12788902	255,102,0	1	24	0	.	Leucine-zipper.
chr12	13716259	13716298	Q13224	0	-	13716259	13716298	255,102,0	1	39	0	.	Interaction	with	DAPK1.
chr12	14589077	14613721	Q6VMQ6	0	+	14589077	14613721	255,102,0	1	24644	0	.	Interaction	with	SETDB1.
chr12	14628853	14628886	Q6VMQ6	0	+	14628853	14628886	255,102,0	1	33	0	.	Interaction	with	SUMO.	Pubmed:16757475
chr12	14650653	14651004	Q6VMQ6	0	+	14650653	14651004	255,102,0	1	351	0	.	Interaction	with	MBD1.
chr12	14944187	14944202	Q9Y2W2	0	-	14944187	14944202	255,102,0	1	15	0	.	Interaction	with	PP1.
chr12	14947528	14947543	Q9Y2W2	0	-	14947528	14947543	255,102,0	1	15	0	.	Interaction	with	PP1.
chr12	14952623	14954317	Q9Y2W2	0	-	14952623	14954317	255,102,0	1	1694	0	.	Required	for	nuclear	import.
chr12	15068497	15068509	Q96DN0	0	-	15068497	15068509	255,102,0	1	12	0	.	PDIA3-binding	site.
chr12	15739980	15742404	Q16827	0	+	15739980	15742404	255,102,0	1	2424	0	.	Substrate	binding.
chr12	15774253	15784475	Q12929	0	-	15774253	15784475	255,102,0	1	10222	0	.	Effector	region.
chr12	15776091	15776151	Q12929	0	-	15776091	15776151	255,102,0	1	60	0	.	Helix	bundle	4.
chr12	15776145	15776163	Q12929	0	-	15776145	15776163	255,102,0	1	18	0	.	Helix	bundle	3.
chr12	15776175	15776193	Q12929	0	-	15776175	15776193	255,102,0	1	18	0	.	Helix	bundle	2.
chr12	15777171	15777234	Q12929	0	-	15777171	15777234	255,102,0	1	63	0	.	Helix	bundle	1.
chr12	15777291	15784382	Q12929	0	-	15777291	15784382	255,102,0	1	7091	0	.	Amphipathic	helix.
chr12	18234127	18242217	Q9H628	0	-	18234127	18242217	255,102,0	1	8090	0	.	Small	GTPase-like.
chr12	19593257	19626184	Q6ZN18	0	+	19593257	19626184	255,102,0	1	32927	0	.	Interaction	with	RBBP4.
chr12	19646802	19671651	Q6ZN18	0	+	19646802	19671651	255,102,0	1	24849	0	.	Interaction	with	SUZ12.
chr12	20792821	20833037	Q14432	0	+	20792821	20833037	255,102,0	1	40216	0	.	Catalytic.
chr12	22354728	22354737	Q92185	0	-	22354728	22354737	255,102,0	1	9	0	.	Substrate	binding.
chr12	22401953	22401962	Q92185	0	-	22401953	22401962	255,102,0	1	9	0	.	Substrate	binding.
chr12	25368389	25368449	P01116	0	-	25368389	25368449	255,102,0	1	60	0	.	Hypervariable	region.
chr12	26277025	26277040	Q9C0J9	0	-	26277025	26277040	255,102,0	1	15	0	.	Necessary	for	interaction	with	RXRA	and	repressor	activity	towards	RXRA.	Pubmed:19786558
chr12	26816623	26816632	Q14571	0	-	26816623	26816632	255,102,0	1	9	0	.	Inositol	1,4,5-trisphosphate	binding.
chr12	26818863	26818875	Q14571	0	-	26818863	26818875	255,102,0	1	12	0	.	Inositol	1,4,5-trisphosphate	binding.
chr12	26868279	26868294	Q14571	0	-	26868279	26868294	255,102,0	1	15	0	.	Inositol	1,4,5-trisphosphate	binding.
chr12	27461271	27461349	Q9Y2H1	0	+	27461271	27461349	255,102,0	1	78	0	.	S100B	binding.
chr12	27521298	27542228	Q8WYA1	0	+	27521298	27542228	255,102,0	1	20930	0	.	Interaction	with	PER2.
chr12	28116600	28116636	P12272	0	-	28116600	28116636	255,102,0	1	36	0	.	Important	for	receptor	binding.
chr12	28410148	28412314	Q7Z6B0	0	+	28410148	28412314	255,102,0	1	2166	0	.	GGA1-binding	motif.
chr12	28515421	28702019	Q7Z6B0	0	+	28515421	28702019	255,102,0	1	186598	0	.	Homodimerization.
chr12	32481375	32490589	Q96G01	0	+	32481375	32490589	255,102,0	1	9214	0	.	Interaction	with	RAB6A.
chr12	32729291	32735251	Q96M96	0	+	32729291	32735251	255,102,0	1	5960	0	.	Actin	filament-binding.
chr12	32832297	32875517	O00429	0	+	32832297	32875517	255,102,0	1	43220	0	.	GTPase	domain.
chr12	32875517	32886669	O00429	0	+	32875517	32886669	255,102,0	1	11152	0	.	Middle	domain.
chr12	32884430	32895583	O00429	0	+	32884430	32895583	255,102,0	1	11153	0	.	Interaction	with	GSK3B.
chr12	32886705	32891230	O00429	0	+	32886705	32891230	255,102,0	1	4525	0	.	B	domain.
chr12	32893417	32895532	O00429	0	+	32893417	32895532	255,102,0	1	2115	0	.	Important	for	homodimerization.
chr12	33592352	33592421	Q6XYQ8	0	-	33592352	33592421	255,102,0	1	69	0	.	Cysteine	motif.
chr12	40012763	40013417	Q9UBJ2	0	-	40012763	40013417	255,102,0	1	654	0	.	Interaction	with	PEX19.
chr12	46764320	46765076	Q96QD8	0	-	46764320	46765076	255,102,0	1	756	0	.	Regulates	protein	turnover	upon	amino	acid	deprivation.
chr12	48141912	48142288	O95398	0	-	48141912	48142288	255,102,0	1	376	0	.	Interaction	with	PDE3B.	Pubmed:21393242
chr12	48144153	48144850	O95398	0	-	48144153	48144850	255,102,0	1	697	0	.	Interaction	with	PDE3B.	Pubmed:21393242
chr12	48177626	48179215	Q8WUI4	0	-	48177626	48179215	255,102,0	1	1589	0	.	Interaction	with	SIN3A.
chr12	48179248	48187161	Q8WUI4	0	-	48179248	48187161	255,102,0	1	7913	0	.	Histone	deacetylase.
chr12	48185710	48190016	Q8WUI4	0	-	48185710	48190016	255,102,0	1	4306	0	.	Transcription	repression	2.
chr12	48189535	48192708	Q8WUI4	0	-	48189535	48192708	255,102,0	1	3173	0	.	Transcription	repression	1.
chr12	48191179	48192432	Q8WUI4	0	-	48191179	48192432	255,102,0	1	1253	0	.	Interaction	with	MEF2A.
chr12	48191940	48192708	Q8WUI4	0	-	48191940	48192708	255,102,0	1	768	0	.	Interaction	with	MEF2C.
chr12	48238531	48250921	P11473	0	-	48238531	48250921	255,102,0	1	12390	0	.	Ligand-binding.
chr12	48240512	48240536	P11473	0	-	48240512	48240536	255,102,0	1	24	0	.	Vitamin	D3	binding.
chr12	48249456	48249489	P11473	0	-	48249456	48249489	255,102,0	1	33	0	.	Vitamin	D3	binding.
chr12	48250921	48251460	P11473	0	-	48250921	48251460	255,102,0	1	539	0	.	Hinge.
chr12	48369262	48369343	P02458	0	-	48369262	48369343	255,102,0	1	81	0	.	Nonhelical	region	(C-terminal).
chr12	48369343	48390339	P02458	0	-	48369343	48390339	255,102,0	1	20996	0	.	Triple-helical	region.
chr12	48440171	48457552	Q9P0U3	0	-	48440171	48457552	255,102,0	1	17381	0	.	Protease.
chr12	48468528	48495255	Q9P0U3	0	-	48468528	48495255	255,102,0	1	26727	0	.	Interaction	with	CCAR2.	Pubmed:25406032
chr12	48516557	48533674	A0A024R0Y5	0	+	48516557	48533674	255,102,0	1	17117	0	.	N-terminal	catalytic	PFK	domain	1.
chr12	48516560	48533674	P08237	0	+	48516560	48533674	255,102,0	1	17114	0	.	N-terminal	catalytic	PFK	domain	1.
chr12	48527159	48527168	A0A024R0Y5	0	+	48527159	48527168	255,102,0	1	9	0	.	Substrate	binding.
chr12	48527159	48527168	P08237	0	+	48527159	48527168	255,102,0	1	9	0	.	Substrate	binding.
chr12	48528042	48528051	A0A024R0Y5	0	+	48528042	48528051	255,102,0	1	9	0	.	Substrate	binding.
chr12	48528042	48528051	P08237	0	+	48528042	48528051	255,102,0	1	9	0	.	Substrate	binding.
chr12	48529121	48529133	A0A024R0Y5	0	+	48529121	48529133	255,102,0	1	12	0	.	Substrate	binding.
chr12	48529121	48529133	P08237	0	+	48529121	48529133	255,102,0	1	12	0	.	Substrate	binding.
chr12	48533674	48534516	P08237	0	+	48533674	48534516	255,102,0	1	842	0	.	Interdomain	linker.
chr12	48534516	48539488	A0A024R0Y5	0	+	48534516	48539488	255,102,0	1	4972	0	.	C-terminal	regulatory	PFK	domain	2.
chr12	48534516	48539488	P08237	0	+	48534516	48539488	255,102,0	1	4972	0	.	C-terminal	regulatory	PFK	domain	2.
chr12	48535777	48535792	A0A024R0Y5	0	+	48535777	48535792	255,102,0	1	15	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr12	48535777	48535792	P08237	0	+	48535777	48535792	255,102,0	1	15	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr12	48536627	48536636	A0A024R0Y5	0	+	48536627	48536636	255,102,0	1	9	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr12	48536627	48536636	P08237	0	+	48536627	48536636	255,102,0	1	9	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr12	48537928	48537940	A0A024R0Y5	0	+	48537928	48537940	255,102,0	1	12	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr12	48537928	48537940	P08237	0	+	48537928	48537940	255,102,0	1	12	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr12	48737277	48738433	Q96N77	0	-	48737277	48738433	255,102,0	1	1156	0	.	Transactivation.
chr12	49219225	49220801	P54284	0	+	49219225	49220801	255,102,0	1	1576	0	.	Mediates	interaction	with	the	alpha	subunit.
chr12	49390531	49391437	O94850	0	-	49390531	49391437	255,102,0	1	906	0	.	Interaction	with	CD2AP	and	NPHS1.
chr12	49391350	49391638	O94850	0	-	49391350	49391638	255,102,0	1	288	0	.	Interaction	with	ACTN1.	Pubmed:16464232
chr12	49391950	49392103	O94850	0	-	49391950	49392103	255,102,0	1	153	0	.	Interaction	with	MAGI2.
chr12	49392265	49392322	O94850	0	-	49392265	49392322	255,102,0	1	57	0	.	Nuclear	localization.
chr12	49415921	49415927	O14686	0	-	49415921	49415927	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr12	49445461	49446151	O14686	0	-	49445461	49446151	255,102,0	1	690	0	.	15	X	5	AA	repeats	of	S/P-P-P-E/P-E/A.
chr12	49498631	49504338	Q6UX01	0	-	49498631	49504338	255,102,0	1	5707	0	.	LCN1-binding.
chr12	49688983	49689280	P41219	0	+	49688983	49689280	255,102,0	1	297	0	.	Head.
chr12	49689280	49689379	P41219	0	+	49689280	49689379	255,102,0	1	99	0	.	Coil	1A.
chr12	49689280	49691358	P41219	0	+	49689280	49691358	255,102,0	1	2078	0	.	Rod.
chr12	49689379	49689412	P41219	0	+	49689379	49689412	255,102,0	1	33	0	.	Linker	1.
chr12	49689412	49690686	P41219	0	+	49689412	49690686	255,102,0	1	1274	0	.	Coil	1B.
chr12	49690686	49690755	P41219	0	+	49690686	49690755	255,102,0	1	69	0	.	Linker	2.
chr12	49690755	49691358	P41219	0	+	49690755	49691358	255,102,0	1	603	0	.	Coil	2.
chr12	49691358	49692133	P41219	0	+	49691358	49692133	255,102,0	1	775	0	.	Tail.
chr12	49724173	49724569	Q12815	0	+	49724173	49724569	255,102,0	1	396	0	.	4	X	33	AA	approximate	tandem	repeats.
chr12	50392947	50399148	Q9H0H5	0	-	50392947	50399148	255,102,0	1	6201	0	.	Interaction	with	SLC26A8.	Pubmed:11278976
chr12	50479278	50480631	Q96GM5	0	+	50479278	50480631	255,102,0	1	1353	0	.	Interaction	with	ESR1,	NR1H4,	NR3C1,	PGR	and	SMARCA4.	Pubmed:12917342
chr12	50480631	50492526	Q96GM5	0	+	50480631	50492526	255,102,0	1	11895	0	.	Interaction	with	SMARCC1	and	SMARCC2.	Pubmed:12917342
chr12	50481151	50492780	Q96GM5	0	+	50481151	50492780	255,102,0	1	11629	0	.	Necessary	for	GR/NR3C1-mediated	remodeling	and	transcription	from	chromatin;	required	for	GR/NR3C1	interaction	with	the	BRG1/SMARCA4	complex	in	vivo.
chr12	50501541	50501547	A0A024R138	0	+	50501541	50501547	255,102,0	1	6	0	.	Substrate	binding.
chr12	50501541	50501547	P21695	0	+	50501541	50501547	255,102,0	1	6	0	.	Substrate	binding.
chr12	50821562	50821592	Q71RC2	0	+	50821562	50821592	255,102,0	1	30	0	.	Interaction	with	PABPC1.	Pubmed:21098120
chr12	50824285	50847347	Q71RC2	0	+	50824285	50847347	255,102,0	1	23062	0	.	Interaction	with	the	poly-A	tract	of	mRNA.	Pubmed:21098120
chr12	51208193	51213463	P18846	0	+	51208193	51213463	255,102,0	1	5270	0	.	Basic	motif.
chr12	51213466	51213532	P18846	0	+	51213466	51213532	255,102,0	1	66	0	.	Leucine-zipper.
chr12	51318821	51318905	Q9H8H3	0	+	51318821	51318905	255,102,0	1	84	0	.	Targeting	to	lipid	droplets.
chr12	51442139	51445930	Q6P1Q0	0	+	51442139	51445930	255,102,0	1	3791	0	.	Required	and	sufficient	for	mitochondrial	import.
chr12	51493528	51510158	Q12800	0	-	51493528	51510158	255,102,0	1	16630	0	.	DNA-binding.
chr12	51753053	51757912	Q8NCL4	0	-	51753053	51757912	255,102,0	1	4859	0	.	Catalytic	subdomain	B.
chr12	51758098	51771117	Q8NCL4	0	-	51758098	51771117	255,102,0	1	13019	0	.	Catalytic	subdomain	A.
chr12	52307037	52307049	P37023	0	+	52307037	52307049	255,102,0	1	12	0	.	Mediates	specificity	for	BMP	ligand.
chr12	52407556	52408569	Q7Z6J2	0	+	52407556	52408569	255,102,0	1	1013	0	.	Interaction	with	PSCD3.
chr12	52450906	52451151	P22736	0	+	52450906	52451151	255,102,0	1	245	0	.	Ligand-binding.
chr12	52470770	52470785	Q9BSB4	0	+	52470770	52470785	255,102,0	1	15	0	.	Important	for	interaction	with	ATG13.	Pubmed:26299944
chr12	52565184	52565989	Q6KB66	0	-	52565184	52565989	255,102,0	1	805	0	.	Tail.
chr12	52565989	52567461	Q6KB66	0	-	52565989	52567461	255,102,0	1	1472	0	.	Coil	2.
chr12	52565989	52585440	Q6KB66	0	-	52565989	52585440	255,102,0	1	19451	0	.	Rod.
chr12	52567461	52567533	Q6KB66	0	-	52567461	52567533	255,102,0	1	72	0	.	Linker	12.
chr12	52567533	52579266	Q6KB66	0	-	52567533	52579266	255,102,0	1	11733	0	.	Coil	1B.
chr12	52579266	52579317	Q6KB66	0	-	52579266	52579317	255,102,0	1	51	0	.	Linker	1.
chr12	52579317	52585443	Q6KB66	0	-	52579317	52585443	255,102,0	1	6126	0	.	Coil	1A.
chr12	52585440	52585686	Q6KB66	0	-	52585440	52585686	255,102,0	1	246	0	.	Head.
chr12	52627083	52627350	P08729	0	+	52627083	52627350	255,102,0	1	267	0	.	Head.
chr12	52627347	52628992	P08729	0	+	52627347	52628992	255,102,0	1	1645	0	.	Coil	1A.
chr12	52627350	52639408	P08729	0	+	52627350	52639408	255,102,0	1	12058	0	.	Rod.
chr12	52627353	52627371	P08729	0	+	52627353	52627371	255,102,0	1	18	0	.	Interaction	with	HPV16	E7.	Pubmed:12072504
chr12	52628992	52629046	P08729	0	+	52628992	52629046	255,102,0	1	54	0	.	Linker	1.
chr12	52629046	52635270	P08729	0	+	52629046	52635270	255,102,0	1	6224	0	.	Coil	1B.
chr12	52635270	52635342	P08729	0	+	52635270	52635342	255,102,0	1	72	0	.	Linker	12.
chr12	52635342	52639408	P08729	0	+	52635342	52639408	255,102,0	1	4066	0	.	Coil	2.
chr12	52639408	52642541	P08729	0	+	52639408	52642541	255,102,0	1	3133	0	.	Tail.
chr12	52680041	52680893	Q14533	0	-	52680041	52680893	255,102,0	1	852	0	.	Tail.
chr12	52680893	52681860	Q14533	0	-	52680893	52681860	255,102,0	1	967	0	.	Coil	2.
chr12	52680893	52684931	Q14533	0	-	52680893	52684931	255,102,0	1	4038	0	.	Rod.
chr12	52681860	52681911	Q14533	0	-	52681860	52681911	255,102,0	1	51	0	.	Linker	12.
chr12	52681911	52683986	Q14533	0	-	52681911	52683986	255,102,0	1	2075	0	.	Coil	1B.
chr12	52683986	52684016	Q14533	0	-	52683986	52684016	255,102,0	1	30	0	.	Linker	1.
chr12	52684016	52684931	Q14533	0	-	52684016	52684931	255,102,0	1	915	0	.	Coil	1A.
chr12	52684931	52685249	Q14533	0	-	52684931	52685249	255,102,0	1	318	0	.	Head.
chr12	52695700	52696018	O43790	0	+	52695700	52696018	255,102,0	1	318	0	.	Head.
chr12	52696018	52696937	O43790	0	+	52696018	52696937	255,102,0	1	919	0	.	Coil	1A.
chr12	52696018	52700056	O43790	0	+	52696018	52700056	255,102,0	1	4038	0	.	Rod.
chr12	52696937	52696967	O43790	0	+	52696937	52696967	255,102,0	1	30	0	.	Linker	1.
chr12	52696967	52699044	O43790	0	+	52696967	52699044	255,102,0	1	2077	0	.	Coil	1B.
chr12	52699044	52699095	O43790	0	+	52699044	52699095	255,102,0	1	51	0	.	Linker	12.
chr12	52699095	52700056	O43790	0	+	52699095	52700056	255,102,0	1	961	0	.	Coil	2.
chr12	52700056	52702366	O43790	0	+	52700056	52702366	255,102,0	1	2310	0	.	Tail.
chr12	52708417	52709684	P78385	0	-	52708417	52709684	255,102,0	1	1267	0	.	Tail.
chr12	52709684	52710735	P78385	0	-	52709684	52710735	255,102,0	1	1051	0	.	Coil	2.
chr12	52709684	52714786	P78385	0	-	52709684	52714786	255,102,0	1	5102	0	.	Rod.
chr12	52710735	52710786	P78385	0	-	52710735	52710786	255,102,0	1	51	0	.	Linker	12.
chr12	52710786	52713064	P78385	0	-	52710786	52713064	255,102,0	1	2278	0	.	Coil	1B.
chr12	52713064	52713094	P78385	0	-	52713064	52713094	255,102,0	1	30	0	.	Linker	1.
chr12	52713094	52714786	P78385	0	-	52713094	52714786	255,102,0	1	1692	0	.	Coil	1A.
chr12	52714786	52715119	P78385	0	-	52714786	52715119	255,102,0	1	333	0	.	Head.
chr12	52754639	52756042	P78386	0	-	52754639	52756042	255,102,0	1	1403	0	.	Tail.
chr12	52756042	52757122	P78386	0	-	52756042	52757122	255,102,0	1	1080	0	.	Coil	2.
chr12	52756042	52760820	P78386	0	-	52756042	52760820	255,102,0	1	4778	0	.	Rod.
chr12	52757122	52757173	P78386	0	-	52757122	52757173	255,102,0	1	51	0	.	Linker	12.
chr12	52757173	52758870	P78386	0	-	52757173	52758870	255,102,0	1	1697	0	.	Coil	1B.
chr12	52758870	52758900	P78386	0	-	52758870	52758900	255,102,0	1	30	0	.	Linker	1.
chr12	52758900	52760820	P78386	0	-	52758900	52760820	255,102,0	1	1920	0	.	Coil	1A.
chr12	52760820	52761189	P78386	0	-	52760820	52761189	255,102,0	1	369	0	.	Head.
chr12	52771820	52774154	Q9NSB2	0	-	52771820	52774154	255,102,0	1	2334	0	.	Tail.
chr12	52774154	52775237	Q9NSB2	0	-	52774154	52775237	255,102,0	1	1083	0	.	Coil	2.
chr12	52774154	52778874	Q9NSB2	0	-	52774154	52778874	255,102,0	1	4720	0	.	Rod.
chr12	52775237	52775288	Q9NSB2	0	-	52775237	52775288	255,102,0	1	51	0	.	Linker	12.
chr12	52775288	52777498	Q9NSB2	0	-	52775288	52777498	255,102,0	1	2210	0	.	Coil	1B.
chr12	52777498	52777528	Q9NSB2	0	-	52777498	52777528	255,102,0	1	30	0	.	Linker	1.
chr12	52777528	52778874	Q9NSB2	0	-	52777528	52778874	255,102,0	1	1346	0	.	Coil	1A.
chr12	52778874	52779369	Q9NSB2	0	-	52778874	52779369	255,102,0	1	495	0	.	Head.
chr12	52788761	52789803	Q9NSB4	0	-	52788761	52789803	255,102,0	1	1042	0	.	Tail.
chr12	52789803	52793861	Q9NSB4	0	-	52789803	52793861	255,102,0	1	4058	0	.	Coil	2.
chr12	52789803	52799701	Q9NSB4	0	-	52789803	52799701	255,102,0	1	9898	0	.	Rod.
chr12	52793861	52793912	Q9NSB4	0	-	52793861	52793912	255,102,0	1	51	0	.	Linker	12.
chr12	52793912	52797609	Q9NSB4	0	-	52793912	52797609	255,102,0	1	3697	0	.	Coil	1B.
chr12	52797609	52797639	Q9NSB4	0	-	52797609	52797639	255,102,0	1	30	0	.	Linker	1.
chr12	52797639	52799701	Q9NSB4	0	-	52797639	52799701	255,102,0	1	2062	0	.	Coil	1A.
chr12	52799701	52800061	Q9NSB4	0	-	52799701	52800061	255,102,0	1	360	0	.	Head.
chr12	52818303	52822047	O95678	0	-	52818303	52822047	255,102,0	1	3744	0	.	Tail.
chr12	52822047	52824402	O95678	0	-	52822047	52824402	255,102,0	1	2355	0	.	Coil	2.
chr12	52822047	52827644	O95678	0	-	52822047	52827644	255,102,0	1	5597	0	.	Rod.
chr12	52824402	52824471	O95678	0	-	52824402	52824471	255,102,0	1	69	0	.	Linker	12.
chr12	52824471	52826925	O95678	0	-	52824471	52826925	255,102,0	1	2454	0	.	Coil	1B.
chr12	52826925	52826982	O95678	0	-	52826925	52826982	255,102,0	1	57	0	.	Linker	1.
chr12	52826982	52827644	O95678	0	-	52826982	52827644	255,102,0	1	662	0	.	Coil	1A.
chr12	52827644	52828088	O95678	0	-	52827644	52828088	255,102,0	1	444	0	.	Head.
chr12	52840976	52841569	P04259	0	-	52840976	52841569	255,102,0	1	593	0	.	Tail.
chr12	52841569	52843330	P04259	0	-	52841569	52843330	255,102,0	1	1761	0	.	Coil	2.
chr12	52841569	52845376	P04259	0	-	52841569	52845376	255,102,0	1	3807	0	.	Rod.
chr12	52843330	52843402	P04259	0	-	52843330	52843402	255,102,0	1	72	0	.	Linker	12.
chr12	52843402	52844293	P04259	0	-	52843402	52844293	255,102,0	1	891	0	.	Coil	1B.
chr12	52844293	52844350	P04259	0	-	52844293	52844350	255,102,0	1	57	0	.	Linker	1.
chr12	52844350	52845376	P04259	0	-	52844350	52845376	255,102,0	1	1026	0	.	Coil	1A.
chr12	52845376	52845859	P04259	0	-	52845376	52845859	255,102,0	1	483	0	.	Head.
chr12	52862848	52863461	P48668	0	-	52862848	52863461	255,102,0	1	613	0	.	Tail.
chr12	52863461	52864993	P48668	0	-	52863461	52864993	255,102,0	1	1532	0	.	Coil	2.
chr12	52863461	52867035	P48668	0	-	52863461	52867035	255,102,0	1	3574	0	.	Rod.
chr12	52864993	52865065	P48668	0	-	52864993	52865065	255,102,0	1	72	0	.	Linker	12.
chr12	52865065	52865953	P48668	0	-	52865065	52865953	255,102,0	1	888	0	.	Coil	1B.
chr12	52865953	52866010	P48668	0	-	52865953	52866010	255,102,0	1	57	0	.	Linker	1.
chr12	52866010	52867035	P48668	0	-	52866010	52867035	255,102,0	1	1025	0	.	Coil	1A.
chr12	52867035	52867518	P48668	0	-	52867035	52867518	255,102,0	1	483	0	.	Head.
chr12	52881506	52882119	P02538	0	-	52881506	52882119	255,102,0	1	613	0	.	Tail.
chr12	52882119	52884430	P02538	0	-	52882119	52884430	255,102,0	1	2311	0	.	Coil	2.
chr12	52882119	52886486	P02538	0	-	52882119	52886486	255,102,0	1	4367	0	.	Rod.
chr12	52884430	52884502	P02538	0	-	52884430	52884502	255,102,0	1	72	0	.	Linker	12.
chr12	52884502	52885409	P02538	0	-	52884502	52885409	255,102,0	1	907	0	.	Coil	1B.
chr12	52885409	52885466	P02538	0	-	52885409	52885466	255,102,0	1	57	0	.	Linker	1.
chr12	52885466	52886486	P02538	0	-	52885466	52886486	255,102,0	1	1020	0	.	Coil	1A.
chr12	52886486	52886969	P02538	0	-	52886486	52886969	255,102,0	1	483	0	.	Head.
chr12	52908728	52910428	P13647	0	-	52908728	52910428	255,102,0	1	1700	0	.	Tail.
chr12	52910428	52911451	P13647	0	-	52910428	52911451	255,102,0	1	1023	0	.	Coil	2.
chr12	52910428	52913579	P13647	0	-	52910428	52913579	255,102,0	1	3151	0	.	Rod.
chr12	52911451	52911520	P13647	0	-	52911451	52911520	255,102,0	1	69	0	.	Linker	12.
chr12	52911520	52912833	P13647	0	-	52911520	52912833	255,102,0	1	1313	0	.	Coil	1B.
chr12	52912833	52912890	P13647	0	-	52912833	52912890	255,102,0	1	57	0	.	Linker	1.
chr12	52912890	52913579	P13647	0	-	52912890	52913579	255,102,0	1	689	0	.	Coil	1A.
chr12	52913579	52914080	P13647	0	-	52913579	52914080	255,102,0	1	501	0	.	Head.
chr12	52938318	52940077	Q3SY84	0	-	52938318	52940077	255,102,0	1	1759	0	.	Tail.
chr12	52940077	52942013	Q3SY84	0	-	52940077	52942013	255,102,0	1	1936	0	.	Coil	2.
chr12	52940077	52946474	Q3SY84	0	-	52940077	52946474	255,102,0	1	6397	0	.	Rod.
chr12	52942013	52942085	Q3SY84	0	-	52942013	52942085	255,102,0	1	72	0	.	Linker	12.
chr12	52942085	52943916	Q3SY84	0	-	52942085	52943916	255,102,0	1	1831	0	.	Coil	1B.
chr12	52943916	52943973	Q3SY84	0	-	52943916	52943973	255,102,0	1	57	0	.	Linker	1.
chr12	52943973	52946474	Q3SY84	0	-	52943973	52946474	255,102,0	1	2501	0	.	Coil	1A.
chr12	52946474	52946861	Q3SY84	0	-	52946474	52946861	255,102,0	1	387	0	.	Head.
chr12	52960755	52961960	Q7RTS7	0	-	52960755	52961960	255,102,0	1	1205	0	.	Tail.
chr12	52961960	52964530	Q7RTS7	0	-	52961960	52964530	255,102,0	1	2570	0	.	Coil	2.
chr12	52961960	52967144	Q7RTS7	0	-	52961960	52967144	255,102,0	1	5184	0	.	Rod.
chr12	52964530	52964602	Q7RTS7	0	-	52964530	52964602	255,102,0	1	72	0	.	Linker	12.
chr12	52964602	52966340	Q7RTS7	0	-	52964602	52966340	255,102,0	1	1738	0	.	Coil	1B.
chr12	52966340	52966397	Q7RTS7	0	-	52966340	52966397	255,102,0	1	57	0	.	Linker	1.
chr12	52966397	52967144	Q7RTS7	0	-	52966397	52967144	255,102,0	1	747	0	.	Coil	1A.
chr12	52967144	52967561	Q7RTS7	0	-	52967144	52967561	255,102,0	1	417	0	.	Head.
chr12	52979768	52981422	Q14CN4	0	-	52979768	52981422	255,102,0	1	1654	0	.	Tail.
chr12	52981422	52985325	Q14CN4	0	-	52981422	52985325	255,102,0	1	3903	0	.	Coil	2.
chr12	52981422	52994864	Q14CN4	0	-	52981422	52994864	255,102,0	1	13442	0	.	Rod.
chr12	52985325	52985397	Q14CN4	0	-	52985325	52985397	255,102,0	1	72	0	.	Linker	12.
chr12	52985397	52992785	Q14CN4	0	-	52985397	52992785	255,102,0	1	7388	0	.	Coil	1B.
chr12	52992785	52992842	Q14CN4	0	-	52992785	52992842	255,102,0	1	57	0	.	Linker	1.
chr12	52992842	52994864	Q14CN4	0	-	52992842	52994864	255,102,0	1	2022	0	.	Coil	1A.
chr12	52994864	52995236	Q14CN4	0	-	52994864	52995236	255,102,0	1	372	0	.	Head.
chr12	53001982	53004406	Q86Y46	0	-	53001982	53004406	255,102,0	1	2424	0	.	Tail.
chr12	53004406	53007549	Q86Y46	0	-	53004406	53007549	255,102,0	1	3143	0	.	Coil	2.
chr12	53004406	53011915	Q86Y46	0	-	53004406	53011915	255,102,0	1	7509	0	.	Rod.
chr12	53007549	53007621	Q86Y46	0	-	53007549	53007621	255,102,0	1	72	0	.	Linker	12.
chr12	53007621	53010053	Q86Y46	0	-	53007621	53010053	255,102,0	1	2432	0	.	Coil	1B.
chr12	53010053	53010110	Q86Y46	0	-	53010053	53010110	255,102,0	1	57	0	.	Linker	1.
chr12	53010110	53011915	Q86Y46	0	-	53010110	53011915	255,102,0	1	1805	0	.	Coil	1A.
chr12	53011915	53012308	Q86Y46	0	-	53011915	53012308	255,102,0	1	393	0	.	Head.
chr12	53038805	53040531	P35908	0	-	53038805	53040531	255,102,0	1	1726	0	.	Tail.
chr12	53040531	53042034	P35908	0	-	53040531	53042034	255,102,0	1	1503	0	.	Coil	2.
chr12	53040531	53045395	P35908	0	-	53040531	53045395	255,102,0	1	4864	0	.	Rod.
chr12	53042034	53042106	P35908	0	-	53042034	53042106	255,102,0	1	72	0	.	Linker	12.
chr12	53042106	53044226	P35908	0	-	53042106	53044226	255,102,0	1	2120	0	.	Coil	1B.
chr12	53044226	53044283	P35908	0	-	53044226	53044283	255,102,0	1	57	0	.	Linker	1.
chr12	53044283	53045395	P35908	0	-	53044283	53045395	255,102,0	1	1112	0	.	Coil	1A.
chr12	53045395	53045926	P35908	0	-	53045395	53045926	255,102,0	1	531	0	.	Head.
chr12	53068979	53070066	P04264	0	-	53068979	53070066	255,102,0	1	1087	0	.	Tail.
chr12	53070066	53071177	P04264	0	-	53070066	53071177	255,102,0	1	1111	0	.	Coil	2.
chr12	53070066	53073595	P04264	0	-	53070066	53073595	255,102,0	1	3529	0	.	Rod.
chr12	53071177	53071249	P04264	0	-	53071177	53071249	255,102,0	1	72	0	.	Linker	12.
chr12	53071249	53072429	P04264	0	-	53071249	53072429	255,102,0	1	1180	0	.	Coil	1B.
chr12	53072429	53072486	P04264	0	-	53072429	53072486	255,102,0	1	57	0	.	Linker	1.
chr12	53072486	53073595	P04264	0	-	53072486	53073595	255,102,0	1	1109	0	.	Coil	1A.
chr12	53073595	53074129	P04264	0	-	53073595	53074129	255,102,0	1	534	0	.	Head.
chr12	53084951	53086209	Q7Z794	0	-	53084951	53086209	255,102,0	1	1258	0	.	Tail.
chr12	53086209	53088484	Q7Z794	0	-	53086209	53088484	255,102,0	1	2275	0	.	Coil	2.
chr12	53086209	53096729	Q7Z794	0	-	53086209	53096729	255,102,0	1	10520	0	.	Rod.
chr12	53088484	53088556	Q7Z794	0	-	53088484	53088556	255,102,0	1	72	0	.	Linker	12.
chr12	53088556	53091566	Q7Z794	0	-	53088556	53091566	255,102,0	1	3010	0	.	Coil	1B.
chr12	53091566	53091623	Q7Z794	0	-	53091566	53091623	255,102,0	1	57	0	.	Linker	1.
chr12	53091623	53096729	Q7Z794	0	-	53091623	53096729	255,102,0	1	5106	0	.	Coil	1A.
chr12	53096729	53097218	Q7Z794	0	-	53096729	53097218	255,102,0	1	489	0	.	Head.
chr12	53162499	53164790	Q01546	0	-	53162499	53164790	255,102,0	1	2291	0	.	Tail.
chr12	53164790	53165955	Q01546	0	-	53164790	53165955	255,102,0	1	1165	0	.	Coil	2.
chr12	53164790	53170529	Q01546	0	-	53164790	53170529	255,102,0	1	5739	0	.	Rod.
chr12	53165955	53166027	Q01546	0	-	53165955	53166027	255,102,0	1	72	0	.	Linker	12.
chr12	53166027	53169275	Q01546	0	-	53166027	53169275	255,102,0	1	3248	0	.	Coil	1B.
chr12	53169275	53169332	Q01546	0	-	53169275	53169332	255,102,0	1	57	0	.	Linker	1.
chr12	53169332	53170529	Q01546	0	-	53169332	53170529	255,102,0	1	1197	0	.	Coil	1A.
chr12	53170529	53171075	Q01546	0	-	53170529	53171075	255,102,0	1	546	0	.	Head.
chr12	53183828	53184997	P12035	0	-	53183828	53184997	255,102,0	1	1169	0	.	Tail.
chr12	53184997	53186100	P12035	0	-	53184997	53186100	255,102,0	1	1103	0	.	Coil	2.
chr12	53184997	53189235	P12035	0	-	53184997	53189235	255,102,0	1	4238	0	.	Rod.
chr12	53186100	53186172	P12035	0	-	53186100	53186172	255,102,0	1	72	0	.	Linker	12.
chr12	53186172	53187998	P12035	0	-	53186172	53187998	255,102,0	1	1826	0	.	Coil	1B.
chr12	53187998	53188061	P12035	0	-	53187998	53188061	255,102,0	1	63	0	.	Linker	1.
chr12	53188061	53189235	P12035	0	-	53188061	53189235	255,102,0	1	1174	0	.	Coil	1A.
chr12	53189235	53189826	P12035	0	-	53189235	53189826	255,102,0	1	591	0	.	Head.
chr12	53215658	53216807	Q5XKE5	0	-	53215658	53216807	255,102,0	1	1149	0	.	Tail.
chr12	53216807	53218059	Q5XKE5	0	-	53216807	53218059	255,102,0	1	1252	0	.	Coil	2.
chr12	53216807	53227621	Q5XKE5	0	-	53216807	53227621	255,102,0	1	10814	0	.	Rod.
chr12	53218059	53218131	Q5XKE5	0	-	53218059	53218131	255,102,0	1	72	0	.	Linker	12.
chr12	53218131	53225293	Q5XKE5	0	-	53218131	53225293	255,102,0	1	7162	0	.	Coil	1B.
chr12	53225293	53225356	Q5XKE5	0	-	53225293	53225356	255,102,0	1	63	0	.	Linker	1.
chr12	53225356	53227621	Q5XKE5	0	-	53225356	53227621	255,102,0	1	2265	0	.	Coil	1A.
chr12	53227621	53228044	Q5XKE5	0	-	53227621	53228044	255,102,0	1	423	0	.	Head.
chr12	53232899	53233552	Q8N1N4	0	-	53232899	53233552	255,102,0	1	653	0	.	Tail.
chr12	53233552	53238420	Q8N1N4	0	-	53233552	53238420	255,102,0	1	4868	0	.	Coil	2.
chr12	53233552	53242384	Q8N1N4	0	-	53233552	53242384	255,102,0	1	8832	0	.	Rod.
chr12	53238420	53238489	Q8N1N4	0	-	53238420	53238489	255,102,0	1	69	0	.	Linker	12.
chr12	53238489	53241794	Q8N1N4	0	-	53238489	53241794	255,102,0	1	3305	0	.	Coil	1B.
chr12	53241794	53241851	Q8N1N4	0	-	53241794	53241851	255,102,0	1	57	0	.	Linker	1.
chr12	53241851	53242384	Q8N1N4	0	-	53241851	53242384	255,102,0	1	533	0	.	Coil	1A.
chr12	53242384	53242714	Q8N1N4	0	-	53242384	53242714	255,102,0	1	330	0	.	Head.
chr12	53291214	53292470	P05787	0	-	53291214	53292470	255,102,0	1	1256	0	.	Tail.
chr12	53292470	53293762	P05787	0	-	53292470	53293762	255,102,0	1	1292	0	.	Coil	2.
chr12	53292470	53298495	P05787	0	-	53292470	53298495	255,102,0	1	6025	0	.	Rod.
chr12	53292518	53293759	P05787	0	-	53292518	53293759	255,102,0	1	1241	0	.	Necessary	for	interaction	with	PNN.	Pubmed:10809736
chr12	53293762	53293834	P05787	0	-	53293762	53293834	255,102,0	1	72	0	.	Linker	12.
chr12	53293834	53295751	P05787	0	-	53293834	53295751	255,102,0	1	1917	0	.	Coil	1B.
chr12	53295751	53295802	P05787	0	-	53295751	53295802	255,102,0	1	51	0	.	Linker	1.
chr12	53295802	53298495	P05787	0	-	53295802	53298495	255,102,0	1	2693	0	.	Coil	1A.
chr12	53298495	53298765	P05787	0	-	53298495	53298765	255,102,0	1	270	0	.	Head.
chr12	53342960	53343194	P05783	0	+	53342960	53343194	255,102,0	1	234	0	.	Head.
chr12	53343164	53346073	P05783	0	+	53343164	53346073	255,102,0	1	2909	0	.	Necessary	for	interaction	with	PNN.	Pubmed:10809736
chr12	53343185	53343341	P05783	0	+	53343185	53343341	255,102,0	1	156	0	.	Interaction	with	TRADD.	Pubmed:11684708
chr12	53343194	53343302	P05783	0	+	53343194	53343302	255,102,0	1	108	0	.	Coil	1A.
chr12	53343194	53346115	P05783	0	+	53343194	53346115	255,102,0	1	2921	0	.	Rod.
chr12	53343302	53343353	P05783	0	+	53343302	53343353	255,102,0	1	51	0	.	Linker	1.
chr12	53343353	53345279	P05783	0	+	53343353	53345279	255,102,0	1	1926	0	.	Coil	1B.
chr12	53345279	53345351	P05783	0	+	53345279	53345351	255,102,0	1	72	0	.	Linker	12.
chr12	53345333	53346127	P05783	0	+	53345333	53346127	255,102,0	1	794	0	.	Interaction	with	DNAJB6.	Pubmed:10954706
chr12	53345351	53346115	P05783	0	+	53345351	53346115	255,102,0	1	764	0	.	Coil	2.
chr12	53346115	53346623	P05783	0	+	53346115	53346623	255,102,0	1	508	0	.	Tail.
chr12	53586500	53587562	P26010	0	-	53586500	53587562	255,102,0	1	1062	0	.	Cysteine-rich	tandem	repeats.
chr12	53605561	53608262	P13631	0	-	53605561	53608262	255,102,0	1	2701	0	.	Ligand-binding.
chr12	53608262	53609086	P13631	0	-	53608262	53609086	255,102,0	1	824	0	.	Hinge.
chr12	53609495	53621329	P13631	0	-	53609495	53621329	255,102,0	1	11834	0	.	Modulating.
chr12	53774078	53775977	P08047	0	+	53774078	53775977	255,102,0	1	1899	0	.	Repressor	domain.
chr12	53776166	53776484	P08047	0	+	53776166	53776484	255,102,0	1	318	0	.	Transactivation	domain	A	(Gln-rich).
chr12	53776511	53777216	P08047	0	+	53776511	53777216	255,102,0	1	705	0	.	Transactivation	domain	B	(Gln-rich).
chr12	53777216	53800523	P08047	0	+	53777216	53800523	255,102,0	1	23307	0	.	Transactivation	domain	C	(highly	charged).
chr12	53803155	53805021	P08047	0	+	53803155	53805021	255,102,0	1	1866	0	.	VZV	IE62-binding.
chr12	53804787	53805021	P08047	0	+	53804787	53805021	255,102,0	1	234	0	.	Domain	D.
chr12	53877254	53877440	Q12852	0	-	53877254	53877440	255,102,0	1	186	0	.	Leucine-zipper	2.
chr12	53877720	53877786	Q12852	0	-	53877720	53877786	255,102,0	1	66	0	.	Leucine-zipper	1.
chr12	53895808	53896902	Q15633	0	+	53895808	53896902	255,102,0	1	1094	0	.	Sufficient	for	interaction	with	PRKRA.
chr12	53898211	53899007	Q15633	0	+	53898211	53899007	255,102,0	1	796	0	.	Sufficient	for	interaction	with	PRKRA.
chr12	53898986	53899929	Q15633	0	+	53898986	53899929	255,102,0	1	943	0	.	Sufficient	for	interaction	with	DICER1.
chr12	53899549	53899929	Q15633	0	+	53899549	53899929	255,102,0	1	380	0	.	Sufficient	for	interaction	with	PRKRA.
chr12	53910923	53918500	P17544	0	-	53910923	53918500	255,102,0	1	7577	0	.	Essential	for	binding	adenovirus	2	E1A.
chr12	53917129	53918395	P17544	0	-	53917129	53918395	255,102,0	1	1266	0	.	Leucine-zipper.
chr12	53918410	53918473	P17544	0	-	53918410	53918473	255,102,0	1	63	0	.	Basic	motif.
chr12	53925599	53994784	P17544	0	-	53925599	53994784	255,102,0	1	69185	0	.	Transactivation	domain.
chr12	54105730	54108007	Q9P1Z2	0	-	54105730	54108007	255,102,0	1	2277	0	.	C-terminal	AD	(CTNNB1	binding	site);	interaction	with	CCAR1.
chr12	54115847	54119026	Q9P1Z2	0	-	54115847	54119026	255,102,0	1	3179	0	.	N-terminal	AD	(CTNNB1	binding	site).
chr12	54117451	54118894	Q9P1Z2	0	-	54117451	54118894	255,102,0	1	1443	0	.	Interaction	with	GATA1.
chr12	54118936	54119026	Q9P1Z2	0	-	54118936	54119026	255,102,0	1	90	0	.	p300	KIX-binding.
chr12	54576131	54576176	Q53HV7	0	-	54576131	54576176	255,102,0	1	45	0	.	DNA	binding.
chr12	54635541	54639978	P45973	0	-	54635541	54639978	255,102,0	1	4437	0	.	Interaction	with	ASXL1.	Pubmed:19880879
chr12	54674600	54675876	P09651	0	+	54674600	54675876	255,102,0	1	1276	0	.	Globular	A	domain.
chr12	54675876	54676242	P09651	0	+	54675876	54676242	255,102,0	1	366	0	.	Globular	B	domain.
chr12	54676424	54676627	P09651	0	+	54676424	54676627	255,102,0	1	203	0	.	RNA-binding	RGG-box.
chr12	54677645	54678049	P09651	0	+	54677645	54678049	255,102,0	1	404	0	.	Nuclear	targeting	sequence	(M9).
chr12	54686385	54686409	Q16621	0	-	54686385	54686409	255,102,0	1	24	0	.	Leucine-zipper.
chr12	54686418	54686478	Q16621	0	-	54686418	54686478	255,102,0	1	60	0	.	Basic	motif.
chr12	54686661	54689032	Q16621	0	-	54686661	54689032	255,102,0	1	2371	0	.	Transactivation	domain.
chr12	54687030	54689032	Q16621	0	-	54687030	54689032	255,102,0	1	2002	0	.	Required	for	interaction	with	MAPK8.
chr12	54764147	54765488	Q96PM9	0	-	54764147	54765488	255,102,0	1	1341	0	.	Necessary	for	binding	to	ITPR1,	CEBPA	and	p53/TP53	mRNAs.
chr12	54790142	54791154	P08648	0	-	54790142	54791154	255,102,0	1	1012	0	.	Interaction	with	HPS5.
chr12	54943734	54960785	Q01064	0	+	54943734	54960785	255,102,0	1	17051	0	.	Calmodulin-binding.
chr12	54964135	54970466	Q01064	0	+	54964135	54970466	255,102,0	1	6331	0	.	Catalytic.
chr12	55250588	55250660	Q96DR8	0	+	55250588	55250660	255,102,0	1	72	0	.	3	X	8	AA	tandem	repeat	of	T-T-A-A-[APS]-T-T-A.
chr12	56078859	56078919	Q13683	0	-	56078859	56078919	255,102,0	1	60	0	.	3	X	4	AA	repeats	of	D-X-H-P.
chr12	56295658	56295817	Q9BRP8	0	-	56295658	56295817	255,102,0	1	159	0	.	eIF2A-like.
chr12	56297202	56321545	Q9BRP8	0	-	56297202	56321545	255,102,0	1	24343	0	.	Required	for	interaction	with	MAGOH	and	RBM8A.
chr12	56350754	56351144	P40967	0	-	56350754	56351144	255,102,0	1	390	0	.	10	X	13	AA	approximate	tandem	repeats,	RPT	domain.
chr12	56397665	56397695	P51687	0	+	56397665	56397695	255,102,0	1	30	0	.	Hinge.
chr12	56397695	56398376	P51687	0	+	56397695	56398376	255,102,0	1	681	0	.	Moco	domain.
chr12	56397815	56397830	P51687	0	+	56397815	56397830	255,102,0	1	15	0	.	Molybdopterin-binding.
chr12	56398301	56398310	P51687	0	+	56398301	56398310	255,102,0	1	9	0	.	Molybdopterin-binding.
chr12	56398376	56398787	P51687	0	+	56398376	56398787	255,102,0	1	411	0	.	Homodimerization.
chr12	56426469	56429112	Q9H2S9	0	+	56426469	56429112	255,102,0	1	2643	0	.	Interaction	with	FOXP3.
chr12	56498524	56500427	Q9UQ80	0	+	56498524	56500427	255,102,0	1	1903	0	.	Necessary	for	nucleolar	localization.	Pubmed:15064750
chr12	56500418	56500445	Q9UQ80	0	+	56500418	56500445	255,102,0	1	27	0	.	RNA-binding.	Pubmed:15064750
chr12	56504805	56506669	Q9UQ80	0	+	56504805	56506669	255,102,0	1	1864	0	.	Necessary	for	nucleolar	localization.	Pubmed:15064750
chr12	56505274	56506612	Q9UQ80	0	+	56505274	56506612	255,102,0	1	1338	0	.	Interaction	with	RNA.
chr12	56524389	56526071	Q9BSJ8	0	+	56524389	56526071	255,102,0	1	1682	0	.	Glycerophospholipid-binding	barrel-like	domain.
chr12	56536864	56536888	Q9BSJ8	0	+	56536864	56536888	255,102,0	1	24	0	.	Required	for	phosphatidylinositol	4,5-bisphosphate-dependent	location	at	the	cell	membrane.
chr12	56811502	56812128	Q9UNS1	0	-	56811502	56812128	255,102,0	1	626	0	.	Required	for	nuclear	localization.
chr12	56824047	56827954	Q9UNS1	0	-	56824047	56827954	255,102,0	1	3907	0	.	Required	for	homodimerization	and	for	interaction	with	CRY1	and	CHEK1.
chr12	56845144	56845177	P30301	0	-	56845144	56845177	255,102,0	1	33	0	.	Interaction	with	CALM.
chr12	57107377	57107425	Q13765	0	-	57107377	57107425	255,102,0	1	48	0	.	RNA/DNA-binding.
chr12	57107461	57108175	E9PAV3	0	-	57107461	57108175	255,102,0	1	714	0	.	Required	for	DNA-binding.
chr12	57107461	57108175	Q13765	0	-	57107461	57108175	255,102,0	1	714	0	.	Required	for	DNA-binding.
chr12	57431834	57432245	Q9UBC5	0	-	57431834	57432245	255,102,0	1	411	0	.	Actin-binding.
chr12	57453664	57454703	O14524	0	-	57453664	57454703	255,102,0	1	1039	0	.	Required	for	nuclear	localization.
chr12	57453781	57454703	O14524	0	-	57453781	57454703	255,102,0	1	922	0	.	B;	required	for	interaction	with	RAN-GTP.
chr12	57456990	57458512	O14524	0	-	57456990	57458512	255,102,0	1	1522	0	.	A;	required	for	its	colocalization	with	lamins	at	the	nuclear	envelope.
chr12	57484926	57485163	Q15742	0	+	57484926	57485163	255,102,0	1	237	0	.	NCD1.
chr12	57485622	57486341	Q15742	0	+	57485622	57486341	255,102,0	1	719	0	.	NCD2.
chr12	57486329	57486854	Q15742	0	+	57486329	57486854	255,102,0	1	525	0	.	Necessary	for	nuclear	localization.
chr12	57605783	57606335	Q07954	0	+	57605783	57606335	255,102,0	1	552	0	.	Interaction	with	MAFB.
chr12	57618672	57618855	O95158	0	+	57618672	57618855	255,102,0	1	183	0	.	II.
chr12	57618855	57619092	O95158	0	+	57618855	57619092	255,102,0	1	237	0	.	III.
chr12	57619092	57619275	O95158	0	+	57619092	57619275	255,102,0	1	183	0	.	IV	(linker	domain).
chr12	57619275	57619527	O95158	0	+	57619275	57619527	255,102,0	1	252	0	.	V	(Cys-rich).
chr12	57857474	57857534	P08151	0	+	57857474	57857534	255,102,0	1	60	0	.	SNAG	domain.
chr12	57858619	57858634	P08151	0	+	57858619	57858634	255,102,0	1	15	0	.	Interaction	with	SUFU.	Pubmed:24217340,	Pubmed:24311597
chr12	57860106	57860133	P08151	0	+	57860106	57860133	255,102,0	1	27	0	.	Interaction	with	DNA.	Pubmed:8378770
chr12	57861235	57861253	P08151	0	+	57861235	57861253	255,102,0	1	18	0	.	Interaction	with	DNA.	Pubmed:8378770
chr12	57861821	57861842	P08151	0	+	57861821	57861842	255,102,0	1	21	0	.	Interaction	with	DNA.	Pubmed:8378770
chr12	57910657	57910702	P35638	0	-	57910657	57910702	255,102,0	1	45	0	.	Leucine-zipper.
chr12	57910711	57910801	P35638	0	-	57910711	57910801	255,102,0	1	90	0	.	Basic	motif.
chr12	57911111	57911162	P35638	0	-	57911111	57911162	255,102,0	1	51	0	.	N-terminal.
chr12	57911135	57911162	P35638	0	-	57911135	57911162	255,102,0	1	27	0	.	Interaction	with	TRIB3.
chr12	57960926	57963164	Q12840	0	+	57960926	57963164	255,102,0	1	2238	0	.	Microtubule-binding.
chr12	57962841	57963432	Q12840	0	+	57962841	57963432	255,102,0	1	591	0	.	Necessary	for	interaction	with	ZFYVE27.
chr12	57963405	57976959	Q12840	0	+	57963405	57976959	255,102,0	1	13554	0	.	Interaction	with	BICD2.	Pubmed:20386726
chr12	57974918	57976959	Q12840	0	+	57974918	57976959	255,102,0	1	2041	0	.	Globular.
chr12	58008486	58008552	Q86VW2	0	+	58008486	58008552	255,102,0	1	66	0	.	Important	for	binding	to	Rho	GTPases.
chr12	58009778	58010125	Q86VW2	0	+	58009778	58010125	255,102,0	1	347	0	.	Sufficient	to	bind	activated	GNAQ.
chr12	58145332	58145353	P11802	0	-	58145332	58145353	255,102,0	1	21	0	.	Required	for	binding	D-type	cyclins.
chr12	58162889	58162898	Q9UBP6	0	-	58162889	58162898	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr12	58163590	58163596	Q9UBP6	0	-	58163590	58163596	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr12	58163689	58163695	Q9UBP6	0	-	58163689	58163695	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr12	58166868	58166877	Q96AZ1	0	+	58166868	58166877	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr12	58191667	58194956	O75366	0	-	58191667	58194956	255,102,0	1	3289	0	.	Headpiece.
chr12	58194953	58209823	O75366	0	-	58194953	58209823	255,102,0	1	14870	0	.	Core.
chr12	58204819	58204846	O75366	0	-	58204819	58204846	255,102,0	1	27	0	.	Polyphosphoinositide	binding.
chr12	58204900	58207023	O75366	0	-	58204900	58207023	255,102,0	1	2123	0	.	Polyphosphoinositide	binding.
chr12	62654198	62719700	Q9Y4E8	0	+	62654198	62719700	255,102,0	1	65502	0	.	Mediates	interaction	with	SART3.	Pubmed:24526689
chr12	64803815	64816997	O43592	0	+	64803815	64816997	255,102,0	1	13182	0	.	Necessary	for	interaction	with	Ran,	nuclear	localization	and	nuclear	import.
chr12	64818836	64841908	O43592	0	+	64818836	64841908	255,102,0	1	23072	0	.	Necessary	for	tRNA-binding,	cytoplasmic	localization	and	nuclear	export.
chr12	64890828	64890967	Q9UHD2	0	+	64890828	64890967	255,102,0	1	139	0	.	Interaction	with	AZI2,	TANK	and	TBKBP1.	Pubmed:21931631
chr12	65633986	65640102	Q9Y2U8	0	+	65633986	65640102	255,102,0	1	6116	0	.	Interaction	with	SMAD1,	SMAD2,	SMAD3	and	SMAD5.	Pubmed:15647271
chr12	66221798	66221858	P52926	0	+	66221798	66221858	255,102,0	1	60	0	.	Interaction	with	E4F1.	Pubmed:14645522
chr12	69044194	69047909	P61224	0	+	69044194	69047909	255,102,0	1	3715	0	.	Interaction	with	KRIT1.	Pubmed:22577140
chr12	69645088	69650585	Q16630	0	+	69645088	69650585	255,102,0	1	5497	0	.	Necessary	for	interaction	with	NUDT21/CPSF5.
chr12	69656210	69656336	Q16630	0	+	69656210	69656336	255,102,0	1	126	0	.	Sufficient	for	nuclear	targeting.
chr12	69764727	69784093	O95619	0	+	69764727	69784093	255,102,0	1	19366	0	.	Interaction	with	MLLT10.	Pubmed:11756182
chr12	69764742	69784093	O95619	0	+	69764742	69784093	255,102,0	1	19351	0	.	Interaction	with	TACC1.	Pubmed:11903063
chr12	70737925	70747692	Q9NZN8	0	+	70737925	70747692	255,102,0	1	9767	0	.	Repressor	domain.
chr12	70925934	70928272	P23467	0	-	70925934	70928272	255,102,0	1	2338	0	.	Substrate	binding.
chr12	71050581	71054724	Q15256	0	-	71050581	71054724	255,102,0	1	4143	0	.	Substrate	binding.
chr12	72863566	72863581	Q9UKU6	0	+	72863566	72863581	255,102,0	1	15	0	.	Substrate	binding.
chr12	75444458	75444476	Q96PR1	0	-	75444458	75444476	255,102,0	1	18	0	.	Selectivity	filter.
chr12	76420514	76420628	Q8WV24	0	-	76420514	76420628	255,102,0	1	114	0	.	14	X	2	AA	repeats	of	P-H.
chr12	76420643	76420751	Q8WV24	0	-	76420643	76420751	255,102,0	1	108	0	.	15	X	2	AA	repeats	of	P-Q.
chr12	76422670	76422784	Q8WV24	0	-	76422670	76422784	255,102,0	1	114	0	.	14	X	2	AA	repeats	of	P-H.
chr12	76422799	76422907	Q8WV24	0	-	76422799	76422907	255,102,0	1	108	0	.	15	X	2	AA	repeats	of	P-Q.
chr12	76778118	76778124	Q9BZF1	0	-	76778118	76778124	255,102,0	1	6	0	.	Phosphatidylinositol	4-phosphate	binding.
chr12	76780025	76780037	Q9BZF1	0	-	76780025	76780037	255,102,0	1	12	0	.	Phosphatidylinositol	4-phosphate	binding.
chr12	76783501	76783519	Q9BZF1	0	-	76783501	76783519	255,102,0	1	18	0	.	Phosphatidylinositol	4-phosphate	binding.
chr12	76783501	76783519	Q9BZF1	0	-	76783501	76783519	255,102,0	1	18	0	.	Phosphatidylserine	binding.
chr12	77158046	77220705	Q8IUH5	0	+	77158046	77220705	255,102,0	1	62659	0	.	Necessary	and	sufficient	for	interaction	with	DNAJC5	and	SNAP25.
chr12	79685841	79842781	P21579	0	+	79685841	79842781	255,102,0	1	156940	0	.	Phospholipid	binding.
chr12	79986389	79988147	Q96IZ0	0	-	79986389	79988147	255,102,0	1	1758	0	.	Leucine-zipper.
chr12	80014894	80083592	Q96IZ0	0	-	80014894	80083592	255,102,0	1	68698	0	.	Selective	for	apoptosis	induction	in	cancer	cells	(SAC).
chr12	80187699	80192321	O14974	0	-	80187699	80192321	255,102,0	1	4622	0	.	Interaction	with	ROCK2.	Pubmed:19131646
chr12	81532942	81532954	Q9H6R3	0	+	81532942	81532954	255,102,0	1	12	0	.	Coenzyme	A	binding.
chr12	85680672	85695250	Q15699	0	+	85680672	85695250	255,102,0	1	14578	0	.	Transactivation	domain.
chr12	88442963	88465186	O15078	0	-	88442963	88465186	255,102,0	1	22223	0	.	Self-association	(with	itself	or	N-terminus).	Pubmed:18723859
chr12	88500580	88505602	O15078	0	-	88500580	88505602	255,102,0	1	5022	0	.	Interaction	with	IQCB1.	Pubmed:18723859
chr12	88505602	88535084	O15078	0	-	88505602	88535084	255,102,0	1	29482	0	.	Self-association	(with	itself	or	C-terminus).	Pubmed:18723859
chr12	89917231	89917420	Q8N4A0	0	-	89917231	89917420	255,102,0	1	189	0	.	Catalytic	subdomain	B.
chr12	89917597	89917927	Q8N4A0	0	-	89917597	89917927	255,102,0	1	330	0	.	Catalytic	subdomain	A.
chr12	93772149	93772158	Q9NZJ9	0	+	93772149	93772158	255,102,0	1	9	0	.	Substrate	binding.
chr12	93792555	93792564	Q9NZJ9	0	+	93792555	93792564	255,102,0	1	9	0	.	Substrate	binding.
chr12	95416007	95416067	P13056	0	-	95416007	95416067	255,102,0	1	60	0	.	Required	for	interaction	with	NRIP1.
chr12	95452095	95461160	P13056	0	-	95452095	95461160	255,102,0	1	9065	0	.	Required	for	interaction	with	KAT2B.
chr12	96396757	96396766	P09960	0	-	96396757	96396766	255,102,0	1	9	0	.	Substrate	binding.
chr12	96412576	96412594	P09960	0	-	96412576	96412594	255,102,0	1	18	0	.	Substrate	binding.
chr12	96421221	96421230	P09960	0	-	96421221	96421230	255,102,0	1	9	0	.	Substrate	binding.
chr12	98909645	98941501	P42167	0	+	98909645	98941501	255,102,0	1	31856	0	.	Nucleoplasmic.
chr12	98909789	98921708	P42166	0	+	98909789	98921708	255,102,0	1	11919	0	.	Linker.
chr12	98909789	98921708	P42167	0	+	98909789	98921708	255,102,0	1	11919	0	.	Linker.
chr12	98925462	98938073	P42167	0	+	98925462	98938073	255,102,0	1	12611	0	.	NAKAP95-binding	N.
chr12	98938743	98941384	P42167	0	+	98938743	98941384	255,102,0	1	2641	0	.	Binds	lamins	B.
chr12	98938746	98941393	P42167	0	+	98938746	98941393	255,102,0	1	2647	0	.	NAKAP95-binding	C.
chr12	99102368	99102404	O14727	0	+	99102368	99102404	255,102,0	1	36	0	.	Interpropeller	linker.
chr12	100731233	100732947	Q6P3W7	0	+	100731233	100732947	255,102,0	1	1714	0	.	Necessary	for	interaction	with	AP2	complex	and	clathrin,	interaction	with	clathrin	is	necessary	for	its	targeting	to	the	TGN	and	endosomal	membranes.
chr12	100930292	100957228	Q96RI1	0	+	100930292	100957228	255,102,0	1	26936	0	.	Ligand-binding.
chr12	100934511	100934538	Q96RI1	0	+	100934511	100934538	255,102,0	1	27	0	.	Agonist	binding.
chr12	102122707	102122725	Q8IZU3	0	-	102122707	102122725	255,102,0	1	18	0	.	Important	for	oligomerization	and	fiber	formation.	Pubmed:24950965
chr12	102128784	102128796	Q8IZU3	0	-	102128784	102128796	255,102,0	1	12	0	.	Interaction	with	DNA.	Pubmed:24950965
chr12	102130827	102130845	Q8IZU3	0	-	102130827	102130845	255,102,0	1	18	0	.	Important	for	oligomerization	and	fiber	formation.	Pubmed:24950965
chr12	102131038	102131056	Q8IZU3	0	-	102131038	102131056	255,102,0	1	18	0	.	Interaction	with	DNA.	Pubmed:24950965
chr12	102813334	102813358	P05019	0	-	102813334	102813358	255,102,0	1	24	0	.	D.
chr12	102813358	102813421	P05019	0	-	102813358	102813421	255,102,0	1	63	0	.	A.
chr12	102813421	102813457	P05019	0	-	102813421	102813457	255,102,0	1	36	0	.	C.
chr12	102813457	102869496	P05019	0	-	102813457	102869496	255,102,0	1	56039	0	.	B.
chr12	104157290	104157323	Q8WWQ8	0	+	104157290	104157323	255,102,0	1	33	0	.	Interaction	with	TMSB4X.	Pubmed:18519035
chr12	104187751	104190674	Q86UY8	0	-	104187751	104190674	255,102,0	1	2923	0	.	Substrate	binding.
chr12	104513517	104517006	P25208	0	-	104513517	104517006	255,102,0	1	3489	0	.	C	domain.
chr12	104517006	104519966	P25208	0	-	104517006	104519966	255,102,0	1	2960	0	.	B	domain.
chr12	104517141	104517177	P25208	0	-	104517141	104517177	255,102,0	1	36	0	.	Subunit	association	domain	(SAD).
chr12	104519966	104529231	P25208	0	-	104519966	104529231	255,102,0	1	9265	0	.	A	domain.
chr12	105418204	105446685	Q3SY69	0	-	105418204	105446685	255,102,0	1	28481	0	.	Aldehyde	dehydrogenase.
chr12	105460366	105467765	Q3SY69	0	-	105460366	105467765	255,102,0	1	7399	0	.	GART.
chr12	105538166	105560706	Q2M389	0	+	105538166	105560706	255,102,0	1	22540	0	.	Sufficient	for	interaction	with	WASHC5.	Pubmed:20498093
chr12	105583890	105629790	Q8NEU8	0	-	105583890	105629790	255,102,0	1	45900	0	.	Required	for	RAB5A	binding.
chr12	107105238	107126017	Q33E94	0	+	107105238	107126017	255,102,0	1	20779	0	.	Necessary	for	dimerization.
chr12	107391278	107391347	Q16526	0	-	107391278	107391347	255,102,0	1	69	0	.	Interaction	with	TIMELESS.
chr12	107391347	107393355	Q16526	0	-	107391347	107393355	255,102,0	1	2008	0	.	Required	for	inhibition	of	CLOCK-ARNTL/BMAL1-mediated	transcription.
chr12	108920235	108924036	Q15020	0	-	108920235	108924036	255,102,0	1	3801	0	.	Required	for	nuclear	localization.	Pubmed:11959860
chr12	108926106	108929232	Q15020	0	-	108926106	108929232	255,102,0	1	3126	0	.	Required	for	interaction	with	USP4.	Pubmed:20595234
chr12	108932718	108954927	Q15020	0	-	108932718	108954927	255,102,0	1	22209	0	.	Mediates	interaction	with	PRPF3.	Pubmed:15314151
chr12	109017300	109017720	Q14242	0	-	109017300	109017720	255,102,0	1	420	0	.	12	X	10	AA	tandem	repeats.
chr12	109181766	109182225	Q8WYL5	0	-	109181766	109182225	255,102,0	1	459	0	.	Interaction	with	YWHAG.	Pubmed:15159416
chr12	109526034	109526055	Q6NS38	0	-	109526034	109526055	255,102,0	1	21	0	.	Alpha-ketoglutarate	binding.	Pubmed:18432238
chr12	109526313	109527818	Q6NS38	0	-	109526313	109527818	255,102,0	1	1505	0	.	Alpha-ketoglutarate	binding.	Pubmed:18432238
chr12	109527920	109527929	Q6NS38	0	-	109527920	109527929	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:18432238
chr12	109527980	109527989	Q6NS38	0	-	109527980	109527989	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:18432238
chr12	109535484	109535559	P13051	0	+	109535484	109535559	255,102,0	1	75	0	.	FAM72A-binding.
chr12	109680301	109703007	O00763	0	+	109680301	109703007	255,102,0	1	22706	0	.	Carboxyltransferase.
chr12	110221548	110222145	Q9HBA0	0	-	110221548	110222145	255,102,0	1	597	0	.	Interaction	with	calmodulin	and	ITPR3.	Pubmed:18826956,	Pubmed:12724311
chr12	110295428	110296517	Q9NZD2	0	-	110295428	110296517	255,102,0	1	1089	0	.	2	X	12	AA	approximate	tandem	repeats.
chr12	110295461	110296508	Q9NZD2	0	-	110295461	110296508	255,102,0	1	1047	0	.	Glycolipid	binding.
chr12	110341769	110354425	Q9BT92	0	+	110341769	110354425	255,102,0	1	12656	0	.	Interaction	with	keratin	proteins.	Pubmed:15731013
chr12	110346465	110352387	Q9BT92	0	+	110346465	110352387	255,102,0	1	5922	0	.	Trichohyalin/plectin	homology	domain.	Pubmed:15731013
chr12	110565188	110566869	Q8WYA0	0	+	110565188	110566869	255,102,0	1	1681	0	.	CH	(calponin-homology)-like	region.
chr12	110770413	110771001	P16615	0	+	110770413	110771001	255,102,0	1	588	0	.	Interaction	with	phospholamban	1.
chr12	110777487	110778484	P16615	0	+	110777487	110778484	255,102,0	1	997	0	.	Interaction	with	HAX1.	Pubmed:18971376
chr12	110781076	110781139	P16615	0	+	110781076	110781139	255,102,0	1	63	0	.	Interaction	with	phospholamban	2.
chr12	110781079	110784272	P16615	0	+	110781079	110784272	255,102,0	1	3193	0	.	Interaction	with	TMEM64	and	PDIA3.
chr12	112924428	112926262	Q06124	0	+	112924428	112926262	255,102,0	1	1834	0	.	Substrate	binding.
chr12	113344880	113345024	P00973	0	+	113344880	113345024	255,102,0	1	144	0	.	Interaction	with	dsRNA.
chr12	113348983	113349016	P00973	0	+	113348983	113349016	255,102,0	1	33	0	.	Interaction	with	dsRNA.
chr12	113376350	113385904	Q9Y6K5	0	+	113376350	113385904	255,102,0	1	9554	0	.	OAS	domain	1.
chr12	113376368	113376506	Q9Y6K5	0	+	113376368	113376506	255,102,0	1	138	0	.	Interaction	with	dsRNA.	Pubmed:25775560
chr12	113382375	113382420	Q9Y6K5	0	+	113382375	113382420	255,102,0	1	45	0	.	Interaction	with	dsRNA.	Pubmed:25775560
chr12	113386665	113386866	Q9Y6K5	0	+	113386665	113386866	255,102,0	1	201	0	.	Linker.
chr12	113386866	113401259	Q9Y6K5	0	+	113386866	113401259	255,102,0	1	14393	0	.	OAS	domain	2.
chr12	113402057	113407560	Q9Y6K5	0	+	113402057	113407560	255,102,0	1	5503	0	.	OAS	domain	3.
chr12	113416443	113436212	P29728	0	+	113416443	113436212	255,102,0	1	19769	0	.	OAS	domain	1.
chr12	113440754	113447045	P29728	0	+	113440754	113447045	255,102,0	1	6291	0	.	OAS	domain	2.
chr12	113601076	113601997	Q8TDD1	0	-	113601076	113601997	255,102,0	1	921	0	.	Interaction	with	nuclear	receptors.
chr12	113629193	113629280	Q96K30	0	+	113629193	113629280	255,102,0	1	87	0	.	Interaction	with	RBPJ/RBPSUH.	Pubmed:21102556
chr12	113629277	113629619	Q96K30	0	+	113629277	113629619	255,102,0	1	342	0	.	Interaction	with	tubulin.
chr12	115109792	115112110	O15119	0	-	115109792	115112110	255,102,0	1	2318	0	.	Transcription	repression.
chr12	116424205	116424271	Q71F56	0	-	116424205	116424271	255,102,0	1	66	0	.	Leucine-zipper.
chr12	117698314	117698374	P29475	0	-	117698314	117698374	255,102,0	1	60	0	.	Tetrahydrobiopterin-binding.
chr12	117698386	117701728	P29475	0	-	117698386	117701728	255,102,0	1	3342	0	.	Calmodulin-binding.
chr12	117749387	117768388	P29475	0	-	117749387	117768388	255,102,0	1	19001	0	.	PIN	(nNOS-inhibiting	protein)	binding.
chr12	117768259	117768874	P29475	0	-	117768259	117768874	255,102,0	1	615	0	.	Interaction	with	NOSIP.
chr12	118577286	118582446	P30086	0	+	118577286	118582446	255,102,0	1	5160	0	.	Interaction	with	RAF1.	Pubmed:18294816
chr12	118814499	118829080	Q9H7L9	0	+	118814499	118829080	255,102,0	1	14581	0	.	Mediates	interaction	with	USP17L2.	Pubmed:21239494
chr12	118838507	118839790	Q9H7L9	0	+	118838507	118839790	255,102,0	1	1283	0	.	Sin3	interaction	domain	(SID).
chr12	120110147	120112216	Q9Y478	0	+	120110147	120112216	255,102,0	1	2069	0	.	Glycogen-binding	domain.
chr12	120156185	120168389	O14578	0	-	120156185	120168389	255,102,0	1	12204	0	.	Interaction	with	Rho/Rac.
chr12	120899887	120899926	Q13242	0	-	120899887	120899926	255,102,0	1	39	0	.	Interaction	with	SAFB1.
chr12	120935941	120936010	P63167	0	+	120935941	120936010	255,102,0	1	69	0	.	Interaction	with	ESR1.	Pubmed:15891768
chr12	120947900	120947906	B4DP72	0	-	120947900	120947906	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr12	120947900	120947906	Q5HYK3	0	-	120947900	120947906	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr12	120984350	120990502	Q8N5U6	0	+	120984350	120990502	255,102,0	1	6152	0	.	Interaction	with	MEOX2.	Pubmed:16335786
chr12	121176344	121176356	P16219	0	+	121176344	121176356	255,102,0	1	12	0	.	Substrate	binding.
chr12	121682995	121686438	Q96RR4	0	-	121682995	121686438	255,102,0	1	3443	0	.	Calmodulin-binding.
chr12	121686429	121686447	Q96RR4	0	-	121686429	121686447	255,102,0	1	18	0	.	Autoinhibitory	domain.
chr12	121701689	121706456	Q96RR4	0	-	121701689	121706456	255,102,0	1	4767	0	.	RP	domain.
chr12	122615443	122618137	Q9HAP2	0	+	122615443	122618137	255,102,0	1	2694	0	.	Transactivation	domain.	Pubmed:12446771
chr12	122623018	122623084	Q9HAP2	0	+	122623018	122623084	255,102,0	1	66	0	.	Leucine-zipper.
chr12	122623470	122626242	Q9HAP2	0	+	122623470	122626242	255,102,0	1	2772	0	.	Mediates	heterotypic	interactions	between	MLXIP	and	MLX	and	is	required	for	cytoplasmic	localization.	Pubmed:12446771
chr12	122862289	122862304	P30622	0	-	122862289	122862304	255,102,0	1	15	0	.	Important	for	tubulin	binding.	Pubmed:17889670
chr12	123345008	123345468	O75146	0	+	123345008	123345468	255,102,0	1	460	0	.	Important	for	actin	binding.
chr12	123352010	123355572	Q9H9H4	0	-	123352010	123355572	255,102,0	1	3562	0	.	Interaction	with	IST1.	Pubmed:19129479
chr12	123738389	123741440	Q9H3J6	0	+	123738389	123741440	255,102,0	1	3051	0	.	GGQ	domain.
chr12	123749842	123756165	O14519	0	-	123749842	123756165	255,102,0	1	6323	0	.	intrinsically	disordered.
chr12	123889448	123889457	A0A0C4DFR3	0	+	123889448	123889457	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr12	123889448	123889457	C9JKQ0	0	+	123889448	123889457	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr12	123892082	123892088	A0A0C4DFR3	0	+	123892082	123892088	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr12	123892082	123892088	C9JKQ0	0	+	123892082	123892088	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr12	124069183	124081213	Q15363	0	+	124069183	124081213	255,102,0	1	12030	0	.	Interaction	with	F2RL1.	Pubmed:17693410
chr12	124071464	124074986	Q15363	0	+	124071464	124074986	255,102,0	1	3522	0	.	Required	for	TMED10	and	TMED2	cis-Golgi	network	localization.
chr12	124247066	124330620	Q8IVF4	0	+	124247066	124330620	255,102,0	1	83554	0	.	Stem.
chr12	124330620	124337860	Q8IVF4	0	+	124330620	124337860	255,102,0	1	7240	0	.	AAA	1.
chr12	124341740	124352082	Q8IVF4	0	+	124341740	124352082	255,102,0	1	10342	0	.	AAA	2.
chr12	124354995	124362432	Q8IVF4	0	+	124354995	124362432	255,102,0	1	7437	0	.	AAA	3.
chr12	124366183	124382432	Q8IVF4	0	+	124366183	124382432	255,102,0	1	16249	0	.	AAA	4.
chr12	124382474	124397803	Q8IVF4	0	+	124382474	124397803	255,102,0	1	15329	0	.	Stalk.
chr12	124399071	124403231	Q8IVF4	0	+	124399071	124403231	255,102,0	1	4160	0	.	AAA	5.
chr12	124409716	124414234	Q8IVF4	0	+	124409716	124414234	255,102,0	1	4518	0	.	AAA	6.
chr12	130834413	130834422	Q96J94	0	+	130834413	130834422	255,102,0	1	9	0	.	Required	for	binding	2'-O-methylated	3'-end	of	piRNAs.
chr12	130842050	130847371	Q96J94	0	+	130842050	130847371	255,102,0	1	5321	0	.	RNA-binding.
chr12	132395255	132398382	O75385	0	+	132395255	132398382	255,102,0	1	3127	0	.	Interaction	with	GABARAP	and	GABARAPL2.	Pubmed:11146101
chr12	132403196	132405903	O75385	0	+	132403196	132405903	255,102,0	1	2707	0	.	C-terminal	domain;	mediates	interaction	with	SESN2.	Pubmed:25040165
chr12	133197892	133198063	Q9UBL9	0	+	133197892	133198063	255,102,0	1	171	0	.	Pore-forming	motif.
chr12	133291480	133291498	Q96HS1	0	+	133291480	133291498	255,102,0	1	18	0	.	Interaction	with	KEAP1.
chr12	133384883	133389898	Q08378	0	-	133384883	133389898	255,102,0	1	5015	0	.	Golgi-targeting	domain.
chr12	133389988	133393171	Q08378	0	-	133389988	133393171	255,102,0	1	3183	0	.	Interaction	with	GOPC.	Pubmed:15951434
chr13	20216278	20216302	Q99549	0	+	20216278	20216302	255,102,0	1	24	0	.	Histone	H3K9me3	binding.	Pubmed:21419134
chr13	20304462	20333542	Q8WXF1	0	-	20304462	20333542	255,102,0	1	29080	0	.	Sufficient	for	perinucleolar	caps	localization	and	interaction	with	NONO.	Pubmed:16148043
chr13	20304462	20346683	Q8WXF1	0	-	20304462	20346683	255,102,0	1	42221	0	.	Sufficient	for	paraspeckles	localization.
chr13	21721037	21721478	O00422	0	+	21721037	21721478	255,102,0	1	441	0	.	Involved	in	splicing	regulation	activity.
chr13	24858274	24860375	Q96N96	0	+	24858274	24860375	255,102,0	1	2101	0	.	ABR	(APC-binding	region)	domain.
chr13	24871845	24876908	Q96N96	0	+	24871845	24876908	255,102,0	1	5063	0	.	C-terminal	tail.
chr13	24995259	25008595	Q9UKK3	0	-	24995259	25008595	255,102,0	1	13336	0	.	Interaction	with	the	major	vault	protein.
chr13	25457317	25479493	Q9HC77	0	-	25457317	25479493	255,102,0	1	22176	0	.	Interaction	with	STIL.	Pubmed:22020124,	Pubmed:25385835
chr13	25480993	25482175	Q9HC77	0	-	25480993	25482175	255,102,0	1	1182	0	.	Alpha/beta-tubulin	binding.	Pubmed:19131341
chr13	25831402	25831423	Q9Y217	0	-	25831402	25831423	255,102,0	1	21	0	.	Substrate	binding.
chr13	25832734	25832740	Q9Y217	0	-	25832734	25832740	255,102,0	1	6	0	.	Substrate	binding.
chr13	25832803	25832815	Q9Y217	0	-	25832803	25832815	255,102,0	1	12	0	.	Substrate	binding.
chr13	25875929	25914209	Q9BVL2	0	+	25875929	25914209	255,102,0	1	38280	0	.	14	X	2	AA	repeats	of	F-G.
chr13	26787963	26788200	Q9Y252	0	-	26787963	26788200	255,102,0	1	237	0	.	Required	for	polyubiquitination.
chr13	26828778	26828823	P49336	0	+	26828778	26828823	255,102,0	1	45	0	.	Interaction	with	CCNC.
chr13	27845129	27847625	Q6T310	0	+	27845129	27847625	255,102,0	1	2496	0	.	Small	GTPase-like.
chr13	28366827	28366887	Q9H4S2	0	+	28366827	28366887	255,102,0	1	60	0	.	SNAG	domain.
chr13	28494311	28494494	P52945	0	+	28494311	28494494	255,102,0	1	183	0	.	Transactivation	domain.
chr13	28552395	28552410	A6NGE7	0	-	28552395	28552410	255,102,0	1	15	0	.	Substrate	binding.
chr13	28552500	28552515	A6NGE7	0	-	28552500	28552515	255,102,0	1	15	0	.	Substrate	binding.
chr13	28608264	28608285	P36888	0	-	28608264	28608285	255,102,0	1	21	0	.	Important	for	normal	regulation	of	the	kinase	activity	and	for	maintaining	the	kinase	in	an	inactive	state	in	the	absence	of	bound	ligand.
chr13	28712794	28840913	Q58A45	0	+	28712794	28840913	255,102,0	1	128119	0	.	Interaction	with	polyadenylate-binding	protein.	Pubmed:14583602
chr13	28840913	28866656	Q58A45	0	+	28840913	28866656	255,102,0	1	25743	0	.	Interaction	with	PAN2.	Pubmed:23932717,	Pubmed:14583602
chr13	28840922	28866656	A0A0C4DFZ9	0	+	28840922	28866656	255,102,0	1	25734	0	.	Interaction	with	PAN2.
chr13	31035592	31036698	P09429	0	-	31035592	31036698	255,102,0	1	1106	0	.	Binding	to	AGER/RAGE.
chr13	31036821	31037375	P09429	0	-	31036821	31037375	255,102,0	1	554	0	.	Cytokine-stimulating	activity.	Pubmed:12765338
chr13	31037348	31037814	P09429	0	-	31037348	31037814	255,102,0	1	466	0	.	Sufficient	for	interaction	with	HAVCR2.
chr13	31037351	31037402	P09429	0	-	31037351	31037402	255,102,0	1	51	0	.	LPS	binding	(Lipid	A).	Pubmed:21660935
chr13	31037772	31037811	P09429	0	-	31037772	31037811	255,102,0	1	39	0	.	LPS	binding	(delipidated).	Pubmed:21660935
chr13	31037787	31037814	P09429	0	-	31037787	31037814	255,102,0	1	27	0	.	Heparin-binding.
chr13	31205448	31231699	Q5W0Q7	0	+	31205448	31231699	255,102,0	1	26251	0	.	SUMO-binding.
chr13	31309799	31318207	P20292	0	+	31309799	31318207	255,102,0	1	8408	0	.	Inhibitor	binding.
chr13	31338090	31338126	P20292	0	+	31338090	31338126	255,102,0	1	36	0	.	Inhibitor	binding.
chr13	33629395	33638143	Q9UEF7	0	+	33629395	33638143	255,102,0	1	8748	0	.	Glycosyl	hydrolase-1	2.
chr13	37399603	37401881	O00287	0	+	37399603	37401881	255,102,0	1	2278	0	.	C-terminal	domain.
chr13	38211042	38211051	Q9UBN4	0	-	38211042	38211051	255,102,0	1	9	0	.	PDZ-binding	domain.
chr13	38211042	38229266	Q9UBN4	0	-	38211042	38229266	255,102,0	1	18224	0	.	Binds	to	ITPR1,	ITPR2	and	ITPR3.
chr13	38266457	38320211	Q9UBN4	0	-	38266457	38320211	255,102,0	1	53754	0	.	Multimerization	domain.
chr13	38320454	38357212	Q9UBN4	0	-	38320454	38357212	255,102,0	1	36758	0	.	Multimerization	domain.
chr13	41133938	41134781	Q12778	0	-	41133938	41134781	255,102,0	1	843	0	.	Sufficient	for	interaction	with	NLK.
chr13	41134250	41134541	Q12778	0	-	41134250	41134541	255,102,0	1	291	0	.	Required	for	interaction	with	RUNX2.
chr13	41134916	41134928	Q12778	0	-	41134916	41134928	255,102,0	1	12	0	.	DNA-binding.
chr13	41134973	41134997	Q12778	0	-	41134973	41134997	255,102,0	1	24	0	.	DNA-binding.
chr13	42877829	42877871	Q9UKA4	0	+	42877829	42877871	255,102,0	1	42	0	.	PKA-RII	subunit	binding	domain.
chr13	45008902	45008968	Q15714	0	-	45008902	45008968	255,102,0	1	66	0	.	Leucine-zipper.
chr13	46632376	46632382	Q96IY4	0	-	46632376	46632382	255,102,0	1	6	0	.	Substrate	binding.
chr13	46638807	46638813	Q96IY4	0	-	46638807	46638813	255,102,0	1	6	0	.	Substrate	binding.
chr13	46648046	46648058	Q96IY4	0	-	46648046	46648058	255,102,0	1	12	0	.	Substrate	binding.
chr13	47409367	47409382	P28223	0	-	47409367	47409382	255,102,0	1	15	0	.	Agonist	binding.
chr13	47466657	47466675	P28223	0	-	47466657	47466675	255,102,0	1	18	0	.	Agonist	binding.
chr13	48523699	48523708	E5KS60	0	-	48523699	48523708	255,102,0	1	9	0	.	Substrate	binding;	shared	with	subunit	alpha.
chr13	48523699	48523708	Q9P2R7	0	-	48523699	48523708	255,102,0	1	9	0	.	Substrate	binding;	shared	with	subunit	alpha.
chr13	48615122	48619932	Q9NV35	0	+	48615122	48619932	255,102,0	1	4810	0	.	Interaction	with	PCNA.	Pubmed:19419956
chr13	48830369	48830468	Q9Y287	0	+	48830369	48830468	255,102,0	1	99	0	.	Necessary	for	interaction	with	APP	and	inhibitor	effects	on	APP	processing.
chr13	48942729	49027170	P06400	0	+	48942729	49027170	255,102,0	1	84441	0	.	Domain	A.
chr13	48942729	49039235	P06400	0	+	48942729	49039235	255,102,0	1	96506	0	.	Pocket;	binds	T	and	E1A.
chr13	49027170	49030442	P06400	0	+	49027170	49030442	255,102,0	1	3272	0	.	Spacer.
chr13	49030442	49039235	P06400	0	+	49030442	49039235	255,102,0	1	8793	0	.	Domain	B.
chr13	49039208	49054204	P06400	0	+	49039208	49054204	255,102,0	1	14996	0	.	Interaction	with	LIMD1.	Pubmed:15542589
chr13	49039232	49054204	P06400	0	+	49039232	49054204	255,102,0	1	14972	0	.	Domain	C;	mediates	interaction	with	E4F1.	Pubmed:10869426
chr13	50055188	50055197	Q96T68	0	+	50055188	50055197	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr13	50062763	50064960	Q96T68	0	+	50062763	50064960	255,102,0	1	2197	0	.	S-adenosyl-L-methionine	binding.
chr13	50280260	50283824	O00505	0	-	50280260	50283824	255,102,0	1	3564	0	.	NLS	binding	site	(minor).
chr13	50296129	50299612	O00505	0	-	50296129	50299612	255,102,0	1	3483	0	.	NLS	binding	site	(major).
chr13	52718071	52730326	P51956	0	-	52718071	52730326	255,102,0	1	12255	0	.	Interaction	with	VAV2.	Pubmed:15618286
chr13	53216636	53216909	Q32P51	0	+	53216636	53216909	255,102,0	1	273	0	.	Globular	A	domain.
chr13	53216909	53217182	Q32P51	0	+	53216909	53217182	255,102,0	1	273	0	.	Globular	B	domain.
chr13	53217278	53217347	Q32P51	0	+	53217278	53217347	255,102,0	1	69	0	.	RNA-binding	RGG-box.
chr13	53217428	53217542	Q32P51	0	+	53217428	53217542	255,102,0	1	114	0	.	Nuclear	targeting	sequence.
chr13	61141709	61141772	Q9H7E2	0	+	61141709	61141772	255,102,0	1	63	0	.	EBM	motif;	may	mediate	interaction	with	the	EJC.
chr13	73357607	73369695	Q8WXW3	0	+	73357607	73369695	255,102,0	1	12088	0	.	Sufficient	for	NK	inhibitory	function.	Pubmed:14634107
chr13	73357607	73428228	Q8WXW3	0	+	73357607	73428228	255,102,0	1	70621	0	.	Mediates	modulation	of	Th2	dominant	cytokine	production.	Pubmed:14634107
chr13	73401151	73402044	Q8WXW3	0	+	73401151	73402044	255,102,0	1	893	0	.	Required	for	interaction	with	PCM1.	Pubmed:23110211
chr13	73636706	73636721	Q13887	0	+	73636706	73636721	255,102,0	1	15	0	.	Interaction	with	WWP1.	Pubmed:15735697
chr13	76123977	76123995	P15374	0	+	76123977	76123995	255,102,0	1	18	0	.	Interaction	with	ubiquitin.	Pubmed:15531586
chr13	76143622	76169053	P15374	0	+	76143622	76169053	255,102,0	1	25431	0	.	Interaction	with	ubiquitin.	Pubmed:15531586
chr13	76179909	76179927	P15374	0	+	76179909	76179927	255,102,0	1	18	0	.	Interaction	with	ubiquitin.	Pubmed:15531586
chr13	77574936	77575056	O75503	0	+	77574936	77575056	255,102,0	1	120	0	.	Membrane-anchoring.	Pubmed:24038957
chr13	77713339	77742613	O75592	0	-	77713339	77742613	255,102,0	1	29274	0	.	RAE1	binding.	Pubmed:22357847
chr13	77748444	77752047	O75592	0	-	77748444	77752047	255,102,0	1	3603	0	.	PHR	domain	2.
chr13	77763178	77779620	O75592	0	-	77763178	77779620	255,102,0	1	16442	0	.	PHR	domain	1.
chr13	78167706	78202142	O95171	0	+	78167706	78202142	255,102,0	1	34436	0	.	16	X	approximate	tandem	repeats.
chr13	80095064	80095076	Q9NV92	0	+	80095064	80095076	255,102,0	1	12	0	.	Interaction	with	NEDD4.
chr13	96438239	96438296	Q13217	0	+	96438239	96438296	255,102,0	1	57	0	.	Flexible	linker.
chr13	96454046	96513124	Q9NYU1	0	-	96454046	96513124	255,102,0	1	59078	0	.	Glucosyltransferase.
chr13	96743578	96743599	Q8IZP7	0	+	96743578	96743599	255,102,0	1	21	0	.	5'-phosphosulfate-binding.
chr13	97484768	97484795	Q8IZP7	0	+	97484768	97484795	255,102,0	1	27	0	.	3'-phosphate	binding.
chr13	98649843	98654737	O00410	0	+	98649843	98654737	255,102,0	1	4894	0	.	Ran-GTP	binding.
chr13	99947997	99948024	P32249	0	-	99947997	99948024	255,102,0	1	27	0	.	Interaction	with	G	proteins.
chr13	100634615	100635083	O95409	0	+	100634615	100635083	255,102,0	1	468	0	.	Necessary	for	interaction	with	MDFIC	and	transcriptional	activation	or	repression.
chr13	101184815	101184827	Q9BVM4	0	-	101184815	101184827	255,102,0	1	12	0	.	Substrate	binding.
chr13	103339323	103339332	Q5VZV1	0	-	103339323	103339332	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr13	103498616	103506127	P28715	0	+	103498616	103506127	255,102,0	1	7511	0	.	N-domain.
chr13	103518668	103520572	P28715	0	+	103518668	103520572	255,102,0	1	1904	0	.	I-domain.
chr13	103525669	103527719	P28715	0	+	103525669	103527719	255,102,0	1	2050	0	.	Interaction	with	PCNA.	Pubmed:9305916
chr13	109753193	109792757	Q9Y6X6	0	+	109753193	109792757	255,102,0	1	39564	0	.	Involved	in	CYFIP1-	and	NCKAP1-binding.
chr13	109757861	109797425	Q9Y6X6	0	+	109757861	109797425	255,102,0	1	39564	0	.	Involved	in	CYFIP1-	and	NCKAP1-binding.
chr13	111082747	111158811	P08572	0	+	111082747	111158811	255,102,0	1	76064	0	.	Triple-helical	region.
chr13	111287087	111287108	A0A024RDX4	0	+	111287087	111287108	255,102,0	1	21	0	.	NAD(P)HX.
chr13	113798208	113798271	P00742	0	+	113798208	113798271	255,102,0	1	63	0	.	O-glycosylated	at	one	site.
chr13	113803789	113803819	P00742	0	+	113803789	113803819	255,102,0	1	30	0	.	O-glycosylated	at	one	site.
chr13	113960822	113973803	P11279	0	+	113960822	113973803	255,102,0	1	12981	0	.	First	lumenal	domain.
chr13	113973803	113973902	P11279	0	+	113973803	113973902	255,102,0	1	99	0	.	Hinge.
chr13	113973902	113976628	P11279	0	+	113973902	113976628	255,102,0	1	2726	0	.	Second	lumenal	domain.
chr13	114287438	114287507	Q14186	0	+	114287438	114287507	255,102,0	1	69	0	.	Interaction	with	CEBPA.	Pubmed:20176812
chr13	114288339	114290435	Q14186	0	+	114288339	114290435	255,102,0	1	2096	0	.	Dimerization.
chr13	114288860	114290990	Q14186	0	+	114288860	114290990	255,102,0	1	2130	0	.	Enhances	binding	of	RB	protein	to	E2F.
chr13	114288869	114290342	Q14186	0	+	114288869	114290342	255,102,0	1	1473	0	.	DCB1.
chr13	114290378	114290954	Q14186	0	+	114290378	114290954	255,102,0	1	576	0	.	DCB2.
chr13	114303691	114306018	P51164	0	-	114303691	114306018	255,102,0	1	2327	0	.	immunoglobulin-like.
chr13	114321701	114322268	Q15835	0	+	114321701	114322268	255,102,0	1	567	0	.	N-terminal.
chr13	114436027	114438333	Q15835	0	+	114436027	114438333	255,102,0	1	2306	0	.	C-terminal.
chr13	115047309	115048417	Q9H1J1	0	+	115047309	115048417	255,102,0	1	1108	0	.	Required	for	interaction	with	UPF2.
chr13	115067458	115067500	Q9H1J1	0	+	115067458	115067500	255,102,0	1	42	0	.	Required	for	association	with	EIF4A3	and	ECJ	core	components	CASC3,	MAGOH	and	RBM8A.
chr13	115090127	115090787	Q96JM3	0	+	115090127	115090787	255,102,0	1	660	0	.	Mediates	interaction	with	MAD2L2.	Pubmed:21063390
chr13	115090667	115091087	Q96JM3	0	+	115090667	115091087	255,102,0	1	420	0	.	Mediates	localization	to	the	spindle	and	the	kinetochore	and	is	required	for	the	attachment	of	spindle	microtubules	to	the	kinetochore.
chr13	115091087	115091753	Q96JM3	0	+	115091087	115091753	255,102,0	1	666	0	.	Mediates	localization	to	the	chromosome	and	the	spindle	and	negatively	regulates	chromosome	alignment.
chr14	20920141	20920156	Q9NPF4	0	-	20920141	20920156	255,102,0	1	15	0	.	Substrate	binding.
chr14	20923807	20924113	P27695	0	+	20923807	20924113	255,102,0	1	306	0	.	Necessary	for	interaction	with	YBX1,	binding	to	RNA,	NPM1-dependent	association	with	rRNA,	endoribonuclease	activity	on	abasic	RNA	and	localization	in	the	nucleoli.	Pubmed:18809583
chr14	20924080	20924113	P27695	0	+	20924080	20924113	255,102,0	1	33	0	.	Necessary	for	interaction	with	NPM1	and	for	efficient	rRNA	binding.
chr14	20925574	20925664	P27695	0	+	20925574	20925664	255,102,0	1	90	0	.	Mitochondrial	targeting	sequence	(MTS).
chr14	20942698	20942707	P00491	0	+	20942698	20942707	255,102,0	1	9	0	.	Phosphate	binding.
chr14	20942698	20942707	V9HWH6	0	+	20942698	20942707	255,102,0	1	9	0	.	Phosphate	binding.
chr14	21052276	21052291	Q8TAA1	0	-	21052276	21052291	255,102,0	1	15	0	.	Substrate	binding.
chr14	21161912	21161927	P03950	0	+	21161912	21161927	255,102,0	1	15	0	.	Substrate	binding.
chr14	21167731	21167746	P34096	0	+	21167731	21167746	255,102,0	1	15	0	.	Substrate	binding.
chr14	21250038	21250053	Q93091	0	+	21250038	21250053	255,102,0	1	15	0	.	Substrate	binding.
chr14	21270008	21270023	P07998	0	-	21270008	21270023	255,102,0	1	15	0	.	Substrate	binding.
chr14	21359926	21360061	P12724	0	+	21359926	21360061	255,102,0	1	135	0	.	Required	for	nearly	all	of	the	bactericidal	activity;	partially	involved	in	LPS-binding	and	bacterial	membrane	depolarization.
chr14	21360037	21360052	P12724	0	+	21360037	21360052	255,102,0	1	15	0	.	Substrate	binding.
chr14	21424122	21424137	P10153	0	+	21424122	21424137	255,102,0	1	15	0	.	Substrate	binding.
chr14	21469330	21469336	Q9NP94	0	+	21469330	21469336	255,102,0	1	6	0	.	Heavy	metals	binding.
chr14	21511346	21511361	Q9H1E1	0	+	21511346	21511361	255,102,0	1	15	0	.	Substrate	binding.
chr14	21512493	21512508	Q9H1E1	0	+	21512493	21512508	255,102,0	1	15	0	.	Substrate	binding.
chr14	21526243	21526258	Q8TDE3	0	+	21526243	21526258	255,102,0	1	15	0	.	Substrate	binding.
chr14	21802795	21819357	Q96KN7	0	+	21802795	21819357	255,102,0	1	16562	0	.	Interaction	with	RPGR.	Pubmed:24981858
chr14	21859780	21863096	Q9HCK8	0	-	21859780	21863096	255,102,0	1	3316	0	.	Interaction	with	FAM124B.	Pubmed:23285124
chr14	21966494	21966500	Q86U44	0	-	21966494	21966500	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:27373337,	Pubmed:27281194
chr14	21967182	21967194	Q86U44	0	-	21967182	21967194	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.	Pubmed:27373337,	Pubmed:27281194
chr14	21967254	21967281	Q86U44	0	-	21967254	21967281	255,102,0	1	27	0	.	Gate	loop	2.	Pubmed:27281194
chr14	21967647	21967698	Q86U44	0	-	21967647	21967698	255,102,0	1	51	0	.	Interaction	with	METTL14.	Pubmed:27281194
chr14	21967650	21967704	Q86U44	0	-	21967650	21967704	255,102,0	1	54	0	.	Interphase	loop.	Pubmed:27281194
chr14	21967653	21967695	Q86U44	0	-	21967653	21967695	255,102,0	1	42	0	.	Positively	charged	region	required	for	RNA-binding.	Pubmed:27281194
chr14	21967725	21967740	Q86U44	0	-	21967725	21967740	255,102,0	1	15	0	.	Interaction	with	METTL14.	Pubmed:27281194
chr14	21968710	21968755	Q86U44	0	-	21968710	21968755	255,102,0	1	45	0	.	Gate	loop	1.	Pubmed:27281194
chr14	21968806	21968812	Q86U44	0	-	21968806	21968812	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:27373337,	Pubmed:27281194
chr14	23390115	23392352	O14744	0	-	23390115	23392352	255,102,0	1	2237	0	.	Beta	barrel.	Pubmed:23071334
chr14	23392262	23392283	O14744	0	-	23392262	23392283	255,102,0	1	21	0	.	Dimerization.	Pubmed:23071334
chr14	23393331	23393337	O14744	0	-	23393331	23393337	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:23071334
chr14	23393855	23393861	O14744	0	-	23393855	23393861	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:23071334
chr14	23394150	23398534	O14744	0	-	23394150	23398534	255,102,0	1	4384	0	.	TIM	barrel.	Pubmed:23071334
chr14	23450470	23451475	Q96IF1	0	-	23450470	23451475	255,102,0	1	1005	0	.	PreLIM.
chr14	23528671	23530364	Q9UKV3	0	-	23528671	23530364	255,102,0	1	1693	0	.	Sufficient	for	interaction	with	RNPS1	and	SAP18	and	formation	of	th	ASAP	complex.
chr14	23586830	23586854	Q15744	0	-	23586830	23586854	255,102,0	1	24	0	.	Leucine-zipper.
chr14	23586857	23586920	Q15744	0	-	23586857	23586920	255,102,0	1	63	0	.	Basic	motif.
chr14	23770716	23770743	Q9H7J1	0	-	23770716	23770743	255,102,0	1	27	0	.	Substrate-binding	motif.
chr14	23770890	23770959	Q9H7J1	0	-	23770890	23770959	255,102,0	1	69	0	.	Glycogen-binding	motif.
chr14	23790681	23791473	Q86U42	0	+	23790681	23791473	255,102,0	1	792	0	.	Interaction	with	SKIP.	Pubmed:11371506
chr14	23791392	23791479	Q86U42	0	+	23791392	23791479	255,102,0	1	87	0	.	Stimulates	PAPOLA.
chr14	23791500	23794492	Q86U42	0	+	23791500	23794492	255,102,0	1	2992	0	.	Necessary	for	homooligomerization.
chr14	23793472	23794492	Q86U42	0	+	23793472	23794492	255,102,0	1	1020	0	.	Interaction	with	PAPOLA.
chr14	23826656	23826809	O43281	0	-	23826656	23826809	255,102,0	1	153	0	.	Divergent	helix-loop-helix	motif.
chr14	23865602	23865920	P13533	0	-	23865602	23865920	255,102,0	1	318	0	.	Actin-binding.
chr14	23866391	23866460	P13533	0	-	23866391	23866460	255,102,0	1	69	0	.	Actin-binding.
chr14	23894600	23894921	P12883	0	-	23894600	23894921	255,102,0	1	321	0	.	Actin-binding.
chr14	23895998	23896067	P12883	0	-	23895998	23896067	255,102,0	1	69	0	.	Actin-binding.
chr14	23940162	23945339	Q8NEJ9	0	+	23940162	23945339	255,102,0	1	5177	0	.	Necessary	for	interaction	with	EIF4E.
chr14	24033019	24033052	O75843	0	-	24033019	24033052	255,102,0	1	33	0	.	Essential	for	ubiquitin-binding.
chr14	24534203	24534305	Q8ND23	0	+	24534203	24534305	255,102,0	1	102	0	.	Necessary	for	localization	at	the	cell	membrane.	Pubmed:26578515
chr14	24544437	24545080	O95741	0	+	24544437	24545080	255,102,0	1	643	0	.	Linker	region.
chr14	24550534	24550600	P54845	0	-	24550534	24550600	255,102,0	1	66	0	.	Leucine-zipper.
chr14	24550603	24550684	P54845	0	-	24550603	24550684	255,102,0	1	81	0	.	Basic	motif.
chr14	24551778	24551970	P54845	0	-	24551778	24551970	255,102,0	1	192	0	.	Minimal	transactivation	domain	(MTD).
chr14	24616907	24620064	Q96EP0	0	+	24616907	24620064	255,102,0	1	3157	0	.	Polyubiquitin-binding.
chr14	24620537	24620804	Q96EP0	0	+	24620537	24620804	255,102,0	1	267	0	.	Interaction	with	RBCK1.
chr14	24627106	24629779	Q96EP0	0	+	24627106	24629779	255,102,0	1	2673	0	.	LDD	domain.
chr14	24679085	24679883	Q9BY43	0	-	24679085	24679883	255,102,0	1	798	0	.	Intramolecular	interaction	with	N-terminus.
chr14	24679883	24682645	Q9BY43	0	-	24679883	24682645	255,102,0	1	2762	0	.	Intramolecular	interaction	with	C-terminus.
chr14	24680631	24682645	Q9BY43	0	-	24680631	24682645	255,102,0	1	2014	0	.	Interaction	with	phosphoinosides.
chr14	24686362	24686371	Q15843	0	-	24686362	24686371	255,102,0	1	9	0	.	Interaction	with	UBE1C.
chr14	24706725	24706734	A0A087WWM4	0	+	24706725	24706734	255,102,0	1	9	0	.	GMP	binding.
chr14	24706725	24706734	F8WAN9	0	+	24706725	24706734	255,102,0	1	9	0	.	GMP	binding.
chr14	24706725	24706734	H0YLV5	0	+	24706725	24706734	255,102,0	1	9	0	.	GMP	binding.
chr14	24706725	24706734	H0YMB3	0	+	24706725	24706734	255,102,0	1	9	0	.	GMP	binding.
chr14	24706725	24706734	H0YNJ6	0	+	24706725	24706734	255,102,0	1	9	0	.	GMP	binding.
chr14	24706725	24706734	Q9P2T1	0	+	24706725	24706734	255,102,0	1	9	0	.	GMP	binding.
chr14	24707477	24707483	A0A087WWM4	0	+	24707477	24707483	255,102,0	1	6	0	.	GMP	binding.
chr14	24707477	24707483	F8WAN9	0	+	24707477	24707483	255,102,0	1	6	0	.	GMP	binding.
chr14	24707477	24707483	H0YLV5	0	+	24707477	24707483	255,102,0	1	6	0	.	GMP	binding.
chr14	24707477	24707483	H0YMB3	0	+	24707477	24707483	255,102,0	1	6	0	.	GMP	binding.
chr14	24707477	24707483	H0YNJ6	0	+	24707477	24707483	255,102,0	1	6	0	.	GMP	binding.
chr14	24707477	24707483	Q9P2T1	0	+	24707477	24707483	255,102,0	1	6	0	.	GMP	binding.
chr14	24707555	24707564	A0A087WWM4	0	+	24707555	24707564	255,102,0	1	9	0	.	GMP	binding.
chr14	24707555	24707564	F8WAN9	0	+	24707555	24707564	255,102,0	1	9	0	.	GMP	binding.
chr14	24707555	24707564	H0YLV5	0	+	24707555	24707564	255,102,0	1	9	0	.	GMP	binding.
chr14	24707555	24707564	H0YMB3	0	+	24707555	24707564	255,102,0	1	9	0	.	GMP	binding.
chr14	24707555	24707564	H0YNJ6	0	+	24707555	24707564	255,102,0	1	9	0	.	GMP	binding.
chr14	24707555	24707564	Q9P2T1	0	+	24707555	24707564	255,102,0	1	9	0	.	GMP	binding.
chr14	24707609	24707807	A0A087WWM4	0	+	24707609	24707807	255,102,0	1	198	0	.	GMP	binding.
chr14	24707609	24707807	F8WAN9	0	+	24707609	24707807	255,102,0	1	198	0	.	GMP	binding.
chr14	24707609	24707807	H0YLV5	0	+	24707609	24707807	255,102,0	1	198	0	.	GMP	binding.
chr14	24707609	24707807	H0YMB3	0	+	24707609	24707807	255,102,0	1	198	0	.	GMP	binding.
chr14	24707609	24707807	Q9P2T1	0	+	24707609	24707807	255,102,0	1	198	0	.	GMP	binding.
chr14	24731258	24731558	P22735	0	-	24731258	24731558	255,102,0	1	300	0	.	Membrane	anchorage	region.
chr14	24838943	24838961	Q14934	0	+	24838943	24838961	255,102,0	1	18	0	.	Calcineurin-binding.
chr14	24839240	24839483	Q14934	0	+	24839240	24839483	255,102,0	1	243	0	.	2	approximate	SP	repeats.
chr14	24896997	24898047	Q6UW01	0	-	24896997	24898047	255,102,0	1	1050	0	.	Necessary	for	interaction	with	CBLN3,	and	homotrimerization.
chr14	25077529	25077538	P20718	0	-	25077529	25077538	255,102,0	1	9	0	.	Mediates	the	preference	for	acidic	residues	at	the	P3'	and	P4'	sites.
chr14	29237631	29237703	P55316	0	+	29237631	29237703	255,102,0	1	72	0	.	Interaction	with	KDM5B.	Pubmed:12657635
chr14	31416462	31420115	Q13033	0	-	31416462	31420115	255,102,0	1	3653	0	.	Calmodulin-binding.
chr14	31495154	31495181	Q13033	0	-	31495154	31495181	255,102,0	1	27	0	.	Caveolin-binding.
chr14	33293205	33293247	Q13023	0	+	33293205	33293247	255,102,0	1	42	0	.	PKA-RII	subunit	binding	domain.
chr14	34419646	34419697	Q9H6Z9	0	-	34419646	34419697	255,102,0	1	51	0	.	Required	for	interaction	with	ADRB2.	Pubmed:19584355
chr14	34419739	34419775	Q9H6Z9	0	-	34419739	34419775	255,102,0	1	36	0	.	Beta(2)beta(3)	'finger-like'	loop.
chr14	35182338	35182608	Q9Y281	0	-	35182338	35182608	255,102,0	1	270	0	.	Interaction	with	CSRP3.	Pubmed:19752190
chr14	35182605	35182767	Q9Y281	0	-	35182605	35182767	255,102,0	1	162	0	.	Interaction	with	CSRP3.	Pubmed:19752190
chr14	35245158	35252437	Q9NRL2	0	-	35245158	35252437	255,102,0	1	7279	0	.	Interaction	with	SMARCA5.
chr14	35295355	35343810	Q9NRL2	0	-	35295355	35343810	255,102,0	1	48455	0	.	Required	for	interaction	with	NCOR1.	Pubmed:17519354
chr14	35331257	35343810	Q9NRL2	0	-	35331257	35343810	255,102,0	1	12553	0	.	Required	for	association	with	the	CHRAC1/POLE3	complex.
chr14	35465915	35483107	P61011	0	+	35465915	35483107	255,102,0	1	17192	0	.	G-domain.
chr14	35483948	35498355	P61011	0	+	35483948	35498355	255,102,0	1	14407	0	.	M-domain.
chr14	36003458	36003518	Q96T92	0	+	36003458	36003518	255,102,0	1	60	0	.	SNAG	domain.
chr14	36017742	36123683	Q6GYQ0	0	-	36017742	36123683	255,102,0	1	105941	0	.	Minimal	domain	that	binds	to	TCF3/E12.
chr14	36768291	36783775	Q9NS73	0	-	36768291	36783775	255,102,0	1	15484	0	.	Interaction	with	MAP3K12.
chr14	36768336	36768384	Q9NS73	0	-	36768336	36768384	255,102,0	1	48	0	.	Leucine-zipper	2.
chr14	36777330	36777375	Q9NS73	0	-	36777330	36777375	255,102,0	1	45	0	.	Leucine-zipper	1.
chr14	37132598	37132664	P55771	0	+	37132598	37132664	255,102,0	1	66	0	.	Interaction	with	KDM5B.	Pubmed:12657635
chr14	39746254	39815226	O15320	0	+	39746254	39815226	255,102,0	1	68972	0	.	Mediates	interaction	with	MIA3.	Pubmed:21525241
chr14	39815226	39819465	O15320	0	+	39815226	39819465	255,102,0	1	4239	0	.	Proline-rich	domain	(PRD);	probably	mediates	interaction	with	COPII	coat	subunits.	Pubmed:21525241
chr14	45431903	45432560	Q9Y4F4	0	+	45431903	45432560	255,102,0	1	657	0	.	TOG	1.
chr14	45432677	45433412	Q9Y4F4	0	+	45432677	45433412	255,102,0	1	735	0	.	TOG	2.
chr14	45501532	45521759	Q9Y4F4	0	+	45501532	45521759	255,102,0	1	20227	0	.	TOG	3.
chr14	45535829	45542761	Q9Y4F4	0	+	45535829	45542761	255,102,0	1	6932	0	.	TOG	4.
chr14	45636344	45644357	Q8IYD8	0	+	45636344	45644357	255,102,0	1	8013	0	.	Interaction	with	CENPS/CENPSX.	Pubmed:20347428
chr14	45658403	45669208	Q8IYD8	0	+	45658403	45669208	255,102,0	1	10805	0	.	Interaction	with	FAAP24.	Pubmed:17289582
chr14	50583039	50583048	Q9H867	0	-	50583039	50583048	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr14	50779738	50789304	Q99766	0	+	50779738	50789304	255,102,0	1	9566	0	.	N-terminal	domain.
chr14	51094970	51099054	Q8WXF7	0	+	51094970	51099054	255,102,0	1	4084	0	.	Sufficient	for	membrane	association.
chr14	53245082	53245091	Q96EK6	0	-	53245082	53245091	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:18601654
chr14	53245127	53245133	Q96EK6	0	-	53245127	53245133	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:18675810,	Pubmed:18601654
chr14	53247398	53247416	Q96EK6	0	-	53247398	53247416	255,102,0	1	18	0	.	Acetyl-CoA	binding.	Pubmed:18601654
chr14	53247437	53247446	Q96EK6	0	-	53247437	53247446	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:18675810,	Pubmed:18601654
chr14	53248513	53248525	Q96EK6	0	-	53248513	53248525	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:18675810,	Pubmed:18601654
chr14	53385988	53417169	Q96AC1	0	-	53385988	53417169	255,102,0	1	31181	0	.	Interaction	with	membranes	containing	phosphatidylinositol	phosphate.
chr14	54863786	54868251	Q16667	0	+	54863786	54868251	255,102,0	1	4465	0	.	Interaction	with	CDK2.
chr14	55604849	55605071	P17931	0	+	55604849	55605071	255,102,0	1	222	0	.	8	X	9	AA	tandem	repeats	of	Y-P-G-X(3)-P-G-A.
chr14	55609410	55609431	P17931	0	+	55609410	55609431	255,102,0	1	21	0	.	Beta-galactoside	binding.
chr14	55836339	55836579	Q6ZNE5	0	-	55836339	55836579	255,102,0	1	240	0	.	BATS.
chr14	55878366	55878414	Q6ZNE5	0	-	55878366	55878414	255,102,0	1	48	0	.	Cysteine	repeats.
chr14	58831657	58831699	P29374	0	+	58831657	58831699	255,102,0	1	42	0	.	Retinoblastoma	protein	binding.
chr14	58924557	58926611	Q9BVV6	0	+	58924557	58926611	255,102,0	1	2054	0	.	Required	for	centrosomal	localization.
chr14	59105193	59107576	Q9NYF0	0	+	59105193	59107576	255,102,0	1	2383	0	.	Required	for	self-association.
chr14	59806869	59806899	Q9Y4D1	0	+	59806869	59806899	255,102,0	1	30	0	.	Actin-binding.
chr14	59942700	59942706	Q96EM0	0	-	59942700	59942706	255,102,0	1	6	0	.	Substrate	binding.
chr14	59950716	59950722	Q96EM0	0	-	59950716	59950722	255,102,0	1	6	0	.	Substrate	binding.
chr14	62162522	62203781	Q16665	0	+	62162522	62203781	255,102,0	1	41259	0	.	Interaction	with	TSGA10.
chr14	62203715	62204806	Q16665	0	+	62203715	62204806	255,102,0	1	1091	0	.	N-terminal	VHL	recognition	site.
chr14	62203778	62207622	Q16665	0	+	62203778	62207622	255,102,0	1	3844	0	.	ODD.
chr14	62207276	62207538	Q16665	0	+	62207276	62207538	255,102,0	1	262	0	.	NTAD.
chr14	62207478	62207529	Q16665	0	+	62207478	62207529	255,102,0	1	51	0	.	C-terminal	VHL	recognition	site.
chr14	62207538	62213677	Q16665	0	+	62207538	62213677	255,102,0	1	6139	0	.	ID.
chr14	62213677	62213800	Q16665	0	+	62213677	62213800	255,102,0	1	123	0	.	CTAD.
chr14	62229178	62235428	Q16533	0	+	62229178	62235428	255,102,0	1	6250	0	.	SNAPC3-binding.
chr14	62235413	62245607	Q16533	0	+	62235413	62245607	255,102,0	1	10194	0	.	SNAPC4-binding.
chr14	63174348	63174468	Q8NCM2	0	-	63174348	63174468	255,102,0	1	120	0	.	CAD	(involved	in	subunit	assembly).
chr14	63175047	63175083	Q8NCM2	0	-	63175047	63175083	255,102,0	1	36	0	.	Calmodulin-binding.
chr14	64692199	64692241	Q8WXH0	0	+	64692199	64692241	255,102,0	1	42	0	.	Sufficient	for	interaction	with	SUN2.	Pubmed:22632968
chr14	64699857	64735522	Q92731	0	-	64699857	64735522	255,102,0	1	35665	0	.	Steroid-binding.
chr14	64746789	64749703	Q92731	0	-	64746789	64749703	255,102,0	1	2914	0	.	Modulating.
chr14	64935112	64935622	P24588	0	+	64935112	64935622	255,102,0	1	510	0	.	Essential	to	the	intracellular	anchoring	function.
chr14	64936285	64936327	P24588	0	+	64936285	64936327	255,102,0	1	42	0	.	PKA-RII	subunit	binding	domain.
chr14	65007570	65008734	P54652	0	+	65007570	65008734	255,102,0	1	1164	0	.	Nucleotide-binding	domain	(NBD).
chr14	65008755	65009103	P54652	0	+	65008755	65009103	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr14	65507556	65507568	P49356	0	+	65507556	65507568	255,102,0	1	12	0	.	Farnesyl	diphosphate	binding.
chr14	65511076	65511088	P49356	0	+	65511076	65511088	255,102,0	1	12	0	.	Farnesyl	diphosphate	binding.
chr14	65511103	65511115	P49356	0	+	65511103	65511115	255,102,0	1	12	0	.	Farnesyl	diphosphate	binding.
chr14	65543370	65544685	P61244	0	-	65543370	65544685	255,102,0	1	1315	0	.	Leucine-zipper.
chr14	66190874	66190880	Q9BYC5	0	+	66190874	66190880	255,102,0	1	6	0	.	Important	for	donor	substrate	binding.
chr14	67382747	67525406	Q9NQX3	0	+	67382747	67525406	255,102,0	1	142659	0	.	Interaction	with	GABARAP.
chr14	67525433	67647651	Q9NQX3	0	+	67525433	67647651	255,102,0	1	122218	0	.	MPT	adenylyltransferase.
chr14	67745947	67759280	Q8N3R9	0	+	67745947	67759280	255,102,0	1	13333	0	.	Interaction	with	PARD6B.
chr14	67759400	67768763	Q8N3R9	0	+	67759400	67768763	255,102,0	1	9363	0	.	Interaction	with	LIN7C.
chr14	68112429	68112444	P78540	0	+	68112429	68112444	255,102,0	1	15	0	.	Substrate	binding.	Pubmed:12859189
chr14	68112462	68112471	P78540	0	+	68112462	68112471	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:12859189
chr14	68126594	68126609	Q9UEU0	0	-	68126594	68126609	255,102,0	1	15	0	.	Interaction	with	CLINT1.	Pubmed:18033301
chr14	68141137	68141203	Q9UEU0	0	-	68141137	68141203	255,102,0	1	66	0	.	Interaction	with	CLINT1.	Pubmed:18033301
chr14	68290260	68301823	O15315	0	+	68290260	68301823	255,102,0	1	11563	0	.	Interaction	with	RAD51C.
chr14	69256252	69256714	Q07352	0	-	69256252	69256714	255,102,0	1	462	0	.	Necessary	for	mRNA	decay	activation.	Pubmed:15687258
chr14	69256933	69259655	Q07352	0	-	69256933	69259655	255,102,0	1	2722	0	.	Necessary	and	sufficient	for	the	association	with	mRNA	decay	enzymes	and	mRNA	decay	activation.	Pubmed:15687258
chr14	69346759	69360407	P12814	0	-	69346759	69360407	255,102,0	1	13648	0	.	Interaction	with	DDN.	Pubmed:16464232
chr14	69791436	69795279	Q8N428	0	+	69791436	69795279	255,102,0	1	3843	0	.	Catalytic	subdomain	A.
chr14	69799878	69805444	Q8N428	0	+	69799878	69805444	255,102,0	1	5566	0	.	Catalytic	subdomain	B.
chr14	70634323	70634383	P57103	0	-	70634323	70634383	255,102,0	1	60	0	.	Putative	calmodulin-binding	region.
chr14	71209176	71209242	P80192	0	-	71209176	71209242	255,102,0	1	66	0	.	Leucine-zipper	2.
chr14	71209281	71215584	P80192	0	-	71209281	71215584	255,102,0	1	6303	0	.	Leucine-zipper	1.
chr14	73566443	73577778	P49756	0	+	73566443	73577778	255,102,0	1	11335	0	.	Necessary	for	nuclear	speckle	localization.
chr14	73678484	73685943	P49768	0	+	73678484	73685943	255,102,0	1	7459	0	.	Required	for	interaction	with	CTNNB1.	Pubmed:9738936
chr14	73678634	73683901	P49768	0	+	73678634	73683901	255,102,0	1	5267	0	.	Required	for	interaction	with	CTNND2.	Pubmed:10037471
chr14	73685982	73685994	P49768	0	+	73685982	73685994	255,102,0	1	12	0	.	Interaction	with	MTCH1.	Pubmed:10551805
chr14	74340863	74340869	Q8N8N7	0	+	74340863	74340869	255,102,0	1	6	0	.	Substrate	binding.
chr14	74347917	74347926	Q8N8N7	0	+	74347917	74347926	255,102,0	1	9	0	.	Substrate	binding.
chr14	74967589	74969611	Q14767	0	-	74967589	74969611	255,102,0	1	2022	0	.	C-terminal	domain.	Pubmed:17293099
chr14	75019724	75019757	Q14767	0	-	75019724	75019757	255,102,0	1	33	0	.	Heparin-binding.
chr14	75052639	75052693	Q14767	0	-	75052639	75052693	255,102,0	1	54	0	.	Heparin-binding.
chr14	75078302	75078368	Q14767	0	-	75078302	75078368	255,102,0	1	66	0	.	Heparin-binding.
chr14	75413080	75413467	P49763	0	-	75413080	75413467	255,102,0	1	387	0	.	Heparin-binding.
chr14	75553864	75562114	Q8TD19	0	-	75553864	75562114	255,102,0	1	8250	0	.	Interaction	with	NEK6.	Pubmed:19001501
chr14	75601590	75601629	P49755	0	-	75601590	75601629	255,102,0	1	39	0	.	Interaction	with	ARF1.	Pubmed:11726511
chr14	75601590	75601638	P49755	0	-	75601590	75601638	255,102,0	1	48	0	.	Interaction	with	COPG1.
chr14	75602466	75602562	P49755	0	-	75602466	75602562	255,102,0	1	96	0	.	Required	for	TMED10	and	TMED2	cis-Golgi	network	localization.
chr14	75602574	75643282	P49755	0	-	75602574	75643282	255,102,0	1	40708	0	.	Required	for	interaction	with	STX17.	Pubmed:21545355
chr14	75747283	75747346	P01100	0	+	75747283	75747346	255,102,0	1	63	0	.	Basic	motif;	required	for	the	activation	of	phospholipid	synthesis,	but	not	for	CDS1-binding.
chr14	75747361	75747563	P01100	0	+	75747361	75747563	255,102,0	1	202	0	.	Leucine-zipper.
chr14	75928146	75928215	Q8WYK2	0	+	75928146	75928215	255,102,0	1	69	0	.	Basic	motif.
chr14	75928224	75936070	Q8WYK2	0	+	75928224	75936070	255,102,0	1	7846	0	.	Leucine-zipper.
chr14	75991444	75991513	Q16520	0	+	75991444	75991513	255,102,0	1	69	0	.	Basic	motif.
chr14	75991522	76012861	Q16520	0	+	75991522	76012861	255,102,0	1	21339	0	.	Leucine-zipper.
chr14	76045387	76045531	Q9UPI3	0	+	76045387	76045531	255,102,0	1	144	0	.	8	X	6	AA	tandem	repeats	of	P-S-[VS]-S-[VIAG]-[HNP].
chr14	76200338	76211901	Q6EMB2	0	+	76200338	76211901	255,102,0	1	11563	0	.	c-MTBD	region.	Pubmed:25959773
chr14	77244343	77245358	Q7L8A9	0	+	77244343	77245358	255,102,0	1	1015	0	.	Involved	in	heparin-binding	and	antiangiogenic	activity.
chr14	77732887	77737280	Q9NPG2	0	-	77732887	77737280	255,102,0	1	4393	0	.	Globin.
chr14	78140157	78170748	Q13686	0	-	78140157	78170748	255,102,0	1	30591	0	.	tRNA-binding.	Pubmed:27745969
chr14	78140292	78140313	Q13686	0	-	78140292	78140313	255,102,0	1	21	0	.	Alpha-ketoglutarate	binding.
chr14	78142072	78142081	Q13686	0	-	78142072	78142081	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.
chr14	78146237	78146246	Q13686	0	-	78146237	78146246	255,102,0	1	9	0	.	Substrate	binding.
chr14	78197346	78205134	Q13573	0	-	78197346	78205134	255,102,0	1	7788	0	.	SNW.
chr14	78217754	78217817	Q13573	0	-	78217754	78217817	255,102,0	1	63	0	.	Interaction	with	PPIL1.	Pubmed:16595688
chr14	81943318	81943489	Q9UBV2	0	-	81943318	81943489	255,102,0	1	171	0	.	Mediates	retention	in	the	endoplasmic	reticulum.
chr14	81943489	82000025	Q9UBV2	0	-	81943489	82000025	255,102,0	1	56536	0	.	Interaction	with	ERLEC1,	OS9	and	SYVN1.
chr14	81945961	81950688	Q9UBV2	0	-	81945961	81950688	255,102,0	1	4727	0	.	Interaction	with	SYVN1.
chr14	81953754	81964310	Q9UBV2	0	-	81953754	81964310	255,102,0	1	10556	0	.	Important	for	homodimerization	and	oligomerization.
chr14	88935313	88935334	Q16825	0	-	88935313	88935334	255,102,0	1	21	0	.	Substrate	binding.
chr14	90455314	90455326	Q9NUW8	0	+	90455314	90455326	255,102,0	1	12	0	.	Interaction	with	DNA.	Pubmed:12470949
chr14	91738971	91738980	Q9P219	0	-	91738971	91738980	255,102,0	1	9	0	.	DVL1-binding.
chr14	93119152	93125675	Q8TB24	0	+	93119152	93125675	255,102,0	1	6523	0	.	Interaction	with	RAB5B.	Pubmed:12972505
chr14	93392976	93393033	P10645	0	+	93392976	93393033	255,102,0	1	57	0	.	O-glycosylated	at	one	site	only	in	cerebrospinal	fluid.
chr14	93397779	93397812	P10645	0	+	93397779	93397812	255,102,0	1	33	0	.	O-glycosylated	at	one	site	only	in	cerebrospinal	fluid.
chr14	93649972	93649984	Q96BY2	0	-	93649972	93649984	255,102,0	1	12	0	.	RASSF1-binding.
chr14	93650206	93650230	Q96BY2	0	-	93650206	93650230	255,102,0	1	24	0	.	BH3-like.
chr14	94756471	94756525	Q9UK55	0	-	94756471	94756525	255,102,0	1	54	0	.	Heparin-binding.
chr14	94844866	94844941	P01009	0	-	94844866	94844941	255,102,0	1	75	0	.	RCL.
chr14	94953738	94953795	Q8IW75	0	-	94953738	94953795	255,102,0	1	57	0	.	RCL.
chr14	95089983	95090061	P01011	0	+	95089983	95090061	255,102,0	1	78	0	.	RCL.
chr14	95090019	95090046	P01011	0	+	95090019	95090046	255,102,0	1	27	0	.	O-glycosylated	at	one	site.
chr14	95582125	95593054	Q9UPY3	0	-	95582125	95593054	255,102,0	1	10929	0	.	Required	for	interaction	with	PRKRA	and	TARBP2.
chr14	96001714	96010291	Q86SX6	0	+	96001714	96010291	255,102,0	1	8577	0	.	Glutathione	binding.	Pubmed:21029046
chr14	96010351	96010357	Q86SX6	0	+	96010351	96010357	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:21029046
chr14	96851943	96852018	Q9P0R6	0	+	96851943	96852018	255,102,0	1	75	0	.	Interaction	with	GSK3B.	Pubmed:16981698
chr14	96922683	96949418	Q96M32	0	+	96922683	96949418	255,102,0	1	26735	0	.	Adenylate	kinase.	Pubmed:21080915
chr14	96922773	96937822	Q96M32	0	+	96922773	96937822	255,102,0	1	15049	0	.	NMPbind.
chr14	96944854	96944887	Q96M32	0	+	96944854	96944887	255,102,0	1	33	0	.	LID.
chr14	96953294	96954677	Q96M32	0	+	96953294	96954677	255,102,0	1	1383	0	.	DPY-30.	Pubmed:21080915
chr14	97018816	97022675	P51003	0	+	97018816	97022675	255,102,0	1	3859	0	.	Ser/Thr-rich.
chr14	97027009	97031384	P51003	0	+	97027009	97031384	255,102,0	1	4375	0	.	Required	for	interaction	with	NUDT21.
chr14	100357542	100406446	O00423	0	+	100357542	100406446	255,102,0	1	48904	0	.	Tandem	atypical	propeller	in	EMLs.
chr14	100595037	100595914	Q9UI08	0	+	100595037	100595914	255,102,0	1	877	0	.	EVH2	block	A.
chr14	100595037	100610063	Q9UI08	0	+	100595037	100610063	255,102,0	1	15026	0	.	EVH2.
chr14	100595980	100599068	Q9UI08	0	+	100595980	100599068	255,102,0	1	3088	0	.	EVH2	block	B.
chr14	100607562	100610063	Q9UI08	0	+	100607562	100610063	255,102,0	1	2501	0	.	EVH2	block	C.
chr14	100615832	100615847	Q6QHC5	0	-	100615832	100615847	255,102,0	1	15	0	.	Required	for	C4-hydroxylase	activity.
chr14	100705581	100706091	P25490	0	+	100705581	100706091	255,102,0	1	510	0	.	Interaction	with	the	SMAD1/SMAD4	complex.
chr14	100728729	100742946	P25490	0	+	100728729	100742946	255,102,0	1	14217	0	.	Involved	in	nuclear	matrix	association.
chr14	100741074	100743934	P25490	0	+	100741074	100743934	255,102,0	1	2860	0	.	Binding	to	DNA.
chr14	100742919	100743805	P25490	0	+	100742919	100743805	255,102,0	1	886	0	.	Involved	in	repression	of	activated	transcription.
chr14	100743802	100743883	P25490	0	+	100743802	100743883	255,102,0	1	81	0	.	Involved	in	masking	transactivation	domain.
chr14	102431184	102472392	Q14204	0	+	102431184	102472392	255,102,0	1	41208	0	.	Stem.
chr14	102449826	102452671	Q14204	0	+	102449826	102452671	255,102,0	1	2845	0	.	Interaction	with	DYNC1I2.
chr14	102452512	102452968	Q14204	0	+	102452512	102452968	255,102,0	1	456	0	.	Interaction	with	DYNC1LI2.
chr14	102472392	102476688	Q14204	0	+	102472392	102476688	255,102,0	1	4296	0	.	AAA	1.
chr14	102477208	102482306	Q14204	0	+	102477208	102482306	255,102,0	1	5098	0	.	AAA	2.
chr14	102483153	102486301	Q14204	0	+	102483153	102486301	255,102,0	1	3148	0	.	AAA	3.
chr14	102492967	102495911	Q14204	0	+	102492967	102495911	255,102,0	1	2944	0	.	AAA	4.
chr14	102495971	102500399	Q14204	0	+	102495971	102500399	255,102,0	1	4428	0	.	Stalk.
chr14	102500691	102505477	Q14204	0	+	102500691	102505477	255,102,0	1	4786	0	.	AAA	5.
chr14	102507981	102510361	Q14204	0	+	102507981	102510361	255,102,0	1	2380	0	.	AAA	6.
chr14	102548051	102548063	P07900	0	-	102548051	102548063	255,102,0	1	12	0	.	Essential	for	interaction	with	SGTA	and	TTC1.	Pubmed:15708368
chr14	102548051	102548066	P07900	0	-	102548051	102548066	255,102,0	1	15	0	.	Essential	for	interaction	with	SMYD3.	Pubmed:25738358
chr14	102548051	102548493	P07900	0	-	102548051	102548493	255,102,0	1	442	0	.	Required	for	homodimerization.	Pubmed:8289821
chr14	102548051	102551149	P07900	0	-	102548051	102551149	255,102,0	1	3098	0	.	Interaction	with	FLCN	and	FNIP1.	Pubmed:27353360
chr14	102548676	102551149	P07900	0	-	102548676	102551149	255,102,0	1	2473	0	.	Interaction	with	FNIP2.	Pubmed:27353360
chr14	103059454	103174912	Q9UKL0	0	+	103059454	103174912	255,102,0	1	115458	0	.	Interaction	with	HDAC1.	Pubmed:11516394
chr14	103180786	103187677	Q9UKL0	0	+	103180786	103187677	255,102,0	1	6891	0	.	Interaction	with	KDM1A.	Pubmed:16885027
chr14	103996372	103996381	Q96FX7	0	+	103996372	103996381	255,102,0	1	9	0	.	Substrate.	Pubmed:26470919
chr14	103996417	103996441	Q96FX7	0	+	103996417	103996441	255,102,0	1	24	0	.	Substrate.	Pubmed:26470919
chr14	103996504	103996510	Q96FX7	0	+	103996504	103996510	255,102,0	1	6	0	.	Substrate.	Pubmed:26470919
chr14	103996567	103996582	Q96FX7	0	+	103996567	103996582	255,102,0	1	15	0	.	Substrate.	Pubmed:26470919
chr14	103996642	103998938	Q96FX7	0	+	103996642	103998938	255,102,0	1	2296	0	.	Substrate.	Pubmed:26470919
chr14	103998926	103998935	Q96FX7	0	+	103998926	103998935	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.	Pubmed:26470919
chr14	103999073	103999079	Q96FX7	0	+	103999073	103999079	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:26470919
chr14	103999124	103999136	Q96FX7	0	+	103999124	103999136	255,102,0	1	12	0	.	Substrate.	Pubmed:26470919
chr14	104000900	104000924	Q96FX7	0	+	104000900	104000924	255,102,0	1	24	0	.	Substrate.	Pubmed:26470919
chr14	104194211	104199352	Q9BQ24	0	+	104194211	104199352	255,102,0	1	5141	0	.	PH-like.
chr14	104559007	104571072	Q86U10	0	+	104559007	104571072	255,102,0	1	12065	0	.	Asparaginase.
chr14	104559885	104559894	Q86U10	0	+	104559885	104559894	255,102,0	1	9	0	.	Substrate	binding.
chr14	104561909	104561915	Q86U10	0	+	104561909	104561915	255,102,0	1	6	0	.	Substrate	binding.
chr14	105190733	105190745	Q8N142	0	+	105190733	105190745	255,102,0	1	12	0	.	IMP	binding.
chr14	105201365	105201377	Q8N142	0	+	105201365	105201377	255,102,0	1	12	0	.	IMP	binding.
chr14	105209445	105209466	Q8N142	0	+	105209445	105209466	255,102,0	1	21	0	.	Substrate	binding.
chr14	105219643	105222013	O15304	0	+	105219643	105222013	255,102,0	1	2370	0	.	Interaction	with	BCL2L1	isoform	Bcl-x(L)	and	inhibition	of	BCL2L1	anti-apoptotic	activity.
chr14	105222939	105222996	O15304	0	+	105222939	105222996	255,102,0	1	57	0	.	Interaction	with	coxsackievirus	B3	VP2.
chr14	105240260	105240269	P31749	0	-	105240260	105240269	255,102,0	1	9	0	.	Inhibitor	binding.
chr14	105246524	105246533	P31749	0	-	105246524	105246533	255,102,0	1	9	0	.	Inositol-(1,3,4,5)-tetrakisphosphate	binding.
chr14	105246542	105258941	P31749	0	-	105246542	105258941	255,102,0	1	12399	0	.	Inositol-(1,3,4,5)-tetrakisphosphate	binding.
chr14	106090815	106091136	P01861	0	-	106090815	106091136	255,102,0	1	321	0	.	CH3.
chr14	106091233	106091563	P01861	0	-	106091233	106091563	255,102,0	1	330	0	.	CH2.
chr14	106091586	106091907	P01861	0	-	106091586	106091907	255,102,0	1	321	0	.	CH3.
chr14	106091681	106091717	P01861	0	-	106091681	106091717	255,102,0	1	36	0	.	Hinge.
chr14	106092004	106092334	P01861	0	-	106092004	106092334	255,102,0	1	330	0	.	CH2.
chr14	106092109	106092403	P01861	0	-	106092109	106092403	255,102,0	1	294	0	.	CH1.
chr14	106092452	106092488	P01861	0	-	106092452	106092488	255,102,0	1	36	0	.	Hinge.
chr14	106092880	106093174	P01861	0	-	106092880	106093174	255,102,0	1	294	0	.	CH1.
chr14	106109542	106109863	P01859	0	-	106109542	106109863	255,102,0	1	321	0	.	CH3.
chr14	106109960	106110287	P01859	0	-	106109960	106110287	255,102,0	1	327	0	.	CH2.
chr14	106110313	106110634	P01859	0	-	106110313	106110634	255,102,0	1	321	0	.	CH3.
chr14	106110405	106110441	P01859	0	-	106110405	106110441	255,102,0	1	36	0	.	Hinge.
chr14	106110731	106111058	P01859	0	-	106110731	106111058	255,102,0	1	327	0	.	CH2.
chr14	106110833	106111127	P01859	0	-	106110833	106111127	255,102,0	1	294	0	.	CH1.
chr14	106111176	106111212	P01859	0	-	106111176	106111212	255,102,0	1	36	0	.	Hinge.
chr14	106111604	106111898	P01859	0	-	106111604	106111898	255,102,0	1	294	0	.	CH1.
chr14	106207812	106208133	P01857	0	-	106207812	106208133	255,102,0	1	321	0	.	CH3.
chr14	106208230	106208687	P01857	0	-	106208230	106208687	255,102,0	1	457	0	.	CH2.
chr14	106208583	106208904	P01857	0	-	106208583	106208904	255,102,0	1	321	0	.	CH3.
chr14	106208687	106208723	P01857	0	-	106208687	106208723	255,102,0	1	36	0	.	Hinge.
chr14	106209001	106209458	P01857	0	-	106209001	106209458	255,102,0	1	457	0	.	CH2.
chr14	106209114	106209408	P01857	0	-	106209114	106209408	255,102,0	1	294	0	.	CH1.
chr14	106209458	106209494	P01857	0	-	106209458	106209494	255,102,0	1	36	0	.	Hinge.
chr14	106209885	106210179	P01857	0	-	106209885	106210179	255,102,0	1	294	0	.	CH1.
chr14	106829593	106829887	P06331	0	-	106829593	106829887	255,102,0	1	294	0	.	V	region.
chr15	23811724	23811808	Q13064	0	+	23811724	23811808	255,102,0	1	84	0	.	Makorin-type	Cys-His.
chr15	25223026	25223576	P63162	0	+	25223026	25223576	255,102,0	1	550	0	.	Repeat-rich	region.
chr15	25615778	25616078	Q05086	0	-	25615778	25616078	255,102,0	1	300	0	.	Interaction	with	HCV	core	protein.
chr15	25616075	25616129	Q05086	0	-	25616075	25616129	255,102,0	1	54	0	.	E6-binding.
chr15	26806225	26806291	P28472	0	-	26806225	26806291	255,102,0	1	66	0	.	Allosteric	effector	binding.
chr15	26825601	26828485	P28472	0	-	26825601	26828485	255,102,0	1	2884	0	.	Agonist	binding.
chr15	26866555	26866564	P28472	0	-	26866555	26866564	255,102,0	1	9	0	.	Agonist	binding.
chr15	29346639	29346897	Q99767	0	+	29346639	29346897	255,102,0	1	258	0	.	STXBP1-binding.
chr15	29487311	29487569	Q99767	0	+	29487311	29487569	255,102,0	1	258	0	.	STXBP1-binding.
chr15	29560997	29561678	Q96MG7	0	-	29560997	29561678	255,102,0	1	681	0	.	Interaction	with	NSMCE1.
chr15	29702261	29702942	Q96MG7	0	-	29702261	29702942	255,102,0	1	681	0	.	Interaction	with	NSMCE1.
chr15	31779399	31851175	Q8TE49	0	-	31779399	31851175	255,102,0	1	71776	0	.	Catalytic.
chr15	31779689	31851220	Q8TE49	0	-	31779689	31851220	255,102,0	1	71531	0	.	TRAF-binding.
chr15	32792115	32976490	Q68DA7	0	-	32792115	32976490	255,102,0	1	184375	0	.	Mediates	interaction	with	alpha-catenin.
chr15	32975989	32977855	Q68DA7	0	-	32975989	32977855	255,102,0	1	1866	0	.	Microtubule-binding.
chr15	33261375	33445750	Q68DA7	0	-	33261375	33445750	255,102,0	1	184375	0	.	Mediates	interaction	with	alpha-catenin.
chr15	33445249	33447115	Q68DA7	0	-	33445249	33447115	255,102,0	1	1866	0	.	Microtubule-binding.
chr15	33916167	34047326	Q15413	0	+	33916167	34047326	255,102,0	1	131159	0	.	4	X	approximate	repeats.
chr15	34018637	34018679	Q15413	0	+	34018637	34018679	255,102,0	1	42	0	.	Interaction	with	FKBP1A.	Pubmed:22100703
chr15	34105682	34105772	Q15413	0	+	34105682	34105772	255,102,0	1	90	0	.	Interaction	with	CALM.
chr15	34673614	34674040	A7E2F4	0	-	34673614	34674040	255,102,0	1	426	0	.	Golgi-targeting	domain.
chr15	34819835	34820261	A8MQT2	0	-	34819835	34820261	255,102,0	1	426	0	.	Golgi-targeting	domain.
chr15	37184376	37188847	O14770	0	-	37184376	37188847	255,102,0	1	4471	0	.	Transcriptional	activation	domain.
chr15	37385847	37390202	O14770	0	-	37385847	37390202	255,102,0	1	4355	0	.	Required	for	interaction	with	PBX1.
chr15	38782757	38786690	O95267	0	-	38782757	38786690	255,102,0	1	3933	0	.	PT	region;	mediates	the	BCR-dependent	translocation	to	plasma	membrane.
chr15	38786759	38786786	O95267	0	-	38786759	38786786	255,102,0	1	27	0	.	Suppress	the	PT	region-mediated	translocation	to	plasma	membrane.
chr15	38811568	38852073	O95267	0	-	38811568	38852073	255,102,0	1	40505	0	.	Ras	exchanger	motif	region;	required	for	transforming	activity.
chr15	39874464	39874611	P07996	0	+	39874464	39874611	255,102,0	1	147	0	.	Heparin-binding.
chr15	40293329	40318267	Q9P2K8	0	+	40293329	40318267	255,102,0	1	24938	0	.	Histidyl-tRNA	synthetase-like.
chr15	40398062	40398089	Q96LC9	0	-	40398062	40398089	255,102,0	1	27	0	.	Interaction	with	DLC2.
chr15	40468746	40468848	O60566	0	+	40468746	40468848	255,102,0	1	102	0	.	Necessary	for	interaction	with	KNL1.	Pubmed:17981135
chr15	40557061	40564784	Q9NQU5	0	+	40557061	40564784	255,102,0	1	7723	0	.	Linker.
chr15	40679396	40685795	Q9Y448	0	+	40679396	40685795	255,102,0	1	6399	0	.	Interaction	with	SPAG5.	Pubmed:21402792
chr15	40895129	40914568	Q8NG31	0	+	40895129	40914568	255,102,0	1	19439	0	.	Interaction	with	BUB1	and	BUB1B.	Pubmed:17981135
chr15	40914946	40915987	Q8NG31	0	+	40914946	40915987	255,102,0	1	1041	0	.	2	X	104	AA	approximate	repeats.
chr15	40920312	40954305	Q8NG31	0	+	40920312	40954305	255,102,0	1	33993	0	.	Necessary	for	kinetochore	localization	and	for	interaction	with	NSL1	and	DSN1.	Pubmed:17981135
chr15	41020927	41021829	Q06609	0	+	41020927	41021829	255,102,0	1	902	0	.	Interaction	with	PALB2.
chr15	41120764	41120779	Q9NXH3	0	-	41120764	41120779	255,102,0	1	15	0	.	Interaction	with	protein	phosphatase	1.
chr15	41223858	41223867	Q9NR61	0	+	41223858	41223867	255,102,0	1	9	0	.	Interaction	with	Notch1.
chr15	41223876	41223891	Q9NR61	0	+	41223876	41223891	255,102,0	1	15	0	.	Interaction	with	Notch1.
chr15	41245883	41245901	Q9BUX1	0	+	41245883	41245901	255,102,0	1	18	0	.	Substrate	binding.
chr15	41272423	41364091	Q9ULG1	0	-	41272423	41364091	255,102,0	1	91668	0	.	Assembles	INO80	complex	module	consisting	of	conserved	components	INO80B,	INO80C,	ACTR5,	RVBL1,	RVBL2.
chr15	41364073	41379784	Q9ULG1	0	-	41364073	41379784	255,102,0	1	15711	0	.	Assembles	INO80	complex	module	consisting	of	conserved	components	ACTR8,	ACTL6A	and	YY1.
chr15	41377641	41388508	Q9ULG1	0	-	41377641	41388508	255,102,0	1	10867	0	.	Assembles	INO80	complex	module	with	putative	regulatory	components	INO80E,	INO80F,	UCHL5,	NFRKB,	MCRS1	and	IN80D.
chr15	41570979	41571554	Q99653	0	+	41570979	41571554	255,102,0	1	575	0	.	Necessary	for	nuclear	export	signal.
chr15	41657647	41669416	Q9BXS6	0	+	41657647	41669416	255,102,0	1	11769	0	.	Interaction	with	microtubules.
chr15	41794249	41794276	P23677	0	+	41794249	41794276	255,102,0	1	27	0	.	Calmodulin-binding.
chr15	41794324	41794348	P23677	0	+	41794324	41794348	255,102,0	1	24	0	.	Substrate	binding.	Pubmed:15350214
chr15	42691747	42695951	P20807	0	+	42691747	42695951	255,102,0	1	4204	0	.	Domain	III.
chr15	42695951	42701533	P20807	0	+	42695951	42701533	255,102,0	1	5582	0	.	Linker.
chr15	42701533	42703968	P20807	0	+	42701533	42703968	255,102,0	1	2435	0	.	Domain	IV.
chr15	43028221	43028507	Q8IWY9	0	-	43028221	43028507	255,102,0	1	286	0	.	Interaction	with	ASF1A/B.	Pubmed:22407294
chr15	43477699	43483213	O95273	0	+	43477699	43483213	255,102,0	1	5514	0	.	Interaction	with	TCF3.	Pubmed:10915743
chr15	43477699	43483231	O95273	0	+	43477699	43483231	255,102,0	1	5532	0	.	Interaction	with	RPLP0.	Pubmed:17621266
chr15	43477699	43483637	O95273	0	+	43477699	43483637	255,102,0	1	5938	0	.	Required	for	interaction	with	CCND1.
chr15	43482541	43487036	O95273	0	+	43482541	43487036	255,102,0	1	4495	0	.	Interaction	with	TCF3.	Pubmed:10915743
chr15	43483730	43487036	O95273	0	+	43483730	43487036	255,102,0	1	3306	0	.	Interaction	with	RPLP0.	Pubmed:17621266
chr15	43508544	43508571	P16452	0	-	43508544	43508571	255,102,0	1	27	0	.	Band	3	binding.
chr15	43622201	43622207	O60294	0	-	43622201	43622207	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr15	43708471	43712719	Q12888	0	-	43708471	43712719	255,102,0	1	4248	0	.	Tudor-like.	Pubmed:17190600
chr15	43712599	43712686	Q12888	0	-	43712599	43712686	255,102,0	1	87	0	.	Interaction	with	dimethylated	histone	H4.	Pubmed:17190600
chr15	43814913	43815294	P78559	0	+	43814913	43815294	255,102,0	1	381	0	.	9	X	3	AA	repeats	of	K-K-[DE].
chr15	43869896	43871236	Q6PFW1	0	-	43869896	43871236	255,102,0	1	1340	0	.	Polyphosphoinositide-binding	domain.	Pubmed:21222653
chr15	43873240	43873252	Q6PFW1	0	-	43873240	43873252	255,102,0	1	12	0	.	Substrate	binding.
chr15	43874292	43874298	Q6PFW1	0	-	43874292	43874298	255,102,0	1	6	0	.	Substrate	binding.
chr15	43875749	43875755	Q6PFW1	0	-	43875749	43875755	255,102,0	1	6	0	.	Substrate	binding.
chr15	43886533	43887212	P12532	0	+	43886533	43887212	255,102,0	1	679	0	.	Cardiolipin-binding.
chr15	43986365	43987044	P12532	0	+	43986365	43987044	255,102,0	1	679	0	.	Cardiolipin-binding.
chr15	44829395	44843633	O75822	0	+	44829395	44843633	255,102,0	1	14238	0	.	Sufficient	for	interaction	with	EIF3B.
chr15	44853296	44853344	A0A024R5S5	0	+	44853296	44853344	255,102,0	1	48	0	.	Promotes	stable	association	with	the	40S	ribosome.
chr15	44853296	44853344	O75822	0	+	44853296	44853344	255,102,0	1	48	0	.	Promotes	stable	association	with	the	40S	ribosome.
chr15	45028902	45047547	Q86WT6	0	+	45028902	45047547	255,102,0	1	18645	0	.	Necessary	for	nuclear	localization.
chr15	45389547	45393446	Q9NRD8	0	-	45389547	45393446	255,102,0	1	3899	0	.	Interaction	with	TXNDC11.
chr15	45399072	45405257	Q9NRD8	0	-	45399072	45405257	255,102,0	1	6185	0	.	Peroxidase-like;	mediates	peroxidase	activity.
chr15	45426078	45434267	Q9NRD9	0	+	45426078	45434267	255,102,0	1	8189	0	.	Peroxidase-like;	mediates	peroxidase	activity.
chr15	45442876	45453076	Q9NRD9	0	+	45442876	45453076	255,102,0	1	10200	0	.	Interaction	with	TXNDC11.
chr15	48628247	48628256	P33316	0	+	48628247	48628256	255,102,0	1	9	0	.	Substrate	binding.
chr15	48633487	48633499	P33316	0	+	48633487	48633499	255,102,0	1	12	0	.	Substrate	binding.
chr15	48634251	48634257	P33316	0	+	48634251	48634257	255,102,0	1	6	0	.	Substrate	binding.
chr15	49090155	49097846	O94986	0	-	49090155	49097846	255,102,0	1	7691	0	.	Interaction	with	PLK4.	Pubmed:24997597
chr15	49127127	49148284	Q6S5L8	0	-	49127127	49148284	255,102,0	1	21157	0	.	CH1.
chr15	49170532	49170733	Q9Y6B2	0	+	49170532	49170733	255,102,0	1	201	0	.	Interaction	with	NR0B2.
chr15	49254657	49255212	Q6S5L8	0	-	49254657	49255212	255,102,0	1	555	0	.	CH2.
chr15	49426195	49447775	P61201	0	-	49426195	49447775	255,102,0	1	21580	0	.	Mediates	interaction	with	NIF3L1.
chr15	49509388	49509400	Q01415	0	+	49509388	49509400	255,102,0	1	12	0	.	Substrate	binding.
chr15	49574237	49574249	Q01415	0	+	49574237	49574249	255,102,0	1	12	0	.	Substrate	binding.
chr15	50578318	50581827	Q06547	0	-	50578318	50581827	255,102,0	1	3509	0	.	Transcription	activation	and	HCFC1	interaction.
chr15	51350080	51350632	Q5GJ75	0	-	51350080	51350632	255,102,0	1	552	0	.	Binding	to	phosphoinositides.
chr15	52675304	52675373	Q9Y4I1	0	-	52675304	52675373	255,102,0	1	69	0	.	Actin-binding.
chr15	55653046	55681622	Q9ULG6	0	-	55653046	55681622	255,102,0	1	28576	0	.	Interaction	with	MCF2L	and	SRC.
chr15	55783416	55790509	Q8WXU2	0	-	55783416	55790509	255,102,0	1	7093	0	.	Mediates	interaction	with	ESR1	and	STUB1.	Pubmed:19423554
chr15	55838307	55838364	Q9Y3Y4	0	-	55838307	55838364	255,102,0	1	57	0	.	Interaction	with	BCL9.	Pubmed:18498752
chr15	55838316	55838460	Q9Y3Y4	0	-	55838316	55838460	255,102,0	1	144	0	.	Interaction	with	H3K4me2.
chr15	56134283	56161809	P46934	0	-	56134283	56161809	255,102,0	1	27526	0	.	Mediates	interaction	with	TNIK.
chr15	57458628	57484385	Q99081	0	+	57458628	57484385	255,102,0	1	25757	0	.	Leucine-zipper.
chr15	57489987	57523358	Q99081	0	+	57489987	57523358	255,102,0	1	33371	0	.	Interaction	with	RUNX1T1.	Pubmed:23812588
chr15	57565447	57574701	Q99081	0	+	57565447	57574701	255,102,0	1	9254	0	.	Class	A	specific	domain.
chr15	57730197	57732634	Q0VF96	0	+	57730197	57732634	255,102,0	1	2437	0	.	Head.
chr15	57839565	57839685	Q0VF96	0	+	57839565	57839685	255,102,0	1	120	0	.	Tail.
chr15	58834816	58837945	P11150	0	+	58834816	58837945	255,102,0	1	3129	0	.	Heparin-binding.
chr15	59139645	59144104	Q8NBR6	0	+	59139645	59144104	255,102,0	1	4459	0	.	Ubiquitin-binding	domain	(UBD).	Pubmed:27292798
chr15	59323741	59350595	Q6ZNA4	0	+	59323741	59350595	255,102,0	1	26854	0	.	Interaction	with	AXIN1.	Pubmed:16601693
chr15	59383332	59383341	Q6ZNA4	0	+	59383332	59383341	255,102,0	1	9	0	.	Ubiquitin	binding.
chr15	59386982	59386997	Q6ZNA4	0	+	59386982	59386997	255,102,0	1	15	0	.	Ubiquitin	binding.
chr15	59487691	59487724	Q12965	0	-	59487691	59487724	255,102,0	1	33	0	.	Actin-binding.
chr15	60674616	60678271	P07355	0	-	60674616	60678271	255,102,0	1	3655	0	.	S100A10-binding	site.
chr15	60789656	60803431	P35398	0	-	60789656	60803431	255,102,0	1	13775	0	.	Ligand-binding.
chr15	60803431	60806824	P35398	0	-	60803431	60806824	255,102,0	1	3393	0	.	Hinge.
chr15	62967496	62986517	Q9Y4G6	0	+	62967496	62986517	255,102,0	1	19021	0	.	Interaction	with	PIP5K1C.
chr15	63632552	63632558	O43570	0	-	63632552	63632558	255,102,0	1	6	0	.	Substrate	binding.
chr15	64204106	64217044	Q9UIK4	0	-	64204106	64217044	255,102,0	1	12938	0	.	Calmodulin-binding.
chr15	64204351	64204381	Q9UIK4	0	-	64204351	64204381	255,102,0	1	30	0	.	Autoinhibitory	domain.
chr15	64422147	64422201	Q13596	0	+	64422147	64422201	255,102,0	1	54	0	.	Membrane-binding	amphipathic	helix.	Pubmed:19816406
chr15	64689996	64701884	Q15650	0	+	64689996	64701884	255,102,0	1	11888	0	.	Mediates	interaction	with	DDRGK1.	Pubmed:25219498
chr15	64701881	64710769	Q15650	0	+	64701881	64710769	255,102,0	1	8888	0	.	Mediates	interaction	with	UFL1.	Pubmed:25219498
chr15	65043771	65043804	Q6ZRY4	0	-	65043771	65043804	255,102,0	1	33	0	.	Important	for	homodimerization.	Pubmed:25064856
chr15	65108499	65116036	Q9H611	0	-	65108499	65116036	255,102,0	1	7537	0	.	Hydrolyzes	ATP	in	the	presence	of	both	magnesium	and	single-stranded	DNA;	weak	activity	in	the	presence	of	RNA	or	double-stranded	DNA;	No	unwinding	activity.
chr15	65115994	65116534	Q9H611	0	-	65115994	65116534	255,102,0	1	540	0	.	PINT.
chr15	66641443	66644480	Q9BVW5	0	-	66641443	66644480	255,102,0	1	3037	0	.	Interaction	with	TIMELESS.
chr15	66727512	66727518	Q02750	0	+	66727512	66727518	255,102,0	1	6	0	.	Inhibitor	binding.
chr15	66729221	66729230	Q02750	0	+	66729221	66729230	255,102,0	1	9	0	.	Inhibitor	binding.
chr15	66774145	66774160	Q02750	0	+	66774145	66774160	255,102,0	1	15	0	.	Inhibitor	binding.
chr15	66777441	66779591	Q02750	0	+	66777441	66779591	255,102,0	1	2150	0	.	RAF1-binding.
chr15	67457598	67473613	P84022	0	+	67457598	67473613	255,102,0	1	16015	0	.	Linker.
chr15	67473730	67477165	P84022	0	+	67473730	67477165	255,102,0	1	3435	0	.	Sufficient	for	interaction	with	XPO4.	Pubmed:16449645
chr15	67835724	67835748	Q13163	0	+	67835724	67835748	255,102,0	1	24	0	.	Interaction	with	MAPK7.
chr15	67855625	67855640	Q13163	0	+	67855625	67855640	255,102,0	1	15	0	.	Interaction	with	MAP3K2/MAP3K3.
chr15	67878253	67879213	Q13163	0	+	67878253	67879213	255,102,0	1	960	0	.	Interaction	with	MAPK7.
chr15	68468894	68468930	O75925	0	+	68468894	68468930	255,102,0	1	36	0	.	SUMO1-binding.
chr15	68473625	68480062	O75925	0	+	68473625	68480062	255,102,0	1	6437	0	.	4	X	4	AA	repeats	of	N-T-S-L.
chr15	69072422	69076769	P39687	0	-	69072422	69076769	255,102,0	1	4347	0	.	Interaction	with	E4F1.
chr15	69076739	69076814	P39687	0	-	69076739	69076814	255,102,0	1	75	0	.	Necessary	for	tumor-suppressive	function.
chr15	69307074	69324039	Q96PH1	0	+	69307074	69324039	255,102,0	1	16964	0	.	N-terminal	regulatory	region;	interacts	with	the	C-terminal	catalytic	region	in	a	calcium-dependent	manner.
chr15	69329523	69339755	Q96PH1	0	+	69329523	69339755	255,102,0	1	10232	0	.	C-terminal	catalytic	region.
chr15	69737128	69738640	Q02241	0	+	69737128	69738640	255,102,0	1	1512	0	.	Interaction	with	ARF6.	Pubmed:22522702
chr15	70347618	70351115	Q04726	0	-	70347618	70351115	255,102,0	1	3497	0	.	SP	domain.
chr15	70351115	70352985	Q04726	0	-	70351115	70352985	255,102,0	1	1870	0	.	CcN	domain.
chr15	70352985	70358536	Q04726	0	-	70352985	70358536	255,102,0	1	5551	0	.	GP	domain.
chr15	70358536	70389137	Q04726	0	-	70358536	70389137	255,102,0	1	30601	0	.	Q	domain.
chr15	72119034	72191357	B2RTY4	0	-	72119034	72191357	255,102,0	1	72323	0	.	Tail.
chr15	72191357	72193621	B2RTY4	0	-	72191357	72193621	255,102,0	1	2264	0	.	Neck	or	regulatory	domain.
chr15	72197278	72197314	B2RTY4	0	-	72197278	72197314	255,102,0	1	36	0	.	Actin-binding.
chr15	72431994	72432486	Q96LD8	0	+	72431994	72432486	255,102,0	1	492	0	.	Protease.
chr15	72491993	72499536	P14618	0	-	72491993	72499536	255,102,0	1	7543	0	.	Interaction	with	POU5F1.	Pubmed:18191611
chr15	72492023	72492041	P14618	0	-	72492023	72492041	255,102,0	1	18	0	.	D-fructose	1,6-bisphosphate	binding;	part	of	allosteric	site.	Pubmed:15996096,	Pubmed:23530218
chr15	72492992	72494808	P14618	0	-	72492992	72494808	255,102,0	1	1816	0	.	D-fructose	1,6-bisphosphate	binding;	part	of	allosteric	site.	Pubmed:15996096,	Pubmed:23530218
chr15	72494802	72494937	P14618	0	-	72494802	72494937	255,102,0	1	135	0	.	Intersubunit	contact.
chr15	72638925	72638931	P06865	0	-	72638925	72638931	255,102,0	1	6	0	.	Critical	for	hydrolyzis	GM2	gangliosides.
chr15	72767292	72837176	Q9Y4X5	0	+	72767292	72837176	255,102,0	1	69884	0	.	UBA-like.	Pubmed:23707686
chr15	72873077	72875630	Q9Y4X5	0	+	72873077	72875630	255,102,0	1	2553	0	.	Ariadne	domain.	Pubmed:23707686
chr15	72978568	73004626	Q96RK4	0	+	72978568	73004626	255,102,0	1	26058	0	.	Required	for	localization	to	centrosomes.
chr15	73007711	73024042	Q96RK4	0	+	73007711	73024042	255,102,0	1	16331	0	.	Interaction	with	PCM1.	Pubmed:15107855
chr15	73024042	73029925	Q96RK4	0	+	73024042	73029925	255,102,0	1	5883	0	.	Required	for	localization	to	centrosomes.
chr15	73659831	73659987	Q9Y3Q4	0	-	73659831	73659987	255,102,0	1	156	0	.	Involved	in	subunit	assembly.
chr15	73884434	73884473	Q9Y639	0	-	73884434	73884473	255,102,0	1	39	0	.	Narpin;	mediates	binding	with	FGFR1	and	has	antidepressant-like	activity.
chr15	74235199	74244175	Q08397	0	+	74235199	74244175	255,102,0	1	8976	0	.	Lysyl-oxidase	like.
chr15	74324999	74326826	P29590	0	+	74324999	74326826	255,102,0	1	1827	0	.	Interaction	with	PER2.	Pubmed:22274616
chr15	74326826	74326847	P29590	0	+	74326826	74326847	255,102,0	1	21	0	.	Sumo	interaction	motif	(SIM).
chr15	74708320	74708918	O75326	0	-	74708320	74708918	255,102,0	1	598	0	.	Interaction	with	integrins.
chr15	74865256	74883705	Q8IVW6	0	+	74865256	74883705	255,102,0	1	18449	0	.	Interaction	with	RB1.	Pubmed:10446990
chr15	74885522	74887968	Q8IVW6	0	+	74885522	74887968	255,102,0	1	2446	0	.	Interaction	with	ARID3A.	Pubmed:17400556
chr15	74932892	74948323	Q96F86	0	-	74932892	74948323	255,102,0	1	15431	0	.	Required	for	interaction	with	DDX6.
chr15	74964042	74967465	Q96F86	0	-	74964042	74967465	255,102,0	1	3423	0	.	Required	for	P-body	targeting	and	interaction	with	DCP1A.
chr15	75090964	75091247	P41240	0	+	75090964	75091247	255,102,0	1	283	0	.	Interaction	with	PTPN22.
chr15	75141020	75142880	O15127	0	-	75141020	75142880	255,102,0	1	1860	0	.	Interaction	with	SLC9A7.	Pubmed:15840657
chr15	75682112	75684772	Q96ST3	0	-	75682112	75684772	255,102,0	1	2660	0	.	Interaction	with	OGT.	Pubmed:12150998
chr15	75684883	75693241	Q96ST3	0	-	75684883	75693241	255,102,0	1	8358	0	.	Interaction	with	NCOR1.
chr15	75684946	75688633	Q96ST3	0	-	75684946	75688633	255,102,0	1	3687	0	.	Interaction	with	HDAC1	and	ARID4B.	Pubmed:12724404
chr15	75688714	75693238	Q96ST3	0	-	75688714	75693238	255,102,0	1	4524	0	.	Interaction	with	SUDS3	and	SAP130.	Pubmed:12724404
chr15	75693232	75699431	Q96ST3	0	-	75693232	75699431	255,102,0	1	6199	0	.	Interaction	with	SAP30.
chr15	75694278	75705247	Q96ST3	0	-	75694278	75705247	255,102,0	1	10969	0	.	Interaction	with	REST.
chr15	75705271	75714999	Q96ST3	0	-	75705271	75714999	255,102,0	1	9728	0	.	Interaction	with	HCFC1.	Pubmed:12670868
chr15	75762136	75762157	P43378	0	-	75762136	75762157	255,102,0	1	21	0	.	Substrate	binding.
chr15	75890797	75897547	O95149	0	-	75890797	75897547	255,102,0	1	6750	0	.	Necessary	for	binding	to	the	m3G-cap	structure.	Pubmed:9670026
chr15	75901923	75913392	O95149	0	-	75901923	75913392	255,102,0	1	11469	0	.	Necessary	for	interaction	with	XPO1.	Pubmed:10209022
chr15	75902251	75902260	O95149	0	-	75902251	75902260	255,102,0	1	9	0	.	Interaction	with	m3G-cap	structure.	Pubmed:15920472
chr15	75909856	75913392	O95149	0	-	75909856	75913392	255,102,0	1	3536	0	.	Necessary	for	interaction	with	KPNB1	and	m3G-cap	U1	and	U5	snRNP	import	receptor	activity.	Pubmed:18187419,	Pubmed:9670026
chr15	75968196	75974972	Q6UVK1	0	-	75968196	75974972	255,102,0	1	6776	0	.	Cysteine-containing.
chr15	75968196	75974975	Q6UVK1	0	-	75968196	75974975	255,102,0	1	6779	0	.	Neurite	growth	inhibition.
chr15	75977187	75981515	Q6UVK1	0	-	75977187	75981515	255,102,0	1	4328	0	.	Interaction	with	COL5A1.
chr15	75980285	75981686	Q6UVK1	0	-	75980285	75981686	255,102,0	1	1401	0	.	Interaction	with	COL6A2.
chr15	75981488	75985575	Q6UVK1	0	-	75981488	75985575	255,102,0	1	4087	0	.	Globular	or	compact	configuration	stabilized	by	disulfide	bonds.
chr15	75981488	75985575	Q6UVK1	0	-	75981488	75985575	255,102,0	1	4087	0	.	Neurite	growth	inhibition.
chr15	76508902	76578029	P13804	0	-	76508902	76578029	255,102,0	1	69127	0	.	Domain	II.	Pubmed:8962055
chr15	76578029	76588060	P13804	0	-	76578029	76588060	255,102,0	1	10031	0	.	Domain	I.	Pubmed:8962055
chr15	76633492	76633582	Q96A47	0	+	76633492	76633582	255,102,0	1	90	0	.	LIM-binding	domain	(LID).
chr15	78640298	78640307	P29762	0	+	78640298	78640307	255,102,0	1	9	0	.	Retinoic	acid	binding.
chr15	79063594	79065464	Q9UKP4	0	-	79063594	79065464	255,102,0	1	1870	0	.	Spacer.
chr15	79170589	79177339	Q9UBU8	0	+	79170589	79177339	255,102,0	1	6750	0	.	Interaction	with	KAT8.	Pubmed:12397079
chr15	79179647	79186451	Q9UBU8	0	+	79179647	79186451	255,102,0	1	6804	0	.	Sufficient	for	interaction	with	SIN3A.	Pubmed:12391155
chr15	79183848	79185913	Q9UBU8	0	+	79183848	79185913	255,102,0	1	2065	0	.	Interaction	with	RB1-1.
chr15	79184559	79189346	Q9UBU8	0	+	79184559	79189346	255,102,0	1	4787	0	.	Sufficient	for	interaction	with	PHF12.	Pubmed:12391155
chr15	79187208	79189352	Q9UBU8	0	+	79187208	79189352	255,102,0	1	2144	0	.	Interaction	with	RB1-2.
chr15	80137707	80137722	P49914	0	-	80137707	80137722	255,102,0	1	15	0	.	Substrate	binding.
chr15	81181055	81201623	Q8WUJ3	0	+	81181055	81201623	255,102,0	1	20568	0	.	Necessary	for	its	endoplasmic	reticulum	(ER)	retention	and	interaction	with	HSPA5.	Pubmed:23990668
chr15	81271652	81271772	Q14696	0	-	81271652	81271772	255,102,0	1	120	0	.	Escort	domain.
chr15	81271772	81282132	Q14696	0	-	81271772	81282132	255,102,0	1	10360	0	.	Chaperone	domain.
chr15	81558124	81582817	Q14005	0	+	81558124	81582817	255,102,0	1	24693	0	.	Interaction	with	GRIN2A.	Pubmed:12923170
chr15	81592766	81595925	Q14005	0	+	81592766	81595925	255,102,0	1	3159	0	.	Interaction	with	HTLV-1	tax.
chr15	81593850	81598434	Q14005	0	+	81593850	81598434	255,102,0	1	4584	0	.	Interaction	with	PPP1R12A,	PPP1R12B	and	PPP1R12C.	Pubmed:12923170
chr15	83478478	83482025	Q8TF30	0	+	83478478	83482025	255,102,0	1	3547	0	.	Mediates	association	with	membranes.	Pubmed:18614018
chr15	83482025	83499599	Q8TF30	0	+	83482025	83499599	255,102,0	1	17574	0	.	Mediates	interaction	with	microtubules.	Pubmed:23027905
chr15	83499599	83502285	Q8TF30	0	+	83499599	83502285	255,102,0	1	2686	0	.	Mediates	actin	nucleation.	Pubmed:18614018
chr15	83657773	83657935	Q9BTL3	0	+	83657773	83657935	255,102,0	1	162	0	.	Interaction	with	RNMT.	Pubmed:22099306
chr15	83657935	83658816	Q9BTL3	0	+	83657935	83658816	255,102,0	1	881	0	.	RNA-binding.
chr15	83933255	83933285	Q01954	0	-	83933255	83933285	255,102,0	1	30	0	.	Hydrophobic.
chr15	84116285	84228022	Q99963	0	+	84116285	84228022	255,102,0	1	111737	0	.	Membrane-binding	amphipathic	helix.
chr15	84233948	84237354	Q99963	0	+	84233948	84237354	255,102,0	1	3406	0	.	Required	for	dimerization	upon	membrane	association.
chr15	84255761	84257447	Q99963	0	+	84255761	84257447	255,102,0	1	1686	0	.	Interaction	with	ARC.
chr15	85658678	85658702	O60658	0	+	85658678	85658702	255,102,0	1	24	0	.	Involved	in	RAF1-binding.	Pubmed:23509299
chr15	85660926	85681083	O60658	0	+	85660926	85681083	255,102,0	1	20157	0	.	Catalytic.
chr15	86122778	86122847	Q12802	0	+	86122778	86122847	255,102,0	1	69	0	.	Important	for	interaction	with	PRKAR2A.
chr15	86201774	86225432	Q12802	0	+	86201774	86225432	255,102,0	1	23658	0	.	Important	for	interaction	with	MAP2K3.	Pubmed:21224381
chr15	86260539	86287905	Q12802	0	+	86260539	86287905	255,102,0	1	27366	0	.	Interaction	with	ESR1.	Pubmed:9627117
chr15	90185502	90190850	Q2M1P5	0	-	90185502	90190850	255,102,0	1	5348	0	.	Sufficient	for	interaction	with	NPHP1.	Pubmed:21633164
chr15	90210838	90210925	O60240	0	-	90210838	90210925	255,102,0	1	87	0	.	Required	for	interaction	with	CIDEC.
chr15	90226634	90226694	O75192	0	-	90226634	90226694	255,102,0	1	60	0	.	Required	for	homodimerization,	interaction	with	PEX11G,	and	peroxisomal	localization.	Pubmed:20826455
chr15	90293907	90293919	Q9BRJ9	0	-	90293907	90293919	255,102,0	1	12	0	.	2	X	2	AA	tandem	repeats	of	G-Q.
chr15	90320122	90320200	Q0VG99	0	+	90320122	90320200	255,102,0	1	78	0	.	13	X	2	AA	tandem	repeats	of	G-Q.
chr15	90328582	90349610	P15144	0	-	90328582	90349610	255,102,0	1	21028	0	.	Metalloprotease.
chr15	90347594	90347609	P15144	0	-	90347594	90347609	255,102,0	1	15	0	.	Substrate	binding.	Pubmed:22932899
chr15	90348320	90348344	P15144	0	-	90348320	90348344	255,102,0	1	24	0	.	Necessary	and	sufficient	to	mediate	interaction	with	HCoV-229E.	Pubmed:8887485,	Pubmed:1350662
chr15	90349610	90349718	P15144	0	-	90349610	90349718	255,102,0	1	108	0	.	Cytosolic	Ser/Thr-rich	junction.
chr15	90445029	90446489	Q7Z6K5	0	-	90445029	90446489	255,102,0	1	1460	0	.	Necessary	and	sufficient	for	interaction	with	ARPC2.	Pubmed:24132237
chr15	90631932	90631953	P48735	0	-	90631932	90631953	255,102,0	1	21	0	.	Substrate	binding.
chr15	91019975	91027485	P46940	0	+	91019975	91027485	255,102,0	1	7510	0	.	C1.
chr15	91027488	91043337	P46940	0	+	91027488	91043337	255,102,0	1	15849	0	.	C2.
chr15	91073303	91136945	Q6UUV7	0	+	91073303	91136945	255,102,0	1	63642	0	.	Required	for	interaction	with	HTLV-1	TAX.
chr15	91295117	91304403	P54132	0	+	91295117	91304403	255,102,0	1	9286	0	.	Necessary	for	interaction	with	SPIDR.	Pubmed:23509288
chr15	91424997	91425009	P09958	0	+	91424997	91425009	255,102,0	1	12	0	.	Cell	surface	signal.
chr15	91428275	91432840	P07332	0	+	91428275	91432840	255,102,0	1	4565	0	.	Important	for	interaction	with	membranes	containing	phosphoinositides.
chr15	91510363	91517428	O43663	0	-	91510363	91517428	255,102,0	1	7065	0	.	Unstructured,	Arg/Lys	rich.
chr15	91517428	91522471	O43663	0	-	91517428	91522471	255,102,0	1	5043	0	.	Spectrin-fold.
chr15	91522471	91537647	O43663	0	-	91522471	91537647	255,102,0	1	15176	0	.	Dimerization.
chr15	92987932	92987941	Q92186	0	+	92987932	92987941	255,102,0	1	9	0	.	Substrate	binding.
chr15	93007366	93007375	Q92186	0	+	93007366	93007375	255,102,0	1	9	0	.	Substrate	binding.
chr15	93007471	93007477	Q92186	0	+	93007471	93007477	255,102,0	1	6	0	.	Substrate	binding.
chr15	96875682	96880848	P24468	0	+	96875682	96880848	255,102,0	1	5166	0	.	Interaction	with	ZFPM2.
chr15	96877408	96880848	P24468	0	+	96877408	96880848	255,102,0	1	3440	0	.	Ligand-binding.
chr15	96880614	96880848	P24468	0	+	96880614	96880848	255,102,0	1	234	0	.	Important	for	dimerization.
chr15	100591894	100636594	Q8TE56	0	-	100591894	100636594	255,102,0	1	44700	0	.	Spacer.
chr15	101815507	101815546	Q9BQE4	0	-	101815507	101815546	255,102,0	1	39	0	.	VCP/p97-interacting	motif	(VIM).	Pubmed:21896481
chr15	101847439	101866679	P29122	0	-	101847439	101866679	255,102,0	1	19240	0	.	CRM	(Cys-rich	motif).
chr16	339534	347783	O15169	0	-	339534	347783	255,102,0	1	8249	0	.	Interaction	with	PPP2CA.	Pubmed:9920888
chr16	341212	347987	O15169	0	-	341212	347987	255,102,0	1	6775	0	.	Interaction	with	RNF111.	Pubmed:16601693
chr16	341227	343645	O15169	0	-	341227	343645	255,102,0	1	2418	0	.	Interaction	with	HIPK2.
chr16	347999	348206	O15169	0	-	347999	348206	255,102,0	1	207	0	.	Interaction	with	CTNNB1.
chr16	348206	360047	O15169	0	-	348206	360047	255,102,0	1	11841	0	.	Interaction	with	GSK3B.
chr16	364547	396401	O15169	0	-	364547	396401	255,102,0	1	31854	0	.	Interaction	with	TP53.
chr16	460280	460289	Q9NUI1	0	+	460280	460289	255,102,0	1	9	0	.	Substrate	binding.
chr16	555577	569795	O75154	0	+	555577	569795	255,102,0	1	14218	0	.	ARF-binding	domain	(ABD).
chr16	559123	573317	O75154	0	+	559123	573317	255,102,0	1	14194	0	.	ARF-binding	domain	(ABD).
chr16	815605	815753	Q13421	0	+	815605	815753	255,102,0	1	148	0	.	Required	for	megakaryocyte-potentiating	factor	activity.
chr16	1364067	1364085	P63279	0	+	1364067	1364085	255,102,0	1	18	0	.	Interaction	with	SUMO1.
chr16	1859310	1859322	Q16775	0	-	1859310	1859322	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:10508780
chr16	1866971	1866980	Q16775	0	-	1866971	1866980	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:10508780
chr16	1867234	1867243	Q16775	0	-	1867234	1867243	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:10508780
chr16	1961956	1961962	Q96QI5	0	-	1961956	1961962	255,102,0	1	6	0	.	Substrate	binding.
chr16	1962151	1962163	Q96QI5	0	-	1962151	1962163	255,102,0	1	12	0	.	Substrate	binding.
chr16	1963980	1963986	Q96QI5	0	-	1963980	1963986	255,102,0	1	6	0	.	Substrate	binding.
chr16	1964175	1964187	Q96QI5	0	-	1964175	1964187	255,102,0	1	12	0	.	Substrate	binding.
chr16	1967940	1967961	Q96QI5	0	-	1967940	1967961	255,102,0	1	21	0	.	Substrate	binding.
chr16	1969964	1969985	Q96QI5	0	-	1969964	1969985	255,102,0	1	21	0	.	Substrate	binding.
chr16	2029172	2029202	Q8NFA2	0	-	2029172	2029202	255,102,0	1	30	0	.	Proline-rich	region;	mediates	mutually	exclusive	interactions	with	itself	and	NOXA1.
chr16	2098616	2111952	P49815	0	+	2098616	2111952	255,102,0	1	13336	0	.	Required	for	interaction	with	TSC1.
chr16	2234786	2235335	Q8WXD9	0	-	2234786	2235335	255,102,0	1	549	0	.	CASK-binding.
chr16	2273734	2278470	Q66K89	0	+	2273734	2278470	255,102,0	1	4736	0	.	Required	for	ubiquitin	ligase	activity.
chr16	2282305	2282815	Q66K89	0	+	2282305	2282815	255,102,0	1	510	0	.	Mediates	dimerization,	DNA-binding,	transcription	repression	of	CCNA2	and	interaction	with	HMGA2.	Pubmed:14645522
chr16	2283486	2284688	Q66K89	0	+	2283486	2284688	255,102,0	1	1202	0	.	Mediates	interaction	with	CDKN2A.
chr16	2283918	2284864	Q66K89	0	+	2283918	2284864	255,102,0	1	946	0	.	Interaction	with	BMI1.	Pubmed:16882984
chr16	2284356	2284730	Q66K89	0	+	2284356	2284730	255,102,0	1	374	0	.	Mediates	interaction	with	TP53.
chr16	2284712	2284781	Q66K89	0	+	2284712	2284781	255,102,0	1	69	0	.	Mediates	interaction	with	RASSF1.	Pubmed:14729613
chr16	2294517	2294532	P42126	0	-	2294517	2294532	255,102,0	1	15	0	.	Substrate	binding.	Pubmed:15351645
chr16	2303967	2305692	Q15287	0	-	2303967	2305692	255,102,0	1	1725	0	.	Necessary	for	interaction	with	TRA2B,	nuclear	localization	and	exon-skipping.	Pubmed:14729963
chr16	2305671	2312788	Q15287	0	-	2305671	2312788	255,102,0	1	7117	0	.	Interaction	with	SAP18	and	ACIN1.	Pubmed:20966198
chr16	2305677	2312797	Q15287	0	-	2305677	2312797	255,102,0	1	7120	0	.	Necessary	for	interaction	with	PNN	and	exon-skipping.
chr16	2312294	2314644	Q15287	0	-	2312294	2314644	255,102,0	1	2350	0	.	Necessary	for	interaction	with	the	cleaved	p110	isoform	of	CDC2L1.
chr16	2312779	2314644	Q15287	0	-	2312779	2314644	255,102,0	1	1865	0	.	Necessary	for	interaction	with	SRP54,	nuclear	localization	and	exon-skipping.	Pubmed:14729963
chr16	2313152	2314199	Q15287	0	-	2313152	2314199	255,102,0	1	1047	0	.	Necessary	for	interactions	with	UPF2	and	UPF3B	and	UPF2-dependent	NMD.
chr16	2505423	2506958	P41002	0	+	2505423	2506958	255,102,0	1	1535	0	.	PEST.
chr16	2577817	2577823	Q9Y303	0	+	2577817	2577823	255,102,0	1	6	0	.	Substrate	binding.
chr16	2578134	2578140	Q9Y303	0	+	2578134	2578140	255,102,0	1	6	0	.	Substrate	binding.
chr16	2578323	2578335	Q9Y303	0	+	2578323	2578335	255,102,0	1	12	0	.	Substrate	binding.
chr16	2578661	2578670	Q9Y303	0	+	2578661	2578670	255,102,0	1	9	0	.	Substrate	binding.
chr16	2611779	2615558	O15530	0	+	2611779	2615558	255,102,0	1	3779	0	.	PIF-pocket.	Pubmed:22999883
chr16	2808543	2809606	Q9UQ35	0	+	2808543	2809606	255,102,0	1	1063	0	.	Sufficient	for	RNA-binding.
chr16	3022956	3024002	Q99640	0	-	3022956	3024002	255,102,0	1	1046	0	.	Interaction	with	CDC2-CCNB1.
chr16	3022956	3024119	Q99640	0	-	3022956	3024119	255,102,0	1	1163	0	.	Interaction	with	PIN1.
chr16	3065362	3065368	P56747	0	-	3065362	3065368	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2	and	TJP3.
chr16	3073277	3073289	Q9NWW0	0	-	3073277	3073289	255,102,0	1	12	0	.	Interaction	with	HCFC1.	Pubmed:12235138
chr16	3294266	3299433	O15553	0	-	3294266	3299433	255,102,0	1	5167	0	.	Required	for	homotrimerization	and	induction	of	pyroptosomes.
chr16	3304227	3304272	O15553	0	-	3304227	3304272	255,102,0	1	45	0	.	Interaction	with	RELA.	Pubmed:18577712
chr16	3532561	3532570	Q9H7X0	0	+	3532561	3532570	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:27320834,	Pubmed:27550639
chr16	3532585	3533367	Q9H7X0	0	+	3532585	3533367	255,102,0	1	782	0	.	Acetyl-CoA	binding.	Pubmed:27320834,	Pubmed:27550639
chr16	3533472	3533484	Q9H7X0	0	+	3533472	3533484	255,102,0	1	12	0	.	Acetyl-CoA	binding.	Pubmed:27320834,	Pubmed:27550639
chr16	3533508	3533544	Q9H7X0	0	+	3533508	3533544	255,102,0	1	36	0	.	Required	for	homodimerization.	Pubmed:27320834
chr16	3632345	3633357	Q8IY92	0	-	3632345	3633357	255,102,0	1	1012	0	.	Interaction	with	SLX1.
chr16	3632345	3644564	Q8IY92	0	-	3632345	3644564	255,102,0	1	12219	0	.	Interaction	with	PLK1	and	TERF2-TERF2IP.	Pubmed:19596235
chr16	3633306	3639657	Q8IY92	0	-	3633306	3639657	255,102,0	1	6351	0	.	Interaction	with	MUS81.
chr16	3645611	3658965	Q8IY92	0	-	3645611	3658965	255,102,0	1	13354	0	.	Interaction	with	SLX4IP,	ERCC4	and	MSH2.	Pubmed:19596235
chr16	3779374	3788576	Q92793	0	-	3779374	3788576	255,102,0	1	9202	0	.	Interaction	with	TRERF1.	Pubmed:11349124
chr16	3788612	3788618	I3L466	0	-	3788612	3788618	255,102,0	1	6	0	.	Acetyl-CoA	binding.
chr16	3788612	3788618	Q92793	0	-	3788612	3788618	255,102,0	1	6	0	.	Acetyl-CoA	binding.
chr16	3788645	3788654	I3L466	0	-	3788645	3788654	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr16	3788645	3788654	Q92793	0	-	3788645	3788654	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr16	3788648	3788657	Q92793	0	-	3788648	3788657	255,102,0	1	9	0	.	Interaction	with	histone.
chr16	3807878	3807935	Q92793	0	-	3807878	3807935	255,102,0	1	57	0	.	Interaction	with	ASF1A.	Pubmed:24616510
chr16	3807908	3808049	Q92793	0	-	3807908	3808049	255,102,0	1	141	0	.	Interaction	with	histone.	Pubmed:24361270
chr16	3842081	3900417	Q92793	0	-	3842081	3900417	255,102,0	1	58336	0	.	Interaction	with	SRCAP.	Pubmed:10347196
chr16	4310584	4311854	Q01664	0	-	4310584	4311854	255,102,0	1	1270	0	.	Leucine-zipper	2.
chr16	4311944	4312381	Q01664	0	-	4311944	4312381	255,102,0	1	437	0	.	Leucine-zipper	1.
chr16	4382383	4384978	Q9BZE0	0	+	4382383	4384978	255,102,0	1	2595	0	.	Interaction	with	CTNND1.
chr16	4383385	4384867	Q9BZE0	0	+	4383385	4384867	255,102,0	1	1482	0	.	Transcription	activation.
chr16	4384897	4384969	Q9BZE0	0	+	4384897	4384969	255,102,0	1	72	0	.	Transcription	repression.
chr16	4390367	4391422	Q9Y3D7	0	-	4390367	4391422	255,102,0	1	1055	0	.	J-like.
chr16	4513813	4516226	Q9HBL8	0	-	4513813	4516226	255,102,0	1	2413	0	.	Interaction	with	ASS1.
chr16	4515772	4518185	Q9HBL8	0	-	4515772	4518185	255,102,0	1	2413	0	.	Interaction	with	ASS1.
chr16	4744176	4745159	Q9BRJ7	0	+	4744176	4745159	255,102,0	1	983	0	.	Interaction	with	PXN.
chr16	4827800	4829742	Q8IYM1	0	-	4827800	4829742	255,102,0	1	1942	0	.	Self-association	(via	N-terminus)	to	polymerize	octomeric	septin	12-7-6-2/4-2/4-6-7-12	filaments.
chr16	4827917	4837511	Q8IYM1	0	-	4827917	4837511	255,102,0	1	9594	0	.	Interaction	with	SEPT7.	Pubmed:25588830
chr16	4902918	4909091	Q9NPG3	0	+	4902918	4909091	255,102,0	1	6173	0	.	Sufficient	for	interaction	with	HIRA.	Pubmed:19029251
chr16	5075547	5075571	Q9UK23	0	-	5075547	5075571	255,102,0	1	24	0	.	Mediates	the	interaction	with	AP4M1.	Pubmed:26544806
chr16	5140325	5140334	Q96G04	0	-	5140325	5140334	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr16	8858636	8858642	P80404	0	+	8858636	8858642	255,102,0	1	6	0	.	Pyridoxal	phosphate	binding.
chr16	8993520	8996315	Q93009	0	-	8993520	8996315	255,102,0	1	2795	0	.	Interaction	with	ICP0/VMW110.	Pubmed:16160161
chr16	9012983	9024177	Q93009	0	-	9012983	9024177	255,102,0	1	11194	0	.	Interaction	with	p53/TP53,	MDM2	and	EBNA1.	Pubmed:14506283
chr16	9012983	9057142	Q93009	0	-	9012983	9057142	255,102,0	1	44159	0	.	Interaction	with	TSPYL5.	Pubmed:21170034
chr16	9012992	9017247	Q93009	0	-	9012992	9017247	255,102,0	1	4255	0	.	Necessary	for	nuclear	localization.
chr16	9916218	9916224	Q12879	0	-	9916218	9916224	255,102,0	1	6	0	.	Glutamate	binding.
chr16	9934615	9934624	Q12879	0	-	9934615	9934624	255,102,0	1	9	0	.	Glutamate	binding.
chr16	11348789	11348819	O15524	0	-	11348789	11348819	255,102,0	1	30	0	.	Interaction	with	Elongin	BC	complex.
chr16	11349101	11349137	O15524	0	-	11349101	11349137	255,102,0	1	36	0	.	Extended	SH2	subdomain	(ESS).
chr16	11349137	11349173	O15524	0	-	11349137	11349173	255,102,0	1	36	0	.	Kinase	inhibitory	region	(KIR).
chr16	11980374	11980383	P15170	0	-	11980374	11980383	255,102,0	1	9	0	.	G5.
chr16	11980662	11980674	P15170	0	-	11980662	11980674	255,102,0	1	12	0	.	G4.
chr16	11981486	11981498	P15170	0	-	11981486	11981498	255,102,0	1	12	0	.	G3.
chr16	11981546	11981561	P15170	0	-	11981546	11981561	255,102,0	1	15	0	.	G2.
chr16	11988830	11990424	P15170	0	-	11988830	11990424	255,102,0	1	1594	0	.	G1.
chr16	12758937	12875192	Q9BRF8	0	-	12758937	12875192	255,102,0	1	116255	0	.	Catalytic.
chr16	14014022	14029160	Q92889	0	+	14014022	14029160	255,102,0	1	15138	0	.	Helicase-like.
chr16	14021996	14022062	Q92889	0	+	14021996	14022062	255,102,0	1	66	0	.	Leucine-zipper	1.
chr16	14024581	14024668	Q92889	0	+	14024581	14024668	255,102,0	1	87	0	.	Leucine-zipper	2.
chr16	14038646	14041892	Q92889	0	+	14038646	14041892	255,102,0	1	3246	0	.	Nuclease.
chr16	14041961	14042168	Q92889	0	+	14041961	14042168	255,102,0	1	207	0	.	HhH2,	dimerization	with	ERCC1.
chr16	15122444	15128933	Q9NYV6	0	+	15122444	15128933	255,102,0	1	6489	0	.	Interaction	with	TWISTNB.	Pubmed:12393749
chr16	15125422	15128933	Q9NYV6	0	+	15125422	15128933	255,102,0	1	3511	0	.	Interaction	with	EIF3L.	Pubmed:12393749
chr16	15155603	15159113	Q9NYV6	0	-	15155603	15159113	255,102,0	1	3510	0	.	Interaction	with	EIF3L.	Pubmed:12393749
chr16	15155603	15162081	Q9NYV6	0	-	15155603	15162081	255,102,0	1	6478	0	.	Interaction	with	TWISTNB.	Pubmed:12393749
chr16	15489799	15489919	Q2QL34	0	+	15489799	15489919	255,102,0	1	120	0	.	Targeting	to	peroxisomes.
chr16	15574905	15575025	Q2QL34	0	+	15574905	15575025	255,102,0	1	120	0	.	Targeting	to	peroxisomes.
chr16	15797850	15797964	P35749	0	-	15797850	15797964	255,102,0	1	114	0	.	C-terminal.
chr16	15841509	15841554	P35749	0	-	15841509	15841554	255,102,0	1	45	0	.	Actin-binding.
chr16	15844003	15844072	P35749	0	-	15844003	15844072	255,102,0	1	69	0	.	Actin-binding.
chr16	15883004	15883118	P35749	0	-	15883004	15883118	255,102,0	1	114	0	.	C-terminal.
chr16	15926663	15926708	P35749	0	-	15926663	15926708	255,102,0	1	45	0	.	Actin-binding.
chr16	15929157	15929226	P35749	0	-	15929157	15929226	255,102,0	1	69	0	.	Actin-binding.
chr16	15973659	15982442	Q96NB1	0	-	15973659	15982442	255,102,0	1	8783	0	.	Necessary	and	sufficient	for	homooligomerization	and	localization	to	centrosomes	and	pericentriolar	satellites.
chr16	16058797	16067586	Q96NB1	0	-	16058797	16067586	255,102,0	1	8789	0	.	Necessary	and	sufficient	for	homooligomerization	and	localization	to	centrosomes	and	pericentriolar	satellites.
chr16	18858839	18937363	Q96Q15	0	-	18858839	18937363	255,102,0	1	78524	0	.	Interaction	with	SMG8	and	SMG9.	Pubmed:21245168
chr16	19083317	19089477	Q99807	0	+	19083317	19089477	255,102,0	1	6160	0	.	2	X	approximate	tandem	repeats.
chr16	19539203	19547660	O43303	0	+	19539203	19547660	255,102,0	1	8457	0	.	CEP97	binding.
chr16	19543785	19543842	O43303	0	+	19543785	19543842	255,102,0	1	57	0	.	Calmodulin-binding.
chr16	19543794	19543842	O43303	0	+	19543794	19543842	255,102,0	1	48	0	.	Required	for	interaction	with	CEP290.	Pubmed:18694559
chr16	19548038	19548686	O43303	0	+	19548038	19548686	255,102,0	1	648	0	.	Interaction	with	CEP76.	Pubmed:19460342
chr16	19554055	19554295	O43303	0	+	19554055	19554295	255,102,0	1	240	0	.	Calmodulin-binding.
chr16	19557159	19557207	O43303	0	+	19557159	19557207	255,102,0	1	48	0	.	Calmodulin-binding.
chr16	19718234	19725442	Q1ED39	0	-	19718234	19725442	255,102,0	1	7208	0	.	Interaction	with	ZNF106.
chr16	20347968	20347998	P07911	0	-	20347968	20347998	255,102,0	1	30	0	.	Regulates	polymerization	into	filaments.	Pubmed:19005207
chr16	20348022	20348034	P07911	0	-	20348022	20348034	255,102,0	1	12	0	.	Essential	for	cleavage	by	HPN.	Pubmed:26811476,	Pubmed:19005207,	Pubmed:26673890
chr16	20352630	20355389	P07911	0	-	20352630	20355389	255,102,0	1	2759	0	.	Important	for	secretion	and	polymerization	into	filaments.	Pubmed:26811476
chr16	20492017	20492147	Q08AH3	0	+	20492017	20492147	255,102,0	1	130	0	.	Coenzyme	A	binding.	Pubmed:19345228
chr16	20494487	20494496	Q08AH3	0	+	20494487	20494496	255,102,0	1	9	0	.	Coenzyme	A	binding.	Pubmed:19345228
chr16	20551978	20551987	Q68CK6	0	-	20551978	20551987	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr16	20554331	20554461	Q68CK6	0	-	20554331	20554461	255,102,0	1	130	0	.	Coenzyme	A	binding.
chr16	20963806	20974744	Q8TD57	0	-	20963806	20974744	255,102,0	1	10938	0	.	AAA	6.
chr16	20975380	20976073	Q8TD57	0	-	20975380	20976073	255,102,0	1	693	0	.	AAA	5.
chr16	20976325	20990747	Q8TD57	0	-	20976325	20990747	255,102,0	1	14422	0	.	Stalk.
chr16	20990789	20996881	Q8TD57	0	-	20990789	20996881	255,102,0	1	6092	0	.	AAA	4.
chr16	20999044	21014446	Q8TD57	0	-	20999044	21014446	255,102,0	1	15402	0	.	AAA	3.
chr16	21033359	21048107	Q8TD57	0	-	21033359	21048107	255,102,0	1	14748	0	.	AAA	2.
chr16	21063058	21170762	Q8TD57	0	-	21063058	21170762	255,102,0	1	107704	0	.	Stem.
chr16	21213057	21213126	Q05996	0	-	21213057	21213126	255,102,0	1	69	0	.	Disordered.
chr16	21245058	21261643	Q8N8V4	0	+	21245058	21261643	255,102,0	1	16585	0	.	Mediates	localization	to	microvilli.	Pubmed:26812018
chr16	21261643	21261925	Q8N8V4	0	+	21261643	21261925	255,102,0	1	282	0	.	Mediates	interaction	with	MYO7B.	Pubmed:26812018
chr16	22284961	22285012	O00418	0	+	22284961	22285012	255,102,0	1	51	0	.	Calmodulin-binding.
chr16	22285009	22285063	O00418	0	+	22285009	22285063	255,102,0	1	54	0	.	Pseudosubstrate/autoinhibitory	domain.
chr16	22826366	22826387	Q9Y278	0	+	22826366	22826387	255,102,0	1	21	0	.	Substrate	binding.
chr16	22926307	22926319	Q9Y278	0	+	22926307	22926319	255,102,0	1	12	0	.	Substrate	binding.
chr16	22926511	22926517	Q9Y278	0	+	22926511	22926517	255,102,0	1	6	0	.	Substrate	binding.
chr16	23486225	23492026	Q9UJY4	0	-	23486225	23492026	255,102,0	1	5801	0	.	Unstructured	hinge.
chr16	23546470	23546485	Q5JPH6	0	-	23546470	23546485	255,102,0	1	15	0	.	Glutamate	binding.
chr16	23568538	23568547	Q5JPH6	0	-	23568538	23568547	255,102,0	1	9	0	.	Glutamate	binding.
chr16	23614782	23640554	Q86YC2	0	-	23614782	23640554	255,102,0	1	25772	0	.	Interaction	with	RAD51,	BRCA2	and	POLH.	Pubmed:24485656
chr16	23614782	23641152	Q86YC2	0	-	23614782	23641152	255,102,0	1	26370	0	.	Required	for	interaction	with	POLH	and	POLH	DNA	synthesis	stimulation.	Pubmed:24485656
chr16	23641737	23652478	Q86YC2	0	-	23641737	23652478	255,102,0	1	10741	0	.	DNA-binding	(with	the	preference	D	loop	>	dsDNA	>	ssDNA).
chr16	23646528	23646684	Q86YC2	0	-	23646528	23646684	255,102,0	1	156	0	.	ChAM	(Chromatin-association	motif);	required	for	chromatin	association,	mediates	nucleosome	association.
chr16	23646909	23652478	Q86YC2	0	-	23646909	23652478	255,102,0	1	5569	0	.	Interaction	with	BRCA1.	Pubmed:19369211
chr16	23647266	23652478	Q86YC2	0	-	23647266	23652478	255,102,0	1	5212	0	.	Interaction	with	RAD51.
chr16	23647386	23652478	Q86YC2	0	-	23647386	23652478	255,102,0	1	5092	0	.	Required	for	its	oligomerization	and	is	important	for	its	focal	concentration	at	DNA	damage	sites.
chr16	23692236	23692320	P53350	0	+	23692236	23692320	255,102,0	1	84	0	.	Activation	loop.
chr16	23700865	23700910	P53350	0	+	23700865	23700910	255,102,0	1	45	0	.	Linker.
chr16	23701183	23701192	P53350	0	+	23701183	23701192	255,102,0	1	9	0	.	Important	for	interaction	with	phosphorylated	proteins.
chr16	24580954	24581428	Q7Z6E9	0	+	24580954	24581428	255,102,0	1	474	0	.	Interaction	with	RB1.
chr16	24582683	24583019	Q7Z6E9	0	+	24582683	24583019	255,102,0	1	336	0	.	Interaction	with	p53.
chr16	24741162	24802759	Q8NDV7	0	+	24741162	24802759	255,102,0	1	61597	0	.	Interaction	with	argonaute	family	proteins.
chr16	24800722	24801472	Q8NDV7	0	+	24800722	24801472	255,102,0	1	750	0	.	Sufficient	for	interaction	with	AGO1,	AGO3	and	AGO4.
chr16	24800770	24801001	Q8NDV7	0	+	24800770	24801001	255,102,0	1	231	0	.	Sufficient	for	interaction	with	AGO2.
chr16	24800914	24801160	Q8NDV7	0	+	24800914	24801160	255,102,0	1	246	0	.	Sufficient	for	interaction	with	AGO2.
chr16	24800980	24801280	Q8NDV7	0	+	24800980	24801280	255,102,0	1	300	0	.	Sufficient	for	interaction	with	AGO2.
chr16	24801187	24801448	Q8NDV7	0	+	24801187	24801448	255,102,0	1	261	0	.	Sufficient	for	interaction	with	AGO2.
chr16	24801466	24802216	Q8NDV7	0	+	24801466	24802216	255,102,0	1	750	0	.	Sufficient	for	interaction	with	AGO2.
chr16	24801658	24816379	Q8NDV7	0	+	24801658	24816379	255,102,0	1	14721	0	.	Sufficient	for	interaction	with	AGO1	and	AGO4.
chr16	24804837	24805944	Q8NDV7	0	+	24804837	24805944	255,102,0	1	1107	0	.	Sufficient	for	interaction	with	AGO2.
chr16	24826604	24828171	Q8NDV7	0	+	24826604	24828171	255,102,0	1	1567	0	.	PABPC1-interacting	motif-2	(PAM2).
chr16	24829948	24835125	Q8NDV7	0	+	24829948	24835125	255,102,0	1	5177	0	.	Sufficient	for	interaction	with	AGO2.
chr16	25172466	25172472	Q9UIC8	0	+	25172466	25172472	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr16	25704422	25704443	Q9Y661	0	+	25704422	25704443	255,102,0	1	21	0	.	Substrate	binding.
chr16	26146975	26146987	Q9Y661	0	+	26146975	26146987	255,102,0	1	12	0	.	Substrate	binding.
chr16	26147179	26147185	Q9Y661	0	+	26147179	26147185	255,102,0	1	6	0	.	Substrate	binding.
chr16	27245538	27268891	Q8WV22	0	-	27245538	27268891	255,102,0	1	23353	0	.	Interaction	with	NSMCE3.
chr16	27373981	27374344	P24394	0	+	27373981	27374344	255,102,0	1	363	0	.	Required	for	IRS1	activation	and	IL4-induced	cell	growth.
chr16	27374344	27374644	P24394	0	+	27374344	27374644	255,102,0	1	300	0	.	Required	for	IL4-induced	gene	expression.
chr16	28601964	28601973	Q96ES7	0	+	28601964	28601973	255,102,0	1	9	0	.	Histone	H3K4me3	N-terminus	binding.
chr16	28602208	28602220	Q96ES7	0	+	28602208	28602220	255,102,0	1	12	0	.	Histone	H3K4me3	N-terminus	binding.
chr16	28602934	28602943	Q96ES7	0	+	28602934	28602943	255,102,0	1	9	0	.	Histone	H3K4me3	binding.
chr16	28606735	28606744	P50226	0	-	28606735	28606744	255,102,0	1	9	0	.	Substrate	binding.
chr16	28619659	28619668	P50225	0	-	28619659	28619668	255,102,0	1	9	0	.	Substrate	binding.
chr16	28834871	28836971	Q8WWM7	0	+	28834871	28836971	255,102,0	1	2100	0	.	Interaction	with	MPL.	Pubmed:11784712
chr16	28877415	28883662	Q9NRF2	0	+	28877415	28883662	255,102,0	1	6247	0	.	Interaction	with	JAK2	(low-affinity	binding;	independent	of	JAK2	phosphorylation).
chr16	28877484	28877670	Q9NRF2	0	+	28877484	28877670	255,102,0	1	186	0	.	Required	for	self-association.
chr16	28877667	28878003	Q9NRF2	0	+	28877667	28878003	255,102,0	1	336	0	.	Interaction	with	RAC1.
chr16	28877712	28878144	Q9NRF2	0	+	28877712	28878144	255,102,0	1	432	0	.	Required	for	NGF	signaling.
chr16	28878084	28878114	Q9NRF2	0	+	28878084	28878114	255,102,0	1	30	0	.	Required	for	nuclear	localization.
chr16	28905487	28905841	O14983	0	+	28905487	28905841	255,102,0	1	354	0	.	Interaction	with	phospholamban	1.
chr16	28913544	28913607	O14983	0	+	28913544	28913607	255,102,0	1	63	0	.	Interaction	with	phospholamban	2.
chr16	28998030	28998126	O43561	0	+	28998030	28998126	255,102,0	1	96	0	.	Interaction	with	PLCG1.
chr16	29000864	29000876	O43561	0	+	29000864	29000876	255,102,0	1	12	0	.	Interaction	with	GRB2,	GRAP2	and	PIK3R1.	Pubmed:10811803
chr16	29001108	29001120	O43561	0	+	29001108	29001120	255,102,0	1	12	0	.	Interaction	with	GRB2,	GRAP2	and	PIK3R1.	Pubmed:10811803
chr16	29473214	29473223	P0DMM9	0	+	29473214	29473223	255,102,0	1	9	0	.	Substrate	binding.
chr16	29473214	29473223	P0DMN0	0	+	29473214	29473223	255,102,0	1	9	0	.	Substrate	binding.
chr16	29706379	29706388	Q15274	0	+	29706379	29706388	255,102,0	1	9	0	.	Substrate	binding.
chr16	29708579	29708588	Q15274	0	+	29708579	29708588	255,102,0	1	9	0	.	Substrate	binding.
chr16	29708642	29708651	Q15274	0	+	29708642	29708651	255,102,0	1	9	0	.	Substrate	binding.
chr16	29828191	29828326	Q9BTK6	0	+	29828191	29828326	255,102,0	1	135	0	.	Sufficient	for	interaction	with	NCOA1.	Pubmed:19039327
chr16	29828326	29831072	Q9BTK6	0	+	29828326	29831072	255,102,0	1	2746	0	.	Sufficient	for	interaction	with	ESR1.	Pubmed:19039327
chr16	29909240	29909264	Q6UXD5	0	-	29909240	29909264	255,102,0	1	24	0	.	O-glycosylated	at	one	site.
chr16	30017509	30018505	Q14183	0	-	30017509	30018505	255,102,0	1	996	0	.	Interaction	with	UNC13D.	Pubmed:18354201
chr16	30020873	30021543	Q14183	0	-	30020873	30021543	255,102,0	1	670	0	.	Interaction	with	UNC13D	and	DYNLT1.	Pubmed:9804756,	Pubmed:18354201
chr16	30212557	30212566	P0DMM9	0	+	30212557	30212566	255,102,0	1	9	0	.	Substrate	binding.
chr16	30212557	30212566	P0DMN0	0	+	30212557	30212566	255,102,0	1	9	0	.	Substrate	binding.
chr16	30440436	30440451	Q9H773	0	-	30440436	30440451	255,102,0	1	15	0	.	Substrate	binding.
chr16	30768024	30768187	P15735	0	+	30768024	30768187	255,102,0	1	163	0	.	Calmodulin-binding	(domain-N).
chr16	30768232	30768307	P15735	0	+	30768232	30768307	255,102,0	1	75	0	.	Calmodulin-binding	(domain-C).
chr16	30991349	30991457	O15047	0	+	30991349	30991457	255,102,0	1	108	0	.	Interaction	with	CFP1.
chr16	30991454	30992089	O15047	0	+	30991454	30992089	255,102,0	1	635	0	.	Interaction	with	ASH2L,	RBBP5	and	WDR5.	Pubmed:17998332
chr16	31049327	31051121	Q12846	0	+	31049327	31051121	255,102,0	1	1794	0	.	Interaction	with	CENPF.
chr16	31138512	31142577	Q9H7Z6	0	+	31138512	31142577	255,102,0	1	4065	0	.	Sufficient	for	interaction	with	KANSL1.
chr16	31141623	31141632	Q9H7Z6	0	+	31141623	31141632	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:21217699
chr16	31141644	31141665	Q9H7Z6	0	+	31141644	31141665	255,102,0	1	21	0	.	Acetyl-CoA	binding.	Pubmed:21217699
chr16	31483509	31485964	O43294	0	+	31483509	31485964	255,102,0	1	2455	0	.	Transcription	activation.
chr16	31483509	31487338	O43294	0	+	31483509	31487338	255,102,0	1	3829	0	.	Interaction	with	PTK2B/PYK2.
chr16	31485219	31485555	O43294	0	+	31485219	31485555	255,102,0	1	336	0	.	Interaction	with	PTK2/FAK1.
chr16	46694386	46706233	Q96QK1	0	-	46694386	46706233	255,102,0	1	11847	0	.	Interaction	with	SLC11A2.	Pubmed:24344282
chr16	46695761	46705643	Q96QK1	0	-	46695761	46705643	255,102,0	1	9882	0	.	Interaction	with	IGF2R	cytoplasmic	domain.	Pubmed:15078903
chr16	46712929	46712962	Q96QK1	0	-	46712929	46712962	255,102,0	1	33	0	.	Interaction	with	SNX3.	Pubmed:24344282
chr16	46716057	46717449	Q96QK1	0	-	46716057	46717449	255,102,0	1	1392	0	.	Interaction	with	SNX3.	Pubmed:24344282
chr16	47495279	47531320	Q93100	0	+	47495279	47531320	255,102,0	1	36041	0	.	Calmodulin-binding.
chr16	47697610	47698844	Q93100	0	+	47697610	47698844	255,102,0	1	1234	0	.	Calmodulin-binding.
chr16	47723078	47727376	Q93100	0	+	47723078	47727376	255,102,0	1	4298	0	.	Calmodulin-binding.
chr16	48389573	48390152	Q8IUQ4	0	-	48389573	48390152	255,102,0	1	579	0	.	SBD.
chr16	48395493	48396072	Q8IUQ4	0	-	48395493	48396072	255,102,0	1	579	0	.	SBD.
chr16	49313317	49315193	P23435	0	-	49313317	49315193	255,102,0	1	1876	0	.	Necessary	for	interaction	with	CBLN3,	and	homotrimerization.
chr16	50659401	50664204	Q969G9	0	+	50659401	50664204	255,102,0	1	4803	0	.	Interaction	with	DVL1,	DVL2	and	DVL3.
chr16	50744542	50744644	Q9HC29	0	+	50744542	50744644	255,102,0	1	102	0	.	Required	for	CARD9	binding.	Pubmed:24960071
chr16	50783924	50816330	Q9NQC7	0	+	50783924	50816330	255,102,0	1	32406	0	.	Interaction	with	TRIP.	Pubmed:14676304
chr16	50813616	50813844	Q9NQC7	0	+	50813616	50813844	255,102,0	1	228	0	.	Interaction	with	TRAF2.
chr16	50813844	50815300	Q9NQC7	0	+	50813844	50815300	255,102,0	1	1456	0	.	Interaction	with	IKBKG/NEMO.	Pubmed:15341735
chr16	53341805	53348815	Q3L8U1	0	+	53341805	53348815	255,102,0	1	7010	0	.	Binds	A/T-rich	DNA.
chr16	53348350	53348374	Q3L8U1	0	+	53348350	53348374	255,102,0	1	24	0	.	A.T	hook-like.
chr16	53493431	53499499	Q08999	0	+	53493431	53499499	255,102,0	1	6068	0	.	Domain	A.
chr16	53493431	53514669	Q08999	0	+	53493431	53514669	255,102,0	1	21238	0	.	Pocket;	binds	E1A.
chr16	53499499	53504530	Q08999	0	+	53499499	53504530	255,102,0	1	5031	0	.	Spacer.
chr16	53504530	53514669	Q08999	0	+	53504530	53514669	255,102,0	1	10139	0	.	Domain	B.
chr16	53844099	53913761	Q9C0B1	0	+	53844099	53913761	255,102,0	1	69662	0	.	Fe2OG	dioxygenase	domain.
chr16	53860288	53860324	Q9C0B1	0	+	53860288	53860324	255,102,0	1	36	0	.	Loop	L1;	predicted	to	block	binding	of	double-stranded	DNA	or	RNA.
chr16	53860342	53860354	Q9C0B1	0	+	53860342	53860354	255,102,0	1	12	0	.	Substrate	binding.
chr16	53907747	53907756	Q9C0B1	0	+	53907747	53907756	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.
chr16	55516994	55519520	P08253	0	+	55516994	55519520	255,102,0	1	2526	0	.	Collagenase-like	1.
chr16	55519520	55525720	P08253	0	+	55519520	55525720	255,102,0	1	6200	0	.	Collagen-binding.
chr16	55525720	55527128	P08253	0	+	55525720	55527128	255,102,0	1	1408	0	.	Collagenase-like	2.
chr16	55525771	55539351	P08253	0	+	55525771	55539351	255,102,0	1	13580	0	.	Required	for	inhibitor	TIMP2	binding.
chr16	56396832	56396889	Q9UKV5	0	-	56396832	56396889	255,102,0	1	57	0	.	VCP/p97-interacting	motif	(VIM).	Pubmed:21914798
chr16	56468732	56481777	O43809	0	-	56468732	56481777	255,102,0	1	13045	0	.	Necessary	for	interactions	with	PAPOLA	and	PABPN1.
chr16	56473598	56485111	O43809	0	-	56473598	56485111	255,102,0	1	11513	0	.	Necessary	for	RNA-binding.
chr16	56481705	56481714	O43809	0	-	56481705	56481714	255,102,0	1	9	0	.	Interaction	with	RNA.
chr16	56623502	56623840	P25713	0	+	56623502	56623840	255,102,0	1	338	0	.	Beta.
chr16	56623840	56624858	P25713	0	+	56623840	56624858	255,102,0	1	1018	0	.	Alpha.
chr16	56642567	56642962	P02795	0	+	56642567	56642962	255,102,0	1	395	0	.	Beta.
chr16	56642962	56643263	P02795	0	+	56642962	56643263	255,102,0	1	301	0	.	Alpha.
chr16	56659763	56660436	P04732	0	+	56659763	56660436	255,102,0	1	673	0	.	Beta.
chr16	56660436	56660880	P04732	0	+	56660436	56660880	255,102,0	1	444	0	.	Alpha.
chr16	56666643	56667310	Q8N339	0	+	56666643	56667310	255,102,0	1	667	0	.	Beta.
chr16	56667310	56667751	Q8N339	0	+	56667310	56667751	255,102,0	1	441	0	.	Alpha.
chr16	56672650	56673234	P04731	0	+	56672650	56673234	255,102,0	1	584	0	.	Beta.
chr16	56673234	56673859	P04731	0	+	56673234	56673859	255,102,0	1	625	0	.	Alpha.
chr16	56685865	56686541	P07438	0	+	56685865	56686541	255,102,0	1	676	0	.	Beta.
chr16	56686541	56686974	P07438	0	+	56686541	56686974	255,102,0	1	433	0	.	Alpha.
chr16	56691970	56692645	P04733	0	+	56691970	56692645	255,102,0	1	675	0	.	Beta.
chr16	56692645	56693073	P04733	0	+	56692645	56693073	255,102,0	1	428	0	.	Alpha.
chr16	56700793	56701230	P13640	0	-	56700793	56701230	255,102,0	1	437	0	.	Alpha.
chr16	56701233	56701905	P13640	0	-	56701233	56701905	255,102,0	1	672	0	.	Beta.
chr16	56703796	56704476	P80294	0	+	56703796	56704476	255,102,0	1	680	0	.	Beta.
chr16	56704476	56704898	P80294	0	+	56704476	56704898	255,102,0	1	422	0	.	Alpha.
chr16	56716452	56717135	P80297	0	+	56716452	56717135	255,102,0	1	683	0	.	Beta.
chr16	56717135	56717958	P80297	0	+	56717135	56717958	255,102,0	1	823	0	.	Alpha.
chr16	56970640	56973852	Q15011	0	+	56970640	56973852	255,102,0	1	3212	0	.	Interaction	with	UBQLN1.	Pubmed:18307982
chr16	57155061	57157370	Q96FN4	0	+	57155061	57157370	255,102,0	1	2309	0	.	Linker	region.
chr16	57413547	57416050	P78423	0	+	57413547	57416050	255,102,0	1	2503	0	.	Chemokine	and	involved	in	interaction	with	ITGAV:ITGB3	and	ITGA4:ITGB1.	Pubmed:23125415
chr16	57416050	57416773	P78423	0	+	57416050	57416773	255,102,0	1	723	0	.	Mucin-like	stalk.
chr16	57463084	57465139	Q6FI81	0	-	57463084	57465139	255,102,0	1	2055	0	.	Intrinsically	disordered.
chr16	57465139	57467995	Q6FI81	0	-	57465139	57467995	255,102,0	1	2856	0	.	Linker.
chr16	57467995	57474840	Q6FI81	0	-	57467995	57474840	255,102,0	1	6845	0	.	N-terminal	domain.
chr16	57493485	57493497	O75208	0	+	57493485	57493497	255,102,0	1	12	0	.	Lipid	binding.	Pubmed:25339443
chr16	57685122	57685146	Q9Y653	0	+	57685122	57685146	255,102,0	1	24	0	.	Heparin-binding.	Pubmed:27068534
chr16	57687194	57687227	Q9Y653	0	+	57687194	57687227	255,102,0	1	33	0	.	Heparin-binding.	Pubmed:27068534
chr16	57771155	57786837	Q9BVA0	0	+	57771155	57786837	255,102,0	1	15682	0	.	Interaction	with	dynein.
chr16	57771155	57787033	Q9BVA0	0	+	57771155	57787033	255,102,0	1	15878	0	.	Interaction	with	centrosomes.
chr16	57786837	57789036	Q9BVA0	0	+	57786837	57789036	255,102,0	1	2199	0	.	Interaction	with	PAFAH1B1.
chr16	57789030	57790855	Q9BVA0	0	+	57789030	57790855	255,102,0	1	1825	0	.	Interaction	with	KATNA1	and	NDEL1.
chr16	58426505	58426553	Q9BRX5	0	+	58426505	58426553	255,102,0	1	48	0	.	Not	essential	for	folding	and	stability	of	GINS	complex,	but	may	regulate	accessibility	to	the	central	complex	pore.
chr16	58573848	58585110	A5YKK6	0	-	58573848	58585110	255,102,0	1	11262	0	.	Interaction	with	CNOT6,	CNOT6L,	CNOT7	and	CNOT8.	Pubmed:22977175
chr16	58585648	58590832	A5YKK6	0	-	58585648	58590832	255,102,0	1	5184	0	.	Interaction	with	ZFP36.
chr16	66792685	66803918	Q8NA31	0	-	66792685	66803918	255,102,0	1	11233	0	.	Interaction	with	TERF1.
chr16	66847468	66847510	Q13564	0	-	66847468	66847510	255,102,0	1	42	0	.	Interaction	with	UBA3.
chr16	66886698	66886704	P43166	0	+	66886698	66886704	255,102,0	1	6	0	.	Substrate	binding.
chr16	66943203	66944334	O75309	0	-	66943203	66944334	255,102,0	1	1131	0	.	Ectodomain	G.
chr16	66956014	66956074	P55042	0	-	66956014	66956074	255,102,0	1	60	0	.	Calmodulin-binding.
chr16	67188623	67188827	Q15628	0	-	67188623	67188827	255,102,0	1	204	0	.	Interaction	with	KRT14	and	KRT18.	Pubmed:11684708
chr16	67199872	67200508	Q9ULV5	0	+	67199872	67200508	255,102,0	1	636	0	.	Hydrophobic	repeat	HR-A/B.
chr16	67201380	67201734	Q9ULV5	0	+	67201380	67201734	255,102,0	1	354	0	.	Interactions	with	DUSP26,	MAPK1	and	MAPK2.
chr16	67202740	67202818	Q9ULV5	0	+	67202740	67202818	255,102,0	1	78	0	.	Hydrophobic	repeat	HR-C.
chr16	67220971	67223579	Q86VI1	0	-	67220971	67223579	255,102,0	1	2608	0	.	Mediates	interaction	with	EXOC2,	EXOC4	and	EXOC5.
chr16	67226256	67226723	Q16254	0	+	67226256	67226723	255,102,0	1	467	0	.	Leucine-zipper.
chr16	67226921	67228618	Q16254	0	+	67226921	67228618	255,102,0	1	1697	0	.	Dimerization.
chr16	67229884	67232023	Q16254	0	+	67229884	67232023	255,102,0	1	2139	0	.	Transactivation.
chr16	67231951	67232005	Q16254	0	+	67231951	67232005	255,102,0	1	54	0	.	Interaction	with	RBL1	and	RBL2.
chr16	67265416	67267772	Q9Y613	0	-	67265416	67267772	255,102,0	1	2356	0	.	Interaction	with	ROCK1.	Pubmed:18694941
chr16	67470690	67470705	P80365	0	+	67470690	67470705	255,102,0	1	15	0	.	Essential	for	protein	stability.
chr16	67516598	67516607	O00253	0	-	67516598	67516607	255,102,0	1	9	0	.	Interaction	with	melanocortin	receptors.
chr16	67683184	67683790	Q6F5E8	0	+	67683184	67683790	255,102,0	1	606	0	.	Tropomodulin-like.
chr16	67688271	67688355	Q6F5E8	0	+	67688271	67688355	255,102,0	1	84	0	.	Necessary	for	localization	at	the	cell	membrane.	Pubmed:26578515
chr16	67692533	67693153	Q96AP0	0	-	67692533	67693153	255,102,0	1	620	0	.	Interaction	with	POT1.
chr16	67694941	67695857	Q9NPB6	0	+	67694941	67695857	255,102,0	1	916	0	.	Interaction	with	PRKCI	and	PRKCZ.
chr16	67695884	67696268	Q9NPB6	0	+	67695884	67696268	255,102,0	1	384	0	.	Interaction	with	PARD3	and	CDC42.
chr16	67863342	67866143	Q96BT3	0	-	67863342	67866143	255,102,0	1	2801	0	.	Flexible	stalk	domain.
chr16	67915267	67915412	Q6P2E9	0	+	67915267	67915412	255,102,0	1	145	0	.	Sufficient	for	nuclear	localization.
chr16	68156110	68156128	Q12968	0	+	68156110	68156128	255,102,0	1	18	0	.	Calcineurin-binding.
chr16	68156404	68156710	Q12968	0	+	68156404	68156710	255,102,0	1	306	0	.	3	X	SP	repeats.
chr16	68862183	68863568	P12830	0	+	68862183	68863568	255,102,0	1	1385	0	.	Required	for	binding	CTNND1	and	PSEN1.
chr16	68863691	68867399	P12830	0	+	68863691	68867399	255,102,0	1	3708	0	.	Required	for	binding	alpha,	beta	and	gamma	catenins.
chr16	69334755	69334824	Q13425	0	+	69334755	69334824	255,102,0	1	69	0	.	Calmodulin-binding.
chr16	69345414	69350246	Q9UN37	0	+	69345414	69350246	255,102,0	1	4832	0	.	Interaction	with	CHMP1B.
chr16	69363948	69363981	Q9HBH1	0	-	69363948	69363981	255,102,0	1	33	0	.	Hydrophobic	dimerization	interface.
chr16	69373732	69374229	Q9Y221	0	+	69373732	69374229	255,102,0	1	497	0	.	N-terminal	domain.
chr16	69374229	69375552	Q9Y221	0	+	69374229	69375552	255,102,0	1	1323	0	.	C-terminal	domain.
chr16	69402364	69419625	Q15554	0	-	69402364	69419625	255,102,0	1	17261	0	.	TRFH	dimerization.
chr16	69748899	69748908	P15559	0	-	69748899	69748908	255,102,0	1	9	0	.	Substrate	binding.
chr16	70333203	70363848	Q9UMR2	0	+	70333203	70363848	255,102,0	1	30645	0	.	N-terminal	lobe.
chr16	70349873	70349915	Q9UMR2	0	+	70349873	70349915	255,102,0	1	42	0	.	N-terminal	helix.
chr16	70363848	70367482	Q9UMR2	0	+	70363848	70367482	255,102,0	1	3634	0	.	C-terminal	lobe.
chr16	70380897	70400641	Q9NUU7	0	+	70380897	70400641	255,102,0	1	19744	0	.	N-terminal	lobe.
chr16	70390016	70390058	Q9NUU7	0	+	70390016	70390058	255,102,0	1	42	0	.	N-terminal	helix.
chr16	70400641	70405886	Q9NUU7	0	+	70400641	70405886	255,102,0	1	5245	0	.	C-terminal	lobe.
chr16	70721848	70721863	Q08AM6	0	-	70721848	70721863	255,102,0	1	15	0	.	Mediates	interaction	with	the	PDZ	domain	of	NOS1.
chr16	71883700	71884234	P0C7T5	0	+	71883700	71884234	255,102,0	1	534	0	.	Interaction	with	NCOR2	and	ATXN1.	Pubmed:16121196
chr16	71883700	71884234	P0C7T5	0	+	71883700	71884234	255,102,0	1	534	0	.	Self-association.
chr16	71964059	71967412	Q7Z443	0	-	71964059	71967412	255,102,0	1	3353	0	.	Channel	pore-region.
chr16	72048566	72050932	Q02127	0	+	72048566	72050932	255,102,0	1	2366	0	.	Substrate	binding.
chr16	72055135	72055153	Q02127	0	+	72055135	72055153	255,102,0	1	18	0	.	Substrate	binding.
chr16	72057090	72057096	Q02127	0	+	72057090	72057096	255,102,0	1	6	0	.	Substrate	binding.
chr16	72094519	72094537	P00738	0	+	72094519	72094537	255,102,0	1	18	0	.	Interaction	with	CD163.
chr16	75033572	75033599	Q8ND25	0	+	75033572	75033599	255,102,0	1	27	0	.	Required	for	endosomal	and	lysosomal	localization	and	myristoylation.
chr16	75263633	75263786	P56945	0	-	75263633	75263786	255,102,0	1	153	0	.	Divergent	helix-loop-helix	motif.
chr16	75269548	75276658	P56945	0	-	75269548	75276658	255,102,0	1	7110	0	.	Substrate	for	kinases.
chr16	75428986	75429106	Q9UEE9	0	-	75428986	75429106	255,102,0	1	120	0	.	Hydrophilic.
chr16	75600384	75600781	P60520	0	+	75600384	75600781	255,102,0	1	397	0	.	Interaction	with	beta-tubulin.
chr16	75601949	75602048	P60520	0	+	75601949	75602048	255,102,0	1	99	0	.	Interaction	with	GABRG2.
chr16	77334205	77355015	Q8TE60	0	-	77334205	77355015	255,102,0	1	20810	0	.	Spacer.
chr16	78149014	79245690	Q9NZC7	0	+	78149014	79245690	255,102,0	1	1096676	0	.	Interaction	with	MAPT.
chr16	78458785	78466412	Q9NZC7	0	+	78458785	78466412	255,102,0	1	7627	0	.	Mediates	targeting	to	the	mitochondria.
chr16	79632680	79633424	O75444	0	-	79632680	79633424	255,102,0	1	744	0	.	Represses	ARE-mediated	transcription.
chr16	79632788	79632854	O75444	0	-	79632788	79632854	255,102,0	1	66	0	.	Leucine-zipper.
chr16	79632860	79632938	O75444	0	-	79632860	79632938	255,102,0	1	78	0	.	Basic	motif.
chr16	81076769	81077429	O43313	0	+	81076769	81077429	255,102,0	1	660	0	.	Required	for	formation	of	RAD51	foci.
chr16	83932866	83940633	O95822	0	+	83932866	83940633	255,102,0	1	7767	0	.	Alpha-helical	domain.
chr16	83940633	83949091	O95822	0	+	83940633	83949091	255,102,0	1	8458	0	.	Catalytic	domain.
chr16	83945918	83945939	O95822	0	+	83945918	83945939	255,102,0	1	21	0	.	Malonyl-CoA	binding.
chr16	84164010	84164923	Q3SXM5	0	-	84164010	84164923	255,102,0	1	913	0	.	Required	for	mitochondria	translocation.
chr16	84623803	84623833	Q14019	0	-	84623803	84623833	255,102,0	1	30	0	.	Flexible	and	important	for	F-actin	binding.
chr16	84733699	84778387	Q14694	0	+	84733699	84778387	255,102,0	1	44688	0	.	Interaction	with	p53/TP53.	Pubmed:20096447
chr16	87925470	87925476	P35218	0	-	87925470	87925476	255,102,0	1	6	0	.	Substrate	binding.
chr16	88038015	88061243	Q8N9N5	0	+	88038015	88061243	255,102,0	1	23228	0	.	Interaction	with	CUX1	and	HDAC1.
chr16	88061174	88066722	Q8N9N5	0	+	88061174	88066722	255,102,0	1	5548	0	.	Necessary	and	sufficient	for	TP53	activation.
chr16	88061240	88068940	Q8N9N5	0	+	88061240	88068940	255,102,0	1	7700	0	.	DNA-binding.
chr16	88599062	88599098	Q8IX07	0	+	88599062	88599098	255,102,0	1	36	0	.	Interaction	with	TACC3.
chr16	88600745	88600766	Q8IX07	0	+	88600745	88600766	255,102,0	1	21	0	.	Interaction	with	CTBP2.
chr16	88752754	88752814	Q3KNW1	0	-	88752754	88752814	255,102,0	1	60	0	.	SNAG	domain.
chr16	88871265	88871929	Q9H211	0	+	88871265	88871929	255,102,0	1	664	0	.	Interaction	with	GMNN.
chr16	88873763	88874683	Q9H211	0	+	88873763	88874683	255,102,0	1	920	0	.	Interaction	with	LRWD1.	Pubmed:22645314
chr16	88893111	88923207	P34059	0	-	88893111	88923207	255,102,0	1	30096	0	.	Catalytic	domain.
chr16	88945740	88947146	O75081	0	-	88945740	88947146	255,102,0	1	1406	0	.	Nervy	homology	region	3	(NHR3);	essential	for	down-regulation	of	PFKFB3,	PFKFB4	and	PDK1	expression.	Pubmed:23840896
chr16	88945821	88947146	O75081	0	-	88945821	88947146	255,102,0	1	1325	0	.	Mediates	interaction	with	PRKAR2A.	Pubmed:11823486
chr16	88947795	89043215	O75081	0	-	88947795	89043215	255,102,0	1	95420	0	.	Mediates	localization	to	the	nucleus.
chr16	88947810	89043215	O75081	0	-	88947810	89043215	255,102,0	1	95405	0	.	Mediates	interaction	with	PDE7A	(in	isoform	2).
chr16	88947864	88949107	O75081	0	-	88947864	88949107	255,102,0	1	1243	0	.	Nervy	homology	region	2	(NHR2);	essential	for	down-regulation	of	PFKFB3,	PFKFB4	and	PDK1	expression.	Pubmed:23840896
chr16	88952457	88958747	O75081	0	-	88952457	88958747	255,102,0	1	6290	0	.	Interaction	with	HIF1A.	Pubmed:25974097
chr16	88952535	88958840	O75081	0	-	88952535	88958840	255,102,0	1	6305	0	.	Interaction	with	ZBTB33.	Pubmed:23251453
chr16	88958891	89043215	O75081	0	-	88958891	89043215	255,102,0	1	84324	0	.	Required	for	nucleolar	targeting	(in	isoform	1).
chr16	89334888	89345845	Q6UB99	0	-	89334888	89345845	255,102,0	1	10957	0	.	Important	for	protein	degradation.	Pubmed:25413698
chr16	89929907	89929970	Q8WWL2	0	+	89929907	89929970	255,102,0	1	63	0	.	Spir-box.
chr16	90089129	90099179	O95995	0	+	90089129	90099179	255,102,0	1	10050	0	.	Regulates	microtubule-binding.
chr16	90099179	90103657	O95995	0	+	90099179	90103657	255,102,0	1	4478	0	.	Microtubule-binding.
chr17	649077	649143	P57678	0	-	649077	649143	255,102,0	1	66	0	.	Leucine-zipper.
chr17	1399119	1401232	Q9BT40	0	-	1399119	1401232	255,102,0	1	2113	0	.	Required	for	ruffle	localization.
chr17	1401238	1417272	Q9BT40	0	-	1401238	1417272	255,102,0	1	16034	0	.	Catalytic.
chr17	1550228	1551651	Q96NA2	0	-	1550228	1551651	255,102,0	1	1423	0	.	Necessary	for	interaction	with	RAB7A	and	RAB34,	lysosomal	distribution	and	morphology.
chr17	1554098	1554203	Q6P2Q9	0	-	1554098	1554203	255,102,0	1	105	0	.	Required	for	interaction	with	EFTUD2	and	SNRNP200.	Pubmed:17317632
chr17	1557195	1562784	Q6P2Q9	0	-	1557195	1562784	255,102,0	1	5589	0	.	Involved	in	interaction	with	pre-mRNA	5'	splice	site.
chr17	1557237	1561897	Q6P2Q9	0	-	1557237	1561897	255,102,0	1	4660	0	.	RNase	H	homology	domain.
chr17	1561939	1563770	Q6P2Q9	0	-	1561939	1563770	255,102,0	1	1831	0	.	Restriction	endonuclease	homology	domain.
chr17	1563779	1565312	Q6P2Q9	0	-	1563779	1565312	255,102,0	1	1533	0	.	Linker.
chr17	1564051	1564093	Q6P2Q9	0	-	1564051	1564093	255,102,0	1	42	0	.	Important	for	branch	point	selection.
chr17	1565312	1579619	Q6P2Q9	0	-	1565312	1579619	255,102,0	1	14307	0	.	Reverse	transcriptase	homology	domain.
chr17	1680593	1680632	P36955	0	+	1680593	1680632	255,102,0	1	39	0	.	O-glycosylated	at	one	site.
chr17	1690815	1690821	Q8IYR2	0	-	1690815	1690821	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr17	1707946	1707955	Q8IYR2	0	-	1707946	1707955	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr17	1960386	1960872	Q14526	0	+	1960386	1960872	255,102,0	1	486	0	.	Mediates	HDAC-dependent	transcriptional	repression.
chr17	1960647	1960668	Q14526	0	+	1960647	1960668	255,102,0	1	21	0	.	Interaction	with	CTBP1.
chr17	2202537	2203707	Q86US8	0	-	2202537	2203707	255,102,0	1	1170	0	.	Interaction	with	telomeric	DNA.
chr17	2203587	2203650	Q86US8	0	-	2203587	2203650	255,102,0	1	63	0	.	EJC-binding	motif	2;	mediates	interaction	with	the	EJC.
chr17	2203869	2203932	Q86US8	0	-	2203869	2203932	255,102,0	1	63	0	.	EJC-binding	motif	1;	mediates	interaction	with	the	EJC.
chr17	2226546	2226552	Q9GZT4	0	+	2226546	2226552	255,102,0	1	6	0	.	Substrate	binding.
chr17	2291253	2291340	Q99583	0	-	2291253	2291340	255,102,0	1	87	0	.	Leucine-zipper.
chr17	2541582	2568747	P43034	0	+	2541582	2568747	255,102,0	1	27165	0	.	Required	for	self-association	and	interaction	with	PAFAH1B2	and	PAFAH1B3.
chr17	2541582	2570291	P43034	0	+	2541582	2570291	255,102,0	1	28709	0	.	Interaction	with	NDE1.
chr17	2541582	2570399	P43034	0	+	2541582	2570399	255,102,0	1	28817	0	.	Interaction	with	NDEL1.
chr17	2570339	2585093	P43034	0	+	2570339	2585093	255,102,0	1	14754	0	.	Interaction	with	dynein	and	dynactin.
chr17	2583553	2585090	P43034	0	+	2583553	2585090	255,102,0	1	1537	0	.	Interaction	with	DCX.	Pubmed:11001923
chr17	2585024	2585093	P43034	0	+	2585024	2585093	255,102,0	1	69	0	.	Interaction	with	NDEL1.
chr17	3379660	3379666	P45381	0	+	3379660	3379666	255,102,0	1	6	0	.	Substrate	binding.
chr17	3379660	3379666	Q6FH48	0	+	3379660	3379666	255,102,0	1	6	0	.	Substrate	binding.
chr17	3386849	3386864	P45381	0	+	3386849	3386864	255,102,0	1	15	0	.	Substrate	binding.
chr17	3386849	3386864	Q6FH48	0	+	3386849	3386864	255,102,0	1	15	0	.	Substrate	binding.
chr17	3470222	3474863	Q8NER1	0	-	3470222	3474863	255,102,0	1	4641	0	.	Interaction	with	calmodulin.
chr17	3470249	3474833	Q8NER1	0	-	3470249	3474833	255,102,0	1	4584	0	.	Required	for	PIP2-mediated	channel	inhibition.
chr17	3475507	3476977	Q8NER1	0	-	3475507	3476977	255,102,0	1	1470	0	.	AD.
chr17	3494583	3494589	Q8NER1	0	-	3494583	3494589	255,102,0	1	6	0	.	Important	for	channel	activation	by	agonists	and	heat.
chr17	3664307	3664472	P38570	0	-	3664307	3664472	255,102,0	1	165	0	.	X-domain	(extra	domain).
chr17	3729429	3732642	Q53F19	0	-	3729429	3732642	255,102,0	1	3213	0	.	RNA	recognition	motif	(RRM)	domain.	Pubmed:26382858
chr17	3769257	3772810	Q8N5S9	0	-	3769257	3772810	255,102,0	1	3553	0	.	Calmodulin-binding.
chr17	3772801	3772819	Q8N5S9	0	-	3772801	3772819	255,102,0	1	18	0	.	Autoinhibitory	domain.
chr17	3786416	3786738	Q8N5S9	0	-	3786416	3786738	255,102,0	1	322	0	.	RP	domain.
chr17	3801795	3801819	P51575	0	-	3801795	3801819	255,102,0	1	24	0	.	Pore-forming	motif.
chr17	3839660	3839723	Q93084	0	-	3839660	3839723	255,102,0	1	63	0	.	Interaction	with	phospholamban	2.
chr17	3848084	3848430	Q93084	0	-	3848084	3848430	255,102,0	1	346	0	.	Interaction	with	phospholamban	1.
chr17	4083135	4086697	Q9P2R3	0	-	4083135	4086697	255,102,0	1	3562	0	.	Interaction	with	RHOD	and	RAB5A.	Pubmed:24102721
chr17	4442712	4443246	Q9BQG0	0	-	4442712	4443246	255,102,0	1	534	0	.	Required	for	nuclear	and	nucleolar	localization.
chr17	4451330	4458619	Q9BQG0	0	-	4451330	4458619	255,102,0	1	7289	0	.	Interaction	with	MYB.
chr17	4621917	4624331	P32121	0	+	4621917	4624331	255,102,0	1	2414	0	.	Interaction	with	TRAF6.	Pubmed:16378096
chr17	4623885	4624331	P32121	0	+	4623885	4624331	255,102,0	1	446	0	.	Interaction	with	AP2B1.
chr17	4719094	4722779	O14939	0	+	4719094	4722779	255,102,0	1	3685	0	.	Catalytic.
chr17	4797313	4800579	Q8N4C8	0	+	4797313	4800579	255,102,0	1	3266	0	.	Mediates	interaction	with	RAP2A.	Pubmed:18930710
chr17	4859907	4859919	P13929	0	+	4859907	4859919	255,102,0	1	12	0	.	Substrate	binding.
chr17	5336672	5337063	Q07021	0	-	5336672	5337063	255,102,0	1	391	0	.	Interaction	with	MAVS.	Pubmed:19164550
chr17	5341546	5342168	Q07021	0	-	5341546	5342168	255,102,0	1	622	0	.	C1q	binding.
chr17	5418832	5434023	Q9C000	0	-	5418832	5434023	255,102,0	1	15191	0	.	FIIND.
chr17	6483069	6493232	Q2KHM9	0	-	6483069	6493232	255,102,0	1	10163	0	.	Necessary	and	sufficient	for	FOPNL-binding.	Pubmed:26643951
chr17	7123498	7127476	P49748	0	+	7123498	7127476	255,102,0	1	3978	0	.	Catalytic.
chr17	7126118	7126130	P49748	0	+	7126118	7126130	255,102,0	1	12	0	.	Substrate	binding.
chr17	7127337	7127343	P49748	0	+	7127337	7127343	255,102,0	1	6	0	.	Substrate	binding.
chr17	7127476	7127655	P49748	0	+	7127476	7127655	255,102,0	1	179	0	.	Membrane-anchoring.
chr17	7131332	7132766	O14641	0	-	7131332	7132766	255,102,0	1	1434	0	.	Required	for	interaction	with	FOXK2.	Pubmed:25805136
chr17	7144175	7144983	O95166	0	-	7144175	7144983	255,102,0	1	808	0	.	Interaction	with	GPHN.
chr17	7144744	7144983	O95166	0	-	7144744	7144983	255,102,0	1	239	0	.	Interaction	with	GABRG2.
chr17	7145583	7145649	O95166	0	-	7145583	7145649	255,102,0	1	66	0	.	Interaction	with	beta-tubulin.
chr17	7163695	7163701	O95471	0	-	7163695	7163701	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2	and	TJP3.
chr17	7185271	7186569	P14672	0	+	7185271	7186569	255,102,0	1	1298	0	.	SRFBP1-binding.
chr17	7187967	7187988	P14672	0	+	7187967	7187988	255,102,0	1	21	0	.	Monosaccharide	binding.
chr17	7192109	7193665	Q9Y2T7	0	-	7192109	7193665	255,102,0	1	1556	0	.	Required	for	mRNA-binding.
chr17	7193806	7197561	Q9Y2T7	0	-	7193806	7197561	255,102,0	1	3755	0	.	Required	for	cytoplasmic	retention.
chr17	7213011	7214441	P63241	0	+	7213011	7214441	255,102,0	1	1430	0	.	DOHH-binding.
chr17	7240053	7250364	Q15027	0	+	7240053	7250364	255,102,0	1	10311	0	.	Required	for	formation	of	endosomal	tubules	when	overexpressed	with	PIP5K1C.
chr17	7250430	7254711	Q15027	0	+	7250430	7254711	255,102,0	1	4281	0	.	Required	for	interaction	with	GULP1.
chr17	7251688	7252333	Q15027	0	+	7251688	7252333	255,102,0	1	645	0	.	Prevents	interaction	with	ITGB1	when	S-554	is	not	phosphorylated.
chr17	7296991	7297429	Q9NRY6	0	-	7296991	7297429	255,102,0	1	438	0	.	Proline-rich	domain	(PRD).
chr17	7369076	7369565	Q9P1Z0	0	-	7369076	7369565	255,102,0	1	489	0	.	Interaction	with	CBFA2T3.	Pubmed:23251453
chr17	7468844	7474705	Q9H4L4	0	+	7468844	7474705	255,102,0	1	5860	0	.	Protease.
chr17	7483144	7483498	P34810	0	+	7483144	7483498	255,102,0	1	354	0	.	Mucin-like.
chr17	7483285	7483465	P34810	0	+	7483285	7483465	255,102,0	1	180	0	.	2	X	30	AA	tandem	repeats.
chr17	7529872	7529881	Q96F10	0	-	7529872	7529881	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr17	7530094	7530112	Q96F10	0	-	7530094	7530112	255,102,0	1	18	0	.	Acetyl-CoA	binding.
chr17	7530276	7530285	Q96F10	0	-	7530276	7530285	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr17	7530714	7530720	Q96F10	0	-	7530714	7530720	255,102,0	1	6	0	.	Substrate	binding.
chr17	7557969	7559210	P14415	0	+	7557969	7559210	255,102,0	1	1241	0	.	immunoglobulin-like.
chr17	7572929	7577040	P04637	0	-	7572929	7577040	255,102,0	1	4111	0	.	Interaction	with	CARM1.	Pubmed:15186775
chr17	7572947	7573007	P04637	0	-	7572947	7573007	255,102,0	1	60	0	.	Basic	(repression	of	DNA-binding).
chr17	7572998	7579389	P04637	0	-	7572998	7579389	255,102,0	1	6391	0	.	Interaction	with	HIPK1.
chr17	7573937	7573952	P04637	0	-	7573937	7573952	255,102,0	1	15	0	.	Interaction	with	USP7.
chr17	7573946	7576891	P04637	0	-	7573946	7576891	255,102,0	1	2945	0	.	Interaction	with	HIPK2.
chr17	7573958	7576873	P04637	0	-	7573958	7576873	255,102,0	1	2915	0	.	Oligomerization.
chr17	7576885	7579912	P04637	0	-	7576885	7579912	255,102,0	1	3027	0	.	Interaction	with	CCAR2.	Pubmed:25732823
chr17	7577037	7579389	P04637	0	-	7577037	7579389	255,102,0	1	2352	0	.	Required	for	interaction	with	ZNF385A.	Pubmed:17719541
chr17	7577055	7577515	P04637	0	-	7577055	7577515	255,102,0	1	460	0	.	Interaction	with	E4F1.	Pubmed:10644996
chr17	7577061	7579341	P04637	0	-	7577061	7579341	255,102,0	1	2280	0	.	Interaction	with	AXIN1.
chr17	7577097	7577121	P04637	0	-	7577097	7577121	255,102,0	1	24	0	.	Interaction	with	DNA.
chr17	7577536	7577560	P04637	0	-	7577536	7577560	255,102,0	1	24	0	.	Interaction	with	the	53BP2	SH3	domain.
chr17	7577572	7579350	P04637	0	-	7577572	7579350	255,102,0	1	1778	0	.	Required	for	interaction	with	FBXO42.	Pubmed:19509332
chr17	7579356	7579491	P04637	0	-	7579356	7579491	255,102,0	1	135	0	.	Interaction	with	WWOX.
chr17	7579437	7579912	P04637	0	-	7579437	7579912	255,102,0	1	475	0	.	Interaction	with	HRMT1L2.	Pubmed:15186775
chr17	7579554	7579912	P04637	0	-	7579554	7579912	255,102,0	1	358	0	.	Transcription	activation	(acidic).
chr17	7623052	7681439	Q9P225	0	+	7623052	7681439	255,102,0	1	58387	0	.	Stem.
chr17	7681439	7684055	Q9P225	0	+	7681439	7684055	255,102,0	1	2616	0	.	AAA	1.
chr17	7689447	7691481	Q9P225	0	+	7689447	7691481	255,102,0	1	2034	0	.	AAA	2.
chr17	7695647	7700505	Q9P225	0	+	7695647	7700505	255,102,0	1	4858	0	.	AAA	3.
chr17	7701080	7705285	Q9P225	0	+	7701080	7705285	255,102,0	1	4205	0	.	AAA	4.
chr17	7705327	7719975	Q9P225	0	+	7705327	7719975	255,102,0	1	14648	0	.	Stalk.
chr17	7720929	7722330	Q9P225	0	+	7720929	7722330	255,102,0	1	1401	0	.	AAA	5.
chr17	7727231	7733999	Q9P225	0	+	7727231	7733999	255,102,0	1	6768	0	.	AAA	6.
chr17	7810472	7814798	Q12873	0	+	7810472	7814798	255,102,0	1	4326	0	.	Required	for	interaction	with	PCNT.	Pubmed:17626165
chr17	7842995	7852825	Q8N137	0	+	7842995	7852825	255,102,0	1	9830	0	.	Required	for	centrosome	localization.
chr17	8044388	8045591	O15534	0	-	8044388	8045591	255,102,0	1	1203	0	.	CRY	binding	domain.
chr17	8048084	8050033	O15534	0	-	8048084	8050033	255,102,0	1	1949	0	.	Required	for	phosphorylation	by	CSNK1E.
chr17	8053364	8054024	O15534	0	-	8053364	8054024	255,102,0	1	660	0	.	Interaction	with	BTRC.	Pubmed:15917222
chr17	8349107	8351976	Q9GZM8	0	+	8349107	8351976	255,102,0	1	2869	0	.	Self-association.
chr17	8349131	8354138	Q9GZM8	0	+	8349131	8354138	255,102,0	1	5007	0	.	Interaction	with	KATNB1.
chr17	8350170	8351877	Q9GZM8	0	+	8350170	8351877	255,102,0	1	1707	0	.	Required	for	interaction	with	PAFAH1B1.
chr17	8352000	8370338	Q9GZM8	0	+	8352000	8370338	255,102,0	1	18338	0	.	Interaction	with	CENPF.	Pubmed:17600710
chr17	8354135	8358181	Q9GZM8	0	+	8354135	8358181	255,102,0	1	4046	0	.	Interaction	with	YWHAE.
chr17	8354141	8370338	Q9GZM8	0	+	8354141	8370338	255,102,0	1	16197	0	.	Interaction	with	NEFL.
chr17	8354153	8358181	Q9GZM8	0	+	8354153	8358181	255,102,0	1	4028	0	.	Interaction	with	KATNA1.
chr17	8358133	8363374	Q9GZM8	0	+	8358133	8363374	255,102,0	1	5241	0	.	Interaction	with	DISC1.
chr17	8358178	8363407	Q9GZM8	0	+	8358178	8363407	255,102,0	1	5229	0	.	Required	for	localization	to	the	centrosome	and	interaction	with	dynein,	dynactin,	tubulin	gamma,	PCM1	and	PCNT.	Pubmed:16291865
chr17	8785144	8789871	Q8WYR1	0	-	8785144	8789871	255,102,0	1	4727	0	.	Interaction	with	beta-gamma	G	protein	dimers.
chr17	8808202	8814739	Q8WYR1	0	-	8808202	8814739	255,102,0	1	6537	0	.	Heterodimerization.
chr17	10233813	10235433	Q9UKX3	0	-	10233813	10235433	255,102,0	1	1620	0	.	Actin-binding.
chr17	10243479	10243548	Q9UKX3	0	-	10243479	10243548	255,102,0	1	69	0	.	Actin-binding.
chr17	10309467	10309608	P13535	0	-	10309467	10309608	255,102,0	1	141	0	.	Actin-binding.
chr17	10310221	10310290	P13535	0	-	10310221	10310290	255,102,0	1	69	0	.	Actin-binding.
chr17	10358367	10358506	Q9Y623	0	-	10358367	10358506	255,102,0	1	139	0	.	Actin-binding.
chr17	10359143	10359212	Q9Y623	0	-	10359143	10359212	255,102,0	1	69	0	.	Actin-binding.
chr17	10408589	10408722	P12882	0	-	10408589	10408722	255,102,0	1	133	0	.	Actin-binding.
chr17	10409341	10409410	P12882	0	-	10409341	10409410	255,102,0	1	69	0	.	Actin-binding.
chr17	10436711	10436843	Q9UKX2	0	-	10436711	10436843	255,102,0	1	132	0	.	Actin-binding.
chr17	10438607	10438676	Q9UKX2	0	-	10438607	10438676	255,102,0	1	69	0	.	Actin-binding.
chr17	10543759	10543897	P11055	0	-	10543759	10543897	255,102,0	1	138	0	.	Actin-binding.
chr17	10544614	10544683	P11055	0	-	10544614	10544683	255,102,0	1	69	0	.	Actin-binding.
chr17	10596249	10599070	O75880	0	-	10596249	10599070	255,102,0	1	2821	0	.	Important	for	dimerization.
chr17	11501815	11608443	Q9NYC9	0	+	11501815	11608443	255,102,0	1	106628	0	.	Stem.
chr17	11608443	11648161	Q9NYC9	0	+	11608443	11648161	255,102,0	1	39718	0	.	AAA	1.
chr17	11648338	11666763	Q9NYC9	0	+	11648338	11666763	255,102,0	1	18425	0	.	AAA	2.
chr17	11671916	11696822	Q9NYC9	0	+	11671916	11696822	255,102,0	1	24906	0	.	AAA	3.
chr17	11701048	11726213	Q9NYC9	0	+	11701048	11726213	255,102,0	1	25165	0	.	AAA	4.
chr17	11726255	11772540	Q9NYC9	0	+	11726255	11772540	255,102,0	1	46285	0	.	Stalk.
chr17	11778307	11787064	Q9NYC9	0	+	11778307	11787064	255,102,0	1	8757	0	.	AAA	5.
chr17	11806224	11835501	Q9NYC9	0	+	11806224	11835501	255,102,0	1	29277	0	.	AAA	6.
chr17	11924311	11958246	P45985	0	+	11924311	11958246	255,102,0	1	33935	0	.	D	domain.
chr17	12044466	12044538	P45985	0	+	12044466	12044538	255,102,0	1	72	0	.	DVD	domain.
chr17	12639518	12642543	Q8IZQ8	0	+	12639518	12642543	255,102,0	1	3025	0	.	HDAC5-binding.
chr17	12888098	12893485	Q17R89	0	+	12888098	12893485	255,102,0	1	5387	0	.	Interaction	with	BST2.	Pubmed:19273615
chr17	13399624	13399636	Q9Y663	0	-	13399624	13399636	255,102,0	1	12	0	.	Substrate	binding.
chr17	13399882	13399888	Q9Y663	0	-	13399882	13399888	255,102,0	1	6	0	.	Substrate	binding.
chr17	13399957	13399972	Q9Y663	0	-	13399957	13399972	255,102,0	1	15	0	.	Substrate	binding.
chr17	13400080	13400092	Q9Y663	0	-	13400080	13400092	255,102,0	1	12	0	.	Substrate	binding.
chr17	13503876	13503897	Q9Y663	0	-	13503876	13503897	255,102,0	1	21	0	.	Substrate	binding.
chr17	14205339	14205360	Q9Y662	0	+	14205339	14205360	255,102,0	1	21	0	.	Substrate	binding.
chr17	14248387	14248399	Q9Y662	0	+	14248387	14248399	255,102,0	1	12	0	.	Substrate	binding.
chr17	14248591	14248597	Q9Y662	0	+	14248591	14248597	255,102,0	1	6	0	.	Substrate	binding.
chr17	15878173	15878203	P29275	0	+	15878173	15878203	255,102,0	1	30	0	.	Agonist	binding.
chr17	15878395	15878419	P29275	0	+	15878395	15878419	255,102,0	1	24	0	.	Agonist	binding.
chr17	15878452	15878485	P29275	0	+	15878452	15878485	255,102,0	1	33	0	.	Agonist	binding.
chr17	15935612	15973491	O75376	0	-	15935612	15973491	255,102,0	1	37879	0	.	Interaction	with	C1D.
chr17	15942882	15950310	O75376	0	-	15942882	15950310	255,102,0	1	7428	0	.	ID2.
chr17	15960874	15961295	O75376	0	-	15960874	15961295	255,102,0	1	421	0	.	ID1.
chr17	15961238	15961250	O75376	0	-	15961238	15961250	255,102,0	1	12	0	.	Required	for	interaction	with	RARA	in	the	absence	of	its	ligand.
chr17	15965147	15995231	O75376	0	-	15965147	15995231	255,102,0	1	30084	0	.	Interaction	with	ETO.
chr17	16046973	16097883	O75376	0	-	16046973	16097883	255,102,0	1	50910	0	.	Interaction	with	ZBTB33	and	HEXIM1.	Pubmed:17452463,	Pubmed:14527417
chr17	16049835	16056682	O75376	0	-	16049835	16056682	255,102,0	1	6847	0	.	Interaction	with	SIN3A/B.
chr17	16320982	16330104	Q9Y5S1	0	+	16320982	16330104	255,102,0	1	9122	0	.	Required	for	interaction	with	SLC50A1.
chr17	16946162	17046983	Q6WCQ1	0	+	16946162	17046983	255,102,0	1	100821	0	.	Interaction	with	F-actin.
chr17	17061905	17077272	Q6WCQ1	0	+	17061905	17077272	255,102,0	1	15367	0	.	Interaction	with	RHOA.	Pubmed:14506264
chr17	17077269	17078654	Q6WCQ1	0	+	17077269	17078654	255,102,0	1	1385	0	.	Interaction	with	PPP1R12A.
chr17	17109483	17109600	Q8N2A8	0	-	17109483	17109600	255,102,0	1	117	0	.	Required	for	mitochondrial	localization.
chr17	17409539	17409545	Q9UBM1	0	-	17409539	17409545	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:12842883
chr17	17415877	17415886	Q9UBM1	0	-	17415877	17415886	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.	Pubmed:12842883
chr17	17720684	17722863	P36956	0	-	17720684	17722863	255,102,0	1	2179	0	.	Interaction	with	LMNA.
chr17	17721574	17721640	P36956	0	-	17721574	17721640	255,102,0	1	66	0	.	Leucine-zipper.
chr17	17723746	17740131	P36956	0	-	17723746	17740131	255,102,0	1	16385	0	.	Transcriptional	activation	(acidic).
chr17	18044113	18044137	Q9UKN7	0	+	18044113	18044137	255,102,0	1	24	0	.	Actin-binding.
chr17	18045404	18047224	Q9UKN7	0	+	18045404	18047224	255,102,0	1	1820	0	.	Neck	or	regulatory	domain.
chr17	18047224	18082181	Q9UKN7	0	+	18047224	18082181	255,102,0	1	34957	0	.	Tail.
chr17	18088133	18088142	Q6P6C2	0	+	18088133	18088142	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.	Pubmed:24778178
chr17	18150976	18154692	Q13045	0	-	18150976	18154692	255,102,0	1	3716	0	.	Interaction	with	ACTL6A.	Pubmed:14966289
chr17	18155095	18162004	Q13045	0	-	18155095	18162004	255,102,0	1	6909	0	.	Interaction	with	LRRFIP1	and	LRRFIP2.
chr17	18181046	18181382	Q13472	0	-	18181046	18181382	255,102,0	1	336	0	.	2	X	27	AA	approximate	repeats.
chr17	18389359	18389380	Q6DKI2	0	+	18389359	18389380	255,102,0	1	21	0	.	Beta-galactoside	binding	1.
chr17	18396110	18396131	Q6DKI2	0	+	18396110	18396131	255,102,0	1	21	0	.	Beta-galactoside	binding	2.
chr17	19216498	19237558	O95208	0	+	19216498	19237558	255,102,0	1	21060	0	.	6	X	3	AA	repeats	of	[DE]-P-W.
chr17	19235362	19237558	O95208	0	+	19235362	19237558	255,102,0	1	2196	0	.	3	X	3	AA	repeats	of	N-P-F.
chr17	19282216	19282444	Q13164	0	+	19282216	19282444	255,102,0	1	228	0	.	Required	for	cytoplasmic	targeting.
chr17	19283093	19283939	Q13164	0	+	19283093	19283939	255,102,0	1	846	0	.	Required	for	binding	to	MAP2K5.
chr17	19283939	19284740	Q13164	0	+	19283939	19284740	255,102,0	1	801	0	.	Necessary	for	oligomerization.
chr17	19284740	19286511	Q13164	0	+	19284740	19286511	255,102,0	1	1771	0	.	May	not	be	required	for	kinase	activity;	required	to	stimulate	MEF2C	activity.
chr17	19679664	19687036	Q8IYT8	0	-	19679664	19687036	255,102,0	1	7372	0	.	CTD-like	region.
chr17	19812535	19812577	O43572	0	-	19812535	19812577	255,102,0	1	42	0	.	PKA-RII	subunit	binding.
chr17	20354835	20354856	Q3B8N2	0	-	20354835	20354856	255,102,0	1	21	0	.	Beta-galactoside	binding	2.
chr17	20361564	20361585	Q3B8N2	0	-	20361564	20361585	255,102,0	1	21	0	.	Beta-galactoside	binding	1.
chr17	25967709	25967730	O00182	0	+	25967709	25967730	255,102,0	1	21	0	.	Beta-galactoside	binding	1.
chr17	25974395	25974416	O00182	0	+	25974395	25974416	255,102,0	1	21	0	.	Beta-galactoside	binding	2.
chr17	26099450	26100221	P35228	0	-	26099450	26100221	255,102,0	1	771	0	.	Calmodulin-binding.
chr17	26369899	26370274	Q9UBE8	0	+	26369899	26370274	255,102,0	1	375	0	.	Sufficient	for	interaction	with	DAPK3.	Pubmed:21454679
chr17	26369899	26495548	Q9UBE8	0	+	26369899	26495548	255,102,0	1	125649	0	.	Required	for	interaction	with	TAB2.
chr17	26370268	26518058	Q9UBE8	0	+	26370268	26518058	255,102,0	1	147790	0	.	Sufficient	for	interaction	with	DAPK3.	Pubmed:21454679
chr17	26518091	26521659	Q9UBE8	0	+	26518091	26521659	255,102,0	1	3568	0	.	Required	for	homodimerization	and	kinase	activation	and	localization	to	the	nucleus.
chr17	26518109	26521659	Q9UBE8	0	+	26518109	26521659	255,102,0	1	3550	0	.	Required	for	interaction	with	TAB2.
chr17	26655680	26657474	Q8IY31	0	-	26655680	26657474	255,102,0	1	1794	0	.	IFT57-binding.
chr17	26694874	26694976	P04004	0	-	26694874	26694976	255,102,0	1	102	0	.	Heparin-binding.
chr17	26874317	26875093	Q13432	0	-	26874317	26875093	255,102,0	1	776	0	.	Required	for	centrosome	localization.
chr17	26879398	26879575	Q13432	0	-	26879398	26879575	255,102,0	1	177	0	.	Required	for	midbody	localization.
chr17	26910663	26913511	Q96R06	0	-	26910663	26913511	255,102,0	1	2848	0	.	Interaction	with	KNSTRN.	Pubmed:21402792
chr17	27000422	27008379	Q7KZ85	0	+	27000422	27008379	255,102,0	1	7957	0	.	Interaction	with	IWS1.
chr17	27000422	27014153	Q7KZ85	0	+	27000422	27014153	255,102,0	1	13731	0	.	Interaction	with	PAAF1.	Pubmed:22316138
chr17	27004783	27022495	Q7KZ85	0	+	27004783	27022495	255,102,0	1	17712	0	.	Interaction	with	KDM6A.
chr17	27028048	27028640	Q7KZ85	0	+	27028048	27028640	255,102,0	1	592	0	.	Interaction	with	histone	H2B	and	H3.	Pubmed:10933715
chr17	27044351	27044708	P0DI83	0	-	27044351	27044708	255,102,0	1	357	0	.	13	x	9	AA	approximate	tandem-repeats	of	P-R-V-I-V-G-(S/T)-P-R.
chr17	27238232	27246232	Q96QT6	0	-	27238232	27246232	255,102,0	1	8000	0	.	Interaction	with	SIN3A.	Pubmed:11390640
chr17	27248722	27254026	Q96QT6	0	-	27248722	27254026	255,102,0	1	5304	0	.	Interaction	with	SIN3A.	Pubmed:11390640
chr17	27251257	27254017	Q96QT6	0	-	27251257	27254017	255,102,0	1	2760	0	.	PBR.
chr17	27308923	27308938	Q53EL9	0	-	27308923	27308938	255,102,0	1	15	0	.	O-glycosylated	at	two	sites.
chr17	27308971	27309001	Q53EL9	0	-	27308971	27309001	255,102,0	1	30	0	.	O-glycosylated	at	two	sites.
chr17	27448868	27493958	Q92614	0	-	27448868	27493958	255,102,0	1	45090	0	.	Mediates	nucleotide-independent	binding	to	F-actin	and	interaction	with	GOLPH3.
chr17	27573881	27576218	P05813	0	+	27573881	27576218	255,102,0	1	2337	0	.	N-terminal	arm.
chr17	27579217	27580669	P05813	0	+	27579217	27580669	255,102,0	1	1452	0	.	Connecting	peptide.
chr17	27901722	27902406	Q9Y2X7	0	-	27901722	27902406	255,102,0	1	684	0	.	Interaction	with	PXN	and	TGFB1I1.
chr17	27903674	27908366	Q9Y2X7	0	-	27903674	27908366	255,102,0	1	4692	0	.	PTK2/FAK1-binding.
chr17	27904006	27908357	Q9Y2X7	0	-	27904006	27908357	255,102,0	1	4351	0	.	ARHGEF6-binding.
chr17	28506122	28507927	Q9H0G5	0	+	28506122	28507927	255,102,0	1	1805	0	.	Necessary	for	alternative	splicing	activity.
chr17	28525476	28525536	P31645	0	-	28525476	28525536	255,102,0	1	60	0	.	Required	for	serotonin	uptake	activity.	Pubmed:19270731
chr17	28525494	28525521	P31645	0	-	28525494	28525521	255,102,0	1	27	0	.	Interaction	with	RAB4A.
chr17	28706091	28749863	O75976	0	+	28706091	28749863	255,102,0	1	43772	0	.	Carboxypeptidase-like	1.
chr17	28749863	28772856	O75976	0	+	28749863	28772856	255,102,0	1	22993	0	.	Carboxypeptidase-like	2.
chr17	28772856	28789468	O75976	0	+	28772856	28789468	255,102,0	1	16612	0	.	Carboxypeptidase-like	3.
chr17	29592259	29654759	P21359	0	+	29592259	29654759	255,102,0	1	62500	0	.	Lipid	binding.
chr17	29758914	29858747	Q86YS3	0	+	29758914	29858747	255,102,0	1	99833	0	.	Necessary	for	interaction	with	RAB11A,	subcellular	location,	homo-	or	heterooligomerization.
chr17	30322673	30325719	Q15022	0	+	30322673	30325719	255,102,0	1	3046	0	.	VEFS-box.
chr17	30677304	30685629	O43670	0	+	30677304	30685629	255,102,0	1	8325	0	.	Microtubule-binding	region.	Pubmed:24462186
chr17	30694991	30696370	O43670	0	+	30694991	30696370	255,102,0	1	1379	0	.	GLEBS.	Pubmed:24462186,	Pubmed:24462187
chr17	33316621	33316633	P49916	0	+	33316621	33316633	255,102,0	1	12	0	.	Interaction	with	DNA.	Pubmed:20518483
chr17	33318043	33318061	P49916	0	+	33318043	33318061	255,102,0	1	18	0	.	Interaction	with	DNA.	Pubmed:20518483
chr17	33318809	33318821	P49916	0	+	33318809	33318821	255,102,0	1	12	0	.	Interaction	with	DNA.	Pubmed:20518483
chr17	33319028	33319049	P49916	0	+	33319028	33319049	255,102,0	1	21	0	.	Interaction	with	DNA.	Pubmed:20518483
chr17	33445533	33446632	O75771	0	-	33445533	33446632	255,102,0	1	1099	0	.	preferentially	binds	ssDNA.
chr17	33879939	33881610	P0C7P3	0	-	33879939	33881610	255,102,0	1	1671	0	.	Required	for	ribosome	binding.	Pubmed:25996083
chr17	33881610	33884466	P0C7P3	0	-	33881610	33884466	255,102,0	1	2856	0	.	Required	for	endoribonuclease	activity.	Pubmed:25996083
chr17	34037275	34050715	P63010	0	+	34037275	34050715	255,102,0	1	13440	0	.	Interaction	with	ARRB1.
chr17	34062203	34068321	Q96S79	0	+	34062203	34068321	255,102,0	1	6118	0	.	Small	GTPase-like.
chr17	34171521	34172028	Q92804	0	+	34171521	34172028	255,102,0	1	507	0	.	21	X	approximate	tandem	repeats	of	D-R-[S,G](0,3)-G-G-Y-G-G.
chr17	34252518	34257088	Q8NG50	0	-	34252518	34257088	255,102,0	1	4570	0	.	Necessary	for	nuclear	and	nucleolar	localization.
chr17	34257079	34257731	Q8NG50	0	-	34257079	34257731	255,102,0	1	652	0	.	Necessary	for	nuclear	localization	and	for	nucleolar	accumulation	in	response	to	heat	shock.
chr17	34852097	34854382	Q96H55	0	-	34852097	34854382	255,102,0	1	2285	0	.	Mitochondrial	targeting.
chr17	34852469	34854754	Q96H55	0	-	34852469	34854754	255,102,0	1	2285	0	.	Mitochondrial	targeting.
chr17	35344028	35345986	Q9NY61	0	+	35344028	35345986	255,102,0	1	1958	0	.	RB1	binding.
chr17	35345860	35347818	Q9NY61	0	+	35345860	35347818	255,102,0	1	1958	0	.	RB1	binding.
chr17	35913466	35921621	Q9UMZ2	0	-	35913466	35921621	255,102,0	1	8155	0	.	Interaction	with	A1P1G1	and	A1P1G2.
chr17	36104782	36104875	P35680	0	-	36104782	36104875	255,102,0	1	93	0	.	Dimerization.
chr17	36109305	36109398	P35680	0	-	36109305	36109398	255,102,0	1	93	0	.	Dimerization.
chr17	36631379	36631409	A6NHQ4	0	-	36631379	36631409	255,102,0	1	30	0	.	BC-box.
chr17	36830604	36830634	A6NHQ4	0	-	36830604	36830634	255,102,0	1	30	0	.	BC-box.
chr17	37564210	37564729	Q15648	0	-	37564210	37564729	255,102,0	1	519	0	.	Interaction	with	TP53.	Pubmed:9444950
chr17	37565275	37566508	Q15648	0	-	37565275	37566508	255,102,0	1	1233	0	.	Interaction	with	ESR1.
chr17	37566106	37566850	Q15648	0	-	37566106	37566850	255,102,0	1	744	0	.	Interaction	with	VDR.
chr17	37566328	37566433	Q15648	0	-	37566328	37566433	255,102,0	1	105	0	.	Interaction	with	GATA1.	Pubmed:24245781
chr17	37566370	37566610	Q15648	0	-	37566370	37566610	255,102,0	1	240	0	.	Interaction	with	PPARGC1A	and	THRA.	Pubmed:14636573
chr17	37566463	37607315	Q15648	0	-	37566463	37607315	255,102,0	1	40852	0	.	Interaction	with	the	Mediator	complex	and	THRA.
chr17	37566541	37576054	Q15648	0	-	37566541	37576054	255,102,0	1	9513	0	.	Interaction	with	THRA.
chr17	37566703	37604137	Q15648	0	-	37566703	37604137	255,102,0	1	37434	0	.	Interaction	with	ESR1.
chr17	37576096	37587374	Q15648	0	-	37576096	37587374	255,102,0	1	11278	0	.	Interaction	with	the	Mediator	complex.
chr17	37587380	37596716	Q15648	0	-	37587380	37596716	255,102,0	1	9336	0	.	Interaction	with	the	Mediator	complex.
chr17	37825913	37825919	P11086	0	+	37825913	37825919	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr17	37826264	37826270	P11086	0	+	37826264	37826270	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr17	37879650	37879692	P04626	0	+	37879650	37879692	255,102,0	1	42	0	.	Required	for	interaction	with	KPNB1	and	EEA1.	Pubmed:16314522
chr17	37884111	37884120	P04626	0	+	37884111	37884120	255,102,0	1	9	0	.	Interaction	with	PIK3C2B.
chr17	38121940	38130527	Q96QA5	0	+	38121940	38130527	255,102,0	1	8587	0	.	Triggers	pyroptosis.	Pubmed:27281216
chr17	38230741	38233795	P10827	0	+	38230741	38233795	255,102,0	1	3054	0	.	Modulating.
chr17	38241059	38245586	P10827	0	+	38241059	38245586	255,102,0	1	4527	0	.	Ligand-binding.
chr17	38249338	38252092	P20393	0	-	38249338	38252092	255,102,0	1	2754	0	.	Ligand-binding.
chr17	38252092	38252329	P20393	0	-	38252092	38252329	255,102,0	1	237	0	.	Hinge.
chr17	38252092	38253543	P20393	0	-	38252092	38253543	255,102,0	1	1451	0	.	Crucial	for	activation	of	GJA1.
chr17	38253018	38256347	P20393	0	-	38253018	38256347	255,102,0	1	3329	0	.	Modulating.
chr17	38279531	38279576	Q68DK7	0	+	38279531	38279576	255,102,0	1	45	0	.	Interaction	with	MSL2.
chr17	38289297	38289360	Q68DK7	0	+	38289297	38289360	255,102,0	1	63	0	.	Interaction	with	KAT8.
chr17	38289877	38290550	Q68DK7	0	+	38289877	38290550	255,102,0	1	673	0	.	Sufficient	for	interaction	with	MSL3	MRG	domain.
chr17	38318116	38319797	O15234	0	+	38318116	38319797	255,102,0	1	1681	0	.	Necessary	for	RNA-binding,	interaction	with	MAGOH	and	localization	in	nucleus	speckles.	Pubmed:15166247
chr17	38318116	38319797	O15234	0	+	38318116	38319797	255,102,0	1	1681	0	.	Sufficient	to	form	the	EJC.
chr17	38320076	38325871	O15234	0	+	38320076	38325871	255,102,0	1	5795	0	.	Necessary	for	localization	in	cytoplasmic	stress	granules.
chr17	38416867	38416879	Q8TF74	0	+	38416867	38416879	255,102,0	1	12	0	.	Binds	actin.
chr17	38487470	38504650	P10276	0	+	38487470	38504650	255,102,0	1	17180	0	.	Modulating.
chr17	38506167	38508289	P10276	0	+	38506167	38508289	255,102,0	1	2122	0	.	Hinge.
chr17	38508289	38512346	P10276	0	+	38508289	38512346	255,102,0	1	4057	0	.	Ligand-binding.
chr17	38512298	38512346	P10276	0	+	38512298	38512346	255,102,0	1	48	0	.	Required	for	binding	corepressor	NCOR1.
chr17	38556463	38556493	P11388	0	-	38556463	38556493	255,102,0	1	30	0	.	Interaction	with	DNA.	Pubmed:22841979
chr17	38567638	38567647	P11388	0	-	38567638	38567647	255,102,0	1	9	0	.	Interaction	with	DNA.	Pubmed:23022727
chr17	38854491	38855700	Q2M2I5	0	-	38854491	38855700	255,102,0	1	1209	0	.	Tail.
chr17	38855700	38856551	Q2M2I5	0	-	38855700	38856551	255,102,0	1	851	0	.	Coil	2.
chr17	38855700	38859528	Q2M2I5	0	-	38855700	38859528	255,102,0	1	3828	0	.	Rod.
chr17	38856551	38856620	Q2M2I5	0	-	38856551	38856620	255,102,0	1	69	0	.	Linker	12.
chr17	38856620	38859351	Q2M2I5	0	-	38856620	38859351	255,102,0	1	2731	0	.	Coil	1B.
chr17	38859351	38859420	Q2M2I5	0	-	38859351	38859420	255,102,0	1	69	0	.	Linker	1.
chr17	38859420	38859528	Q2M2I5	0	-	38859420	38859528	255,102,0	1	108	0	.	Coil	1A.
chr17	38859528	38859945	Q2M2I5	0	-	38859528	38859945	255,102,0	1	417	0	.	Head.
chr17	38904531	38906636	Q7Z3Z0	0	-	38904531	38906636	255,102,0	1	2105	0	.	Tail.
chr17	38906636	38907494	Q7Z3Z0	0	-	38906636	38907494	255,102,0	1	858	0	.	Coil	2.
chr17	38906636	38911289	Q7Z3Z0	0	-	38906636	38911289	255,102,0	1	4653	0	.	Rod.
chr17	38907494	38907563	Q7Z3Z0	0	-	38907494	38907563	255,102,0	1	69	0	.	Linker	12.
chr17	38907563	38911115	Q7Z3Z0	0	-	38907563	38911115	255,102,0	1	3552	0	.	Coil	1B.
chr17	38911115	38911181	Q7Z3Z0	0	-	38911115	38911181	255,102,0	1	66	0	.	Linker	1.
chr17	38911181	38911289	Q7Z3Z0	0	-	38911181	38911289	255,102,0	1	108	0	.	Coil	1A.
chr17	38911289	38911523	Q7Z3Z0	0	-	38911289	38911523	255,102,0	1	234	0	.	Head.
chr17	38922778	38925135	Q7Z3Y9	0	-	38922778	38925135	255,102,0	1	2357	0	.	Tail.
chr17	38925135	38926290	Q7Z3Y9	0	-	38925135	38926290	255,102,0	1	1155	0	.	Coil	2.
chr17	38925135	38928119	Q7Z3Y9	0	-	38925135	38928119	255,102,0	1	2984	0	.	Rod.
chr17	38926290	38926359	Q7Z3Y9	0	-	38926290	38926359	255,102,0	1	69	0	.	Linker	12.
chr17	38926359	38927945	Q7Z3Y9	0	-	38926359	38927945	255,102,0	1	1586	0	.	Coil	1B.
chr17	38927945	38928011	Q7Z3Y9	0	-	38927945	38928011	255,102,0	1	66	0	.	Linker	1.
chr17	38928011	38928119	Q7Z3Y9	0	-	38928011	38928119	255,102,0	1	108	0	.	Coil	1A.
chr17	38928119	38928365	Q7Z3Y9	0	-	38928119	38928365	255,102,0	1	246	0	.	Head.
chr17	38933253	38933771	Q7Z3Y8	0	-	38933253	38933771	255,102,0	1	518	0	.	Tail.
chr17	38933771	38936029	Q7Z3Y8	0	-	38933771	38936029	255,102,0	1	2258	0	.	Coil	2.
chr17	38933771	38938496	Q7Z3Y8	0	-	38933771	38938496	255,102,0	1	4725	0	.	Rod.
chr17	38936029	38936098	Q7Z3Y8	0	-	38936029	38936098	255,102,0	1	69	0	.	Linker	12.
chr17	38936098	38938322	Q7Z3Y8	0	-	38936098	38938322	255,102,0	1	2224	0	.	Coil	1B.
chr17	38938322	38938388	Q7Z3Y8	0	-	38938322	38938388	255,102,0	1	66	0	.	Linker	1.
chr17	38938388	38938496	Q7Z3Y8	0	-	38938388	38938496	255,102,0	1	108	0	.	Coil	1A.
chr17	38938496	38938745	Q7Z3Y8	0	-	38938496	38938745	255,102,0	1	249	0	.	Head.
chr17	38948681	38950085	Q7Z3Y7	0	-	38948681	38950085	255,102,0	1	1404	0	.	Tail.
chr17	38950085	38953449	Q7Z3Y7	0	-	38950085	38953449	255,102,0	1	3364	0	.	Coil	2.
chr17	38950085	38955890	Q7Z3Y7	0	-	38950085	38955890	255,102,0	1	5805	0	.	Rod.
chr17	38953449	38953518	Q7Z3Y7	0	-	38953449	38953518	255,102,0	1	69	0	.	Linker	12.
chr17	38953518	38955716	Q7Z3Y7	0	-	38953518	38955716	255,102,0	1	2198	0	.	Coil	1B.
chr17	38955716	38955782	Q7Z3Y7	0	-	38955716	38955782	255,102,0	1	66	0	.	Linker	1.
chr17	38955782	38955890	Q7Z3Y7	0	-	38955782	38955890	255,102,0	1	108	0	.	Coil	1A.
chr17	38955890	38956145	Q7Z3Y7	0	-	38955890	38956145	255,102,0	1	255	0	.	Head.
chr17	38974730	38975773	P13645	0	-	38974730	38975773	255,102,0	1	1043	0	.	Tail.
chr17	38975773	38976591	P13645	0	-	38975773	38976591	255,102,0	1	818	0	.	Coil	2.
chr17	38975773	38978402	P13645	0	-	38975773	38978402	255,102,0	1	2629	0	.	Rod.
chr17	38976591	38976660	P13645	0	-	38976591	38976660	255,102,0	1	69	0	.	Linker	12.
chr17	38976660	38978231	P13645	0	-	38976660	38978231	255,102,0	1	1571	0	.	Coil	1B.
chr17	38978231	38978294	P13645	0	-	38978231	38978294	255,102,0	1	63	0	.	Linker	1.
chr17	38978294	38978402	P13645	0	-	38978294	38978402	255,102,0	1	108	0	.	Coil	1A.
chr17	38978402	38978837	P13645	0	-	38978402	38978837	255,102,0	1	435	0	.	Head.
chr17	39017915	39019385	Q99456	0	-	39017915	39019385	255,102,0	1	1470	0	.	Tail.
chr17	39019385	39020032	Q99456	0	-	39019385	39020032	255,102,0	1	647	0	.	Coil	2.
chr17	39019385	39023066	Q99456	0	-	39019385	39023066	255,102,0	1	3681	0	.	Rod.
chr17	39020032	39020101	Q99456	0	-	39020032	39020101	255,102,0	1	69	0	.	Linker	12.
chr17	39020101	39022892	Q99456	0	-	39020101	39022892	255,102,0	1	2791	0	.	Coil	1B.
chr17	39022892	39022949	Q99456	0	-	39022892	39022949	255,102,0	1	57	0	.	Linker	1.
chr17	39022958	39023066	Q99456	0	-	39022958	39023066	255,102,0	1	108	0	.	Coil	1A.
chr17	39023066	39023438	Q99456	0	-	39023066	39023438	255,102,0	1	372	0	.	Head.
chr17	39032615	39034404	P35900	0	-	39032615	39034404	255,102,0	1	1789	0	.	Tail.
chr17	39034404	39036429	P35900	0	-	39034404	39036429	255,102,0	1	2025	0	.	Coil	2.
chr17	39034404	39041230	P35900	0	-	39034404	39041230	255,102,0	1	6826	0	.	Rod.
chr17	39036429	39036498	P35900	0	-	39036429	39036498	255,102,0	1	69	0	.	Linker	12.
chr17	39036498	39041068	P35900	0	-	39036498	39041068	255,102,0	1	4570	0	.	Coil	1B.
chr17	39041068	39041122	P35900	0	-	39041068	39041122	255,102,0	1	54	0	.	Linker	1.
chr17	39041122	39041230	P35900	0	-	39041122	39041230	255,102,0	1	108	0	.	Coil	1A.
chr17	39041230	39041437	P35900	0	-	39041230	39041437	255,102,0	1	207	0	.	Head.
chr17	39079243	39081613	Q9C075	0	-	39079243	39081613	255,102,0	1	2370	0	.	Rod-like	helical	tail.
chr17	39081613	39084775	Q9C075	0	-	39081613	39084775	255,102,0	1	3162	0	.	Coil	2.
chr17	39081613	39092642	Q9C075	0	-	39081613	39092642	255,102,0	1	11029	0	.	Rod.
chr17	39084775	39084844	Q9C075	0	-	39084775	39084844	255,102,0	1	69	0	.	Linker	12.
chr17	39084844	39092480	Q9C075	0	-	39084844	39092480	255,102,0	1	7636	0	.	Coil	1B.
chr17	39092480	39092534	Q9C075	0	-	39092480	39092534	255,102,0	1	54	0	.	Linker	1.
chr17	39092534	39092642	Q9C075	0	-	39092534	39092642	255,102,0	1	108	0	.	Coil	1A.
chr17	39092642	39092855	Q9C075	0	-	39092642	39092855	255,102,0	1	213	0	.	Head.
chr17	39114855	39116540	Q6A163	0	-	39114855	39116540	255,102,0	1	1685	0	.	Tail.
chr17	39114982	39116667	Q6A163	0	-	39114982	39116667	255,102,0	1	1685	0	.	Tail.
chr17	39116540	39118746	Q6A163	0	-	39116540	39118746	255,102,0	1	2206	0	.	Coil	2.
chr17	39116540	39122820	Q6A163	0	-	39116540	39122820	255,102,0	1	6280	0	.	Rod.
chr17	39116667	39118873	Q6A163	0	-	39116667	39118873	255,102,0	1	2206	0	.	Coil	2.
chr17	39116667	39122947	Q6A163	0	-	39116667	39122947	255,102,0	1	6280	0	.	Rod.
chr17	39118746	39118794	Q6A163	0	-	39118746	39118794	255,102,0	1	48	0	.	Linker	12.
chr17	39118794	39122682	Q6A163	0	-	39118794	39122682	255,102,0	1	3888	0	.	Coil	1B.
chr17	39118873	39118921	Q6A163	0	-	39118873	39118921	255,102,0	1	48	0	.	Linker	12.
chr17	39118921	39122809	Q6A163	0	-	39118921	39122809	255,102,0	1	3888	0	.	Coil	1B.
chr17	39122682	39122715	Q6A163	0	-	39122682	39122715	255,102,0	1	33	0	.	Linker	1.
chr17	39122715	39122820	Q6A163	0	-	39122715	39122820	255,102,0	1	105	0	.	Coil	1A.
chr17	39122809	39122842	Q6A163	0	-	39122809	39122842	255,102,0	1	33	0	.	Linker	1.
chr17	39122820	39123108	Q6A163	0	-	39122820	39123108	255,102,0	1	288	0	.	Head.
chr17	39122842	39122947	Q6A163	0	-	39122842	39122947	255,102,0	1	105	0	.	Coil	1A.
chr17	39122947	39123235	Q6A163	0	-	39122947	39123235	255,102,0	1	288	0	.	Head.
chr17	39134451	39135063	Q6A162	0	-	39134451	39135063	255,102,0	1	612	0	.	Tail.
chr17	39134578	39135190	Q6A162	0	-	39134578	39135190	255,102,0	1	612	0	.	Tail.
chr17	39135063	39137334	Q6A162	0	-	39135063	39137334	255,102,0	1	2271	0	.	Coil	2.
chr17	39135063	39140258	Q6A162	0	-	39135063	39140258	255,102,0	1	5195	0	.	Rod.
chr17	39135190	39137461	Q6A162	0	-	39135190	39137461	255,102,0	1	2271	0	.	Coil	2.
chr17	39135190	39140385	Q6A162	0	-	39135190	39140385	255,102,0	1	5195	0	.	Rod.
chr17	39137334	39137382	Q6A162	0	-	39137334	39137382	255,102,0	1	48	0	.	Linker	12.
chr17	39137382	39140120	Q6A162	0	-	39137382	39140120	255,102,0	1	2738	0	.	Coil	1B.
chr17	39137461	39137509	Q6A162	0	-	39137461	39137509	255,102,0	1	48	0	.	Linker	12.
chr17	39137509	39140247	Q6A162	0	-	39137509	39140247	255,102,0	1	2738	0	.	Coil	1B.
chr17	39140120	39140153	Q6A162	0	-	39140120	39140153	255,102,0	1	33	0	.	Linker	1.
chr17	39140153	39140258	Q6A162	0	-	39140153	39140258	255,102,0	1	105	0	.	Coil	1A.
chr17	39140247	39140280	Q6A162	0	-	39140247	39140280	255,102,0	1	33	0	.	Linker	1.
chr17	39140258	39140525	Q6A162	0	-	39140258	39140525	255,102,0	1	267	0	.	Head.
chr17	39140280	39140385	Q6A162	0	-	39140280	39140385	255,102,0	1	105	0	.	Coil	1A.
chr17	39140385	39140652	Q6A162	0	-	39140385	39140652	255,102,0	1	267	0	.	Head.
chr17	39150172	39150343	Q9BYR6	0	-	39150172	39150343	255,102,0	1	171	0	.	3	X	5	AA	repeats	of	C-C-X(3).
chr17	39150299	39150470	Q9BYR6	0	-	39150299	39150470	255,102,0	1	171	0	.	3	X	5	AA	repeats	of	C-C-X(3).
chr17	39155928	39156099	Q9BYR7	0	-	39155928	39156099	255,102,0	1	171	0	.	3	X	5	AA	repeats	of	C-C-X(3).
chr17	39156055	39156226	Q9BYR7	0	-	39156055	39156226	255,102,0	1	171	0	.	3	X	5	AA	repeats	of	C-C-X(3).
chr17	39165149	39165320	Q9BYR8	0	-	39165149	39165320	255,102,0	1	171	0	.	4	X	5	AA	repeats	of	C-C-X(3).
chr17	39165276	39165447	Q9BYR8	0	-	39165276	39165447	255,102,0	1	171	0	.	4	X	5	AA	repeats	of	C-C-X(3).
chr17	39182891	39183401	Q9BYS1	0	-	39182891	39183401	255,102,0	1	510	0	.	15	X	5	AA	repeats	of	C-C-[QEPVRC]-[TPIVLE]-[SRHVP].
chr17	39183018	39183528	Q9BYS1	0	-	39183018	39183528	255,102,0	1	510	0	.	15	X	5	AA	repeats	of	C-C-[QEPVRC]-[TPIVLE]-[SRHVP].
chr17	39203183	39203507	Q9BYU5	0	-	39203183	39203507	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39203308	39203632	Q9BYU5	0	-	39203308	39203632	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39211127	39211451	Q9BYT5	0	-	39211127	39211451	255,102,0	1	324	0	.	11	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39211252	39211681	Q9BYT5	0	-	39211252	39211681	255,102,0	1	429	0	.	11	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39211357	39211681	Q9BYU5	0	-	39211357	39211681	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39215966	39216290	P0C7H8	0	-	39215966	39216290	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39215966	39216290	Q9BYR9	0	-	39215966	39216290	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	39216196	39216520	P0C7H8	0	-	39216196	39216520	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39216196	39216520	Q9BYR9	0	-	39216196	39216520	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	39221761	39222085	P0C7H8	0	-	39221761	39222085	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39221761	39222085	Q9BYR9	0	-	39221761	39222085	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	39221991	39222315	P0C7H8	0	-	39221991	39222315	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	39221991	39222315	Q9BYR9	0	-	39221991	39222315	255,102,0	1	324	0	.	10	X	5	AA	repeats	of	C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	39253844	39254297	Q9BYQ9	0	-	39253844	39254297	255,102,0	1	453	0	.	25	X	5	AA	repeats	of	C-C-[IKRQVHEC]-[SPRT]-[STCVQPR].
chr17	39261709	39262174	Q9BYQ8	0	+	39261709	39262174	255,102,0	1	465	0	.	29	X	5	AA	repeats	of	C-C-[RQVHIEK]-[SPTR]-[VSTQCRNP].
chr17	39274078	39274555	Q9BYQ6	0	-	39274078	39274555	255,102,0	1	477	0	.	27	X	5	AA	repeats	of	C-C-[GIKRQVHEL]-[SPTR]-[STVQRMC].
chr17	39279867	39280362	Q9BQ66	0	-	39279867	39280362	255,102,0	1	495	0	.	31	X	5	AA	repeats	of	C-C-[GRQVIL]-[SPTR]-[VSTQPC].
chr17	39280335	39280830	Q9BQ66	0	-	39280335	39280830	255,102,0	1	495	0	.	31	X	5	AA	repeats	of	C-C-[GRQVIL]-[SPTR]-[VSTQPC].
chr17	39296220	39296682	Q9BYQ5	0	-	39296220	39296682	255,102,0	1	462	0	.	30	X	5	AA	repeats	of	C-C-[IRQVEL]-[SPTR]-[STVQRCP].
chr17	39305557	39306007	Q9BYR2	0	-	39305557	39306007	255,102,0	1	450	0	.	26	X	5	AA	repeats	of	C-C-[GRQVCHIEK]-[SPTR]-[VSTQYC].
chr17	39316481	39316931	Q9BYR3	0	-	39316481	39316931	255,102,0	1	450	0	.	26	X	5	AA	repeats	of	C-C-[GRQVCH]-[SPT]-[VSTQR].
chr17	39323845	39324325	Q9BYR4	0	-	39323845	39324325	255,102,0	1	480	0	.	29	X	5	AA	repeats	of	C-C-[GIKRQVH]-[SPT]-[STA].
chr17	39334029	39334404	Q9BYR5	0	-	39334029	39334404	255,102,0	1	375	0	.	20	X	5	AA	repeats	OF	C-C-[GRQVS]-[SPT]-[VSTQ].
chr17	39340671	39341094	Q9BYQ7	0	-	39340671	39341094	255,102,0	1	423	0	.	18	X	5	AA	repeats	of	C-C-[GRQC]-[SPT]-[VSTL].
chr17	39346159	39346882	A8MXZ3	0	+	39346159	39346882	255,102,0	1	723	0	.	30	X	5	AA	repeats	of	C-C-[CGSVRQH]-[SQTNP]-[PTSI].
chr17	39382906	39400768	Q9BYP9	0	+	39382906	39400768	255,102,0	1	17862	0	.	14	X	5	AA	repeats	of	C-C-[RQVGE]-[SPSTNQ]-[TASL].
chr17	39382927	39383422	Q9BYQ4	0	+	39382927	39383422	255,102,0	1	495	0	.	17	X	5	AA	repeats	of	C-C-[RQVSGE]-[SPTQ]-[TASP].
chr17	39388773	39389223	Q9BYQ3	0	+	39388773	39389223	255,102,0	1	450	0	.	16	X	5	AA	repeats	of	C-C-[RQVSHE]-[SPTN]-[TASPI].
chr17	39388774	39389224	Q9BYQ3	0	+	39388774	39389224	255,102,0	1	450	0	.	16	X	5	AA	repeats	of	C-C-[RQVSHE]-[SPTN]-[TASPI].
chr17	39394324	39394774	Q9BYQ0	0	+	39394324	39394774	255,102,0	1	450	0	.	15	X	5	AA	repeats	of	C-C-[RQVSGE]-[SPSNQ]-[TASPI].
chr17	39394623	39395058	Q9BYQ2	0	+	39394623	39395058	255,102,0	1	435	0	.	15	X	5	AA	repeats	of	C-C-[RQVGE]-[SPTN]-[TASPF].
chr17	39405993	39406428	Q9BYQ2	0	+	39405993	39406428	255,102,0	1	435	0	.	15	X	5	AA	repeats	of	C-C-[RQVGE]-[SPTN]-[TASPF].
chr17	39410268	39410733	A8MVA2	0	+	39410268	39410733	255,102,0	1	465	0	.	16	X	5	AA	repeats	of	C-C-[GSVRQ]-[QTSPHN]-[TPSGYC].
chr17	39411593	39412088	Q9BYP9	0	+	39411593	39412088	255,102,0	1	495	0	.	14	X	5	AA	repeats	of	C-C-[RQVGE]-[SPSTNQ]-[TASL].
chr17	39420600	39421080	A8MTY7	0	+	39420600	39421080	255,102,0	1	480	0	.	17	X	5	AA	repeats	of	C-C-[VGSREQH]-[SQTPN]-[STPAI].
chr17	39421638	39422103	A8MVA2	0	+	39421638	39422103	255,102,0	1	465	0	.	16	X	5	AA	repeats	of	C-C-[GSVRQ]-[QTSPHN]-[TPSGYC].
chr17	39431970	39432450	A8MTY7	0	+	39431970	39432450	255,102,0	1	480	0	.	17	X	5	AA	repeats	of	C-C-[VGSREQH]-[SQTPN]-[STPAI].
chr17	39446800	39447721	A8MX34	0	-	39446800	39447721	255,102,0	1	921	0	.	7	X	5	AA	repeats	of	C-C-X(3).
chr17	39447848	39448769	A8MX34	0	-	39447848	39448769	255,102,0	1	921	0	.	7	X	5	AA	repeats	of	C-C-X(3).
chr17	39458170	39459091	A8MX34	0	-	39458170	39459091	255,102,0	1	921	0	.	7	X	5	AA	repeats	of	C-C-X(3).
chr17	39464584	39465289	A8MUX0	0	-	39464584	39465289	255,102,0	1	705	0	.	11	X	5	AA	repeats	of	C-C-X(3).
chr17	39502373	39502707	O76009	0	-	39502373	39502707	255,102,0	1	334	0	.	Tail.
chr17	39502707	39503405	O76009	0	-	39502707	39503405	255,102,0	1	698	0	.	Coil	2.
chr17	39502707	39506851	O76009	0	-	39502707	39506851	255,102,0	1	4144	0	.	Rod.
chr17	39503405	39503453	O76009	0	-	39503405	39503453	255,102,0	1	48	0	.	Linker	12.
chr17	39503453	39506713	O76009	0	-	39503453	39506713	255,102,0	1	3260	0	.	Coil	1B.
chr17	39506713	39506746	O76009	0	-	39506713	39506746	255,102,0	1	33	0	.	Linker	1.
chr17	39506746	39506851	O76009	0	-	39506746	39506851	255,102,0	1	105	0	.	Coil	1A.
chr17	39506851	39507019	O76009	0	-	39506851	39507019	255,102,0	1	168	0	.	Head.
chr17	39520090	39521038	Q14525	0	-	39520090	39521038	255,102,0	1	948	0	.	Tail.
chr17	39521038	39521736	Q14525	0	-	39521038	39521736	255,102,0	1	698	0	.	Coil	2.
chr17	39521038	39525834	Q14525	0	-	39521038	39525834	255,102,0	1	4796	0	.	Rod.
chr17	39521736	39521784	Q14525	0	-	39521736	39521784	255,102,0	1	48	0	.	Linker	12.
chr17	39521784	39525696	Q14525	0	-	39521784	39525696	255,102,0	1	3912	0	.	Coil	1B.
chr17	39525696	39525729	Q14525	0	-	39525696	39525729	255,102,0	1	33	0	.	Linker	1.
chr17	39525729	39525834	Q14525	0	-	39525729	39525834	255,102,0	1	105	0	.	Coil	1A.
chr17	39525834	39526002	Q14525	0	-	39525834	39526002	255,102,0	1	168	0	.	Head.
chr17	39534313	39535215	O76011	0	-	39534313	39535215	255,102,0	1	902	0	.	Tail.
chr17	39535215	39535914	O76011	0	-	39535215	39535914	255,102,0	1	699	0	.	Coil	2.
chr17	39535215	39538330	O76011	0	-	39535215	39538330	255,102,0	1	3115	0	.	Rod.
chr17	39535914	39535962	O76011	0	-	39535914	39535962	255,102,0	1	48	0	.	Linker	12.
chr17	39535962	39538192	O76011	0	-	39535962	39538192	255,102,0	1	2230	0	.	Coil	1B.
chr17	39538192	39538225	O76011	0	-	39538192	39538225	255,102,0	1	33	0	.	Linker	1.
chr17	39538225	39538330	O76011	0	-	39538225	39538330	255,102,0	1	105	0	.	Coil	1A.
chr17	39538330	39538624	O76011	0	-	39538330	39538624	255,102,0	1	294	0	.	Head.
chr17	39550270	39551107	Q15323	0	-	39550270	39551107	255,102,0	1	837	0	.	Tail.
chr17	39551107	39551806	Q15323	0	-	39551107	39551806	255,102,0	1	699	0	.	Coil	2.
chr17	39551107	39553623	Q15323	0	-	39551107	39553623	255,102,0	1	2516	0	.	Rod.
chr17	39551806	39551854	Q15323	0	-	39551806	39551854	255,102,0	1	48	0	.	Linker	12.
chr17	39551854	39553485	Q15323	0	-	39551854	39553485	255,102,0	1	1631	0	.	Coil	1B.
chr17	39553485	39553518	Q15323	0	-	39553485	39553518	255,102,0	1	33	0	.	Linker	1.
chr17	39553518	39553623	Q15323	0	-	39553518	39553623	255,102,0	1	105	0	.	Coil	1A.
chr17	39553623	39553791	Q15323	0	-	39553623	39553791	255,102,0	1	168	0	.	Head.
chr17	39557570	39558407	Q15323	0	-	39557570	39558407	255,102,0	1	837	0	.	Tail.
chr17	39558407	39559106	Q15323	0	-	39558407	39559106	255,102,0	1	699	0	.	Coil	2.
chr17	39558407	39560923	Q15323	0	-	39558407	39560923	255,102,0	1	2516	0	.	Rod.
chr17	39559106	39559154	Q15323	0	-	39559106	39559154	255,102,0	1	48	0	.	Linker	12.
chr17	39559154	39560785	Q15323	0	-	39559154	39560785	255,102,0	1	1631	0	.	Coil	1B.
chr17	39560785	39560818	Q15323	0	-	39560785	39560818	255,102,0	1	33	0	.	Linker	1.
chr17	39560818	39560923	Q15323	0	-	39560818	39560923	255,102,0	1	105	0	.	Coil	1A.
chr17	39560923	39561091	Q15323	0	-	39560923	39561091	255,102,0	1	168	0	.	Head.
chr17	39577132	39577234	O76014	0	-	39577132	39577234	255,102,0	1	102	0	.	Tail.
chr17	39577626	39578617	O76014	0	-	39577626	39578617	255,102,0	1	991	0	.	Coil	2.
chr17	39577626	39580463	O76014	0	-	39577626	39580463	255,102,0	1	2837	0	.	Rod.
chr17	39578617	39578665	O76014	0	-	39578617	39578665	255,102,0	1	48	0	.	Linker	12.
chr17	39578665	39580325	O76014	0	-	39578665	39580325	255,102,0	1	1660	0	.	Coil	1B.
chr17	39580325	39580358	O76014	0	-	39580325	39580358	255,102,0	1	33	0	.	Linker	1.
chr17	39580358	39580463	O76014	0	-	39580358	39580463	255,102,0	1	105	0	.	Coil	1A.
chr17	39580463	39580775	O76014	0	-	39580463	39580775	255,102,0	1	312	0	.	Head.
chr17	39584457	39584559	O76014	0	-	39584457	39584559	255,102,0	1	102	0	.	Tail.
chr17	39584951	39585942	O76014	0	-	39584951	39585942	255,102,0	1	991	0	.	Coil	2.
chr17	39584951	39587788	O76014	0	-	39584951	39587788	255,102,0	1	2837	0	.	Rod.
chr17	39585942	39585990	O76014	0	-	39585942	39585990	255,102,0	1	48	0	.	Linker	12.
chr17	39585990	39587650	O76014	0	-	39585990	39587650	255,102,0	1	1660	0	.	Coil	1B.
chr17	39587650	39587683	O76014	0	-	39587650	39587683	255,102,0	1	33	0	.	Linker	1.
chr17	39587683	39587788	O76014	0	-	39587683	39587788	255,102,0	1	105	0	.	Coil	1A.
chr17	39587788	39588100	O76014	0	-	39587788	39588100	255,102,0	1	312	0	.	Head.
chr17	39593666	39594352	O76015	0	-	39593666	39594352	255,102,0	1	686	0	.	Tail.
chr17	39594352	39595041	O76015	0	-	39594352	39595041	255,102,0	1	689	0	.	Coil	2.
chr17	39594352	39596861	O76015	0	-	39594352	39596861	255,102,0	1	2509	0	.	Rod.
chr17	39595041	39595089	O76015	0	-	39595041	39595089	255,102,0	1	48	0	.	Linker	12.
chr17	39595089	39596723	O76015	0	-	39595089	39596723	255,102,0	1	1634	0	.	Coil	1B.
chr17	39596723	39596756	O76015	0	-	39596723	39596756	255,102,0	1	33	0	.	Linker	1.
chr17	39596756	39596861	O76015	0	-	39596756	39596861	255,102,0	1	105	0	.	Coil	1A.
chr17	39596861	39597173	O76015	0	-	39596861	39597173	255,102,0	1	312	0	.	Head.
chr17	39616364	39619089	Q14532	0	-	39616364	39619089	255,102,0	1	2725	0	.	Tail.
chr17	39619089	39620626	Q14532	0	-	39619089	39620626	255,102,0	1	1537	0	.	Coil	2.
chr17	39619089	39623289	Q14532	0	-	39619089	39623289	255,102,0	1	4200	0	.	Rod.
chr17	39620626	39620674	Q14532	0	-	39620626	39620674	255,102,0	1	48	0	.	Linker	12.
chr17	39620674	39623151	Q14532	0	-	39620674	39623151	255,102,0	1	2477	0	.	Coil	1B.
chr17	39623151	39623184	Q14532	0	-	39623151	39623184	255,102,0	1	33	0	.	Linker	1.
chr17	39623184	39623289	Q14532	0	-	39623184	39623289	255,102,0	1	105	0	.	Coil	1A.
chr17	39623289	39623577	Q14532	0	-	39623289	39623577	255,102,0	1	288	0	.	Head.
chr17	39633310	39633777	Q92764	0	-	39633310	39633777	255,102,0	1	467	0	.	Tail.
chr17	39633777	39635178	Q92764	0	-	39633777	39635178	255,102,0	1	1401	0	.	Coil	2.
chr17	39633777	39637058	Q92764	0	-	39633777	39637058	255,102,0	1	3281	0	.	Rod.
chr17	39635178	39635226	Q92764	0	-	39635178	39635226	255,102,0	1	48	0	.	Linker	12.
chr17	39635226	39636920	Q92764	0	-	39635226	39636920	255,102,0	1	1694	0	.	Coil	1B.
chr17	39636920	39636953	Q92764	0	-	39636920	39636953	255,102,0	1	33	0	.	Linker	1.
chr17	39636953	39637058	Q92764	0	-	39636953	39637058	255,102,0	1	105	0	.	Coil	1A.
chr17	39637058	39637349	Q92764	0	-	39637058	39637349	255,102,0	1	291	0	.	Head.
chr17	39642630	39643209	O76013	0	-	39642630	39643209	255,102,0	1	579	0	.	Tail.
chr17	39643209	39643920	O76013	0	-	39643209	39643920	255,102,0	1	711	0	.	Coil	2.
chr17	39643209	39645837	O76013	0	-	39643209	39645837	255,102,0	1	2628	0	.	Rod.
chr17	39643920	39643968	O76013	0	-	39643920	39643968	255,102,0	1	48	0	.	Linker	12.
chr17	39643968	39645699	O76013	0	-	39643968	39645699	255,102,0	1	1731	0	.	Coil	1B.
chr17	39645699	39645732	O76013	0	-	39645699	39645732	255,102,0	1	33	0	.	Linker	1.
chr17	39645732	39645837	O76013	0	-	39645732	39645837	255,102,0	1	105	0	.	Coil	1A.
chr17	39645837	39646116	O76013	0	-	39645837	39646116	255,102,0	1	279	0	.	Head.
chr17	39657510	39658633	P13646	0	-	39657510	39658633	255,102,0	1	1123	0	.	Tail.
chr17	39658633	39659266	P13646	0	-	39658633	39659266	255,102,0	1	633	0	.	Coil	2.
chr17	39658633	39661493	P13646	0	-	39658633	39661493	255,102,0	1	2860	0	.	Rod.
chr17	39659266	39659335	P13646	0	-	39659266	39659335	255,102,0	1	69	0	.	Linker	12.
chr17	39659335	39661328	P13646	0	-	39659335	39661328	255,102,0	1	1993	0	.	Coil	1B.
chr17	39661328	39661385	P13646	0	-	39661328	39661385	255,102,0	1	57	0	.	Linker	1.
chr17	39661385	39661493	P13646	0	-	39661385	39661493	255,102,0	1	108	0	.	Coil	1A.
chr17	39661493	39661802	P13646	0	-	39661493	39661802	255,102,0	1	309	0	.	Head.
chr17	39670277	39671731	P19012	0	-	39670277	39671731	255,102,0	1	1454	0	.	Tail.
chr17	39671731	39672442	P19012	0	-	39671731	39672442	255,102,0	1	711	0	.	Coil	2.
chr17	39671731	39674767	P19012	0	-	39671731	39674767	255,102,0	1	3036	0	.	Rod.
chr17	39672442	39672502	P19012	0	-	39672442	39672502	255,102,0	1	60	0	.	Linker	12.
chr17	39672502	39674602	P19012	0	-	39672502	39674602	255,102,0	1	2100	0	.	Coil	1B.
chr17	39674602	39674659	P19012	0	-	39674602	39674659	255,102,0	1	57	0	.	Linker	1.
chr17	39674659	39674767	P19012	0	-	39674659	39674767	255,102,0	1	108	0	.	Coil	1A.
chr17	39674767	39675079	P19012	0	-	39674767	39675079	255,102,0	1	312	0	.	Head.
chr17	39679997	39680036	P08727	0	-	39679997	39680036	255,102,0	1	39	0	.	Rod-like	helical	tail.
chr17	39680027	39680723	P08727	0	-	39680027	39680723	255,102,0	1	696	0	.	Necessary	for	interaction	with	PNN.	Pubmed:10809736
chr17	39680036	39680708	P08727	0	-	39680036	39680708	255,102,0	1	672	0	.	Coil	2.
chr17	39680036	39684262	P08727	0	-	39680036	39684262	255,102,0	1	4226	0	.	Rod.
chr17	39680708	39680777	P08727	0	-	39680708	39680777	255,102,0	1	69	0	.	Linker	12.
chr17	39680777	39684100	P08727	0	-	39680777	39684100	255,102,0	1	3323	0	.	Coil	1B.
chr17	39684100	39684154	P08727	0	-	39684100	39684154	255,102,0	1	54	0	.	Linker	1.
chr17	39684154	39684262	P08727	0	-	39684154	39684262	255,102,0	1	108	0	.	Coil	1A.
chr17	39684262	39684499	P08727	0	-	39684262	39684499	255,102,0	1	237	0	.	Head.
chr17	39723527	39724424	P35527	0	-	39723527	39724424	255,102,0	1	897	0	.	Tail.
chr17	39724424	39725755	P35527	0	-	39724424	39725755	255,102,0	1	1331	0	.	Coil	2.
chr17	39724424	39727788	P35527	0	-	39724424	39727788	255,102,0	1	3364	0	.	Rod.
chr17	39725755	39725824	P35527	0	-	39725755	39725824	255,102,0	1	69	0	.	Linker	12.
chr17	39725824	39727623	P35527	0	-	39725824	39727623	255,102,0	1	1799	0	.	Coil	1B.
chr17	39727623	39727680	P35527	0	-	39727623	39727680	255,102,0	1	57	0	.	Linker	1.
chr17	39727680	39727788	P35527	0	-	39727680	39727788	255,102,0	1	108	0	.	Coil	1A.
chr17	39727788	39728244	P35527	0	-	39727788	39728244	255,102,0	1	456	0	.	Head.
chr17	39738689	39739488	P02533	0	-	39738689	39739488	255,102,0	1	799	0	.	Interaction	with	Type	I	keratins	and	keratin	filaments.
chr17	39738689	39739494	P02533	0	-	39738689	39739494	255,102,0	1	805	0	.	Tail.
chr17	39739494	39740089	P02533	0	-	39739494	39740089	255,102,0	1	595	0	.	Coil	2.
chr17	39739494	39742744	P02533	0	-	39739494	39742744	255,102,0	1	3250	0	.	Rod.
chr17	39740089	39740158	P02533	0	-	39740089	39740158	255,102,0	1	69	0	.	Linker	12.
chr17	39740158	39742582	P02533	0	-	39740158	39742582	255,102,0	1	2424	0	.	Coil	1B.
chr17	39742582	39742636	P02533	0	-	39742582	39742636	255,102,0	1	54	0	.	Linker	1.
chr17	39742636	39742744	P02533	0	-	39742636	39742744	255,102,0	1	108	0	.	Coil	1A.
chr17	39742744	39743086	P02533	0	-	39742744	39743086	255,102,0	1	342	0	.	Head.
chr17	39766189	39766590	P08779	0	-	39766189	39766590	255,102,0	1	401	0	.	Tail.
chr17	39766590	39767398	P08779	0	-	39766590	39767398	255,102,0	1	808	0	.	Coil	2.
chr17	39766590	39768592	P08779	0	-	39766590	39768592	255,102,0	1	2002	0	.	Rod.
chr17	39767398	39767467	P08779	0	-	39767398	39767467	255,102,0	1	69	0	.	Linker	12.
chr17	39767467	39768430	P08779	0	-	39767467	39768430	255,102,0	1	963	0	.	Coil	1B.
chr17	39768430	39768484	P08779	0	-	39768430	39768484	255,102,0	1	54	0	.	Linker	1.
chr17	39768484	39768592	P08779	0	-	39768484	39768592	255,102,0	1	108	0	.	Coil	1A.
chr17	39768592	39768940	P08779	0	-	39768592	39768940	255,102,0	1	348	0	.	Head.
chr17	39775848	39776915	Q04695	0	-	39775848	39776915	255,102,0	1	1067	0	.	Tail.
chr17	39776915	39777928	Q04695	0	-	39776915	39777928	255,102,0	1	1013	0	.	Coil	2.
chr17	39776915	39780512	Q04695	0	-	39776915	39780512	255,102,0	1	3597	0	.	Rod.
chr17	39777053	39777098	Q04695	0	-	39777053	39777098	255,102,0	1	45	0	.	Peptide	epitope	S4;	induces	T-cell	and	keratinocyte	proliferation	and	IFN-gamma	production.
chr17	39777928	39777988	Q04695	0	-	39777928	39777988	255,102,0	1	60	0	.	Linker	12.
chr17	39777988	39780347	Q04695	0	-	39777988	39780347	255,102,0	1	2359	0	.	Coil	1B.
chr17	39779215	39779260	Q04695	0	-	39779215	39779260	255,102,0	1	45	0	.	Peptide	epitope	S2;	induces	T-cell	proliferation	and	IFN-gamma	production.
chr17	39780347	39780401	Q04695	0	-	39780347	39780401	255,102,0	1	54	0	.	Linker	1.
chr17	39780401	39780512	Q04695	0	-	39780401	39780512	255,102,0	1	111	0	.	Coil	1A.
chr17	39780413	39780458	Q04695	0	-	39780413	39780458	255,102,0	1	45	0	.	Peptide	epitope	S1;	induces	T-cell	and	keratinocyte	proliferation	and	IFN-gamma	production.
chr17	39780512	39780761	Q04695	0	-	39780512	39780761	255,102,0	1	249	0	.	Head.
chr17	39913729	39914704	P14923	0	-	39913729	39914704	255,102,0	1	975	0	.	Interaction	with	DSC1.
chr17	39923648	39925744	P14923	0	-	39923648	39925744	255,102,0	1	2096	0	.	Interaction	with	DSC1	and	DSG1.
chr17	39985137	39985143	Q969T7	0	-	39985137	39985143	255,102,0	1	6	0	.	Substrate	binding.
chr17	40035075	40035108	P53396	0	-	40035075	40035108	255,102,0	1	33	0	.	CoA-binding.
chr17	40173595	40175908	Q9NYR9	0	+	40173595	40175908	255,102,0	1	2313	0	.	Small	GTPase-like.
chr17	40253850	40255666	Q96C10	0	-	40253850	40255666	255,102,0	1	1816	0	.	RNA-binding.
chr17	40267755	40267767	Q92830	0	-	40267755	40267767	255,102,0	1	12	0	.	Acetyl-CoA	binding.	Pubmed:17410582
chr17	40267839	40269061	Q92830	0	-	40267839	40269061	255,102,0	1	1222	0	.	Acetyl-CoA	binding.	Pubmed:17410582
chr17	40269073	40269082	Q92830	0	-	40269073	40269082	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:17410582
chr17	40370766	40371469	P51692	0	-	40370766	40371469	255,102,0	1	703	0	.	Required	for	interaction	with	NMI.	Pubmed:9989503
chr17	40715177	40716753	Q13057	0	+	40715177	40716753	255,102,0	1	1576	0	.	Phosphopantetheine	adenylyltransferase.
chr17	40720940	40721263	Q9UH92	0	+	40720940	40721263	255,102,0	1	323	0	.	Leucine-zipper.
chr17	40725175	40725627	Q9P2W1	0	-	40725175	40725627	255,102,0	1	452	0	.	DNA	binding.
chr17	40962780	40962858	Q14457	0	-	40962780	40962858	255,102,0	1	78	0	.	Required	for	membrane-association.	Pubmed:23878393
chr17	40970572	40970822	Q14457	0	-	40970572	40970822	255,102,0	1	250	0	.	Interaction	with	BCL2	and	BCL2L1	isoform	Bcl-X(L).	Pubmed:17446862
chr17	40997774	40997807	O75106	0	+	40997774	40997807	255,102,0	1	33	0	.	Substrate	binding.
chr17	40998026	40998044	O75106	0	+	40998026	40998044	255,102,0	1	18	0	.	Substrate	binding.
chr17	41001233	41001257	O75106	0	+	41001233	41001257	255,102,0	1	24	0	.	Heparin-binding.
chr17	41004509	41004542	Q16853	0	+	41004509	41004542	255,102,0	1	33	0	.	Substrate	binding.
chr17	41004761	41004779	Q16853	0	+	41004761	41004779	255,102,0	1	18	0	.	Substrate	binding.
chr17	41158976	41164252	P80217	0	+	41158976	41164252	255,102,0	1	5276	0	.	Leucine-zipper.
chr17	41234505	41234589	P38398	0	-	41234505	41234589	255,102,0	1	84	0	.	Interaction	with	PALB2.	Pubmed:19369211
chr17	41346465	41349005	Q14596	0	+	41346465	41349005	255,102,0	1	2540	0	.	ATG8	family	protein-binding.
chr17	41352335	41352371	Q14596	0	+	41352335	41352371	255,102,0	1	36	0	.	ATG8	family	protein-binding.
chr17	42082085	42084722	Q8N159	0	+	42082085	42084722	255,102,0	1	2637	0	.	Amino-acid	kinase	domain	(AAK).
chr17	42085109	42085127	Q8N159	0	+	42085109	42085127	255,102,0	1	18	0	.	Substrate	binding.
chr17	42156241	42162524	Q9UQL6	0	-	42156241	42162524	255,102,0	1	6283	0	.	Histone	deacetylase.
chr17	42332574	42333166	P02730	0	-	42332574	42333166	255,102,0	1	592	0	.	Involved	in	anion	transport.
chr17	42335796	42335958	P02730	0	-	42335796	42335958	255,102,0	1	162	0	.	Dimerization	arm.
chr17	42336536	42338948	P02730	0	-	42336536	42338948	255,102,0	1	2412	0	.	Globular.
chr17	42337230	42337260	P02730	0	-	42337230	42337260	255,102,0	1	30	0	.	Interaction	with	ANK1.
chr17	42386200	42392918	Q59EK9	0	+	42386200	42392918	255,102,0	1	6718	0	.	Interaction	with	RAP2A.
chr17	42984717	42988022	P14136	0	-	42984717	42988022	255,102,0	1	3305	0	.	Tail.
chr17	42988022	42990648	P14136	0	-	42988022	42990648	255,102,0	1	2626	0	.	Coil	2B.
chr17	42988022	42992638	P14136	0	-	42988022	42992638	255,102,0	1	4616	0	.	Rod.
chr17	42990648	42990660	P14136	0	-	42990648	42990660	255,102,0	1	12	0	.	Linker	2.
chr17	42990660	42990726	P14136	0	-	42990660	42990726	255,102,0	1	66	0	.	Coil	2A.
chr17	42990726	42990774	P14136	0	-	42990726	42990774	255,102,0	1	48	0	.	Linker	12.
chr17	42990774	42992509	P14136	0	-	42990774	42992509	255,102,0	1	1735	0	.	Coil	1B.
chr17	42992509	42992542	P14136	0	-	42992509	42992542	255,102,0	1	33	0	.	Linker	1.
chr17	42992542	42992638	P14136	0	-	42992542	42992638	255,102,0	1	96	0	.	Coil	1A.
chr17	42992638	42992854	P14136	0	-	42992638	42992854	255,102,0	1	216	0	.	Head.
chr17	43163986	43163995	P30419	0	+	43163986	43163995	255,102,0	1	9	0	.	Myristoyl-CoA	binding.	Pubmed:25255805
chr17	43175777	43175786	P30419	0	+	43175777	43175786	255,102,0	1	9	0	.	Myristoyl-CoA	binding.	Pubmed:25255805
chr17	43175801	43175816	P30419	0	+	43175801	43175816	255,102,0	1	15	0	.	Myristoyl-CoA	binding.	Pubmed:25255805
chr17	43198599	43198686	Q8N3E9	0	-	43198599	43198686	255,102,0	1	87	0	.	Substrate	binding.
chr17	43213577	43213874	Q8NC06	0	+	43213577	43213874	255,102,0	1	297	0	.	Acyl-CoA	binding.
chr17	43213904	43213919	Q8NC06	0	+	43213904	43213919	255,102,0	1	15	0	.	Acyl-CoA	binding.
chr17	43227004	43227088	O94992	0	+	43227004	43227088	255,102,0	1	84	0	.	Basic	region;	mediates	nuclear	localization	and	interaction	with	7SK	snRNA	and	NR3C1.	Pubmed:15941832
chr17	43227160	43227172	O94992	0	+	43227160	43227172	255,102,0	1	12	0	.	Interaction	with	P-TEFb.
chr17	43227184	43227307	O94992	0	+	43227184	43227307	255,102,0	1	123	0	.	Autoinhibitory	acidic	region;	in	absence	of	7SK	snRNA	interacts	with	the	basic	region	preventing	interaction	with	P-TEFb	and	modulating	subcellular	localization.
chr17	43227412	43227499	O94992	0	+	43227412	43227499	255,102,0	1	87	0	.	Mediates	interaction	with	CCNT1.
chr17	43227484	43227622	O94992	0	+	43227484	43227622	255,102,0	1	138	0	.	Required	for	inhibition	of	ESR1-dependent	transcription.
chr17	43246732	43246744	Q96MH2	0	+	43246732	43246744	255,102,0	1	12	0	.	Interaction	with	P-TEFb.
chr17	43246990	43247173	Q96MH2	0	+	43246990	43247173	255,102,0	1	183	0	.	Interaction	with	CCNT1,	HEXIM1	and	HEXIM2.	Pubmed:15713661,	Pubmed:15994294
chr17	43347792	43362268	Q99558	0	-	43347792	43362268	255,102,0	1	14476	0	.	Interaction	with	ZFP91.	Pubmed:20682767
chr17	43515158	43531192	Q9Y4G2	0	-	43515158	43531192	255,102,0	1	16034	0	.	Interaction	with	RAB7A.	Pubmed:25500191
chr17	43515226	43531258	Q9Y4G2	0	-	43515226	43531258	255,102,0	1	16032	0	.	Interaction	with	RAB7A.	Pubmed:25500191
chr17	43515228	43530913	Q9Y4G2	0	-	43515228	43530913	255,102,0	1	15685	0	.	Interaction	with	RAB7A.	Pubmed:25500191
chr17	43898773	43898803	P34998	0	+	43898773	43898803	255,102,0	1	30	0	.	Important	for	peptide	agonist	binding.
chr17	43910392	43910422	P34998	0	+	43910392	43910422	255,102,0	1	30	0	.	Important	for	peptide	agonist	binding.
chr17	43910570	43910844	P34998	0	+	43910570	43910844	255,102,0	1	274	0	.	Important	for	antagonist	binding.
chr17	43922189	43922463	P34998	0	+	43922189	43922463	255,102,0	1	274	0	.	Important	for	antagonist	binding.
chr17	44341535	44341809	P34998	0	-	44341535	44341809	255,102,0	1	274	0	.	Important	for	antagonist	binding.
chr17	44353615	44353645	P34998	0	-	44353615	44353645	255,102,0	1	30	0	.	Important	for	peptide	agonist	binding.
chr17	45362053	45363641	P05106	0	+	45362053	45363641	255,102,0	1	1588	0	.	Involved	in	CX3CL1-,	NRG1-,	FGF1-	and	IGF1-binding.	Pubmed:20682778,	Pubmed:23125415
chr17	45364534	45364597	P05106	0	+	45364534	45364597	255,102,0	1	63	0	.	CX3CL1-binding.	Pubmed:24789099
chr17	45369630	45376870	P05106	0	+	45369630	45376870	255,102,0	1	7240	0	.	Cysteine-rich	tandem	repeats.
chr17	45663729	45663744	P55786	0	+	45663729	45663744	255,102,0	1	15	0	.	Substrate	binding.
chr17	45742509	45745578	Q14974	0	+	45742509	45745578	255,102,0	1	3069	0	.	IAB-binding.
chr17	45745551	45747076	Q14974	0	+	45745551	45747076	255,102,0	1	1525	0	.	Ran-GTP	binding.
chr17	45773478	45777028	A7MCY6	0	+	45773478	45777028	255,102,0	1	3550	0	.	Homodimerization.
chr17	45777028	45785874	A7MCY6	0	+	45777028	45785874	255,102,0	1	8846	0	.	Interaction	with	TBK1	and	IKBKE.
chr17	46019152	46019164	V9HW45	0	+	46019152	46019164	255,102,0	1	12	0	.	Substrate	binding.
chr17	46019164	46019176	Q9NVS9	0	+	46019164	46019176	255,102,0	1	12	0	.	Pyridoxal	5'-phosphate	binding.
chr17	46024034	46024043	Q9NVS9	0	+	46024034	46024043	255,102,0	1	9	0	.	Pyridoxal	5'-phosphate	binding.
chr17	46024034	46024043	V9HW45	0	+	46024034	46024043	255,102,0	1	9	0	.	Substrate	binding.
chr17	46054083	46058865	Q96JB5	0	+	46054083	46058865	255,102,0	1	4782	0	.	Required	for	interaction	with	UFL1	and	mediates	interaction	with	CHEK1.	Pubmed:19223857,	Pubmed:20228063
chr17	46136649	46136709	Q14494	0	+	46136649	46136709	255,102,0	1	60	0	.	Basic	motif.
chr17	46136727	46136772	Q14494	0	+	46136727	46136772	255,102,0	1	45	0	.	Leucine-zipper.
chr17	46196411	46196426	Q9Y5W9	0	+	46196411	46196426	255,102,0	1	15	0	.	Important	for	membrane	trafficking.
chr17	46239923	46247980	Q86WV1	0	-	46239923	46247980	255,102,0	1	8057	0	.	Interaction	with	FYB.
chr17	46937777	46937810	Q13137	0	+	46937777	46937810	255,102,0	1	33	0	.	Interaction	with	LGALS8.	Pubmed:23386746,	Pubmed:23511477
chr17	46940208	46940364	Q13137	0	+	46940208	46940364	255,102,0	1	156	0	.	Interaction	with	MYO6.	Pubmed:17635994
chr17	47115686	47126782	Q9NZI8	0	+	47115686	47126782	255,102,0	1	11096	0	.	Necessary	for	interaction	with	ELAVL4	and	binding	to	TAU	mRNA.
chr17	47118848	47119634	Q9NZI8	0	+	47118848	47119634	255,102,0	1	786	0	.	Sufficient	for	nuclear	export.
chr17	47123308	47123341	Q9NZI8	0	+	47123308	47123341	255,102,0	1	33	0	.	Sufficient	for	nuclear	export.
chr17	47375777	47376104	Q9Y2D9	0	-	47375777	47376104	255,102,0	1	327	0	.	Mediates	interaction	with	CBFA2T3.	Pubmed:16966434
chr17	47589407	47590110	P08138	0	+	47589407	47590110	255,102,0	1	703	0	.	Mediates	interaction	with	KIDINS220.
chr17	47655969	47656128	O95157	0	+	47655969	47656128	255,102,0	1	159	0	.	II.
chr17	47656128	47656374	O95157	0	+	47656128	47656374	255,102,0	1	246	0	.	III.
chr17	47656374	47656401	O95157	0	+	47656374	47656401	255,102,0	1	27	0	.	IV	(linker	domain).
chr17	47656401	47656659	O95157	0	+	47656401	47656659	255,102,0	1	258	0	.	V	(Cys-rich).
chr17	47677799	47679318	O43791	0	-	47677799	47679318	255,102,0	1	1519	0	.	Important	for	homodimerization.
chr17	47688648	47688744	O43791	0	-	47688648	47688744	255,102,0	1	96	0	.	Important	for	homodimerization.
chr17	47688726	47696737	O43791	0	-	47688726	47696737	255,102,0	1	8011	0	.	Required	for	nuclear	localization.
chr17	47696423	47696456	O43791	0	-	47696423	47696456	255,102,0	1	33	0	.	Important	for	binding	substrate	proteins.
chr17	47900599	47900608	O95251	0	+	47900599	47900608	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr17	47900620	47900641	O95251	0	+	47900620	47900641	255,102,0	1	21	0	.	Acetyl-CoA	binding.
chr17	48165230	48165606	P26006	0	+	48165230	48165606	255,102,0	1	376	0	.	Interaction	with	HPS5.
chr17	48557265	48557271	Q9HA92	0	+	48557265	48557271	255,102,0	1	6	0	.	S-adenosyl-L-methionine	2	binding.
chr17	48617676	48618392	Q9H201	0	+	48617676	48618392	255,102,0	1	716	0	.	5	X	3	AA	repeats	of	[DE]-P-W.
chr17	48619039	48619512	Q9H201	0	+	48619039	48619512	255,102,0	1	473	0	.	3	X	3	AA	repeats	of	N-P-F.
chr17	48940724	48940898	P50616	0	-	48940724	48940898	255,102,0	1	174	0	.	Required	for	interaction	with	CPEB3.	Pubmed:21336257
chr17	48941102	48941135	P50616	0	-	48941102	48941135	255,102,0	1	33	0	.	Important	for	nuclear	localization.
chr17	49244191	49245674	P22392	0	+	49244191	49245674	255,102,0	1	1483	0	.	Interaction	with	AKAP13.	Pubmed:15249197
chr17	53024664	53026881	O75674	0	+	53024664	53026881	255,102,0	1	2217	0	.	Interaction	with	GRB2.
chr17	53027440	53027452	O75674	0	+	53027440	53027452	255,102,0	1	12	0	.	Interaction	with	PIK3R1.
chr17	53398030	53398093	Q16534	0	+	53398030	53398093	255,102,0	1	63	0	.	Basic	motif.
chr17	53398093	53398117	Q16534	0	+	53398093	53398117	255,102,0	1	24	0	.	Leucine-zipper.
chr17	54972716	54990812	Q14258	0	-	54972716	54990812	255,102,0	1	18096	0	.	Interaction	with	influenza	A	virus	NS1.
chr17	55019482	55027447	P38432	0	-	55019482	55027447	255,102,0	1	7965	0	.	2	X	4	AA	repeats	of	S-L-P-A.
chr17	55027342	55027366	P38432	0	-	55027342	55027366	255,102,0	1	24	0	.	4	X	2	AA	tandem	repeats	of	R-G.
chr17	55027342	55027429	P38432	0	-	55027342	55027429	255,102,0	1	87	0	.	Required	for	interaction	with	SMN.	Pubmed:11641277
chr17	55027789	55027936	P38432	0	-	55027789	55027936	255,102,0	1	147	0	.	2	X	4	AA	repeats	of	A-R-N-S.
chr17	55183854	55183896	Q92667	0	+	55183854	55183896	255,102,0	1	42	0	.	PKA-RII	subunit	binding	domain.
chr17	56051944	56052220	Q14119	0	-	56051944	56052220	255,102,0	1	276	0	.	4	X	7	AA	repeats	of	P-[LV]-T-[IL]-T-[ST]-P.
chr17	56082772	56082922	Q07955	0	-	56082772	56082922	255,102,0	1	150	0	.	Interaction	with	SAFB1.
chr17	56428818	56429493	P63272	0	-	56428818	56429493	255,102,0	1	675	0	.	Interaction	with	SUPT5H.
chr17	56582199	56582220	Q9NYA4	0	-	56582199	56582220	255,102,0	1	21	0	.	Substrate	binding.
chr17	56582897	56582903	Q9NYA4	0	-	56582897	56582903	255,102,0	1	6	0	.	Substrate	binding.
chr17	56584125	56584137	Q9NYA4	0	-	56584125	56584137	255,102,0	1	12	0	.	Substrate	binding.
chr17	56770004	56772524	O43502	0	+	56770004	56772524	255,102,0	1	2520	0	.	Required	for	Holliday	junction	resolution	activity.
chr17	56772380	56774057	O43502	0	+	56772380	56774057	255,102,0	1	1677	0	.	Interaction	with	RAD51B,	RAD51D	and	XRCC3.	Pubmed:14704354
chr17	57697495	57741271	Q00610	0	+	57697495	57741271	255,102,0	1	43776	0	.	Globular	terminal	domain.
chr17	57721663	57721795	Q00610	0	+	57721663	57721795	255,102,0	1	132	0	.	WD40-like	repeat	1.
chr17	57721795	57724829	Q00610	0	+	57721795	57724829	255,102,0	1	3034	0	.	WD40-like	repeat	2.
chr17	57724829	57724955	Q00610	0	+	57724829	57724955	255,102,0	1	126	0	.	WD40-like	repeat	3.
chr17	57724955	57725666	Q00610	0	+	57724955	57725666	255,102,0	1	711	0	.	WD40-like	repeat	4.
chr17	57725666	57728653	Q00610	0	+	57725666	57728653	255,102,0	1	2987	0	.	WD40-like	repeat	5.
chr17	57728653	57733322	Q00610	0	+	57728653	57733322	255,102,0	1	4669	0	.	WD40-like	repeat	6.
chr17	57733322	57737772	Q00610	0	+	57733322	57737772	255,102,0	1	4450	0	.	WD40-like	repeat	7.
chr17	57738980	57741229	Q00610	0	+	57738980	57741229	255,102,0	1	2249	0	.	Binding	site	for	the	uncoating	ATPase,	involved	in	lattice	disassembly.
chr17	57741202	57741355	Q00610	0	+	57741202	57741355	255,102,0	1	153	0	.	Involved	in	spindle	localization	and	interaction	with	TACC3.	Pubmed:23918938
chr17	57741271	57742195	Q00610	0	+	57741271	57742195	255,102,0	1	924	0	.	Flexible	linker.
chr17	57742195	57743960	Q00610	0	+	57742195	57743960	255,102,0	1	1765	0	.	Distal	segment.
chr17	57742195	57771210	Q00610	0	+	57742195	57771210	255,102,0	1	29015	0	.	Heavy	chain	arm.
chr17	57743972	57771210	Q00610	0	+	57743972	57771210	255,102,0	1	27238	0	.	Proximal	segment.
chr17	57760025	57762548	Q00610	0	+	57760025	57762548	255,102,0	1	2523	0	.	Involved	in	binding	clathrin	light	chain.
chr17	57762989	57771210	Q00610	0	+	57762989	57771210	255,102,0	1	8221	0	.	Trimerization.
chr17	58022808	58024146	P23443	0	+	58022808	58024146	255,102,0	1	1338	0	.	Autoinhibitory	domain.
chr17	58235735	58235741	P22748	0	+	58235735	58235741	255,102,0	1	6	0	.	Substrate	binding.
chr17	58677775	58678078	O15297	0	+	58677775	58678078	255,102,0	1	303	0	.	Interaction	with	CHEK1.	Pubmed:15870257
chr17	59483062	59485531	Q13207	0	+	59483062	59485531	255,102,0	1	2469	0	.	Repression	domain	1	(RD1).
chr17	61554542	61561871	P12821	0	+	61554542	61561871	255,102,0	1	7329	0	.	Peptidase	M2	1.
chr17	61561871	61574502	P12821	0	+	61561871	61574502	255,102,0	1	12631	0	.	Peptidase	M2	2.
chr17	61895152	61895440	Q86XP3	0	+	61895152	61895440	255,102,0	1	288	0	.	Necessary	for	interaction	with	TP53BP2.	Pubmed:19377511
chr17	61908171	61909326	P62195	0	+	61908171	61909326	255,102,0	1	1155	0	.	May	mediate	interaction	with	PRPF9.
chr17	62496043	62496679	P17844	0	-	62496043	62496679	255,102,0	1	636	0	.	Transactivation	domain.
chr17	64208253	64210766	P02749	0	-	64208253	64210766	255,102,0	1	2513	0	.	Sushi-like.
chr17	65871724	65887964	Q12830	0	+	65871724	65887964	255,102,0	1	16240	0	.	Interaction	with	KEAP1.	Pubmed:15379550
chr17	65889566	65889815	Q12830	0	+	65889566	65889815	255,102,0	1	249	0	.	Interaction	with	MAZ.	Pubmed:10727212
chr17	66038321	66039263	P52292	0	+	66038321	66039263	255,102,0	1	942	0	.	NLS	binding	site	(major).
chr17	66039965	66040481	P52292	0	+	66039965	66040481	255,102,0	1	516	0	.	NLS	binding	site	(minor).
chr17	66511540	66519925	P10644	0	+	66511540	66519925	255,102,0	1	8385	0	.	Dimerization	and	phosphorylation.
chr17	67411134	67501961	P52564	0	+	67411134	67501961	255,102,0	1	90827	0	.	D	domain.
chr17	67537819	67537891	P52564	0	+	67537819	67537891	255,102,0	1	72	0	.	DVD	domain.
chr17	73235456	73237532	Q9NZ52	0	-	73235456	73237532	255,102,0	1	2076	0	.	Unstructured	hinge.
chr17	73237487	73257668	Q9NZ52	0	-	73237487	73257668	255,102,0	1	20181	0	.	Binds	to	ARF1	(in	long	isoform).
chr17	73625327	73625549	O94762	0	-	73625327	73625549	255,102,0	1	222	0	.	Interaction	with	RAD51.
chr17	73625874	73627310	O94762	0	-	73625874	73627310	255,102,0	1	1436	0	.	Interaction	with	POLR2A.
chr17	73725358	73725376	P16144	0	+	73725358	73725376	255,102,0	1	18	0	.	Involved	in	NRG1-	and	IGF1-binding.	Pubmed:20682778,	Pubmed:22351760
chr17	73728042	73732464	P16144	0	+	73728042	73732464	255,102,0	1	4422	0	.	Cysteine-rich	tandem	repeats.
chr17	73733698	73735779	P16144	0	+	73733698	73735779	255,102,0	1	2081	0	.	Palmitoylated	on	several	cysteines.
chr17	73759147	73759159	P51570	0	-	73759147	73759159	255,102,0	1	12	0	.	Substrate	binding.
chr17	73761079	73761091	P51570	0	-	73761079	73761091	255,102,0	1	12	0	.	Substrate	binding.
chr17	73831825	73836623	Q70J99	0	-	73831825	73836623	255,102,0	1	4798	0	.	Interaction	with	RAB27A.
chr17	74003186	74004266	Q92817	0	-	74003186	74004266	255,102,0	1	1080	0	.	Globular	2.
chr17	74004266	74007897	Q92817	0	-	74004266	74007897	255,102,0	1	3631	0	.	Central	fibrous	rod	domain.
chr17	74007897	74023279	Q92817	0	-	74007897	74023279	255,102,0	1	15382	0	.	Globular	1.
chr17	74023195	74023246	Q92817	0	-	74023195	74023246	255,102,0	1	51	0	.	4	X	4	AA	tandem	repeats	of	K-G-S-P.
chr17	74382372	74382384	Q9NYA1	0	+	74382372	74382384	255,102,0	1	12	0	.	Substrate	binding.
chr17	74465797	74465806	Q16613	0	+	74465797	74465806	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr17	74465821	74465839	Q16613	0	+	74465821	74465839	255,102,0	1	18	0	.	Acetyl-CoA	binding.
chr17	74465929	74465938	Q16613	0	+	74465929	74465938	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chr17	74527098	74533576	Q8WWM9	0	-	74527098	74533576	255,102,0	1	6478	0	.	Globin.
chr17	75139678	75205477	Q92503	0	+	75139678	75205477	255,102,0	1	65799	0	.	Required	for	interaction	and	inhibitory	function	toward	DDX58.	Pubmed:23843640
chr17	76045143	76064004	Q9HCJ0	0	+	76045143	76064004	255,102,0	1	18861	0	.	Sufficient	for	interaction	with	argonaute	family	proteins.
chr17	76083149	76100923	Q9HCJ0	0	+	76083149	76100923	255,102,0	1	17774	0	.	Silencing	domain;	interaction	with	CNOT1	and	PAN3.	Pubmed:21981923
chr17	76089153	76089789	Q9HCJ0	0	+	76089153	76089789	255,102,0	1	636	0	.	Required	for	interaction	with	PABPC1.
chr17	76089153	76100923	Q9HCJ0	0	+	76089153	76100923	255,102,0	1	11770	0	.	Sufficient	for	translational	repression	when	tethered	to	a	target	mRNA.
chr17	76089183	76089735	Q9HCJ0	0	+	76089183	76089735	255,102,0	1	552	0	.	PABPC1-interacting	motif-2	(PAM2).
chr17	76100638	76100923	Q9HCJ0	0	+	76100638	76100923	255,102,0	1	285	0	.	Interaction	with	the	CCR4-NOT	complex.
chr17	76171016	76171031	P04183	0	-	76171016	76171031	255,102,0	1	15	0	.	Substrate	binding.	Pubmed:15733844,	Pubmed:15611477,	Pubmed:22385435
chr17	76355041	76355077	O14543	0	-	76355041	76355077	255,102,0	1	36	0	.	Extended	SH2	subdomain	(ESS).
chr17	76355077	76355113	O14543	0	-	76355077	76355113	255,102,0	1	36	0	.	Kinase	inhibitory	region	(KIR).
chr17	76672181	76672208	Q15438	0	-	76672181	76672208	255,102,0	1	27	0	.	C-terminal	autoinhibitory	region.
chr17	76688558	76694357	Q15438	0	-	76688558	76694357	255,102,0	1	5799	0	.	Phosphatidylinositol	3,4,5-trisphosphate	binding.
chr17	76867031	76867037	P16035	0	-	76867031	76867037	255,102,0	1	6	0	.	Involved	in	metalloproteinase-binding.
chr17	76921077	76921092	P16035	0	-	76921077	76921092	255,102,0	1	15	0	.	Involved	in	metalloproteinase-binding.
chr17	77807760	77807823	O00257	0	-	77807760	77807823	255,102,0	1	63	0	.	Interaction	with	RNF2.
chr17	77807823	77813050	O00257	0	-	77807823	77813050	255,102,0	1	5227	0	.	Interaction	with	BMI1.
chr17	78972177	78972213	Q96FZ7	0	+	78972177	78972213	255,102,0	1	36	0	.	Interaction	with	VPS4A.
chr17	79660542	79663699	O14964	0	+	79660542	79663699	255,102,0	1	3157	0	.	Interaction	with	SNX1.
chr17	79662968	79663699	O14964	0	+	79662968	79663699	255,102,0	1	731	0	.	Interaction	with	SNAP25	and	TRAK2.
chr17	79662995	79663862	O14964	0	+	79662995	79663862	255,102,0	1	867	0	.	Interaction	with	STAM.
chr17	79663430	79668645	O14964	0	+	79663430	79668645	255,102,0	1	5215	0	.	Interaction	with	NF2.	Pubmed:10861283
chr17	79880690	79880735	O15525	0	-	79880690	79880735	255,102,0	1	45	0	.	Leucine-zipper.
chr17	79880741	79880813	O15525	0	-	79880741	79880813	255,102,0	1	72	0	.	Basic	motif.
chr17	79966927	79967413	Q9BZE9	0	+	79966927	79967413	255,102,0	1	486	0	.	Interaction	with	GLUT4.
chr17	80037021	80038775	P49327	0	-	80037021	80038775	255,102,0	1	1754	0	.	Thioesterase.
chr17	80039528	80040967	P49327	0	-	80039528	80040967	255,102,0	1	1439	0	.	Beta-ketoacyl	reductase.
chr17	80040967	80042126	P49327	0	-	80040967	80042126	255,102,0	1	1159	0	.	Enoyl	reductase.
chr17	80046407	80049305	P49327	0	-	80046407	80049305	255,102,0	1	2898	0	.	Acyl	and	malonyl	transferases.
chr17	80049347	80054321	P49327	0	-	80049347	80054321	255,102,0	1	4974	0	.	Beta-ketoacyl	synthase.
chr17	80206855	80209308	P48730	0	-	80206855	80209308	255,102,0	1	2453	0	.	Centrosomal	localization	signal	(CLS).
chr17	80207337	80207415	P48730	0	-	80207337	80207415	255,102,0	1	78	0	.	Autoinhibitory.
chr17	80274142	80274250	P09564	0	-	80274142	80274250	255,102,0	1	108	0	.	4	X	9	AA	tandem	repeats,	potential	spacer	function.
chr17	80478148	80521323	Q01167	0	+	80478148	80521323	255,102,0	1	43175	0	.	Required	for	interaction	with	DVL2	and	SUDS3.	Pubmed:25805136
chr17	80529734	80540661	Q01167	0	+	80529734	80540661	255,102,0	1	10927	0	.	DNA-binding;	major	groove.
chr17	80540688	80540703	Q01167	0	+	80540688	80540703	255,102,0	1	15	0	.	DNA-binding;	minor	groove.
chr17	80540748	80540766	Q01167	0	+	80540748	80540766	255,102,0	1	18	0	.	DNA-binding;	minor	groove.
chr18	677421	677430	Q7L5Y1	0	-	677421	677430	255,102,0	1	9	0	.	Substrate	binding.
chr18	712509	712518	Q7L5Y1	0	-	712509	712518	255,102,0	1	9	0	.	Substrate	binding.
chr18	909552	909579	P18509	0	+	909552	909579	255,102,0	1	27	0	.	Important	for	receptor	binding.
chr18	2572984	2587909	O14777	0	+	2572984	2587909	255,102,0	1	14925	0	.	Nuclear	localization.
chr18	2572984	2599131	O14777	0	+	2572984	2599131	255,102,0	1	26147	0	.	Interaction	with	the	N-terminus	of	CDCA1.
chr18	2578045	2587912	O14777	0	+	2578045	2587912	255,102,0	1	9867	0	.	Interaction	with	RB1.
chr18	2587909	2599089	O14777	0	+	2587909	2599089	255,102,0	1	11180	0	.	Interaction	with	SMC1A.
chr18	2587909	2616498	O14777	0	+	2587909	2616498	255,102,0	1	28589	0	.	Interaction	with	NEK2	and	ZWINT.	Pubmed:16732327
chr18	2595479	2608782	O14777	0	+	2595479	2608782	255,102,0	1	13303	0	.	Interaction	with	PSMC2	and	SMC1A.
chr18	2599131	2616570	O14777	0	+	2599131	2616570	255,102,0	1	17439	0	.	Interaction	with	the	C-terminus	of	CDCA1	and	the	SPBC24-SPBC25	subcomplex.
chr18	2920810	2925257	Q92539	0	-	2920810	2925257	255,102,0	1	4447	0	.	C-LIP.
chr18	2951318	2960838	Q92539	0	-	2951318	2960838	255,102,0	1	9520	0	.	N-LIP.
chr18	3188865	3188973	P52179	0	-	3188865	3188973	255,102,0	1	108	0	.	6	X	6	AA	tandem	repeats.
chr18	3567495	3567531	O14490	0	-	3567495	3567531	255,102,0	1	36	0	.	Interaction	with	DYL2.
chr18	3567561	3581890	O14490	0	-	3567561	3581890	255,102,0	1	14329	0	.	Interaction	with	DYL2.
chr18	5145671	5145722	P0CW23	0	-	5145671	5145722	255,102,0	1	51	0	.	PKA-RII	subunit	binding	domain.
chr18	5394696	5397317	Q9Y2J2	0	-	5394696	5397317	255,102,0	1	2621	0	.	C-terminal	(CTD).
chr18	5397317	5416344	Q9Y2J2	0	-	5397317	5416344	255,102,0	1	19027	0	.	Spectrin--actin-binding.
chr18	5416344	5423536	Q9Y2J2	0	-	5416344	5423536	255,102,0	1	7192	0	.	Hydrophilic.
chr18	6976076	6997881	P25391	0	-	6976076	6997881	255,102,0	1	21805	0	.	Domain	II	and	I.
chr18	8376193	8376475	P28827	0	+	8376193	8376475	255,102,0	1	282	0	.	Substrate	binding.
chr18	8705658	8706405	Q9Y4B5	0	+	8705658	8706405	255,102,0	1	747	0	.	Necessary	for	colocalization	and	binding	with	microtubules.
chr18	8705658	8783554	Q9Y4B5	0	+	8705658	8783554	255,102,0	1	77896	0	.	Necessary	for	self-assembly,	microtubule	bundling	activity	and	apicobasal	microtubule	organization.
chr18	8813207	8821497	Q9Y4B5	0	+	8813207	8821497	255,102,0	1	8290	0	.	Necessary	for	interaction	with	MARK2	and	apicobasal	microtubule	bundle	formation	in	polarized	epithelial	cells.	Pubmed:23902687
chr18	8825582	8825870	Q9Y4B5	0	+	8825582	8825870	255,102,0	1	288	0	.	Necessary	for	colocalization	and	binding	with	microtubules.
chr18	9524744	9533374	Q15311	0	+	9524744	9533374	255,102,0	1	8630	0	.	Interaction	with	RalA.
chr18	9886812	9887802	Q86VQ3	0	+	9886812	9887802	255,102,0	1	990	0	.	22	X	15	AA	approximate	tandem	repeat	of	Q-P-K-X-G-D-I-P-K-S-[PS]-E-[KE]-X-I.
chr18	11851903	11851978	Q7LBR1	0	+	11851903	11851978	255,102,0	1	75	0	.	Interaction	with	IST1.
chr18	11852029	11852107	Q7LBR1	0	+	11852029	11852107	255,102,0	1	78	0	.	Interaction	with	SPAST.	Pubmed:15537668
chr18	11852047	11852098	Q7LBR1	0	+	11852047	11852098	255,102,0	1	51	0	.	Interaction	with	VPS4A,	MITD1	and	STAMBP.	Pubmed:19129480
chr18	11852047	11852107	Q7LBR1	0	+	11852047	11852107	255,102,0	1	60	0	.	Interaction	with	VTA1.
chr18	11852056	11852107	Q7LBR1	0	+	11852056	11852107	255,102,0	1	51	0	.	Interaction	with	VPS4B.
chr18	12009957	12009969	O14732	0	+	12009957	12009969	255,102,0	1	12	0	.	Substrate	binding.
chr18	12028853	12028862	O14732	0	+	12028853	12028862	255,102,0	1	9	0	.	Substrate	binding.
chr18	12454392	12454455	Q08AE8	0	-	12454392	12454455	255,102,0	1	63	0	.	Spir-box.
chr18	12546861	12546885	Q08AE8	0	-	12546861	12546885	255,102,0	1	24	0	.	Important	for	interaction	with	FMN2.
chr18	12794279	12794399	P17706	0	-	12794279	12794399	255,102,0	1	120	0	.	Mediates	interaction	with	STX17.	Pubmed:23006999
chr18	12794279	12801973	P17706	0	-	12794279	12801973	255,102,0	1	7694	0	.	Endoplasmic	reticulum	location.
chr18	12817193	12817214	A8K3N4	0	-	12817193	12817214	255,102,0	1	21	0	.	Substrate	binding.
chr18	12817193	12817214	K7EQG9	0	-	12817193	12817214	255,102,0	1	21	0	.	Substrate	binding.
chr18	12817193	12817214	P17706	0	-	12817193	12817214	255,102,0	1	21	0	.	Substrate	binding.
chr18	13734570	13734576	O43148	0	+	13734570	13734576	255,102,0	1	6	0	.	mRNA	cap	binding.
chr18	13740266	13740272	K7EP06	0	+	13740266	13740272	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr18	13740266	13740272	O43148	0	+	13740266	13740272	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr18	13741565	13741574	K7EP06	0	+	13741565	13741574	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr18	13741565	13741574	O43148	0	+	13741565	13741574	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr18	18533537	18546887	Q13464	0	-	18533537	18546887	255,102,0	1	13350	0	.	Auto-inhibitory.
chr18	18547874	18548744	Q13464	0	-	18547874	18548744	255,102,0	1	870	0	.	RHOA	binding.
chr18	18567033	18608846	Q13464	0	-	18567033	18608846	255,102,0	1	41813	0	.	Interaction	with	FHOD1.	Pubmed:18694941
chr18	19192390	19203857	P62314	0	+	19192390	19203857	255,102,0	1	11467	0	.	Sufficient	for	interaction	with	CLNS1A.	Pubmed:11747828
chr18	20516877	20526432	Q99708	0	+	20516877	20526432	255,102,0	1	9555	0	.	Essential	for	binding	to	the	MRN	complex	and	for	RPA	focus	formation	on	DNA	damage.
chr18	20573314	20573461	Q99708	0	+	20573314	20573461	255,102,0	1	147	0	.	Damage-recruitment	motif.
chr18	20715726	20716053	Q8TDN4	0	+	20715726	20716053	255,102,0	1	327	0	.	Interaction	with	TDRD7.
chr18	20716260	20832953	Q8TDN4	0	+	20716260	20832953	255,102,0	1	116693	0	.	Interaction	with	CDK3.
chr18	21141339	21141432	O15118	0	-	21141339	21141432	255,102,0	1	93	0	.	Important	for	cholesterol	binding	and	cholesterol	transfer	from	NPC1	to	liposomes.
chr18	21898585	21957497	Q9BXW6	0	-	21898585	21957497	255,102,0	1	58912	0	.	Interaction	with	RAB7A.	Pubmed:16176980
chr18	23612485	23615035	Q15532	0	-	23612485	23615035	255,102,0	1	2550	0	.	2	X	13	AA	imperfect	tandem	repeats.
chr18	23632636	23670530	Q15532	0	-	23632636	23670530	255,102,0	1	37894	0	.	Transcriptional	activation.
chr18	23866403	23872218	Q92750	0	+	23866403	23872218	255,102,0	1	5815	0	.	Required	for	interaction	with	P65/RELA.
chr18	23969874	23969973	Q92750	0	+	23969874	23969973	255,102,0	1	99	0	.	Required	for	interaction	with	TAF12.	Pubmed:15601843
chr18	29178596	29178611	P02766	0	+	29178596	29178611	255,102,0	1	15	0	.	Thyroid	hormone	binding.
chr18	29206274	29206280	Q9UBX8	0	-	29206274	29206280	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr18	29206975	29206987	Q9UBX8	0	-	29206975	29206987	255,102,0	1	12	0	.	N-acetyl-D-glucosamine	binding.
chr18	29211007	29211013	Q9UBX8	0	-	29211007	29211013	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr18	29211085	29211094	Q9UBX8	0	-	29211085	29211094	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr18	29218693	29218708	Q9UBX8	0	-	29218693	29218708	255,102,0	1	15	0	.	UDP-alpha-D-galactose	binding.
chr18	29598952	29598961	Q96EQ8	0	+	29598952	29598961	255,102,0	1	9	0	.	Interaction	with	the	C2HC	RNF-type	zinc	finger.	Pubmed:27411375
chr18	29622147	29622162	Q96EQ8	0	+	29622147	29622162	255,102,0	1	15	0	.	Interaction	with	the	RING-type	zinc	finger.	Pubmed:27411375
chr18	29622180	29622207	Q96EQ8	0	+	29622180	29622207	255,102,0	1	27	0	.	Linker	region.	Pubmed:27411375
chr18	29648275	29648320	Q96EQ8	0	+	29648275	29648320	255,102,0	1	45	0	.	Required	for	interaction	with	ubiquitin	and	for	autoubiquitination.	Pubmed:17990982
chr18	29775387	29788092	Q16820	0	+	29775387	29788092	255,102,0	1	12705	0	.	Metalloprotease.
chr18	29796976	29797015	Q16820	0	+	29796976	29797015	255,102,0	1	39	0	.	Required	for	proteolytic	processing.
chr18	29850262	29867068	Q9H706	0	-	29850262	29867068	255,102,0	1	16806	0	.	Necessary	for	interaction	with	GRB2.	Pubmed:19509291
chr18	29867599	30050358	Q9H706	0	-	29867599	30050358	255,102,0	1	182759	0	.	CABIT.
chr18	32335940	32398282	Q9Y4J8	0	+	32335940	32398282	255,102,0	1	62342	0	.	Interaction	with	MAGEE1.
chr18	32418733	32428344	Q9Y4J8	0	+	32418733	32428344	255,102,0	1	9611	0	.	Syntrophin-binding	region.
chr18	32682071	32720330	Q15555	0	+	32682071	32720330	255,102,0	1	38259	0	.	DCTN1-binding.
chr18	32712019	32712151	Q15555	0	+	32712019	32712151	255,102,0	1	132	0	.	APC-binding.
chr18	32917399	32917552	P17028	0	-	32917399	32917552	255,102,0	1	153	0	.	Necessary	and	sufficient	for	nuclear	localization.
chr18	33257582	33263548	Q10472	0	+	33257582	33263548	255,102,0	1	5966	0	.	Catalytic	subdomain	A.
chr18	33267142	33271038	Q10472	0	+	33267142	33271038	255,102,0	1	3896	0	.	Catalytic	subdomain	B.
chr18	34853033	35145604	Q9BZC1	0	-	34853033	35145604	255,102,0	1	292571	0	.	Sufficient	for	RNA-binding	and	MSE-dependent	splicing	activity.
chr18	34854300	34854360	Q9BZC1	0	-	34854300	34854360	255,102,0	1	60	0	.	Necessary	for	TNNT2	exon	5	inclusion.
chr18	40851755	40853955	Q9H2B2	0	-	40851755	40853955	255,102,0	1	2200	0	.	Phospholipid	binding.
chr18	42643429	42643501	Q9Y6X0	0	+	42643429	42643501	255,102,0	1	72	0	.	3	X	8	AA	tandem	repeats	of	P-P-L-P-P-P-P-P.
chr18	44030741	44030750	Q6ZSG1	0	+	44030741	44030750	255,102,0	1	9	0	.	Ubiquitin	binding.	Pubmed:26656854
chr18	44036482	44036497	Q6ZSG1	0	+	44036482	44036497	255,102,0	1	15	0	.	Ubiquitin	binding.	Pubmed:26656854
chr18	44260229	44260238	O15466	0	-	44260229	44260238	255,102,0	1	9	0	.	Substrate	binding.
chr18	44261948	44261957	O15466	0	-	44261948	44261957	255,102,0	1	9	0	.	Substrate	binding.
chr18	44408010	44408031	O75928	0	-	44408010	44408031	255,102,0	1	21	0	.	SUMO1-binding.
chr18	44542970	44543450	A6NLF2	0	-	44542970	44543450	255,102,0	1	480	0	.	Activation	domain.
chr18	44543336	44543366	A6NLF2	0	-	44543336	44543366	255,102,0	1	30	0	.	BC-box.
chr18	44543336	44543366	A6NLF2	0	-	44543336	44543366	255,102,0	1	30	0	.	Interaction	with	elongin	BC.
chr18	44555178	44555208	Q3SY89	0	-	44555178	44555208	255,102,0	1	30	0	.	BC-box.
chr18	44554812	44555292	Q8NG57	0	-	44554812	44555292	255,102,0	1	480	0	.	Activation	domain.
chr18	44555178	44555208	Q8NG57	0	-	44555178	44555208	255,102,0	1	30	0	.	BC-box.
chr18	44555178	44555208	Q8NG57	0	-	44555178	44555208	255,102,0	1	30	0	.	Interaction	with	elongin	BC.
chr18	44559658	44560138	Q8IYF1	0	-	44559658	44560138	255,102,0	1	480	0	.	Activation	domain.
chr18	44560024	44560054	Q8IYF1	0	-	44560024	44560054	255,102,0	1	30	0	.	BC-box.
chr18	44560024	44560054	Q8IYF1	0	-	44560024	44560054	255,102,0	1	30	0	.	Interacting	with	Elongin	BC	complex.
chr18	44661035	44661041	Q9H0R4	0	-	44661035	44661041	255,102,0	1	6	0	.	Substrate	binding.
chr18	44662765	44662774	Q9H0R4	0	-	44662765	44662774	255,102,0	1	9	0	.	Substrate	binding.
chr18	46145936	46284620	O43310	0	+	46145936	46284620	255,102,0	1	138684	0	.	Interaction	with	NCBP1/CBP80.	Pubmed:19648179
chr18	46474769	46474799	O15105	0	-	46474769	46474799	255,102,0	1	30	0	.	Important	for	interaction	with	SMURF2.
chr18	47107963	47108002	Q9Y5X9	0	+	47107963	47108002	255,102,0	1	39	0	.	Heparin-binding.
chr18	47462638	47462707	Q9ULV0	0	-	47462638	47462707	255,102,0	1	69	0	.	Actin-binding.
chr18	47799048	47799325	Q9UIS9	0	-	47799048	47799325	255,102,0	1	277	0	.	TRD.
chr18	47911667	47918614	Q96BD8	0	+	47911667	47918614	255,102,0	1	6947	0	.	Microtubule	binding.	Pubmed:23085020
chr18	48584744	48591797	Q13485	0	+	48584744	48591797	255,102,0	1	7053	0	.	SAD.
chr18	51056972	51056996	P43146	0	+	51056972	51056996	255,102,0	1	24	0	.	Interaction	with	MYO10.	Pubmed:21642953
chr18	51750482	51750929	Q9UBB5	0	-	51750482	51750929	255,102,0	1	447	0	.	Necessary	for	interaction	with	DHX9.	Pubmed:12665568
chr18	51809382	51810312	Q9UNA4	0	+	51809382	51810312	255,102,0	1	930	0	.	DNA	binding.
chr18	51813684	51813741	Q9UNA4	0	+	51813684	51813741	255,102,0	1	57	0	.	DNA	binding.
chr18	52895533	52896090	P15884	0	-	52895533	52896090	255,102,0	1	557	0	.	Class	A	specific	domain.
chr18	52921877	52924557	P15884	0	-	52921877	52924557	255,102,0	1	2680	0	.	Leucine-zipper.
chr18	53128304	53254347	P15884	0	-	53128304	53254347	255,102,0	1	126043	0	.	Essential	for	MYOD1	inhibition.
chr18	55024471	55024480	O43173	0	+	55024471	55024480	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:26192331
chr18	55027262	55027271	O43173	0	+	55027262	55027271	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:26192331
chr18	55027370	55027376	O43173	0	+	55027370	55027376	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:26192331
chr18	56390302	56409179	Q9UDY8	0	+	56390302	56409179	255,102,0	1	18877	0	.	Caspase-like.
chr18	57016348	57016357	P49257	0	-	57016348	57016357	255,102,0	1	9	0	.	Carbohydrate	binding.
chr18	57569940	57569970	Q13794	0	+	57569940	57569970	255,102,0	1	30	0	.	Required	for	mitochondrial	location.
chr18	59483201	59483381	Q8N8N0	0	-	59483201	59483381	255,102,0	1	180	0	.	Necessary	for	interaction	with	RRAGA.	Pubmed:25936802
chr18	60612405	60639801	O60346	0	+	60612405	60639801	255,102,0	1	27396	0	.	Interaction	with	SLC9A3R1.	Pubmed:21804599
chr18	72178086	72178092	Q96KP4	0	+	72178086	72178092	255,102,0	1	6	0	.	Substrate	binding.
chr18	74153717	74155010	Q92618	0	-	74153717	74155010	255,102,0	1	1293	0	.	Mediates	promoter	DNA-binding	and	activation	of	transcription.
chr18	74696832	74700465	P02686	0	-	74696832	74700465	255,102,0	1	3633	0	.	Induces	experimental	autoimmune	encephalomyelitis	(EAE)	2.
chr18	74701926	74728829	P02686	0	-	74701926	74728829	255,102,0	1	26903	0	.	Induces	experimental	autoimmune	encephalomyelitis	(EAE)	1.
chr18	77170626	77170644	O95644	0	+	77170626	77170644	255,102,0	1	18	0	.	Calcineurin-binding.
chr18	77170650	77170929	O95644	0	+	77170650	77170929	255,102,0	1	279	0	.	Trans-activation	domain	A	(TAD-A).
chr18	77170881	77171169	O95644	0	+	77170881	77171169	255,102,0	1	288	0	.	3	X	SP	repeats.
chr18	77246261	77287574	O95644	0	+	77246261	77287574	255,102,0	1	41313	0	.	Trans-activation	domain	B	(TAD-B).
chr18	77918022	77918406	Q9BYG4	0	-	77918022	77918406	255,102,0	1	384	0	.	Interaction	with	PARD3	and	CDC42.
chr19	422307	434831	P98077	0	-	422307	434831	255,102,0	1	12524	0	.	CH1.
chr19	501676	504767	Q13477	0	+	501676	504767	255,102,0	1	3091	0	.	Mucin-like.
chr19	501682	501814	Q13477	0	+	501682	501814	255,102,0	1	132	0	.	5.5	X	8	AA	tandem	repeats	of	[PS]-P-D-T-T-S-[QP]-E.
chr19	541408	541549	P49427	0	+	541408	541549	255,102,0	1	141	0	.	SCF-binding.
chr19	590416	590572	Q9UL51	0	+	590416	590572	255,102,0	1	156	0	.	Involved	in	subunit	assembly.
chr19	617276	621294	O00411	0	-	617276	621294	255,102,0	1	4018	0	.	Mediates	interaction	with	TEFM.	Pubmed:21278163
chr19	828306	828381	P20160	0	+	828306	828381	255,102,0	1	75	0	.	Possesses	antibiotic	activity.	Pubmed:8506327
chr19	929882	932517	Q99856	0	+	929882	932517	255,102,0	1	2635	0	.	Acidic.
chr19	966705	966837	Q99856	0	+	966705	966837	255,102,0	1	132	0	.	Important	for	nuclear	localization.
chr19	966840	968448	Q99856	0	+	966840	968448	255,102,0	1	1608	0	.	Homodimerization.
chr19	971891	971954	Q99856	0	+	971891	971954	255,102,0	1	63	0	.	Important	for	cytoplasmic	localization.
chr19	1207044	1207182	Q15831	0	+	1207044	1207182	255,102,0	1	138	0	.	Sufficient	for	interaction	with	SIRT1.	Pubmed:18687677
chr19	1398968	1398974	Q14353	0	-	1398968	1398974	255,102,0	1	6	0	.	Substrate	binding.
chr19	1398968	1398974	V9HWB2	0	-	1398968	1398974	255,102,0	1	6	0	.	Substrate	binding.
chr19	1399559	1399565	Q14353	0	-	1399559	1399565	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr19	1399559	1399565	V9HWB2	0	-	1399559	1399565	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr19	1399842	1399851	Q14353	0	-	1399842	1399851	255,102,0	1	9	0	.	S-adenosyl-L-methionine.
chr19	1399842	1399851	V9HWB2	0	-	1399842	1399851	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr19	1399896	1399914	Q14353	0	-	1399896	1399914	255,102,0	1	18	0	.	S-adenosyl-L-methionine	binding.
chr19	1399896	1399914	V9HWB2	0	-	1399896	1399914	255,102,0	1	18	0	.	S-adenosyl-L-methionine	binding.
chr19	1466471	1468061	O95996	0	+	1466471	1468061	255,102,0	1	1590	0	.	5	X	20	AA	approximate	repeat	of	F-X-V-E-X-T-P-X-C-F-S-R-X-S-S-L-S-S-L-S.
chr19	1466471	1468061	O95996	0	+	1466471	1468061	255,102,0	1	1590	0	.	Interaction	with	CTNNB1.	Pubmed:9823329
chr19	1468760	1469000	O95996	0	+	1468760	1469000	255,102,0	1	240	0	.	Required	for	localization	to	microtubules	and	function	in	microtubule	stabilization.	Pubmed:25753423
chr19	1469498	1469732	O95996	0	+	1469498	1469732	255,102,0	1	234	0	.	Interaction	with	MAPRE1	and	MAPRE3.	Pubmed:10644998
chr19	1619365	1619781	P15923	0	-	1619365	1619781	255,102,0	1	416	0	.	Leucine-zipper.
chr19	1827056	1827296	Q8N1G1	0	-	1827056	1827296	255,102,0	1	240	0	.	Interaction	with	ELOA.	Pubmed:12943681
chr19	2043129	2043138	Q9HBH9	0	-	2043129	2043138	255,102,0	1	9	0	.	Staurosporine	binding.
chr19	2254219	2255307	Q96MG2	0	-	2254219	2255307	255,102,0	1	1088	0	.	Mediates	interaction	with	CACNA1S.
chr19	2430911	2434294	Q03252	0	-	2430911	2434294	255,102,0	1	3383	0	.	Tail.
chr19	2434294	2435085	Q03252	0	-	2434294	2435085	255,102,0	1	791	0	.	Coil	2.
chr19	2434294	2456787	Q03252	0	-	2434294	2456787	255,102,0	1	22493	0	.	Rod.
chr19	2435085	2435166	Q03252	0	-	2435085	2435166	255,102,0	1	81	0	.	Linker	2.
chr19	2435166	2444517	Q03252	0	-	2435166	2444517	255,102,0	1	9351	0	.	Coil	1B.
chr19	2444517	2456682	Q03252	0	-	2444517	2456682	255,102,0	1	12165	0	.	Linker	1.
chr19	2456682	2456787	Q03252	0	-	2456682	2456787	255,102,0	1	105	0	.	Coil	1A.
chr19	2456787	2456931	Q03252	0	-	2456787	2456931	255,102,0	1	144	0	.	Head.
chr19	3006648	3013777	Q04725	0	-	3006648	3013777	255,102,0	1	7129	0	.	SP	domain.
chr19	3013777	3015755	Q04725	0	-	3013777	3015755	255,102,0	1	1978	0	.	CcN	domain.
chr19	3015755	3019449	Q04725	0	-	3015755	3019449	255,102,0	1	3694	0	.	GP	domain.
chr19	3019449	3028902	Q04725	0	-	3019449	3028902	255,102,0	1	9453	0	.	Q	domain.
chr19	3053819	3053915	Q08117	0	-	3053819	3053915	255,102,0	1	96	0	.	CCN	domain.
chr19	3633434	3633518	O60331	0	-	3633434	3633518	255,102,0	1	84	0	.	Mediates	interaction	with	TLN2.	Pubmed:12422219
chr19	3905637	3907733	Q86WG3	0	+	3905637	3907733	255,102,0	1	2096	0	.	Required	for	interaction	with	KLC1.
chr19	3908288	3924587	Q86WG3	0	+	3908288	3924587	255,102,0	1	16299	0	.	Mediates	interaction	with	GLS.	Pubmed:16899818
chr19	3936648	3936660	Q9NPI5	0	+	3936648	3936660	255,102,0	1	12	0	.	Substrate	binding.
chr19	3937279	3937285	Q9NPI5	0	+	3937279	3937285	255,102,0	1	6	0	.	Substrate	binding.
chr19	3941078	3941084	Q9NPI5	0	+	3941078	3941084	255,102,0	1	6	0	.	Substrate	binding.
chr19	3959140	3959185	O43293	0	-	3959140	3959185	255,102,0	1	45	0	.	Leucine-zipper.	Pubmed:9488481
chr19	3963657	3964314	O43293	0	-	3963657	3964314	255,102,0	1	657	0	.	Activation	segment.
chr19	4168365	4168455	Q68CJ9	0	+	4168365	4168455	255,102,0	1	90	0	.	Basic	motif.
chr19	4170167	4171115	Q68CJ9	0	+	4170167	4171115	255,102,0	1	948	0	.	Leucine-zipper.
chr19	4362699	4363443	Q99961	0	-	4362699	4363443	255,102,0	1	744	0	.	Interaction	with	ARC.
chr19	4365548	4366507	Q99961	0	-	4365548	4366507	255,102,0	1	959	0	.	Required	for	dimerization	upon	membrane	association.
chr19	4366973	4400365	Q99961	0	-	4366973	4400365	255,102,0	1	33392	0	.	Membrane-binding	amphipathic	helix.
chr19	4453984	4454023	Q9BZV1	0	-	4453984	4454023	255,102,0	1	39	0	.	VCP/p97-interacting	motif	(VIM).	Pubmed:21896481
chr19	4510974	4513647	Q96Q06	0	-	4510974	4513647	255,102,0	1	2673	0	.	27	X	33	AA	approximate	tandem	repeat.
chr19	4523542	4523602	Q00G26	0	-	4523542	4523602	255,102,0	1	60	0	.	Recruits	mitochondria	at	the	lipid	droplet	surface.
chr19	4523542	4525812	Q00G26	0	-	4523542	4525812	255,102,0	1	2270	0	.	Interaction	with	PNPLA2	and	ABHD5.
chr19	4529085	4534086	Q00G26	0	-	4529085	4534086	255,102,0	1	5001	0	.	Essential	for	lipid	droplet	targeting.
chr19	4529810	4534086	Q00G26	0	-	4529810	4534086	255,102,0	1	4276	0	.	Interaction	with	LIPE.
chr19	4816253	4816856	Q8IUC6	0	-	4816253	4816856	255,102,0	1	603	0	.	Sufficient	to	induce	apoptosis.
chr19	4817930	4818389	Q8IUC6	0	-	4817930	4818389	255,102,0	1	459	0	.	TRIF-NTD.	Pubmed:24311583
chr19	4929476	4932810	Q96T88	0	+	4929476	4932810	255,102,0	1	3334	0	.	Tudor-like	1.
chr19	4932828	4941603	Q96T88	0	+	4932828	4941603	255,102,0	1	8775	0	.	Tudor-like	2.
chr19	4941755	4941773	Q96T88	0	+	4941755	4941773	255,102,0	1	18	0	.	Linker.
chr19	4941866	4941881	Q96T88	0	+	4941866	4941881	255,102,0	1	15	0	.	Histone	H3R2me0	binding.
chr19	4941926	4941935	Q96T88	0	+	4941926	4941935	255,102,0	1	9	0	.	Histone	H3R2me0	binding.
chr19	4945899	4945905	Q96T88	0	+	4945899	4945905	255,102,0	1	6	0	.	Required	to	promote	base	flipping.
chr19	4945953	4945959	Q96T88	0	+	4945953	4945959	255,102,0	1	6	0	.	Methylcytosine	binding.
chr19	4945962	4945974	Q96T88	0	+	4945962	4945974	255,102,0	1	12	0	.	Required	for	formation	of	a	5-methylcytosine-binding	pocket.
chr19	4947137	4947149	Q96T88	0	+	4947137	4947149	255,102,0	1	12	0	.	Required	for	formation	of	a	5-methylcytosine-binding	pocket.
chr19	5212245	5212352	Q13332	0	-	5212245	5212352	255,102,0	1	107	0	.	Substrate	binding.
chr19	5587256	5595493	Q14151	0	-	5587256	5595493	255,102,0	1	8237	0	.	Interaction	with	SAFB1.
chr19	5654126	5667098	Q15424	0	+	5654126	5667098	255,102,0	1	12972	0	.	Interaction	with	POLR2A.	Pubmed:9671816
chr19	5657290	5668299	Q15424	0	+	5657290	5668299	255,102,0	1	11009	0	.	Interaction	with	SAFB2.
chr19	6374906	6374915	Q9BT30	0	+	6374906	6374915	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.	Pubmed:25122757
chr19	6415226	6415722	Q92945	0	-	6415226	6415722	255,102,0	1	496	0	.	4	X	12	AA	imperfect	repeats.
chr19	6680256	6682032	P01024	0	-	6680256	6682032	255,102,0	1	1776	0	.	Properdin-binding.
chr19	6739772	6743210	Q15642	0	+	6739772	6743210	255,102,0	1	3438	0	.	Required	for	podosome	formation	and	interaction	with	AKAP9	and	microtubules.	Pubmed:15047863
chr19	6739772	6743210	Q15642	0	+	6739772	6743210	255,102,0	1	3438	0	.	Required	for	translocation	to	the	plasma	membrane	in	response	to	insulin.
chr19	6744897	6750598	Q15642	0	+	6744897	6750598	255,102,0	1	5701	0	.	Interaction	with	CDC42.
chr19	6744897	6751219	Q15642	0	+	6744897	6751219	255,102,0	1	6322	0	.	Interaction	with	PDE6G.
chr19	6750317	6751219	Q15642	0	+	6750317	6751219	255,102,0	1	902	0	.	Required	for	interaction	with	FASLG	and	localization	to	lysosomes.	Pubmed:16318909
chr19	6750365	6750610	Q15642	0	+	6750365	6750610	255,102,0	1	245	0	.	Interaction	with	DNM2	and	WASL.
chr19	6750571	6751219	Q15642	0	+	6750571	6751219	255,102,0	1	648	0	.	Interaction	with	DNM1	and	WASL.	Pubmed:16326391
chr19	6750598	6751219	Q15642	0	+	6750598	6751219	255,102,0	1	621	0	.	Required	for	podosome	formation.
chr19	6750616	6751219	Q15642	0	+	6750616	6751219	255,102,0	1	603	0	.	Interaction	with	WAS.	Pubmed:10713100
chr19	6750622	6751219	Q15642	0	+	6750622	6751219	255,102,0	1	597	0	.	Interaction	with	ARHGAP17,	DAAM1,	DIAPH1	and	DIAPH2.	Pubmed:11431473,	Pubmed:16630611
chr19	7117123	7117135	P06213	0	-	7117123	7117135	255,102,0	1	12	0	.	PIK3R1-binding.
chr19	7126610	7126613	P06213	0	-	7126610	7126613	255,102,0	1	3	0	.	Important	for	interaction	with	IRS1,	SHC1	and	STAT5B.	Pubmed:9428692
chr19	7152744	7152771	P06213	0	-	7152744	7152771	255,102,0	1	27	0	.	Insulin-binding.
chr19	7809955	7810866	Q9NNX6	0	-	7809955	7810866	255,102,0	1	911	0	.	7	X	approximate	tandem	repeats.
chr19	7830630	7831564	Q9H2X3	0	+	7830630	7831564	255,102,0	1	934	0	.	7	X	approximate	tandem	repeats.
chr19	7968937	7974686	O14733	0	+	7968937	7974686	255,102,0	1	5749	0	.	D	domain.
chr19	7977184	7977256	O14733	0	+	7977184	7977256	255,102,0	1	72	0	.	DVD	domain.
chr19	8550509	8551136	P52272	0	+	8550509	8551136	255,102,0	1	627	0	.	27	X	6	AA	repeats	of	[GEVSTPAN]-[ILMV]-[DE]-[RH]-[MLVI]-[GAV].
chr19	8601864	8601897	O00160	0	-	8601864	8601897	255,102,0	1	33	0	.	Actin-binding.
chr19	8953354	8953666	Q8WWY6	0	+	8953354	8953666	255,102,0	1	312	0	.	Transcription	repressor.
chr19	8987269	9033738	Q8WXI7	0	-	8987269	9033738	255,102,0	1	46469	0	.	12	X	approximate	tandem	repeats.	Pubmed:11786729
chr19	10077413	10108686	P25940	0	-	10077413	10108686	255,102,0	1	31273	0	.	Triple-helical	region.
chr19	10108686	10114785	P25940	0	-	10108686	10114785	255,102,0	1	6099	0	.	Nonhelical	region.
chr19	10200642	10201991	Q9NUL5	0	+	10200642	10201991	255,102,0	1	1349	0	.	Interaction	with	PABPC1.	Pubmed:26735137
chr19	10244345	10251517	P26358	0	-	10244345	10251517	255,102,0	1	7172	0	.	Catalytic.
chr19	10244345	10251571	P26358	0	-	10244345	10251571	255,102,0	1	7226	0	.	Interaction	with	the	PRC2/EED-EZH2	complex.
chr19	10250906	10250912	P26358	0	-	10250906	10250912	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine	binding.
chr19	10250972	10250978	P26358	0	-	10250972	10250978	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine	binding.	Pubmed:21163962
chr19	10251478	10251484	P26358	0	-	10251478	10251484	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine	binding.
chr19	10251571	10251802	P26358	0	-	10251571	10251802	255,102,0	1	231	0	.	6	X	2	AA	tandem	repeats	of	K-G.
chr19	10260599	10262214	P26358	0	-	10260599	10262214	255,102,0	1	1615	0	.	Autoinhibitory	linker.
chr19	10262199	10264989	P26358	0	-	10262199	10264989	255,102,0	1	2790	0	.	Required	for	activity.
chr19	10265121	10273381	P26358	0	-	10265121	10273381	255,102,0	1	8260	0	.	Interaction	with	the	PRC2/EED-EZH2	complex.
chr19	10265395	10271064	P26358	0	-	10265395	10271064	255,102,0	1	5669	0	.	DNA	replication	foci-targeting	sequence.
chr19	10265670	10273375	P26358	0	-	10265670	10273375	255,102,0	1	7705	0	.	Homodimerization.
chr19	10270726	10305575	P26358	0	-	10270726	10305575	255,102,0	1	34849	0	.	Interaction	with	the	PRC2/EED-EZH2	complex.
chr19	10283834	10288044	P26358	0	-	10283834	10288044	255,102,0	1	4210	0	.	Interaction	with	DNMT3B.	Pubmed:12145218
chr19	10287966	10288002	P26358	0	-	10287966	10288002	255,102,0	1	36	0	.	Interaction	with	PCNA.	Pubmed:9302295
chr19	10291026	10305575	P26358	0	-	10291026	10305575	255,102,0	1	14549	0	.	Interaction	with	DNMT3A.	Pubmed:12145218
chr19	10291110	10305575	P26358	0	-	10291110	10305575	255,102,0	1	14465	0	.	Interaction	with	DMAP1.	Pubmed:10888872
chr19	10432282	10434080	Q8IY67	0	-	10432282	10434080	255,102,0	1	1798	0	.	Interaction	with	PTBP1.
chr19	10568664	10577805	P27815	0	+	10568664	10577805	255,102,0	1	9141	0	.	Catalytic.
chr19	10654955	10655532	Q86TL0	0	+	10654955	10655532	255,102,0	1	577	0	.	Cryptic	mitochondrial	signal	peptide.
chr19	10794191	10799985	Q12906	0	+	10794191	10799985	255,102,0	1	5794	0	.	Interaction	with	PRMT1.	Pubmed:10749851
chr19	10812791	10812806	Q9BXR0	0	+	10812791	10812806	255,102,0	1	15	0	.	Substrate	binding.
chr19	10822967	10823241	Q9BXR0	0	+	10822967	10823241	255,102,0	1	274	0	.	RNA	binding.
chr19	10823292	10823436	Q9BXR0	0	+	10823292	10823436	255,102,0	1	144	0	.	RNA	binding;	important	for	wobble	base	34	recognition.
chr19	11031579	11032430	Q86X55	0	+	11031579	11032430	255,102,0	1	851	0	.	Transactivation	domain.
chr19	11094827	11097666	P51532	0	+	11094827	11097666	255,102,0	1	2839	0	.	Necessary	for	interaction	with	SS18L1/CREST.
chr19	11233869	11234013	P01130	0	+	11233869	11234013	255,102,0	1	144	0	.	Clustered	O-linked	oligosaccharides.
chr19	11240229	11241989	P01130	0	+	11240229	11241989	255,102,0	1	1760	0	.	Required	for	MYLIP-triggered	down-regulation	of	LDLR.	Pubmed:19520913
chr19	11277284	11285212	Q63ZY3	0	-	11277284	11285212	255,102,0	1	7928	0	.	Interaction	with	NCOA1.	Pubmed:17476305
chr19	11304539	11305187	Q63ZY3	0	-	11304539	11305187	255,102,0	1	648	0	.	Interaction	with	AIFM1.	Pubmed:22371500
chr19	11488818	11488827	P19235	0	-	11488818	11488827	255,102,0	1	9	0	.	Required	for	high-affinity	SOCS3	binding.
chr19	12786857	12786878	P49366	0	-	12786857	12786878	255,102,0	1	21	0	.	Spermidine	binding.
chr19	12786896	12786905	P49366	0	-	12786896	12786905	255,102,0	1	9	0	.	Spermidine	binding.
chr19	12790697	12790703	P49366	0	-	12790697	12790703	255,102,0	1	6	0	.	Spermidine	binding.
chr19	12874098	12875705	Q96ED9	0	-	12874098	12875705	255,102,0	1	1607	0	.	Sufficient	for	interaction	with	CNTRL.	Pubmed:17140400
chr19	12874098	12876743	Q96ED9	0	-	12874098	12876743	255,102,0	1	2645	0	.	Required	for	localization	to	the	centrosome	and	induction	of	aggresome	formation.
chr19	12875891	12886263	Q96ED9	0	-	12875891	12886263	255,102,0	1	10372	0	.	Sufficient	for	interaction	with	microtubules.
chr19	12883039	12886263	Q96ED9	0	-	12883039	12886263	255,102,0	1	3224	0	.	Required	for	localization	to	the	centrosome	and	induction	of	aggresome	formation.
chr19	12903386	12903470	P17275	0	+	12903386	12903470	255,102,0	1	84	0	.	Basic	motif.
chr19	12903470	12903557	P17275	0	+	12903470	12903557	255,102,0	1	87	0	.	Leucine-zipper.
chr19	13004373	13004379	Q92947	0	+	13004373	13004379	255,102,0	1	6	0	.	Substrate	binding.
chr19	13007729	13007753	Q92947	0	+	13007729	13007753	255,102,0	1	24	0	.	Substrate	binding.
chr19	13035525	13035534	Q9Y285	0	-	13035525	13035534	255,102,0	1	9	0	.	L-phenylalanine	binding.	Pubmed:20223217
chr19	13049544	13051155	P27797	0	+	13049544	13051155	255,102,0	1	1611	0	.	N-domain.
chr19	13051134	13051417	P27797	0	+	13051134	13051417	255,102,0	1	283	0	.	4	X	approximate	repeats.
chr19	13051155	13051665	P27797	0	+	13051155	13051665	255,102,0	1	510	0	.	P-domain.
chr19	13051360	13051462	P27797	0	+	13051360	13051462	255,102,0	1	102	0	.	Interaction	with	PPIB.
chr19	13051426	13051632	P27797	0	+	13051426	13051632	255,102,0	1	206	0	.	3	X	approximate	repeats.
chr19	13051665	13054724	P27797	0	+	13051665	13054724	255,102,0	1	3059	0	.	C-domain.
chr19	13063643	13063860	P54725	0	+	13063643	13063860	255,102,0	1	217	0	.	HIV-1	vpr	binding.
chr19	14073509	14074801	P22670	0	-	14073509	14074801	255,102,0	1	1292	0	.	Necessary	for	dimerization.
chr19	14231411	14247268	Q9NVP2	0	-	14231411	14247268	255,102,0	1	15857	0	.	Interaction	with	histone	H3.
chr19	14231414	14247268	Q9NVP2	0	-	14231414	14247268	255,102,0	1	15854	0	.	Interaction	with	CHAF1B.
chr19	14281527	14281539	O94910	0	-	14281527	14281539	255,102,0	1	12	0	.	Carbohydrate	binding.
chr19	14557303	14557318	Q16512	0	+	14557303	14557318	255,102,0	1	15	0	.	Important	for	interaction	with	bacterial	SspH1	and	SspH1-mediated	polyubiquitination.	Pubmed:24248594
chr19	15226446	15227026	A1L0T0	0	-	15226446	15227026	255,102,0	1	580	0	.	Thiamine	pyrophosphate	binding.
chr19	15349190	15353741	O60885	0	-	15349190	15353741	255,102,0	1	4551	0	.	C-terminal	(CTD)	region.
chr19	15366888	15367056	O60885	0	-	15366888	15367056	255,102,0	1	168	0	.	BID	region.
chr19	15367816	15367876	O60885	0	-	15367816	15367876	255,102,0	1	60	0	.	NPS	region.
chr19	15466025	15466079	O43823	0	-	15466025	15466079	255,102,0	1	54	0	.	Required	for	interaction	with	MYCBP.
chr19	15466037	15466091	O43823	0	-	15466037	15466091	255,102,0	1	54	0	.	RII-binding.
chr19	15466097	15469828	O43823	0	-	15466097	15469828	255,102,0	1	3731	0	.	Involved	in	condensin	complex	recruitment.	Pubmed:11964380
chr19	15472585	15479047	O43823	0	-	15472585	15479047	255,102,0	1	6462	0	.	Involved	in	chromatin-binding.	Pubmed:11964380
chr19	15483892	15490542	O43823	0	-	15483892	15490542	255,102,0	1	6650	0	.	Interaction	with	DPY30.	Pubmed:23995757
chr19	15483919	15484643	O43823	0	-	15483919	15484643	255,102,0	1	724	0	.	Interaction	with	DDX5.
chr19	15483937	15490542	O43823	0	-	15483937	15490542	255,102,0	1	6605	0	.	Interaction	with	MCM2.	Pubmed:12740381
chr19	16436281	16436755	Q9Y5W3	0	+	16436281	16436755	255,102,0	1	474	0	.	Interaction	with	WWP1.
chr19	16472670	16506218	Q9UBC2	0	-	16472670	16506218	255,102,0	1	33548	0	.	15	X	3	AA	repeats	of	D-P-F.
chr19	16528761	16553021	Q9UBC2	0	-	16528761	16553021	255,102,0	1	24260	0	.	Interaction	with	DAB2.
chr19	16589944	16593296	Q96L12	0	-	16589944	16593296	255,102,0	1	3352	0	.	C-domain.
chr19	16593296	16594827	Q96L12	0	-	16593296	16594827	255,102,0	1	1531	0	.	P-domain.
chr19	16593329	16593530	Q96L12	0	-	16593329	16593530	255,102,0	1	201	0	.	3	X	approximate	repeats.
chr19	16593539	16594848	Q96L12	0	-	16593539	16594848	255,102,0	1	1309	0	.	4	X	approximate	repeats.
chr19	16594827	16606883	Q96L12	0	-	16594827	16606883	255,102,0	1	12056	0	.	N-domain.
chr19	16940231	16963954	O75182	0	+	16940231	16963954	255,102,0	1	23723	0	.	Interaction	with	CRY1.
chr19	16940655	16942392	O75182	0	+	16940655	16942392	255,102,0	1	1737	0	.	Interaction	with	REST.
chr19	16963879	16976361	O75182	0	+	16963879	16976361	255,102,0	1	12482	0	.	Interaction	with	NCOR1.
chr19	16973277	16977238	O75182	0	+	16973277	16977238	255,102,0	1	3961	0	.	Interaction	with	SUDS3	and	HDAC1.
chr19	17343163	17343397	P10588	0	-	17343163	17343397	255,102,0	1	234	0	.	Important	for	dimerization.
chr19	17343163	17346737	P10588	0	-	17343163	17346737	255,102,0	1	3574	0	.	Ligand-binding.
chr19	17379897	17389761	Q9NWV8	0	+	17379897	17389761	255,102,0	1	9864	0	.	VWFA-like.
chr19	17534541	17535799	Q96EY5	0	+	17534541	17535799	255,102,0	1	1258	0	.	Interaction	with	TSG101,	VPS37B	and	VPS28.	Pubmed:18005716
chr19	17597990	17611395	Q6PCB7	0	+	17597990	17611395	255,102,0	1	13405	0	.	Sufficient	for	oligomerization.
chr19	17830311	17838584	Q66K74	0	+	17830311	17838584	255,102,0	1	8273	0	.	Necessary	for	the	microtubule-organizing	center	localization.
chr19	17838188	17845234	Q66K74	0	+	17838188	17845234	255,102,0	1	7046	0	.	Necessary	for	interaction	with	RASSF1	isoform	A	and	isoform	C.
chr19	17838332	17844111	Q66K74	0	+	17838332	17844111	255,102,0	1	5779	0	.	Necessary	for	association	with	microtubules.
chr19	17844090	17845234	Q66K74	0	+	17844090	17845234	255,102,0	1	1144	0	.	Necessary	for	association	with	actin.
chr19	17844111	17844186	Q66K74	0	+	17844111	17844186	255,102,0	1	75	0	.	Necessary	for	the	mitochondrial	aggregation	and	genome	destruction.
chr19	17865973	17885082	O14526	0	+	17865973	17885082	255,102,0	1	19109	0	.	Mediates	membrane-binding.
chr19	17885055	17889012	O14526	0	+	17885055	17889012	255,102,0	1	3957	0	.	Mediates	interaction	with	the	adaptor	protein	complex	AP-2.
chr19	17892344	17899112	O14526	0	+	17892344	17899112	255,102,0	1	6768	0	.	Mediates	interaction	with	AGFG1,	CALM,	DAB2,	EPS15,	EPS15R,	ITSN1	and	clathrin.	Pubmed:22484487
chr19	17953316	17955226	P52333	0	-	17953316	17955226	255,102,0	1	1910	0	.	Interaction	with	cytokine/interferon/growth	hormone	receptors.
chr19	18099313	18108972	Q92952	0	+	18099313	18108972	255,102,0	1	9659	0	.	Calmodulin-binding.
chr19	18391322	18391409	P17535	0	-	18391322	18391409	255,102,0	1	87	0	.	Leucine-zipper.
chr19	18391409	18391493	P17535	0	-	18391409	18391493	255,102,0	1	84	0	.	Basic	motif.
chr19	18893727	18896572	P49747	0	-	18893727	18896572	255,102,0	1	2845	0	.	Mediates	cell	survival	and	induction	of	the	IAP	family	of	survival	proteins.
chr19	18900882	18902015	P49747	0	-	18900882	18902015	255,102,0	1	1133	0	.	COMP	N-terminal.
chr19	18943018	18965465	Q92900	0	+	18943018	18965465	255,102,0	1	22447	0	.	Sufficient	for	interaction	with	RENT2.
chr19	19338550	19338565	O14594	0	+	19338550	19338565	255,102,0	1	15	0	.	O-glycosylated	at	one	site.
chr19	19431668	19446981	Q9Y6X3	0	+	19431668	19446981	255,102,0	1	15313	0	.	Sufficient	for	interaction	with	NIPBL.
chr19	19603416	19603521	Q86YP4	0	+	19603416	19603521	255,102,0	1	105	0	.	CR1;	MBD2-binding.
chr19	19609344	19612165	Q86YP4	0	+	19609344	19612165	255,102,0	1	2821	0	.	CR2;	histone	tail-binding.
chr19	19638567	19638932	Q9P0J0	0	+	19638567	19638932	255,102,0	1	365	0	.	Important	for	inducing	cell	death.
chr19	33098675	33106665	Q96NW4	0	-	33098675	33106665	255,102,0	1	7990	0	.	Sufficient	for	interaction	with	VPS29.	Pubmed:24856514
chr19	33098723	33119058	Q96NW4	0	-	33098723	33119058	255,102,0	1	20335	0	.	Interaction	with	RAB32.
chr19	33106617	33110201	Q96NW4	0	-	33106617	33110201	255,102,0	1	3584	0	.	Required	for	interaction	with	VAMP7.	Pubmed:23104059,	Pubmed:19745841
chr19	33113354	33119058	Q96NW4	0	-	33113354	33119058	255,102,0	1	5704	0	.	Interaction	with	RAB38.	Pubmed:18477474
chr19	33119028	33122331	Q96NW4	0	-	33119028	33122331	255,102,0	1	3303	0	.	Sufficient	for	interaction	with	VPS29.	Pubmed:24856514
chr19	33130261	33149921	Q96NW4	0	-	33130261	33149921	255,102,0	1	19660	0	.	Sufficient	for	GEF	activity	towards	RAB21.	Pubmed:16525121
chr19	33167625	33167769	Q6ZS82	0	+	33167625	33167769	255,102,0	1	144	0	.	SNARE-like.
chr19	33467417	33467585	Q9BTP7	0	+	33467417	33467585	255,102,0	1	168	0	.	RuvA	domain	2-like.
chr19	33517525	33535204	Q8IUC4	0	-	33517525	33535204	255,102,0	1	17679	0	.	Interaction	with	Rho.
chr19	33792246	33792591	P49715	0	-	33792246	33792591	255,102,0	1	345	0	.	Interaction	with	FOXO1.
chr19	33792285	33792372	P49715	0	-	33792285	33792372	255,102,0	1	87	0	.	Leucine-zipper.
chr19	33792381	33792465	P49715	0	-	33792381	33792465	255,102,0	1	84	0	.	Basic	motif.
chr19	33792708	33792939	P49715	0	-	33792708	33792939	255,102,0	1	231	0	.	Required	to	induce	adipocyte	differentiation.
chr19	33792726	33792777	P49715	0	-	33792726	33792777	255,102,0	1	51	0	.	Required	to	functionally	cooperate	with	SREBF1	in	promoter	activation.
chr19	33793104	33793161	P49715	0	-	33793104	33793161	255,102,0	1	57	0	.	Required	for	interaction	with	TRIB1.	Pubmed:26455797
chr19	33793110	33793320	P49715	0	-	33793110	33793320	255,102,0	1	210	0	.	Required	to	repress	E2F1:TFDP1-mediated	transcription,	to	inhibit	cell	cycle	and	to	induce	adipocyte	differentiation.
chr19	33870340	33870424	P53567	0	+	33870340	33870424	255,102,0	1	84	0	.	Basic	motif.
chr19	33870433	33870499	P53567	0	+	33870433	33870499	255,102,0	1	66	0	.	Leucine-zipper.
chr19	35769944	35770102	Q15853	0	+	35769944	35770102	255,102,0	1	158	0	.	Leucine-zipper.
chr19	35786526	35793355	P20916	0	+	35786526	35793355	255,102,0	1	6829	0	.	Interaction	with	RTN4R	and	RTN4RL2.
chr19	35786661	35786670	P20916	0	+	35786661	35786670	255,102,0	1	9	0	.	Ganglioside	GT1b	binding.
chr19	35786838	35786853	P20916	0	+	35786838	35786853	255,102,0	1	15	0	.	Ganglioside	GT1b	binding.
chr19	35804204	35804354	P20916	0	+	35804204	35804354	255,102,0	1	150	0	.	Required	for	normal	axon	myelination	in	the	central	nervous	system.
chr19	35842712	35842727	O14842	0	+	35842712	35842727	255,102,0	1	15	0	.	Agonist	binding.	Pubmed:25043059
chr19	36024429	36027866	O14556	0	+	36024429	36027866	255,102,0	1	3437	0	.	Testis-specific	N-terminal	extension.
chr19	36033853	36033862	O14556	0	+	36033853	36033862	255,102,0	1	9	0	.	Glyceraldehyde	3-phosphate	binding.
chr19	36034346	36034352	O14556	0	+	36034346	36034352	255,102,0	1	6	0	.	Glyceraldehyde	3-phosphate	binding.
chr19	36124609	36128453	Q9BTD8	0	+	36124609	36128453	255,102,0	1	3844	0	.	Necessary	for	interaction	with	HNRNPK.
chr19	36229263	36229269	Q9UMN6	0	+	36229263	36229269	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr19	36246777	36247909	O14558	0	-	36246777	36247909	255,102,0	1	1132	0	.	Involved	in	stabilization	of	the	HSPB1:HSBP6	heterodimer.	Pubmed:27717639
chr19	36317418	36321958	O60500	0	-	36317418	36321958	255,102,0	1	4540	0	.	Binds	to	NPHS2.
chr19	36395035	36395044	Q9UBK5	0	+	36395035	36395044	255,102,0	1	9	0	.	GRB2	binding	site.
chr19	36395035	36395047	Q9UBK5	0	+	36395035	36395047	255,102,0	1	12	0	.	PIK3R1	binding	site.
chr19	36500236	36500257	Q3KRA9	0	-	36500236	36500257	255,102,0	1	21	0	.	Alpha-ketoglutarate	binding.
chr19	36501816	36501825	Q3KRA9	0	-	36501816	36501825	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.
chr19	36507062	36508342	Q96DZ5	0	-	36507062	36508342	255,102,0	1	1280	0	.	GoLD.
chr19	36727975	36728218	Q15072	0	+	36727975	36728218	255,102,0	1	243	0	.	Interaction	with	TERF2IP.	Pubmed:15838871
chr19	37100816	37117114	Q96SR6	0	+	37100816	37117114	255,102,0	1	16298	0	.	Mediates	interaction	with	TRIM28.
chr19	37100828	37100954	Q96SR6	0	+	37100828	37100954	255,102,0	1	126	0	.	Represses	transcription.
chr19	37101619	37117432	Q96SR6	0	+	37101619	37117432	255,102,0	1	15813	0	.	Represses	transcription.
chr19	37117684	37118449	Q96SR6	0	+	37117684	37118449	255,102,0	1	765	0	.	Required	for	transcriptional	repression	activity;	probably	mediates	sequence-specific	DNA-binding.
chr19	38742041	38746877	Q96A00	0	-	38742041	38746877	255,102,0	1	4836	0	.	Inhibitory.
chr19	38875054	38876431	Q86UU5	0	-	38875054	38876431	255,102,0	1	1377	0	.	Interactions	with	ZNF403/GGNBP2	and	OAZ3.
chr19	38876443	38877535	Q86UU5	0	-	38876443	38877535	255,102,0	1	1092	0	.	Interaction	with	GGNBP1.
chr19	38951174	38998412	P21817	0	+	38951174	38998412	255,102,0	1	47238	0	.	6	X	approximate	repeats.
chr19	39018960	39019050	P21817	0	+	39018960	39019050	255,102,0	1	90	0	.	Interaction	with	CALM.	Pubmed:18650434
chr19	39138418	39138463	O43707	0	+	39138418	39138463	255,102,0	1	45	0	.	Interaction	with	VCL.	Pubmed:15988023
chr19	39138502	39191260	O43707	0	+	39138502	39191260	255,102,0	1	52758	0	.	Interaction	with	VCL.	Pubmed:15988023
chr19	39191685	39191742	O43707	0	+	39191685	39191742	255,102,0	1	57	0	.	Interaction	with	VCL.	Pubmed:15988023
chr19	39196727	39198760	O43707	0	+	39196727	39198760	255,102,0	1	2033	0	.	Polyphosphoinositide	(PIP2)-binding.
chr19	39217611	39220069	O43707	0	+	39217611	39220069	255,102,0	1	2458	0	.	Mediates	interaction	with	MICALL2.
chr19	39221494	39226147	Q6ZSI9	0	-	39221494	39226147	255,102,0	1	4653	0	.	Domain	IV.
chr19	39226147	39228220	Q6ZSI9	0	-	39226147	39228220	255,102,0	1	2073	0	.	Domain	III.
chr19	39262537	39262558	P47929	0	-	39262537	39262558	255,102,0	1	21	0	.	Beta-galactoside	binding.
chr19	39281440	39281461	P47929	0	+	39281440	39281461	255,102,0	1	21	0	.	Beta-galactoside	binding.
chr19	39292670	39292691	P56470	0	-	39292670	39292691	255,102,0	1	21	0	.	Beta-galactoside	binding.
chr19	39308204	39321721	Q13011	0	-	39308204	39321721	255,102,0	1	13517	0	.	Substrate	binding.
chr19	39370315	39371793	Q8IXJ6	0	-	39370315	39371793	255,102,0	1	1478	0	.	Peptide	inhibitor	binding.
chr19	39380509	39380524	Q8IXJ6	0	-	39380509	39380524	255,102,0	1	15	0	.	Peptide	inhibitor	binding.
chr19	39409074	39409083	Q9NP81	0	-	39409074	39409083	255,102,0	1	9	0	.	Serine	binding.
chr19	39660265	39664512	O96013	0	+	39660265	39664512	255,102,0	1	4247	0	.	Linker.
chr19	39664443	39664521	O96013	0	+	39664443	39664521	255,102,0	1	78	0	.	GEF-interaction	domain	(GID).
chr19	39950199	39955623	O00267	0	+	39950199	39955623	255,102,0	1	5424	0	.	Interaction	with	SUPT4H1.
chr19	39957179	39959924	O00267	0	+	39957179	39959924	255,102,0	1	2745	0	.	Interaction	with	RNA	polymerase	II.
chr19	39963843	39964120	O00267	0	+	39963843	39964120	255,102,0	1	277	0	.	9	X	7	AA	approximate	tandem	repeats	of	G-S-[QR]-T-P-X-[YQ],	motif	CTR1.
chr19	39964639	39965184	O00267	0	+	39964639	39965184	255,102,0	1	545	0	.	10	X	8	AA	approximate	tandem	repeats	of	P-[TS]-P-S-P-[QA]-[SG]-Y,	motif	CTR2.
chr19	40316684	40316900	Q9Y463	0	-	40316684	40316900	255,102,0	1	216	0	.	Interaction	with	RANBP9.	Pubmed:14500717
chr19	40325330	40325429	P22087	0	-	40325330	40325429	255,102,0	1	99	0	.	Helical.
chr19	40327273	40327285	P22087	0	-	40327273	40327285	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr19	40328381	40328387	P22087	0	-	40328381	40328387	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr19	40328456	40328462	P22087	0	-	40328456	40328462	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr19	40329704	40329710	P22087	0	-	40329704	40329710	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr19	40711164	40711844	Q02779	0	+	40711164	40711844	255,102,0	1	680	0	.	Leucine-zipper	1.
chr19	40711883	40711949	Q02779	0	+	40711883	40711949	255,102,0	1	66	0	.	Leucine-zipper	2.
chr19	40742244	40742250	P31751	0	-	40742244	40742250	255,102,0	1	6	0	.	Inhibitor	binding.
chr19	40742286	40743878	P31751	0	-	40742286	40743878	255,102,0	1	1592	0	.	Inhibitor	binding.
chr19	40744823	40744832	P31751	0	-	40744823	40744832	255,102,0	1	9	0	.	Inhibitor	binding.
chr19	40901909	40902968	Q9BXM0	0	-	40901909	40902968	255,102,0	1	1059	0	.	55	X	5	AA	approximate	tandem	repeats	of	[LVMAG]-[PSREQC]-[EDKL]-[LIVMAP]-[AQKHRPE];	that	may	have	a	tripeptide	spacer	of	[LV]-P-[KER].
chr19	41239113	41239134	Q96DU7	0	+	41239113	41239134	255,102,0	1	21	0	.	Substrate	binding.
chr19	41239119	41239146	Q96DU7	0	+	41239119	41239146	255,102,0	1	27	0	.	Calmodulin-binding.
chr19	41239194	41239218	Q96DU7	0	+	41239194	41239218	255,102,0	1	24	0	.	Substrate	binding.
chr19	41307149	41307182	Q96KS0	0	+	41307149	41307182	255,102,0	1	33	0	.	Beta(2)beta(3)	'finger-like'	loop.
chr19	41770408	41774141	Q9BUJ2	0	+	41770408	41774141	255,102,0	1	3733	0	.	Necessary	for	interaction	with	HRMT1L1.
chr19	41779950	41812467	Q9BUJ2	0	+	41779950	41812467	255,102,0	1	32517	0	.	Necessary	for	interaction	with	TP53.	Pubmed:15907477
chr19	41800341	41808664	Q9BUJ2	0	+	41800341	41808664	255,102,0	1	8323	0	.	Necessary	for	interaction	with	BRD7	and	transcriptional	activation.	Pubmed:12489984
chr19	41808715	41809878	Q9BUJ2	0	+	41808715	41809878	255,102,0	1	1163	0	.	5	X	3	AA	repeats	of	R-G-G.
chr19	41808715	41809878	Q9BUJ2	0	+	41808715	41809878	255,102,0	1	1163	0	.	Necessary	for	transcription	repression.
chr19	41920046	41920055	P12694	0	+	41920046	41920055	255,102,0	1	9	0	.	Thiamine	pyrophosphate	binding.
chr19	42461000	42461033	Q9UI14	0	-	42461000	42461033	255,102,0	1	33	0	.	Homodimerization.
chr19	42461000	42461033	Q9UI14	0	-	42461000	42461033	255,102,0	1	33	0	.	Required	for	interaction	with	prenylated	RAB3A	and	VAMP2.
chr19	42461000	42461063	Q9UI14	0	-	42461000	42461063	255,102,0	1	63	0	.	Required	for	interaction	with	GDI1.
chr19	42462994	42463069	Q9UI14	0	-	42462994	42463069	255,102,0	1	75	0	.	Required	for	interaction	with	prenylated	RAB3A	and	VAMP2.
chr19	42492222	42492231	P13637	0	-	42492222	42492231	255,102,0	1	9	0	.	Interaction	with	phosphoinositide-3	kinase.
chr19	42596390	42598014	P09086	0	-	42596390	42598014	255,102,0	1	1624	0	.	Leucine-zipper.
chr19	42790936	42790993	Q96RK0	0	+	42790936	42790993	255,102,0	1	57	0	.	Interaction	with	ATXN1.
chr19	43013263	43013377	P13688	0	-	43013263	43013377	255,102,0	1	114	0	.	Required	for	interaction	with	PTPN11	and	PTPN6	and	for	control	of	phosphorylation	level.
chr19	43013263	43016524	P13688	0	-	43013263	43016524	255,102,0	1	3261	0	.	Interaction	with	FLNA.
chr19	43013272	43013284	P13688	0	-	43013272	43013284	255,102,0	1	12	0	.	Essential	for	interaction	with	PTPN11	and	PTPN6.
chr19	43015770	43016530	P13688	0	-	43015770	43016530	255,102,0	1	760	0	.	Interaction	with	calmodulin.
chr19	43026352	43031502	P13688	0	-	43026352	43031502	255,102,0	1	5150	0	.	Required	for	homophilic	binding.
chr19	44273601	44273945	O15554	0	-	44273601	44273945	255,102,0	1	344	0	.	Calmodulin-binding.
chr19	44514428	44514692	Q9UIE0	0	+	44514428	44514692	255,102,0	1	264	0	.	KRNB.
chr19	44660439	44660610	Q14588	0	+	44660439	44660610	255,102,0	1	171	0	.	KRNB.
chr19	45281206	45284243	Q9ULV8	0	+	45281206	45284243	255,102,0	1	3037	0	.	4H.
chr19	45284243	45284617	Q9ULV8	0	+	45284243	45284617	255,102,0	1	374	0	.	EF-hand-like.
chr19	45284617	45293306	Q9ULV8	0	+	45284617	45293306	255,102,0	1	8689	0	.	SH2-like.
chr19	45293306	45295684	Q9ULV8	0	+	45293306	45295684	255,102,0	1	2378	0	.	Linker.
chr19	45295684	45303697	Q9ULV8	0	+	45295684	45303697	255,102,0	1	8013	0	.	Interaction	with	RET.	Pubmed:18753381
chr19	45317863	45317875	P50895	0	+	45317863	45317875	255,102,0	1	12	0	.	Interaction	with	laminin	alpha5.
chr19	45411790	45412318	P02649	0	+	45411790	45412318	255,102,0	1	528	0	.	8	X	22	AA	approximate	tandem	repeats.
chr19	45412024	45412057	P02649	0	+	45412024	45412057	255,102,0	1	33	0	.	LDL	receptor	binding.	Pubmed:2063194
chr19	45412036	45412048	P02649	0	+	45412036	45412048	255,102,0	1	12	0	.	Heparin-binding.	Pubmed:3947350
chr19	45412237	45412261	P02649	0	+	45412237	45412261	255,102,0	1	24	0	.	Heparin-binding.	Pubmed:3947350
chr19	45451968	45452016	P02655	0	+	45451968	45452016	255,102,0	1	48	0	.	O-glycosylated	at	one	site.
chr19	45452097	45452422	P02655	0	+	45452097	45452422	255,102,0	1	325	0	.	Lipid	binding.	Pubmed:6772077
chr19	45452431	45452503	P02655	0	+	45452431	45452503	255,102,0	1	72	0	.	Lipoprotein	lipase	cofactor.	Pubmed:6772077,	Pubmed:1555583
chr19	45506217	45515234	Q01201	0	+	45506217	45515234	255,102,0	1	9017	0	.	Leucine-zipper.
chr19	45855898	45860797	P18074	0	-	45855898	45860797	255,102,0	1	4899	0	.	Mediates	interaction	with	MMS19.
chr19	45912935	45918163	P07992	0	-	45912935	45918163	255,102,0	1	5228	0	.	HhH2,	dimerization	with	ERCC4.
chr19	45974472	45974550	P53539	0	+	45974472	45974550	255,102,0	1	78	0	.	Basic	motif.
chr19	45974550	45975886	P53539	0	+	45974550	45975886	255,102,0	1	1336	0	.	Leucine-zipper.
chr19	46025791	46025990	P50552	0	+	46025791	46025990	255,102,0	1	199	0	.	EVH2	block	A.
chr19	46025791	46029423	P50552	0	+	46025791	46029423	255,102,0	1	3632	0	.	EVH2.
chr19	46026029	46026914	P50552	0	+	46026029	46026914	255,102,0	1	885	0	.	EVH2	block	B.
chr19	46027897	46029423	P50552	0	+	46027897	46029423	255,102,0	1	1526	0	.	EVH2	block	C.
chr19	46027900	46029411	P50552	0	+	46027900	46029411	255,102,0	1	1511	0	.	2	X	15	AA	tandem	repeats	of	L-[EQ]-[KR]-[MV]-K-[EQ]-E-[IL]-[IL]-E-[AEV]-[FV]-[KRV]-[KQ]-E.
chr19	46112923	46142124	O95834	0	-	46112923	46142124	255,102,0	1	29201	0	.	Tandem	atypical	propeller	in	EMLs.
chr19	46248456	46248498	C9JSJ3	0	+	46248456	46248498	255,102,0	1	42	0	.	Basic	motif;	degenerate.
chr19	46248498	46253974	C9JSJ3	0	+	46248498	46253974	255,102,0	1	5476	0	.	Helix-loop-helix	motif.
chr19	46352061	46357753	Q92797	0	-	46352061	46357753	255,102,0	1	5692	0	.	Interaction	with	HSF1.	Pubmed:14707147
chr19	46387382	46387526	Q8IU81	0	-	46387382	46387526	255,102,0	1	144	0	.	Cys-rich.
chr19	46808512	46808584	Q9Y2N7	0	+	46808512	46808584	255,102,0	1	72	0	.	Nuclear	localization	signal.
chr19	46812533	46815469	Q9Y2N7	0	+	46812533	46815469	255,102,0	1	2936	0	.	Nuclear	export	signal.
chr19	46828809	46834443	Q9Y2N7	0	+	46828809	46834443	255,102,0	1	5634	0	.	ODD.
chr19	46828815	46832541	Q9Y2N7	0	+	46828815	46832541	255,102,0	1	3726	0	.	NTAD.
chr19	46879747	46893600	P53041	0	+	46879747	46893600	255,102,0	1	13853	0	.	Catalytic.
chr19	46890351	46890357	P53041	0	+	46890351	46890357	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:15155720
chr19	46893585	46893600	P53041	0	+	46893585	46893600	255,102,0	1	15	0	.	Required	for	autoinhibition.
chr19	47236486	47240126	Q9NRL3	0	-	47236486	47240126	255,102,0	1	3640	0	.	Calmodulin-binding.
chr19	47249450	47249477	Q9NRL3	0	-	47249450	47249477	255,102,0	1	27	0	.	Caveolin-binding.
chr19	47421932	47422730	Q9NRY4	0	+	47421932	47422730	255,102,0	1	798	0	.	Has	GTPase	activity,	required	for	proper	localization.
chr19	47425568	47440547	Q9NRY4	0	+	47425568	47440547	255,102,0	1	14979	0	.	Required	for	phospholipid	binding	and	regulation	of	the	substrate	preference.	Pubmed:19673492
chr19	47823061	47823088	P21730	0	+	47823061	47823088	255,102,0	1	27	0	.	Required	for	CHIPS	binding.	Pubmed:15542591
chr19	47823094	47823124	P21730	0	+	47823094	47823124	255,102,0	1	30	0	.	Involved	in	C5a	binding.	Pubmed:9553099
chr19	47960725	47960785	Q9UPR5	0	-	47960725	47960785	255,102,0	1	60	0	.	Putative	calmodulin-binding	region.
chr19	48239667	48239730	Q9NZN4	0	+	48239667	48239730	255,102,0	1	63	0	.	Mediates	membrane-binding.
chr19	48631166	48631175	P18858	0	-	48631166	48631175	255,102,0	1	9	0	.	Interaction	with	target	DNA.
chr19	48639339	48639369	P18858	0	-	48639339	48639369	255,102,0	1	30	0	.	Interaction	with	target	DNA.
chr19	49123771	49130962	Q9NRA0	0	+	49123771	49130962	255,102,0	1	7191	0	.	Required	for	binding	to	sulfatide	and	phosphoinositides	and	for	membrane	localization.
chr19	49131302	49131314	Q9NRA0	0	+	49131302	49131314	255,102,0	1	12	0	.	Substrate	binding.
chr19	49134180	49134225	Q10586	0	-	49134180	49134225	255,102,0	1	45	0	.	Leucine-zipper.
chr19	49134234	49134303	Q10586	0	-	49134234	49134303	255,102,0	1	69	0	.	Basic	motif.
chr19	49216526	49217703	Q6ZN01	0	-	49216526	49217703	255,102,0	1	1177	0	.	Transcription	activation.
chr19	49246720	49246759	Q8IYV9	0	-	49246720	49246759	255,102,0	1	39	0	.	Important	for	interaction	with	IZUMO1R.	Pubmed:27309818
chr19	49376490	49376670	O75807	0	+	49376490	49376670	255,102,0	1	180	0	.	Required	for	localization	in	the	endoplasmic	reticulum.
chr19	49377498	49378020	O75807	0	+	49377498	49378020	255,102,0	1	522	0	.	4	X	34	AA	approximate	repeats.
chr19	49377498	49378020	O75807	0	+	49377498	49378020	255,102,0	1	522	0	.	Interaction	with	SMAD7.	Pubmed:14718519
chr19	49377936	49378155	O75807	0	+	49377936	49378155	255,102,0	1	219	0	.	Interaction	with	KMT2A/MLL1.
chr19	49378095	49378954	O75807	0	+	49378095	49378954	255,102,0	1	859	0	.	Interaction	with	SMARCB1.
chr19	49404176	49407621	Q02818	0	+	49404176	49407621	255,102,0	1	3445	0	.	O-glycosylated	at	one	site.
chr19	49416745	49422504	Q02818	0	+	49416745	49422504	255,102,0	1	5759	0	.	Binds	to	GNAI2	and	GNAI3.
chr19	49469083	49469107	P02792	0	+	49469083	49469107	255,102,0	1	24	0	.	Catalytic	site	for	iron	oxidation.
chr19	49655267	49656541	P23327	0	-	49655267	49656541	255,102,0	1	1274	0	.	Metal-binding.
chr19	49657399	49658179	P23327	0	-	49657399	49658179	255,102,0	1	780	0	.	4	X	tandem	repeats,	acidic.
chr19	49657468	49658179	P23327	0	-	49657468	49658179	255,102,0	1	711	0	.	6	X	approximate	tandem	repeats.
chr19	49713559	49714338	Q8TD43	0	+	49713559	49714338	255,102,0	1	779	0	.	Calmodulin-binding.
chr19	49714043	49714061	Q8TD43	0	+	49714043	49714061	255,102,0	1	18	0	.	Mediates	modulation	by	decavanadate	and	PIP2-binding.
chr19	49844583	49858418	Q15562	0	-	49844583	49858418	255,102,0	1	13835	0	.	Transcriptional	activation.
chr19	50016726	50017472	P55899	0	+	50016726	50017472	255,102,0	1	746	0	.	Alpha-1.	Pubmed:10933786
chr19	50017472	50017742	P55899	0	+	50017472	50017742	255,102,0	1	270	0	.	Alpha-2.	Pubmed:10933786
chr19	50027762	50028032	P55899	0	+	50027762	50028032	255,102,0	1	270	0	.	Alpha-3.	Pubmed:10933786
chr19	50028712	50028733	P55899	0	+	50028712	50028733	255,102,0	1	21	0	.	Connecting	peptide.
chr19	50062186	50063204	Q9Y314	0	-	50062186	50063204	255,102,0	1	1018	0	.	U-box-like.
chr19	50158067	50161653	Q9H7N4	0	+	50158067	50161653	255,102,0	1	3586	0	.	Necessary	for	interaction	with	the	CTD	domain	of	POLR2A.
chr19	50163987	50165685	Q14653	0	-	50163987	50165685	255,102,0	1	1698	0	.	Involved	in	HERC5	binding.
chr19	50213663	50213702	Q8TCG5	0	+	50213663	50213702	255,102,0	1	39	0	.	Coenzyme	A	binding.
chr19	50321598	50333195	Q71SY5	0	+	50321598	50333195	255,102,0	1	11597	0	.	Interaction	with	the	Mediator	complex.
chr19	50334652	50338389	Q71SY5	0	+	50334652	50338389	255,102,0	1	3737	0	.	Interaction	with	VP16.
chr19	50334670	50338395	Q71SY5	0	+	50334670	50338395	255,102,0	1	3725	0	.	Interaction	with	CREBBP.	Pubmed:17641689
chr19	50338805	50339196	Q71SY5	0	+	50338805	50339196	255,102,0	1	391	0	.	Interaction	with	RARA.	Pubmed:17641689
chr19	50339154	50339638	Q71SY5	0	+	50339154	50339638	255,102,0	1	484	0	.	Interaction	with	RARA.	Pubmed:17641689
chr19	50358325	50363533	Q86YD1	0	+	50358325	50363533	255,102,0	1	5208	0	.	Interaction	with	FLOT1.	Pubmed:15713644
chr19	50364522	50365636	Q96T60	0	-	50364522	50365636	255,102,0	1	1114	0	.	Kinase.
chr19	50365645	50368446	Q96T60	0	-	50365645	50368446	255,102,0	1	2801	0	.	Phosphatase.
chr19	50412635	50413049	P37198	0	-	50412635	50413049	255,102,0	1	414	0	.	5	X	2	AA	repeats	of	F-G.
chr19	50434107	50434170	Q9Y2D1	0	+	50434107	50434170	255,102,0	1	63	0	.	Required	for	protein	stabilization	induced	by	IL1B.	Pubmed:24379400
chr19	50435854	50436151	Q9Y2D1	0	+	50435854	50436151	255,102,0	1	297	0	.	Interaction	with	PTP4A1.
chr19	50436127	50436190	Q9Y2D1	0	+	50436127	50436190	255,102,0	1	63	0	.	Basic	motif.
chr19	50436205	50436250	Q9Y2D1	0	+	50436205	50436250	255,102,0	1	45	0	.	Leucine-zipper.
chr19	50548633	50549356	Q8WTR7	0	+	50548633	50549356	255,102,0	1	723	0	.	Interaction	with	SLBP/pre-mRNA	complex.
chr19	50832105	50832339	Q14003	0	-	50832105	50832339	255,102,0	1	234	0	.	Important	for	normal	N-type	inactivation.	Pubmed:26997484
chr19	50880862	50881479	P55055	0	+	50880862	50881479	255,102,0	1	617	0	.	Transactivation	AF-1;	required	for	ligand-independent	transactivation	function.	Pubmed:25661920
chr19	50881960	50885856	P55055	0	+	50881960	50885856	255,102,0	1	3896	0	.	Transactivation	AF-2;	required	for	ligand-dependent	transactivation	function;	mediates	interaction	with	CCAR2.	Pubmed:25661920
chr19	50881993	50885856	P55055	0	+	50881993	50885856	255,102,0	1	3863	0	.	Ligand-binding.
chr19	50922219	50925771	Q01892	0	+	50922219	50925771	255,102,0	1	3552	0	.	TAD1	(Acidic).
chr19	50925798	50926138	Q01892	0	+	50925798	50926138	255,102,0	1	340	0	.	TAD2.
chr19	51140566	51140641	Q9BQG1	0	-	51140566	51140641	255,102,0	1	75	0	.	Cysteine	motif.
chr19	51646016	51646031	Q9Y286	0	+	51646016	51646031	255,102,0	1	15	0	.	Sialic	acid	binding.	Pubmed:16623661,	Pubmed:16895906,	Pubmed:12438315
chr19	51848617	51850204	P38117	0	-	51848617	51850204	255,102,0	1	1587	0	.	Recognition	loop.	Pubmed:15159392,	Pubmed:25023281
chr19	52693370	52723012	P30153	0	+	52693370	52723012	255,102,0	1	29642	0	.	PP2A	subunit	B	binding.
chr19	52705256	52719297	P30153	0	+	52705256	52719297	255,102,0	1	14041	0	.	Polyoma	small	and	medium	T	antigens	Binding.
chr19	52709298	52716273	P30153	0	+	52709298	52716273	255,102,0	1	6975	0	.	SV40	small	T	antigen	binding.
chr19	52723012	52729231	P30153	0	+	52723012	52729231	255,102,0	1	6219	0	.	PP2A	subunit	C	binding.
chr19	54656679	54659142	O75175	0	+	54656679	54659142	255,102,0	1	2462	0	.	Repressor	domain.
chr19	54657162	54659625	O75175	0	+	54657162	54659625	255,102,0	1	2462	0	.	Repressor	domain.
chr19	54657162	54659626	O75175	0	+	54657162	54659626	255,102,0	1	2463	0	.	Repressor	domain.
chr19	55665499	55665562	P19429	0	-	55665499	55665562	255,102,0	1	63	0	.	Involved	in	binding	TNC	and	actin.
chr19	55667613	55668432	P19429	0	-	55667613	55668432	255,102,0	1	819	0	.	Involved	in	binding	TNC.
chr19	55752399	55758444	Q9UPN7	0	-	55752399	55758444	255,102,0	1	6045	0	.	Interaction	with	PPP6C.
chr19	55858463	55858733	Q86Y97	0	+	55858463	55858733	255,102,0	1	270	0	.	Required	for	heterochromatin	localization.
chr19	55877404	55877431	P20809	0	-	55877404	55877431	255,102,0	1	27	0	.	Important	for	interaction	with	IL11RA	and	for	the	stimulation	of	cell	proliferation.
chr19	55995011	55995152	Q5EBL2	0	+	55995011	55995152	255,102,0	1	141	0	.	4	X	approximate	tandem	repeats.
chr19	56166473	56171930	P26368	0	+	56166473	56171930	255,102,0	1	5457	0	.	Required	for	interaction	with	PRPF19.	Pubmed:21536736
chr19	56203176	56204122	Q9Y6I3	0	+	56203176	56204122	255,102,0	1	946	0	.	8	X	3	AA	repeats	of	[ED]-P-W.
chr19	56206330	56206713	Q9Y6I3	0	+	56206330	56206713	255,102,0	1	383	0	.	3	X	3	AA	repeats	of	N-P-F.
chr19	57325480	57325558	Q9GZU2	0	-	57325480	57325558	255,102,0	1	78	0	.	4	X	5	AA	repeat	of	P-X-G-E-A.
chr19	57325558	57325621	Q9GZU2	0	-	57325558	57325621	255,102,0	1	63	0	.	3	X	7	AA	repeat	of	P-E-V-E-A-A-E.
chr19	57746728	57746782	Q9UQB9	0	+	57746728	57746782	255,102,0	1	54	0	.	Interaction	with	BIRC5.	Pubmed:27332895
chr19	59056316	59059687	Q13263	0	+	59056316	59059687	255,102,0	1	3371	0	.	RBCC	domain.
chr19	59058976	59059687	Q13263	0	+	59058976	59059687	255,102,0	1	711	0	.	Leucine	zipper	alpha	helical	coiled-coil	region.
chr19	59058979	59059687	Q13263	0	+	59058979	59059687	255,102,0	1	708	0	.	Interaction	with	MAGEC2.
chr19	59059541	59059669	Q13263	0	+	59059541	59059669	255,102,0	1	128	0	.	Involved	in	binding	PPP1CA.
chr19	59060370	59060484	Q13263	0	+	59060370	59060484	255,102,0	1	114	0	.	HP1	box.
chr19	59063018	59063036	O43633	0	-	59063018	59063036	255,102,0	1	18	0	.	Interaction	with	VTA1.
chr19	59063018	59065414	O43633	0	-	59063018	59065414	255,102,0	1	2396	0	.	Interaction	with	VPS4B.
chr19	59068462	59069748	P61081	0	-	59068462	59069748	255,102,0	1	1286	0	.	Interaction	with	UBA3.
chr2	669582	669666	Q96B42	0	-	669582	669666	255,102,0	1	84	0	.	DNA-binding.
chr2	8870852	8870867	Q9ULH0	0	-	8870852	8870867	255,102,0	1	15	0	.	Mediates	interaction	with	SNTA1.
chr2	8890379	8890391	Q9ULH0	0	-	8890379	8890391	255,102,0	1	12	0	.	Mediates	interaction	with	CRKL.
chr2	9547685	9547694	O14713	0	-	9547685	9547694	255,102,0	1	9	0	.	Interaction	with	ITGB1.
chr2	9547691	9547703	O14713	0	-	9547691	9547703	255,102,0	1	12	0	.	Interaction	with	KRIT1.
chr2	9633095	9634873	P78536	0	-	9633095	9634873	255,102,0	1	1778	0	.	Crambin-like.
chr2	9989501	9989588	Q53T94	0	+	9989501	9989588	255,102,0	1	87	0	.	B-reader.
chr2	9991668	9991683	Q53T94	0	+	9991668	9991683	255,102,0	1	15	0	.	B-linker.
chr2	9991683	10022910	Q53T94	0	+	9991683	10022910	255,102,0	1	31227	0	.	N-terminal	cyclin	fold.
chr2	10022910	10051025	Q53T94	0	+	10022910	10051025	255,102,0	1	28115	0	.	C-terminal	cyclin	fold.
chr2	10091962	10098980	Q9NZI5	0	+	10091962	10098980	255,102,0	1	7018	0	.	Transcription	activation.
chr2	10581972	10581978	P11926	0	-	10581972	10581978	255,102,0	1	6	0	.	Substrate	binding.
chr2	10582219	10582231	P11926	0	-	10582219	10582231	255,102,0	1	12	0	.	Pyridoxal	phosphate	binding.	Pubmed:17407445,	Pubmed:26305948,	Pubmed:26443277
chr2	11337789	11338876	O75116	0	-	11337789	11338876	255,102,0	1	1087	0	.	RHOA	binding.
chr2	11348424	11362221	O75116	0	-	11348424	11362221	255,102,0	1	13797	0	.	Interaction	with	PPP1R12A.
chr2	11361322	11361466	O75116	0	-	11361322	11361466	255,102,0	1	144	0	.	Interaction	with	NPM1.	Pubmed:17015463
chr2	11586605	11591796	O75461	0	-	11586605	11591796	255,102,0	1	5191	0	.	Transcription	repression.
chr2	11587885	11591925	O75461	0	-	11587885	11591925	255,102,0	1	4040	0	.	Dimerization.
chr2	11591820	11591886	O75461	0	-	11591820	11591886	255,102,0	1	66	0	.	Leucine-zipper.
chr2	11905667	11911533	Q14693	0	+	11905667	11911533	255,102,0	1	5866	0	.	N-LIP.
chr2	11943123	11960617	Q14693	0	+	11943123	11960617	255,102,0	1	17494	0	.	C-LIP.
chr2	15307174	15536565	A2RRP1	0	-	15307174	15536565	255,102,0	1	229391	0	.	Interaction	with	ZW10	and	RINT1.	Pubmed:20462495,	Pubmed:19369418
chr2	15536565	15701428	A2RRP1	0	-	15536565	15701428	255,102,0	1	164863	0	.	Interaction	with	USE1L.	Pubmed:19369418
chr2	15732057	15747366	Q92499	0	+	15732057	15747366	255,102,0	1	15309	0	.	Necessary	for	interaction	with	HNRNPK.	Pubmed:12183465
chr2	15732057	15763687	Q92499	0	+	15732057	15763687	255,102,0	1	31630	0	.	Necessary	for	interaction	with	RELA.	Pubmed:19058135
chr2	15763684	15771027	Q92499	0	+	15763684	15771027	255,102,0	1	7343	0	.	Necessary	for	interaction	with	HNRNPK.	Pubmed:12183465
chr2	15767188	15769743	Q92499	0	+	15767188	15769743	255,102,0	1	2555	0	.	Necessary	for	interaction	with	replicase	polyprotein	1ab	nsp14	of	IBV.
chr2	16086120	16086186	P04198	0	+	16086120	16086186	255,102,0	1	66	0	.	Leucine-zipper.
chr2	17692073	17692220	Q09MP3	0	-	17692073	17692220	255,102,0	1	147	0	.	Interaction	with	RAD51.	Pubmed:16990250
chr2	17888514	17897524	Q96SB8	0	-	17888514	17897524	255,102,0	1	9010	0	.	Flexible	hinge.
chr2	17941210	17942789	Q17RS7	0	+	17941210	17942789	255,102,0	1	1579	0	.	N-domain.
chr2	17946178	17947956	Q17RS7	0	+	17946178	17947956	255,102,0	1	1778	0	.	I-domain.
chr2	24260729	24260750	Q9H6R7	0	-	24260729	24260750	255,102,0	1	21	0	.	Interaction	with	HCK.	Pubmed:25469238
chr2	24297007	24297049	Q9Y3B4	0	-	24297007	24297049	255,102,0	1	42	0	.	Interaction	with	pre-mRNA	branch	site.
chr2	24928085	24930040	Q15788	0	+	24928085	24930040	255,102,0	1	1955	0	.	Interaction	with	STAT3.	Pubmed:11773079
chr2	24930679	24952447	Q15788	0	+	24930679	24952447	255,102,0	1	21768	0	.	Interaction	with	CREBBP.
chr2	25194719	25194773	Q9NZQ0	0	-	25194719	25194773	255,102,0	1	54	0	.	Required	for	interaction	with	MAPK1.
chr2	25457207	25457216	Q9Y6K1	0	-	25457207	25457216	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine	binding.	Pubmed:17713477
chr2	25464448	25464457	Q9Y6K1	0	-	25464448	25464457	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine	binding.	Pubmed:17713477
chr2	25466767	25466782	Q9Y6K1	0	-	25466767	25466782	255,102,0	1	15	0	.	S-adenosyl-L-homocysteine	binding.	Pubmed:17713477
chr2	25467116	25468196	Q9Y6K1	0	-	25467116	25468196	255,102,0	1	1080	0	.	Interaction	with	the	PRC2/EED-EZH2	complex.
chr2	25469558	25497854	Q9Y6K1	0	-	25469558	25497854	255,102,0	1	28296	0	.	Interaction	with	DNMT1	and	DNMT3B.	Pubmed:12145218
chr2	25656777	25674479	O60941	0	-	25656777	25674479	255,102,0	1	17702	0	.	Syntrophin-binding	region.
chr2	26396122	26407734	Q75VX8	0	+	26396122	26407734	255,102,0	1	11612	0	.	CABIT.
chr2	27015012	27015060	P49450	0	+	27015012	27015060	255,102,0	1	48	0	.	Important	for	flexibility	of	DNA	ends	that	protrude	from	nucleosomes.	Pubmed:27499292
chr2	27015635	27016072	P49450	0	+	27015635	27016072	255,102,0	1	437	0	.	CATD.	Pubmed:7962047,	Pubmed:15282608
chr2	27248771	27249150	Q9UPY8	0	+	27248771	27249150	255,102,0	1	379	0	.	APC-binding.
chr2	27248771	27249213	Q9UPY8	0	+	27248771	27249213	255,102,0	1	442	0	.	DCTN1-binding.
chr2	27440422	27446884	P27708	0	+	27440422	27446884	255,102,0	1	6462	0	.	GATase	(Glutamine	amidotransferase).
chr2	27446884	27447286	P27708	0	+	27446884	27447286	255,102,0	1	402	0	.	Linker.
chr2	27447286	27455469	P27708	0	+	27447286	27455469	255,102,0	1	8183	0	.	CPSase	A.
chr2	27447286	27459667	P27708	0	+	27447286	27459667	255,102,0	1	12381	0	.	CPSase	(Carbamoyl-phosphate	synthase).
chr2	27455469	27459667	P27708	0	+	27455469	27459667	255,102,0	1	4198	0	.	CPSase	B.
chr2	27459667	27462309	P27708	0	+	27459667	27462309	255,102,0	1	2642	0	.	DHOase	(dihydroorotase).
chr2	27462309	27464038	P27708	0	+	27462309	27464038	255,102,0	1	1729	0	.	Linker.
chr2	27464038	27466383	P27708	0	+	27464038	27466383	255,102,0	1	2345	0	.	ATCase	(Aspartate	transcarbamylase).
chr2	27522272	27528475	Q9BYV2	0	+	27522272	27528475	255,102,0	1	6203	0	.	Mediates	microtubule-binding	and	homooligomerization.
chr2	27596748	27599384	Q15036	0	+	27596748	27599384	255,102,0	1	2636	0	.	FERM-like.
chr2	27598405	27599384	Q15036	0	+	27598405	27599384	255,102,0	1	979	0	.	PTB-like	F3	module.
chr2	27804215	27805244	Q68DN1	0	+	27804215	27805244	255,102,0	1	1029	0	.	27	X	8	AA	approximative	tandem	repeat	of	P-S-E-R-S-H-H-S.
chr2	28081356	28081371	Q9H477	0	-	28081356	28081371	255,102,0	1	15	0	.	Substrate	binding.
chr2	28113131	28113140	Q9H477	0	-	28113131	28113140	255,102,0	1	9	0	.	Substrate	binding.
chr2	28117510	28248233	Q9NXR7	0	+	28117510	28248233	255,102,0	1	130723	0	.	UEV-like	1.
chr2	28464231	28561320	Q9NXR7	0	+	28464231	28561320	255,102,0	1	97089	0	.	UEV-like	2.
chr2	28631646	28631655	P15408	0	+	28631646	28631655	255,102,0	1	9	0	.	Basic	motif.
chr2	28631655	28631679	P15408	0	+	28631655	28631679	255,102,0	1	24	0	.	Leucine-zipper.
chr2	28865756	28865885	Q6P1J6	0	+	28865756	28865885	255,102,0	1	129	0	.	Necessary	for	membrane	localization.
chr2	29039081	29063085	Q5MJ70	0	+	29039081	29063085	255,102,0	1	24004	0	.	Speedy/Ringo	box;	Required	for	CDK-binding.
chr2	29074154	29075287	Q9BVS5	0	-	29074154	29075287	255,102,0	1	1133	0	.	Substrate.
chr2	29075347	29075359	Q9BVS5	0	-	29075347	29075359	255,102,0	1	12	0	.	Substrate.
chr2	29084139	29084145	Q9BVS5	0	-	29084139	29084145	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr2	29087904	29087928	Q9BVS5	0	-	29087904	29087928	255,102,0	1	24	0	.	Substrate.
chr2	29092447	29092462	Q9BVS5	0	-	29092447	29092462	255,102,0	1	15	0	.	Substrate.
chr2	29092522	29092528	Q9BVS5	0	-	29092522	29092528	255,102,0	1	6	0	.	Substrate.
chr2	29092606	29092747	Q9BVS5	0	-	29092606	29092747	255,102,0	1	141	0	.	Substrate.
chr2	29092906	29092915	Q9BVS5	0	-	29092906	29092915	255,102,0	1	9	0	.	Substrate.
chr2	29443619	29443628	Q9UM73	0	-	29443619	29443628	255,102,0	1	9	0	.	Inhibitor	binding.
chr2	31154983	31167731	Q96FL9	0	-	31154983	31167731	255,102,0	1	12748	0	.	Catalytic	subdomain	B.
chr2	31178492	31189140	Q96FL9	0	-	31178492	31189140	255,102,0	1	10648	0	.	Catalytic	subdomain	A.
chr2	31397552	31410659	A8MX76	0	-	31397552	31410659	255,102,0	1	13107	0	.	Domain	IV.
chr2	31410659	31411204	A8MX76	0	-	31410659	31411204	255,102,0	1	545	0	.	Linker.
chr2	31411204	31416102	A8MX76	0	-	31411204	31416102	255,102,0	1	4898	0	.	Domain	III.
chr2	32288900	32289050	Q9UBP0	0	+	32288900	32289050	255,102,0	1	150	0	.	Required	for	nuclear	localization.	Pubmed:15147984
chr2	32288900	32289140	Q9UBP0	0	+	32288900	32289140	255,102,0	1	240	0	.	Required	for	interaction	with	ATL1.	Pubmed:16815977,	Pubmed:16339213
chr2	32288900	32314670	Q9UBP0	0	+	32288900	32314670	255,102,0	1	25770	0	.	Required	for	midbody	localization.	Pubmed:18997780
chr2	32288900	32340800	Q9UBP0	0	+	32288900	32340800	255,102,0	1	51900	0	.	Required	for	interaction	with	RTN1.	Pubmed:16602018
chr2	32289047	32289161	Q9UBP0	0	+	32289047	32289161	255,102,0	1	114	0	.	Required	for	interaction	with	SSNA1	and	microtubules.	Pubmed:15269182
chr2	32289233	32323866	Q9UBP0	0	+	32289233	32323866	255,102,0	1	34633	0	.	Sufficient	for	interaction	with	CHMP1B.	Pubmed:18997780
chr2	32289239	32323878	Q9UBP0	0	+	32289239	32323878	255,102,0	1	34639	0	.	Required	for	interaction	with	microtubules.	Pubmed:15269182
chr2	32339705	32379562	Q9UBP0	0	+	32339705	32379562	255,102,0	1	39857	0	.	Sufficient	for	microtubule	severing.	Pubmed:15269182
chr2	32339831	32340884	Q9UBP0	0	+	32339831	32340884	255,102,0	1	1053	0	.	Required	for	interaction	with	microtubules	and	microtubule	severing.	Pubmed:15269182
chr2	32340827	32340836	Q9UBP0	0	+	32340827	32340836	255,102,0	1	9	0	.	Required	for	interaction	with	microtubules.	Pubmed:23272056
chr2	32475543	32475867	Q9NPP4	0	-	32475543	32475867	255,102,0	1	324	0	.	Winged-helix	domain	(WHD).
chr2	32476038	32476650	Q9NPP4	0	-	32476038	32476650	255,102,0	1	612	0	.	Nucleotide-binding	domain	(NBD).
chr2	33589401	33623609	Q14766	0	+	33589401	33623609	255,102,0	1	34208	0	.	C-terminal	domain.	Pubmed:17293099
chr2	37129887	37132729	O43815	0	-	37129887	37132729	255,102,0	1	2842	0	.	Calmodulin-binding.
chr2	37193417	37193444	O43815	0	-	37193417	37193444	255,102,0	1	27	0	.	Caveolin-binding.
chr2	37334418	37353544	P19525	0	-	37334418	37353544	255,102,0	1	19126	0	.	Interaction	with	TRAF5.	Pubmed:15121867
chr2	37347278	37349725	P19525	0	-	37347278	37349725	255,102,0	1	2447	0	.	2	X	13	AA	approximate	repeats.
chr2	38903103	38903109	Q96C23	0	+	38903103	38903109	255,102,0	1	6	0	.	Substrate	binding.
chr2	38972313	38975725	Q16629	0	-	38972313	38975725	255,102,0	1	3412	0	.	6	X	8	AA	repeats	of	R-R-S-R-S-X-S-X.
chr2	38976762	38976816	Q16629	0	-	38976762	38976816	255,102,0	1	54	0	.	Sufficient	for	interaction	with	NXF1.
chr2	40656601	40656661	P32418	0	-	40656601	40656661	255,102,0	1	60	0	.	Putative	calmodulin-binding	region.
chr2	42994579	42996951	P46952	0	-	42994579	42996951	255,102,0	1	2372	0	.	Domain	B.
chr2	42996951	42997286	P46952	0	-	42996951	42997286	255,102,0	1	335	0	.	Linker.
chr2	42997286	43019676	P46952	0	-	42997286	43019676	255,102,0	1	22390	0	.	Domain	A	(catalytic).
chr2	43452309	43452435	P47974	0	-	43452309	43452435	255,102,0	1	126	0	.	RNA-binding.	Pubmed:20506496,	Pubmed:14981510
chr2	44115741	44132834	P42704	0	-	44115741	44132834	255,102,0	1	17093	0	.	RNA-binding.
chr2	45169456	45169600	O95343	0	+	45169456	45169600	255,102,0	1	144	0	.	Interaction	with	AES.
chr2	45169936	45169945	O95343	0	+	45169936	45169945	255,102,0	1	9	0	.	Bind	to	RHO	promoter.
chr2	46605837	46607437	Q99814	0	+	46605837	46607437	255,102,0	1	1600	0	.	NTAD.
chr2	46611673	46611796	Q99814	0	+	46611673	46611796	255,102,0	1	123	0	.	CTAD.
chr2	46851342	46851363	Q9P021	0	+	46851342	46851363	255,102,0	1	21	0	.	Sufficient	for	interaction	with	DLG4.	Pubmed:17474715
chr2	46851351	46851363	Q9P021	0	+	46851351	46851363	255,102,0	1	12	0	.	PDZ3-binding.
chr2	46985669	46985819	O75159	0	+	46985669	46985819	255,102,0	1	150	0	.	Required	for	interaction	with	IL4R.
chr2	47702204	47703513	P43246	0	+	47702204	47703513	255,102,0	1	1309	0	.	Interaction	with	EXO1.
chr2	53995029	53995047	Q8WUX2	0	+	53995029	53995047	255,102,0	1	18	0	.	Substrate	binding.
chr2	54096561	54101628	Q14997	0	-	54096561	54101628	255,102,0	1	5067	0	.	Bromodomain-like	(BRDL).
chr2	54873432	54886326	Q01082	0	+	54873432	54886326	255,102,0	1	12894	0	.	Interaction	with	ANK2.	Pubmed:15262991
chr2	54891613	54891700	Q01082	0	+	54891613	54891700	255,102,0	1	87	0	.	Mediates	interaction	with	CAMSAP1.	Pubmed:24117850
chr2	55476533	55476542	P46199	0	-	55476533	55476542	255,102,0	1	9	0	.	G5.
chr2	55476638	55476650	P46199	0	-	55476638	55476650	255,102,0	1	12	0	.	G4.
chr2	55479742	55479754	P46199	0	-	55479742	55479754	255,102,0	1	12	0	.	G3.
chr2	55481192	55481207	P46199	0	-	55481192	55481207	255,102,0	1	15	0	.	G2.
chr2	55481258	55481282	P46199	0	-	55481258	55481282	255,102,0	1	24	0	.	G1.
chr2	55536107	55536302	Q3V6T2	0	-	55536107	55536302	255,102,0	1	195	0	.	Phosphoinositide-binding.	Pubmed:16139227
chr2	56094210	56103863	Q12805	0	-	56094210	56103863	255,102,0	1	9653	0	.	Mediates	interaction	with	TIMP3.	Pubmed:15123717
chr2	58386489	58386825	Q86Y07	0	+	58386489	58386825	255,102,0	1	336	0	.	Interaction	with	MAP3K7.	Pubmed:17709393
chr2	58390021	58449141	Q9NW38	0	-	58390021	58449141	255,102,0	1	59120	0	.	UBC-RWD	region	(URD).
chr2	60689416	60780405	Q9H165	0	-	60689416	60780405	255,102,0	1	90989	0	.	Required	for	nuclear	body	formation	and	for	SUMO1	recruitment.
chr2	61175257	61175305	Q3MIT2	0	-	61175257	61175305	255,102,0	1	48	0	.	RNA	binding	thumb	loop.
chr2	61187575	61187617	Q3MIT2	0	-	61187575	61187617	255,102,0	1	42	0	.	RNA	binding	forefinger	loop.
chr2	61258893	61259160	Q92968	0	+	61258893	61259160	255,102,0	1	267	0	.	Targeting	to	peroxisomes.
chr2	61258983	61259049	Q92968	0	+	61258983	61259049	255,102,0	1	66	0	.	Interaction	with	PEX19.
chr2	61712950	61713013	O14980	0	-	61712950	61713013	255,102,0	1	63	0	.	Interaction	with	HIV-1	Rev.
chr2	61715891	61761032	O14980	0	-	61715891	61761032	255,102,0	1	45141	0	.	Necessary	for	HTLV-1	Rex-mediated	mRNA	export.
chr2	61719824	61721043	O14980	0	-	61719824	61721043	255,102,0	1	1219	0	.	Interaction	with	RANBP3.
chr2	61720083	61722658	O14980	0	-	61720083	61722658	255,102,0	1	2575	0	.	Interaction	with	Ran	and	nuclear	export	complex	formation.
chr2	61721031	61721043	O14980	0	-	61721031	61721043	255,102,0	1	12	0	.	Necessary	for	HTLV-1	Rex	multimerization.
chr2	62132816	62228024	Q8N668	0	+	62132816	62228024	255,102,0	1	95208	0	.	Sufficient	for	interaction	with	SLC12A2.	Pubmed:23515529
chr2	62228027	62363073	Q8N668	0	+	62228027	62363073	255,102,0	1	135046	0	.	Required	for	binding	to	PtdIns(4,5)P2.	Pubmed:18940794
chr2	63223792	63272575	Q8NDI1	0	+	63223792	63272575	255,102,0	1	48783	0	.	RAB-binding	domain	(RBD).	Pubmed:27552051
chr2	64109680	64109692	Q16851	0	+	64109680	64109692	255,102,0	1	12	0	.	UTP	binding.
chr2	64109686	64109692	Q16851	0	+	64109686	64109692	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:25860585
chr2	64112897	64112906	Q16851	0	+	64112897	64112906	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:25860585
chr2	64117268	64118358	Q16851	0	+	64117268	64118358	255,102,0	1	1090	0	.	Oligomerization.
chr2	64118337	64118343	Q16851	0	+	64118337	64118343	255,102,0	1	6	0	.	Critical	for	end-to-end	subunit	interaction.
chr2	64863072	64863303	Q14140	0	-	64863072	64863303	255,102,0	1	231	0	.	Required	for	transactivation	activity.
chr2	66794621	66796237	O00470	0	+	66794621	66796237	255,102,0	1	1616	0	.	Required	for	transcriptional	activation.
chr2	68270023	68270149	Q13901	0	-	68270023	68270149	255,102,0	1	126	0	.	Interaction	with	NCOR1	and	NCOR2.
chr2	68270146	68273533	Q13901	0	-	68270146	68273533	255,102,0	1	3387	0	.	Interaction	with	NR1D1.
chr2	68270146	68274442	Q13901	0	-	68270146	68274442	255,102,0	1	4296	0	.	Required	for	transcriptional	repression.
chr2	68772373	68772406	Q8IW19	0	+	68772373	68772406	255,102,0	1	33	0	.	Flexible	linker.
chr2	69300200	69300221	Q9H6X2	0	+	69300200	69300221	255,102,0	1	21	0	.	Interaction	with	PA.
chr2	69554060	69575375	Q06210	0	-	69554060	69575375	255,102,0	1	21315	0	.	Isomerase.
chr2	69565577	69565586	Q06210	0	-	69565577	69565586	255,102,0	1	9	0	.	Substrate-binding.	Pubmed:19059404
chr2	69569301	69569307	Q06210	0	-	69569301	69569307	255,102,0	1	6	0	.	Substrate-binding.	Pubmed:19059404
chr2	69623419	69633182	Q9UMS0	0	-	69623419	69633182	255,102,0	1	9763	0	.	NifU.
chr2	70890574	70890628	P35612	0	-	70890574	70890628	255,102,0	1	54	0	.	Interaction	with	calmodulin.
chr2	70905886	70905946	P35612	0	-	70905886	70905946	255,102,0	1	60	0	.	Interaction	with	calmodulin.
chr2	71299799	71299805	Q9UJ70	0	+	71299799	71299805	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17010375
chr2	71299847	71299856	Q9UJ70	0	+	71299847	71299856	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:17010375
chr2	71590316	71591378	Q14966	0	+	71590316	71591378	255,102,0	1	1062	0	.	Involved	in	localization	to	nuclear	speckles.
chr2	73115606	73115612	P35270	0	+	73115606	73115612	255,102,0	1	6	0	.	Substrate	binding.
chr2	74057983	74074519	O95630	0	+	74057983	74074519	255,102,0	1	16536	0	.	Interaction	with	CHMP3.
chr2	74074816	74074831	O95630	0	+	74074816	74074831	255,102,0	1	15	0	.	Interaction	with	STAM.
chr2	74588628	74593400	Q14203	0	-	74588628	74593400	255,102,0	1	4772	0	.	Interaction	with	HPS6.	Pubmed:25189619
chr2	74691790	74692149	Q13724	0	-	74691790	74692149	255,102,0	1	359	0	.	Required	for	endoplasmic	reticulum	targeting.
chr2	74732284	74733110	Q9BSM1	0	-	74732284	74733110	255,102,0	1	826	0	.	Sufficient	for	interaction	with	BCOR	and	BCORL1.	Pubmed:23523425
chr2	74732308	74733955	Q9BSM1	0	-	74732308	74733955	255,102,0	1	1647	0	.	Required	for	repressor	activity.
chr2	74757628	74758810	O43464	0	+	74757628	74758810	255,102,0	1	1182	0	.	Serine	protease.
chr2	74760798	74761896	P58215	0	-	74760798	74761896	255,102,0	1	1098	0	.	Lysyl-oxidase	like.
chr2	75061707	75061743	P52789	0	+	75061707	75061743	255,102,0	1	36	0	.	Hydrophobic.
chr2	75061743	75107551	P52789	0	+	75061743	75107551	255,102,0	1	45808	0	.	Regulatory.
chr2	75081572	75101000	P52789	0	+	75081572	75101000	255,102,0	1	19428	0	.	Hexokinase	small	subdomain	1.
chr2	75094785	75094800	P52789	0	+	75094785	75094800	255,102,0	1	15	0	.	Glucose-6-phosphate	1	binding.
chr2	75099513	75099519	P52789	0	+	75099513	75099519	255,102,0	1	6	0	.	Substrate	1	binding.
chr2	75100420	75100426	P52789	0	+	75100420	75100426	255,102,0	1	6	0	.	Substrate	1	binding.
chr2	75101000	75101006	P52789	0	+	75101000	75101006	255,102,0	1	6	0	.	Substrate	1	binding.
chr2	75101000	75107467	P52789	0	+	75101000	75107467	255,102,0	1	6467	0	.	Hexokinase	large	subdomain	1.
chr2	75101571	75104299	P52789	0	+	75101571	75104299	255,102,0	1	2728	0	.	Substrate	1	binding.
chr2	75106019	75106028	P52789	0	+	75106019	75106028	255,102,0	1	9	0	.	Glucose-6-phosphate	1	binding.
chr2	75107551	75118065	P52789	0	+	75107551	75118065	255,102,0	1	10514	0	.	Catalytic.
chr2	75107686	75113450	P52789	0	+	75107686	75113450	255,102,0	1	5764	0	.	Hexokinase	small	subdomain	2.
chr2	75108860	75108875	P52789	0	+	75108860	75108875	255,102,0	1	15	0	.	Glucose-6-phosphate	2	binding.
chr2	75109333	75109339	P52789	0	+	75109333	75109339	255,102,0	1	6	0	.	Substrate	2	binding.
chr2	75112638	75112644	P52789	0	+	75112638	75112644	255,102,0	1	6	0	.	Substrate	2	binding.
chr2	75113450	75113456	P52789	0	+	75113450	75113456	255,102,0	1	6	0	.	Substrate	2	binding.
chr2	75113450	75117999	P52789	0	+	75113450	75117999	255,102,0	1	4549	0	.	Hexokinase	large	subdomain	2.
chr2	75113624	75113630	P52789	0	+	75113624	75113630	255,102,0	1	6	0	.	Substrate	2	binding.
chr2	75113795	75115036	P52789	0	+	75113795	75115036	255,102,0	1	1241	0	.	Substrate	2	binding.
chr2	75116576	75116585	P52789	0	+	75116576	75116585	255,102,0	1	9	0	.	Glucose-6-phosphate	2	binding.
chr2	75720640	75745266	Q9H8M9	0	-	75720640	75745266	255,102,0	1	24626	0	.	Necessary	for	the	localization	and	biological	activity.
chr2	84668466	84668475	P53597	0	-	84668466	84668475	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr2	84676772	84676784	P53597	0	-	84676772	84676784	255,102,0	1	12	0	.	Coenzyme	A	binding.
chr2	84744950	84851690	Q9C0G6	0	+	84744950	84851690	255,102,0	1	106740	0	.	Stem.
chr2	84851690	84867697	Q9C0G6	0	+	84851690	84867697	255,102,0	1	16007	0	.	AAA	1.
chr2	84880506	84885502	Q9C0G6	0	+	84880506	84885502	255,102,0	1	4996	0	.	AAA	2.
chr2	84896499	84912451	Q9C0G6	0	+	84896499	84912451	255,102,0	1	15952	0	.	AAA	3.
chr2	84915646	84928379	Q9C0G6	0	+	84915646	84928379	255,102,0	1	12733	0	.	AAA	4.
chr2	84928427	84934675	Q9C0G6	0	+	84928427	84934675	255,102,0	1	6248	0	.	Stalk.
chr2	84936541	84949772	Q9C0G6	0	+	84936541	84949772	255,102,0	1	13231	0	.	AAA	5.
chr2	84989890	85014377	Q9C0G6	0	+	84989890	85014377	255,102,0	1	24487	0	.	AAA	6.
chr2	85360807	85361029	Q9HCS4	0	+	85360807	85361029	255,102,0	1	222	0	.	CTNNB1-binding.
chr2	85768799	85768838	P31153	0	+	85768799	85768838	255,102,0	1	39	0	.	Flexible	loop.
chr2	85981999	85982041	Q96SQ7	0	+	85981999	85982041	255,102,0	1	42	0	.	Basic	motif;	degenerate.
chr2	85982041	85991191	Q96SQ7	0	+	85982041	85991191	255,102,0	1	9150	0	.	Helix-loop-helix	motif.
chr2	86272450	86272745	O95602	0	-	86272450	86272745	255,102,0	1	295	0	.	Bridging	helix.
chr2	86732929	86732935	Q9Y3E7	0	-	86732929	86732935	255,102,0	1	6	0	.	Interaction	with	STAMBP.
chr2	86732929	86734674	Q9Y3E7	0	-	86732929	86734674	255,102,0	1	1745	0	.	Interaction	with	VPS4A.
chr2	86732935	86734674	Q9Y3E7	0	-	86732935	86734674	255,102,0	1	1739	0	.	Intramolecular	interaction	with	N-terminus.
chr2	86732974	86732989	Q9Y3E7	0	-	86732974	86732989	255,102,0	1	15	0	.	Interaction	with	STAMBP.
chr2	86734617	86734623	Q9Y3E7	0	-	86734617	86734623	255,102,0	1	6	0	.	Important	for	autoinhibitory	function.
chr2	86737549	86790468	Q9Y3E7	0	-	86737549	86790468	255,102,0	1	52919	0	.	Intramolecular	interaction	with	C-terminus.
chr2	86756434	86756452	Q9Y3E7	0	-	86756434	86756452	255,102,0	1	18	0	.	Important	for	autoinhibitory	function.
chr2	88367431	88367440	Q8NB12	0	+	88367431	88367440	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr2	88390614	88390620	Q8NB12	0	+	88390614	88390620	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr2	88396222	88396231	Q8NB12	0	+	88396222	88396231	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr2	89185366	89185435	P06312	0	+	89185366	89185435	255,102,0	1	69	0	.	Framework-1.	Pubmed:2997712
chr2	89185435	89185486	P06312	0	+	89185435	89185486	255,102,0	1	51	0	.	Complementarity-determining-1.	Pubmed:2997712
chr2	89185486	89185531	P06312	0	+	89185486	89185531	255,102,0	1	45	0	.	Framework-2.	Pubmed:2997712
chr2	89185531	89185552	P06312	0	+	89185531	89185552	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:2997712
chr2	89185552	89185648	P06312	0	+	89185552	89185648	255,102,0	1	96	0	.	Framework-3.	Pubmed:2997712
chr2	89185648	89185669	P06312	0	+	89185648	89185669	255,102,0	1	21	0	.	Complementarity-determining-3.	Pubmed:2997712
chr2	89197015	89197084	P06315	0	+	89197015	89197084	255,102,0	1	69	0	.	Framework-1.	Pubmed:3925437
chr2	89197084	89197117	P06315	0	+	89197084	89197117	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:3925437
chr2	89197117	89197162	P06315	0	+	89197117	89197162	255,102,0	1	45	0	.	Framework-2.	Pubmed:3925437
chr2	89197162	89197183	P06315	0	+	89197162	89197183	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:3925437
chr2	89197183	89197279	P06315	0	+	89197183	89197279	255,102,0	1	96	0	.	Framework-3.	Pubmed:3925437
chr2	89197279	89197300	P06315	0	+	89197279	89197300	255,102,0	1	21	0	.	Complementarity-determining-3.	Pubmed:3925437
chr2	89246839	89246935	P01602	0	-	89246839	89246935	255,102,0	1	96	0	.	Framework-3.	Pubmed:6779204
chr2	89246935	89246956	P01602	0	-	89246935	89246956	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6779204
chr2	89246956	89247001	P01602	0	-	89246956	89247001	255,102,0	1	45	0	.	Framework-2.	Pubmed:6779204
chr2	89247001	89247034	P01602	0	-	89247001	89247034	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:6779204
chr2	89247034	89247103	P01602	0	-	89247034	89247103	255,102,0	1	69	0	.	Framework-1.	Pubmed:6779204
chr2	89326667	89326688	P04433	0	-	89326667	89326688	255,102,0	1	21	0	.	Complementarity-determining-3.	Pubmed:6440122
chr2	89326688	89326784	P04433	0	-	89326688	89326784	255,102,0	1	96	0	.	Framework-3.	Pubmed:6440122
chr2	89326784	89326805	P04433	0	-	89326784	89326805	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6440122
chr2	89326805	89326850	P04433	0	-	89326805	89326850	255,102,0	1	45	0	.	Framework-2.	Pubmed:6440122
chr2	89326850	89326883	P04433	0	-	89326850	89326883	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:6440122
chr2	89326883	89326952	P04433	0	-	89326883	89326952	255,102,0	1	69	0	.	Framework-1.	Pubmed:6440122
chr2	89384693	89384789	P01624	0	-	89384693	89384789	255,102,0	1	96	0	.	Framework-3.	Pubmed:3083417
chr2	89384789	89384810	P01624	0	-	89384789	89384810	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:3083417
chr2	89384810	89384855	P01624	0	-	89384810	89384855	255,102,0	1	45	0	.	Framework-2.	Pubmed:3083417
chr2	89384855	89384888	P01624	0	-	89384855	89384888	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:3083417
chr2	89384888	89384957	P01624	0	-	89384888	89384957	255,102,0	1	69	0	.	Framework-1.	Pubmed:3083417
chr2	89399372	89399468	P04430	0	-	89399372	89399468	255,102,0	1	96	0	.	Framework-3.
chr2	89399468	89399489	P04430	0	-	89399468	89399489	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89399489	89399534	P04430	0	-	89399489	89399534	255,102,0	1	45	0	.	Framework-2.
chr2	89399534	89399567	P04430	0	-	89399534	89399567	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89399567	89399636	P04430	0	-	89399567	89399636	255,102,0	1	69	0	.	Framework-1.
chr2	89416853	89416949	P01599	0	-	89416853	89416949	255,102,0	1	96	0	.	Framework-3.
chr2	89416949	89416970	P01599	0	-	89416949	89416970	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89416970	89417015	P01599	0	-	89416970	89417015	255,102,0	1	45	0	.	Framework-2.
chr2	89417015	89417048	P01599	0	-	89417015	89417048	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89417048	89417117	P01599	0	-	89417048	89417117	255,102,0	1	69	0	.	Framework-1.
chr2	89442077	89442173	P01619	0	-	89442077	89442173	255,102,0	1	96	0	.	Framework-3.	Pubmed:2997711
chr2	89442173	89442194	P01619	0	-	89442173	89442194	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:2997711
chr2	89442194	89442239	P01619	0	-	89442194	89442239	255,102,0	1	45	0	.	Framework-2.	Pubmed:2997711
chr2	89442239	89442275	P01619	0	-	89442239	89442275	255,102,0	1	36	0	.	Complementarity-determining-1.	Pubmed:2997711
chr2	89442275	89442344	P01619	0	-	89442275	89442344	255,102,0	1	69	0	.	Framework-1.	Pubmed:2997711
chr2	89521199	89521295	P01615	0	-	89521199	89521295	255,102,0	1	96	0	.	Framework-3.	Pubmed:6325927
chr2	89521295	89521316	P01615	0	-	89521295	89521316	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6325927
chr2	89521316	89521361	P01615	0	-	89521316	89521361	255,102,0	1	45	0	.	Framework-2.	Pubmed:6325927
chr2	89521361	89521409	P01615	0	-	89521361	89521409	255,102,0	1	48	0	.	Complementarity-determining-1.	Pubmed:6325927
chr2	89521409	89521478	P01615	0	-	89521409	89521478	255,102,0	1	69	0	.	Framework-1.	Pubmed:6325927
chr2	89544284	89544380	P06310	0	-	89544284	89544380	255,102,0	1	96	0	.	Framework-3.	Pubmed:2997711
chr2	89544380	89544401	P06310	0	-	89544380	89544401	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:2997711
chr2	89544401	89544446	P06310	0	-	89544401	89544446	255,102,0	1	45	0	.	Framework-2.	Pubmed:2997711
chr2	89544446	89544494	P06310	0	-	89544446	89544494	255,102,0	1	48	0	.	Complementarity-determining-1.	Pubmed:2997711
chr2	89544494	89544563	P06310	0	-	89544494	89544563	255,102,0	1	69	0	.	Framework-1.	Pubmed:2997711
chr2	89567757	89567778	P01593	0	-	89567757	89567778	255,102,0	1	21	0	.	Complementarity-determining-3.
chr2	89567778	89567874	P01593	0	-	89567778	89567874	255,102,0	1	96	0	.	Framework-3.
chr2	89567778	89567874	P01594	0	-	89567778	89567874	255,102,0	1	96	0	.	Framework-3.
chr2	89567874	89567895	P01593	0	-	89567874	89567895	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89567874	89567895	P01594	0	-	89567874	89567895	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89567895	89567940	P01593	0	-	89567895	89567940	255,102,0	1	45	0	.	Framework-2.
chr2	89567895	89567940	P01594	0	-	89567895	89567940	255,102,0	1	45	0	.	Framework-2.
chr2	89567940	89567973	P01593	0	-	89567940	89567973	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89567940	89567973	P01594	0	-	89567940	89567973	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89567973	89568042	P01593	0	-	89567973	89568042	255,102,0	1	69	0	.	Framework-1.
chr2	89567973	89568042	P01594	0	-	89567973	89568042	255,102,0	1	69	0	.	Framework-1.
chr2	89619403	89619499	P01597	0	-	89619403	89619499	255,102,0	1	96	0	.	Framework-3.	Pubmed:6091049
chr2	89619403	89619499	P04432	0	-	89619403	89619499	255,102,0	1	96	0	.	Framework-3.	Pubmed:6091049
chr2	89619499	89619520	P01597	0	-	89619499	89619520	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6091049
chr2	89619499	89619520	P04432	0	-	89619499	89619520	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6091049
chr2	89619520	89619565	P01597	0	-	89619520	89619565	255,102,0	1	45	0	.	Framework-2.	Pubmed:6091049
chr2	89619520	89619565	P04432	0	-	89619520	89619565	255,102,0	1	45	0	.	Framework-2.	Pubmed:6091049
chr2	89619565	89619598	P01597	0	-	89619565	89619598	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:6091049
chr2	89619565	89619598	P04432	0	-	89619565	89619598	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:6091049
chr2	89619598	89619667	P01597	0	-	89619598	89619667	255,102,0	1	69	0	.	Framework-1.	Pubmed:6091049
chr2	89619598	89619667	P04432	0	-	89619598	89619667	255,102,0	1	69	0	.	Framework-1.	Pubmed:6091049
chr2	89901504	89901573	P01597	0	+	89901504	89901573	255,102,0	1	69	0	.	Framework-1.	Pubmed:6091049
chr2	89901504	89901573	P04432	0	+	89901504	89901573	255,102,0	1	69	0	.	Framework-1.	Pubmed:6091049
chr2	89901573	89901606	P01597	0	+	89901573	89901606	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:6091049
chr2	89901573	89901606	P04432	0	+	89901573	89901606	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:6091049
chr2	89901606	89901651	P01597	0	+	89901606	89901651	255,102,0	1	45	0	.	Framework-2.	Pubmed:6091049
chr2	89901606	89901651	P04432	0	+	89901606	89901651	255,102,0	1	45	0	.	Framework-2.	Pubmed:6091049
chr2	89901651	89901672	P01597	0	+	89901651	89901672	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6091049
chr2	89901651	89901672	P04432	0	+	89901651	89901672	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6091049
chr2	89901672	89901768	P01597	0	+	89901672	89901768	255,102,0	1	96	0	.	Framework-3.	Pubmed:6091049
chr2	89901672	89901768	P04432	0	+	89901672	89901768	255,102,0	1	96	0	.	Framework-3.	Pubmed:6091049
chr2	89953070	89953139	P01593	0	+	89953070	89953139	255,102,0	1	69	0	.	Framework-1.
chr2	89953070	89953139	P01594	0	+	89953070	89953139	255,102,0	1	69	0	.	Framework-1.
chr2	89953139	89953172	P01593	0	+	89953139	89953172	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89953139	89953172	P01594	0	+	89953139	89953172	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89953172	89953217	P01593	0	+	89953172	89953217	255,102,0	1	45	0	.	Framework-2.
chr2	89953172	89953217	P01594	0	+	89953172	89953217	255,102,0	1	45	0	.	Framework-2.
chr2	89953217	89953238	P01593	0	+	89953217	89953238	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89953217	89953238	P01594	0	+	89953217	89953238	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89953238	89953334	P01593	0	+	89953238	89953334	255,102,0	1	96	0	.	Framework-3.
chr2	89953238	89953334	P01594	0	+	89953238	89953334	255,102,0	1	96	0	.	Framework-3.
chr2	89953334	89953355	P01593	0	+	89953334	89953355	255,102,0	1	21	0	.	Complementarity-determining-3.
chr2	89999258	89999327	P01615	0	+	89999258	89999327	255,102,0	1	69	0	.	Framework-1.	Pubmed:6325927
chr2	89999327	89999375	P01615	0	+	89999327	89999375	255,102,0	1	48	0	.	Complementarity-determining-1.	Pubmed:6325927
chr2	89999375	89999420	P01615	0	+	89999375	89999420	255,102,0	1	45	0	.	Framework-2.	Pubmed:6325927
chr2	89999420	89999441	P01615	0	+	89999420	89999441	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6325927
chr2	89999441	89999537	P01615	0	+	89999441	89999537	255,102,0	1	96	0	.	Framework-3.	Pubmed:6325927
chr2	90139295	90139364	P01601	0	+	90139295	90139364	255,102,0	1	69	0	.	Framework-1.	Pubmed:6779204
chr2	90139364	90139397	P01601	0	+	90139364	90139397	255,102,0	1	33	0	.	Complementarity-determining-1.	Pubmed:6779204
chr2	90139397	90139442	P01601	0	+	90139397	90139442	255,102,0	1	45	0	.	Framework-2.	Pubmed:6779204
chr2	90139442	90139463	P01601	0	+	90139442	90139463	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6779204
chr2	90139463	90139559	P01601	0	+	90139463	90139559	255,102,0	1	96	0	.	Framework-3.	Pubmed:6779204
chr2	90198905	90198974	P01611	0	+	90198905	90198974	255,102,0	1	69	0	.	Framework-1.
chr2	90198974	90199007	P01611	0	+	90198974	90199007	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	90199007	90199052	P01611	0	+	90199007	90199052	255,102,0	1	45	0	.	Framework-2.
chr2	90199052	90199073	P01611	0	+	90199052	90199073	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	90199073	90199169	P01611	0	+	90199073	90199169	255,102,0	1	96	0	.	Framework-3.
chr2	96049752	96049794	Q9Y2W7	0	+	96049752	96049794	255,102,0	1	42	0	.	Interaction	with	KCND2.
chr2	96692483	96693786	Q6NUI2	0	-	96692483	96693786	255,102,0	1	1303	0	.	Acyltransferase.
chr2	97377396	97377405	Q9H0V9	0	-	97377396	97377405	255,102,0	1	9	0	.	Carbohydrate	binding.
chr2	97399273	97399282	Q9H0V9	0	-	97399273	97399282	255,102,0	1	9	0	.	Carbohydrate	binding.
chr2	97506007	97506061	Q86SG2	0	-	97506007	97506061	255,102,0	1	54	0	.	Interaction	with	TTN.	Pubmed:14583192
chr2	97527607	97532142	Q9C0C4	0	-	97527607	97532142	255,102,0	1	4535	0	.	Dominant	negative	effect	on	myogenic	differentiation.
chr2	98340805	98341638	P43403	0	+	98340805	98341638	255,102,0	1	833	0	.	Interdomain	A.
chr2	98349647	98351104	P43403	0	+	98349647	98351104	255,102,0	1	1457	0	.	Interdomain	B.
chr2	99634667	99636894	Q9BZW7	0	-	99634667	99636894	255,102,0	1	2227	0	.	Interaction	with	HIF1A.
chr2	99785894	99787091	Q8WV92	0	-	99785894	99787091	255,102,0	1	1197	0	.	Important	for	association	with	membranes.
chr2	99995550	99995574	O60841	0	+	99995550	99995574	255,102,0	1	24	0	.	G1.
chr2	99995816	99995831	O60841	0	+	99995816	99995831	255,102,0	1	15	0	.	G2.
chr2	99998663	99998675	O60841	0	+	99998663	99998675	255,102,0	1	12	0	.	G3.
chr2	99999378	100006186	O60841	0	+	99999378	100006186	255,102,0	1	6808	0	.	G4.
chr2	100006747	100006756	O60841	0	+	100006747	100006756	255,102,0	1	9	0	.	G5.
chr2	100017712	100019200	Q9UBZ9	0	-	100017712	100019200	255,102,0	1	1488	0	.	Protein	interaction	domain;	mediates	interaction	with	DNA	polymerase	zeta.
chr2	100029213	100029240	Q9UBZ9	0	-	100029213	100029240	255,102,0	1	27	0	.	Interaction	with	target	DNA.
chr2	100029396	100029408	Q9UBZ9	0	-	100029396	100029408	255,102,0	1	12	0	.	Interaction	with	target	DNA.
chr2	100055189	100055222	Q9UBZ9	0	-	100055189	100055222	255,102,0	1	33	0	.	Interaction	with	target	DNA.
chr2	101186085	101192955	Q9H2J4	0	+	101186085	101192955	255,102,0	1	6870	0	.	Thioredoxin	fold.
chr2	101521216	101549373	Q99743	0	+	101521216	101549373	255,102,0	1	28157	0	.	Sufficient	for	heterodimer	formation	with	ARNTL/BMAL1,	E-box	binding	and	for	the	effect	of	NADPH.
chr2	102490162	102505397	O95819	0	+	102490162	102505397	255,102,0	1	15235	0	.	Mediates	interaction	with	RAP2A.	Pubmed:14966141
chr2	102642669	102642714	P27930	0	+	102642669	102642714	255,102,0	1	45	0	.	Contains	proteolytic	cleavage	site.
chr2	102957269	102958705	Q01638	0	+	102957269	102958705	255,102,0	1	1436	0	.	Flexible	linker.
chr2	108627077	108627314	Q9GZV3	0	+	108627077	108627314	255,102,0	1	237	0	.	Mediates	interaction	with	SEC14L1.
chr2	108869841	108869850	Q6IMI6	0	+	108869841	108869850	255,102,0	1	9	0	.	Substrate	binding.
chr2	108917334	108917343	O00338	0	+	108917334	108917343	255,102,0	1	9	0	.	Substrate	binding.
chr2	108998881	108998890	O75897	0	+	108998881	108998890	255,102,0	1	9	0	.	Substrate	binding.
chr2	109113502	109116065	Q8IWJ2	0	+	109113502	109116065	255,102,0	1	2563	0	.	Mediates	interaction	with	RAB6A.
chr2	109113502	109124083	Q8IWJ2	0	+	109113502	109124083	255,102,0	1	10581	0	.	Mediates	interaction	with	RAB9A.
chr2	109383433	109383856	P49792	0	+	109383433	109383856	255,102,0	1	423	0	.	Interaction	with	BICD2.	Pubmed:20386726
chr2	109388197	109388212	P49792	0	+	109388197	109388212	255,102,0	1	15	0	.	Interaction	with	sumoylated	RANGAP1.
chr2	109388203	109388979	P49792	0	+	109388203	109388979	255,102,0	1	776	0	.	Interaction	with	UBE2I.
chr2	109388203	109389340	P49792	0	+	109388203	109389340	255,102,0	1	1137	0	.	Required	for	E3	SUMO-ligase	activity.
chr2	109388203	109389493	P49792	0	+	109388203	109389493	255,102,0	1	1290	0	.	2	X	50	AA	approximate	repeats.
chr2	109388979	109389493	P49792	0	+	109388979	109389493	255,102,0	1	514	0	.	Interaction	with	SUMO1.	Pubmed:15608651
chr2	111416074	111416224	O43683	0	-	111416074	111416224	255,102,0	1	150	0	.	Essential	for	loading	of	BUBR1,	MAD1L1	and	MAD2L1	to	kinetochores.
chr2	111425134	111425218	O43683	0	-	111425134	111425218	255,102,0	1	84	0	.	Necessary	for	interaction	with	BUB3.
chr2	111428129	111435572	O43683	0	-	111428129	111435572	255,102,0	1	7443	0	.	Necessary	for	kinetochore	localization.
chr2	111430263	111430365	O43683	0	-	111430263	111430365	255,102,0	1	102	0	.	Necessary	for	interaction	with	KNL1.	Pubmed:17981135
chr2	113418003	113418030	Q8WUM9	0	+	113418003	113418030	255,102,0	1	27	0	.	A.
chr2	118677921	118703113	Q567U6	0	-	118677921	118703113	255,102,0	1	25192	0	.	Sufficient	for	interaction	with	WASHC2C.	Pubmed:25355947
chr2	118704392	118771571	Q567U6	0	-	118704392	118771571	255,102,0	1	67179	0	.	Sufficient	for	interaction	with	CCDC22.	Pubmed:25355947
chr2	120125838	120125853	P07108	0	+	120125838	120125853	255,102,0	1	15	0	.	Acyl-CoA	binding.
chr2	120373273	120383251	Q4G0U5	0	+	120373273	120383251	255,102,0	1	9978	0	.	Interaction	with	calmodulin.
chr2	120723216	120725428	A0A024RAE8	0	+	120723216	120725428	255,102,0	1	2212	0	.	Substrate	binding.
chr2	120723216	120725428	P29074	0	+	120723216	120725428	255,102,0	1	2212	0	.	Substrate	binding.
chr2	122038753	122042685	Q9NZI6	0	-	122038753	122042685	255,102,0	1	3932	0	.	Mediate	transcriptional	repression.
chr2	122098439	122125284	Q7Z460	0	-	122098439	122125284	255,102,0	1	26845	0	.	Localization	to	kinetochores.
chr2	122098439	122125290	Q7Z460	0	-	122098439	122125290	255,102,0	1	26851	0	.	Interaction	with	CLIP2.
chr2	122098439	122125290	Q7Z460	0	-	122098439	122125290	255,102,0	1	26851	0	.	Interaction	with	PHLDB2	and	RSN.	Pubmed:16824950
chr2	122168510	122187682	Q7Z460	0	-	122168510	122187682	255,102,0	1	19172	0	.	Interaction	with	microtubules,	MAPRE1	and	MAPRE3.	Pubmed:15631994
chr2	122485374	122485881	Q9BYG3	0	-	122485374	122485881	255,102,0	1	507	0	.	Interaction	with	MKI67.
chr2	122516380	122518997	Q15631	0	+	122516380	122518997	255,102,0	1	2617	0	.	DNA/RNA	binding.
chr2	122522784	122522850	Q15631	0	+	122522784	122522850	255,102,0	1	66	0	.	Leucine-zipper.
chr2	127810997	127811588	O00499	0	-	127810997	127811588	255,102,0	1	591	0	.	Clathrin-binding.
chr2	127827615	127864516	O00499	0	-	127827615	127864516	255,102,0	1	36901	0	.	Interaction	with	BIN2.	Pubmed:10903846
chr2	128238622	128253723	Q96ST2	0	-	128238622	128253723	255,102,0	1	15101	0	.	Interaction	with	SUPT6H	and	ALYREF.	Pubmed:17234882
chr2	128262590	128262776	Q96ST2	0	-	128262590	128262776	255,102,0	1	186	0	.	3	X	approximate	tandem	repeats.
chr2	128366384	128387299	Q6PIF6	0	+	128366384	128387299	255,102,0	1	20915	0	.	Mediates	interaction	with	ANKS4B.	Pubmed:24725409
chr2	128386064	128394989	Q6PIF6	0	+	128386064	128394989	255,102,0	1	8925	0	.	Mediates	interaction	with	CDHR2,	CDHR5	and	USH1C.	Pubmed:26812017,	Pubmed:24725409
chr2	128699585	128707872	Q9H0E3	0	-	128699585	128707872	255,102,0	1	8287	0	.	Interactions	with	SIN3A	and	HDAC1.
chr2	128936057	128947313	Q9NYU2	0	+	128936057	128947313	255,102,0	1	11256	0	.	Glucosyltransferase.
chr2	129026392	129026419	O60243	0	-	129026392	129026419	255,102,0	1	27	0	.	3'-phosphate	binding.
chr2	129075831	129075852	O60243	0	-	129075831	129075852	255,102,0	1	21	0	.	5'-phosphosulfate-binding.
chr2	130737688	130738210	Q9H0N0	0	+	130737688	130738210	255,102,0	1	522	0	.	Required	for	centrosome	localization.
chr2	130831819	130832941	A5A3E0	0	-	130831819	130832941	255,102,0	1	1122	0	.	Actin-like.
chr2	131127758	131128145	Q99952	0	+	131127758	131128145	255,102,0	1	387	0	.	Substrate	binding.
chr2	131220391	131221510	P0CG38	0	-	131220391	131221510	255,102,0	1	1119	0	.	Actin-like.
chr2	131414328	131415447	P0CG39	0	+	131414328	131415447	255,102,0	1	1119	0	.	Actin-like.
chr2	131688746	131704159	Q9NR80	0	+	131688746	131704159	255,102,0	1	15413	0	.	ABR	(APC-binding	region)	domain.
chr2	132021131	132022253	Q6S8J3	0	+	132021131	132022253	255,102,0	1	1122	0	.	Actin-like.
chr2	135676424	135710925	O60583	0	+	135676424	135710925	255,102,0	1	34501	0	.	Interaction	with	MDFIC	and	MDFI.	Pubmed:17289077
chr2	135710254	135710925	O60583	0	+	135710254	135710925	255,102,0	1	671	0	.	Interaction	with	POLR2A.	Pubmed:15563843
chr2	135957914	135960512	Q5FWF4	0	-	135957914	135960512	255,102,0	1	2598	0	.	Endonuclease	activity.
chr2	136023199	136261924	Q5FWF4	0	-	136023199	136261924	255,102,0	1	238725	0	.	DNA	annealing	helicase	activity.
chr2	136499499	136519479	Q92575	0	+	136499499	136519479	255,102,0	1	19980	0	.	Interaction	with	UBQLN1.	Pubmed:19822669
chr2	136547180	136594481	P09848	0	-	136547180	136594481	255,102,0	1	47301	0	.	4	X	approximate	repeats.
chr2	136669048	136669063	P14868	0	-	136669048	136669063	255,102,0	1	15	0	.	Binding	site	for	the	3'-end	of	tRNA.
chr2	136680402	136680414	P14868	0	-	136680402	136680414	255,102,0	1	12	0	.	Aspartate.
chr2	136872693	136872702	P61073	0	-	136872693	136872702	255,102,0	1	9	0	.	Involved	in	dimerization.
chr2	136872867	136872927	P61073	0	-	136872867	136872927	255,102,0	1	60	0	.	Involved	in	dimerization.
chr2	136872927	136872942	P61073	0	-	136872927	136872942	255,102,0	1	15	0	.	Chemokine	binding,	important	for	signaling	and	HIV-1	coreceptor	activity.
chr2	136873056	136873095	P61073	0	-	136873056	136873095	255,102,0	1	39	0	.	Involved	in	dimerization;	when	bound	to	chemokine.
chr2	136873146	136873161	P61073	0	-	136873146	136873161	255,102,0	1	15	0	.	Chemokine	binding.
chr2	136873206	136873218	P61073	0	-	136873206	136873218	255,102,0	1	12	0	.	Chemokine	binding.
chr2	136873434	136875630	P61073	0	-	136873434	136875630	255,102,0	1	2196	0	.	Important	for	chemokine	binding,	signaling	and	HIV-1	coreceptor	activity.
chr2	139428494	139428752	O95156	0	-	139428494	139428752	255,102,0	1	258	0	.	V	(Cys-rich).
chr2	139428752	139428779	O95156	0	-	139428752	139428779	255,102,0	1	27	0	.	IV	(linker	domain).
chr2	139428779	139429016	O95156	0	-	139428779	139429016	255,102,0	1	237	0	.	III.
chr2	139429016	139429220	O95156	0	-	139429016	139429220	255,102,0	1	204	0	.	II.
chr2	143713828	143713840	Q16719	0	+	143713828	143713840	255,102,0	1	12	0	.	Pyridoxal	phosphate	binding.
chr2	145157292	145157445	O60315	0	-	145157292	145157445	255,102,0	1	153	0	.	SMAD-MH2	binding	domain.
chr2	149799204	149806953	O60282	0	+	149799204	149806953	255,102,0	1	7749	0	.	Microtubule-binding.
chr2	149866672	149868184	O60282	0	+	149866672	149868184	255,102,0	1	1512	0	.	Globular.
chr2	152321803	152331582	Q5UIP0	0	+	152321803	152331582	255,102,0	1	9779	0	.	Interaction	with	condensed	chromosomes	in	telophase.
chr2	152346484	152348732	P20929	0	-	152346484	152348732	255,102,0	1	2248	0	.	Interaction	with	SVIL.	Pubmed:18639526
chr2	152982814	152988653	O75886	0	-	152982814	152988653	255,102,0	1	5839	0	.	Interaction	with	HGS.
chr2	153000384	153000390	O75886	0	-	153000384	153000390	255,102,0	1	6	0	.	Interaction	with	USP8.
chr2	155098570	155099404	Q8IUC8	0	+	155098570	155099404	255,102,0	1	834	0	.	Catalytic	subdomain	A.
chr2	155102487	155157984	Q8IUC8	0	+	155102487	155157984	255,102,0	1	55497	0	.	Catalytic	subdomain	B.
chr2	157182824	157183366	P43354	0	-	157182824	157183366	255,102,0	1	542	0	.	Ligand-binding.
chr2	158140821	158152245	Q7Z7M9	0	+	158140821	158152245	255,102,0	1	11424	0	.	Catalytic	subdomain	A.
chr2	158153017	158157250	Q7Z7M9	0	+	158153017	158157250	255,102,0	1	4233	0	.	Catalytic	subdomain	B.
chr2	158177785	158177845	Q8TAM6	0	-	158177785	158177845	255,102,0	1	60	0	.	Binds	actin.
chr2	158275083	158283913	O60759	0	-	158275083	158283913	255,102,0	1	8830	0	.	Interaction	with	CYTH1.
chr2	160958339	160964267	P18564	0	-	160958339	160964267	255,102,0	1	5928	0	.	Interaction	with	HAX1.	Pubmed:17545607
chr2	160982915	160994239	P18564	0	-	160982915	160994239	255,102,0	1	11324	0	.	Cysteine-rich	tandem	repeats.
chr2	162036173	162036266	Q92844	0	+	162036173	162036266	255,102,0	1	93	0	.	Necessary	for	interaction	with	ZC3H12A.	Pubmed:25861989
chr2	162061184	162087534	Q92844	0	+	162061184	162087534	255,102,0	1	26350	0	.	Necessary	for	interaction	with	TRAF6.	Pubmed:25861989
chr2	162080494	162081253	Q92844	0	+	162080494	162081253	255,102,0	1	759	0	.	Interaction	with	TBK1	and	IKBKE.
chr2	162081250	162087534	Q92844	0	+	162081250	162087534	255,102,0	1	6284	0	.	TRAF	family	member	interaction.
chr2	166613694	166615853	Q14435	0	-	166613694	166615853	255,102,0	1	2159	0	.	Catalytic	subdomain	B.
chr2	166616039	166621532	Q14435	0	-	166616039	166621532	255,102,0	1	5493	0	.	Catalytic	subdomain	A.
chr2	166848876	166848930	P35498	0	-	166848876	166848930	255,102,0	1	54	0	.	S3b-S4	loop	of	repeat	IV.
chr2	166850794	166850827	P35498	0	-	166850794	166850827	255,102,0	1	33	0	.	S1-S2	loop	of	repeat	IV.
chr2	169727943	169732600	Q9HBM1	0	-	169727943	169732600	255,102,0	1	4657	0	.	Interaction	with	the	C-terminus	of	SPBC24.
chr2	169732600	169746029	Q9HBM1	0	-	169732600	169746029	255,102,0	1	13429	0	.	Interaction	with	the	N-terminus	of	SPBC24.
chr2	169744935	169749589	Q9HBM1	0	-	169744935	169749589	255,102,0	1	4654	0	.	Interaction	with	the	C-terminus	of	SPBC24.
chr2	169745766	169746029	Q9HBM1	0	-	169745766	169746029	255,102,0	1	263	0	.	Interaction	with	the	NDC80-NUF2	subcomplex.
chr2	169749589	169763018	Q9HBM1	0	-	169749589	169763018	255,102,0	1	13429	0	.	Interaction	with	the	N-terminus	of	SPBC24.
chr2	169762755	169763018	Q9HBM1	0	-	169762755	169763018	255,102,0	1	263	0	.	Interaction	with	the	NDC80-NUF2	subcomplex.
chr2	169824995	169825920	O95342	0	-	169824995	169825920	255,102,0	1	925	0	.	Interaction	with	HAX1.
chr2	169985334	169985558	P98164	0	-	169985334	169985558	255,102,0	1	224	0	.	Interaction	with	DAB2.
chr2	171693322	171693331	Q99259	0	+	171693322	171693331	255,102,0	1	9	0	.	Substrate	binding.
chr2	171811172	171811190	Q9H8Y8	0	+	171811172	171811190	255,102,0	1	18	0	.	Important	for	membrane	binding.
chr2	173362825	173368836	P23229	0	+	173362825	173368836	255,102,0	1	6011	0	.	Interaction	with	HPS5.
chr2	174081849	174081915	Q9NYL2	0	+	174081849	174081915	255,102,0	1	66	0	.	Leucine-zipper.
chr2	174228596	174229570	Q9BWT1	0	+	174228596	174229570	255,102,0	1	974	0	.	Interaction	with	MYC.	Pubmed:23166294
chr2	174230260	174232389	Q9BWT1	0	+	174230260	174232389	255,102,0	1	2129	0	.	Mediates	transcriptional	activity.
chr2	174777966	174819640	Q02447	0	-	174777966	174819640	255,102,0	1	41674	0	.	Repressor	domain.
chr2	174819742	174820192	Q02447	0	-	174819742	174820192	255,102,0	1	450	0	.	Transactivation	domain	(Gln-rich).
chr2	174820528	174820828	Q02447	0	-	174820528	174820828	255,102,0	1	300	0	.	Transactivation	domain	(Gln-rich).
chr2	175213881	175215455	Q86X95	0	-	175213881	175215455	255,102,0	1	1574	0	.	Interaction	with	RP9.
chr2	175244932	175260350	Q86X95	0	-	175244932	175260350	255,102,0	1	15418	0	.	Interaction	with	RBPJ.	Pubmed:9874765
chr2	175446074	175446086	O43516	0	-	175446074	175446086	255,102,0	1	12	0	.	Binds	actin.
chr2	175945454	175957836	P15336	0	-	175945454	175957836	255,102,0	1	12382	0	.	Leucine-zipper.
chr2	175957851	175957914	P15336	0	-	175957851	175957914	255,102,0	1	63	0	.	Basic	motif.
chr2	175962252	175962264	P15336	0	-	175962252	175962264	255,102,0	1	12	0	.	Essential	for	its	histone	acetyltransferase	activity.
chr2	178095542	178095560	Q16236	0	-	178095542	178095560	255,102,0	1	18	0	.	Mediates	interaction	with	CHD6	and	is	necessary	to	activate	transcription.
chr2	178095743	178095767	Q16236	0	-	178095743	178095767	255,102,0	1	24	0	.	Leucine-zipper.
chr2	178095776	178095836	Q16236	0	-	178095776	178095836	255,102,0	1	60	0	.	Basic	motif.
chr2	178388520	178388529	O00116	0	+	178388520	178388529	255,102,0	1	9	0	.	Important	for	enzyme	activity.
chr2	178494221	178592771	Q9HCR9	0	-	178494221	178592771	255,102,0	1	98550	0	.	Catalytic.
chr2	179296826	179306363	O75569	0	-	179296826	179306363	255,102,0	1	9537	0	.	Sufficient	for	self-association	and	interaction	with	TARBP2.
chr2	179306360	179312245	O75569	0	-	179306360	179312245	255,102,0	1	5885	0	.	Sufficient	for	self-association	and	interaction	with	TARBP2.
chr2	179312239	179315757	O75569	0	-	179312239	179315757	255,102,0	1	3518	0	.	Sufficient	for	self-association	and	interaction	with	TARBP2.
chr2	179642590	179642683	Q8WZ42	0	-	179642590	179642683	255,102,0	1	93	0	.	ZIS5.
chr2	179659870	179664371	Q8WZ42	0	-	179659870	179664371	255,102,0	1	4501	0	.	ZIS1.
chr2	180307979	180409670	Q569K4	0	-	180307979	180409670	255,102,0	1	101691	0	.	Interaction	with	p53/TP53.	Pubmed:22945289
chr2	180409670	180634482	Q569K4	0	-	180409670	180634482	255,102,0	1	224812	0	.	Required	for	induction	of	apoptosis.
chr2	183050637	183095747	P54750	0	-	183050637	183095747	255,102,0	1	45110	0	.	Catalytic.
chr2	183129110	183387034	P54750	0	-	183129110	183387034	255,102,0	1	257924	0	.	Calmodulin-binding.
chr2	183594643	183605088	Q8IXB1	0	+	183594643	183605088	255,102,0	1	10445	0	.	Trxb	1.
chr2	183605079	183616467	Q8IXB1	0	+	183605079	183616467	255,102,0	1	11388	0	.	Trxb	2.
chr2	187368929	187370240	Q8WU90	0	+	187368929	187370240	255,102,0	1	1311	0	.	Required	for	interaction	with	DRG1.
chr2	189850501	189851838	P02461	0	+	189850501	189851838	255,102,0	1	1337	0	.	Nonhelical	region	(N-terminal).
chr2	189851838	189873712	P02461	0	+	189851838	189873712	255,102,0	1	21874	0	.	Triple-helical	region.
chr2	189873712	189873739	P02461	0	+	189873712	189873739	255,102,0	1	27	0	.	Nonhelical	region	(C-terminal).
chr2	190617678	190617684	Q9H4B0	0	-	190617678	190617684	255,102,0	1	6	0	.	Substrate	binding.
chr2	190619988	190620003	Q9H4B0	0	-	190619988	190620003	255,102,0	1	15	0	.	Substrate	binding.
chr2	191064751	191064808	Q9BSF0	0	+	191064751	191064808	255,102,0	1	57	0	.	PKA-RI-binding.
chr2	191231617	191233836	P49441	0	+	191231617	191233836	255,102,0	1	2219	0	.	Substrate	binding.
chr2	191523911	191524148	Q13506	0	+	191523911	191524148	255,102,0	1	237	0	.	NCD1.
chr2	191524562	191535162	Q13506	0	+	191524562	191535162	255,102,0	1	10600	0	.	NCD2.
chr2	191535150	191548472	Q13506	0	+	191535150	191548472	255,102,0	1	13322	0	.	Necessary	for	nuclear	localization.
chr2	192818472	192818526	Q9UIK5	0	-	192818472	192818526	255,102,0	1	54	0	.	Required	for	shedding.
chr2	196651751	196664184	Q8WXX0	0	-	196651751	196664184	255,102,0	1	12433	0	.	AAA	6.
chr2	196681560	196709811	Q8WXX0	0	-	196681560	196709811	255,102,0	1	28251	0	.	AAA	5.
chr2	196718228	196726463	Q8WXX0	0	-	196718228	196726463	255,102,0	1	8235	0	.	Stalk.
chr2	196726511	196729475	Q8WXX0	0	-	196726511	196729475	255,102,0	1	2964	0	.	AAA	4.
chr2	196737039	196746668	Q8WXX0	0	-	196737039	196746668	255,102,0	1	9629	0	.	AAA	3.
chr2	196752981	196759885	Q8WXX0	0	-	196752981	196759885	255,102,0	1	6904	0	.	AAA	2.
chr2	196765020	196786879	Q8WXX0	0	-	196765020	196786879	255,102,0	1	21859	0	.	AAA	1.
chr2	196786879	196933435	Q8WXX0	0	-	196786879	196933435	255,102,0	1	146556	0	.	Stem.
chr2	197138778	197183405	Q9P2P5	0	-	197138778	197183405	255,102,0	1	44627	0	.	Interaction	with	TP73.	Pubmed:12890487
chr2	198268323	198268443	O75533	0	-	198268323	198268443	255,102,0	1	120	0	.	Interaction	with	SF3B14.
chr2	198269865	198274731	O75533	0	-	198269865	198274731	255,102,0	1	4866	0	.	Interaction	with	PPP1R8.	Pubmed:12105215
chr2	198273183	198281563	O75533	0	-	198273183	198281563	255,102,0	1	8380	0	.	U2AF	homology	region;	mediates	interaction	with	RBM39.	Pubmed:24795046
chr2	198948487	198948907	Q15111	0	+	198948487	198948907	255,102,0	1	420	0	.	Interaction	with	PPP1C.
chr2	198949867	198949942	Q15111	0	+	198949867	198949942	255,102,0	1	75	0	.	Interaction	with	GABA	A	beta	subunit.
chr2	201761801	201768398	Q9GZT8	0	+	201761801	201768398	255,102,0	1	6597	0	.	Mediates	interaction	with	COPS2.
chr2	201994588	202005141	O15519	0	+	201994588	202005141	255,102,0	1	10553	0	.	Interaction	with	caspase-8.
chr2	201994588	202013745	O15519	0	+	201994588	202013745	255,102,0	1	19157	0	.	Interaction	with	FADD.
chr2	201994588	202025276	O15519	0	+	201994588	202025276	255,102,0	1	30688	0	.	Interaction	with	caspase-8	propeptide.
chr2	201994588	202025666	O15519	0	+	201994588	202025666	255,102,0	1	31078	0	.	Not	proteolytically	processed	and	involved	in	apoptosis	inhibition.
chr2	202005129	202025666	O15519	0	+	202005129	202025666	255,102,0	1	20537	0	.	Interaction	with	caspase-3.
chr2	202005129	202028693	O15519	0	+	202005129	202028693	255,102,0	1	23564	0	.	Interaction	with	TRAF1	and	TRAF2.
chr2	202010142	202028693	O15519	0	+	202010142	202028693	255,102,0	1	18551	0	.	Interaction	with	caspase-8	subunits	p18	and	p10.
chr2	202014551	202025435	O15519	0	+	202014551	202025435	255,102,0	1	10884	0	.	Caspase.
chr2	202025468	202028693	O15519	0	+	202025468	202028693	255,102,0	1	3225	0	.	Interaction	with	caspase-8.
chr2	202252594	202257670	O60296	0	-	202252594	202257670	255,102,0	1	5076	0	.	Interaction	with	HGS.
chr2	203745585	203764300	Q9GZL7	0	-	203745585	203764300	255,102,0	1	18715	0	.	Sufficient	for	nucleolar	localization.
chr2	204735334	204735349	P16410	0	+	204735334	204735349	255,102,0	1	15	0	.	Homodimerization.
chr2	204735646	204736108	P16410	0	+	204735646	204736108	255,102,0	1	462	0	.	Homodimerization.
chr2	207437868	207437886	O75077	0	+	207437868	207437886	255,102,0	1	18	0	.	May	bind	the	integrin	receptor.
chr2	208442347	208461683	P16220	0	+	208442347	208461683	255,102,0	1	19336	0	.	Basic	motif.
chr2	208461686	208461752	P16220	0	+	208461686	208461752	255,102,0	1	66	0	.	Leucine-zipper.
chr2	208486563	208486572	Q8WXB1	0	-	208486563	208486572	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr2	208986660	208988838	P07320	0	-	208986660	208988838	255,102,0	1	2178	0	.	Connecting	peptide.
chr2	208993190	208994167	P07315	0	-	208993190	208994167	255,102,0	1	977	0	.	Connecting	peptide.
chr2	209007625	209010500	P07316	0	-	209007625	209010500	255,102,0	1	2875	0	.	Connecting	peptide.
chr2	209025791	209027930	P11844	0	-	209025791	209027930	255,102,0	1	2139	0	.	Connecting	peptide.
chr2	209113206	209113227	O75874	0	-	209113206	209113227	255,102,0	1	21	0	.	Substrate	binding.
chr2	209113206	209113227	V9HWJ2	0	-	209113206	209113227	255,102,0	1	21	0	.	Substrate	binding.
chr2	209215583	209220026	Q9Y2I7	0	+	209215583	209220026	255,102,0	1	4443	0	.	Catalytic.
chr2	210561423	210561654	P11137	0	+	210561423	210561654	255,102,0	1	231	0	.	Calmodulin-binding.
chr2	210881323	210881335	C9IZU8	0	+	210881323	210881335	255,102,0	1	12	0	.	Substrate	binding.
chr2	210881323	210881335	C9J9T0	0	+	210881323	210881335	255,102,0	1	12	0	.	Substrate	binding.
chr2	210881323	210881335	Q96AT9	0	+	210881323	210881335	255,102,0	1	12	0	.	Substrate	binding.
chr2	210884416	210884422	Q96AT9	0	+	210884416	210884422	255,102,0	1	6	0	.	Substrate	binding.
chr2	211300132	211300144	O43813	0	-	211300132	211300144	255,102,0	1	12	0	.	Glutathione	binding.
chr2	211421571	211452814	P31327	0	+	211421571	211452814	255,102,0	1	31243	0	.	Anthranilate	phosphoribosyltransferase	homolog.
chr2	215617173	215617188	Q99728	0	-	215617173	215617188	255,102,0	1	15	0	.	Flexible	linker.
chr2	215657027	215674218	Q99728	0	-	215657027	215674218	255,102,0	1	17191	0	.	Interaction	with	BRCA1.
chr2	216191631	216191637	P31939	0	+	216191631	216191637	255,102,0	1	6	0	.	AICAR	binding.
chr2	216226769	216232715	P02751	0	-	216226769	216232715	255,102,0	1	5946	0	.	Fibrin-binding	2.
chr2	216236766	216237099	P02751	0	-	216236766	216237099	255,102,0	1	333	0	.	Connecting	strand	3	(CS-3)	(V	region).
chr2	216238045	216241398	P02751	0	-	216238045	216241398	255,102,0	1	3353	0	.	Binds	to	FBLN1.
chr2	216238045	216244041	P02751	0	-	216238045	216244041	255,102,0	1	5996	0	.	Heparin-binding	2.
chr2	216248743	216256535	P02751	0	-	216248743	216256535	255,102,0	1	7792	0	.	Cell-attachment.
chr2	216279676	216289931	P02751	0	-	216279676	216289931	255,102,0	1	10255	0	.	Collagen-binding.
chr2	216286928	216288076	P02751	0	-	216286928	216288076	255,102,0	1	1148	0	.	Critical	for	collagen	binding.
chr2	216292930	216299542	P02751	0	-	216292930	216299542	255,102,0	1	6612	0	.	Fibrin-	and	heparin-binding	1.
chr2	216983808	216986788	P13010	0	+	216983808	216986788	255,102,0	1	2980	0	.	Leucine-zipper.
chr2	217279430	217279517	Q9NZC9	0	+	217279430	217279517	255,102,0	1	87	0	.	Mediates	interaction	with	RPA2.
chr2	219209179	219209188	Q8N490	0	+	219209179	219209188	255,102,0	1	9	0	.	Substrate	binding.
chr2	219209671	219209683	Q8N490	0	+	219209671	219209683	255,102,0	1	12	0	.	Substrate	binding.
chr2	219288504	219292718	P09327	0	+	219288504	219292718	255,102,0	1	4214	0	.	Necessary	for	homodimerization.
chr2	219288504	219303422	P09327	0	+	219288504	219303422	255,102,0	1	14918	0	.	Core.
chr2	219290520	219292697	P09327	0	+	219290520	219292697	255,102,0	1	2177	0	.	LPA/PIP2-binding	site	1.
chr2	219292751	219292778	P09327	0	+	219292751	219292778	255,102,0	1	27	0	.	LPA/PIP2-binding	site	2.
chr2	219303422	219314056	P09327	0	+	219303422	219314056	255,102,0	1	10634	0	.	Headpiece.
chr2	219314020	219314047	P09327	0	+	219314020	219314047	255,102,0	1	27	0	.	LPA/PIP2-binding	site	3.
chr2	219480679	219480763	Q9BRC7	0	+	219480679	219480763	255,102,0	1	84	0	.	Substrate	binding.
chr2	219614747	219617596	Q14679	0	+	219614747	219617596	255,102,0	1	2849	0	.	c-MTBD	region.	Pubmed:25959773
chr2	219678875	219679112	Q02318	0	+	219678875	219679112	255,102,0	1	237	0	.	Sterol-binding.
chr2	219846391	219846721	Q99581	0	-	219846391	219846721	255,102,0	1	330	0	.	May	mediate	active	transcriptional	repression.
chr2	219855704	219856829	P53672	0	-	219855704	219856829	255,102,0	1	1125	0	.	Connecting	peptide.
chr2	219857865	219857898	P53672	0	-	219857865	219857898	255,102,0	1	33	0	.	N-terminal	arm.
chr2	220012502	220023084	Q9H9Q4	0	-	220012502	220023084	255,102,0	1	10582	0	.	Globular	head.
chr2	220072746	220072996	Q8WV99	0	+	220072746	220072996	255,102,0	1	250	0	.	VCP/p97-interacting	motif	(VIM).	Pubmed:21896481
chr2	220100585	220100758	Q9H8Y5	0	+	220100585	220100758	255,102,0	1	173	0	.	VCP/p97-interacting	motif	(VIM).	Pubmed:21896481
chr2	220112191	220112428	O75716	0	+	220112191	220112428	255,102,0	1	237	0	.	Activation	loop.
chr2	220161746	220162693	Q16849	0	-	220161746	220162693	255,102,0	1	947	0	.	Sufficient	for	dimerization	of	proICA512.
chr2	220162768	220164798	Q16849	0	-	220162768	220164798	255,102,0	1	2030	0	.	Sufficient	for	dimerization	of	proICA512.	Pubmed:25561468
chr2	220167543	220173952	Q16849	0	-	220167543	220173952	255,102,0	1	6409	0	.	RESP18	homology	domain.
chr2	220283184	220283508	P17661	0	+	220283184	220283508	255,102,0	1	324	0	.	Head.
chr2	220283508	220283607	P17661	0	+	220283508	220283607	255,102,0	1	99	0	.	Coil	1A.
chr2	220283508	220286274	P17661	0	+	220283508	220286274	255,102,0	1	2766	0	.	Rod.
chr2	220283607	220283637	P17661	0	+	220283607	220283637	255,102,0	1	30	0	.	Linker	1.
chr2	220283637	220285237	P17661	0	+	220283637	220285237	255,102,0	1	1600	0	.	Coil	1B.
chr2	220285237	220285285	P17661	0	+	220285237	220285285	255,102,0	1	48	0	.	Linker	12.
chr2	220285285	220285342	P17661	0	+	220285285	220285342	255,102,0	1	57	0	.	Coil	2A.
chr2	220285342	220285366	P17661	0	+	220285342	220285366	255,102,0	1	24	0	.	Linker	2.
chr2	220285366	220286274	P17661	0	+	220285366	220286274	255,102,0	1	908	0	.	Coil	2B.
chr2	220286274	220290709	P17661	0	+	220286274	220290709	255,102,0	1	4435	0	.	Tail.
chr2	220435672	220435702	O75147	0	-	220435672	220435702	255,102,0	1	30	0	.	Interaction	with	TTN.
chr2	220435897	220435906	O75147	0	-	220435897	220435906	255,102,0	1	9	0	.	Interaction	with	TTN.
chr2	220500546	220506447	P48751	0	+	220500546	220506447	255,102,0	1	5901	0	.	Membrane	(anion	exchange).
chr2	224463400	224463457	P13521	0	-	224463400	224463457	255,102,0	1	57	0	.	O-glycosylated	at	one	site.
chr2	226378312	226378348	Q9P242	0	+	226378312	226378348	255,102,0	1	36	0	.	Involved	in	CYFIP1-	and	NCKAP1-binding.
chr2	227597251	227597260	P35568	0	-	227597251	227597260	255,102,0	1	9	0	.	GRB2-binding.
chr2	227599534	227599939	P35568	0	-	227599534	227599939	255,102,0	1	405	0	.	Mediates	interaction	with	PHIP.
chr2	227779015	227779063	Q8TEB9	0	+	227779015	227779063	255,102,0	1	48	0	.	Ubiquitin-binding	domain	(UBD).
chr2	227860190	227860235	Q8TEB9	0	+	227860190	227860235	255,102,0	1	45	0	.	VCP/p97-interacting	motif	(VIM).
chr2	227875173	227985864	P53420	0	-	227875173	227985864	255,102,0	1	110691	0	.	Triple-helical	region.
chr2	228004876	228004954	P53420	0	-	228004876	228004954	255,102,0	1	78	0	.	7S	domain.
chr2	228029526	228102722	Q01955	0	+	228029526	228102722	255,102,0	1	73196	0	.	7S	domain.
chr2	228102722	228172487	Q01955	0	+	228102722	228172487	255,102,0	1	69765	0	.	Triple-helical	region.
chr2	228172451	228172505	Q01955	0	+	228172451	228172505	255,102,0	1	54	0	.	Epitope	recognized	by	Goodpasture	antibodies.
chr2	228172607	228173950	Q01955	0	+	228172607	228173950	255,102,0	1	1343	0	.	Required	for	the	anti-angiogenic	activity	of	tumstatin.
chr2	228175563	228175620	Q01955	0	+	228175563	228175620	255,102,0	1	57	0	.	Required	for	the	anti-tumor	cell	activity	of	tumstatin.
chr2	228882731	228882785	Q2M3C7	0	-	228882731	228882785	255,102,0	1	54	0	.	PKA-RII	subunit	binding	domain.
chr2	230231650	230231662	Q8NFT8	0	-	230231650	230231662	255,102,0	1	12	0	.	Interaction	with	AP1G1	and	somatodendritic	targeting.
chr2	230456481	230579010	Q8NFT8	0	-	230456481	230579010	255,102,0	1	122529	0	.	Interaction	with	NOTCH1.
chr2	230652280	230653641	Q14669	0	-	230652280	230653641	255,102,0	1	1361	0	.	K-box.
chr2	231042256	231042271	Q9HB58	0	-	231042256	231042271	255,102,0	1	15	0	.	Nuclear	hormone	receptor	interaction.
chr2	231327172	231338043	P23497	0	+	231327172	231338043	255,102,0	1	10871	0	.	Sufficient	to	mediate	interaction	with	ETS1.
chr2	231973653	231973668	P41595	0	-	231973653	231973668	255,102,0	1	15	0	.	Agonist	binding.
chr2	231978575	231978593	P41595	0	-	231978575	231978593	255,102,0	1	18	0	.	Agonist	binding.
chr2	232326458	232326692	P19338	0	-	232326458	232326692	255,102,0	1	234	0	.	8	X	8	AA	tandem	repeats	of	X-T-P-X-K-K-X-X.
chr2	232597664	232597685	O43924	0	-	232597664	232597685	255,102,0	1	21	0	.	Required	for	association	with	membranes.	Pubmed:9712853
chr2	233422617	233422629	O60573	0	+	233422617	233422629	255,102,0	1	12	0	.	EIF4EBP1/2/3	binding.
chr2	233422689	233422695	O60573	0	+	233422689	233422695	255,102,0	1	6	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr2	233428968	233428983	O60573	0	+	233428968	233428983	255,102,0	1	15	0	.	EIF4EBP1/2/3	binding.
chr2	233429055	233429061	O60573	0	+	233429055	233429061	255,102,0	1	6	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr2	233431610	233431634	O60573	0	+	233431610	233431634	255,102,0	1	24	0	.	EIF4EBP1/2/3	binding.
chr2	233431682	233431796	O60573	0	+	233431682	233431796	255,102,0	1	114	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr2	233431922	233433661	O60573	0	+	233431922	233433661	255,102,0	1	1739	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr2	233671199	233671250	Q6Y7W6	0	+	233671199	233671250	255,102,0	1	51	0	.	Required	for	GRB10-binding.
chr2	233785002	233839600	Q8N5V2	0	-	233785002	233839600	255,102,0	1	54598	0	.	Regulatory	region;	modulates	activity	toward	RHOA,	RAC1	and	CDC42.
chr2	234112841	234112886	Q92835	0	+	234112841	234112886	255,102,0	1	45	0	.	Interaction	with	DAB2.
chr2	234160509	234164761	Q676U5	0	+	234160509	234164761	255,102,0	1	4252	0	.	Interaction	with	ATG5.	Pubmed:25484072
chr2	234173766	234178696	Q676U5	0	+	234173766	234178696	255,102,0	1	4930	0	.	WIPI2-binding.	Pubmed:24954904
chr2	234178693	234181630	Q676U5	0	+	234178693	234181630	255,102,0	1	2937	0	.	RB1CC1-binding.	Pubmed:24954904,	Pubmed:23392225
chr2	234851251	234851278	Q7Z2W7	0	+	234851251	234851278	255,102,0	1	27	0	.	Epitope;	activates	specific	cytotoxic	T	lymphocytes.
chr2	236617854	236708037	Q9UPQ3	0	+	236617854	236708037	255,102,0	1	90183	0	.	Small	GTPase-like.
chr2	237490077	237490194	P25106	0	+	237490077	237490194	255,102,0	1	117	0	.	C-terminal	cytoplasmic	tail.
chr2	238233419	238253737	P12111	0	-	238233419	238253737	255,102,0	1	20318	0	.	Nonhelical	region.
chr2	238253823	238270423	P12111	0	-	238253823	238270423	255,102,0	1	16600	0	.	Triple-helical	region.
chr2	238270423	238305385	P12111	0	-	238270423	238305385	255,102,0	1	34962	0	.	Nonhelical	region.
chr2	238671808	238672108	Q32MZ4	0	+	238671808	238672108	255,102,0	1	300	0	.	DNA-binding.
chr2	238881749	238881836	Q969M7	0	+	238881749	238881836	255,102,0	1	87	0	.	Interaction	with	UBA3.	Pubmed:19250909
chr2	239155018	239159196	O15055	0	-	239155018	239159196	255,102,0	1	4178	0	.	CRY	binding	domain.
chr2	239160300	239162002	O15055	0	-	239160300	239162002	255,102,0	1	1702	0	.	Interaction	with	PPARG.
chr2	239164304	239167244	O15055	0	-	239164304	239167244	255,102,0	1	2940	0	.	CSNK1E	binding	domain.
chr2	239169558	239169573	O15055	0	-	239169558	239169573	255,102,0	1	15	0	.	Important	for	protein	stability.
chr2	239229303	239241518	Q8TDR0	0	+	239229303	239241518	255,102,0	1	12215	0	.	Abolishes	microtubules-binding	when	missing.
chr2	239237734	239307557	Q8TDR0	0	+	239237734	239307557	255,102,0	1	69823	0	.	DISC1-interaction	domain.
chr2	239974795	240029880	P56524	0	-	239974795	240029880	255,102,0	1	55085	0	.	Histone	deacetylase.
chr2	240061418	240098247	P56524	0	-	240061418	240098247	255,102,0	1	36829	0	.	Interaction	with	MEF2A.	Pubmed:10487761
chr2	241516109	241516124	Q9HAU8	0	+	241516109	241516124	255,102,0	1	15	0	.	Substrate	binding.
chr2	241534092	241535939	Q9HC96	0	+	241534092	241535939	255,102,0	1	1847	0	.	Domain	III	1.
chr2	241536152	241537787	Q9HC96	0	+	241536152	241537787	255,102,0	1	1635	0	.	Domain	III	2.
chr2	242035577	242035631	Q7Z6M4	0	-	242035577	242035631	255,102,0	1	54	0	.	Dimerization	with	NSUN4.
chr2	242283247	242283280	Q15019	0	+	242283247	242283280	255,102,0	1	33	0	.	Important	for	dimerization.
chr2	242498940	242499033	Q9UMX3	0	+	242498940	242499033	255,102,0	1	93	0	.	Interactions	with	ITPR1.
chr2	242499105	242501776	Q9UMX3	0	+	242499105	242501776	255,102,0	1	2671	0	.	Nuclear	export	signal.	Pubmed:16302269
chr20	126057	126186	Q9BYW3	0	+	126057	126186	255,102,0	1	129	0	.	In	vitro	binds	to	LPS,	mediates	antimicrobial	activity	and	inhibits	LPS-mediated	inflammation.	Pubmed:23229569
chr20	368654	372020	Q96RU7	0	+	368654	372020	255,102,0	1	3366	0	.	Interaction	with	DDIT3/CHOP.
chr20	389401	400279	Q9BYM8	0	+	389401	400279	255,102,0	1	10878	0	.	Interaction	with	IRF3.	Pubmed:18711448
chr20	389401	401568	Q9BYM8	0	+	389401	401568	255,102,0	1	12167	0	.	Interaction	with	TAB2.	Pubmed:17449468
chr20	398206	398507	Q9BYM8	0	+	398206	398507	255,102,0	1	301	0	.	Interaction	with	RNF31.	Pubmed:22430200
chr20	485851	485869	P68400	0	-	485851	485869	255,102,0	1	18	0	.	Interaction	with	beta	subunit.
chr20	656185	656245	Q9NQ03	0	-	656185	656245	255,102,0	1	60	0	.	SNAG	domain.
chr20	1099419	1115848	Q92530	0	+	1099419	1115848	255,102,0	1	16429	0	.	Important	for	homodimerization	and	interaction	with	FBXO7.	Pubmed:18495667
chr20	2442416	2443771	P14678	0	-	2442416	2443771	255,102,0	1	1355	0	.	Repeat-rich	region.
chr20	2686274	2686286	Q9BQW3	0	+	2686274	2686286	255,102,0	1	12	0	.	Interaction	with	DNA.
chr20	2729228	2729252	Q9BQW3	0	+	2729228	2729252	255,102,0	1	24	0	.	Interaction	with	DNA.
chr20	2730115	2730127	Q9BQW3	0	+	2730115	2730127	255,102,0	1	12	0	.	Interaction	with	DNA.
chr20	2845297	2846078	Q9H269	0	+	2845297	2846078	255,102,0	1	781	0	.	Interaction	with	VPS33A.	Pubmed:23901104
chr20	3171301	3175502	Q96HY6	0	-	3171301	3175502	255,102,0	1	4201	0	.	Mediates	interaction	with	UFL1.	Pubmed:25219498
chr20	3175499	3181044	Q96HY6	0	-	3175499	3181044	255,102,0	1	5545	0	.	Mediates	interaction	with	TRIP4.	Pubmed:25219498
chr20	3181053	3185273	Q96HY6	0	-	3181053	3185273	255,102,0	1	4220	0	.	Mediates	interaction	with	CDK5RAP3.	Pubmed:20228063
chr20	3190236	3190254	Q9BY32	0	+	3190236	3190254	255,102,0	1	18	0	.	Substrate	binding.
chr20	3194654	3194660	Q9BY32	0	+	3194654	3194660	255,102,0	1	6	0	.	Substrate	binding.
chr20	3202519	3202531	Q9BY32	0	+	3202519	3202531	255,102,0	1	12	0	.	Substrate	binding.
chr20	3204051	3204057	Q9BY32	0	+	3204051	3204057	255,102,0	1	6	0	.	Substrate	binding.
chr20	3208435	3211669	Q8NBS3	0	-	3208435	3211669	255,102,0	1	3234	0	.	Membrane	(bicarbonate	transporter).
chr20	3687024	3687039	Q9BZZ2	0	-	3687024	3687039	255,102,0	1	15	0	.	Sialic	acid	binding.
chr20	3765333	3765525	P07199	0	-	3765333	3765525	255,102,0	1	192	0	.	Homodimerization.
chr20	3835298	3838395	Q7Z434	0	+	3835298	3838395	255,102,0	1	3097	0	.	Required	for	interaction	with	NLRX1.	Pubmed:18200010
chr20	3842112	3842127	Q7Z434	0	+	3842112	3842127	255,102,0	1	15	0	.	Interaction	with	TRAF2.	Pubmed:16153868
chr20	3842142	3842909	Q7Z434	0	+	3842142	3842909	255,102,0	1	767	0	.	Interaction	with	TRAF6.
chr20	3846533	3846551	Q7Z434	0	+	3846533	3846551	255,102,0	1	18	0	.	Interaction	with	TRAF6.
chr20	4679932	4679980	P04156	0	+	4679932	4679980	255,102,0	1	48	0	.	Interaction	with	ADGRG6.
chr20	4679932	4680556	P04156	0	+	4679932	4680556	255,102,0	1	624	0	.	Interaction	with	GRB2,	ERI3	and	SYN1.
chr20	4680016	4680139	P04156	0	+	4680016	4680139	255,102,0	1	123	0	.	5	X	8	AA	tandem	repeats	of	P-H-G-G-G-W-G-Q.
chr20	4705275	4705347	Q9UKY0	0	+	4705275	4705347	255,102,0	1	72	0	.	Flexible	tail.
chr20	4705347	4705653	Q9UKY0	0	+	4705347	4705653	255,102,0	1	306	0	.	Globular.
chr20	5099433	5100426	P12004	0	-	5099433	5100426	255,102,0	1	993	0	.	Interaction	with	NUDT15.	Pubmed:19419956
chr20	5566879	5566885	Q9NPB8	0	-	5566879	5566885	255,102,0	1	6	0	.	Substrate	binding.
chr20	5903135	5903150	P05060	0	+	5903135	5903150	255,102,0	1	15	0	.	O-glycosylated	at	one	site.
chr20	5919351	5921701	Q9UJA5	0	-	5919351	5921701	255,102,0	1	2350	0	.	Substrate.	Pubmed:26470919
chr20	5921731	5921758	Q9UJA5	0	-	5921731	5921758	255,102,0	1	27	0	.	Substrate.	Pubmed:26470919
chr20	5924325	5924613	Q9UJA5	0	-	5924325	5924613	255,102,0	1	288	0	.	Substrate.	Pubmed:26470919
chr20	5924673	5924833	Q9UJA5	0	-	5924673	5924833	255,102,0	1	160	0	.	Substrate.	Pubmed:26470919
chr20	5925504	5925537	Q9UJA5	0	-	5925504	5925537	255,102,0	1	33	0	.	Substrate.	Pubmed:26470919
chr20	9546677	9624904	Q9P286	0	-	9546677	9624904	255,102,0	1	78226	0	.	Linker.
chr20	10256139	10273870	P60880	0	+	10256139	10273870	255,102,0	1	17731	0	.	Interaction	with	CENPF.
chr20	10389326	10393571	Q9NPJ1	0	-	10389326	10393571	255,102,0	1	4245	0	.	Substrate-binding	apical	domain.
chr20	10639188	10639215	P78504	0	-	10639188	10639215	255,102,0	1	27	0	.	Important	for	interaction	with	NOTCH1.	Pubmed:18660822
chr20	14307951	14308041	Q9NZU0	0	-	14307951	14308041	255,102,0	1	90	0	.	Interaction	with	ADGRL3.	Pubmed:26235030
chr20	17474721	17477664	Q12934	0	-	17474721	17477664	255,102,0	1	2943	0	.	Tail.
chr20	17477664	17492644	Q12934	0	-	17477664	17492644	255,102,0	1	14980	0	.	Coil	2.
chr20	17477664	17511854	Q12934	0	-	17477664	17511854	255,102,0	1	34190	0	.	Rod.
chr20	17492644	17492695	Q12934	0	-	17492644	17492695	255,102,0	1	51	0	.	Linker	12.
chr20	17492695	17511722	Q12934	0	-	17492695	17511722	255,102,0	1	19027	0	.	Coil	1B.
chr20	17511722	17511749	Q12934	0	-	17511722	17511749	255,102,0	1	27	0	.	Linker	1.
chr20	17511749	17511854	Q12934	0	-	17511749	17511854	255,102,0	1	105	0	.	Coil	1A.
chr20	17511854	17511974	Q12934	0	-	17511854	17511974	255,102,0	1	120	0	.	Head.
chr20	17930783	17933239	Q9Y5X3	0	-	17930783	17933239	255,102,0	1	2456	0	.	Interaction	with	DOCK1.	Pubmed:18596235
chr20	17932152	17932206	Q9Y5X3	0	-	17932152	17932206	255,102,0	1	54	0	.	Membrane-binding	amphipathic	helix.	Pubmed:23085988
chr20	17934680	17934692	Q9Y5X3	0	-	17934680	17934692	255,102,0	1	12	0	.	Phosphatidylinositol	bisphosphate	binding.
chr20	17934713	17934734	Q9Y5X3	0	-	17934713	17934734	255,102,0	1	21	0	.	Phosphatidylinositol	bisphosphate	binding.
chr20	17937594	17937615	Q9Y5X3	0	-	17937594	17937615	255,102,0	1	21	0	.	Phosphatidylinositol	bisphosphate	binding.
chr20	18474639	18474684	O75884	0	-	18474639	18474684	255,102,0	1	45	0	.	Retinoblastoma	protein	binding.
chr20	20020396	20026005	Q9BZJ0	0	-	20020396	20026005	255,102,0	1	5609	0	.	Mediates	interaction	with	HSP90.
chr20	20348911	20348971	Q01101	0	+	20348911	20348971	255,102,0	1	60	0	.	SNAG	domain.
chr20	20349037	20349085	Q01101	0	+	20349037	20349085	255,102,0	1	48	0	.	Necessary	for	interaction	with	CCND1.
chr20	22562490	22562781	Q9Y261	0	-	22562490	22562781	255,102,0	1	291	0	.	Transactivation	domain	2.
chr20	22563582	22564859	Q9Y261	0	-	22563582	22564859	255,102,0	1	1277	0	.	Transactivation	domain	1.
chr20	23028596	23028701	P07204	0	-	23028596	23028701	255,102,0	1	105	0	.	Involved	in	alpha-L/beta-2	and	alpha-M/beta-2	integrin	binding.	Pubmed:27055590
chr20	23966525	23966531	Q9BX51	0	-	23966525	23966531	255,102,0	1	6	0	.	Glutamate	binding.
chr20	23966591	23966597	Q9BX51	0	-	23966591	23966597	255,102,0	1	6	0	.	Glutamate	binding.
chr20	25004227	25004239	Q9NUB1	0	-	25004227	25004239	255,102,0	1	12	0	.	Coenzyme	A	binding.
chr20	25273100	25273106	P11216	0	+	25273100	25273106	255,102,0	1	6	0	.	Pyridoxal	5'-phosphate.	Pubmed:27402852
chr20	25596911	25596917	Q8TBE9	0	-	25596911	25596917	255,102,0	1	6	0	.	Substrate	binding.
chr20	25604542	25604551	Q8TBE9	0	-	25604542	25604551	255,102,0	1	9	0	.	Substrate	binding.
chr20	30072137	30072197	O75628	0	+	30072137	30072197	255,102,0	1	60	0	.	Calmodulin-binding.
chr20	30421528	30421567	Q9H1R3	0	+	30421528	30421567	255,102,0	1	39	0	.	Calmodulin-binding.
chr20	30797878	30797887	Q9H488	0	+	30797878	30797887	255,102,0	1	9	0	.	Substrate	binding.
chr20	30816234	30816243	Q9H488	0	+	30816234	30816243	255,102,0	1	9	0	.	Substrate	binding.
chr20	30822362	30822368	Q9H488	0	+	30822362	30822368	255,102,0	1	6	0	.	Substrate	binding.
chr20	30904666	30919119	O15066	0	+	30904666	30919119	255,102,0	1	14453	0	.	Globular.
chr20	31368129	31379487	Q9UBC3	0	+	31368129	31379487	255,102,0	1	11358	0	.	Interaction	with	DNMT1	and	DNMT3A.	Pubmed:12145218
chr20	31384600	31386356	Q9UBC3	0	+	31384600	31386356	255,102,0	1	1756	0	.	Interaction	with	the	PRC2/EED-EZH2	complex.
chr20	31387118	31387133	Q9UBC3	0	+	31387118	31387133	255,102,0	1	15	0	.	S-adenosyl-L-homocysteine	binding.
chr20	31388077	31388086	Q9UBC3	0	+	31388077	31388086	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine	binding.
chr20	31395640	31395649	Q9UBC3	0	+	31395640	31395649	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine	binding.
chr20	31424541	31436531	Q15691	0	+	31424541	31436531	255,102,0	1	11990	0	.	Interaction	with	MTUS2/TIP150.	Pubmed:19543227
chr20	31427617	31436531	Q15691	0	+	31427617	31436531	255,102,0	1	8914	0	.	Interaction	with	CDK5RAP2.	Pubmed:19553473
chr20	31434447	31436531	Q15691	0	+	31434447	31436531	255,102,0	1	2084	0	.	DCTN1-binding.
chr20	31434483	31434552	Q15691	0	+	31434483	31434552	255,102,0	1	69	0	.	APC-binding.
chr20	31946896	31958316	Q96SZ6	0	-	31946896	31958316	255,102,0	1	11420	0	.	CDK5R1-binding.
chr20	31980020	31984807	Q96SZ6	0	-	31980020	31984807	255,102,0	1	4787	0	.	CDK5	activation	inhibition.
chr20	31996315	31996384	Q13424	0	-	31996315	31996384	255,102,0	1	69	0	.	Calmodulin-binding.
chr20	32199012	32211028	O43439	0	+	32199012	32211028	255,102,0	1	12016	0	.	Interaction	with	PRDM14.
chr20	32216172	32217596	O43439	0	+	32216172	32217596	255,102,0	1	1424	0	.	Nervy	homology	region	2	(NHR2).
chr20	32224492	32228274	O43439	0	+	32224492	32228274	255,102,0	1	3782	0	.	Nervy	homology	region	3	(NHR3).
chr20	32264540	32264750	Q01094	0	-	32264540	32264750	255,102,0	1	210	0	.	Transactivation.
chr20	32264573	32264627	Q01094	0	-	32264573	32264627	255,102,0	1	54	0	.	RB1	binding.	Pubmed:12598654
chr20	32264705	32266158	Q01094	0	-	32264705	32266158	255,102,0	1	1453	0	.	Required	for	interaction	with	TRIM28.	Pubmed:17704056
chr20	32265124	32266149	Q01094	0	-	32265124	32266149	255,102,0	1	1025	0	.	Dimerization.
chr20	32267559	32268219	Q01094	0	-	32267559	32268219	255,102,0	1	660	0	.	Interaction	with	BIRC2/c-IAP1.	Pubmed:21653699
chr20	32267610	32267676	Q01094	0	-	32267610	32267676	255,102,0	1	66	0	.	Leucine-zipper.
chr20	32268159	32273872	Q01094	0	-	32268159	32273872	255,102,0	1	5713	0	.	Cyclin	A:CDK2	binding.	Pubmed:8033208
chr20	32664853	32664934	Q9UKM9	0	+	32664853	32664934	255,102,0	1	81	0	.	Epitope	(recognized	by	BKRF1	antibodies).
chr20	33033185	33045274	Q96J02	0	+	33033185	33045274	255,102,0	1	12089	0	.	Required	for	interaction	with	FYN.	Pubmed:16387660
chr20	33065603	33065633	Q96J02	0	+	33065603	33065633	255,102,0	1	30	0	.	MAP	kinase	docking	site.
chr20	33147198	33147213	Q9H492	0	+	33147198	33147213	255,102,0	1	15	0	.	Important	for	interaction	with	ATG13	and	for	autophagosome	formation.	Pubmed:24290141
chr20	33173299	33173362	Q9H490	0	-	33173299	33173362	255,102,0	1	63	0	.	May	be	involved	in	recognition	of	long-chain	fatty	acids	in	GPI.
chr20	33303128	33329139	Q14686	0	-	33303128	33329139	255,102,0	1	26011	0	.	EP300/CRSP3-binding	region.
chr20	33337213	33370158	Q14686	0	-	33337213	33370158	255,102,0	1	32945	0	.	TBP/GTF2A-binding	region.
chr20	33337216	33337681	Q14686	0	-	33337216	33337681	255,102,0	1	465	0	.	NCOA6IP-binding	region.
chr20	33501909	33501921	Q9NR19	0	+	33501909	33501921	255,102,0	1	12	0	.	Coenzyme	A	binding.
chr20	33516669	33516675	P48637	0	-	33516669	33516675	255,102,0	1	6	0	.	Substrate	binding.
chr20	33523402	33523414	P48637	0	-	33523402	33523414	255,102,0	1	12	0	.	Substrate	binding.
chr20	33524786	33524795	P48637	0	-	33524786	33524795	255,102,0	1	9	0	.	Substrate	binding.
chr20	33530328	33530340	P48637	0	-	33530328	33530340	255,102,0	1	12	0	.	Substrate	binding.
chr20	33609010	33680581	Q8TEL6	0	-	33609010	33680581	255,102,0	1	71571	0	.	Interaction	with	TNFRSF1A.
chr20	34268677	34268686	Q9Y697	0	-	34268677	34268686	255,102,0	1	9	0	.	Pyridoxal	phosphate	binding.
chr20	34284322	34284328	Q9Y697	0	-	34284322	34284328	255,102,0	1	6	0	.	Pyridoxal	phosphate	binding.
chr20	34287677	34288768	P60602	0	+	34287677	34288768	255,102,0	1	1091	0	.	Sufficient	for	antibacterial	activity.
chr20	34292405	34297155	Q14498	0	-	34292405	34297155	255,102,0	1	4750	0	.	Interaction	with	NCOA6.
chr20	34297152	34302140	Q14498	0	-	34297152	34302140	255,102,0	1	4988	0	.	Interaction	with	ESR1	and	ESR2.
chr20	34297152	34304682	Q14498	0	-	34297152	34304682	255,102,0	1	7530	0	.	Interaction	with	JUN.
chr20	34302137	34304682	Q14498	0	-	34302137	34304682	255,102,0	1	2545	0	.	Activating	domain.
chr20	34782279	34785918	Q9H4G0	0	+	34782279	34785918	255,102,0	1	3639	0	.	Spectrin--actin-binding.
chr20	34802329	34817259	Q9H4G0	0	+	34802329	34817259	255,102,0	1	14930	0	.	C-terminal	(CTD).
chr20	35219426	35219831	Q9GZN2	0	+	35219426	35219831	255,102,0	1	405	0	.	Repressive	function.
chr20	35242271	35242790	Q9H6Q3	0	-	35242271	35242790	255,102,0	1	519	0	.	SLA	C-terminal.
chr20	35540892	35540910	Q9Y3Z3	0	-	35540892	35540910	255,102,0	1	18	0	.	Substrate	binding.
chr20	35545359	35545380	Q9Y3Z3	0	-	35545359	35545380	255,102,0	1	21	0	.	Substrate	binding.
chr20	35635837	35661109	P28749	0	-	35635837	35661109	255,102,0	1	25272	0	.	Domain	B.
chr20	35635837	35689603	P28749	0	-	35635837	35689603	255,102,0	1	53766	0	.	Pocket;	binds	T	and	E1A.
chr20	35661109	35672506	P28749	0	-	35661109	35672506	255,102,0	1	11397	0	.	Spacer.
chr20	35672506	35689603	P28749	0	-	35672506	35689603	255,102,0	1	17097	0	.	Domain	A.
chr20	36932640	36940306	P17213	0	+	36932640	36940306	255,102,0	1	7666	0	.	N-terminal	barrel.	Pubmed:10843855
chr20	36940306	36954738	P17213	0	+	36940306	36954738	255,102,0	1	14432	0	.	Central	sheet.	Pubmed:10843855
chr20	36948625	36948643	P17213	0	+	36948625	36948643	255,102,0	1	18	0	.	Cleavage	sites	for	elastase.
chr20	36952280	36962837	P17213	0	+	36952280	36962837	255,102,0	1	10557	0	.	C-terminal	barrel.	Pubmed:10843855
chr20	37580422	37581160	Q9H4H8	0	+	37580422	37581160	255,102,0	1	738	0	.	Required	for	interaction	with	KIF22	and	function	in	chromosome	congression.	Pubmed:18485706
chr20	39316629	39316695	Q9Y5Q3	0	-	39316629	39316695	255,102,0	1	66	0	.	Leucine-zipper.
chr20	39316701	39316779	Q9Y5Q3	0	-	39316701	39316779	255,102,0	1	78	0	.	Basic	motif.
chr20	39729957	39729963	P11387	0	+	39729957	39729963	255,102,0	1	6	0	.	Interaction	with	DNA.
chr20	39742618	39742636	P11387	0	+	39742618	39742636	255,102,0	1	18	0	.	Interaction	with	DNA.
chr20	39744962	39744971	P11387	0	+	39744962	39744971	255,102,0	1	9	0	.	Interaction	with	DNA.
chr20	39831891	39832068	Q9H4I2	0	-	39831891	39832068	255,102,0	1	177	0	.	Required	for	nuclear	localization.
chr20	39832050	39832650	Q9H4I2	0	-	39832050	39832650	255,102,0	1	600	0	.	Required	for	repressor	activity.
chr20	39832092	39832833	Q9H4I2	0	-	39832092	39832833	255,102,0	1	741	0	.	Required	for	homodimerization	and	interaction	with	NFYA.	Pubmed:12659632
chr20	39833235	39833556	Q9H4I2	0	-	39833235	39833556	255,102,0	1	321	0	.	Required	for	nuclear	localization.
chr20	39974443	39977294	Q9BQK8	0	+	39974443	39977294	255,102,0	1	2851	0	.	N-LIP.
chr20	39984638	39987147	Q9BQK8	0	+	39984638	39987147	255,102,0	1	2509	0	.	C-LIP.
chr20	40735545	40738977	O14522	0	-	40735545	40738977	255,102,0	1	3432	0	.	Substrate	binding.
chr20	42635219	42635336	Q96NM4	0	+	42635219	42635336	255,102,0	1	117	0	.	Required	for	transcriptional	activation.
chr20	43254258	43254312	P00813	0	-	43254258	43254312	255,102,0	1	54	0	.	Required	for	binding	to	DDP4.	Pubmed:15016824
chr20	43804506	43804638	P19957	0	+	43804506	43804638	255,102,0	1	132	0	.	2	X	tandem	repeats	of	SVP-1	like	motif.
chr20	43836145	43837255	P04279	0	+	43836145	43837255	255,102,0	1	1110	0	.	Repeat-rich	region.
chr20	43836427	43836787	P04279	0	+	43836427	43836787	255,102,0	1	360	0	.	Interaction	with	EPPIN.	Pubmed:15590901
chr20	43836718	43837078	P04279	0	+	43836718	43837078	255,102,0	1	360	0	.	2	X	60	AA	tandem	repeats,	type	1.
chr20	43850480	43851950	Q02383	0	+	43850480	43851950	255,102,0	1	1470	0	.	Repeat-rich	region.
chr20	43851053	43851773	Q02383	0	+	43851053	43851773	255,102,0	1	720	0	.	4	X	60	AA	tandem	repeats,	type	I.
chr20	43881058	43881787	P03973	0	-	43881058	43881787	255,102,0	1	729	0	.	Elastase	inhibitory	domain.
chr20	44170785	44171381	O95925	0	-	44170785	44171381	255,102,0	1	596	0	.	Interaction	with	LTF.	Pubmed:22699487
chr20	44170785	44171426	O95925	0	-	44170785	44171426	255,102,0	1	641	0	.	Interaction	with	SEMG1.
chr20	44421375	44429781	Q9H147	0	+	44421375	44429781	255,102,0	1	8406	0	.	Important	for	dimerization.	Pubmed:25653165
chr20	44432002	44439792	Q9H147	0	+	44432002	44439792	255,102,0	1	7790	0	.	Important	for	DNA	and	nucleosome	binding.	Pubmed:25653165
chr20	44690941	44691307	Q9HCD5	0	-	44690941	44691307	255,102,0	1	366	0	.	Transcription	activation.
chr20	44697168	44708063	Q9HCD5	0	-	44697168	44708063	255,102,0	1	10895	0	.	Transcription	repression.
chr20	45839408	45839528	Q9ULU4	0	-	45839408	45839528	255,102,0	1	120	0	.	Interaction	with	PRKCB1.
chr20	45905259	45927643	Q9ULU4	0	-	45905259	45927643	255,102,0	1	22384	0	.	Interaction	with	histone	H3K14ac.	Pubmed:27477906
chr20	45912332	45927643	Q9ULU4	0	-	45912332	45927643	255,102,0	1	15311	0	.	Interaction	with	histone	H3K4me0.	Pubmed:27477906
chr20	46268781	46275843	Q9Y6Q9	0	+	46268781	46275843	255,102,0	1	7062	0	.	Interaction	with	CREBBP.	Pubmed:9346901
chr20	46275852	46279986	Q9Y6Q9	0	+	46275852	46279986	255,102,0	1	4134	0	.	Acetyltransferase.
chr20	47538429	47570161	Q9Y6D5	0	+	47538429	47570161	255,102,0	1	31732	0	.	DCB;	DCB:DCB	domain	and	DCB:HUS	domain	interaction.
chr20	47588958	47589740	Q9Y6D5	0	+	47588958	47589740	255,102,0	1	782	0	.	HUS;	DCB:HUS	domain	interaction.
chr20	47990653	47990755	Q14721	0	-	47990653	47990755	255,102,0	1	102	0	.	Self-association.
chr20	48098792	48098843	Q14721	0	-	48098792	48098843	255,102,0	1	51	0	.	Self-association.
chr20	48253906	48253912	O43286	0	-	48253906	48253912	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr20	48256228	48256240	O43286	0	-	48256228	48256240	255,102,0	1	12	0	.	N-acetyl-D-glucosamine	binding.
chr20	48257100	48257106	O43286	0	-	48257100	48257106	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr20	48257178	48257187	O43286	0	-	48257178	48257187	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr20	48259091	48259106	O43286	0	-	48259091	48259106	255,102,0	1	15	0	.	UDP-alpha-D-galactose	binding.
chr20	48599596	48599656	O95863	0	+	48599596	48599656	255,102,0	1	60	0	.	SNAG	domain.
chr20	48599623	48600398	O95863	0	+	48599623	48600398	255,102,0	1	775	0	.	LATS2	binding.
chr20	48600635	48600731	O95863	0	+	48600635	48600731	255,102,0	1	96	0	.	Required	for	FBXL14-triggered	degradation.
chr20	48600728	48604590	O95863	0	+	48600728	48604590	255,102,0	1	3862	0	.	Required	for	nuclear	localization	and	interaction	with	KPNB1,	NOTCH1	and	PARP1.	Pubmed:21577210,	Pubmed:22128911
chr20	48807570	48807642	P17676	0	+	48807570	48807642	255,102,0	1	72	0	.	Required	for	Lys-174	sumoylation.
chr20	48807639	48807975	P17676	0	+	48807639	48807975	255,102,0	1	336	0	.	Required	for	MYC	transcriptional	repression.
chr20	48808392	48808455	P17676	0	+	48808392	48808455	255,102,0	1	63	0	.	Basic	motif.
chr20	48808458	48808482	P17676	0	+	48808458	48808482	255,102,0	1	24	0	.	Leucine-zipper.
chr20	49195106	49195127	A8K3M3	0	+	49195106	49195127	255,102,0	1	21	0	.	Substrate	binding.
chr20	49195106	49195127	B4DSN5	0	+	49195106	49195127	255,102,0	1	21	0	.	Substrate	binding.
chr20	49195106	49195127	P18031	0	+	49195106	49195127	255,102,0	1	21	0	.	Substrate	binding.
chr20	49366281	49366665	Q9BYG5	0	+	49366281	49366665	255,102,0	1	384	0	.	Interaction	with	PARD3	and	CDC42.
chr20	49510167	49510191	Q9H2P0	0	-	49510167	49510191	255,102,0	1	24	0	.	Neuroprotective	peptide	(NAP).	Pubmed:19091000
chr20	50139921	50140230	Q13469	0	-	50139921	50140230	255,102,0	1	309	0	.	3	X	approximate	SP	repeats.
chr20	50140182	50140425	Q13469	0	-	50140182	50140425	255,102,0	1	243	0	.	Trans-activation	domain	A	(TAD-A).
chr20	50140254	50140299	Q13469	0	-	50140254	50140299	255,102,0	1	45	0	.	Required	for	cytoplasmic	retention	of	the	phosphorylated	form.
chr20	50140431	50140449	Q13469	0	-	50140431	50140449	255,102,0	1	18	0	.	Calcineurin-binding.
chr20	54970647	54970713	Q05048	0	+	54970647	54970713	255,102,0	1	66	0	.	Hydrophobic.
chr20	55209278	55212988	Q92754	0	+	55209278	55212988	255,102,0	1	3710	0	.	H-S-H	(helix-span-helix),	dimerization.
chr20	56138175	56138184	P35558	0	+	56138175	56138184	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:14552798,	Pubmed:17532214,	Pubmed:11851336
chr20	56139557	56139566	P35558	0	+	56139557	56139566	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:14552798,	Pubmed:17532214,	Pubmed:11851336
chr20	57896180	57896225	P14138	0	+	57896180	57896225	255,102,0	1	45	0	.	Endothelin-like.
chr20	58381232	58416557	Q96KR7	0	+	58381232	58416557	255,102,0	1	35325	0	.	Required	for	PP1CA	binding	and	inhibition	of	PP1	activity.
chr20	60718876	60737875	O75177	0	+	60718876	60737875	255,102,0	1	18999	0	.	N-terminal	auto-inhibitory	domain;	necessary	for	interaction	with	SMARCA4/BRG1.
chr20	60737875	60738653	O75177	0	+	60737875	60738653	255,102,0	1	778	0	.	Methionine-rich	intra-molecular	domain.
chr20	60739214	60747772	O75177	0	+	60739214	60747772	255,102,0	1	8558	0	.	MFD	domain.
chr20	60747820	60754261	O75177	0	+	60747820	60754261	255,102,0	1	6441	0	.	Necessary	for	nuclear	localization.
chr20	60749694	60754261	O75177	0	+	60749694	60754261	255,102,0	1	4567	0	.	Necessary	for	interaction	with	CREBBP	and	for	the	recruitment	of	CREBBP	to	the	nuclear	bodies.
chr20	60768518	60776130	Q9H4K7	0	+	60768518	60776130	255,102,0	1	7612	0	.	Localized	in	the	mitochondria.
chr20	60768563	60776130	Q9H4K7	0	+	60768563	60776130	255,102,0	1	7567	0	.	Not	localized	in	the	mitochondria.
chr20	60878687	60881312	Q16186	0	+	60878687	60881312	255,102,0	1	2625	0	.	Pru	(pleckstrin-like	receptor	for	ubiquitin)	domain.	Pubmed:18497817
chr20	60882784	60883814	Q16186	0	+	60882784	60883814	255,102,0	1	1030	0	.	Interaction	with	UCHL5.	Pubmed:20471946
chr20	60889772	60895944	O15230	0	-	60889772	60895944	255,102,0	1	6172	0	.	Domain	II	and	I.
chr20	60904035	60909609	O15230	0	-	60904035	60909609	255,102,0	1	5574	0	.	Domain	IV	1	(domain	IV	B).
chr20	61389661	61391394	P30989	0	+	61389661	61391394	255,102,0	1	1733	0	.	Neurotensin	binding.
chr20	61444515	61444935	Q9NZT2	0	+	61444515	61444935	255,102,0	1	420	0	.	7	X	20	AA	approximate	tandem	repeats	of	[ST]-P-S-E-T-P-G-P-[SR]-P-A-G-P-[AT]-[GR]-D-E-P-A-[EK].
chr20	61448924	61467838	Q14050	0	+	61448924	61467838	255,102,0	1	18914	0	.	Triple-helical	region	3	(COL3).
chr20	61467838	61468481	Q14050	0	+	61467838	61468481	255,102,0	1	643	0	.	Nonhelical	region	3	(NC3).
chr20	61468481	61471919	Q14050	0	+	61468481	61471919	255,102,0	1	3438	0	.	Triple-helical	region	2	(COL2).
chr20	61471919	61471925	Q14050	0	+	61471919	61471925	255,102,0	1	6	0	.	Nonhelical	region	2	(NC2).
chr20	61471925	61472012	Q14050	0	+	61471925	61472012	255,102,0	1	87	0	.	Triple-helical	region	1	(COL1).
chr20	61472012	61472081	Q14050	0	+	61472012	61472081	255,102,0	1	69	0	.	Nonhelical	region	1	(NC1).
chr20	61473329	61473389	Q9UL49	0	-	61473329	61473389	255,102,0	1	60	0	.	R1	epitope	(recognized	by	Chagas's	antibodies).
chr20	61488916	61488946	Q9UL49	0	-	61488916	61488946	255,102,0	1	30	0	.	R3	epitope	(recognized	by	Chagas's	antibodies).
chr20	61834055	61834061	Q9BYJ9	0	-	61834055	61834061	255,102,0	1	6	0	.	N6-methyladenosine	binding.	Pubmed:26318451
chr20	61834100	61834109	Q9BYJ9	0	-	61834100	61834109	255,102,0	1	9	0	.	N6-methyladenosine	binding.	Pubmed:26318451
chr20	62126190	62126199	Q05639	0	-	62126190	62126199	255,102,0	1	9	0	.	G5.
chr20	62126310	62126322	Q05639	0	-	62126310	62126322	255,102,0	1	12	0	.	G4.
chr20	62127250	62127262	Q05639	0	-	62127250	62127262	255,102,0	1	12	0	.	G3.
chr20	62127310	62127325	Q05639	0	-	62127310	62127325	255,102,0	1	15	0	.	G2.
chr20	62129053	62129077	Q05639	0	-	62129053	62129077	255,102,0	1	24	0	.	G1.
chr20	62165003	62165510	Q13882	0	-	62165003	62165510	255,102,0	1	507	0	.	Linker.
chr20	62178663	62178816	Q9H3Y6	0	-	62178663	62178816	255,102,0	1	153	0	.	N-terminal.
chr20	62190601	62193551	Q9BYK8	0	-	62190601	62193551	255,102,0	1	2950	0	.	Interaction	with	THRAP3.	Pubmed:23525231
chr20	62196997	62199754	Q9BYK8	0	-	62196997	62199754	255,102,0	1	2757	0	.	Interaction	with	THRAP3.	Pubmed:23525231
chr20	62369699	62369711	Q9H400	0	+	62369699	62369711	255,102,0	1	12	0	.	Interaction	with	GRB2.
chr20	62369765	62369777	Q9H400	0	+	62369765	62369777	255,102,0	1	12	0	.	Interaction	with	CSK.	Pubmed:14610046
chr20	62369962	62369974	Q9H400	0	+	62369962	62369974	255,102,0	1	12	0	.	Interaction	with	CSK.	Pubmed:14610046
chr20	62370067	62370079	Q9H400	0	+	62370067	62370079	255,102,0	1	12	0	.	Interaction	with	LCK	and	PIK3R1.
chr20	62370124	62370136	Q9H400	0	+	62370124	62370136	255,102,0	1	12	0	.	Interaction	with	LCK,	PLCG2	and	PIK3R1.
chr20	62705208	62705241	P49795	0	-	62705208	62705241	255,102,0	1	33	0	.	Interaction	with	GIPC.
chr21	44484057	44484072	P0DN79	0	-	44484057	44484072	255,102,0	1	15	0	.	Pyridoxal	phosphate	binding.
chr21	44484057	44484072	P35520	0	-	44484057	44484072	255,102,0	1	15	0	.	Pyridoxal	phosphate	binding.	Pubmed:11483494,	Pubmed:12173932
chr21	16337039	16337162	P48552	0	-	16337039	16337162	255,102,0	1	123	0	.	Repression	domain	4.
chr21	16337039	16338257	P48552	0	-	16337039	16338257	255,102,0	1	1218	0	.	Interaction	with	ZNF366.	Pubmed:17085477
chr21	16337858	16338311	P48552	0	-	16337858	16338311	255,102,0	1	453	0	.	Repression	domain	3.
chr21	16338413	16339286	P48552	0	-	16338413	16339286	255,102,0	1	873	0	.	Repression	domain	2.
chr21	16339097	16339223	P48552	0	-	16339097	16339223	255,102,0	1	126	0	.	Required	for	targeting	to	small	nuclear	foci.
chr21	16339268	16340513	P48552	0	-	16339268	16340513	255,102,0	1	1245	0	.	Interaction	with	ZNF366.	Pubmed:17085477
chr21	16339514	16340282	P48552	0	-	16339514	16340282	255,102,0	1	768	0	.	Repression	domain	1.
chr21	17138420	17150260	Q9UHP3	0	+	17138420	17150260	255,102,0	1	11840	0	.	SUMO	interaction	domain	(SIM).
chr21	27254040	27264051	P05067	0	-	27254040	27264051	255,102,0	1	10010	0	.	Interaction	with	G(o)-alpha.
chr21	27326970	27327961	P05067	0	-	27326970	27327961	255,102,0	1	991	0	.	Collagen-binding.
chr21	27327961	27328057	P05067	0	-	27327961	27328057	255,102,0	1	96	0	.	Heparin-binding.
chr21	27348296	27354710	P05067	0	-	27348296	27354710	255,102,0	1	6414	0	.	Heparin-binding.
chr21	27423413	27423437	P05067	0	-	27423413	27423437	255,102,0	1	24	0	.	Zinc-binding.
chr21	27462283	27462328	P05067	0	-	27462283	27462328	255,102,0	1	45	0	.	Heparin-binding.
chr21	28210254	28210789	Q9UHI8	0	-	28210254	28210789	255,102,0	1	535	0	.	Spacer.
chr21	28296542	28302236	Q9UNA0	0	-	28296542	28302236	255,102,0	1	5694	0	.	Spacer.
chr21	30701921	30701972	O14867	0	+	30701921	30701972	255,102,0	1	51	0	.	Basic	motif.
chr21	30701981	30702005	O14867	0	+	30701981	30702005	255,102,0	1	24	0	.	Leucine-zipper.
chr21	30949298	30949304	P39086	0	-	30949298	30949304	255,102,0	1	6	0	.	Glutamate	binding.
chr21	30959879	30959888	P39086	0	-	30959879	30959888	255,102,0	1	9	0	.	Glutamate	binding.
chr21	31587568	31587574	P56748	0	-	31587568	31587574	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2	and	TJP3.
chr21	31654494	31654674	Q3LI83	0	-	31654494	31654674	255,102,0	1	180	0	.	6	X	10	AA	repeats	of	Y-[ILR]-[SVPC]-[NRTS]-[SNTG]-X-[QHRP]-[PSY]-[QSL]-[SRK].
chr21	31744228	31744396	Q52LG2	0	-	31744228	31744396	255,102,0	1	168	0	.	5	X	10	AA	approximate	repeats.
chr21	31768539	31768707	Q8IUC0	0	+	31768539	31768707	255,102,0	1	168	0	.	5	X	10	AA	approximate	repeats.
chr21	31797927	31798095	Q3SY46	0	-	31797927	31798095	255,102,0	1	168	0	.	5	X	10	AA	approximate	repeats.
chr21	31802713	31802851	Q3LI77	0	+	31802713	31802851	255,102,0	1	138	0	.	4	X	10	AA	approximate	repeats.
chr21	31852384	31852624	Q8IUB9	0	-	31852384	31852624	255,102,0	1	240	0	.	26	X	2	AA	repeats	of	G-[YCGS].
chr21	32185376	32185505	Q8IUC2	0	-	32185376	32185505	255,102,0	1	129	0	.	12	X	2	AA	repeats	of	G-[YCGS].
chr21	32201764	32201890	Q8IUC3	0	-	32201764	32201890	255,102,0	1	126	0	.	11	X	2	AA	repeats	of	G-[YCGS].
chr21	32253393	32253513	Q8IUC1	0	-	32253393	32253513	255,102,0	1	120	0	.	4	X	10	AA	approximate	repeats.
chr21	33954581	33954647	Q8TDR4	0	-	33954581	33954647	255,102,0	1	66	0	.	Leucine-zipper.
chr21	34123276	34132149	Q9Y5B6	0	-	34123276	34132149	255,102,0	1	8873	0	.	Necessary	and	sufficient	for	interaction	with	PAX7.
chr21	34727651	34727681	P17181	0	+	34727651	34727681	255,102,0	1	30	0	.	Important	for	interaction	with	TYK2.	Pubmed:24704786
chr21	34876433	34882114	P22102	0	-	34876433	34882114	255,102,0	1	5681	0	.	GART.
chr21	34876523	34876535	P22102	0	-	34876523	34876535	255,102,0	1	12	0	.	5'-phosphoribosylglycinamide	binding.
chr21	34876610	34876721	P22102	0	-	34876610	34876721	255,102,0	1	111	0	.	10-formyltetrahydrofolate	binding.
chr21	34877895	34877907	P22102	0	-	34877895	34877907	255,102,0	1	12	0	.	10-formyltetrahydrofolate	binding.
chr21	34878403	34878412	P22102	0	-	34878403	34878412	255,102,0	1	9	0	.	5'-phosphoribosylglycinamide	binding.
chr21	34882114	34894588	P22102	0	-	34882114	34894588	255,102,0	1	12474	0	.	AIRS.
chr21	34923712	34924222	P18583	0	+	34923712	34924222	255,102,0	1	510	0	.	17	X	10	AA	tandem	repeats	of	L-A-[ST]-[NSG]-[TS]-MDSQM.
chr21	34924270	34924501	P18583	0	+	34924270	34924501	255,102,0	1	231	0	.	11	X	7	AA	tandem	repeats	of	[DR]-P-Y-R-[LI][AG][QHP].
chr21	34924552	34924915	P18583	0	+	34924552	34924915	255,102,0	1	363	0	.	14	X	6	AA	repeats	of	[ED]-R-S-M-M-S.
chr21	34924975	34925074	P18583	0	+	34924975	34925074	255,102,0	1	99	0	.	3	X	11	AA	tandem	repats	of	P-P-L-P-P-E-E-P-P-[TME]-[MTG].
chr21	34925611	34925707	P18583	0	+	34925611	34925707	255,102,0	1	96	0	.	4	X	8	AA	tandem	repeats	of	V-L-E-SS-[AVT]-VT.
chr21	34927309	34927519	P18583	0	+	34927309	34927519	255,102,0	1	210	0	.	7	X	7	AA	repeats	of	P-S-R-R-S-R-[TS].
chr21	34927336	34927576	P18583	0	+	34927336	34927576	255,102,0	1	240	0	.	2	X	19	AA	repeats	of	P-S-R-R-R-R-S-R-S-V-V-R-R-R-S-F-S-I-S.
chr21	34927573	34927654	P18583	0	+	34927573	34927654	255,102,0	1	81	0	.	3	X	tandem	repeats	of	[ST]-P-[VLI]-R-[RL]-[RK]-[RF]-S-R.
chr21	35140065	35169836	Q15811	0	+	35140065	35169836	255,102,0	1	29771	0	.	KLERQ.
chr21	35821545	35821608	P15382	0	-	35821545	35821608	255,102,0	1	63	0	.	interaction	with	KCNQ1	C-terminus.	Pubmed:25037568
chr21	36042155	36042533	Q96NY7	0	+	36042155	36042533	255,102,0	1	378	0	.	13	X	10	AA	tandem	repeat	of	G-D-[SNG]-[VIM]-[DEQ]-A-[EAG]-[GDVE]-[PRG]-[LAVP].
chr21	36164587	36164710	Q01196	0	-	36164587	36164710	255,102,0	1	123	0	.	Interaction	with	FOXP3.	Pubmed:17377532
chr21	36164593	36164875	Q01196	0	-	36164593	36164875	255,102,0	1	282	0	.	Interaction	with	KAT6B.
chr21	36164680	36171613	Q01196	0	-	36164680	36171613	255,102,0	1	6933	0	.	Interaction	with	KAT6A.	Pubmed:11742995
chr21	36231771	36231801	Q01196	0	-	36231771	36231801	255,102,0	1	30	0	.	Interaction	with	DNA.
chr21	36231873	36252878	Q01196	0	-	36231873	36252878	255,102,0	1	21005	0	.	Interaction	with	DNA.
chr21	36259157	36259172	Q01196	0	-	36259157	36259172	255,102,0	1	15	0	.	Interaction	with	DNA.
chr21	37442695	37443249	P16152	0	+	37442695	37443249	255,102,0	1	554	0	.	Glutathione	binding.
chr21	37444922	37444928	P16152	0	+	37444922	37444928	255,102,0	1	6	0	.	Glutathione	binding.
chr21	37717299	37721662	Q14149	0	+	37717299	37721662	255,102,0	1	4363	0	.	Nuclear	matrix	binding.	Pubmed:11927593
chr21	37736435	37741439	Q14149	0	+	37736435	37741439	255,102,0	1	5004	0	.	RNA	binding.	Pubmed:11927593
chr21	38385907	38390270	P57055	0	+	38385907	38390270	255,102,0	1	4363	0	.	Ripply	homology	domain.
chr21	40762635	40763717	O00258	0	+	40762635	40763717	255,102,0	1	1082	0	.	Interaction	with	ASNA1/TRC40.
chr21	42807862	42817386	P20591	0	+	42807862	42817386	255,102,0	1	9524	0	.	GTPase	domain	(Globular).
chr21	42817386	42817464	P20591	0	+	42817386	42817464	255,102,0	1	78	0	.	Bundle	signaling	element	(BSE).
chr21	42817461	42824637	P20591	0	+	42817461	42824637	255,102,0	1	7176	0	.	Middle	domain.
chr21	42817464	42830592	P20591	0	+	42817464	42830592	255,102,0	1	13128	0	.	Stalk.
chr21	42824697	42824709	P20591	0	+	42824697	42824709	255,102,0	1	12	0	.	Critical	for	lipid-binding.
chr21	43413916	43414117	Q9ULJ3	0	-	43413916	43414117	255,102,0	1	201	0	.	Mediates	homodimerization.
chr21	43852223	43867301	P57075	0	+	43852223	43867301	255,102,0	1	15077	0	.	Phosphatase-like.
chr21	44179159	44190872	O76083	0	+	44179159	44190872	255,102,0	1	11713	0	.	Catalytic.
chr21	44484057	44484072	P0DN79	0	-	44484057	44484072	255,102,0	1	15	0	.	Pyridoxal	phosphate	binding.
chr21	44484057	44484072	P35520	0	-	44484057	44484072	255,102,0	1	15	0	.	Pyridoxal	phosphate	binding.	Pubmed:11483494,	Pubmed:12173932
chr21	44837568	44837649	P57059	0	-	44837568	44837649	255,102,0	1	81	0	.	RK-rich	region.
chr21	45710980	45710992	O43918	0	+	45710980	45710992	255,102,0	1	12	0	.	Interaction	with	histone	H3	not	methylated	at	'Lys-4'.
chr21	45711007	45711034	O43918	0	+	45711007	45711034	255,102,0	1	27	0	.	Interaction	with	histone	H3	not	methylated	at	'Lys-4'.
chr21	45711088	45712194	O43918	0	+	45711088	45712194	255,102,0	1	1106	0	.	Interaction	with	histone	H3	not	methylated	at	'Lys-4'.
chr21	45719991	45740009	P17858	0	+	45719991	45740009	255,102,0	1	20018	0	.	N-terminal	catalytic	PFK	domain	1.
chr21	45732922	45732931	P17858	0	+	45732922	45732931	255,102,0	1	9	0	.	Substrate	binding.
chr21	45733548	45733557	P17858	0	+	45733548	45733557	255,102,0	1	9	0	.	Substrate	binding.
chr21	45736362	45736374	P17858	0	+	45736362	45736374	255,102,0	1	12	0	.	Substrate	binding.
chr21	45740009	45741620	P17858	0	+	45740009	45741620	255,102,0	1	1611	0	.	Interdomain	linker.
chr21	45741620	45746742	P17858	0	+	45741620	45746742	255,102,0	1	5122	0	.	C-terminal	regulatory	PFK	domain	2.
chr21	45743729	45743744	P17858	0	+	45743729	45743744	255,102,0	1	15	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr21	45744436	45744445	P17858	0	+	45744436	45744445	255,102,0	1	9	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr21	45745135	45745147	P17858	0	+	45745135	45745147	255,102,0	1	12	0	.	Allosteric	activator	fructose	2,6-bisphosphate	binding.
chr21	45959235	45959958	P60331	0	-	45959235	45959958	255,102,0	1	723	0	.	24	X	5	AA	repeats	of	C-C-X(3).
chr21	45970657	45971266	P60368	0	-	45970657	45971266	255,102,0	1	609	0	.	22	X	5	AA	repeats	of	C-C-X(3).
chr21	45977956	45978523	P60369	0	-	45977956	45978523	255,102,0	1	567	0	.	18	X	5	AA	repeats	of	C-C-X(3).
chr21	46032092	46032746	P60410	0	+	46032092	46032746	255,102,0	1	654	0	.	19	X	5	AA	repeats	of	C-C-X(3).
chr21	46047163	46047850	P60411	0	+	46047163	46047850	255,102,0	1	687	0	.	25	X	5	AA	repeats	of	C-C-X(3).
chr21	46057409	46058006	P60014	0	+	46057409	46058006	255,102,0	1	597	0	.	15	X	5	AA	repeats	of	C-C-X(3).
chr21	46066450	46067188	P60412	0	+	46066450	46067188	255,102,0	1	738	0	.	25	X	5	AA	repeats	of	C-C-X(3).
chr21	46074231	46074504	P60329	0	-	46074231	46074504	255,102,0	1	273	0	.	15	X	5	AA	approximate	repeats.
chr21	46077923	46078178	P60328	0	+	46077923	46078178	255,102,0	1	255	0	.	14	X	5	AA	approximate	repeats.
chr21	46086386	46086776	P59991	0	-	46086386	46086776	255,102,0	1	390	0	.	23	X	5	AA	approximate	repeats.
chr21	46101756	46102011	P59990	0	-	46101756	46102011	255,102,0	1	255	0	.	14	X	5	AA	approximate	repeats.
chr21	46117221	46117770	P60413	0	+	46117221	46117770	255,102,0	1	549	0	.	19	X	5	AA	repeats	of	C-C-X(3).
chr21	46595862	46595880	P78563	0	+	46595862	46595880	255,102,0	1	18	0	.	Interaction	with	substrate	RNA.
chr21	46595925	46595931	P78563	0	+	46595925	46595931	255,102,0	1	6	0	.	Interaction	with	substrate	RNA.
chr21	46596324	46596342	P78563	0	+	46596324	46596342	255,102,0	1	18	0	.	Interaction	with	substrate	RNA.
chr21	46596390	46596393	P78563	0	+	46596390	46596393	255,102,0	1	3	0	.	Interaction	with	substrate	RNA.
chr21	46685519	46685525	Q9Y2G5	0	-	46685519	46685525	255,102,0	1	6	0	.	Substrate	binding.
chr21	46705806	46705818	Q9Y2G5	0	-	46705806	46705818	255,102,0	1	12	0	.	Substrate	binding.
chr21	46893844	46897666	P39060	0	+	46893844	46897666	255,102,0	1	3822	0	.	Nonhelical	region	1	(NC1).
chr21	46897666	46897768	P39060	0	+	46897666	46897768	255,102,0	1	102	0	.	Triple-helical	region	1	(COL1).
chr21	46897768	46897798	P39060	0	+	46897768	46897798	255,102,0	1	30	0	.	Nonhelical	region	2	(NC2).
chr21	46897798	46900052	P39060	0	+	46897798	46900052	255,102,0	1	2254	0	.	Triple-helical	region	2	(COL2).
chr21	46900052	46900434	P39060	0	+	46900052	46900434	255,102,0	1	382	0	.	Nonhelical	region	3	(NC3).
chr21	46900613	46906891	P39060	0	+	46900613	46906891	255,102,0	1	6278	0	.	Triple-helical	region	3	(COL3).
chr21	46906891	46907414	P39060	0	+	46906891	46907414	255,102,0	1	523	0	.	Nonhelical	region	4	(NC4).
chr21	46907414	46911207	P39060	0	+	46907414	46911207	255,102,0	1	3793	0	.	Triple-helical	region	4	(COL4).
chr21	46911207	46912469	P39060	0	+	46911207	46912469	255,102,0	1	1262	0	.	Nonhelical	region	5	(NC5).
chr21	46912469	46913441	P39060	0	+	46912469	46913441	255,102,0	1	972	0	.	Triple-helical	region	5	(COL5).
chr21	46913441	46913480	P39060	0	+	46913441	46913480	255,102,0	1	39	0	.	Nonhelical	region	6	(NC6).
chr21	46913480	46916467	P39060	0	+	46913480	46916467	255,102,0	1	2987	0	.	Triple-helical	region	6	(COL6).
chr21	46916467	46916978	P39060	0	+	46916467	46916978	255,102,0	1	511	0	.	Nonhelical	region	7	(NC7).
chr21	46916978	46923932	P39060	0	+	46916978	46923932	255,102,0	1	6954	0	.	Triple-helical	region	7	(COL7).
chr21	46923932	46923968	P39060	0	+	46923932	46923968	255,102,0	1	36	0	.	Nonhelical	region	8	(NC8).
chr21	46924329	46924395	P39060	0	+	46924329	46924395	255,102,0	1	66	0	.	Triple-helical	region	8	(COL8).
chr21	46924395	46924416	P39060	0	+	46924395	46924416	255,102,0	1	21	0	.	Nonhelical	region	9	(NC9).
chr21	46924416	46925167	P39060	0	+	46924416	46925167	255,102,0	1	751	0	.	Triple-helical	region	9	(COL9).
chr21	46925167	46925285	P39060	0	+	46925167	46925285	255,102,0	1	118	0	.	Nonhelical	region	10	(NC10).
chr21	46925285	46925339	P39060	0	+	46925285	46925339	255,102,0	1	54	0	.	Triple-helical	region	10	(COL10).
chr21	46925339	46932309	P39060	0	+	46925339	46932309	255,102,0	1	6970	0	.	Nonhelical	region	11	(NC11).
chr21	47401821	47407532	P12109	0	+	47401821	47407532	255,102,0	1	5711	0	.	N-terminal	globular	domain.
chr21	47407532	47419606	P12109	0	+	47407532	47419606	255,102,0	1	12074	0	.	Triple-helical	region.
chr21	47420244	47423924	P12109	0	+	47420244	47423924	255,102,0	1	3680	0	.	C-terminal	globular	domain.
chr21	47531450	47533954	P12110	0	+	47531450	47533954	255,102,0	1	2504	0	.	Nonhelical	region.
chr21	47533954	47544834	P12110	0	+	47533954	47544834	255,102,0	1	10880	0	.	Triple-helical	region.
chr21	47545179	47552463	P12110	0	+	47545179	47552463	255,102,0	1	7284	0	.	Nonhelical	region.
chr21	47556903	47565827	O95954	0	-	47556903	47565827	255,102,0	1	8924	0	.	Cyclodeaminase/cyclohydrolase.
chr21	47565827	47565851	O95954	0	-	47565827	47565851	255,102,0	1	24	0	.	Linker.
chr21	47565851	47571564	O95954	0	-	47565851	47571564	255,102,0	1	5713	0	.	Formiminotransferase	C-subdomain.
chr21	47571564	47575437	O95954	0	-	47571564	47575437	255,102,0	1	3873	0	.	Formiminotransferase	N-subdomain.
chr21	47662771	47664787	O60318	0	-	47662771	47664787	255,102,0	1	2016	0	.	Acetyltransferase.
chr21	47676866	47680804	O60318	0	-	47676866	47680804	255,102,0	1	3938	0	.	CID.
chr21	47685899	47695192	O60318	0	-	47685899	47695192	255,102,0	1	9293	0	.	SAC3	homology.
chr21	47697627	47703711	O60318	0	-	47697627	47703711	255,102,0	1	6084	0	.	DNA	primase.
chr21	47704180	47705104	O60318	0	-	47704180	47705104	255,102,0	1	924	0	.	FG-repeats.
chr21	47856011	47863760	O95613	0	+	47856011	47863760	255,102,0	1	7749	0	.	Interaction	with	NEK2.	Pubmed:20599736
chr21	47860956	47860998	O95613	0	+	47860956	47860998	255,102,0	1	42	0	.	Calmodulin-binding.
chr21	48056863	48078833	P55345	0	+	48056863	48078833	255,102,0	1	21970	0	.	Interaction	with	ESR1.
chr21	48064319	48069618	P55345	0	+	48064319	48069618	255,102,0	1	5299	0	.	Interaction	with	RB1.
chr21	48068438	48078827	P55345	0	+	48068438	48078827	255,102,0	1	10389	0	.	Interaction	with	ESR1.
chr22	17684572	17684596	Q9NZK5	0	-	17684572	17684596	255,102,0	1	24	0	.	Substrate	binding.
chr22	17684650	17688124	Q9NZK5	0	-	17684650	17688124	255,102,0	1	3474	0	.	PRB	domain.
chr22	17690267	17690480	Q9NZK5	0	-	17690267	17690480	255,102,0	1	213	0	.	Dimerization.
chr22	18273530	18293504	Q7RTP6	0	-	18273530	18293504	255,102,0	1	19974	0	.	RAB-binding	domain	(RBD).	Pubmed:27552051
chr22	18376637	18389575	Q7RTP6	0	-	18376637	18389575	255,102,0	1	12938	0	.	Monooxygenase	domain.
chr22	20367040	20367046	B5MD39	0	-	20367040	20367046	255,102,0	1	6	0	.	Glutamate	binding.
chr22	20367106	20367112	B5MD39	0	-	20367106	20367112	255,102,0	1	6	0	.	Glutamate	binding.
chr22	19167734	19171079	P53675	0	-	19167734	19171079	255,102,0	1	3345	0	.	Trimerization.
chr22	19213786	19220073	P53675	0	-	19213786	19220073	255,102,0	1	6287	0	.	Distal	segment.
chr22	19220073	19220772	P53675	0	-	19220073	19220772	255,102,0	1	699	0	.	Flexible	linker.
chr22	19220772	19279161	P53675	0	-	19220772	19279161	255,102,0	1	58389	0	.	Globular	terminal	domain.
chr22	19220814	19220968	P53675	0	-	19220814	19220968	255,102,0	1	154	0	.	Binding	site	for	the	uncoating	ATPase,	involved	in	lattice	disassembly.
chr22	19222208	19223284	P53675	0	-	19222208	19223284	255,102,0	1	1076	0	.	WD40-like	repeat	7.
chr22	19223284	19226821	P53675	0	-	19223284	19226821	255,102,0	1	3537	0	.	WD40-like	repeat	6.
chr22	19226821	19230393	P53675	0	-	19226821	19230393	255,102,0	1	3572	0	.	WD40-like	repeat	5.
chr22	19230393	19241553	P53675	0	-	19230393	19241553	255,102,0	1	11160	0	.	WD40-like	repeat	4.
chr22	19241553	19241679	P53675	0	-	19241553	19241679	255,102,0	1	126	0	.	WD40-like	repeat	3.
chr22	19241679	19263194	P53675	0	-	19241679	19263194	255,102,0	1	21515	0	.	WD40-like	repeat	2.
chr22	19263194	19263326	P53675	0	-	19263194	19263326	255,102,0	1	132	0	.	WD40-like	repeat	1.
chr22	19318965	19346881	P54198	0	-	19318965	19346881	255,102,0	1	27916	0	.	Interaction	with	histone	H4.
chr22	19343359	19346875	P54198	0	-	19343359	19346875	255,102,0	1	3516	0	.	Interaction	with	PAX3.
chr22	19343365	19349453	P54198	0	-	19343365	19349453	255,102,0	1	6088	0	.	Interaction	with	histone	H2B.
chr22	19346875	19349450	P54198	0	-	19346875	19349450	255,102,0	1	2575	0	.	Interaction	with	PAX3.
chr22	19346905	19373112	P54198	0	-	19346905	19373112	255,102,0	1	26207	0	.	Interaction	with	CCNA1.	Pubmed:11238922
chr22	19365567	19373112	P54198	0	-	19365567	19373112	255,102,0	1	7545	0	.	Interaction	with	ASF1A.
chr22	19365579	19373058	P54198	0	-	19365579	19373058	255,102,0	1	7479	0	.	Required	for	repression	of	histone	gene	transcription.
chr22	19511124	19511130	O00501	0	-	19511124	19511130	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2	and	TJP3.
chr22	19951705	19951717	A0A140VJG8	0	+	19951705	19951717	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr22	19951705	19951717	E7EMS6	0	+	19951705	19951717	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr22	19951705	19951717	E7EUU8	0	+	19951705	19951717	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr22	19951705	19951717	P21964	0	+	19951705	19951717	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr22	20073486	20074789	Q8WYQ5	0	+	20073486	20074789	255,102,0	1	1303	0	.	Necessary	for	nuclear	localization	and	retention.
chr22	20073486	20077501	Q8WYQ5	0	+	20073486	20077501	255,102,0	1	4015	0	.	Necessary	for	interaction	with	NCL.	Pubmed:17765891
chr22	20074789	20097562	Q8WYQ5	0	+	20074789	20097562	255,102,0	1	22773	0	.	Necessary	for	heme-binding	and	pri-miRNA	processing.
chr22	20094897	20097628	Q8WYQ5	0	+	20094897	20097628	255,102,0	1	2731	0	.	Interaction	with	DROSHA.	Pubmed:26748718
chr22	20861989	20907442	Q96RN5	0	+	20861989	20907442	255,102,0	1	45453	0	.	Interaction	with	SREBF1.	Pubmed:16799563
chr22	21133801	21133837	P05546	0	+	21133801	21133837	255,102,0	1	36	0	.	Chemotactic	activity.
chr22	21133816	21133891	P05546	0	+	21133816	21133891	255,102,0	1	75	0	.	2	X	11	AA	approximate	repeats,	Asp/Glu-rich	(acidic)	(hirudin-like).
chr22	21134173	21134236	P05546	0	+	21134173	21134236	255,102,0	1	63	0	.	Glycosaminoglycan-binding	site.
chr22	21799919	21799934	Q96JB3	0	+	21799919	21799934	255,102,0	1	15	0	.	Binding	to	CtBP.
chr22	22160168	22160174	P28482	0	-	22160168	22160174	255,102,0	1	6	0	.	Inhibitor-binding.
chr22	22160306	22160318	P28482	0	-	22160306	22160318	255,102,0	1	12	0	.	Inhibitor-binding.
chr22	22599368	22599434	P12018	0	+	22599368	22599434	255,102,0	1	66	0	.	Framework-1.
chr22	22599434	22599479	P12018	0	+	22599434	22599479	255,102,0	1	45	0	.	Complementarity-determining-1.
chr22	22599479	22599521	P12018	0	+	22599479	22599521	255,102,0	1	42	0	.	Framework-2.
chr22	22599521	22599554	P12018	0	+	22599521	22599554	255,102,0	1	33	0	.	Complementarity-determining-2.
chr22	22599554	22599656	P12018	0	+	22599554	22599656	255,102,0	1	102	0	.	Framework-3.
chr22	22749533	22749599	P04211	0	+	22749533	22749599	255,102,0	1	66	0	.	Framework-1.
chr22	22749534	22749600	P04211	0	+	22749534	22749600	255,102,0	1	66	0	.	Framework-1.
chr22	22749599	22749638	P04211	0	+	22749599	22749638	255,102,0	1	39	0	.	Complementarity-determining-1.	Pubmed:6091030
chr22	22749600	22749639	P04211	0	+	22749600	22749639	255,102,0	1	39	0	.	Complementarity-determining-1.	Pubmed:6091030
chr22	22749638	22749686	P04211	0	+	22749638	22749686	255,102,0	1	48	0	.	Framework-2.
chr22	22749639	22749687	P04211	0	+	22749639	22749687	255,102,0	1	48	0	.	Framework-2.
chr22	22749686	22749707	P04211	0	+	22749686	22749707	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6091030
chr22	22749687	22749708	P04211	0	+	22749687	22749708	255,102,0	1	21	0	.	Complementarity-determining-2.	Pubmed:6091030
chr22	22749707	22749803	P04211	0	+	22749707	22749803	255,102,0	1	96	0	.	Framework-3.
chr22	22749708	22749804	P04211	0	+	22749708	22749804	255,102,0	1	96	0	.	Framework-3.
chr22	22749803	22749827	P04211	0	+	22749803	22749827	255,102,0	1	24	0	.	Complementarity-determining-3.	Pubmed:6091030
chr22	22749804	22749828	P04211	0	+	22749804	22749828	255,102,0	1	24	0	.	Complementarity-determining-3.	Pubmed:6091030
chr22	22899594	22899876	P78395	0	-	22899594	22899876	255,102,0	1	282	0	.	Mediates	interaction	with	RARA.	Pubmed:16179254
chr22	22989466	22989472	Q14390	0	+	22989466	22989472	255,102,0	1	6	0	.	Glutamate	binding.
chr22	23235964	23237556	B9A064	0	+	23235964	23237556	255,102,0	1	1592	0	.	J	region	(By	similarity	to	lambda	light-chain).
chr22	23237556	23237871	B9A064	0	+	23237556	23237871	255,102,0	1	315	0	.	C	region	(By	similarity	to	lambda	light-chain).
chr22	23523147	23524425	P11274	0	+	23523147	23524425	255,102,0	1	1278	0	.	Kinase.
chr22	23523735	23524302	P11274	0	+	23523735	23524302	255,102,0	1	567	0	.	Binding	to	ABL	SH2-domain.
chr22	23915455	23915770	P15814	0	-	23915455	23915770	255,102,0	1	315	0	.	C	region	(By	similarity	to	lambda	light-chain).
chr22	23915770	23917187	P15814	0	-	23915770	23917187	255,102,0	1	1417	0	.	J	region	(By	similarity	to	lambda	light-chain).
chr22	24129356	24135852	Q12824	0	+	24129356	24135852	255,102,0	1	6496	0	.	DNA-binding.	Pubmed:26073604
chr22	24145527	24159057	Q12824	0	+	24145527	24159057	255,102,0	1	13530	0	.	HIV-1	integrase-binding.
chr22	24145536	24159063	Q12824	0	+	24145536	24159063	255,102,0	1	13527	0	.	MYC-binding.
chr22	24145536	24167573	Q12824	0	+	24145536	24167573	255,102,0	1	22037	0	.	2	X	approximate	tandem	repeats.
chr22	24167525	24167570	Q12824	0	+	24167525	24167570	255,102,0	1	45	0	.	Interaction	with	PPP1R15A.
chr22	24302479	24302485	P0CG30	0	-	24302479	24302485	255,102,0	1	6	0	.	Glutathione	binding.
chr22	24302518	24302524	P0CG30	0	-	24302518	24302524	255,102,0	1	6	0	.	Glutathione	binding.
chr22	24302557	24302563	P0CG30	0	-	24302557	24302563	255,102,0	1	6	0	.	Glutathione	binding.
chr22	24323186	24323192	P0CG29	0	+	24323186	24323192	255,102,0	1	6	0	.	Glutathione	binding.
chr22	24323225	24323231	P0CG29	0	+	24323225	24323231	255,102,0	1	6	0	.	Glutathione	binding.
chr22	24435959	24435965	P30711	0	-	24435959	24435965	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:16298388
chr22	24435998	24436004	P30711	0	-	24435998	24436004	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:16298388
chr22	24573611	24573725	Q9Y6J0	0	+	24573611	24573725	255,102,0	1	114	0	.	Required	for	interaction	with	calcineurin.
chr22	24621305	24621311	P36269	0	-	24621305	24621311	255,102,0	1	6	0	.	Glutamate	binding.
chr22	24836719	24836749	P29274	0	+	24836719	24836749	255,102,0	1	30	0	.	Agonist	binding.
chr22	24836953	24836977	P29274	0	+	24836953	24836977	255,102,0	1	24	0	.	Agonist	binding.
chr22	24837007	24837040	P29274	0	+	24837007	24837040	255,102,0	1	33	0	.	Agonist	binding.
chr22	24967891	24967921	P62318	0	+	24967891	24967921	255,102,0	1	30	0	.	5	X	2	AA	tandem	repeats	of	[RM]-G.
chr22	25024061	25024067	P19440	0	+	25024061	25024067	255,102,0	1	6	0	.	Glutamate	binding.
chr22	25251611	25255772	Q2NKQ1	0	+	25251611	25255772	255,102,0	1	4161	0	.	Important	for	interaction	with	RAB9A	and	RAB9B.
chr22	25255781	25264398	Q2NKQ1	0	+	25255781	25264398	255,102,0	1	8617	0	.	Required	for	interaction	with	RAP	family	members.
chr22	25597363	25597432	P26998	0	+	25597363	25597432	255,102,0	1	69	0	.	N-terminal	arm.
chr22	25599859	25601198	P26998	0	+	25599859	25601198	255,102,0	1	1339	0	.	Connecting	peptide.
chr22	25603140	25603176	P26998	0	+	25603140	25603176	255,102,0	1	36	0	.	C-terminal	arm.
chr22	25617399	25617444	P43320	0	+	25617399	25617444	255,102,0	1	45	0	.	N-terminal	arm.
chr22	25623949	25625414	P43320	0	+	25623949	25625414	255,102,0	1	1465	0	.	Connecting	peptide.
chr22	25627697	25627736	P43320	0	+	25627697	25627736	255,102,0	1	39	0	.	C-terminal	arm.
chr22	25961007	26070418	P35626	0	+	25961007	26070418	255,102,0	1	109411	0	.	N-terminal.
chr22	26688715	26688760	Q9BYH1	0	+	26688715	26688760	255,102,0	1	45	0	.	O-glycosylated	at	one	site.
chr22	26688802	26688817	Q9BYH1	0	+	26688802	26688817	255,102,0	1	15	0	.	O-glycosylated	at	one	site.
chr22	26830454	26830463	Q6ICH7	0	+	26830454	26830463	255,102,0	1	9	0	.	2-oxoglutarate	binding.
chr22	26879943	26880006	Q9UH36	0	+	26879943	26880006	255,102,0	1	63	0	.	3	X	7	AA	tandem	repeats	of	R-E-A-A-P-R-G.
chr22	26888290	26890135	Q9UBB9	0	-	26888290	26890135	255,102,0	1	1845	0	.	Required	for	nuclear	speckle	localization.
chr22	26906088	26906238	Q9UBB9	0	-	26906088	26906238	255,102,0	1	150	0	.	Required	for	interaction	with	DHX15.	Pubmed:19103666
chr22	26995456	26995510	P53674	0	-	26995456	26995510	255,102,0	1	54	0	.	C-terminal	arm.
chr22	26997973	27003855	P53674	0	-	26997973	27003855	255,102,0	1	5882	0	.	Connecting	peptide.
chr22	27012109	27012280	P53674	0	-	27012109	27012280	255,102,0	1	171	0	.	N-terminal	arm.
chr22	27018563	27018593	P53673	0	+	27018563	27018593	255,102,0	1	30	0	.	N-terminal	arm.
chr22	27021580	27024263	P53673	0	+	27021580	27024263	255,102,0	1	2683	0	.	Connecting	peptide.
chr22	29091774	29091855	O96017	0	-	29091774	29091855	255,102,0	1	81	0	.	T-loop/activation	segment.
chr22	29191536	29191617	P17861	0	-	29191536	29191617	255,102,0	1	81	0	.	Necessary	for	the	translational	pausing	of	its	own	mRNA.	Pubmed:21233347
chr22	29193118	29195077	P17861	0	-	29193118	29195077	255,102,0	1	1959	0	.	Leucine-zipper.
chr22	29195086	29196299	P17861	0	-	29195086	29196299	255,102,0	1	1213	0	.	Basic	motif.
chr22	29195092	29196290	P17861	0	-	29195092	29196290	255,102,0	1	1198	0	.	Nuclear	localization	signal	(NLS);	in	isoforms	1	and	isoform	2.	Pubmed:16461360
chr22	29664325	29684656	Q01844	0	+	29664325	29684656	255,102,0	1	20331	0	.	EAD	(Gln/Pro/Thr-rich).
chr22	29668212	29684656	Q01844	0	+	29668212	29684656	255,102,0	1	16444	0	.	31	X	approximate	tandem	repeats.
chr22	29709292	29711235	Q92737	0	-	29709292	29711235	255,102,0	1	1943	0	.	Small	GTPase-like.
chr22	29935320	29945133	Q13769	0	-	29935320	29945133	255,102,0	1	9813	0	.	Interaction	with	THOC7.	Pubmed:19059247
chr22	29938867	29945133	Q13769	0	-	29938867	29945133	255,102,0	1	6266	0	.	Interaction	with	CSF1R.
chr22	30403987	30403999	Q13615	0	+	30403987	30403999	255,102,0	1	12	0	.	Substrate	binding.
chr22	30405047	30405053	Q13615	0	+	30405047	30405053	255,102,0	1	6	0	.	Substrate	binding.
chr22	30408471	30408492	Q13615	0	+	30408471	30408492	255,102,0	1	21	0	.	Substrate	binding.
chr22	30681829	30681844	Q8WTX7	0	-	30681829	30681844	255,102,0	1	15	0	.	Arginine-binding.	Pubmed:27487210
chr22	30681898	30681904	Q8WTX7	0	-	30681898	30681904	255,102,0	1	6	0	.	Arginine-binding.	Pubmed:27487210
chr22	30683397	30683403	Q8WTX7	0	-	30683397	30683403	255,102,0	1	6	0	.	Arginine-binding.	Pubmed:27487210
chr22	30688366	30688378	Q9BXI6	0	-	30688366	30688378	255,102,0	1	12	0	.	Binding	to	the	PDZ	domain	of	EBP50.
chr22	30973035	30974892	O00541	0	-	30973035	30974892	255,102,0	1	1857	0	.	Required	for	28S	ribosomal	RNA	processing.
chr22	30975846	30976685	O00541	0	-	30975846	30976685	255,102,0	1	839	0	.	Sufficient	for	interaction	with	MAP1B.
chr22	30977371	30987820	O00541	0	-	30977371	30987820	255,102,0	1	10449	0	.	Sufficient	for	nucleolar	localization.
chr22	30984103	30987820	O00541	0	-	30984103	30987820	255,102,0	1	3717	0	.	Required	for	28S	ribosomal	RNA	processing.
chr22	31010361	31010376	P20062	0	+	31010361	31010376	255,102,0	1	15	0	.	Cobalamin	binding.
chr22	31010475	31011289	P20062	0	+	31010475	31011289	255,102,0	1	814	0	.	Cobalamin	binding.
chr22	31019030	31019039	P20062	0	+	31019030	31019039	255,102,0	1	9	0	.	Cobalamin	binding.
chr22	31522362	31524631	Q15735	0	+	31522362	31524631	255,102,0	1	2269	0	.	Catalytic.
chr22	31524631	31529904	Q15735	0	+	31524631	31529904	255,102,0	1	5273	0	.	Required	for	ruffle	localization.
chr22	31533888	31535893	Q9NZ20	0	-	31533888	31535893	255,102,0	1	2005	0	.	Phospholipase	A2-like.
chr22	31795672	31796611	Q9Y295	0	+	31795672	31796611	255,102,0	1	939	0	.	Required	for	interaction	with	STK16.
chr22	31867891	31884617	Q9NRA8	0	-	31867891	31884617	255,102,0	1	16726	0	.	EIF4E-binding.
chr22	31927107	31942898	A8K8P3	0	+	31927107	31942898	255,102,0	1	15791	0	.	Interaction	with	CETN2.
chr22	31985441	31985501	A8K8P3	0	+	31985441	31985501	255,102,0	1	60	0	.	Interaction	with	CETN2.
chr22	32000333	32000857	A8K8P3	0	+	32000333	32000857	255,102,0	1	524	0	.	Interaction	with	CETN2.
chr22	32870989	32875109	Q9Y3I1	0	+	32870989	32875109	255,102,0	1	4120	0	.	Ubiquitin-like.
chr22	32875118	32875232	Q9Y3I1	0	+	32875118	32875232	255,102,0	1	114	0	.	Important	for	interaction	with	PINK1.	Pubmed:23933751
chr22	32875229	32879973	Q9Y3I1	0	+	32875229	32879973	255,102,0	1	4744	0	.	Important	for	interaction	with	CDK6.
chr22	32880003	32889096	Q9Y3I1	0	+	32880003	32889096	255,102,0	1	9093	0	.	Important	for	dimerization	and	interaction	with	PSMF1.	Pubmed:18495667
chr22	32889264	32894514	Q9Y3I1	0	+	32889264	32894514	255,102,0	1	5250	0	.	Important	for	interaction	with	CDK6.
chr22	32909681	32914046	O14994	0	-	32909681	32914046	255,102,0	1	4365	0	.	E.
chr22	32914046	32924893	O14994	0	-	32914046	32924893	255,102,0	1	10847	0	.	J;	Pro-rich	linker.
chr22	33198056	33198071	P35625	0	+	33198056	33198071	255,102,0	1	15	0	.	Involved	in	metalloproteinase-binding.
chr22	33253292	33253298	P35625	0	+	33253292	33253298	255,102,0	1	6	0	.	Involved	in	metalloproteinase-binding.
chr22	33253343	33255292	P35625	0	+	33253343	33255292	255,102,0	1	1949	0	.	Mediates	interaction	with	EFEMP1.	Pubmed:15123717
chr22	33402377	33402566	O14994	0	-	33402377	33402566	255,102,0	1	189	0	.	B;	linker.
chr22	33402563	33402647	O14994	0	-	33402563	33402647	255,102,0	1	84	0	.	A.
chr22	33670415	33733679	O95461	0	-	33670415	33733679	255,102,0	1	63264	0	.	Glucuronyltransferase	activity.	Pubmed:22223806
chr22	35947842	35947983	Q96D21	0	+	35947842	35947983	255,102,0	1	141	0	.	Interaction	with	GNB1,	GNB2	and	GNB3.	Pubmed:19255495
chr22	36702468	36702537	P35579	0	-	36702468	36702537	255,102,0	1	69	0	.	Actin-binding.
chr22	36913440	36914816	O15371	0	-	36913440	36914816	255,102,0	1	1376	0	.	RNA	gate.
chr22	37261014	37261023	Q15080	0	+	37261014	37261023	255,102,0	1	9	0	.	Phosphatidylinositol	3-phosphate	binding.
chr22	37263435	37263444	Q15080	0	+	37263435	37263444	255,102,0	1	9	0	.	Phosphatidylinositol	3-phosphate	binding.
chr22	37414296	37414344	Q16762	0	-	37414296	37414344	255,102,0	1	48	0	.	Hinge.
chr22	37420688	37420736	P25325	0	+	37420688	37420736	255,102,0	1	48	0	.	Hinge.
chr22	37705357	37707045	Q9UIA0	0	+	37705357	37707045	255,102,0	1	1688	0	.	Phosphatidylinositol	3,4,5-trisphosphate	binding.
chr22	37709522	37709549	Q9UIA0	0	+	37709522	37709549	255,102,0	1	27	0	.	C-terminal	autoinhibitory	region.
chr22	37964308	37964476	Q00587	0	+	37964308	37964476	255,102,0	1	168	0	.	8	X	7	AA	tandem	repeats	of	[PT]-[AT]-A-[ENT]-[PT]-[PTS]-[AG].
chr22	37966618	37966639	P05162	0	-	37966618	37966639	255,102,0	1	21	0	.	Beta-galactoside	binding.
chr22	38016280	38019630	Q9UJY5	0	+	38016280	38019630	255,102,0	1	3350	0	.	Interaction	with	ARF3.
chr22	38021040	38027105	Q9UJY5	0	+	38021040	38027105	255,102,0	1	6065	0	.	Unstructured	hinge.
chr22	38054960	38054975	Q96GD0	0	+	38054960	38054975	255,102,0	1	15	0	.	Substrate	binding.
chr22	38074532	38074547	P09382	0	+	38074532	38074547	255,102,0	1	15	0	.	Beta-galactoside	binding.
chr22	38074604	38074616	P09382	0	+	38074604	38074616	255,102,0	1	12	0	.	Beta-galactoside	binding.
chr22	38208965	38208971	O75600	0	+	38208965	38208971	255,102,0	1	6	0	.	Pyridoxal	phosphate	binding.
chr22	38211476	38211488	O75600	0	+	38211476	38211488	255,102,0	1	12	0	.	Pyridoxal	phosphate	binding.
chr22	38211737	38211743	O75600	0	+	38211737	38211743	255,102,0	1	6	0	.	Pyridoxal	phosphate	binding;	shared	with	dimeric	partner.
chr22	38228748	38234561	Q6NXT1	0	-	38228748	38234561	255,102,0	1	5813	0	.	LYN-binding.
chr22	38327877	38336834	Q8N3F8	0	+	38327877	38336834	255,102,0	1	8957	0	.	RAB-binding	domain	(RBD);	mediates	the	interaction	with	RAB13	and	RAB35	and	intramolecular	interaction	with	the	CH	domain.	Pubmed:21795389,	Pubmed:21951725
chr22	38328640	38336834	Q8N3F8	0	+	38328640	38336834	255,102,0	1	8194	0	.	Necessary	and	sufficient	to	associate	with	tubular	recycling	endosome	membranes,	mediate	phosphatidic	acid-binding	and	membrane	tubulation.
chr22	38508509	38508545	O60733	0	-	38508509	38508545	255,102,0	1	36	0	.	Calmodulin-binding.
chr22	38509607	38511539	O60733	0	-	38509607	38511539	255,102,0	1	1932	0	.	Calmodulin-binding.
chr22	38610540	38610618	Q9ULX9	0	+	38610540	38610618	255,102,0	1	78	0	.	Basic	motif.
chr22	38610624	38610669	Q9ULX9	0	+	38610624	38610669	255,102,0	1	45	0	.	Leucine-zipper.
chr22	38823804	38823867	P48050	0	-	38823804	38823867	255,102,0	1	63	0	.	Val/Gly/Ala/Pro	stretch.
chr22	39066987	39069196	Q9Y3M2	0	+	39066987	39069196	255,102,0	1	2209	0	.	Minimal	region	for	the	interaction	with	PKD2.	Pubmed:15194699
chr22	39078330	39078360	Q9NS69	0	+	39078330	39078360	255,102,0	1	30	0	.	Import	sequence;	necessary	for	mitochondrion	outer	membrane	localization	and	integration	in	the	TOM	complex.
chr22	39078893	39078956	Q9NS69	0	+	39078893	39078956	255,102,0	1	63	0	.	TMD;	necessary	for	mitochondrion	outer	membrane	localization	and	integration	in	the	TOM	complex.
chr22	39079783	39079843	Q9NS69	0	+	39079783	39079843	255,102,0	1	60	0	.	C-tail	signal;	necessary	for	mitochondrion	outer	membrane	localization	and	integration	in	the	TOM	complex.
chr22	39112669	39112693	O00178	0	+	39112669	39112693	255,102,0	1	24	0	.	G1.
chr22	39112786	39112801	O00178	0	+	39112786	39112801	255,102,0	1	15	0	.	G2.
chr22	39112924	39112936	O00178	0	+	39112924	39112936	255,102,0	1	12	0	.	G3.
chr22	39117833	39117845	O00178	0	+	39117833	39117845	255,102,0	1	12	0	.	G4.
chr22	39122032	39122041	O00178	0	+	39122032	39122041	255,102,0	1	9	0	.	G5.
chr22	39132274	39135786	Q9UH99	0	-	39132274	39135786	255,102,0	1	3512	0	.	Sufficient	for	interaction	with	SYNE1	and	SYNE2.	Pubmed:22632968
chr22	39146909	39148633	Q9UH99	0	-	39146909	39148633	255,102,0	1	1724	0	.	LMNA-binding.
chr22	39436965	39476946	Q9HC16	0	+	39436965	39476946	255,102,0	1	39981	0	.	Essential	for	cytoplasmic	localization.
chr22	39473366	39476946	Q9HC16	0	+	39473366	39476946	255,102,0	1	3580	0	.	Essential	for	cytoplasmic	localization.
chr22	39479778	39482556	Q9HC16	0	+	39479778	39482556	255,102,0	1	2778	0	.	Necessary	for	homooligomerization.
chr22	39479790	39479799	Q9HC16	0	+	39479790	39479799	255,102,0	1	9	0	.	Interaction	with	DNA.
chr22	39482484	39482508	Q9HC16	0	+	39482484	39482508	255,102,0	1	24	0	.	Interaction	with	DNA.
chr22	39529943	39529985	O95931	0	-	39529943	39529985	255,102,0	1	42	0	.	Required	for	cellular	lifespan	extension.
chr22	39907853	39908499	Q9NQG6	0	+	39907853	39908499	255,102,0	1	646	0	.	Dimerization.
chr22	39908391	39908421	Q9NQG6	0	+	39908391	39908421	255,102,0	1	30	0	.	Important	for	interaction	with	DNM1L.
chr22	39909635	39909662	Q9NQG6	0	+	39909635	39909662	255,102,0	1	27	0	.	Important	for	interaction	with	DNM1L.
chr22	39918388	39918451	P18848	0	+	39918388	39918451	255,102,0	1	63	0	.	Basic	motif.
chr22	39918463	39918574	P18848	0	+	39918463	39918574	255,102,0	1	111	0	.	Interaction	with	GABBR1.
chr22	39918466	39918553	P18848	0	+	39918466	39918553	255,102,0	1	87	0	.	Leucine-zipper.
chr22	40574139	40669445	Q9UPQ9	0	+	40574139	40669445	255,102,0	1	95306	0	.	Interaction	with	argonaute	proteins.
chr22	40681717	40718912	Q9UPQ9	0	+	40681717	40718912	255,102,0	1	37195	0	.	Silencing	domain;	interaction	with	CNOT1	and	PAN3.	Pubmed:21981923
chr22	40706975	40708543	Q9UPQ9	0	+	40706975	40708543	255,102,0	1	1568	0	.	PABPC1-interacting	motif-2	(PAM2).
chr22	40742619	40742625	P30566	0	+	40742619	40742625	255,102,0	1	6	0	.	Substrate	binding;	shared	with	neighboring	subunit.
chr22	40745934	40745943	P30566	0	+	40745934	40745943	255,102,0	1	9	0	.	Substrate	binding.
chr22	40746012	40746018	P30566	0	+	40746012	40746018	255,102,0	1	6	0	.	Substrate	binding.
chr22	40816963	40859231	Q969V6	0	-	40816963	40859231	255,102,0	1	42268	0	.	Mediates	interaction	with	SCAI	and	ACTB.
chr22	41166840	41169987	O43808	0	-	41166840	41169987	255,102,0	1	3147	0	.	Necessary	for	targeting	to	peroxisomes	and	interaction	with	PEX19.
chr22	41175022	41215252	O43808	0	-	41175022	41215252	255,102,0	1	40230	0	.	Necessary	for	targeting	to	peroxisomes	and	interaction	with	PEX19.
chr22	41489011	41513513	Q09472	0	+	41489011	41513513	255,102,0	1	24502	0	.	Interaction	with	ALX1.	Pubmed:12929931
chr22	41489011	41513543	Q09472	0	+	41489011	41513543	255,102,0	1	24532	0	.	Interaction	with	RORA.	Pubmed:9862959
chr22	41548260	41548299	Q09472	0	+	41548260	41548299	255,102,0	1	39	0	.	CRD1;	mediates	transcriptional	repression.
chr22	41565522	41565531	Q09472	0	+	41565522	41565531	255,102,0	1	9	0	.	Interaction	with	histone.	Pubmed:18273021
chr22	41565525	41565534	Q09472	0	+	41565525	41565534	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:24819397
chr22	41565561	41565567	Q09472	0	+	41565561	41565567	255,102,0	1	6	0	.	Acetyl-CoA	binding.	Pubmed:24819397
chr22	41569722	41573169	Q09472	0	+	41569722	41573169	255,102,0	1	3447	0	.	Binding	region	for	E1A	adenovirus.
chr22	41573721	41574351	Q09472	0	+	41573721	41574351	255,102,0	1	630	0	.	Interaction	with	HTLV-1	Tax.
chr22	41573835	41574435	Q09472	0	+	41573835	41574435	255,102,0	1	600	0	.	Interaction	with	NCOA2.	Pubmed:15731352
chr22	41791754	41791817	Q10587	0	+	41791754	41791817	255,102,0	1	63	0	.	Basic	motif.
chr22	41791817	41791841	Q10587	0	+	41791817	41791841	255,102,0	1	24	0	.	Leucine-zipper.
chr22	41911428	41911437	Q99798	0	+	41911428	41911437	255,102,0	1	9	0	.	Substrate	binding.
chr22	41923345	41923351	Q99798	0	+	41923345	41923351	255,102,0	1	6	0	.	Substrate	binding.
chr22	42059636	42059816	P12956	0	+	42059636	42059816	255,102,0	1	180	0	.	Interaction	with	DEAF1.	Pubmed:22442688
chr22	42229274	42262896	Q12772	0	+	42229274	42262896	255,102,0	1	33622	0	.	Transcriptional	activation	(acidic).
chr22	42264784	42273319	Q12772	0	+	42264784	42273319	255,102,0	1	8535	0	.	Interaction	with	LMNA.
chr22	42271388	42271454	Q12772	0	+	42271388	42271454	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42322684	42322702	Q96RJ3	0	-	42322684	42322702	255,102,0	1	18	0	.	Essential	for	TNFSF13B/TALL1/BAFF/BLyS	binding.
chr22	42422777	42423050	Q6ICG8	0	+	42422777	42423050	255,102,0	1	273	0	.	10	X	7	AA	tandem	repeat	of	Y-G-X-P-P-X-G.
chr22	42463855	42463861	P17050	0	-	42463855	42463861	255,102,0	1	6	0	.	Substrate	binding.
chr22	42475772	42475928	Q9H4I9	0	+	42475772	42475928	255,102,0	1	156	0	.	Interaction	with	C2orf47/MAIP1.	Pubmed:27642048
chr22	42595589	42595655	Q9UGU0	0	-	42595589	42595655	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42595591	42595657	Q9UGU0	0	-	42595591	42595657	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42605189	42605255	Q9UGU0	0	-	42605189	42605255	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42607738	42607804	Q9UGU0	0	-	42607738	42607804	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42621400	42621466	Q9UGU0	0	-	42621400	42621466	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42621423	42621489	Q9UGU0	0	-	42621423	42621489	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42635122	42635188	Q9UGU0	0	-	42635122	42635188	255,102,0	1	66	0	.	Leucine-zipper.
chr22	43525236	43525302	Q13323	0	+	43525236	43525302	255,102,0	1	66	0	.	Leucine-zipper.
chr22	43924735	43930582	Q5THR3	0	-	43924735	43930582	255,102,0	1	5847	0	.	Interaction	with	AR.	Pubmed:12612053
chr22	43924735	43933398	Q5THR3	0	-	43924735	43933398	255,102,0	1	8663	0	.	Interaction	with	PARK7.	Pubmed:12612053
chr22	45098381	45122477	P85299	0	+	45098381	45122477	255,102,0	1	24096	0	.	Interaction	with	RICTOR.
chr22	45130912	45131005	P85299	0	+	45130912	45131005	255,102,0	1	93	0	.	Interaction	with	RICTOR.
chr22	45571846	45574690	Q9UKX7	0	+	45571846	45574690	255,102,0	1	2844	0	.	5	X	2	AA	repeats	of	F-G.
chr22	45574207	45574396	Q9UKX7	0	+	45574207	45574396	255,102,0	1	189	0	.	Binding	to	CDKN1B.
chr22	45938033	45939405	P23142	0	+	45938033	45939405	255,102,0	1	1372	0	.	Self-association	and	FN1-binding;	calcium	is	necessary	for	homotypic	binding,	but	not	for	heterotypic	binding.
chr22	46627814	46631274	Q07869	0	+	46627814	46631274	255,102,0	1	3460	0	.	Ligand-binding.
chr22	46627886	46631169	Q07869	0	+	46627886	46631169	255,102,0	1	3283	0	.	Required	for	heterodimerization	with	RXRA.
chr22	46739195	46739204	O75648	0	+	46739195	46739204	255,102,0	1	9	0	.	Interaction	with	target	base	in	tRNA.
chr22	46746219	46746228	O75648	0	+	46746219	46746228	255,102,0	1	9	0	.	Interaction	with	tRNA.
chr22	46751466	46751472	O75648	0	+	46751466	46751472	255,102,0	1	6	0	.	Interaction	with	tRNA.
chr22	47103860	47103872	Q8TCT0	0	-	47103860	47103872	255,102,0	1	12	0	.	Substrate	binding.
chr22	47115986	47134045	Q8TCT0	0	-	47115986	47134045	255,102,0	1	18059	0	.	Required	for	binding	to	sulfatide	and	phosphoinositides.
chr22	50658980	50659709	Q96RT7	0	-	50658980	50659709	255,102,0	1	729	0	.	9	X	27	AA	tandem	repeats.
chr22	50686838	50689461	Q969S8	0	-	50686838	50689461	255,102,0	1	2623	0	.	Histone	deacetylase.
chr22	50705465	50705471	Q15759	0	-	50705465	50705471	255,102,0	1	6	0	.	Inhibitor-binding.
chr22	50705886	50705901	Q15759	0	-	50705886	50705901	255,102,0	1	15	0	.	Inhibitor-binding.
chr22	50926389	50926398	Q9UGB7	0	+	50926389	50926398	255,102,0	1	9	0	.	Substrate	binding.
chr22	50927480	50927486	Q9UGB7	0	+	50927480	50927486	255,102,0	1	6	0	.	Substrate	binding.
chr22	50927981	50927987	Q9UGB7	0	+	50927981	50927987	255,102,0	1	6	0	.	Substrate	binding.
chr22	51009842	51009881	Q92523	0	-	51009842	51009881	255,102,0	1	39	0	.	Coenzyme	A	binding.
chr22	51020773	51020782	Q9Y259	0	-	51020773	51020782	255,102,0	1	9	0	.	Substrate	binding.
chr3	3192719	3194156	Q96SW2	0	-	3192719	3194156	255,102,0	1	1437	0	.	Thalidomide	binding.	Pubmed:25108355
chr3	4345054	4357910	Q53H47	0	+	4345054	4357910	255,102,0	1	12856	0	.	Histone-lysine	N-methyltransferase.
chr3	4354869	4354878	Q53H47	0	+	4354869	4354878	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr3	4355091	4355097	Q53H47	0	+	4355091	4355097	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr3	4357910	4358927	Q53H47	0	+	4357910	4358927	255,102,0	1	1017	0	.	Mariner	transposase	Hsmar1.
chr3	4403872	4403932	Q8NBK3	0	-	4403872	4403932	255,102,0	1	60	0	.	Interaction	with	sulfatases.
chr3	4687349	4687364	Q14643	0	+	4687349	4687364	255,102,0	1	15	0	.	Inositol	1,4,5-trisphosphate	binding.
chr3	4704857	4704869	Q14643	0	+	4704857	4704869	255,102,0	1	12	0	.	Inositol	1,4,5-trisphosphate	binding.
chr3	4706965	4706974	Q14643	0	+	4706965	4706974	255,102,0	1	9	0	.	Inositol	1,4,5-trisphosphate	binding.
chr3	4853089	4856156	Q14643	0	+	4853089	4856156	255,102,0	1	3067	0	.	Interaction	with	ERP44.
chr3	5021403	5024555	O14503	0	+	5021403	5024555	255,102,0	1	3152	0	.	Essential	for	interaction	with	ARNTL/BMAL1,	E-box	binding	and	repressor	activity	against	the	CLOCK-ARNTL/BMAL1	heterodimer.
chr3	5022057	5022072	O14503	0	+	5022057	5022072	255,102,0	1	15	0	.	Necessary	for	interaction	with	RXRA	and	repressor	activity	against	RXRA.	Pubmed:19786558
chr3	7188156	7188165	Q14831	0	+	7188156	7188165	255,102,0	1	9	0	.	Glutamate	binding.
chr3	8787286	8787439	P56539	0	+	8787286	8787439	255,102,0	1	153	0	.	Required	for	interaction	with	DAG1.	Pubmed:10988290
chr3	9775998	9780749	P55201	0	+	9775998	9780749	255,102,0	1	4751	0	.	Interaction	with	KAT6A	and	KAT6B.	Pubmed:18794358
chr3	9781583	9785431	P55201	0	+	9781583	9785431	255,102,0	1	3848	0	.	Interaction	with	MEAF6	and	ING5.	Pubmed:18794358
chr3	9782529	9787545	P55201	0	+	9782529	9787545	255,102,0	1	5016	0	.	Required	for	RUNX1	and	RUNX2	transcriptional	activation.
chr3	9799491	9801198	Q14012	0	-	9799491	9801198	255,102,0	1	1707	0	.	Calmodulin-binding.
chr3	9799494	9801258	Q14012	0	-	9799494	9801258	255,102,0	1	1764	0	.	Autoinhibitory	domain.
chr3	9990893	9990911	Q5FWE3	0	-	9990893	9990911	255,102,0	1	18	0	.	O-glycosylated	at	one	site.
chr3	10070341	10084332	Q9BXW9	0	+	10070341	10084332	255,102,0	1	13991	0	.	Interaction	with	FANCE.
chr3	10083352	10085255	Q9BXW9	0	+	10083352	10085255	255,102,0	1	1903	0	.	Interaction	with	BRCA2.
chr3	10183570	10183690	P40337	0	+	10183570	10183690	255,102,0	1	120	0	.	8	X	5	AA	tandem	repeats	of	G-[PAVG]-E-E-[DAYSLE].
chr3	10183828	10191472	P40337	0	+	10183828	10191472	255,102,0	1	7644	0	.	Involved	in	binding	to	CCT	complex.
chr3	10191475	10191505	P40337	0	+	10191475	10191505	255,102,0	1	30	0	.	Interaction	with	Elongin	BC	complex.
chr3	10370779	10370809	Q01814	0	-	10370779	10370809	255,102,0	1	30	0	.	Calmodulin-binding	subdomain	B.
chr3	10379859	10379913	Q01814	0	-	10379859	10379913	255,102,0	1	54	0	.	Calmodulin-binding	subdomain	A.
chr3	11301041	11301059	P35367	0	+	11301041	11301059	255,102,0	1	18	0	.	Important	for	agonist	binding.
chr3	11301992	11302007	P35367	0	+	11301992	11302007	255,102,0	1	15	0	.	Important	for	agonist	binding.
chr3	12198371	12198377	Q99727	0	-	12198371	12198377	255,102,0	1	6	0	.	Involved	in	metalloproteinase-binding.
chr3	12200238	12200253	Q99727	0	-	12200238	12200253	255,102,0	1	15	0	.	Involved	in	metalloproteinase-binding.
chr3	12434244	12458223	P37231	0	+	12434244	12458223	255,102,0	1	23979	0	.	Interaction	with	FAM120B.
chr3	12458331	12475641	P37231	0	+	12458331	12475641	255,102,0	1	17310	0	.	Ligand-binding.
chr3	12613806	12616314	Q9H000	0	+	12613806	12616314	255,102,0	1	2508	0	.	Makorin-type	Cys-His.
chr3	12641250	12641307	P04049	0	-	12641250	12641307	255,102,0	1	57	0	.	Interaction	with	PEBP1/RKIP.
chr3	13522782	13546117	Q96DB2	0	+	13522782	13546117	255,102,0	1	23335	0	.	Histone	deacetylase.
chr3	13611936	13612386	P98095	0	+	13611936	13612386	255,102,0	1	450	0	.	Subdomain	NA	(Cys-rich).
chr3	13611936	13649587	P98095	0	+	13611936	13649587	255,102,0	1	37651	0	.	N.
chr3	13612386	13649587	P98095	0	+	13612386	13649587	255,102,0	1	37201	0	.	Subdomain	NB	(Cys-free).
chr3	13679071	13679416	P98095	0	+	13679071	13679416	255,102,0	1	345	0	.	Domain	III.
chr3	14187443	14189476	Q01831	0	-	14187443	14189476	255,102,0	1	2033	0	.	Interaction	with	ERCC2	and	GTF2H1.	Pubmed:12509233
chr3	14188795	14188855	Q01831	0	-	14188795	14188855	255,102,0	1	60	0	.	Interaction	with	CETN2.
chr3	14189428	14190183	Q01831	0	-	14189428	14190183	255,102,0	1	755	0	.	DNA-binding;	preference	for	single	stranded	DNA;	required	for	formation	of	stable	nucleoprotein	complex.
chr3	14190183	14199564	Q01831	0	-	14190183	14199564	255,102,0	1	9381	0	.	Minimal	sensor	domain	involved	in	damage	recognition.
chr3	14190340	14199564	Q01831	0	-	14190340	14199564	255,102,0	1	9224	0	.	DNA-binding;	preference	for	heteroduplex	DNA.
chr3	14190361	14199897	Q01831	0	-	14190361	14199897	255,102,0	1	9536	0	.	Interaction	with	RAD23B.
chr3	15073936	15084386	P49116	0	+	15073936	15084386	255,102,0	1	10450	0	.	Ligand-binding.
chr3	15115291	15115765	Q9H1K0	0	-	15115291	15115765	255,102,0	1	474	0	.	Necessary	for	interaction	with	RAB5A.
chr3	15115291	15123924	Q9H1K0	0	-	15115291	15123924	255,102,0	1	8633	0	.	Necessary	for	interaction	with	EHD1.	Pubmed:15020713
chr3	15116143	15123924	Q9H1K0	0	-	15116143	15123924	255,102,0	1	7781	0	.	Necessary	for	interaction	with	RAB4A.
chr3	15123924	15127460	Q9H1K0	0	-	15123924	15127460	255,102,0	1	3536	0	.	Necessary	for	the	correct	targeting	to	endosomes.
chr3	15282328	15288863	Q9Y6W3	0	+	15282328	15288863	255,102,0	1	6535	0	.	Domain	III.
chr3	15288863	15292764	Q9Y6W3	0	+	15288863	15292764	255,102,0	1	3901	0	.	Domain	N.
chr3	15477865	15480641	Q96JC9	0	+	15477865	15480641	255,102,0	1	2776	0	.	Necessary	for	transactivation	activity.
chr3	15512045	15512057	Q9Y215	0	-	15512045	15512057	255,102,0	1	12	0	.	Heparan	sulfate	proteoglycan	binding.
chr3	15518698	15520489	Q9Y215	0	-	15518698	15520489	255,102,0	1	1791	0	.	Heparan	sulfate	proteoglycan	binding.
chr3	15531049	15531100	Q9Y215	0	-	15531049	15531100	255,102,0	1	51	0	.	PRAD.
chr3	15606116	15609988	Q9UJ83	0	-	15606116	15609988	255,102,0	1	3872	0	.	Thiamine	pyrophosphate	binding.
chr3	16237294	16242316	Q8N3T1	0	+	16237294	16242316	255,102,0	1	5022	0	.	Catalytic	subdomain	A.
chr3	16250169	16254138	Q8N3T1	0	+	16250169	16254138	255,102,0	1	3969	0	.	Catalytic	subdomain	B.
chr3	16638358	16639598	Q92904	0	-	16638358	16639598	255,102,0	1	1240	0	.	Homodimerization.
chr3	17202469	17202487	Q92609	0	-	17202469	17202487	255,102,0	1	18	0	.	Required	for	interaction	with	ATG8	family	proteins.	Pubmed:22354992
chr3	17447993	17469943	Q92609	0	-	17447993	17469943	255,102,0	1	21950	0	.	Required	for	interaction	with	retromer;	involved	in	interaction	with	ATG8	family	proteins.	Pubmed:22354992
chr3	18428079	18435962	Q01826	0	-	18428079	18435962	255,102,0	1	7883	0	.	Matrix	attachment	region	(MAR)	DNA-binding.
chr3	18436325	18438752	Q01826	0	-	18436325	18438752	255,102,0	1	2427	0	.	Nuclear	matrix	targeting	sequence	(NMTS).
chr3	18456629	18458514	Q01826	0	-	18456629	18458514	255,102,0	1	1885	0	.	PDZ-like	dimerization	domain.
chr3	20169011	20169020	Q92831	0	+	20169011	20169020	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:10393169
chr3	20169032	20178445	Q92831	0	+	20169032	20178445	255,102,0	1	9413	0	.	Acetyl-CoA	binding.	Pubmed:10393169
chr3	20178517	20178529	Q92831	0	+	20178517	20178529	255,102,0	1	12	0	.	Acetyl-CoA	binding.	Pubmed:10393169
chr3	20216494	20225519	Q5FBB7	0	-	20216494	20225519	255,102,0	1	9025	0	.	Necessary	for	interaction	with	PPP2CA	and	PPP2R1A.	Pubmed:16580887
chr3	23942355	23942463	Q9NYS0	0	-	23942355	23942463	255,102,0	1	108	0	.	Interactions	with	NFKBIA	and	NFKBIB.
chr3	24164377	24185000	P10828	0	-	24164377	24185000	255,102,0	1	20623	0	.	Interaction	with	NR2F6.	Pubmed:10713182
chr3	24164377	24185000	P10828	0	-	24164377	24185000	255,102,0	1	20623	0	.	Ligand-binding.
chr3	24193946	24270450	P10828	0	-	24193946	24270450	255,102,0	1	76504	0	.	Modulating.
chr3	25661355	25661385	Q02880	0	-	25661355	25661385	255,102,0	1	30	0	.	Interaction	with	DNA.
chr3	25674216	25674225	Q02880	0	-	25674216	25674225	255,102,0	1	9	0	.	Interaction	with	DNA.
chr3	27427439	27427448	Q9Y6M7	0	-	27427439	27427448	255,102,0	1	9	0	.	CA2-binding.
chr3	27758563	27758911	O95936	0	-	27758563	27758911	255,102,0	1	348	0	.	Required	for	transcription	activation.
chr3	28365940	28373861	Q9H6S1	0	-	28365940	28373861	255,102,0	1	7921	0	.	Interaction	with	TBK1	and	IKBKE.
chr3	28373915	28382108	Q9H6S1	0	-	28373915	28382108	255,102,0	1	8193	0	.	Homodimerization.
chr3	31725243	31725249	Q9BXB5	0	-	31725243	31725249	255,102,0	1	6	0	.	Phosphatidylinositol	4-phosphate	binding.
chr3	31725411	31725423	Q9BXB5	0	-	31725411	31725423	255,102,0	1	12	0	.	Phosphatidylinositol	4-phosphate	binding.
chr3	31725597	31743859	Q9BXB5	0	-	31725597	31743859	255,102,0	1	18262	0	.	Phosphatidylinositol	4-phosphate	binding.
chr3	31725597	31743859	Q9BXB5	0	-	31725597	31743859	255,102,0	1	18262	0	.	Phosphatidylserine	binding.
chr3	32200559	32200565	Q8N335	0	+	32200559	32200565	255,102,0	1	6	0	.	Substrate	binding.
chr3	33406158	33406191	Q9UKC9	0	+	33406158	33406191	255,102,0	1	33	0	.	Interaction	with	Calmodulin.
chr3	33866741	33886948	Q8WUM4	0	+	33866741	33886948	255,102,0	1	20207	0	.	Interaction	with	CHMP4A,	CHMP4B	and	CHMP4C.
chr3	33866741	33908014	Q8WUM4	0	+	33866741	33908014	255,102,0	1	41273	0	.	Interaction	with	EIAV	p9.
chr3	33883458	33908014	Q8WUM4	0	+	33883458	33908014	255,102,0	1	24556	0	.	Interaction	with	SDCBP.	Pubmed:22660413
chr3	33886945	33908014	Q8WUM4	0	+	33886945	33908014	255,102,0	1	21069	0	.	Self-association.
chr3	33905525	33905537	Q8WUM4	0	+	33905525	33905537	255,102,0	1	12	0	.	Interaction	with	TSG101.
chr3	33906878	33906908	Q8WUM4	0	+	33906878	33906908	255,102,0	1	30	0	.	Interaction	with	CEP55.
chr3	33907999	33908014	Q8WUM4	0	+	33907999	33908014	255,102,0	1	15	0	.	Essential	to	promote	virus	budding.
chr3	37067316	37090061	P40692	0	+	37067316	37090061	255,102,0	1	22745	0	.	Interaction	with	EXO1.
chr3	37125294	37190474	Q9Y608	0	-	37125294	37190474	255,102,0	1	65180	0	.	DVL3-binding.
chr3	37323682	37336496	Q13439	0	+	37323682	37336496	255,102,0	1	12814	0	.	Interaction	with	MACF1.	Pubmed:15265687
chr3	38061706	38061790	P51178	0	-	38061706	38061790	255,102,0	1	84	0	.	Substrate	binding.
chr3	38524754	38524820	Q13705	0	+	38524754	38524820	255,102,0	1	66	0	.	Interaction	with	DYNLT1.
chr3	38591931	38591943	Q14524	0	-	38591931	38591943	255,102,0	1	12	0	.	Interaction	with	NEDD4,	NEDD4L	and	WWP2.	Pubmed:15548568
chr3	38592159	38592348	Q14524	0	-	38592159	38592348	255,102,0	1	189	0	.	Interaction	with	FGF13.	Pubmed:22705208
chr3	39141954	39141993	Q9BQQ3	0	-	39141954	39141993	255,102,0	1	39	0	.	Essential	for	interaction	with	GOLGA2/GM130.
chr3	39225407	39225884	Q702N8	0	-	39225407	39225884	255,102,0	1	477	0	.	Interaction	with	FLNC.	Pubmed:16631741
chr3	39229040	39229346	Q702N8	0	-	39229040	39229346	255,102,0	1	306	0	.	Interaction	with	CTNNB1.
chr3	39230774	39230936	Q702N8	0	-	39230774	39230936	255,102,0	1	162	0	.	Interaction	with	VASP.	Pubmed:16631741
chr3	39450122	39452331	A0A024R2P0	0	+	39450122	39452331	255,102,0	1	2209	0	.	Interaction	with	PPP1R16B.
chr3	39450122	39452331	P08865	0	+	39450122	39452331	255,102,0	1	2209	0	.	Interaction	with	PPP1R16B.	Pubmed:16263087
chr3	39452472	39453181	A0A024R2P0	0	+	39452472	39453181	255,102,0	1	709	0	.	Laminin-binding.
chr3	39452472	39453181	A0A0C4DG17	0	+	39452472	39453181	255,102,0	1	709	0	.	Laminin-binding.
chr3	39452472	39453181	P08865	0	+	39452472	39453181	255,102,0	1	709	0	.	Laminin-binding.
chr3	39453253	39453446	A0A024R2P0	0	+	39453253	39453446	255,102,0	1	193	0	.	Laminin-binding.
chr3	39453253	39453446	A0A0C4DG17	0	+	39453253	39453446	255,102,0	1	193	0	.	Laminin-binding.
chr3	39453253	39453446	P08865	0	+	39453253	39453446	255,102,0	1	193	0	.	Laminin-binding.
chr3	39453482	39453856	A0A024R2P0	0	+	39453482	39453856	255,102,0	1	374	0	.	Laminin-binding.
chr3	39453482	39453856	A0A0C4DG17	0	+	39453482	39453856	255,102,0	1	374	0	.	Laminin-binding.
chr3	39453482	39453856	P08865	0	+	39453482	39453856	255,102,0	1	374	0	.	Laminin-binding.
chr3	39544107	39544227	Q13875	0	+	39544107	39544227	255,102,0	1	120	0	.	4	X	10	AA	tandem	repeats	of	P-R-S-P-P-R-S-E-R-Q.
chr3	40192632	40251359	Q8NFW9	0	+	40192632	40251359	255,102,0	1	58727	0	.	Myosin-binding.
chr3	40208362	40208413	Q8NFW9	0	+	40208362	40208413	255,102,0	1	51	0	.	PKA-binding.
chr3	40208694	40211455	Q8NFW9	0	+	40208694	40211455	255,102,0	1	2761	0	.	Negative	regulation	of	PKA-binding.
chr3	40231771	40299645	Q8NFW9	0	+	40231771	40299645	255,102,0	1	67874	0	.	Actin-binding.
chr3	40503585	40503645	P50914	0	+	40503585	40503645	255,102,0	1	60	0	.	4	X	5	AA	tandem	repeats	of	Q-K-A-[PAS]-X.
chr3	40503651	40503669	P50914	0	+	40503651	40503669	255,102,0	1	18	0	.	2	X	3	AA	tandem	repeats	of	K-[GA]-Q.
chr3	41265562	41266072	P35222	0	+	41265562	41266072	255,102,0	1	510	0	.	Interaction	with	VCL.
chr3	41266668	41266863	P35222	0	+	41266668	41266863	255,102,0	1	195	0	.	Interaction	with	BCL9.	Pubmed:17052462
chr3	41280800	41280830	P35222	0	+	41280800	41280830	255,102,0	1	30	0	.	Interaction	with	SCRIB.
chr3	42236394	42244027	Q9UPV9	0	+	42236394	42244027	255,102,0	1	7633	0	.	Interaction	with	HGS.	Pubmed:18675823
chr3	42681126	42681240	P30414	0	+	42681126	42681240	255,102,0	1	114	0	.	Arg/Ser	tandem	repeat-rich.
chr3	42906972	42907146	O00590	0	+	42906972	42907146	255,102,0	1	174	0	.	C-terminal	cytoplasmic	tail.
chr3	43073911	43073929	Q9UFP1	0	+	43073911	43073929	255,102,0	1	18	0	.	O-glycosylated	at	one	site.
chr3	44692583	44700518	P13682	0	+	44692583	44700518	255,102,0	1	7935	0	.	Globular	domain.
chr3	45636530	45636773	Q9UGP4	0	+	45636530	45636773	255,102,0	1	243	0	.	Mediates	nuclear	export.
chr3	45636926	45637151	Q9UGP4	0	+	45636926	45637151	255,102,0	1	225	0	.	Interaction	with	EGLN1/PHD2.
chr3	45637580	45637697	Q9UGP4	0	+	45637580	45637697	255,102,0	1	117	0	.	Interaction	with	RB1.	Pubmed:15542589
chr3	45677646	45718548	Q9UGP4	0	+	45677646	45718548	255,102,0	1	40902	0	.	Necessary	for	nuclear	localization.
chr3	45867808	45874565	Q9NQ48	0	-	45867808	45874565	255,102,0	1	6757	0	.	Interaction	with	BSS9.
chr3	46501178	46501184	P02788	0	-	46501178	46501184	255,102,0	1	6	0	.	Interaction	with	pspA.
chr3	46501199	46501217	P02788	0	-	46501199	46501217	255,102,0	1	18	0	.	Involved	in	glycosaminoglycan	binding.
chr3	46501205	46501238	P02788	0	-	46501205	46501238	255,102,0	1	33	0	.	Bactericidal	and	antifungal	activity.
chr3	46501205	46501238	P02788	0	-	46501205	46501238	255,102,0	1	33	0	.	Interaction	with	lipopolysaccharide.
chr3	46501214	46501238	P02788	0	-	46501214	46501238	255,102,0	1	24	0	.	Interaction	with	pspA.
chr3	46501265	46501295	P02788	0	-	46501265	46501295	255,102,0	1	30	0	.	Bactericidal	and	antifungal	activity.
chr3	46501280	46501295	P02788	0	-	46501280	46501295	255,102,0	1	15	0	.	Critical	for	glycosaminoglycan,	lipid	A,	lysozyme	and	DNA	binding.
chr3	46501286	46501292	P02788	0	-	46501286	46501292	255,102,0	1	6	0	.	Important	for	full	bactericidal	and	antifungal	activities.
chr3	47058585	47061312	Q9BYW2	0	-	47058585	47061312	255,102,0	1	2727	0	.	Interaction	with	POLR2A.
chr3	47087976	47098865	Q9BYW2	0	-	47087976	47098865	255,102,0	1	10889	0	.	Low	charge	region.
chr3	47139444	47161874	Q9BYW2	0	-	47139444	47161874	255,102,0	1	22430	0	.	Interaction	with	TUBA1A.	Pubmed:27518565
chr3	47144865	47144871	Q9BYW2	0	-	47144865	47144871	255,102,0	1	6	0	.	Inhibitor	binding.
chr3	47144865	47144871	Q9BYW2	0	-	47144865	47144871	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr3	47147510	47147519	Q9BYW2	0	-	47147510	47147519	255,102,0	1	9	0	.	Inhibitor	binding.
chr3	47147510	47147519	Q9BYW2	0	-	47147510	47147519	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr3	47155394	47155403	Q9BYW2	0	-	47155394	47155403	255,102,0	1	9	0	.	Inhibitor	binding.
chr3	47155394	47155403	Q9BYW2	0	-	47155394	47155403	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr3	47451595	47452678	Q9H3S7	0	+	47451595	47452678	255,102,0	1	1083	0	.	His.
chr3	47452144	47452180	Q9H3S7	0	+	47452144	47452180	255,102,0	1	36	0	.	6	X	2	AA	approximate	tandem	repeats	of	P-Q.
chr3	47455346	47459951	Q12770	0	-	47455346	47459951	255,102,0	1	4605	0	.	Interaction	with	SREBF2.
chr3	47462250	47462426	Q12770	0	-	47462250	47462426	255,102,0	1	176	0	.	ER	export	signal.
chr3	47614177	47614234	O95196	0	-	47614177	47614234	255,102,0	1	57	0	.	Interaction	with	GOPC.	Pubmed:12885772
chr3	47618612	47618726	O95196	0	-	47618612	47618726	255,102,0	1	114	0	.	Interaction	with	TNC	and	TNR.
chr3	47957681	47958575	P27816	0	-	47957681	47958575	255,102,0	1	894	0	.	17	X	14	AA	tandem	repeats.
chr3	48491546	48493221	Q8WXE1	0	+	48491546	48493221	255,102,0	1	1675	0	.	Interaction	with	CINP.	Pubmed:19889979
chr3	48508111	48508117	Q9NSU2	0	+	48508111	48508117	255,102,0	1	6	0	.	Substrate	binding.
chr3	48508213	48508243	Q9NSU2	0	+	48508213	48508243	255,102,0	1	30	0	.	Proline-rich	region.
chr3	48508759	48508996	Q9NSU2	0	+	48508759	48508996	255,102,0	1	237	0	.	Necessary	for	endoplasmic	reticulum	localization.
chr3	48508780	48508996	Q9NSU2	0	+	48508780	48508996	255,102,0	1	216	0	.	Interaction	with	UBQLN1.	Pubmed:23979357
chr3	48508894	48508996	Q9NSU2	0	+	48508894	48508996	255,102,0	1	102	0	.	Necessary	for	cytoplasmic	retention.
chr3	48557182	48573781	Q16877	0	-	48557182	48573781	255,102,0	1	16599	0	.	Fructose-2,6-bisphosphatase.
chr3	48573781	48594210	Q16877	0	-	48573781	48594210	255,102,0	1	20429	0	.	6-phosphofructo-2-kinase.
chr3	48601841	48603948	Q02388	0	-	48601841	48603948	255,102,0	1	2107	0	.	Nonhelical	region	(NC2).
chr3	48603948	48623289	Q02388	0	-	48603948	48623289	255,102,0	1	19341	0	.	Triple-helical	region.
chr3	48620831	48623289	Q02388	0	-	48620831	48623289	255,102,0	1	2458	0	.	Interrupted	collagenous	region.
chr3	48623372	48632544	Q02388	0	-	48623372	48632544	255,102,0	1	9172	0	.	Nonhelical	region	(NC1).
chr3	48727078	48727105	Q9UHH9	0	-	48727078	48727105	255,102,0	1	27	0	.	Substrate	binding.
chr3	48827997	48885026	P13861	0	-	48827997	48885026	255,102,0	1	57029	0	.	Dimerization	and	phosphorylation.
chr3	48965183	49002364	O95376	0	+	48965183	49002364	255,102,0	1	37181	0	.	UBA-like.
chr3	49017027	49020700	O95376	0	+	49017027	49020700	255,102,0	1	3673	0	.	Ariadne	domain.
chr3	49062378	49062393	P12268	0	-	49062378	49062393	255,102,0	1	15	0	.	IMP	binding.
chr3	49062459	49062465	P12268	0	-	49062459	49062465	255,102,0	1	6	0	.	IMP	binding.
chr3	49062610	49062619	P12268	0	-	49062610	49062619	255,102,0	1	9	0	.	IMP	binding.
chr3	49158661	49160383	P55268	0	-	49158661	49160383	255,102,0	1	1722	0	.	Domain	I.
chr3	49160383	49160482	P55268	0	-	49160383	49160482	255,102,0	1	99	0	.	Domain	alpha.
chr3	49160482	49161390	P55268	0	-	49160482	49161390	255,102,0	1	908	0	.	Domain	II.
chr3	49338022	49338037	Q13107	0	-	49338022	49338037	255,102,0	1	15	0	.	Necessary	for	interaction	with	RB1	and	RBL2.
chr3	49339882	49339891	Q13107	0	-	49339882	49339891	255,102,0	1	9	0	.	Necessary	for	interaction	with	RBL2.
chr3	49362181	49377379	Q13107	0	-	49362181	49377379	255,102,0	1	15198	0	.	Necessary	for	interaction	with	SART3.	Pubmed:20595234
chr3	49548054	49569168	Q14118	0	+	49548054	49569168	255,102,0	1	21114	0	.	Required	for	laminin	recognition.
chr3	49568448	49568544	Q14118	0	+	49568448	49568544	255,102,0	1	96	0	.	O-glycosylated	at	one	site.
chr3	49568889	49569399	Q14118	0	+	49568889	49569399	255,102,0	1	510	0	.	Mucin-like	domain.
chr3	49569330	49569399	Q14118	0	+	49569330	49569399	255,102,0	1	69	0	.	O-glycosylated	at	seven	sites	with	GalNAc.
chr3	49570398	49570629	Q14118	0	+	49570398	49570629	255,102,0	1	231	0	.	Required	for	interaction	with	CAV3.	Pubmed:10988290
chr3	49570581	49570629	Q14118	0	+	49570581	49570629	255,102,0	1	48	0	.	Required	for	binding	DMD	and	UTRN.
chr3	49592101	49592131	Q9UPA5	0	+	49592101	49592131	255,102,0	1	30	0	.	5	X	2	AA	tandem	repeats	of	P-G.
chr3	49592215	49592257	Q9UPA5	0	+	49592215	49592257	255,102,0	1	42	0	.	7	X	2	AA	tandem	repeats	of	P-G.
chr3	49688236	49688299	Q9UPA5	0	+	49688236	49688299	255,102,0	1	63	0	.	3	X	7	AA	tandem	repeats	of	K-A-S-P-[LQ]-[APS]-[KST].
chr3	49765643	49765670	Q92551	0	-	49765643	49765670	255,102,0	1	27	0	.	Substrate	binding.
chr3	49847524	49851070	P41226	0	-	49847524	49851070	255,102,0	1	3546	0	.	2	approximate	repeats.
chr3	49866538	49878492	Q9BWF2	0	-	49866538	49878492	255,102,0	1	11954	0	.	Interaction	with	CYLD.	Pubmed:14676304
chr3	50144921	50155868	P52756	0	+	50144921	50155868	255,102,0	1	10947	0	.	Required	for	interaction	with	U2AF2.	Pubmed:18851835
chr3	50147886	50150965	P52756	0	+	50147886	50150965	255,102,0	1	3079	0	.	Sufficient	for	interaction	with	ACIN1,	PRPF8,	SFRS3,	SNRPB,	SNRPN,	SNRNP70	and	SNRNP200.	Pubmed:18851835
chr3	50368092	50368104	Q9NS23	0	-	50368092	50368104	255,102,0	1	12	0	.	MOAP1-binding.
chr3	50375347	50378233	Q9NS23	0	-	50375347	50378233	255,102,0	1	2886	0	.	Mediates	interaction	with	E4F1.	Pubmed:14729613
chr3	50378843	50379266	O75800	0	-	50378843	50379266	255,102,0	1	423	0	.	Interaction	with	LRRC6.
chr3	50386865	50388083	Q8WTW4	0	-	50386865	50388083	255,102,0	1	1218	0	.	Interaction	with	PDPK1.	Pubmed:18616680
chr3	50395807	50395879	Q12893	0	-	50395807	50395879	255,102,0	1	72	0	.	Mediates	localization	to	the	Golgi.	Pubmed:24806965
chr3	50395879	50396494	Q12893	0	-	50395879	50396494	255,102,0	1	615	0	.	Mediates	homooligomerization.	Pubmed:24806965
chr3	50614566	50614581	Q9Y5R4	0	+	50614566	50614581	255,102,0	1	15	0	.	S-adenosyl-L-methionine	binding.
chr3	50616301	50616313	Q9Y5R4	0	+	50616301	50616313	255,102,0	1	12	0	.	Substrate	binding.
chr3	50684556	50685357	Q16644	0	+	50684556	50685357	255,102,0	1	801	0	.	Autoinhibitory	helix.
chr3	50685360	50685435	Q16644	0	+	50685360	50685435	255,102,0	1	75	0	.	p38	MAPK-binding	site.
chr3	51430993	51431500	Q8NDT2	0	+	51430993	51431500	255,102,0	1	507	0	.	Interaction	with	Epstein-Barr	virus	BMLF1.
chr3	51436202	51440790	Q9Y4B6	0	-	51436202	51440790	255,102,0	1	4585	0	.	Interaction	with	NF2.
chr3	51451464	51456296	Q9Y4B6	0	-	51451464	51456296	255,102,0	1	4832	0	.	WD	repeat-like	region.
chr3	51746533	51746542	Q14416	0	+	51746533	51746542	255,102,0	1	9	0	.	Glutamate	binding.
chr3	51749817	51749844	Q14416	0	+	51749817	51749844	255,102,0	1	27	0	.	Important	for	interaction	with	HTR2A.
chr3	52436330	52437258	Q92560	0	-	52436330	52437258	255,102,0	1	928	0	.	Interaction	with	BRCA1.
chr3	52489660	52504913	Q9Y2I1	0	+	52489660	52504913	255,102,0	1	15253	0	.	Necessary	for	binding	to	phosphoinositide-3-P;	not	sufficient	for	targeting	to	endosomes.
chr3	52492857	52521593	Q9Y2I1	0	+	52492857	52521593	255,102,0	1	28736	0	.	Necessary	for	homooligomerization	and	targeting	to	endosomes.
chr3	52507812	52522115	Q9Y2I1	0	+	52507812	52522115	255,102,0	1	14303	0	.	Interaction	with	PAK1.
chr3	52521485	52522115	Q9Y2I1	0	+	52521485	52522115	255,102,0	1	630	0	.	Interaction	with	LIMK.
chr3	52521632	52521929	Q9Y2I1	0	+	52521632	52521929	255,102,0	1	297	0	.	Interaction	with	ITGA5.
chr3	52720111	52721327	Q9BVP2	0	+	52720111	52721327	255,102,0	1	1216	0	.	Basic.
chr3	52725619	52727691	Q9BVP2	0	+	52725619	52727691	255,102,0	1	2072	0	.	Intermediate.
chr3	52727715	52728270	Q9BVP2	0	+	52727715	52728270	255,102,0	1	555	0	.	Acidic.
chr3	52817288	52825924	P19827	0	+	52817288	52825924	255,102,0	1	8636	0	.	Hyaluronan-binding.
chr3	52852276	52852297	Q14624	0	-	52852276	52852297	255,102,0	1	21	0	.	O-glycosylated	at	three	sites.
chr3	52853421	52853514	Q14624	0	-	52853421	52853514	255,102,0	1	93	0	.	Proline-rich	(PRR)	potential	bioactive	peptide.
chr3	52876856	52876874	Q86TL2	0	-	52876856	52876874	255,102,0	1	18	0	.	Required	for	localization	in	the	endoplasmic	reticulum.	Pubmed:26322679
chr3	52977606	52988356	Q9UHJ3	0	-	52977606	52988356	255,102,0	1	10750	0	.	Antigenic	epitope.
chr3	53736731	53736785	Q01668	0	+	53736731	53736785	255,102,0	1	54	0	.	Binding	to	the	beta	subunit.
chr3	53781383	53783475	Q01668	0	+	53781383	53783475	255,102,0	1	2092	0	.	Dihydropyridine	binding.
chr3	53809967	53810725	Q01668	0	+	53809967	53810725	255,102,0	1	758	0	.	Dihydropyridine	binding.
chr3	53810003	53810692	Q01668	0	+	53810003	53810692	255,102,0	1	689	0	.	Phenylalkylamine	binding.
chr3	57261911	57291310	Q9UKG1	0	+	57261911	57291310	255,102,0	1	29399	0	.	Required	for	RAB5A	binding.
chr3	57327934	57335933	Q6ZR08	0	-	57327934	57335933	255,102,0	1	7999	0	.	AAA	5.
chr3	57343789	57348599	Q6ZR08	0	-	57343789	57348599	255,102,0	1	4810	0	.	Stalk.
chr3	57391586	57405194	Q6ZR08	0	-	57391586	57405194	255,102,0	1	13608	0	.	AAA	3.
chr3	57419096	57422778	Q6ZR08	0	-	57419096	57422778	255,102,0	1	3682	0	.	AAA	2.
chr3	57430948	57438644	Q6ZR08	0	-	57430948	57438644	255,102,0	1	7696	0	.	AAA	1.
chr3	57438644	57528597	Q6ZR08	0	-	57438644	57528597	255,102,0	1	89953	0	.	Stem.
chr3	57743378	57835513	Q14BN4	0	+	57743378	57835513	255,102,0	1	92135	0	.	Necessary	for	targeting	to	centrosomes.
chr3	58109074	58120361	O75369	0	+	58109074	58120361	255,102,0	1	11287	0	.	Interaction	with	FBLP1.	Pubmed:12496242
chr3	58127587	58128379	O75369	0	+	58127587	58128379	255,102,0	1	792	0	.	Hinge	1.
chr3	58132575	58139178	O75369	0	+	58132575	58139178	255,102,0	1	6603	0	.	Interaction	with	the	cytoplasmic	tail	of	GP1BA.
chr3	58135662	58140558	O75369	0	+	58135662	58140558	255,102,0	1	4896	0	.	Interaction	with	FLNA	1.
chr3	58139121	58156486	O75369	0	+	58139121	58156486	255,102,0	1	17365	0	.	Interaction	with	INPPL1.	Pubmed:11739414
chr3	58154381	58155417	O75369	0	+	58154381	58155417	255,102,0	1	1036	0	.	Hinge	2.
chr3	58154381	58156486	O75369	0	+	58154381	58156486	255,102,0	1	2105	0	.	Self-association	site,	tail.
chr3	58155417	58156486	O75369	0	+	58155417	58156486	255,102,0	1	1069	0	.	Interaction	with	FLNA	2.
chr3	58178416	58178482	Q13609	0	-	58178416	58178482	255,102,0	1	66	0	.	Not	required	for	free	DNA-nuclease	activity	but	required	for	activity	towards	liposome-coated	DNA.
chr3	62257225	62258636	P23470	0	+	62257225	62258636	255,102,0	1	1411	0	.	Substrate	binding.
chr3	62385083	62452037	Q9ULU8	0	-	62385083	62452037	255,102,0	1	66954	0	.	Mediates	targeting	and	association	with	DCVs.
chr3	62459937	62503849	Q9ULU8	0	-	62459937	62503849	255,102,0	1	43912	0	.	Interaction	with	DRD2.	Pubmed:15857609
chr3	63600986	63601085	Q8TBG9	0	+	63600986	63601085	255,102,0	1	99	0	.	5	X	approximate	repeats.
chr3	63819810	63823691	Q6I9Y2	0	-	63819810	63823691	255,102,0	1	3881	0	.	Interaction	with	NIF3L1.	Pubmed:12951069
chr3	63821975	63824165	Q6I9Y2	0	-	63821975	63824165	255,102,0	1	2190	0	.	Interaction	with	THOC5.	Pubmed:19059247
chr3	64607928	64617520	Q9P2N4	0	-	64607928	64617520	255,102,0	1	9592	0	.	Spacer.
chr3	67451236	67451245	Q96I99	0	-	67451236	67451245	255,102,0	1	9	0	.	Substrate	binding;	shared	with	subunit	alpha.
chr3	69096829	69096859	P82094	0	-	69096829	69096859	255,102,0	1	30	0	.	Interaction	with	Elongin	BC	complex.
chr3	69104590	69105416	Q8TBC4	0	-	69104590	69105416	255,102,0	1	826	0	.	Interaction	with	UBE2M	core	domain.
chr3	69105774	69105792	Q8TBC4	0	-	69105774	69105792	255,102,0	1	18	0	.	Interaction	with	NEDD8.
chr3	69105831	69105940	Q8TBC4	0	-	69105831	69105940	255,102,0	1	109	0	.	Interaction	with	UBE2M	N-terminus.
chr3	69110989	69111001	Q8TBC4	0	-	69110989	69111001	255,102,0	1	12	0	.	Interaction	with	NAE1.	Pubmed:12740388
chr3	69111279	69111300	Q8TBC4	0	-	69111279	69111300	255,102,0	1	21	0	.	Interaction	with	NAE1.	Pubmed:12740388
chr3	69112138	69112147	Q8TBC4	0	-	69112138	69112147	255,102,0	1	9	0	.	Interaction	with	NEDD8.
chr3	69112174	69112252	Q8TBC4	0	-	69112174	69112252	255,102,0	1	78	0	.	Interaction	with	UBE2M	N-terminus.
chr3	69112643	69113222	Q8TBC4	0	-	69112643	69113222	255,102,0	1	579	0	.	Interaction	with	UBE2M	N-terminus.
chr3	69124634	69126975	Q8TBC4	0	-	69124634	69126975	255,102,0	1	2341	0	.	Interaction	with	UBE2M	N-terminus.
chr3	69151119	69151164	O75915	0	+	69151119	69151164	255,102,0	1	45	0	.	Required	for	homodimer	formation	and	heterodimer	formation	with	ARL6IP1.
chr3	69153625	69153784	O75915	0	+	69153625	69153784	255,102,0	1	159	0	.	Targeting	to	endoplasmic	reticulum	membrane.
chr3	69171390	69171537	Q0VAK6	0	-	69171390	69171537	255,102,0	1	147	0	.	Interaction	with	tropomyosin	alpha.	Pubmed:25250574
chr3	69990389	70000967	O75030	0	+	69990389	70000967	255,102,0	1	10578	0	.	Transactivation.
chr3	70008511	70014003	O75030	0	+	70008511	70014003	255,102,0	1	5492	0	.	Leucine-zipper.
chr3	70014018	70014111	O75030	0	+	70014018	70014111	255,102,0	1	93	0	.	DNA	binding	regulation.
chr3	71027168	71037147	Q9H334	0	-	71027168	71037147	255,102,0	1	9979	0	.	CTBP1-binding.
chr3	71037183	71050143	Q9H334	0	-	71037183	71050143	255,102,0	1	12960	0	.	Leucine-zipper.
chr3	71739266	71739284	Q8N5X7	0	-	71739266	71739284	255,102,0	1	18	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr3	71745667	71748766	Q8N5X7	0	-	71745667	71748766	255,102,0	1	3099	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr3	81643158	81643170	Q04446	0	-	81643158	81643170	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:26199317
chr3	81720054	81720066	Q04446	0	-	81720054	81720066	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:26199317
chr3	81754628	81754637	Q04446	0	-	81754628	81754637	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:26199317
chr3	81754718	81754724	Q04446	0	-	81754718	81754724	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:26199317
chr3	88040193	88040223	P30939	0	+	88040193	88040223	255,102,0	1	30	0	.	Agonist	binding.
chr3	88040814	88040829	P30939	0	+	88040814	88040829	255,102,0	1	15	0	.	Agonist	binding.
chr3	93624985	93629547	P07225	0	-	93624985	93629547	255,102,0	1	4562	0	.	Thrombin-sensitive.
chr3	93777537	93777555	Q86XF0	0	-	93777537	93777555	255,102,0	1	18	0	.	Substrate	binding.
chr3	93780247	93780265	Q86XF0	0	-	93780247	93780265	255,102,0	1	18	0	.	Substrate	binding.
chr3	93803242	93803263	Q9H649	0	+	93803242	93803263	255,102,0	1	21	0	.	S-adenosyl-L-methionine	binding.
chr3	97593932	97594004	Q68DQ2	0	+	97593932	97594004	255,102,0	1	72	0	.	RII-binding	helix.	Pubmed:25097019
chr3	97705586	97711761	A8MPY1	0	-	97705586	97711761	255,102,0	1	6175	0	.	Interaction	with	SQSTM1.
chr3	98299607	98300354	P36551	0	-	98299607	98300354	255,102,0	1	747	0	.	Important	for	dimerization.
chr3	98300288	98300297	P36551	0	-	98300288	98300297	255,102,0	1	9	0	.	Substrate	binding.
chr3	98309500	98309509	P36551	0	-	98309500	98309509	255,102,0	1	9	0	.	Substrate	binding.
chr3	98309949	98309979	P36551	0	-	98309949	98309979	255,102,0	1	30	0	.	Important	for	dimerization.
chr3	99509610	99513096	P27658	0	+	99509610	99513096	255,102,0	1	3486	0	.	Nonhelical	region	(NC2).
chr3	99513096	99514458	P27658	0	+	99513096	99514458	255,102,0	1	1362	0	.	Triple-helical	region	(COL1).
chr3	99514458	99514977	P27658	0	+	99514458	99514977	255,102,0	1	519	0	.	Nonhelical	region	(NC1).
chr3	100947699	100948229	Q9BZV3	0	-	100947699	100948229	255,102,0	1	530	0	.	Hyaluronan-binding	motif	involved	in	chondroitin	sulfate	A-	and	C-binding	motif.
chr3	100948421	100949817	Q9BZV3	0	-	100948421	100949817	255,102,0	1	1396	0	.	Hyaluronan-binding	motif	involved	in	chondroitin	sulfate	C-binding.
chr3	100949823	100949850	Q9BZV3	0	-	100949823	100949850	255,102,0	1	27	0	.	Hyaluronan-binding	motif	involved	in	chondroitin	sulfate	A-	and	C-binding.
chr3	100949958	100949985	Q9BZV3	0	-	100949958	100949985	255,102,0	1	27	0	.	Hyaluronan-binding	motif	involved	in	chondroitin	sulfate	C-binding.
chr3	100992451	100992478	Q9BZV3	0	-	100992451	100992478	255,102,0	1	27	0	.	Hyaluronan-binding	motif	involved	in	chondroitin	sulfate	A-binding.
chr3	101044789	101059018	Q9BQF6	0	-	101044789	101059018	255,102,0	1	14229	0	.	Protease.
chr3	101475910	101484047	Q8IW35	0	+	101475910	101484047	255,102,0	1	8137	0	.	CCP110-binding.
chr3	101572330	101572552	Q9BYH8	0	+	101572330	101572552	255,102,0	1	222	0	.	Required	for	transcriptional	activity.
chr3	101572579	101578212	Q9BYH8	0	+	101572579	101578212	255,102,0	1	5633	0	.	Interaction	with	NFKB1/p50.
chr3	105377981	105389095	Q13191	0	-	105377981	105389095	255,102,0	1	11114	0	.	Interaction	with	SH3KBP1.	Pubmed:12177062
chr3	105421192	105421270	Q13191	0	-	105421192	105421270	255,102,0	1	78	0	.	Interaction	with	VAV1.	Pubmed:9399639
chr3	105452939	105456056	Q13191	0	-	105452939	105456056	255,102,0	1	3117	0	.	Linker.
chr3	105456056	105470308	Q13191	0	-	105456056	105470308	255,102,0	1	14252	0	.	SH2-like.
chr3	105470308	105495304	Q13191	0	-	105470308	105495304	255,102,0	1	24996	0	.	EF-hand-like.
chr3	105495304	105586319	Q13191	0	-	105495304	105586319	255,102,0	1	91015	0	.	4H.
chr3	107881335	107884319	Q9NWB7	0	-	107881335	107884319	255,102,0	1	2984	0	.	pDED.
chr3	108172962	108174600	Q9Y2K3	0	-	108172962	108174600	255,102,0	1	1638	0	.	Actin-binding.
chr3	108178221	108178290	Q9Y2K3	0	-	108178221	108178290	255,102,0	1	69	0	.	Actin-binding.
chr3	108568032	108568044	Q6PIZ9	0	+	108568032	108568044	255,102,0	1	12	0	.	Interaction	with	PIK3R1.	Pubmed:9687533
chr3	111923202	111927219	Q4G0N8	0	-	111923202	111927219	255,102,0	1	4017	0	.	Ion	transport-like.
chr3	112724706	112724763	Q6NW34	0	-	112724706	112724763	255,102,0	1	57	0	.	Nuclear	localization	signal.
chr3	113441814	113442299	Q9GZZ1	0	-	113441814	113442299	255,102,0	1	485	0	.	Coenzyme	A	binding.
chr3	114014423	114014456	Q495A1	0	+	114014423	114014456	255,102,0	1	33	0	.	Homodimerization.
chr3	115342536	115342548	P17677	0	+	115342536	115342548	255,102,0	1	12	0	.	Important	for	membrane	binding.
chr3	118935115	118935124	O60513	0	-	118935115	118935124	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr3	118937510	118937522	O60513	0	-	118937510	118937522	255,102,0	1	12	0	.	N-acetyl-D-glucosamine	binding.
chr3	118942990	118942996	O60513	0	-	118942990	118942996	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr3	118943068	118943077	O60513	0	-	118943068	118943077	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr3	118945742	118945757	O60513	0	-	118945742	118945757	255,102,0	1	15	0	.	UDP-alpha-D-galactose	binding.
chr3	119344077	119348312	Q53H76	0	+	119344077	119348312	255,102,0	1	4235	0	.	Involved	in	the	recognition	of	diacyl-phospholipids.
chr3	120408672	120461354	Q5HYI8	0	-	120408672	120461354	255,102,0	1	52682	0	.	Small	GTPase-like.
chr3	121151818	121155041	O75417	0	-	121151818	121155041	255,102,0	1	3223	0	.	Loop	3.	Pubmed:21050863
chr3	121186366	121187228	O75417	0	-	121186366	121187228	255,102,0	1	862	0	.	Loop	2.	Pubmed:25643323,	Pubmed:21050863
chr3	121192208	121192316	O75417	0	-	121192208	121192316	255,102,0	1	108	0	.	Loop	1.	Pubmed:21050863
chr3	121209095	121209239	O75417	0	-	121209095	121209239	255,102,0	1	144	0	.	Interaction	with	RAD51.	Pubmed:25642963
chr3	121366255	121377116	P14317	0	-	121366255	121377116	255,102,0	1	10861	0	.	Involved	in	HAX-1	binding.
chr3	121489194	121489401	Q15051	0	-	121489194	121489401	255,102,0	1	207	0	.	Interaction	with	BBS1,	BBS2,	BBS4,	BBS7,	BBS8	and	BBS9.	Pubmed:25552655
chr3	121489194	121515982	Q15051	0	-	121489194	121515982	255,102,0	1	26788	0	.	Interaction	with	CEP290,	BBS1,	BBS2,	BBS4,	BBS5,	BBS7,	BBS8	and	BBS9.	Pubmed:25552655
chr3	121527778	121547807	Q15051	0	-	121527778	121547807	255,102,0	1	20029	0	.	Interaction	with	BBS1,	BBS8	and	BBS9.	Pubmed:25552655
chr3	121554180	121573644	Q96CJ1	0	+	121554180	121573644	255,102,0	1	19464	0	.	Necessary	for	interaction	with	ELL.	Pubmed:12446457
chr3	121591427	121605232	Q96CJ1	0	+	121591427	121605232	255,102,0	1	13805	0	.	Necessary	for	transactivation	activity.
chr3	121605187	121605232	Q96CJ1	0	+	121605187	121605232	255,102,0	1	45	0	.	Necessary	for	interaction	with	TCEA1	and	transactivation	activity.
chr3	122123172	122126170	Q96A26	0	+	122123172	122126170	255,102,0	1	2998	0	.	Required	for	proapoptotic	activity.
chr3	122146502	122170401	P52294	0	-	122146502	122170401	255,102,0	1	23899	0	.	Binding	to	RAG1.
chr3	122152539	122160929	P52294	0	-	122152539	122160929	255,102,0	1	8390	0	.	NLS	binding	site	(minor).
chr3	122170410	122172836	P52294	0	-	122170410	122172836	255,102,0	1	2426	0	.	NLS	binding	site	(major).
chr3	122335944	122335950	Q460N3	0	+	122335944	122335950	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:23473667
chr3	122335980	122335986	Q460N3	0	+	122335980	122335986	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:23473667
chr3	122340451	122345681	Q460N3	0	+	122340451	122345681	255,102,0	1	5230	0	.	Substrate	binding.	Pubmed:23473667
chr3	122420164	122420179	Q460N5	0	+	122420164	122420179	255,102,0	1	15	0	.	Substrate	1	binding.	Pubmed:23473667
chr3	122420467	122420473	Q460N5	0	+	122420467	122420473	255,102,0	1	6	0	.	Substrate	2	binding.	Pubmed:23473667
chr3	122422642	122422654	Q460N5	0	+	122422642	122422654	255,102,0	1	12	0	.	Substrate	2	binding.	Pubmed:23473667
chr3	122423451	122423466	Q460N5	0	+	122423451	122423466	255,102,0	1	15	0	.	Substrate	2	binding.	Pubmed:23473667
chr3	122423577	122423589	Q460N5	0	+	122423577	122423589	255,102,0	1	12	0	.	Substrate	2	binding.	Pubmed:23473667
chr3	122432353	122432359	Q460N5	0	+	122432353	122432359	255,102,0	1	6	0	.	Substrate	3	binding.	Pubmed:23473667
chr3	122433269	122436925	Q460N5	0	+	122433269	122436925	255,102,0	1	3656	0	.	Substrate	3	binding.	Pubmed:23473667
chr3	122474223	122487718	Q96EW2	0	-	122474223	122487718	255,102,0	1	13495	0	.	Interaction	with	HSPB1.
chr3	123339099	123345772	Q15746	0	-	123339099	123345772	255,102,0	1	6673	0	.	Calmodulin-binding.
chr3	123367852	123419134	Q15746	0	-	123367852	123419134	255,102,0	1	51282	0	.	Actin-binding	(calcium/calmodulin-insensitive).
chr3	123419125	123419320	Q15746	0	-	123419125	123419320	255,102,0	1	195	0	.	6	X	12	AA	approximate	tandem	repeats.
chr3	123419320	123419713	Q15746	0	-	123419320	123419713	255,102,0	1	393	0	.	5	X	28	AA	approximate	tandem	repeats.
chr3	123419425	123419473	Q15746	0	-	123419425	123419473	255,102,0	1	48	0	.	Calmodulin-binding.
chr3	123419425	123419548	Q15746	0	-	123419425	123419548	255,102,0	1	123	0	.	Actin-binding	(calcium/calmodulin-sensitive).
chr3	123688004	123688016	Q9HAT0	0	-	123688004	123688016	255,102,0	1	12	0	.	Interaction	with	RHPN1.
chr3	124449321	124456746	P11172	0	+	124449321	124456746	255,102,0	1	7425	0	.	OPRTase.
chr3	124456746	124456764	P11172	0	+	124456746	124456764	255,102,0	1	18	0	.	Domain	linker.
chr3	124456764	124462928	P11172	0	+	124456764	124462928	255,102,0	1	6164	0	.	OMPdecase.
chr3	124492562	124515535	P18084	0	-	124492562	124515535	255,102,0	1	22973	0	.	Cysteine-rich	tandem	repeats.
chr3	125702148	125702160	Q9BZX4	0	+	125702148	125702160	255,102,0	1	12	0	.	Interaction	with	RHPN1.
chr3	125822636	125855702	O75891	0	-	125822636	125855702	255,102,0	1	33066	0	.	Aldehyde	dehydrogenase.
chr3	125874265	125879822	O75891	0	-	125874265	125879822	255,102,0	1	5557	0	.	GART.
chr3	125877339	125877348	O75891	0	-	125877339	125877348	255,102,0	1	9	0	.	Substrate	binding.
chr3	126157220	126160661	Q2QGD7	0	-	126157220	126160661	255,102,0	1	3441	0	.	Interaction	with	CIITA.
chr3	126180440	126180770	Q2QGD7	0	-	126180440	126180770	255,102,0	1	330	0	.	Required	for	transcriptional	activation.
chr3	127317312	127325058	P49736	0	+	127317312	127325058	255,102,0	1	7746	0	.	Interaction	with	KAT7.
chr3	127379255	127379273	Q9NZ53	0	+	127379255	127379273	255,102,0	1	18	0	.	O-glycosylated	at	one	site.
chr3	127872389	127872413	P57772	0	+	127872389	127872413	255,102,0	1	24	0	.	G1.
chr3	127872485	127872500	P57772	0	+	127872485	127872500	255,102,0	1	15	0	.	G2.
chr3	127872623	127872635	P57772	0	+	127872623	127872635	255,102,0	1	12	0	.	G3.
chr3	127965797	127965809	P57772	0	+	127965797	127965809	255,102,0	1	12	0	.	G4.
chr3	127980998	127981007	P57772	0	+	127980998	127981007	255,102,0	1	9	0	.	G5.
chr3	128987824	128996264	Q9Y678	0	+	128987824	128996264	255,102,0	1	8440	0	.	Interaction	with	ZNF289/ARFGAP2.	Pubmed:14690497
chr3	129247912	129249732	P08100	0	+	129247912	129249732	255,102,0	1	1820	0	.	Retinal	chromophore	binding.
chr3	129251181	129251199	P08100	0	+	129251181	129251199	255,102,0	1	18	0	.	Retinal	chromophore	binding.
chr3	130092535	130120653	A8TX70	0	+	130092535	130120653	255,102,0	1	28117	0	.	Nonhelical	region.
chr3	130120653	130145078	A8TX70	0	+	130120653	130145078	255,102,0	1	24425	0	.	Triple-helical	region.
chr3	130145078	130195906	A8TX70	0	+	130145078	130195906	255,102,0	1	50828	0	.	Nonhelical	region.
chr3	130279265	130307981	A6NMZ7	0	+	130279265	130307981	255,102,0	1	28716	0	.	Nonhelical	region.
chr3	130307981	130361696	A6NMZ7	0	+	130307981	130361696	255,102,0	1	53715	0	.	Triple-helical	region.
chr3	130361696	130394238	A6NMZ7	0	+	130361696	130394238	255,102,0	1	32542	0	.	Nonhelical	region.
chr3	132153394	132176122	O75165	0	+	132153394	132176122	255,102,0	1	22728	0	.	Involved	in	membrane	association.	Pubmed:18256511
chr3	133118927	133119269	Q13515	0	+	133118927	133119269	255,102,0	1	342	0	.	Head.
chr3	133119269	133191350	Q13515	0	+	133119269	133191350	255,102,0	1	72081	0	.	Rod.
chr3	133191350	133191410	Q13515	0	+	133191350	133191410	255,102,0	1	60	0	.	Tail.
chr3	135871374	135913955	Q9HCI7	0	-	135871374	135913955	255,102,0	1	42581	0	.	Sufficient	for	interaction	with	MSL1.	Pubmed:23084835
chr3	135969310	136048847	P05166	0	+	135969310	136048847	255,102,0	1	79537	0	.	Carboxyltransferase.
chr3	136035788	136035890	P05166	0	+	136035788	136035890	255,102,0	1	102	0	.	Acyl-CoA	binding.
chr3	138022367	138025314	Q86XW9	0	-	138022367	138025314	255,102,0	1	2947	0	.	NDK.
chr3	138170913	138181006	A0FGR9	0	+	138170913	138181006	255,102,0	1	10093	0	.	Glycerophospholipid-binding	barrel-like	domain.
chr3	138193126	138193150	A0FGR9	0	+	138193126	138193150	255,102,0	1	24	0	.	Required	for	phosphatidylinositol	4,5-bisphosphate-dependent	location	at	the	cell	membrane.
chr3	139280166	139280172	Q96T66	0	-	139280166	139280172	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:12574164
chr3	139297727	139297739	Q96T66	0	-	139297727	139297739	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:12574164
chr3	139297841	139297850	Q96T66	0	-	139297841	139297850	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:12574164
chr3	141162127	141162799	Q8NAP3	0	+	141162127	141162799	255,102,0	1	672	0	.	Interaction	with	CBFA2T3.	Pubmed:23251453
chr3	141634835	141644540	P54709	0	+	141634835	141644540	255,102,0	1	9705	0	.	immunoglobulin-like.
chr3	141678576	141682718	Q14188	0	-	141678576	141682718	255,102,0	1	4142	0	.	DCB2.
chr3	141682661	141692898	Q14188	0	-	141682661	141692898	255,102,0	1	10237	0	.	Dimerization.
chr3	141682754	141688962	Q14188	0	-	141682754	141688962	255,102,0	1	6208	0	.	DCB1.
chr3	141713923	141724291	Q14188	0	-	141713923	141724291	255,102,0	1	10368	0	.	Interaction	with	CEBPA.	Pubmed:20176812
chr3	145924372	145939858	Q9NRQ2	0	-	145924372	145939858	255,102,0	1	15486	0	.	Proline-rich	domain	(PRD).
chr3	146177694	146179660	Q9NRY7	0	-	146177694	146179660	255,102,0	1	1966	0	.	Proline-rich	domain	(PRD).
chr3	146246460	146254339	O15162	0	-	146246460	146254339	255,102,0	1	7879	0	.	Proline-rich	domain	(PRD).
chr3	146318128	146322999	A0PG75	0	-	146318128	146322999	255,102,0	1	4871	0	.	Proline-rich	domain	(PRD).
chr3	148559660	148559672	P15086	0	+	148559660	148559672	255,102,0	1	12	0	.	Substrate	binding.
chr3	148562526	148562532	P15086	0	+	148562526	148562532	255,102,0	1	6	0	.	Substrate	binding.
chr3	148563344	148563350	P15086	0	+	148563344	148563350	255,102,0	1	6	0	.	Substrate	binding.
chr3	148744567	148744666	P46976	0	+	148744567	148744666	255,102,0	1	99	0	.	Interaction	with	GYS1.	Pubmed:17055998
chr3	148750009	148756859	Q14527	0	-	148750009	148756859	255,102,0	1	6850	0	.	Interaction	with	SP1	and	SP3.	Pubmed:10391891
chr3	150459936	150480249	O43255	0	-	150459936	150480249	255,102,0	1	20313	0	.	SBD.
chr3	154033880	154042049	Q9H2U1	0	-	154033880	154042049	255,102,0	1	8169	0	.	Sufficient	and	required	for	interaction	with	TERC	5'-end.
chr3	154033880	154042205	Q9H2U1	0	-	154033880	154042205	255,102,0	1	8325	0	.	RNA-binding;	sufficient	and	required	for	recruitment	to	cytoplasmic	stress	granules.
chr3	154042007	154042046	Q9H2U1	0	-	154042007	154042046	255,102,0	1	39	0	.	RSM.
chr3	156866314	156867140	Q9UK58	0	-	156866314	156867140	255,102,0	1	826	0	.	RS.
chr3	156867871	156870827	Q9UK58	0	-	156867871	156870827	255,102,0	1	2956	0	.	Cyclin-like	2.
chr3	156870863	156877622	Q9UK58	0	-	156870863	156877622	255,102,0	1	6759	0	.	Cyclin-like	1.
chr3	158310322	158315964	P58340	0	+	158310322	158315964	255,102,0	1	5642	0	.	Interaction	with	COPS3.	Pubmed:15861129
chr3	158384437	158387240	Q9BS40	0	-	158384437	158387240	255,102,0	1	2803	0	.	Cystatin-like	fold	2.
chr3	158387240	158387300	Q9BS40	0	-	158387240	158387300	255,102,0	1	60	0	.	Alpha-helical	linker.
chr3	158387300	158390267	Q9BS40	0	-	158387300	158390267	255,102,0	1	2967	0	.	Cystatin-like	fold	1.
chr3	160137238	160141601	Q9NTJ3	0	+	160137238	160141601	255,102,0	1	4363	0	.	Flexible	hinge.
chr3	160227614	160233356	O00629	0	-	160227614	160233356	255,102,0	1	5742	0	.	NLS	binding	site	(minor).
chr3	160243764	160248703	O00629	0	-	160243764	160248703	255,102,0	1	4939	0	.	NLS	binding	site	(major).
chr3	160967310	160968695	Q96D46	0	+	160967310	160968695	255,102,0	1	1385	0	.	Necessary	for	the	nuclear	export	of	the	60S	ribosomal	subunit.
chr3	164697152	164741435	P14410	0	-	164697152	164741435	255,102,0	1	44283	0	.	Sucrase.
chr3	164741435	164786911	P14410	0	-	164741435	164786911	255,102,0	1	45476	0	.	Isomaltase.
chr3	165548386	165548392	P06276	0	-	165548386	165548392	255,102,0	1	6	0	.	Substrate	binding.
chr3	167754722	167759254	O00461	0	-	167754722	167759254	255,102,0	1	4532	0	.	Golgi	targeting.
chr3	167759254	167766103	O00461	0	-	167759254	167766103	255,102,0	1	6849	0	.	Endosome	targeting.
chr3	167762660	167812962	O00461	0	-	167762660	167812962	255,102,0	1	50302	0	.	Golgi	targeting.
chr3	168834339	168849265	Q03112	0	-	168834339	168849265	255,102,0	1	14926	0	.	Interaction	with	MAPK9,	SMAD3	and	probably	SUV39H1.	Pubmed:10856240
chr3	169940460	169940541	P41743	0	+	169940460	169940541	255,102,0	1	81	0	.	Required	for	interaction	with	RAB2.
chr3	169940460	169998068	P41743	0	+	169940460	169998068	255,102,0	1	57608	0	.	Regulatory	domain.
chr3	169953129	169977806	P41743	0	+	169953129	169977806	255,102,0	1	24677	0	.	Interaction	with	PARD6A.
chr3	170723076	170723097	P11168	0	-	170723076	170723097	255,102,0	1	21	0	.	Monosaccharide	binding.
chr3	170801971	170884965	Q9UKE5	0	-	170801971	170884965	255,102,0	1	82994	0	.	Mediates	interaction	with	NEDD4.	Pubmed:20159449
chr3	171330166	171406618	Q13393	0	-	171330166	171406618	255,102,0	1	76452	0	.	Catalytic.
chr3	178525197	178543454	Q9Y691	0	+	178525197	178543454	255,102,0	1	18257	0	.	Ball	and	chain.
chr3	179051862	179052117	Q9UID6	0	+	179051862	179052117	255,102,0	1	255	0	.	Interaction	with	CTNNA2.	Pubmed:16182284
chr3	180685963	180686011	P51114	0	+	180685963	180686011	255,102,0	1	48	0	.	RNA-binding	RGG-box.
chr3	183967482	183975544	O60344	0	+	183967482	183975544	255,102,0	1	8062	0	.	Methyltransferase-like	region.
chr3	183975325	183975331	O60344	0	+	183975325	183975331	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine	binding.
chr3	183975400	183975406	O60344	0	+	183975400	183975406	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine	binding.
chr3	183977977	183978947	Q96S95	0	-	183977977	183978947	255,102,0	1	970	0	.	Inhibitory	domain.
chr3	183994796	184010023	O60344	0	+	183994796	184010023	255,102,0	1	15227	0	.	Endothelin-converting	enzyme	2	region.
chr3	184037565	184038480	Q04637	0	+	184037565	184038480	255,102,0	1	915	0	.	PABPC1-binding.
chr3	184040631	184040667	Q04637	0	+	184040631	184040667	255,102,0	1	36	0	.	EIF4E-binding.
chr3	184040984	184044347	Q04637	0	+	184040984	184044347	255,102,0	1	3363	0	.	eIF3/EIF4A-binding.
chr3	184049346	184052693	Q04637	0	+	184049346	184052693	255,102,0	1	3347	0	.	EIF4A-binding.
chr3	184052648	184052693	Q04637	0	+	184052648	184052693	255,102,0	1	45	0	.	Necessary	but	not	sufficient	for	MKNK1-binding.
chr3	184081325	184082800	P52434	0	+	184081325	184082800	255,102,0	1	1475	0	.	Non-specific	ssDNA	binding.
chr3	184910469	184922267	Q08426	0	-	184910469	184922267	255,102,0	1	11798	0	.	3-hydroxyacyl-CoA	dehydrogenase.
chr3	184922267	184971810	Q08426	0	-	184922267	184971810	255,102,0	1	49543	0	.	Enoyl-CoA	hydratase	/	isomerase.
chr3	185181355	185181421	O43283	0	+	185181355	185181421	255,102,0	1	66	0	.	Leucine-zipper	1.
chr3	185183601	185184629	O43283	0	+	185183601	185184629	255,102,0	1	1028	0	.	Leucine-zipper	2.
chr3	185195125	185195167	O43283	0	+	185195125	185195167	255,102,0	1	42	0	.	Acidic.
chr3	185335342	185344154	Q9HC62	0	+	185335342	185344154	255,102,0	1	8812	0	.	Protease.
chr3	185638923	185639860	P62995	0	-	185638923	185639860	255,102,0	1	937	0	.	Linker.
chr3	186256742	186257146	P22914	0	-	186256742	186257146	255,102,0	1	404	0	.	Connecting	peptide.
chr3	186262100	186262112	P22914	0	-	186262100	186262112	255,102,0	1	12	0	.	N-terminal	arm.
chr3	186383940	186386792	P04196	0	+	186383940	186386792	255,102,0	1	2852	0	.	Interaction	with	ATP5A1.	Pubmed:19285951
chr3	186395135	186395240	P04196	0	+	186395135	186395240	255,102,0	1	105	0	.	Necessary	for	endothelial	cell	focal	adhesions	and	anti-angiogenic	activities.
chr3	186440276	186442944	P01042	0	+	186440276	186442944	255,102,0	1	2668	0	.	O-glycosylated	at	one	site	only.
chr3	186792105	186792114	P15907	0	+	186792105	186792114	255,102,0	1	9	0	.	Substrate	binding.
chr3	186971013	187003792	P48740	0	-	186971013	187003792	255,102,0	1	32779	0	.	Interaction	with	FCN2.
chr3	186974643	187003792	P48740	0	-	186974643	187003792	255,102,0	1	29149	0	.	Homodimerization.
chr3	186974643	187003792	P48740	0	-	186974643	187003792	255,102,0	1	29149	0	.	Interaction	with	MBL2.
chr3	187447055	187447067	P41182	0	-	187447055	187447067	255,102,0	1	12	0	.	Required	for	interaction	with	NuRD	complex	and	for	transcriptional	repressor	activity.
chr3	189349304	189456560	Q9H3D4	0	+	189349304	189456560	255,102,0	1	107256	0	.	Transcription	activation.
chr3	189586429	189587147	Q9H3D4	0	+	189586429	189587147	255,102,0	1	718	0	.	Interaction	with	HIPK2.	Pubmed:11925430
chr3	189587162	189590764	Q9H3D4	0	+	189587162	189590764	255,102,0	1	3602	0	.	Oligomerization.
chr3	189612075	189612288	Q9H3D4	0	+	189612075	189612288	255,102,0	1	213	0	.	Transactivation	inhibition.
chr3	190026068	190026074	O95832	0	-	190026068	190026074	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2,	TJP3	and	PATJ.
chr3	194790827	194790839	Q8NBI6	0	-	194790827	194790839	255,102,0	1	12	0	.	Interaction	with	target	proteins.
chr3	194991469	194991478	Q8NBI6	0	-	194991469	194991478	255,102,0	1	9	0	.	UDP-alpha-D-xylose	binding.
chr3	195245935	195245947	P41236	0	-	195245935	195245947	255,102,0	1	12	0	.	Required	for	binding	PPP1CC	catalytic	center,	displacing	metal	ions	and	inhibition	of	PPP1CC	catyltic	activity.
chr3	195256659	195256698	P41236	0	-	195256659	195256698	255,102,0	1	39	0	.	Required	for	binding	PPP1CC.
chr3	195269797	195269815	P41236	0	-	195269797	195269815	255,102,0	1	18	0	.	Required	for	binding	PPP1CC.
chr3	195451990	195452674	Q8N307	0	+	195451990	195452674	255,102,0	1	684	0	.	12	X	20	AA	approximate	tandem	repeats	of	S-S-E-S-S-A-S-S-D-S-P-H-P-V-I-T-P-S-R-A.
chr3	195452821	195453442	Q8N307	0	+	195452821	195453442	255,102,0	1	621	0	.	Involved	in	oligomerization.
chr3	195456517	195460086	Q8N307	0	+	195456517	195460086	255,102,0	1	3569	0	.	Interaction	with	MET.	Pubmed:15314156
chr3	195594495	195594927	Q07912	0	-	195594495	195594927	255,102,0	1	432	0	.	EBD	domain.
chr3	195595167	195595257	Q07912	0	-	195595167	195595257	255,102,0	1	90	0	.	Required	for	interaction	with	SRC.	Pubmed:21309750
chr3	195595218	195595230	Q07912	0	-	195595218	195595230	255,102,0	1	12	0	.	Required	for	interaction	with	NEDD4.
chr3	195611808	195615459	Q07912	0	-	195611808	195615459	255,102,0	1	3651	0	.	SAM-like	domain.
chr3	195778815	195782145	P02786	0	-	195778815	195782145	255,102,0	1	3330	0	.	Ligand-binding.
chr3	195802066	195803970	P02786	0	-	195802066	195803970	255,102,0	1	1904	0	.	Mediates	interaction	with	SH3BP4.	Pubmed:16325581
chr3	195965618	195965708	P49585	0	-	195965618	195965708	255,102,0	1	90	0	.	3	X	repeats.
chr3	195966450	195966549	P49585	0	-	195966450	195966549	255,102,0	1	99	0	.	3	X	11	AA	approximate	tandem	repeats.
chr3	195966453	195968845	P49585	0	-	195966453	195968845	255,102,0	1	2392	0	.	Amphipathic.
chr3	196528814	196529935	Q13177	0	+	196528814	196529935	255,102,0	1	1121	0	.	GTPase-binding.
chr3	196528814	196530010	Q13177	0	+	196528814	196530010	255,102,0	1	1196	0	.	Autoregulatory	region.
chr3	196626873	196657698	Q96HI0	0	+	196626873	196657698	255,102,0	1	30825	0	.	Protease.
chr3	196663950	196664383	P52298	0	-	196663950	196664383	255,102,0	1	433	0	.	mRNA	cap-binding.
chr3	196664398	196664413	P52298	0	-	196664398	196664413	255,102,0	1	15	0	.	mRNA	cap-binding.
chr3	196664431	196664446	P52298	0	-	196664431	196664446	255,102,0	1	15	0	.	mRNA	cap-binding.
chr3	196754740	196754773	P08582	0	-	196754740	196754773	255,102,0	1	33	0	.	Antigenic	epitope.
chr3	196876613	196888609	Q12959	0	-	196876613	196888609	255,102,0	1	11996	0	.	Interaction	with	SH3	domains.
chr3	197401891	197408736	Q92622	0	-	197401891	197408736	255,102,0	1	6845	0	.	Interaction	with	Rab7.	Pubmed:20943950
chr3	197408149	197409453	Q92622	0	-	197408149	197409453	255,102,0	1	1304	0	.	Interaction	with	CARD9.	Pubmed:22423967
chr3	197410282	197420673	Q92622	0	-	197410282	197420673	255,102,0	1	10391	0	.	Interaction	with	CYBA.	Pubmed:22423966
chr3	197411074	197427847	Q92622	0	-	197411074	197427847	255,102,0	1	16773	0	.	Interaction	with	UVRAG.	Pubmed:21062745
chr3	197421258	197421417	Q92622	0	-	197421258	197421417	255,102,0	1	159	0	.	Interaction	with	BECN1.	Pubmed:22423966
chr3	197423840	197428696	Q92622	0	-	197423840	197428696	255,102,0	1	4856	0	.	Interaction	with	YWHAB.	Pubmed:22423967
chr3	197430448	197444922	Q92622	0	-	197430448	197444922	255,102,0	1	14474	0	.	Interaction	with	PIK3C3.	Pubmed:19270696,	Pubmed:21062745
chr4	780483	786286	O14810	0	-	780483	786286	255,102,0	1	5803	0	.	Interaction	with	the	SNARE	complex.
chr4	995889	995895	P35475	0	+	995889	995895	255,102,0	1	6	0	.	Substrate	binding.
chr4	1206759	1208162	Q13363	0	-	1206759	1208162	255,102,0	1	1403	0	.	Interaction	with	GLIS2	2.
chr4	1222116	1242743	Q13363	0	-	1222116	1242743	255,102,0	1	20627	0	.	Interaction	with	GLIS2	1.
chr4	1283701	1309304	Q7L5Y9	0	+	1283701	1309304	255,102,0	1	25603	0	.	Extracellular	and	involved	in	cell	to	cell	contact.
chr4	1341882	1345508	Q2YD98	0	+	1341882	1345508	255,102,0	1	3626	0	.	VHS-like.
chr4	1389397	1389637	Q8N1N5	0	+	1389397	1389637	255,102,0	1	240	0	.	Interaction	with	PAK1.	Pubmed:16278681
chr4	1697963	1701385	Q14493	0	-	1697963	1701385	255,102,0	1	3422	0	.	RNA-binding.
chr4	1733000	1737544	Q9Y6A5	0	+	1733000	1737544	255,102,0	1	4544	0	.	Necessary	but	not	sufficient	for	spindle	localization.	Pubmed:23918938
chr4	1738998	1746737	Q9Y6A5	0	+	1738998	1746737	255,102,0	1	7739	0	.	Necessary	but	not	sufficient	for	spindle	localization.	Pubmed:23918938
chr4	2263546	2263692	Q14582	0	-	2263546	2263692	255,102,0	1	146	0	.	Interaction	with	SIN3A	and	SIN3B.
chr4	2492220	2498772	P78317	0	+	2492220	2498772	255,102,0	1	6552	0	.	Required	for	ubiquitination	activity.
chr4	2498733	2502444	P78317	0	+	2498733	2502444	255,102,0	1	3711	0	.	Mediates	interaction	with	TRPS1.
chr4	2744232	2746465	Q8NFZ5	0	-	2744232	2746465	255,102,0	1	2233	0	.	Ubiquitin-binding	domain	(UBD).
chr4	2930184	2930238	P35611	0	+	2930184	2930238	255,102,0	1	54	0	.	Interaction	with	calmodulin.
chr4	2965797	3009481	P32298	0	+	2965797	3009481	255,102,0	1	43684	0	.	N-terminal.
chr4	3076558	3076591	P42858	0	+	3076558	3076591	255,102,0	1	33	0	.	Sufficient	for	interaction	with	TPR.	Pubmed:15654337
chr4	3514715	3519803	P30533	0	-	3514715	3519803	255,102,0	1	5088	0	.	LDL	receptor	binding.
chr4	6055704	6083344	Q96N16	0	-	6055704	6083344	255,102,0	1	27640	0	.	Mediates	interaction	with	TYK2	and	GABBR1.	Pubmed:14718537,	Pubmed:15277531
chr4	6083341	6114577	Q96N16	0	-	6083341	6114577	255,102,0	1	31236	0	.	Mediates	association	with	microtubules.
chr4	7774636	7776496	Q8N556	0	-	7774636	7776496	255,102,0	1	1860	0	.	Interaction	with	F-actin.
chr4	8288324	8295897	P83110	0	+	8288324	8295897	255,102,0	1	7573	0	.	Serine	protease.
chr4	9922011	9922032	Q9NRM0	0	-	9922011	9922032	255,102,0	1	21	0	.	Monosaccharide	binding.
chr4	10542179	10542188	Q7Z7G1	0	-	10542179	10542188	255,102,0	1	9	0	.	Mediates	interaction	with	LAT	and	GRB2.
chr4	10543644	10543662	Q7Z7G1	0	-	10543644	10543662	255,102,0	1	18	0	.	Mediates	interaction	with	PLCG1.
chr4	15640236	15656910	Q9UKA1	0	-	15640236	15656910	255,102,0	1	16674	0	.	Hemerythrin-like.
chr4	15937553	15937679	Q14512	0	-	15937553	15937679	255,102,0	1	126	0	.	Sufficient	for	interaction	with	FGF2	and	FGF2-induced	effects.
chr4	16504379	16504496	O43679	0	-	16504379	16504496	255,102,0	1	117	0	.	LIM-binding	domain	(LID).
chr4	20731707	20731749	Q6PIL6	0	-	20731707	20731749	255,102,0	1	42	0	.	Interaction	with	KCND2.
chr4	20884261	21950251	Q6PIL6	0	-	20884261	21950251	255,102,0	1	1065990	0	.	KIS.
chr4	23797447	23816058	Q9UBK2	0	-	23797447	23816058	255,102,0	1	18611	0	.	Mediates	interaction	with	RNF34.	Pubmed:22064484
chr4	23816088	23816229	Q9UBK2	0	-	23816088	23816229	255,102,0	1	141	0	.	Interaction	with	PPARG.
chr4	25125579	25125639	Q9HD40	0	-	25125579	25125639	255,102,0	1	60	0	.	SLA/LP	epitope.	Pubmed:11826415
chr4	25158547	25158580	Q9HD40	0	-	25158547	25158580	255,102,0	1	33	0	.	Phosphate	loop	(P-loop).	Pubmed:19608919
chr4	25160711	25161991	Q9HD40	0	-	25160711	25161991	255,102,0	1	1280	0	.	Tetramerization.	Pubmed:19608919
chr4	25256719	25256728	Q8TCG2	0	+	25256719	25256728	255,102,0	1	9	0	.	Important	for	substrate	binding.
chr4	25256743	25256785	Q8TCG2	0	+	25256743	25256785	255,102,0	1	42	0	.	Important	for	interaction	with	membranes.
chr4	25260691	25260718	Q8TCG2	0	+	25260691	25260718	255,102,0	1	27	0	.	Important	for	interaction	with	membranes.
chr4	25265461	25270084	Q8TCG2	0	+	25265461	25270084	255,102,0	1	4623	0	.	Important	for	interaction	with	membranes.
chr4	37841520	37841526	Q96G03	0	+	37841520	37841526	255,102,0	1	6	0	.	Substrate	binding.
chr4	37847319	37847325	Q96G03	0	+	37847319	37847325	255,102,0	1	6	0	.	Substrate	binding.
chr4	37848903	37848912	Q96G03	0	+	37848903	37848912	255,102,0	1	9	0	.	Substrate	binding.
chr4	38682246	38690370	P57682	0	+	38682246	38690370	255,102,0	1	8124	0	.	Repressor	domain.
chr4	38799504	38799516	Q15399	0	-	38799504	38799516	255,102,0	1	12	0	.	Interaction	with	bacterial	lipopeptide.
chr4	39408797	39439534	Q86Z14	0	+	39408797	39439534	255,102,0	1	30737	0	.	Glycosyl	hydrolase-1	1.
chr4	39439558	39450072	Q86Z14	0	+	39439558	39450072	255,102,0	1	10514	0	.	Glycosyl	hydrolase-1	2.
chr4	39507257	39507263	O60701	0	-	39507257	39507263	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:21502315
chr4	39510272	39511392	O60701	0	-	39510272	39511392	255,102,0	1	1120	0	.	Substrate	binding.	Pubmed:21502315
chr4	39511518	39511978	O60701	0	-	39511518	39511978	255,102,0	1	460	0	.	Substrate	binding.	Pubmed:21502315
chr4	39512140	39512155	O60701	0	-	39512140	39512155	255,102,0	1	15	0	.	Substrate	binding.	Pubmed:21502315
chr4	40245222	40245264	Q15669	0	+	40245222	40245264	255,102,0	1	42	0	.	Interaction	with	ZAP70.
chr4	41259005	41259023	P09936	0	+	41259005	41259023	255,102,0	1	18	0	.	Interaction	with	ubiquitin.	Pubmed:20439756
chr4	41270048	41270066	P09936	0	+	41270048	41270066	255,102,0	1	18	0	.	Interaction	with	ubiquitin.	Pubmed:20439756
chr4	47163382	47163391	P18505	0	+	47163382	47163391	255,102,0	1	9	0	.	Agonist	binding.
chr4	47322219	47405336	P18505	0	+	47322219	47405336	255,102,0	1	83117	0	.	Agonist	binding.
chr4	47408730	47408796	P18505	0	+	47408730	47408796	255,102,0	1	66	0	.	Allosteric	effector	binding.
chr4	49046817	49052726	Q9H720	0	+	49046817	49052726	255,102,0	1	5909	0	.	Required	for	function	in	lipid	remodeling.
chr4	53728758	53731963	Q9BPW5	0	+	53728758	53731963	255,102,0	1	3205	0	.	Small	GTPase-like.
chr4	54244005	54250044	Q6UN15	0	+	54244005	54250044	255,102,0	1	6039	0	.	Sufficient	for	interaction	with	PAPOLA.
chr4	54244005	54294244	Q6UN15	0	+	54244005	54294244	255,102,0	1	50239	0	.	Necessary	for	stimulating	PAPOLA	activity.
chr4	54256698	54265920	Q6UN15	0	+	54256698	54265920	255,102,0	1	9222	0	.	Sufficient	for	interaction	with	CPSF4.	Pubmed:14749727
chr4	54319127	54325613	Q6UN15	0	+	54319127	54325613	255,102,0	1	6486	0	.	Sufficient	for	interaction	with	CPSF1	and	CSTF3.	Pubmed:14749727
chr4	54373526	54374219	Q8TBB1	0	-	54373526	54374219	255,102,0	1	693	0	.	Interaction	with	MAGEB18.	Pubmed:20864041
chr4	55593635	55593644	P10721	0	+	55593635	55593644	255,102,0	1	9	0	.	Important	for	interaction	with	phosphotyrosine-binding	proteins.
chr4	56301587	56319863	O15516	0	-	56301587	56319863	255,102,0	1	18276	0	.	Interaction	with	NR3C1.
chr4	56310045	56315664	O15516	0	-	56310045	56315664	255,102,0	1	5619	0	.	Interaction	with	SIRT1.
chr4	56310799	56310952	O15516	0	-	56310799	56310952	255,102,0	1	153	0	.	Implicated	in	the	circadian	rhythmicity.
chr4	56422726	56435982	Q8N4E4	0	-	56422726	56435982	255,102,0	1	13256	0	.	Thioredoxin	fold.
chr4	57302481	57318046	P22234	0	+	57302481	57318046	255,102,0	1	15565	0	.	SAICAR	synthetase.
chr4	57318046	57318064	P22234	0	+	57318046	57318064	255,102,0	1	18	0	.	Linker.
chr4	57318064	57325701	P22234	0	+	57318064	57325701	255,102,0	1	7637	0	.	AIR	carboxylase.
chr4	57776897	57777170	Q13127	0	+	57776897	57777170	255,102,0	1	273	0	.	Interaction	with	SIN3A.	Pubmed:10734093
chr4	57776930	57776975	Q13127	0	+	57776930	57776975	255,102,0	1	45	0	.	Interaction	with	SIN3B.	Pubmed:16288918
chr4	57777236	57796278	Q13127	0	+	57777236	57796278	255,102,0	1	19042	0	.	Interaction	with	ZFP90.	Pubmed:21284946
chr4	57798048	57798285	Q13127	0	+	57798048	57798285	255,102,0	1	237	0	.	Interaction	with	RCOR1.
chr4	68338325	68355687	Q03188	0	-	68338325	68355687	255,102,0	1	17362	0	.	MIF2	homology	domain	III.
chr4	68359614	68359683	Q03188	0	-	68359614	68359683	255,102,0	1	69	0	.	MIF2	homology	domain	II.
chr4	69197853	69197862	Q96MU7	0	-	69197853	69197862	255,102,0	1	9	0	.	N6-methyladenosine	binding.
chr4	70615486	70615495	O43704	0	-	70615486	70615495	255,102,0	1	9	0	.	Substrate	binding.
chr4	70719982	70719991	P49888	0	-	70719982	70719991	255,102,0	1	9	0	.	Substrate	binding.
chr4	70865389	70865499	P02808	0	+	70865389	70865499	255,102,0	1	110	0	.	Hydroxyapatite-binding;	inhibits	crystal	growth.
chr4	70866588	70866663	P02808	0	+	70866588	70866663	255,102,0	1	75	0	.	Hydrophobic;	inhibits	precipitation	of	calcium	phosphate	salts.
chr4	71064298	71064307	A1E959	0	+	71064298	71064307	255,102,0	1	9	0	.	Interaction	with	ARHGEF5.	Pubmed:25911094
chr4	71099868	71099895	Q8NFU4	0	+	71099868	71099895	255,102,0	1	27	0	.	O-glycosylated	at	one	site.
chr4	72102293	72121049	Q9Y6R1	0	+	72102293	72121049	255,102,0	1	18756	0	.	Required	for	interaction	with	AHCYL1.	Pubmed:16769890
chr4	72397853	72400000	Q9Y6R1	0	+	72397853	72400000	255,102,0	1	2147	0	.	Interaction	with	CA4.
chr4	72425875	72425884	Q9Y6R1	0	+	72425875	72425884	255,102,0	1	9	0	.	CA2-binding.
chr4	72425959	72425971	Q9Y6R1	0	+	72425959	72425971	255,102,0	1	12	0	.	CA2-binding.
chr4	72429578	72429587	Q9Y6R1	0	+	72429578	72429587	255,102,0	1	9	0	.	Required	for	basolateral	targeting.
chr4	73164051	73175156	O15072	0	-	73164051	73175156	255,102,0	1	11105	0	.	Spacer.
chr4	74719806	74719827	P10720	0	+	74719806	74719827	255,102,0	1	21	0	.	Heparin-binding.
chr4	74846932	74846953	P02776	0	-	74846932	74846953	255,102,0	1	21	0	.	Heparin-binding.
chr4	76793206	76811145	O14830	0	-	76793206	76811145	255,102,0	1	17939	0	.	Catalytic.
chr4	77021442	77022171	Q13508	0	+	77021442	77022171	255,102,0	1	729	0	.	3	X	10	AA	tandem	repeats	of	[GS]-E-K-N-[QW]-K-L-E-D-H.
chr4	77038876	77069515	Q7Z3B4	0	-	77038876	77069515	255,102,0	1	30639	0	.	9	X	2	AA	repeats	of	F-G.
chr4	77100708	77100819	Q14108	0	-	77100708	77100819	255,102,0	1	111	0	.	Important	for	interaction	with	GBA.
chr4	78641587	78678034	Q96LI5	0	-	78641587	78678034	255,102,0	1	36447	0	.	Nuclease	domain.
chr4	78678049	78740391	Q96LI5	0	-	78678049	78740391	255,102,0	1	62342	0	.	Required	for	interaction	with	CNOT1,	CNOT3	and	CNOT7.	Pubmed:17452450
chr4	79841719	79841734	Q6TCH7	0	-	79841719	79841734	255,102,0	1	15	0	.	Golgi	targeting.
chr4	79856409	79860198	Q6TCH7	0	-	79856409	79860198	255,102,0	1	3789	0	.	Golgi	targeting.
chr4	80238598	80238772	Q9BSU3	0	-	80238598	80238772	255,102,0	1	174	0	.	Interaction	with	NAA15.
chr4	82065390	82088371	Q13237	0	-	82065390	82088371	255,102,0	1	22981	0	.	cGMP-binding,	high	affinity;	cAMP-binding,	low	affinity.	Pubmed:26769964
chr4	82090815	82096073	Q13237	0	-	82090815	82096073	255,102,0	1	5258	0	.	cGMP-binding,	high	affinity;	cAMP-binding,	moderate	affinity.	Pubmed:26769964
chr4	83347214	83347622	O14979	0	-	83347214	83347622	255,102,0	1	408	0	.	Necessary	for	its	nuclear	import	and	export.
chr4	83347214	83347784	O14979	0	-	83347214	83347784	255,102,0	1	570	0	.	Necessary	for	interaction	with	TNPO1.	Pubmed:9524220
chr4	83375941	83375947	Q9UHY7	0	+	83375941	83375947	255,102,0	1	6	0	.	Substrate	binding.
chr4	83745779	83770061	O94979	0	-	83745779	83770061	255,102,0	1	24282	0	.	Interaction	with	PDCD6.
chr4	83785535	83796897	O94979	0	-	83785535	83796897	255,102,0	1	11362	0	.	Interaction	with	SEC13.	Pubmed:16957052
chr4	84194758	84200157	E2QRG7	0	-	84194758	84200157	255,102,0	1	5399	0	.	Allylic	polyprenyl	diphosphate-binding	site.
chr4	84216499	84216550	Q9Y251	0	-	84216499	84216550	255,102,0	1	51	0	.	Required	for	transferring	proheparanase	to	the	Golgi	apparatus,	secretion	and	subsequent	enzyme	activity	and	for	enhancement	of	PKB/AKT1	phosphorylation.
chr4	84231876	84231909	Q9Y251	0	-	84231876	84231909	255,102,0	1	33	0	.	Heparin/HS-binding.
chr4	84240509	84240524	Q9Y251	0	-	84240509	84240524	255,102,0	1	15	0	.	Heparin/HS-binding.
chr4	84391468	84406195	Q6UWZ7	0	-	84391468	84406195	255,102,0	1	14727	0	.	MPN-like.
chr4	85414444	85414630	P78426	0	-	85414444	85414630	255,102,0	1	186	0	.	Involved	in	DNA-binding.
chr4	85416863	85419078	P78426	0	-	85416863	85419078	255,102,0	1	2215	0	.	Repressor	domain.
chr4	85594023	85614146	Q8IZQ1	0	-	85594023	85614146	255,102,0	1	20123	0	.	Interaction	with	ATG5.	Pubmed:20417604
chr4	85594023	85638168	Q8IZQ1	0	-	85594023	85638168	255,102,0	1	44145	0	.	Interaction	with	SQSTM1.
chr4	85614143	85657385	Q8IZQ1	0	-	85614143	85657385	255,102,0	1	43242	0	.	Sufficient	for	translocalization	to	p62	bodies/ALIS.
chr4	87731059	87731080	Q12923	0	+	87731059	87731080	255,102,0	1	21	0	.	Substrate.
chr4	87731059	87731080	Q12923	0	+	87731059	87731080	255,102,0	1	21	0	.	Substrate	binding.
chr4	88416231	88416261	Q14515	0	-	88416231	88416261	255,102,0	1	30	0	.	O-glycosylated	at	one	additional	site.
chr4	88983147	88989073	Q13563	0	+	88983147	88989073	255,102,0	1	5926	0	.	EF-hand	domain.
chr4	88989097	88989157	Q13563	0	+	88989097	88989157	255,102,0	1	60	0	.	Linker.
chr4	88989172	88996843	Q13563	0	+	88989172	88996843	255,102,0	1	7671	0	.	C-terminal	coiled	coil	domain.
chr4	90743501	90756761	P37840	0	-	90743501	90756761	255,102,0	1	13260	0	.	4	X	11	AA	tandem	repeats	of	[EGS]-K-T-K-[EQ]-[GQ]-V-X(4).
chr4	94693385	94693598	O43424	0	+	94693385	94693598	255,102,0	1	213	0	.	Interaction	with	AP4M1.
chr4	95239057	95239063	O60760	0	-	95239057	95239063	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:16547010,	Pubmed:18341273
chr4	95239096	95239105	O60760	0	-	95239096	95239105	255,102,0	1	9	0	.	Glutathione	binding.	Pubmed:16547010,	Pubmed:18341273
chr4	96123881	96123938	O95185	0	-	96123881	96123938	255,102,0	1	57	0	.	Interaction	with	DCC.
chr4	99802211	99802220	P06730	0	-	99802211	99802220	255,102,0	1	9	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr4	99806125	99806143	P06730	0	-	99806125	99806143	255,102,0	1	18	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr4	99806194	99808235	P06730	0	-	99806194	99808235	255,102,0	1	2041	0	.	EIF4EBP1/2/3	binding.
chr4	99808319	99808325	P06730	0	-	99808319	99808325	255,102,0	1	6	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr4	99809093	99812392	P06730	0	-	99809093	99812392	255,102,0	1	3299	0	.	EIF4EBP1/2/3	binding.
chr4	99812437	99812443	P06730	0	-	99812437	99812443	255,102,0	1	6	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr4	99823031	99823043	P06730	0	-	99823031	99823043	255,102,0	1	12	0	.	EIF4EBP1/2/3	binding.
chr4	99916928	99950059	P53582	0	+	99916928	99950059	255,102,0	1	33131	0	.	Zinc	finger-like;	important	for	proper	ribosome	association.
chr4	100806725	100806767	Q9UHA4	0	-	100806725	100806767	255,102,0	1	42	0	.	Required	for	interaction	with	LAMTOR2.
chr4	100869983	100870016	P0C0S5	0	-	100869983	100870016	255,102,0	1	33	0	.	Required	for	interaction	with	INCENP.
chr4	100869992	100870028	P0C0S5	0	-	100869992	100870028	255,102,0	1	36	0	.	M6	cassette.
chr4	100870849	100870897	P0C0S5	0	-	100870849	100870897	255,102,0	1	48	0	.	Required	for	interaction	with	INCENP.
chr4	101947126	101947195	Q08209	0	-	101947126	101947195	255,102,0	1	69	0	.	Inhibitory	domain.
chr4	101961637	101961706	Q08209	0	-	101961637	101961706	255,102,0	1	69	0	.	Calmodulin-binding.
chr4	102001740	102001758	Q08209	0	-	102001740	102001758	255,102,0	1	18	0	.	Calcineurin	B	binding-site	2.
chr4	102001740	102267950	Q08209	0	-	102001740	102267950	255,102,0	1	266210	0	.	Catalytic.
chr4	102014955	102014976	Q08209	0	-	102014955	102014976	255,102,0	1	21	0	.	Calcineurin	B	binding-site	1.
chr4	102712037	102751356	Q8NDB2	0	+	102712037	102751356	255,102,0	1	39319	0	.	Interaction	with	ITPR2.	Pubmed:11782428
chr4	103514631	103514700	P19838	0	+	103514631	103514700	255,102,0	1	69	0	.	GRR.
chr4	103517299	103537748	P19838	0	+	103517299	103537748	255,102,0	1	20449	0	.	Interaction	with	CFLAR.	Pubmed:13679070
chr4	103527850	103528407	P19838	0	+	103527850	103528407	255,102,0	1	557	0	.	Essential	for	interaction	with	HIF1AN.	Pubmed:17003112
chr4	104027390	104035624	Q02224	0	-	104027390	104035624	255,102,0	1	8234	0	.	Globular	autoinhibitory	domain.
chr4	104037747	104057444	Q02224	0	-	104037747	104057444	255,102,0	1	19697	0	.	Kinetochore-binding	domain.
chr4	106180839	106180881	Q6N021	0	+	106180839	106180881	255,102,0	1	42	0	.	Interaction	with	DNA.
chr4	106197352	106197361	Q6N021	0	+	106197352	106197361	255,102,0	1	9	0	.	2-oxoglutarate	binding.
chr4	106197370	106197379	Q6N021	0	+	106197370	106197379	255,102,0	1	9	0	.	Substrate	binding.
chr4	107246181	107248636	Q12904	0	+	107246181	107248636	255,102,0	1	2455	0	.	Required	for	fibroblast	proliferation.
chr4	107248657	107253019	Q12904	0	+	107248657	107253019	255,102,0	1	4362	0	.	Interaction	with	HSP90B1.
chr4	107249309	107249351	Q12904	0	+	107249309	107249351	255,102,0	1	42	0	.	Required	for	endothelial	cell	death.
chr4	107249348	107253013	Q12904	0	+	107249348	107253013	255,102,0	1	3665	0	.	Required	for	endothelial	cell	migration.
chr4	107845122	107845344	Q9UBU2	0	-	107845122	107845344	255,102,0	1	222	0	.	DKK-type	Cys-2.
chr4	107845849	107847097	Q9UBU2	0	-	107845849	107847097	255,102,0	1	1248	0	.	DKK-type	Cys-1.
chr4	108535407	108581198	O43252	0	-	108535407	108581198	255,102,0	1	45791	0	.	Sulfate	adenylyltransferase.	Pubmed:15755455
chr4	108581222	108641335	O43252	0	-	108581222	108641335	255,102,0	1	60113	0	.	Adenylyl-sulfate	kinase.	Pubmed:17276460,	Pubmed:15755455,	Pubmed:17540769
chr4	108603284	108603290	O43252	0	-	108603284	108603290	255,102,0	1	6	0	.	Adenylyl	sulfate	binding.	Pubmed:17276460,	Pubmed:17540769
chr4	108614938	108614944	O43252	0	-	108614938	108614944	255,102,0	1	6	0	.	Adenylyl	sulfate	binding.	Pubmed:17276460,	Pubmed:17540769
chr4	108615010	108615022	O43252	0	-	108615010	108615022	255,102,0	1	12	0	.	Adenylyl	sulfate	binding.	Pubmed:17276460,	Pubmed:17540769
chr4	108615061	108615073	O43252	0	-	108615061	108615073	255,102,0	1	12	0	.	Adenylyl	sulfate	binding.	Pubmed:17276460
chr4	109088737	109088923	Q9UJU2	0	-	109088737	109088923	255,102,0	1	186	0	.	CTNNB1-binding.
chr4	109862521	109862545	Q9BXS0	0	-	109862521	109862545	255,102,0	1	24	0	.	Interaction	with	beta	amyloid	peptide.	Pubmed:15522881
chr4	110433148	110433223	O95487	0	+	110433148	110433223	255,102,0	1	75	0	.	Zinc	finger-like.
chr4	110737329	110737491	Q9NY12	0	+	110737329	110737491	255,102,0	1	162	0	.	RGG-box	1.
chr4	110743577	110745584	Q9NY12	0	+	110743577	110745584	255,102,0	1	2007	0	.	RGG-box	2.
chr4	110904606	110904627	P01133	0	+	110904606	110904627	255,102,0	1	21	0	.	O-glycosylated	at	one	site.
chr4	111430837	111430852	Q07075	0	+	111430837	111430852	255,102,0	1	15	0	.	Substrate	binding.
chr4	113181967	113186197	Q63HQ0	0	+	113181967	113186197	255,102,0	1	4230	0	.	Interaction	with	AP1G1.
chr4	113187823	113189301	Q63HQ0	0	+	113187823	113189301	255,102,0	1	1478	0	.	Sufficient	for	association	with	the	Arp2/3	complex.
chr4	114239771	114254360	Q01484	0	+	114239771	114254360	255,102,0	1	14589	0	.	Interaction	with	SPTBN1.	Pubmed:15262991
chr4	114260449	114267076	Q01484	0	+	114260449	114267076	255,102,0	1	6627	0	.	UPA	domain.
chr4	114275189	114275723	Q01484	0	+	114275189	114275723	255,102,0	1	534	0	.	Repeat-rich	region.
chr4	114434985	114435018	Q13557	0	-	114434985	114435018	255,102,0	1	33	0	.	Calmodulin-binding.
chr4	114435012	114435042	Q13557	0	-	114435012	114435042	255,102,0	1	30	0	.	Autoinhibitory	domain.
chr4	115748974	115773932	Q9H3R1	0	-	115748974	115773932	255,102,0	1	24958	0	.	Heparan	sulfate	N-sulfotransferase	4.
chr4	115773932	115998087	Q9H3R1	0	-	115773932	115998087	255,102,0	1	224155	0	.	Heparan	sulfate	N-deacetylase	4.
chr4	118975170	119148085	O95803	0	+	118975170	119148085	255,102,0	1	172915	0	.	Heparan	sulfate	N-deacetylase	3.
chr4	119148085	119176864	O95803	0	+	119148085	119176864	255,102,0	1	28779	0	.	Heparan	sulfate	N-sulfotransferase	3.
chr4	119216958	119216994	P56730	0	-	119216958	119216994	255,102,0	1	36	0	.	Zymogen	activation	region.
chr4	119613213	119613219	Q9HCE5	0	+	119613213	119613219	255,102,0	1	6	0	.	Interaction	with	METTL3.	Pubmed:27281194,	Pubmed:24275569
chr4	119621767	119621773	Q9HCE5	0	+	119621767	119621773	255,102,0	1	6	0	.	Interaction	with	METTL3.	Pubmed:27281194,	Pubmed:24275569
chr4	119621791	119625113	Q9HCE5	0	+	119621791	119625113	255,102,0	1	3322	0	.	Positively	charged	region	required	for	RNA-binding.	Pubmed:27281194
chr4	119625113	119625125	Q9HCE5	0	+	119625113	119625125	255,102,0	1	12	0	.	Interaction	with	METTL3.	Pubmed:27281194,	Pubmed:24275569
chr4	119625182	119626771	Q9HCE5	0	+	119625182	119626771	255,102,0	1	1589	0	.	Interaction	with	METTL3.	Pubmed:27281194,	Pubmed:24275569
chr4	119626798	119626804	Q9HCE5	0	+	119626798	119626804	255,102,0	1	6	0	.	Positively	charged	region	required	for	RNA-binding.	Pubmed:27281194
chr4	119626831	119626846	Q9HCE5	0	+	119626831	119626846	255,102,0	1	15	0	.	Interaction	with	METTL3.	Pubmed:27281194,	Pubmed:24275569
chr4	119689343	119689421	O94855	0	-	119689343	119689421	255,102,0	1	78	0	.	Zinc	finger-like.
chr4	120419824	120446721	O76074	0	-	120419824	120446721	255,102,0	1	26897	0	.	Catalytic.
chr4	120981275	120981308	Q13257	0	-	120981275	120981308	255,102,0	1	33	0	.	Required	for	assuming	the	closed	conformation	and	for	interaction	with	CDC20.
chr4	122063922	122071299	Q96KP6	0	-	122063922	122071299	255,102,0	1	7377	0	.	Ubiquitin-binding	domain	(UBD).
chr4	122722579	122732803	Q06265	0	+	122722579	122732803	255,102,0	1	10224	0	.	ARE	binding.
chr4	126412092	126412362	Q6V0I7	0	+	126412092	126412362	255,102,0	1	270	0	.	Necessary	and	sufficient	for	interaction	with	MPDZ.
chr4	138442185	138449695	Q9HCL0	0	-	138442185	138449695	255,102,0	1	7510	0	.	Interaction	with	DAB1.
chr4	139966358	139966391	Q9UK39	0	+	139966358	139966391	255,102,0	1	33	0	.	Interaction	with	PPARG.
chr4	140281740	140309235	Q9BXJ9	0	+	140281740	140309235	255,102,0	1	27495	0	.	Interaction	with	HYPK.	Pubmed:20154145
chr4	140439067	140439073	Q8WTS6	0	-	140439067	140439073	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr4	140439154	140439163	Q8WTS6	0	-	140439154	140439163	255,102,0	1	9	0	.	Substrate	binding.
chr4	140439184	140439193	Q8WTS6	0	-	140439184	140439193	255,102,0	1	9	0	.	Substrate	binding.
chr4	140441508	140441517	D6RJA0	0	-	140441508	140441517	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr4	140441508	140441517	Q8WTS6	0	-	140441508	140441517	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr4	141317071	141317295	O14967	0	-	141317071	141317295	255,102,0	1	224	0	.	Interaction	with	PPIB.
chr4	145628380	145629326	Q96QV1	0	+	145628380	145629326	255,102,0	1	946	0	.	Interaction	with	SHH	zinc	binding	site.
chr4	146083843	146083861	Q01804	0	-	146083843	146083861	255,102,0	1	18	0	.	His-loop.
chr4	146086331	146092836	Q01804	0	-	146086331	146092836	255,102,0	1	6505	0	.	Variable-loop.
chr4	146100990	146101011	Q01804	0	-	146100990	146101011	255,102,0	1	21	0	.	Cys-loop.
chr4	146475189	146478972	Q15797	0	+	146475189	146478972	255,102,0	1	3783	0	.	L3	loop.	Pubmed:11779505
chr4	152069241	152069292	Q5HYK7	0	-	152069241	152069292	255,102,0	1	51	0	.	Interaction	with	SH3GL1.	Pubmed:14551139
chr4	154517502	154524566	A2VDJ0	0	+	154517502	154524566	255,102,0	1	7064	0	.	Required	for	Wnt-signaling	inhibition	and	LRP6	degradation.	Pubmed:23690469
chr4	155486977	155486986	P02675	0	+	155486977	155486986	255,102,0	1	9	0	.	Beta-chain	polymerization,	binding	distal	domain	of	another	fibrin.
chr4	155510654	155510663	P02671	0	-	155510654	155510663	255,102,0	1	9	0	.	Alpha-chain	polymerization,	binding	distal	domain	of	another	fibrin	gamma	chain.
chr4	155526036	155526081	P02679	0	-	155526036	155526081	255,102,0	1	45	0	.	Platelet	aggregation	and	Staphylococcus	clumping.
chr4	155526081	155526150	P02679	0	-	155526081	155526150	255,102,0	1	69	0	.	Gamma-chain	polymerization,	binding	amino	end	of	another	fibrin	alpha	chain.
chr4	156826290	156826305	P48775	0	+	156826290	156826305	255,102,0	1	15	0	.	Substrate	binding.	Pubmed:27762317
chr4	158060088	158064966	P48167	0	+	158060088	158064966	255,102,0	1	4878	0	.	Strychnine-binding.
chr4	158257549	158257558	P42262	0	+	158257549	158257558	255,102,0	1	9	0	.	Glutamate	binding.
chr4	158262593	158262599	P42262	0	+	158262593	158262599	255,102,0	1	6	0	.	Glutamate	binding.
chr4	159630890	159636719	Q08752	0	-	159630890	159636719	255,102,0	1	5829	0	.	Interaction	with	HSP90AB1.
chr4	159636713	159636806	Q08752	0	-	159636713	159636806	255,102,0	1	93	0	.	Chaperone	activity.
chr4	159789417	159790521	Q9P278	0	+	159789417	159790521	255,102,0	1	1104	0	.	Interaction	with	PRKAA1.	Pubmed:18663353
chr4	164449932	164450106	Q8TCQ1	0	-	164449932	164450106	255,102,0	1	174	0	.	Responsible	for	down-regulation	of	CD86	and	MHC	class	II	cell	surface	expression.
chr4	164534509	164775283	Q8TCQ1	0	-	164534509	164775283	255,102,0	1	240774	0	.	Responsible	for	low	stability.
chr4	166915612	166946469	O43897	0	+	166915612	166946469	255,102,0	1	30857	0	.	Metalloprotease.
chr4	170038821	170043279	Q7Z6J0	0	-	170038821	170043279	255,102,0	1	4458	0	.	Interaction	with	AKT2.
chr4	170650731	170658823	Q9NWY4	0	-	170650731	170658823	255,102,0	1	8092	0	.	Interaction	with	PARP1.	Pubmed:27067600
chr4	173269701	173734695	Q49A17	0	+	173269701	173734695	255,102,0	1	464994	0	.	Catalytic	subdomain	A.
chr4	173734866	173852374	Q49A17	0	+	173734866	173852374	255,102,0	1	117508	0	.	Catalytic	subdomain	B.
chr4	174213286	174216980	Q86SF2	0	+	174213286	174216980	255,102,0	1	3694	0	.	Catalytic	subdomain	A.
chr4	174219440	174225209	Q86SF2	0	+	174219440	174225209	255,102,0	1	5769	0	.	Catalytic	subdomain	B.
chr4	174253320	174253368	P26583	0	-	174253320	174253368	255,102,0	1	48	0	.	Required	for	chemotactic	activity.	Pubmed:19811285
chr4	174292333	174294612	O75446	0	+	174292333	174294612	255,102,0	1	2279	0	.	Interaction	with	NCOR1.
chr4	174294612	174298475	O75446	0	+	174294612	174298475	255,102,0	1	3863	0	.	Interaction	with	SIN3A.
chr4	175598435	175603962	O75311	0	-	175598435	175603962	255,102,0	1	5527	0	.	Strychnine-binding.	Pubmed:26416729
chr4	175898890	175899133	Q9UKF5	0	+	175898890	175899133	255,102,0	1	243	0	.	9	X	9	AA	approximate	repeats.
chr4	177608399	177608648	P49767	0	-	177608399	177608648	255,102,0	1	249	0	.	4	X	16	AA	repeats	of	C-X(10)-C-X-C-X(1,3)-C.
chr4	178355561	178355573	P20933	0	-	178355561	178355573	255,102,0	1	12	0	.	Substrate	binding.
chr4	178355630	178355642	P20933	0	-	178355630	178355642	255,102,0	1	12	0	.	Substrate	binding.
chr4	184432051	184432102	Q9H160	0	+	184432051	184432102	255,102,0	1	51	0	.	PBR.	Pubmed:16728974
chr4	187208899	187208911	P03951	0	+	187208899	187208911	255,102,0	1	12	0	.	Heparin-binding.
chr5	434493	434946	A9YTQ3	0	+	434493	434946	255,102,0	1	453	0	.	Needed	for	transcriptional	repression.
chr5	476382	476780	P48764	0	-	476382	476780	255,102,0	1	398	0	.	Interaction	with	PDZD3.
chr5	666201	678175	O94811	0	-	666201	678175	255,102,0	1	11974	0	.	Mediates	interaction	with	LIMK1.	Pubmed:18028908
chr5	1009175	1034963	Q969F2	0	+	1009175	1034963	255,102,0	1	25788	0	.	Targeting	to	the	basolateral	cell	membrane.
chr5	1034355	1034978	Q969F2	0	+	1034355	1034978	255,102,0	1	623	0	.	Interaction	with	DVL1,	DVL2	and	DVL3.
chr5	1038029	1038287	Q969F2	0	+	1038029	1038287	255,102,0	1	258	0	.	Interaction	with	TGFA.
chr5	1253845	1264556	O14746	0	-	1253845	1264556	255,102,0	1	10711	0	.	CTE.
chr5	1264559	1264574	O14746	0	-	1264559	1264574	255,102,0	1	15	0	.	Primer	grip	sequence.
chr5	1264577	1264622	O14746	0	-	1264577	1264622	255,102,0	1	45	0	.	Required	for	oligomerization.
chr5	1282662	1294028	O14746	0	-	1282662	1294028	255,102,0	1	11366	0	.	RNA-interacting	domain	2.
chr5	1282698	1294100	O14746	0	-	1282698	1294100	255,102,0	1	11402	0	.	Required	for	oligomerization.
chr5	1293437	1293875	O14746	0	-	1293437	1293875	255,102,0	1	438	0	.	QFP	motif.
chr5	1293749	1293812	O14746	0	-	1293749	1293812	255,102,0	1	63	0	.	CP	motif.
chr5	1294028	1294310	O14746	0	-	1294028	1294310	255,102,0	1	282	0	.	Linker.
chr5	1294310	1295104	O14746	0	-	1294310	1295104	255,102,0	1	794	0	.	RNA-interacting	domain	1.
chr5	1294409	1294933	O14746	0	-	1294409	1294933	255,102,0	1	524	0	.	GQ	motif.
chr5	1294577	1294592	O14746	0	-	1294577	1294592	255,102,0	1	15	0	.	Required	for	regulating	specificity	for	telomeric	DNA	and	for	processivity	for	primer	elongation.
chr5	1401098	1403123	Q01959	0	-	1401098	1403123	255,102,0	1	2025	0	.	Interaction	with	TGFB1I1.	Pubmed:12177201
chr5	5239347	5242261	Q8TE57	0	+	5239347	5242261	255,102,0	1	2914	0	.	Spacer.
chr5	6622180	6622201	Q08J23	0	-	6622180	6622201	255,102,0	1	21	0	.	S-adenosyl-L-methionine	binding.
chr5	7802414	7802468	Q08462	0	+	7802414	7802468	255,102,0	1	54	0	.	Interaction	with	GNAS.
chr5	7817062	7817074	Q08462	0	+	7817062	7817074	255,102,0	1	12	0	.	Interaction	with	GNAS.
chr5	7878150	7878396	Q9UBK8	0	+	7878150	7878396	255,102,0	1	246	0	.	Hinge.
chr5	13717450	13721354	Q8TE73	0	-	13717450	13721354	255,102,0	1	3904	0	.	AAA	6.
chr5	13737424	13753515	Q8TE73	0	-	13737424	13753515	255,102,0	1	16091	0	.	AAA	5.
chr5	13754420	13770910	Q8TE73	0	-	13754420	13770910	255,102,0	1	16490	0	.	Stalk.
chr5	13770952	13786362	Q8TE73	0	-	13770952	13786362	255,102,0	1	15410	0	.	AAA	4.
chr5	13792141	13809257	Q8TE73	0	-	13792141	13809257	255,102,0	1	17116	0	.	AAA	3.
chr5	13811833	13823389	Q8TE73	0	-	13811833	13823389	255,102,0	1	11556	0	.	AAA	2.
chr5	13824394	13839523	Q8TE73	0	-	13824394	13839523	255,102,0	1	15129	0	.	AAA	1.
chr5	13839523	13944547	Q8TE73	0	-	13839523	13944547	255,102,0	1	105024	0	.	Stem.
chr5	14678842	14678848	Q96BN8	0	+	14678842	14678848	255,102,0	1	6	0	.	Linear	diubiquitin	binding.	Pubmed:23746843,	Pubmed:23708998
chr5	14681617	14681626	Q96BN8	0	+	14681617	14681626	255,102,0	1	9	0	.	Linear	diubiquitin	binding.	Pubmed:23746843,	Pubmed:23708998
chr5	14690315	14690330	Q96BN8	0	+	14690315	14690330	255,102,0	1	15	0	.	Linear	diubiquitin	binding.	Pubmed:23746843,	Pubmed:23708998
chr5	14690399	14692965	Q96BN8	0	+	14690399	14692965	255,102,0	1	2566	0	.	Linear	diubiquitin	binding.	Pubmed:23746843,	Pubmed:23708998
chr5	14693103	14693112	Q96BN8	0	+	14693103	14693112	255,102,0	1	9	0	.	Linear	diubiquitin	binding.	Pubmed:23746843,	Pubmed:23708998
chr5	16479067	16616831	Q9H6L5	0	-	16479067	16616831	255,102,0	1	137764	0	.	Reticulon	homology	domain.	Pubmed:26040720
chr5	16701704	16701857	Q9HD67	0	-	16701704	16701857	255,102,0	1	153	0	.	Mediates	antiparallel	dimerization.	Pubmed:23012428
chr5	16701779	16703101	Q9HD67	0	-	16701779	16703101	255,102,0	1	1322	0	.	SAH.
chr5	31401568	31515217	Q9NRR4	0	-	31401568	31515217	255,102,0	1	113649	0	.	Necessary	for	interaction	with	DGCR8	and	pri-miRNA	processing	activity.	Pubmed:26748718,	Pubmed:26027739
chr5	32126611	32126647	Q9H4A6	0	-	32126611	32126647	255,102,0	1	36	0	.	Beta-hairpin	required	for	oligomerization.
chr5	32233878	32235235	Q9C0I1	0	-	32233878	32235235	255,102,0	1	1357	0	.	Interaction	with	MTM1.	Pubmed:12847286
chr5	32588621	32591746	P53999	0	+	32588621	32591746	255,102,0	1	3125	0	.	Regulatory.
chr5	32599099	32599174	P53999	0	+	32599099	32599174	255,102,0	1	75	0	.	Interaction	with	ssDNA.
chr5	33576182	33577142	P58397	0	-	33576182	33577142	255,102,0	1	960	0	.	Spacer	2.
chr5	33614388	33624378	P58397	0	-	33614388	33624378	255,102,0	1	9990	0	.	Spacer	1.
chr5	38958597	39074479	Q6R327	0	-	38958597	39074479	255,102,0	1	115882	0	.	Interaction	with	NBN.	Pubmed:23762398
chr5	39139349	39202021	O15117	0	-	39139349	39202021	255,102,0	1	62672	0	.	Interaction	with	SKAP1.
chr5	39375123	39376944	P98082	0	-	39375123	39376944	255,102,0	1	1821	0	.	Required	for	interaction	with	MYO6.
chr5	39376149	39377079	P98082	0	-	39376149	39377079	255,102,0	1	930	0	.	Sufficient	for	interaction	with	GRB2.
chr5	39376170	39376764	P98082	0	-	39376170	39376764	255,102,0	1	594	0	.	Sufficient	for	interaction	with	SH3KBP1	SH3	domain.
chr5	39376875	39376902	P98082	0	-	39376875	39376902	255,102,0	1	27	0	.	Required	for	interaction	with	GRB2	and	CSK.
chr5	39377007	39377034	P98082	0	-	39377007	39377034	255,102,0	1	27	0	.	Required	for	interaction	with	CSK.
chr5	39382719	39383373	P98082	0	-	39382719	39383373	255,102,0	1	654	0	.	Required	for	localization	to	clathrin-coated	pits.
chr5	40765018	40765258	Q13131	0	-	40765018	40765258	255,102,0	1	240	0	.	AIS.
chr5	40959693	40964938	P10643	0	+	40959693	40964938	255,102,0	1	5245	0	.	CCP	1.
chr5	40964938	40976856	P10643	0	+	40964938	40976856	255,102,0	1	11918	0	.	CCP	2.
chr5	40976859	40979971	P10643	0	+	40976859	40979971	255,102,0	1	3112	0	.	Factor	I	module	(FIM)	1.
chr5	40979971	40981672	P10643	0	+	40979971	40981672	255,102,0	1	1701	0	.	Factor	I	module	(FIM)	2.
chr5	41142929	41149394	P13671	0	-	41142929	41149394	255,102,0	1	6465	0	.	Factor	I	module	(FIM)	2.
chr5	41142929	41158820	P13671	0	-	41142929	41158820	255,102,0	1	15891	0	.	C5b-binding	domain.
chr5	41149445	41150122	P13671	0	-	41149445	41150122	255,102,0	1	677	0	.	Factor	I	module	(FIM)	1.
chr5	41150122	41155110	P13671	0	-	41150122	41155110	255,102,0	1	4988	0	.	CCP	2.
chr5	41155110	41159209	P13671	0	-	41155110	41159209	255,102,0	1	4099	0	.	CCP	1.
chr5	42711467	42713532	P10912	0	+	42711467	42713532	255,102,0	1	2065	0	.	Required	for	ADAM17-mediated	proteolysis.
chr5	43527480	43529916	Q9H074	0	-	43527480	43529916	255,102,0	1	2436	0	.	PABPC1-interacting	motif-1	(PAM1).
chr5	43555937	43556021	Q9H074	0	-	43555937	43556021	255,102,0	1	84	0	.	PABPC1-interacting	motif-2	(PAM2).
chr5	45695775	45695931	O60741	0	-	45695775	45695931	255,102,0	1	156	0	.	Involved	in	subunit	assembly.
chr5	50687125	50687215	P61371	0	+	50687125	50687215	255,102,0	1	90	0	.	LIM-binding	domain	(LID).
chr5	52394494	52396246	A0A024QZS1	0	-	52394494	52396246	255,102,0	1	1752	0	.	Substrate	binding.
chr5	52394494	52396246	O96007	0	-	52394494	52396246	255,102,0	1	1752	0	.	Substrate	binding.
chr5	52396309	52396315	A0A024QZS1	0	-	52396309	52396315	255,102,0	1	6	0	.	Substrate	binding.
chr5	52396309	52396315	O96007	0	-	52396309	52396315	255,102,0	1	6	0	.	Substrate	binding.
chr5	54516196	54518219	D6RGH6	0	-	54516196	54518219	255,102,0	1	2023	0	.	Necessary	and	sufficient	for	proper	nuclear	localization.
chr5	54516616	54518093	D6RGH6	0	-	54516616	54518093	255,102,0	1	1477	0	.	Necessary	and	sufficient	for	interaction	with	GMNN	and	sufficient	for	homodimerization.	Pubmed:21543332
chr5	54518219	54522966	D6RGH6	0	-	54518219	54522966	255,102,0	1	4747	0	.	Necessary	and	sufficient	for	its	degradation	during	the	cell	cycle.
chr5	61602299	61651078	O00139	0	+	61602299	61651078	255,102,0	1	48779	0	.	Globular.
chr5	63256460	63256475	P08908	0	-	63256460	63256475	255,102,0	1	15	0	.	Agonist	binding.
chr5	63257183	63257213	P08908	0	-	63257183	63257213	255,102,0	1	30	0	.	Agonist	binding.
chr5	63509993	63626121	Q86T96	0	+	63509993	63626121	255,102,0	1	116128	0	.	Interaction	with	ZIC2.
chr5	64510666	64520793	Q9UKP5	0	-	64510666	64520793	255,102,0	1	10127	0	.	Spacer.
chr5	64887598	64900749	P36406	0	-	64887598	64900749	255,102,0	1	13151	0	.	ARF-like.
chr5	68417574	68417685	Q8TAD4	0	+	68417574	68417685	255,102,0	1	111	0	.	His-rich	loop.
chr5	68467237	68467264	P14635	0	+	68467237	68467264	255,102,0	1	27	0	.	Interaction	with	CDK2.
chr5	68470769	68470781	P14635	0	+	68470769	68470781	255,102,0	1	12	0	.	Interaction	with	CDK2.
chr5	68648052	68651480	Q9Y3D8	0	-	68648052	68651480	255,102,0	1	3428	0	.	LID.
chr5	68648063	68651492	Q9Y3D8	0	-	68648063	68651492	255,102,0	1	3429	0	.	LID.
chr5	68651733	68662354	Q9Y3D8	0	-	68651733	68662354	255,102,0	1	10621	0	.	NMPbind.
chr5	68651745	68662367	Q9Y3D8	0	-	68651745	68662367	255,102,0	1	10622	0	.	NMPbind.
chr5	68689052	68710116	O75943	0	+	68689052	68710116	255,102,0	1	21064	0	.	Interaction	with	MCM7.	Pubmed:15538388
chr5	68971447	68971495	Q16637	0	-	68971447	68971495	255,102,0	1	48	0	.	Required	for	interaction	with	SYNCRIP.	Pubmed:11574476
chr5	68977291	68978685	Q16637	0	-	68977291	68978685	255,102,0	1	1394	0	.	P2	(binding	site	for	SNRPB).
chr5	68980562	68981060	Q16637	0	-	68980562	68981060	255,102,0	1	498	0	.	Required	for	interaction	with	RPP20/POP7.
chr5	68984543	68998292	Q16637	0	-	68984543	68998292	255,102,0	1	13749	0	.	P1	(binding	site	for	GEMIN2).
chr5	69345548	69359292	Q16637	0	+	69345548	69359292	255,102,0	1	13744	0	.	P1	(binding	site	for	GEMIN2).
chr5	69362775	69363273	Q16637	0	+	69362775	69363273	255,102,0	1	498	0	.	Required	for	interaction	with	RPP20/POP7.
chr5	69365151	69366545	Q16637	0	+	69365151	69366545	255,102,0	1	1394	0	.	P2	(binding	site	for	SNRPB).
chr5	69366223	69379971	Q16637	0	+	69366223	69379971	255,102,0	1	13748	0	.	P1	(binding	site	for	GEMIN2).
chr5	69372347	69372395	Q16637	0	+	69372347	69372395	255,102,0	1	48	0	.	Required	for	interaction	with	SYNCRIP.	Pubmed:11574476
chr5	69383454	69383952	Q16637	0	+	69383454	69383952	255,102,0	1	498	0	.	Required	for	interaction	with	RPP20/POP7.
chr5	69385829	69387223	Q16637	0	+	69385829	69387223	255,102,0	1	1394	0	.	P2	(binding	site	for	SNRPB).
chr5	69393024	69393072	Q16637	0	+	69393024	69393072	255,102,0	1	48	0	.	Required	for	interaction	with	SYNCRIP.	Pubmed:11574476
chr5	69564737	69578485	Q16637	0	+	69564737	69578485	255,102,0	1	13748	0	.	P1	(binding	site	for	GEMIN2).
chr5	69581968	69582466	Q16637	0	+	69581968	69582466	255,102,0	1	498	0	.	Required	for	interaction	with	RPP20/POP7.
chr5	69584343	69585739	Q16637	0	+	69584343	69585739	255,102,0	1	1396	0	.	P2	(binding	site	for	SNRPB).
chr5	69591535	69591583	Q16637	0	+	69591535	69591583	255,102,0	1	48	0	.	Required	for	interaction	with	SYNCRIP.	Pubmed:11574476
chr5	69967007	69978595	A6H8Y1	0	+	69967007	69978595	255,102,0	1	11588	0	.	Interaction	with	ZBTB43.	Pubmed:16542149
chr5	69995019	70000730	A6H8Y1	0	+	69995019	70000730	255,102,0	1	5711	0	.	Required	for	phosphorylation	by	CSNK2A1.
chr5	70020688	70022203	A6H8Y1	0	+	70020688	70022203	255,102,0	1	1515	0	.	9	X	55	AA	repeats	of	G-R-R-X-I-S-P-X-E-N-G-X-E-E-V-K-P-X-X-E-M-E-T-D-L-K-X-T-G-R-E-X-X-X-R-E-K-T-X-E-X-X-D-A-X-E-E-I-D-X-D-L-E-E-T.
chr5	70220966	70234716	Q16637	0	+	70220966	70234716	255,102,0	1	13750	0	.	P1	(binding	site	for	GEMIN2).
chr5	70238199	70238697	Q16637	0	+	70238199	70238697	255,102,0	1	498	0	.	Required	for	interaction	with	RPP20/POP7.
chr5	70240574	70241970	Q16637	0	+	70240574	70241970	255,102,0	1	1396	0	.	P2	(binding	site	for	SNRPB).
chr5	70247767	70247815	Q16637	0	+	70247767	70247815	255,102,0	1	48	0	.	Required	for	interaction	with	SYNCRIP.	Pubmed:11574476
chr5	70751704	70763292	A6H8Y1	0	+	70751704	70763292	255,102,0	1	11588	0	.	Interaction	with	ZBTB43.	Pubmed:16542149
chr5	70779716	70785427	A6H8Y1	0	+	70779716	70785427	255,102,0	1	5711	0	.	Required	for	phosphorylation	by	CSNK2A1.
chr5	70805385	70806900	A6H8Y1	0	+	70805385	70806900	255,102,0	1	1515	0	.	9	X	55	AA	repeats	of	G-R-R-X-I-S-P-X-E-N-G-X-E-E-V-K-P-X-X-E-M-E-T-D-L-K-X-T-G-R-E-X-X-X-R-E-K-T-X-E-X-X-D-A-X-E-E-I-D-X-D-L-E-E-T.
chr5	70888767	70952660	Q9HCC0	0	+	70888767	70952660	255,102,0	1	63893	0	.	Carboxyltransferase.
chr5	70936856	70939689	Q9HCC0	0	+	70936856	70939689	255,102,0	1	2833	0	.	Acyl-CoA	binding.
chr5	71496061	71501063	P46821	0	+	71496061	71501063	255,102,0	1	5002	0	.	Mediates	interaction	with	TMEM185A.	Pubmed:15525354
chr5	71739585	71743097	Q8N895	0	-	71739585	71743097	255,102,0	1	3512	0	.	Interaction	with	CTBP1.	Pubmed:17085477
chr5	71739585	71752392	Q8N895	0	-	71739585	71752392	255,102,0	1	12807	0	.	Interaction	with	NRIP1.	Pubmed:17085477
chr5	72251929	72330509	Q0JRZ9	0	+	72251929	72330509	255,102,0	1	78580	0	.	Mediates	dimerization	and	binding	to	membranes	enriched	in	Pi(4,5)-P2	and	induces	their	tubulation.
chr5	72364587	72383914	Q0JRZ9	0	+	72364587	72383914	255,102,0	1	19327	0	.	Mediates	interaction	with	DAB2,	EPS15,	EPS15R	and	ITSN1.
chr5	73193827	73193857	Q8N1W1	0	+	73193827	73193857	255,102,0	1	30	0	.	Interaction	with	PTK2/FAK1;	required	for	regulation	of	axonal	branching	and	synapse	formation.
chr5	73200182	73200218	Q8N1W1	0	+	73200182	73200218	255,102,0	1	36	0	.	Mediates	cytoplasmic	retention	and	interaction	with	YWHAH.
chr5	73205347	73236835	Q8N1W1	0	+	73205347	73236835	255,102,0	1	31488	0	.	Interaction	with	microtubules.
chr5	73205560	73205656	Q8N1W1	0	+	73205560	73205656	255,102,0	1	96	0	.	RNA-binding.
chr5	73207147	73207189	Q8N1W1	0	+	73207147	73207189	255,102,0	1	42	0	.	Mediates	cytoplasmic	retention	and	interaction	with	MAPK8IP1.
chr5	74646968	74647406	P04035	0	+	74646968	74647406	255,102,0	1	438	0	.	Linker.
chr5	74647406	74656164	P04035	0	+	74647406	74656164	255,102,0	1	8758	0	.	Catalytic.
chr5	75427575	75427746	Q496J9	0	+	75427575	75427746	255,102,0	1	171	0	.	Interaction	with	SYT1.
chr5	76708990	76722325	O95263	0	+	76708990	76722325	255,102,0	1	13335	0	.	Catalytic.
chr5	78322381	78322390	Q9UI17	0	-	78322381	78322390	255,102,0	1	9	0	.	Tetrahydrofolate	binding.
chr5	78325794	78325803	Q9UI17	0	-	78325794	78325803	255,102,0	1	9	0	.	Tetrahydrofolate	binding.
chr5	78532473	78532851	Q8N9B5	0	+	78532473	78532851	255,102,0	1	378	0	.	Interaction	with	p300/EP300.
chr5	78587026	78596506	Q8N9B5	0	+	78587026	78596506	255,102,0	1	9480	0	.	Interaction	with	p300/EP300.
chr5	79035136	79035220	Q8N3K9	0	+	79035136	79035220	255,102,0	1	84	0	.	Amphipathic	helix	H1.
chr5	79035220	79048523	Q8N3K9	0	+	79035220	79048523	255,102,0	1	13303	0	.	B-box	coiled-coil;	BBC.
chr5	79041200	79041254	Q8N3K9	0	+	79041200	79041254	255,102,0	1	54	0	.	Amphipathic	helix	H2.
chr5	79054715	79057674	Q8N3K9	0	+	79054715	79057674	255,102,0	1	2959	0	.	Amphipathic	helix	H3.
chr5	79616529	79616565	Q9BXG8	0	+	79616529	79616565	255,102,0	1	36	0	.	Helix-loop-helix	motif.
chr5	79616565	79616766	Q9BXG8	0	+	79616565	79616766	255,102,0	1	201	0	.	Basic	motif.
chr5	79616940	79617006	Q9BXG8	0	+	79616940	79617006	255,102,0	1	66	0	.	Leucine-zipper.
chr5	79949854	79949872	P00374	0	-	79949854	79949872	255,102,0	1	18	0	.	Substrate	binding.	Pubmed:2248959
chr5	79950768	79968161	P20585	0	+	79950768	79968161	255,102,0	1	17393	0	.	Interaction	with	EXO1.	Pubmed:11427529
chr5	80409498	80409525	O14827	0	+	80409498	80409525	255,102,0	1	27	0	.	Regulates	proteasomal	degradation.
chr5	80508322	80511724	O14827	0	+	80508322	80511724	255,102,0	1	3402	0	.	Responsible	of	the	affinity	for	farnesylated	versus	geranylgeranylated	Ras.
chr5	80547068	80548553	P17540	0	+	80547068	80548553	255,102,0	1	1485	0	.	Cardiolipin-binding.
chr5	80641768	80641777	Q8WYK0	0	-	80641768	80641777	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr5	80667574	80667583	Q8WYK0	0	-	80667574	80667583	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr5	80681607	80681616	Q8WYK0	0	-	80681607	80681616	255,102,0	1	9	0	.	Coenzyme	A	binding.
chr5	82499425	82499527	Q13426	0	+	82499425	82499527	255,102,0	1	102	0	.	Interaction	with	LIG4.
chr5	82815166	82832827	P13611	0	+	82815166	82832827	255,102,0	1	17661	0	.	GAG-alpha	(glucosaminoglycan	attachment	domain).
chr5	82832827	82841357	P13611	0	+	82832827	82841357	255,102,0	1	8530	0	.	GAG-beta.
chr5	88018645	88018741	Q06413	0	-	88018645	88018741	255,102,0	1	96	0	.	Transcription	repressor.
chr5	88026027	88026051	Q06413	0	-	88026027	88026051	255,102,0	1	24	0	.	Beta	domain.
chr5	95067386	95084146	O94955	0	+	95067386	95084146	255,102,0	1	16760	0	.	Rho-like.
chr5	95103845	95128875	O94955	0	+	95103845	95128875	255,102,0	1	25030	0	.	Interaction	with	Rab9.
chr5	96129616	96129631	Q9NZ08	0	-	96129616	96129631	255,102,0	1	15	0	.	Substrate	binding.
chr5	96228031	96228046	Q6P179	0	+	96228031	96228046	255,102,0	1	15	0	.	Substrate	binding.
chr5	96315107	96315125	Q9UIQ6	0	+	96315107	96315125	255,102,0	1	18	0	.	Tankyrase	binding.
chr5	96329549	96329564	Q9UIQ6	0	+	96329549	96329564	255,102,0	1	15	0	.	Substrate	binding.
chr5	98192284	98192335	O14646	0	-	98192284	98192335	255,102,0	1	51	0	.	3	X	5	AA	repeats	of	H-S-D-H-R.
chr5	100147685	100147691	Q92187	0	-	100147685	100147691	255,102,0	1	6	0	.	Substrate	binding.
chr5	100147787	100147796	Q92187	0	-	100147787	100147796	255,102,0	1	9	0	.	Substrate	binding.
chr5	100192024	100192033	Q92187	0	-	100192024	100192033	255,102,0	1	9	0	.	Substrate	binding.
chr5	102201899	102310139	P19021	0	+	102201899	102310139	255,102,0	1	108240	0	.	Peptidylglycine	alpha-hydroxylating	monooxygenase.
chr5	102325974	102355513	P19021	0	+	102325974	102355513	255,102,0	1	29539	0	.	Peptidyl-alpha-hydroxyglycine	alpha-amidating	lyase.
chr5	102364619	102364673	P19021	0	+	102364619	102364673	255,102,0	1	54	0	.	Interaction	with	RASSF9.
chr5	102469198	102469204	O43314	0	+	102469198	102469204	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:22119861
chr5	102482379	102482385	O43314	0	+	102482379	102482385	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:22119861
chr5	102487025	102487037	O43314	0	+	102487025	102487037	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:22119861
chr5	102488433	102490570	O43314	0	+	102488433	102490570	255,102,0	1	2137	0	.	Polyphosphoinositide-binding	domain.	Pubmed:21222653
chr5	108133883	108207890	P16591	0	+	108133883	108207890	255,102,0	1	74007	0	.	Important	for	interaction	with	membranes	containing	phosphoinositides.
chr5	108672934	108698602	O43164	0	-	108672934	108698602	255,102,0	1	25668	0	.	Interaction	with	PRKAR1A,	PRKAR2A	and	PRKAR2B.	Pubmed:21423175
chr5	110818566	110818617	Q16566	0	+	110818566	110818617	255,102,0	1	51	0	.	Autoinhibitory	domain.
chr5	110818569	110818623	Q16566	0	+	110818569	110818623	255,102,0	1	54	0	.	PP2A-binding.
chr5	110818617	110819765	Q16566	0	+	110818617	110819765	255,102,0	1	1148	0	.	Calmodulin-binding.
chr5	112174168	112175302	P25054	0	+	112174168	112175302	255,102,0	1	1134	0	.	Responsible	for	down-regulation	through	a	process	mediated	by	direct	ubiquitination.
chr5	112176886	112176970	P25054	0	+	112176886	112176970	255,102,0	1	84	0	.	Highly	charged.
chr5	112203204	112203231	P09132	0	+	112203204	112203231	255,102,0	1	27	0	.	Basic	region,	potentially	involved	in	RNA-binding.
chr5	112926791	112926800	Q9H6S0	0	+	112926791	112926800	255,102,0	1	9	0	.	N6-methyladenosine	binding.
chr5	113808840	113831603	Q9H2S1	0	+	113808840	113831603	255,102,0	1	22763	0	.	Calmodulin-binding.
chr5	114557538	114557550	P53609	0	-	114557538	114557550	255,102,0	1	12	0	.	Geranylgeranyl	diphosphate	binding.
chr5	114557565	114557577	P53609	0	-	114557565	114557577	255,102,0	1	12	0	.	Geranylgeranyl	diphosphate	binding.
chr5	114557700	114566676	P53609	0	-	114557700	114566676	255,102,0	1	8976	0	.	Geranylgeranyl	diphosphate	binding.
chr5	115327848	115327863	Q6Q4G3	0	+	115327848	115327863	255,102,0	1	15	0	.	Substrate	binding.
chr5	118788270	118832284	P51659	0	+	118788270	118832284	255,102,0	1	44014	0	.	3R)-hydroxyacyl-CoA	dehydrogenase.
chr5	118832332	118866972	P51659	0	+	118832332	118866972	255,102,0	1	34640	0	.	Enoyl-CoA	hydratase	2.
chr5	118837741	118837747	P51659	0	+	118837741	118837747	255,102,0	1	6	0	.	3R)-3-hydroxydecanoyl-CoA	binding.
chr5	118860934	118860952	P51659	0	+	118860934	118860952	255,102,0	1	18	0	.	3R)-3-hydroxydecanoyl-CoA	binding.
chr5	121402440	121412691	P28300	0	-	121402440	121412691	255,102,0	1	10251	0	.	Lysyl-oxidase	like.
chr5	122151645	122165340	O60749	0	+	122151645	122165340	255,102,0	1	13695	0	.	Interaction	with	RhoG.	Pubmed:20604901
chr5	122152642	122152696	O60749	0	+	122152642	122152696	255,102,0	1	54	0	.	Membrane-binding	amphipathic	helix.	Pubmed:19816406
chr5	122909145	122909172	Q9Y6M4	0	+	122909145	122909172	255,102,0	1	27	0	.	Inhibitors	binding.
chr5	125936657	125960338	Q9H814	0	+	125936657	125960338	255,102,0	1	23681	0	.	Necessary	for	interaction	with	CBP80.
chr5	125939846	125960335	Q9H814	0	+	125939846	125960335	255,102,0	1	20489	0	.	Sufficient	for	poly	U	RNA-binding.
chr5	125952944	125952971	Q9H814	0	+	125952944	125952971	255,102,0	1	27	0	.	Necessary	for	poly	U	RNA-binding	and	snRNA	export.
chr5	126113203	126113302	P20700	0	+	126113203	126113302	255,102,0	1	99	0	.	Head.
chr5	126113302	126113407	P20700	0	+	126113302	126113407	255,102,0	1	105	0	.	Coil	1A.
chr5	126113302	126154832	P20700	0	+	126113302	126154832	255,102,0	1	41530	0	.	Rod.
chr5	126113407	126113443	P20700	0	+	126113407	126113443	255,102,0	1	36	0	.	Linker	1.
chr5	126113443	126145874	P20700	0	+	126113443	126145874	255,102,0	1	32431	0	.	Coil	1B.
chr5	126145874	126145958	P20700	0	+	126145874	126145958	255,102,0	1	84	0	.	Linker	2.
chr5	126145958	126154832	P20700	0	+	126145958	126154832	255,102,0	1	8874	0	.	Coil	2.
chr5	126154832	126171953	P20700	0	+	126154832	126171953	255,102,0	1	17121	0	.	Tail.
chr5	126667000	126781228	Q96KG7	0	+	126667000	126781228	255,102,0	1	114228	0	.	Necessary	for	interaction	with	AP2M1,	self-assembly	and	formation	of	the	irregular,	mosaic-like	adhesion	pattern.	Pubmed:17643423
chr5	126783352	126793007	Q96KG7	0	+	126783352	126793007	255,102,0	1	9655	0	.	Necessary	for	formation	of	large	intracellular	vacuoles.
chr5	127624942	127645089	P35556	0	-	127624942	127645089	255,102,0	1	20147	0	.	Interaction	with	MFAP4.	Pubmed:26601954
chr5	127744367	127863652	P35556	0	-	127744367	127863652	255,102,0	1	119285	0	.	Interaction	with	MFAP4.	Pubmed:26601954
chr5	128994393	129019908	Q8TE59	0	+	128994393	129019908	255,102,0	1	25515	0	.	Spacer.
chr5	130980380	131007352	Q8TF40	0	-	130980380	131007352	255,102,0	1	26972	0	.	Interaction	with	HSP90AA1.	Pubmed:27353360
chr5	131154526	131154538	A0A087WXM9	0	-	131154526	131154538	255,102,0	1	12	0	.	Required	for	localization	to	kinetochores.
chr5	132032328	132032337	Q9Y496	0	-	132032328	132032337	255,102,0	1	9	0	.	Globular.
chr5	133493426	133496683	P63208	0	-	133493426	133496683	255,102,0	1	3257	0	.	Interaction	with	the	F-box	domain	of	F-box	proteins.
chr5	134015327	134015402	O95486	0	+	134015327	134015402	255,102,0	1	75	0	.	Zinc	finger-like.
chr5	134364576	134364975	P78337	0	-	134364576	134364975	255,102,0	1	399	0	.	Interaction	with	PIT-1.
chr5	137522051	137523099	O95235	0	+	137522051	137523099	255,102,0	1	1048	0	.	Globular.
chr5	137622208	137622884	P30307	0	-	137622208	137622884	255,102,0	1	676	0	.	HIV-1	Vpr	binding	site.
chr5	138117616	138160314	P35221	0	+	138117616	138160314	255,102,0	1	42698	0	.	Involved	in	homodimerization.
chr5	138119048	138145869	P35221	0	+	138119048	138145869	255,102,0	1	26821	0	.	Interaction	with	JUP	and	CTNNB1.	Pubmed:9152027
chr5	138163317	138223217	P35221	0	+	138163317	138223217	255,102,0	1	59900	0	.	Interaction	with	alpha-actinin.
chr5	138356858	138463532	Q9H173	0	-	138356858	138463532	255,102,0	1	106674	0	.	Interaction	with	HSPA5	and	localization	to	the	endoplasmic	reticulum.
chr5	138699536	138700339	Q9BPZ3	0	+	138699536	138700339	255,102,0	1	803	0	.	PABPC1-interacting	motif-1	(PAM1).
chr5	138700426	138704463	Q9BPZ3	0	+	138700426	138704463	255,102,0	1	4037	0	.	PABPC1-interacting	motif-2	(PAM2).
chr5	138732551	138732806	Q86W54	0	-	138732551	138732806	255,102,0	1	255	0	.	Required	for	interaction	with	CBX5	and	TBPL1.
chr5	138855848	138855968	Q86WV6	0	-	138855848	138855968	255,102,0	1	120	0	.	C-terminal	tail	(CTT).
chr5	138855965	138860438	Q86WV6	0	-	138855965	138860438	255,102,0	1	4473	0	.	c-di-GMP-binding	domain	(CBD).
chr5	138857890	138857902	Q86WV6	0	-	138857890	138857902	255,102,0	1	12	0	.	c-di-GMP	binding.
chr5	138860393	138860411	Q86WV6	0	-	138860393	138860411	255,102,0	1	18	0	.	c-di-GMP	binding.
chr5	139743403	139752380	Q96Q91	0	+	139743403	139752380	255,102,0	1	8977	0	.	Membrane	(anion	exchange).
chr5	140011443	140011701	P08571	0	-	140011443	140011701	255,102,0	1	258	0	.	Required	for	response	to	bacterial	lipopolysaccharide	(LPS).
chr5	140038596	140038698	Q13123	0	+	140038596	140038698	255,102,0	1	102	0	.	17	X	2	AA	tandem	repeats	of	R-[ED].
chr5	140168074	140389351	Q9Y5I3	0	+	140168074	140389351	255,102,0	1	221277	0	.	5	X	4	AA	repeats	of	P-X-X-P.
chr5	140176748	140389351	Q9Y5H9	0	+	140176748	140389351	255,102,0	1	212603	0	.	5	X	4	AA	repeats	of	P-X-X-P.
chr5	140182981	140389351	Q9Y5H8	0	+	140182981	140389351	255,102,0	1	206370	0	.	6	X	4	AA	repeats	of	P-X-X-P.
chr5	140188971	140389351	Q9UN74	0	+	140188971	140389351	255,102,0	1	200380	0	.	6	X	4	AA	repeats	of	P-X-X-P.
chr5	140188983	140389519	Q9UN74	0	+	140188983	140389519	255,102,0	1	200536	0	.	Required	for	interaction	with	FYN.
chr5	140203676	140389381	Q9Y5H7	0	+	140203676	140389381	255,102,0	1	185705	0	.	5	X	4	AA	repeats	of	P-X-X-P.
chr5	140216287	140389351	Q9UN72	0	+	140216287	140389351	255,102,0	1	173064	0	.	5	X	4	AA	repeats	of	P-X-X-P.
chr5	140223225	140389351	Q9Y5H6	0	+	140223225	140389351	255,102,0	1	166126	0	.	5	X	4	AA	repeats	of	P-X-X-P.
chr5	140230279	140389351	Q9Y5H5	0	+	140230279	140389351	255,102,0	1	159072	0	.	5	X	4	AA	repeats	of	P-X-X-P.
chr5	140237826	140389351	Q9Y5I2	0	+	140237826	140389351	255,102,0	1	151525	0	.	6	X	4	AA	repeats	of	P-X-X-P.
chr5	140250884	140389351	Q9Y5I1	0	+	140250884	140389351	255,102,0	1	138467	0	.	6	X	4	AA	repeats	of	P-X-X-P.
chr5	140257256	140389351	Q9UN75	0	+	140257256	140389351	255,102,0	1	132095	0	.	5	X	4	AA	repeats	of	P-X-X-P.
chr5	140264052	140389351	Q9Y5I0	0	+	140264052	140389351	255,102,0	1	125299	0	.	6	X	4	AA	repeats	of	P-X-X-P.
chr5	140358533	140389351	Q9H158	0	+	140358533	140389351	255,102,0	1	30818	0	.	4	X	4	AA	repeats	of	P-X-X-P.
chr5	140358533	140389351	Q9UN73	0	+	140358533	140389351	255,102,0	1	30818	0	.	4	X	4	AA	repeats	of	P-X-X-P.
chr5	140358533	140389351	Q9Y5I4	0	+	140358533	140389351	255,102,0	1	30818	0	.	4	X	4	AA	repeats	of	P-X-X-P.
chr5	141005610	141016351	O15379	0	-	141005610	141016351	255,102,0	1	10741	0	.	Histone	deacetylase.
chr5	141362961	141367352	Q9UBS8	0	+	141362961	141367352	255,102,0	1	4391	0	.	Interaction	with	androgen	receptor.
chr5	141488542	141511432	Q9BT67	0	+	141488542	141511432	255,102,0	1	22890	0	.	Interaction	with	UBE2L3.
chr5	141511432	141511853	Q9BT67	0	+	141511432	141511853	255,102,0	1	421	0	.	Interaction	with	ITCH.
chr5	141974893	141974944	P05230	0	-	141974893	141974944	255,102,0	1	51	0	.	Heparin-binding.
chr5	142661456	142680215	P04150	0	-	142661456	142680215	255,102,0	1	18759	0	.	Steroid-binding.
chr5	142661456	142689677	P04150	0	-	142661456	142689677	255,102,0	1	28221	0	.	Interaction	with	CLOCK.
chr5	142662222	142680203	P04150	0	-	142662222	142680203	255,102,0	1	17981	0	.	Interaction	with	CRY1.	Pubmed:22170608
chr5	142680215	142689671	P04150	0	-	142680215	142689671	255,102,0	1	9456	0	.	Hinge.
chr5	142693657	142780404	P04150	0	-	142693657	142780404	255,102,0	1	86747	0	.	Modulating.
chr5	142780059	142780113	P04150	0	-	142780059	142780113	255,102,0	1	54	0	.	Required	for	high	transcriptional	activity	of	isoform	Alpha-C3.	Pubmed:23820903
chr5	143543785	143545056	Q969M3	0	-	143543785	143545056	255,102,0	1	1271	0	.	Interaction	with	Sec23.
chr5	145441994	145442012	Q8TEC5	0	+	145441994	145442012	255,102,0	1	18	0	.	Interaction	with	PPP1CA.
chr5	145524248	145537352	Q9P2J5	0	-	145524248	145537352	255,102,0	1	13104	0	.	Editing	domain.
chr5	147778607	147781639	Q6PIJ6	0	+	147778607	147781639	255,102,0	1	3032	0	.	Interaction	with	KLF7.
chr5	148206970	148207015	P07550	0	+	148206970	148207015	255,102,0	1	45	0	.	Agonist	and	antagonist	binding.
chr5	148207249	148207273	P07550	0	+	148207249	148207273	255,102,0	1	24	0	.	Agonist	and	antagonist	binding.
chr5	148207327	148207342	P07550	0	+	148207327	148207342	255,102,0	1	15	0	.	Agonist	and	antagonist	binding.
chr5	149109905	149206256	Q86YN6	0	+	149109905	149206256	255,102,0	1	96351	0	.	Abolishes	DNA	transcriptional	activity	when	missing.
chr5	149435688	149435838	P07333	0	-	149435688	149435838	255,102,0	1	150	0	.	Activation	loop.
chr5	149441316	149447780	P07333	0	-	149441316	149447780	255,102,0	1	6464	0	.	Regulatory	juxtamembrane	domain.
chr5	149624747	149627350	Q9UQM7	0	-	149624747	149627350	255,102,0	1	2603	0	.	Interaction	with	BAALC.
chr5	149629788	149629821	Q9UQM7	0	-	149629788	149629821	255,102,0	1	33	0	.	Calmodulin-binding.
chr5	149786470	149786515	P04233	0	-	149786470	149786515	255,102,0	1	45	0	.	CLIP.
chr5	149900933	149921176	P52848	0	+	149900933	149921176	255,102,0	1	20243	0	.	Heparan	sulfate	N-deacetylase	1.
chr5	149921176	149932891	P52848	0	+	149921176	149932891	255,102,0	1	11715	0	.	Heparan	sulfate	N-sulfotransferase	1.
chr5	150050131	150050185	Q8TDC0	0	+	150050131	150050185	255,102,0	1	54	0	.	Binding	to	ACTN2,	PPP3CA	and	TCAP.	Pubmed:11842093
chr5	150050182	150051376	Q8TDC0	0	+	150050182	150051376	255,102,0	1	1194	0	.	Binding	to	FLNC.	Pubmed:11842093
chr5	150052032	150056302	Q8TDC0	0	+	150052032	150056302	255,102,0	1	4270	0	.	Binding	to	ACTN2.	Pubmed:11842093
chr5	150413183	150416455	Q15025	0	-	150413183	150416455	255,102,0	1	3272	0	.	Required	for	inhibitory	activity	of	TNF-induced	NF-kappa-B	activation.
chr5	150414619	150416392	Q15025	0	-	150414619	150416392	255,102,0	1	1773	0	.	Ubiquitin-binding	domain	(UBD).
chr5	150418684	150441765	Q15025	0	-	150418684	150441765	255,102,0	1	23081	0	.	Interaction	with	Nef.
chr5	150422133	150422184	Q15025	0	-	150422133	150422184	255,102,0	1	51	0	.	Interaction	with	Shigella	flexneri	ipah9.8.
chr5	151231157	151234610	P23415	0	-	151231157	151234610	255,102,0	1	3453	0	.	Strychnine-binding.
chr5	153085277	153085286	P42261	0	+	153085277	153085286	255,102,0	1	9	0	.	Glutamate	binding.
chr5	153144171	153144177	P42261	0	+	153144171	153144177	255,102,0	1	6	0	.	Glutamate	binding.
chr5	153709159	153760012	Q86SR1	0	+	153709159	153760012	255,102,0	1	50853	0	.	Catalytic	subdomain	A.
chr5	153760183	153783726	Q86SR1	0	+	153760183	153783726	255,102,0	1	23543	0	.	Catalytic	subdomain	B.
chr5	153783723	153783759	Q86SR1	0	+	153783723	153783759	255,102,0	1	36	0	.	Flexible	loop.
chr5	153830710	153830719	Q9HAJ7	0	+	153830710	153830719	255,102,0	1	9	0	.	Important	for	DNA	and	phosphoinositide	binding.	Pubmed:19015240
chr5	154315537	154317693	Q8TEQ6	0	-	154315537	154317693	255,102,0	1	2156	0	.	Important	for	interaction	with	U1	snRNA.	Pubmed:19377484
chr5	154317648	154317657	Q8TEQ6	0	-	154317648	154317657	255,102,0	1	9	0	.	Interaction	with	U4	snRNA.	Pubmed:27834343,	Pubmed:27881600,	Pubmed:27881601
chr5	154395405	154397121	Q2VIQ3	0	+	154395405	154397121	255,102,0	1	1716	0	.	Interaction	with	PRC1.
chr5	154396416	154397121	Q2VIQ3	0	+	154396416	154397121	255,102,0	1	705	0	.	Globular.
chr5	157178459	157181035	P83369	0	+	157178459	157181035	255,102,0	1	2576	0	.	SM	1.
chr5	157182215	157182257	P83369	0	+	157182215	157182257	255,102,0	1	42	0	.	SM	2.
chr5	157240128	157240164	Q14677	0	-	157240128	157240164	255,102,0	1	36	0	.	Interaction	with	VTI1B.	Pubmed:18033301
chr5	157241256	157241265	Q14677	0	-	157241256	157241265	255,102,0	1	9	0	.	Interaction	with	VTI1B.	Pubmed:18033301
chr5	157243822	157243831	Q14677	0	-	157243822	157243831	255,102,0	1	9	0	.	Interaction	with	VTI1B.	Pubmed:18033301
chr5	158250244	158250256	Q9UH73	0	-	158250244	158250256	255,102,0	1	12	0	.	Interaction	with	DNA.
chr5	158267060	158267084	Q9UH73	0	-	158267060	158267084	255,102,0	1	24	0	.	Interaction	with	DNA.
chr5	158524074	158524086	Q9UH73	0	-	158524074	158524086	255,102,0	1	12	0	.	Interaction	with	DNA.
chr5	158697599	158710300	Q8WVY7	0	+	158697599	158710300	255,102,0	1	12701	0	.	Phosphatase.
chr5	160758036	160758102	P47870	0	-	160758036	160758102	255,102,0	1	66	0	.	Allosteric	effector	binding.
chr5	160886724	160886733	P47870	0	-	160886724	160886733	255,102,0	1	9	0	.	Agonist	binding.
chr5	161580242	161580296	P18507	0	+	161580242	161580296	255,102,0	1	54	0	.	Interaction	with	GABARAP.
chr5	162911194	162911227	O75330	0	+	162911194	162911227	255,102,0	1	33	0	.	Hyaluronic	acid-binding.
chr5	162917404	162917434	O75330	0	+	162917404	162917434	255,102,0	1	30	0	.	Hyaluronic	acid-binding.
chr5	162945318	162945366	Q9NZL9	0	+	162945318	162945366	255,102,0	1	48	0	.	Required	for	interaction	with	MAT2A.	Pubmed:25075345
chr5	167871579	167896019	Q8IX03	0	+	167871579	167896019	255,102,0	1	24440	0	.	Interaction	with	histone	H3.
chr5	167887687	167891805	Q8IX03	0	+	167887687	167891805	255,102,0	1	4118	0	.	Interaction	with	PRKCZ.
chr5	167913503	167919699	P54136	0	+	167913503	167919699	255,102,0	1	6196	0	.	Could	be	involved	in	the	assembly	of	the	multisynthetase	complex.
chr5	167957058	167957064	A6NHQ2	0	+	167957058	167957064	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr5	167957115	167957121	A6NHQ2	0	+	167957115	167957121	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr5	167957190	167957196	A6NHQ2	0	+	167957190	167957196	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr5	167957250	167957262	A6NHQ2	0	+	167957250	167957262	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr5	169410086	169484631	Q92608	0	+	169410086	169484631	255,102,0	1	74545	0	.	Interaction	with	CRKL.	Pubmed:12393632
chr5	170162765	170162807	Q9NZI2	0	+	170162765	170162807	255,102,0	1	42	0	.	Interaction	with	KCND2.
chr5	170814952	170818802	P06748	0	+	170814952	170818802	255,102,0	1	3850	0	.	Necessary	for	interaction	with	APEX1.	Pubmed:19188445
chr5	170814952	170827190	P06748	0	+	170814952	170827190	255,102,0	1	12238	0	.	Required	for	interaction	with	SENP3.
chr5	170832362	170837566	P06748	0	+	170832362	170837566	255,102,0	1	5204	0	.	Required	for	nucleolar	localization.
chr5	171337600	171337750	Q9UKB1	0	-	171337600	171337750	255,102,0	1	150	0	.	Homodimerization	domain	D.
chr5	171533739	171534854	O94804	0	-	171533739	171534854	255,102,0	1	1115	0	.	Activation	segment.
chr5	172537673	172537703	Q8IUR6	0	+	172537673	172537703	255,102,0	1	30	0	.	Basic	motif.
chr5	172537703	172539321	Q8IUR6	0	+	172537703	172539321	255,102,0	1	1618	0	.	Leucine-zipper.
chr5	173377036	173377045	Q17RY0	0	+	173377036	173377045	255,102,0	1	9	0	.	RNA-binding.
chr5	175305999	175306934	Q6PUV4	0	+	175305999	175306934	255,102,0	1	935	0	.	Interaction	with	the	SNARE	complex.
chr5	175824606	175825006	P09497	0	-	175824606	175825006	255,102,0	1	400	0	.	Involved	in	binding	clathrin	heavy	chain.
chr5	176017686	176022670	Q9BYE9	0	+	176017686	176022670	255,102,0	1	4984	0	.	Mediates	interaction	with	USH1C	and	MYO7B	and	is	required	for	proper	localization	to	microvilli	tips	and	function	in	microvilli	organization.	Pubmed:24725409
chr5	176023811	176024141	Q7Z2K8	0	-	176023811	176024141	255,102,0	1	330	0	.	Interaction	with	GNAO1.
chr5	176053479	176056598	Q16143	0	-	176053479	176056598	255,102,0	1	3119	0	.	4	X	11	AA	tandem	repeats	of	[EGS]-K-T-K-[EQ]-[GQ]-V-X(4).
chr5	176070250	176070262	A6NMX2	0	+	176070250	176070262	255,102,0	1	12	0	.	EIF4EBP1/2/3	binding.
chr5	176070679	176070685	A6NMX2	0	+	176070679	176070685	255,102,0	1	6	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr5	176070730	176071386	A6NMX2	0	+	176070730	176071386	255,102,0	1	656	0	.	EIF4EBP1/2/3	binding.
chr5	176072148	176072154	A6NMX2	0	+	176072148	176072154	255,102,0	1	6	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr5	176072238	176072395	A6NMX2	0	+	176072238	176072395	255,102,0	1	157	0	.	EIF4EBP1/2/3	binding.
chr5	176072446	176072464	A6NMX2	0	+	176072446	176072464	255,102,0	1	18	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr5	176072939	176072948	A6NMX2	0	+	176072939	176072948	255,102,0	1	9	0	.	7-methylguanosine-containing	mRNA	cap	binding.
chr5	176305071	176305128	Q6ZN44	0	+	176305071	176305128	255,102,0	1	57	0	.	Interaction	with	DCC.
chr5	176308076	176314587	P52790	0	-	176308076	176314587	255,102,0	1	6511	0	.	Catalytic.
chr5	176308142	176310840	P52790	0	-	176308142	176310840	255,102,0	1	2698	0	.	Hexokinase	large	subdomain	2.
chr5	176310840	176314461	P52790	0	-	176310840	176314461	255,102,0	1	3621	0	.	Hexokinase	small	subdomain	2.
chr5	176311105	176314053	P52790	0	-	176311105	176314053	255,102,0	1	2948	0	.	Glucose-binding.
chr5	176314587	176323160	P52790	0	-	176314587	176323160	255,102,0	1	8573	0	.	Regulatory.
chr5	176314671	176316715	P52790	0	-	176314671	176316715	255,102,0	1	2044	0	.	Hexokinase	large	subdomain	1.
chr5	176316715	176318398	P52790	0	-	176316715	176318398	255,102,0	1	1683	0	.	Hexokinase	small	subdomain	1.
chr5	176317701	176317873	P52790	0	-	176317701	176317873	255,102,0	1	172	0	.	Glucose-binding.
chr5	176335625	176370420	Q96RL1	0	-	176335625	176370420	255,102,0	1	34795	0	.	Zinc-finger-like	region.
chr5	176370432	176395558	Q96RL1	0	-	176370432	176395558	255,102,0	1	25126	0	.	Necessary	for	interaction	with	NR6A1	C-terminus.
chr5	176395555	176395948	Q96RL1	0	-	176395555	176395948	255,102,0	1	393	0	.	AIR.
chr5	176396155	176397802	Q96RL1	0	-	176396155	176397802	255,102,0	1	1647	0	.	Necessary	for	interaction	with	NR6A1	N-terminus.
chr5	176397790	176397811	Q96RL1	0	-	176397790	176397811	255,102,0	1	21	0	.	UIM-linker.
chr5	176397796	176409616	Q96RL1	0	-	176397796	176409616	255,102,0	1	11820	0	.	Necessary	for	transcriptional	repression.
chr5	176707796	176707805	Q96L73	0	+	176707796	176707805	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr5	176709552	176709564	Q96L73	0	+	176709552	176709564	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr5	176710835	176710841	Q96L73	0	+	176710835	176710841	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr5	176715845	176715866	Q96L73	0	+	176715845	176715866	255,102,0	1	21	0	.	Inhibits	enzyme	activity	in	the	absence	of	bound	histone.
chr5	176738480	176738810	Q9BW11	0	-	176738480	176738810	255,102,0	1	330	0	.	Interaction	with	SIN3A	and	SIN3B.
chr5	176764140	176764149	Q12907	0	-	176764140	176764149	255,102,0	1	9	0	.	Carbohydrate	binding.
chr5	176764721	176764730	Q12907	0	-	176764721	176764730	255,102,0	1	9	0	.	Carbohydrate	binding.
chr5	176795762	176798186	O43566	0	+	176795762	176798186	255,102,0	1	2424	0	.	Necessary	for	interaction	with	RABGEF1.
chr5	176853846	176860369	P43250	0	+	176853846	176860369	255,102,0	1	6523	0	.	N-terminal.
chr5	177020725	177021208	Q9BVK6	0	+	177020725	177021208	255,102,0	1	483	0	.	Required	for	interaction	with	STX17.	Pubmed:21545355
chr5	177031426	177031441	Q9UBV7	0	+	177031426	177031441	255,102,0	1	15	0	.	UDP-alpha-D-galactose	binding.	Pubmed:24052259
chr5	177034303	177034312	Q9UBV7	0	+	177034303	177034312	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.	Pubmed:24052259
chr5	177034378	177034384	Q9UBV7	0	+	177034378	177034384	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.	Pubmed:24052259
chr5	177035575	177035587	Q9UBV7	0	+	177035575	177035587	255,102,0	1	12	0	.	N-acetyl-D-glucosamine	binding.
chr5	177035955	177035964	Q9UBV7	0	+	177035955	177035964	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.	Pubmed:24052259
chr5	178419057	178419066	O15303	0	-	178419057	178419066	255,102,0	1	9	0	.	Glutamate	binding.
chr5	178555023	178559820	O95450	0	-	178555023	178559820	255,102,0	1	4797	0	.	Spacer.
chr5	179028973	179032895	Q96T51	0	+	179028973	179032895	255,102,0	1	3922	0	.	Interaction	with	RAB4.
chr5	179043127	179045161	P31943	0	-	179043127	179045161	255,102,0	1	2034	0	.	2	X	16	AA	Gly-rich	approximate	repeats.
chr5	179043900	179044109	P31943	0	-	179043900	179044109	255,102,0	1	209	0	.	2	X	19	AA	perfect	repeats.
chr5	179143209	179149849	P27824	0	+	179143209	179149849	255,102,0	1	6640	0	.	P	domain	(Extended	arm).
chr5	179143215	179147414	P27824	0	+	179143215	179147414	255,102,0	1	4199	0	.	4	X	approximate	repeats.
chr5	179146732	179147456	P27824	0	+	179146732	179147456	255,102,0	1	724	0	.	Interaction	with	PPIB.
chr5	179147420	179149837	P27824	0	+	179147420	179149837	255,102,0	1	2417	0	.	4	X	approximate	repeats.
chr5	179150768	179155642	P27824	0	+	179150768	179155642	255,102,0	1	4874	0	.	Sufficient	to	mediate	interaction	with	SGIP1.
chr5	179160113	179192380	Q92585	0	+	179160113	179192380	255,102,0	1	32267	0	.	Required	for	interaction	with	NOTCH	proteins.	Pubmed:11101851
chr5	179222676	179222793	Q16873	0	+	179222676	179222793	255,102,0	1	117	0	.	Glutathione	binding.
chr5	179222799	179222805	Q16873	0	+	179222799	179222805	255,102,0	1	6	0	.	Glutathione	binding.
chr5	179222988	179223003	Q16873	0	+	179222988	179223003	255,102,0	1	15	0	.	Glutathione	binding.
chr5	179247939	179248086	Q13501	0	+	179247939	179248086	255,102,0	1	147	0	.	Interaction	with	LCK.
chr5	179248062	179250877	Q13501	0	+	179248062	179250877	255,102,0	1	2815	0	.	Interaction	with	PRKCZ	and	dimerization.
chr5	179248083	179249992	Q13501	0	+	179248083	179249992	255,102,0	1	1909	0	.	Interaction	with	PAWR.	Pubmed:11755531
chr5	179250919	179251322	Q13501	0	+	179250919	179251322	255,102,0	1	403	0	.	Interaction	with	GABRR3.
chr5	179251063	179251310	Q13501	0	+	179251063	179251310	255,102,0	1	247	0	.	LIM	protein-binding	(LB).
chr5	179260081	179263590	Q13501	0	+	179260081	179263590	255,102,0	1	3509	0	.	Interaction	with	NTRK1.
chr5	179260237	179260643	Q13501	0	+	179260237	179260643	255,102,0	1	406	0	.	MAP1LC3B-binding.
chr5	179264711	179264786	Q6NTE8	0	-	179264711	179264786	255,102,0	1	75	0	.	Necessary	for	the	association	with	the	MRN	complex.	Pubmed:27568553
chr5	179743341	179743350	O94808	0	-	179743341	179743350	255,102,0	1	9	0	.	Substrate-binding.
chr5	179743781	179743787	O94808	0	-	179743781	179743787	255,102,0	1	6	0	.	Substrate-binding.
chr5	179991559	180001197	Q9ULM6	0	+	179991559	180001197	255,102,0	1	9638	0	.	Nuclease	domain.
chr6	3015838	3015847	P16083	0	+	3015838	3015847	255,102,0	1	9	0	.	Substrate	binding.
chr6	3089843	3113303	Q13546	0	+	3089843	3113303	255,102,0	1	23460	0	.	Interaction	with	SQSTM1.	Pubmed:10356400
chr6	4117604	4130656	O75521	0	-	4117604	4130656	255,102,0	1	13052	0	.	ECH-like.
chr6	4126436	4126451	O75521	0	-	4126436	4126451	255,102,0	1	15	0	.	Substrate	binding.
chr6	4133785	4133800	O75521	0	-	4133785	4133800	255,102,0	1	15	0	.	Acyl-CoA	binding.
chr6	4735072	4935822	Q9Y232	0	+	4735072	4935822	255,102,0	1	200750	0	.	Interaction	with	EZH2.	Pubmed:22009739
chr6	5369271	5369283	O95363	0	+	5369271	5369283	255,102,0	1	12	0	.	Substrate	binding.
chr6	5369358	5369367	O95363	0	+	5369358	5369367	255,102,0	1	9	0	.	Substrate	binding.
chr6	5369379	5369388	O95363	0	+	5369379	5369388	255,102,0	1	9	0	.	Substrate	binding.
chr6	7542148	7571666	P15924	0	+	7542148	7571666	255,102,0	1	29518	0	.	Interaction	with	plakophilin	1	and	junction	plakoglobin.
chr6	7542148	7579591	P15924	0	+	7542148	7579591	255,102,0	1	37443	0	.	Globular	1.
chr6	7579591	7583330	P15924	0	+	7579591	7583330	255,102,0	1	3739	0	.	Central	fibrous	rod	domain.
chr6	7583330	7586108	P15924	0	+	7583330	7586108	255,102,0	1	2778	0	.	Globular	2.
chr6	7583372	7584119	P15924	0	+	7583372	7584119	255,102,0	1	747	0	.	4.5	X	38	AA	tandem	repeats	(Domain	A).
chr6	7584224	7584833	P15924	0	+	7584224	7584833	255,102,0	1	609	0	.	4.5	X	38	AA	tandem	repeats	(Domain	B).
chr6	7585319	7585961	P15924	0	+	7585319	7585961	255,102,0	1	642	0	.	4.5	X	38	AA	tandem	repeats	(Domain	C).
chr6	7585964	7586036	P15924	0	+	7585964	7586036	255,102,0	1	72	0	.	6	X	4	AA	tandem	repeats	of	G-S-R-[SR].
chr6	8080191	8097598	O43324	0	-	8080191	8097598	255,102,0	1	17407	0	.	C-terminal.
chr6	8097598	8097619	O43324	0	-	8097598	8097619	255,102,0	1	21	0	.	Linker.
chr6	8097619	8102751	O43324	0	-	8097619	8102751	255,102,0	1	5132	0	.	N-terminal.
chr6	10398733	10402770	P05549	0	-	10398733	10402770	255,102,0	1	4037	0	.	H-S-H	(helix-span-helix),	dimerization.
chr6	11104421	11104484	P60508	0	-	11104421	11104484	255,102,0	1	63	0	.	Fusion	peptide.
chr6	11185619	11185772	Q14511	0	-	11185619	11185772	255,102,0	1	153	0	.	Divergent	helix-loop-helix	motif.
chr6	11191414	11213669	Q14511	0	-	11191414	11213669	255,102,0	1	22255	0	.	Interacts	strongly	with	spindle-regulatory	protein	D1M1.
chr6	12294264	12294309	P05305	0	+	12294264	12294309	255,102,0	1	45	0	.	Endothelin-like.
chr6	13622596	13632706	Q96S59	0	-	13622596	13632706	255,102,0	1	10110	0	.	Interaction	with	FMR1.	Pubmed:15381419
chr6	13642714	13642735	Q96S59	0	-	13642714	13642735	255,102,0	1	21	0	.	Interaction	with	CALB1.
chr6	15523268	15533621	Q96EV8	0	-	15523268	15533621	255,102,0	1	10353	0	.	Dysbindin.
chr6	16146934	16146943	Q8WY64	0	+	16146934	16146943	255,102,0	1	9	0	.	Critical	for	homodimerization.
chr6	16286023	16286032	P36959	0	+	16286023	16286032	255,102,0	1	9	0	.	GMP	binding.
chr6	16290718	16290724	P36959	0	+	16290718	16290724	255,102,0	1	6	0	.	GMP	binding.
chr6	16290796	16290805	P36959	0	+	16290796	16290805	255,102,0	1	9	0	.	GMP	binding.
chr6	16290850	16295249	P36959	0	+	16290850	16295249	255,102,0	1	4399	0	.	GMP	binding.
chr6	16306562	16326930	P54253	0	-	16306562	16326930	255,102,0	1	20368	0	.	Interaction	with	USP7.	Pubmed:12093161
chr6	16306709	16326924	P54253	0	-	16306709	16326924	255,102,0	1	20215	0	.	RNA-binding.	Pubmed:11136710
chr6	16326729	16327062	P54253	0	-	16326729	16327062	255,102,0	1	333	0	.	Self-association.	Pubmed:9097953
chr6	18139909	18139915	A0A024QZW0	0	-	18139909	18139915	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	18139909	18139915	P51580	0	-	18139909	18139915	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	18149238	18149274	A0A024QZW0	0	-	18149238	18149274	255,102,0	1	36	0	.	S-adenosyl-L-methionine	binding.
chr6	18149238	18149274	P51580	0	-	18149238	18149274	255,102,0	1	36	0	.	S-adenosyl-L-methionine	binding.
chr6	20402763	20480142	O00716	0	+	20402763	20480142	255,102,0	1	77379	0	.	Cyclin	A/CDK2	binding.
chr6	20481540	20481606	O00716	0	+	20481540	20481606	255,102,0	1	66	0	.	Leucine-zipper.
chr6	20483002	20488355	O00716	0	+	20483002	20488355	255,102,0	1	5353	0	.	Dimerization.
chr6	20490433	20490658	O00716	0	+	20490433	20490658	255,102,0	1	225	0	.	Transactivation.
chr6	20490556	20490610	O00716	0	+	20490556	20490610	255,102,0	1	54	0	.	Retinoblastoma	protein	binding.
chr6	24781818	24785880	O75496	0	+	24781818	24785880	255,102,0	1	4062	0	.	Necessary	and	sufficient	for	interaction	with	IDAS	and	CDT1.	Pubmed:21543332
chr6	24785904	24785967	O75496	0	+	24785904	24785967	255,102,0	1	63	0	.	Homeodomain	binding.
chr6	24871114	24873966	Q9Y4F9	0	-	24871114	24873966	255,102,0	1	2852	0	.	Involved	in	cell	filopodia	formation.
chr6	25581532	25600668	Q5VZK9	0	+	25581532	25600668	255,102,0	1	19136	0	.	Inhibits	capping	activity	of	CAPZA2.
chr6	25600584	25600689	Q5VZK9	0	+	25600584	25600689	255,102,0	1	105	0	.	Necessary	for	localization	at	the	cell	membrane.	Pubmed:26578515
chr6	26087734	26091543	Q30201	0	+	26087734	26091543	255,102,0	1	3809	0	.	Alpha-1.
chr6	26091543	26091816	Q30201	0	+	26091543	26091816	255,102,0	1	273	0	.	Alpha-2.
chr6	26092911	26093187	Q30201	0	+	26092911	26093187	255,102,0	1	276	0	.	Alpha-3.
chr6	26093345	26093372	Q30201	0	+	26093345	26093372	255,102,0	1	27	0	.	Connecting	peptide.
chr6	29568056	29568920	Q9UBS5	0	-	29568056	29568920	255,102,0	1	864	0	.	Interaction	with	ATF4.
chr6	29571259	29572123	Q9UBS5	0	-	29571259	29572123	255,102,0	1	864	0	.	Interaction	with	ATF4.
chr6	29571376	29572240	Q9UBS5	0	-	29571376	29572240	255,102,0	1	864	0	.	Interaction	with	ATF4.
chr6	29571413	29572277	Q9UBS5	0	-	29571413	29572277	255,102,0	1	864	0	.	Interaction	with	ATF4.
chr6	29571457	29572321	Q9UBS5	0	-	29571457	29572321	255,102,0	1	864	0	.	Interaction	with	ATF4.
chr6	29571589	29572453	Q9UBS5	0	-	29571589	29572453	255,102,0	1	864	0	.	Interaction	with	ATF4.
chr6	29691433	29691703	P30511	0	+	29691433	29691703	255,102,0	1	270	0	.	Alpha-1.
chr6	29691948	29692224	P30511	0	+	29691948	29692224	255,102,0	1	276	0	.	Alpha-2.
chr6	29692806	29693082	P30511	0	+	29692806	29693082	255,102,0	1	276	0	.	Alpha-3.
chr6	29693222	29693252	P30511	0	+	29693222	29693252	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29789503	29789773	P17693	0	+	29789503	29789773	255,102,0	1	270	0	.	Alpha-1.
chr6	29789999	29790275	P17693	0	+	29789999	29790275	255,102,0	1	276	0	.	Alpha-2.
chr6	29790874	29791150	P17693	0	+	29790874	29791150	255,102,0	1	276	0	.	Alpha-3.
chr6	29791272	29791302	P17693	0	+	29791272	29791302	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29792700	29792970	P17693	0	+	29792700	29792970	255,102,0	1	270	0	.	Alpha-1.
chr6	29792715	29792985	P17693	0	+	29792715	29792985	255,102,0	1	270	0	.	Alpha-1.
chr6	29792995	29793265	P17693	0	+	29792995	29793265	255,102,0	1	270	0	.	Alpha-1.
chr6	29793042	29793312	P17693	0	+	29793042	29793312	255,102,0	1	270	0	.	Alpha-1.
chr6	29793196	29793472	P17693	0	+	29793196	29793472	255,102,0	1	276	0	.	Alpha-2.
chr6	29793211	29793487	P17693	0	+	29793211	29793487	255,102,0	1	276	0	.	Alpha-2.
chr6	29793318	29793588	P17693	0	+	29793318	29793588	255,102,0	1	270	0	.	Alpha-1.
chr6	29793491	29793767	P17693	0	+	29793491	29793767	255,102,0	1	276	0	.	Alpha-2.
chr6	29793538	29793814	P17693	0	+	29793538	29793814	255,102,0	1	276	0	.	Alpha-2.
chr6	29793814	29794090	P17693	0	+	29793814	29794090	255,102,0	1	276	0	.	Alpha-2.
chr6	29794071	29794347	P17693	0	+	29794071	29794347	255,102,0	1	276	0	.	Alpha-3.
chr6	29794086	29794362	P17693	0	+	29794086	29794362	255,102,0	1	276	0	.	Alpha-3.
chr6	29794366	29794642	P17693	0	+	29794366	29794642	255,102,0	1	276	0	.	Alpha-3.
chr6	29794413	29794689	P17693	0	+	29794413	29794689	255,102,0	1	276	0	.	Alpha-3.
chr6	29794469	29794499	P17693	0	+	29794469	29794499	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29794484	29794514	P17693	0	+	29794484	29794514	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29794689	29794965	P17693	0	+	29794689	29794965	255,102,0	1	276	0	.	Alpha-3.
chr6	29794764	29794794	P17693	0	+	29794764	29794794	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29794811	29794841	P17693	0	+	29794811	29794841	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29795087	29795117	P17693	0	+	29795087	29795117	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29795822	29796092	P17693	0	+	29795822	29796092	255,102,0	1	270	0	.	Alpha-1.
chr6	29796318	29796594	P17693	0	+	29796318	29796594	255,102,0	1	276	0	.	Alpha-2.
chr6	29797193	29797469	P17693	0	+	29797193	29797469	255,102,0	1	276	0	.	Alpha-3.
chr6	29797591	29797621	P17693	0	+	29797591	29797621	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29899810	29900080	P10314	0	+	29899810	29900080	255,102,0	1	270	0	.	Alpha-1.
chr6	29899898	29900168	P30450	0	+	29899898	29900168	255,102,0	1	270	0	.	Alpha-1.
chr6	29900073	29900343	P30443	0	+	29900073	29900343	255,102,0	1	270	0	.	Alpha-1.
chr6	29900321	29900597	P10314	0	+	29900321	29900597	255,102,0	1	276	0	.	Alpha-2.
chr6	29900409	29900685	P30450	0	+	29900409	29900685	255,102,0	1	276	0	.	Alpha-2.
chr6	29900492	29900762	P01892	0	+	29900492	29900762	255,102,0	1	270	0	.	Alpha-1.
chr6	29900584	29900860	P30443	0	+	29900584	29900860	255,102,0	1	276	0	.	Alpha-2.
chr6	29901003	29901279	P01892	0	+	29901003	29901279	255,102,0	1	276	0	.	Alpha-2.
chr6	29901197	29901473	P10314	0	+	29901197	29901473	255,102,0	1	276	0	.	Alpha-3.
chr6	29901285	29901561	P30450	0	+	29901285	29901561	255,102,0	1	276	0	.	Alpha-3.
chr6	29901439	29901715	P30443	0	+	29901439	29901715	255,102,0	1	276	0	.	Alpha-3.
chr6	29901572	29901602	P10314	0	+	29901572	29901602	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29901660	29901690	P30450	0	+	29901660	29901690	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29901817	29901847	P30443	0	+	29901817	29901847	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29901879	29902155	P01892	0	+	29901879	29902155	255,102,0	1	276	0	.	Alpha-3.
chr6	29902254	29902284	P01892	0	+	29902254	29902284	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29902686	29902956	P30443	0	+	29902686	29902956	255,102,0	1	270	0	.	Alpha-1.
chr6	29903197	29903473	P30443	0	+	29903197	29903473	255,102,0	1	276	0	.	Alpha-2.
chr6	29904052	29904328	P30443	0	+	29904052	29904328	255,102,0	1	276	0	.	Alpha-3.
chr6	29904430	29904460	P30443	0	+	29904430	29904460	255,102,0	1	30	0	.	Connecting	peptide.
chr6	29910532	29910802	P04439	0	+	29910532	29910802	255,102,0	1	270	0	.	Alpha-1.
chr6	29911043	29911319	P04439	0	+	29911043	29911319	255,102,0	1	276	0	.	Alpha-2.
chr6	29911897	29912173	P04439	0	+	29911897	29912173	255,102,0	1	276	0	.	Alpha-3.
chr6	29912275	29912305	P04439	0	+	29912275	29912305	255,102,0	1	30	0	.	Connecting	peptide.
chr6	30447004	30447274	P13747	0	+	30447004	30447274	255,102,0	1	270	0	.	Alpha-1.
chr6	30447355	30447625	P13747	0	+	30447355	30447625	255,102,0	1	270	0	.	Alpha-1.
chr6	30447518	30447794	P13747	0	+	30447518	30447794	255,102,0	1	276	0	.	Alpha-2.
chr6	30447740	30448010	P13747	0	+	30447740	30448010	255,102,0	1	270	0	.	Alpha-1.
chr6	30447869	30448145	P13747	0	+	30447869	30448145	255,102,0	1	276	0	.	Alpha-2.
chr6	30448254	30448530	P13747	0	+	30448254	30448530	255,102,0	1	276	0	.	Alpha-2.
chr6	30448415	30448691	P13747	0	+	30448415	30448691	255,102,0	1	276	0	.	Alpha-3.
chr6	30448766	30449042	P13747	0	+	30448766	30449042	255,102,0	1	276	0	.	Alpha-3.
chr6	30448815	30448845	P13747	0	+	30448815	30448845	255,102,0	1	30	0	.	Connecting	peptide.
chr6	30449151	30449427	P13747	0	+	30449151	30449427	255,102,0	1	276	0	.	Alpha-3.
chr6	30449166	30449196	P13747	0	+	30449166	30449196	255,102,0	1	30	0	.	Connecting	peptide.
chr6	30449551	30449581	P13747	0	+	30449551	30449581	255,102,0	1	30	0	.	Connecting	peptide.
chr6	30449735	30450005	P13747	0	+	30449735	30450005	255,102,0	1	270	0	.	Alpha-1.
chr6	30450249	30450525	P13747	0	+	30450249	30450525	255,102,0	1	276	0	.	Alpha-2.
chr6	30451146	30451422	P13747	0	+	30451146	30451422	255,102,0	1	276	0	.	Alpha-3.
chr6	30451546	30451576	P13747	0	+	30451546	30451576	255,102,0	1	30	0	.	Connecting	peptide.
chr6	30560218	30561635	Q96QC0	0	-	30560218	30561635	255,102,0	1	1417	0	.	Interaction	with	WDR82.
chr6	30560565	30561982	Q96QC0	0	-	30560565	30561982	255,102,0	1	1417	0	.	Interaction	with	WDR82.
chr6	30560959	30562376	Q96QC0	0	-	30560959	30562376	255,102,0	1	1417	0	.	Interaction	with	WDR82.
chr6	30561438	30561743	Q96QC0	0	-	30561438	30561743	255,102,0	1	305	0	.	Essential	for	PPP1CA	inhibition.
chr6	30561635	30561725	Q96QC0	0	-	30561635	30561725	255,102,0	1	90	0	.	Necessary	for	interaction	with	PPP1CA.
chr6	30561662	30561710	Q96QC0	0	-	30561662	30561710	255,102,0	1	48	0	.	Necessary	for	interaction	with	PPP1CC.	Pubmed:9450550
chr6	30561785	30562090	Q96QC0	0	-	30561785	30562090	255,102,0	1	305	0	.	Essential	for	PPP1CA	inhibition.
chr6	30561918	30567216	Q96QC0	0	-	30561918	30567216	255,102,0	1	5298	0	.	Interaction	with	TOX4.
chr6	30561982	30562072	Q96QC0	0	-	30561982	30562072	255,102,0	1	90	0	.	Necessary	for	interaction	with	PPP1CA.
chr6	30562009	30562057	Q96QC0	0	-	30562009	30562057	255,102,0	1	48	0	.	Necessary	for	interaction	with	PPP1CC.	Pubmed:9450550
chr6	30562179	30562484	Q96QC0	0	-	30562179	30562484	255,102,0	1	305	0	.	Essential	for	PPP1CA	inhibition.
chr6	30562265	30567564	Q96QC0	0	-	30562265	30567564	255,102,0	1	5299	0	.	Interaction	with	TOX4.
chr6	30562376	30562466	Q96QC0	0	-	30562376	30562466	255,102,0	1	90	0	.	Necessary	for	interaction	with	PPP1CA.
chr6	30562403	30562451	Q96QC0	0	-	30562403	30562451	255,102,0	1	48	0	.	Necessary	for	interaction	with	PPP1CC.	Pubmed:9450550
chr6	30562659	30567958	Q96QC0	0	-	30562659	30567958	255,102,0	1	5299	0	.	Interaction	with	TOX4.
chr6	30562945	30564362	Q96QC0	0	-	30562945	30564362	255,102,0	1	1417	0	.	Interaction	with	WDR82.
chr6	30564165	30564470	Q96QC0	0	-	30564165	30564470	255,102,0	1	305	0	.	Essential	for	PPP1CA	inhibition.
chr6	30564362	30564452	Q96QC0	0	-	30564362	30564452	255,102,0	1	90	0	.	Necessary	for	interaction	with	PPP1CA.
chr6	30564389	30564437	Q96QC0	0	-	30564389	30564437	255,102,0	1	48	0	.	Necessary	for	interaction	with	PPP1CC.	Pubmed:9450550
chr6	30564645	30569944	Q96QC0	0	-	30564645	30569944	255,102,0	1	5299	0	.	Interaction	with	TOX4.
chr6	30570722	30572139	Q96QC0	0	-	30570722	30572139	255,102,0	1	1417	0	.	Interaction	with	WDR82.
chr6	30571942	30572247	Q96QC0	0	-	30571942	30572247	255,102,0	1	305	0	.	Essential	for	PPP1CA	inhibition.
chr6	30572139	30572229	Q96QC0	0	-	30572139	30572229	255,102,0	1	90	0	.	Necessary	for	interaction	with	PPP1CA.
chr6	30572166	30572214	Q96QC0	0	-	30572166	30572214	255,102,0	1	48	0	.	Necessary	for	interaction	with	PPP1CC.	Pubmed:9450550
chr6	30572422	30577721	Q96QC0	0	-	30572422	30577721	255,102,0	1	5299	0	.	Interaction	with	TOX4.
chr6	30585351	30585393	Q5SQI0	0	+	30585351	30585393	255,102,0	1	42	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30585642	30585672	Q5SQI0	0	+	30585642	30585672	255,102,0	1	30	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30585699	30585741	Q5SQI0	0	+	30585699	30585741	255,102,0	1	42	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30585990	30586020	Q5SQI0	0	+	30585990	30586020	255,102,0	1	30	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30586093	30586135	Q5SQI0	0	+	30586093	30586135	255,102,0	1	42	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30586384	30586414	Q5SQI0	0	+	30586384	30586414	255,102,0	1	30	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30588079	30588121	Q5SQI0	0	+	30588079	30588121	255,102,0	1	42	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30588370	30588400	Q5SQI0	0	+	30588370	30588400	255,102,0	1	30	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30595856	30595898	Q5SQI0	0	+	30595856	30595898	255,102,0	1	42	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30596147	30596177	Q5SQI0	0	+	30596147	30596177	255,102,0	1	30	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30615358	30616775	Q96QC0	0	-	30615358	30616775	255,102,0	1	1417	0	.	Interaction	with	WDR82.
chr6	30616578	30616883	Q96QC0	0	-	30616578	30616883	255,102,0	1	305	0	.	Essential	for	PPP1CA	inhibition.
chr6	30616775	30616865	Q96QC0	0	-	30616775	30616865	255,102,0	1	90	0	.	Necessary	for	interaction	with	PPP1CA.
chr6	30616802	30616850	Q96QC0	0	-	30616802	30616850	255,102,0	1	48	0	.	Necessary	for	interaction	with	PPP1CC.	Pubmed:9450550
chr6	30617058	30622357	Q96QC0	0	-	30617058	30622357	255,102,0	1	5299	0	.	Interaction	with	TOX4.
chr6	30640492	30640534	Q5SQI0	0	+	30640492	30640534	255,102,0	1	42	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30640783	30640813	Q5SQI0	0	+	30640783	30640813	255,102,0	1	30	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30649176	30650593	Q96QC0	0	-	30649176	30650593	255,102,0	1	1417	0	.	Interaction	with	WDR82.
chr6	30650396	30650701	Q96QC0	0	-	30650396	30650701	255,102,0	1	305	0	.	Essential	for	PPP1CA	inhibition.
chr6	30650593	30650683	Q96QC0	0	-	30650593	30650683	255,102,0	1	90	0	.	Necessary	for	interaction	with	PPP1CA.
chr6	30650620	30650668	Q96QC0	0	-	30650620	30650668	255,102,0	1	48	0	.	Necessary	for	interaction	with	PPP1CC.	Pubmed:9450550
chr6	30650876	30656175	Q96QC0	0	-	30650876	30656175	255,102,0	1	5299	0	.	Interaction	with	TOX4.
chr6	30658103	30661728	Q14676	0	-	30658103	30661728	255,102,0	1	3625	0	.	Required	for	nuclear	localization	(NLS2).
chr6	30658503	30662127	Q14676	0	-	30658503	30662127	255,102,0	1	3624	0	.	Required	for	nuclear	localization	(NLS2).
chr6	30661989	30663378	Q14676	0	-	30661989	30663378	255,102,0	1	1389	0	.	Interaction	with	the	PRKDC	complex.
chr6	30662388	30663777	Q14676	0	-	30662388	30663777	255,102,0	1	1389	0	.	Interaction	with	the	PRKDC	complex.
chr6	30668244	30671868	Q14676	0	-	30668244	30671868	255,102,0	1	3624	0	.	Required	for	nuclear	localization	(NLS2).
chr6	30669873	30671523	Q14676	0	-	30669873	30671523	255,102,0	1	1650	0	.	Required	for	nuclear	localization	(NLS1).
chr6	30670272	30671922	Q14676	0	-	30670272	30671922	255,102,0	1	1650	0	.	Required	for	nuclear	localization	(NLS1).
chr6	30670917	30672808	Q14676	0	-	30670917	30672808	255,102,0	1	1891	0	.	Interaction	with	the	MRN	complex.
chr6	30671316	30673207	Q14676	0	-	30671316	30673207	255,102,0	1	1891	0	.	Interaction	with	the	MRN	complex.
chr6	30671505	30672811	Q14676	0	-	30671505	30672811	255,102,0	1	1306	0	.	Interaction	with	CHEK2.
chr6	30671904	30673210	Q14676	0	-	30671904	30673210	255,102,0	1	1306	0	.	Interaction	with	CHEK2.
chr6	30672129	30673518	Q14676	0	-	30672129	30673518	255,102,0	1	1389	0	.	Interaction	with	the	PRKDC	complex.
chr6	30674311	30674353	Q5SQI0	0	+	30674311	30674353	255,102,0	1	42	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30674602	30674632	Q5SQI0	0	+	30674602	30674632	255,102,0	1	30	0	.	Acetyl-CoA	binding.	Pubmed:24906155,	Pubmed:23071314,	Pubmed:23071318
chr6	30680014	30681664	Q14676	0	-	30680014	30681664	255,102,0	1	1650	0	.	Required	for	nuclear	localization	(NLS1).
chr6	30681058	30682949	Q14676	0	-	30681058	30682949	255,102,0	1	1891	0	.	Interaction	with	the	MRN	complex.
chr6	30681646	30682952	Q14676	0	-	30681646	30682952	255,102,0	1	1306	0	.	Interaction	with	CHEK2.
chr6	30712903	30716527	Q14676	0	-	30712903	30716527	255,102,0	1	3624	0	.	Required	for	nuclear	localization	(NLS2).
chr6	30716788	30718177	Q14676	0	-	30716788	30718177	255,102,0	1	1389	0	.	Interaction	with	the	PRKDC	complex.
chr6	30724672	30726322	Q14676	0	-	30724672	30726322	255,102,0	1	1650	0	.	Required	for	nuclear	localization	(NLS1).
chr6	30725716	30727607	Q14676	0	-	30725716	30727607	255,102,0	1	1891	0	.	Interaction	with	the	MRN	complex.
chr6	30726304	30727610	Q14676	0	-	30726304	30727610	255,102,0	1	1306	0	.	Interaction	with	CHEK2.
chr6	30732156	30735780	Q14676	0	-	30732156	30735780	255,102,0	1	3624	0	.	Required	for	nuclear	localization	(NLS2).
chr6	30736041	30737430	Q14676	0	-	30736041	30737430	255,102,0	1	1389	0	.	Interaction	with	the	PRKDC	complex.
chr6	30743925	30745575	Q14676	0	-	30743925	30745575	255,102,0	1	1650	0	.	Required	for	nuclear	localization	(NLS1).
chr6	30744969	30746860	Q14676	0	-	30744969	30746860	255,102,0	1	1891	0	.	Interaction	with	the	MRN	complex.
chr6	30745557	30746863	Q14676	0	-	30745557	30746863	255,102,0	1	1306	0	.	Interaction	with	CHEK2.
chr6	30746727	30750351	Q14676	0	-	30746727	30750351	255,102,0	1	3624	0	.	Required	for	nuclear	localization	(NLS2).
chr6	30750612	30752001	Q14676	0	-	30750612	30752001	255,102,0	1	1389	0	.	Interaction	with	the	PRKDC	complex.
chr6	30758496	30760146	Q14676	0	-	30758496	30760146	255,102,0	1	1650	0	.	Required	for	nuclear	localization	(NLS1).
chr6	30759540	30761431	Q14676	0	-	30759540	30761431	255,102,0	1	1891	0	.	Interaction	with	the	MRN	complex.
chr6	30760128	30761434	Q14676	0	-	30760128	30761434	255,102,0	1	1306	0	.	Interaction	with	CHEK2.
chr6	30848739	30850423	Q08345	0	+	30848739	30850423	255,102,0	1	1684	0	.	DS-like	domain.
chr6	30849052	30850736	Q08345	0	+	30849052	30850736	255,102,0	1	1684	0	.	DS-like	domain.
chr6	30849865	30851563	Q08345	0	+	30849865	30851563	255,102,0	1	1698	0	.	DS-like	domain.
chr6	30859164	30860846	Q08345	0	+	30859164	30860846	255,102,0	1	1682	0	.	DS-like	domain.
chr6	30903813	30905491	Q08345	0	+	30903813	30905491	255,102,0	1	1678	0	.	DS-like	domain.
chr6	30954042	30955257	Q5SSG8	0	+	30954042	30955257	255,102,0	1	1215	0	.	28	X	15	AA	approximate	tandem	repeats.
chr6	30955830	30955968	Q5SSG8	0	+	30955830	30955968	255,102,0	1	138	0	.	Cytoplasmic	tail.
chr6	30993664	30997750	E2RYF6	0	+	30993664	30997750	255,102,0	1	4086	0	.	124	X	10	AA	approximate	repeats.
chr6	31227669	31227699	Q9TNN7	0	-	31227669	31227699	255,102,0	1	30	0	.	Connecting	peptide.
chr6	31227820	31228096	Q9TNN7	0	-	31227820	31228096	255,102,0	1	276	0	.	Alpha-3.
chr6	31228683	31228959	Q9TNN7	0	-	31228683	31228959	255,102,0	1	276	0	.	Alpha-2.
chr6	31229205	31229475	Q9TNN7	0	-	31229205	31229475	255,102,0	1	270	0	.	Alpha-1.
chr6	31230037	31230067	Q29963	0	-	31230037	31230067	255,102,0	1	30	0	.	Connecting	peptide.
chr6	31230188	31230464	Q29963	0	-	31230188	31230464	255,102,0	1	276	0	.	Alpha-3.
chr6	31231051	31231327	Q29963	0	-	31231051	31231327	255,102,0	1	276	0	.	Alpha-2.
chr6	31231253	31231283	Q9TNN7	0	-	31231253	31231283	255,102,0	1	30	0	.	Connecting	peptide.
chr6	31231404	31231680	Q9TNN7	0	-	31231404	31231680	255,102,0	1	276	0	.	Alpha-3.
chr6	31231573	31231843	Q29963	0	-	31231573	31231843	255,102,0	1	270	0	.	Alpha-1.
chr6	31232267	31232543	Q9TNN7	0	-	31232267	31232543	255,102,0	1	276	0	.	Alpha-2.
chr6	31232789	31233059	Q9TNN7	0	-	31232789	31233059	255,102,0	1	270	0	.	Alpha-1.
chr6	31237833	31237863	P10321	0	-	31237833	31237863	255,102,0	1	30	0	.	Connecting	peptide.
chr6	31237987	31238263	P10321	0	-	31237987	31238263	255,102,0	1	276	0	.	Alpha-3.
chr6	31238850	31239126	P10321	0	-	31238850	31239126	255,102,0	1	276	0	.	Alpha-2.
chr6	31239376	31239646	P10321	0	-	31239376	31239646	255,102,0	1	270	0	.	Alpha-1.
chr6	31313062	31313095	P30466	0	-	31313062	31313095	255,102,0	1	33	0	.	Connecting	peptide.
chr6	31313199	31313475	P30466	0	-	31313199	31313475	255,102,0	1	276	0	.	Alpha-3.
chr6	31313447	31313480	P30460	0	-	31313447	31313480	255,102,0	1	33	0	.	Connecting	peptide.
chr6	31313573	31313849	P30460	0	-	31313573	31313849	255,102,0	1	276	0	.	Alpha-3.
chr6	31314047	31314323	P30466	0	-	31314047	31314323	255,102,0	1	276	0	.	Alpha-2.
chr6	31314421	31314697	P30460	0	-	31314421	31314697	255,102,0	1	276	0	.	Alpha-2.
chr6	31314569	31314839	P30466	0	-	31314569	31314839	255,102,0	1	270	0	.	Alpha-1.
chr6	31314943	31315213	P30460	0	-	31314943	31315213	255,102,0	1	270	0	.	Alpha-1.
chr6	31314967	31314997	P04222	0	-	31314967	31314997	255,102,0	1	30	0	.	Connecting	peptide.
chr6	31315118	31315394	P04222	0	-	31315118	31315394	255,102,0	1	276	0	.	Alpha-3.
chr6	31315981	31316257	P04222	0	-	31315981	31316257	255,102,0	1	276	0	.	Alpha-2.
chr6	31316502	31316772	P04222	0	-	31316502	31316772	255,102,0	1	270	0	.	Alpha-1.
chr6	31316671	31316704	P30481	0	-	31316671	31316704	255,102,0	1	33	0	.	Connecting	peptide.
chr6	31316797	31317073	P30481	0	-	31316797	31317073	255,102,0	1	276	0	.	Alpha-3.
chr6	31317648	31317924	P30481	0	-	31317648	31317924	255,102,0	1	276	0	.	Alpha-2.
chr6	31318167	31318437	P30481	0	-	31318167	31318437	255,102,0	1	270	0	.	Alpha-1.
chr6	31322968	31323001	P01889	0	-	31322968	31323001	255,102,0	1	33	0	.	Connecting	peptide.
chr6	31323094	31323370	P01889	0	-	31323094	31323370	255,102,0	1	276	0	.	Alpha-3.
chr6	31323944	31324220	P01889	0	-	31323944	31324220	255,102,0	1	276	0	.	Alpha-2.
chr6	31324465	31324735	P01889	0	-	31324465	31324735	255,102,0	1	270	0	.	Alpha-1.
chr6	31399347	31399380	P30464	0	-	31399347	31399380	255,102,0	1	33	0	.	Connecting	peptide.
chr6	31399484	31399760	P30464	0	-	31399484	31399760	255,102,0	1	276	0	.	Alpha-3.
chr6	31400335	31400611	P30464	0	-	31400335	31400611	255,102,0	1	276	0	.	Alpha-2.
chr6	31400856	31401126	P30464	0	-	31400856	31401126	255,102,0	1	270	0	.	Alpha-1.
chr6	31591516	31603421	P48634	0	+	31591516	31603421	255,102,0	1	11905	0	.	4	X	57	AA	type	A	repeats.
chr6	31594574	31595934	P48634	0	+	31594574	31595934	255,102,0	1	1360	0	.	2	X	type	B	repeats.
chr6	31598056	31602858	P46379	0	-	31598056	31602858	255,102,0	1	4802	0	.	4	X	29	AA	approximate	repeats.
chr6	31600875	31605677	P46379	0	-	31600875	31605677	255,102,0	1	4802	0	.	4	X	29	AA	approximate	repeats.
chr6	31601396	31606198	P46379	0	-	31601396	31606198	255,102,0	1	4802	0	.	4	X	29	AA	approximate	repeats.
chr6	31604106	31605086	P48634	0	+	31604106	31605086	255,102,0	1	980	0	.	3	X	50	AA	type	C	repeats.
chr6	31610650	31615450	P46379	0	-	31610650	31615450	255,102,0	1	4800	0	.	4	X	29	AA	approximate	repeats.
chr6	31619795	31619813	P67870	0	+	31619795	31619813	255,102,0	1	18	0	.	Interaction	with	alpha	subunit.
chr6	31625026	31625044	P67870	0	+	31625026	31625044	255,102,0	1	18	0	.	Interaction	with	alpha	subunit.
chr6	31627847	31627865	P67870	0	+	31627847	31627865	255,102,0	1	18	0	.	Interaction	with	alpha	subunit.
chr6	31628365	31628383	P67870	0	+	31628365	31628383	255,102,0	1	18	0	.	Interaction	with	alpha	subunit.
chr6	31637616	31637634	P67870	0	+	31637616	31637634	255,102,0	1	18	0	.	Interaction	with	alpha	subunit.
chr6	31677070	31677088	P67870	0	+	31677070	31677088	255,102,0	1	18	0	.	Interaction	with	alpha	subunit.
chr6	31683785	31686244	O00299	0	-	31683785	31686244	255,102,0	1	2459	0	.	Required	for	insertion	into	the	membrane.
chr6	31689024	31691485	O00299	0	-	31689024	31691485	255,102,0	1	2461	0	.	Required	for	insertion	into	the	membrane.
chr6	31691835	31694300	O00299	0	-	31691835	31694300	255,102,0	1	2465	0	.	Required	for	insertion	into	the	membrane.
chr6	31692378	31694841	O00299	0	-	31692378	31694841	255,102,0	1	2463	0	.	Required	for	insertion	into	the	membrane.
chr6	31701617	31704074	O00299	0	-	31701617	31704074	255,102,0	1	2457	0	.	Required	for	insertion	into	the	membrane.
chr6	31713895	31713913	P67870	0	+	31713895	31713913	255,102,0	1	18	0	.	Interaction	with	alpha	subunit.
chr6	31741071	31743532	O00299	0	-	31741071	31743532	255,102,0	1	2461	0	.	Required	for	insertion	into	the	membrane.
chr6	31760402	31760750	P34931	0	-	31760402	31760750	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31760771	31761929	P34931	0	-	31760771	31761929	255,102,0	1	1158	0	.	Nucleotide-binding	domain	(NBD).
chr6	31765722	31766877	P0DMV8	0	+	31765722	31766877	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31765722	31766877	P0DMV9	0	+	31765722	31766877	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31766898	31767246	P0DMV8	0	+	31766898	31767246	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31766898	31767246	P0DMV9	0	+	31766898	31767246	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31770906	31772061	P0DMV8	0	+	31770906	31772061	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31770906	31772061	P0DMV9	0	+	31770906	31772061	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31772082	31772430	P0DMV8	0	+	31772082	31772430	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31772082	31772430	P0DMV9	0	+	31772082	31772430	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31777899	31780360	O00299	0	-	31777899	31780360	255,102,0	1	2461	0	.	Required	for	insertion	into	the	membrane.
chr6	31777916	31779071	P0DMV8	0	+	31777916	31779071	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31777916	31779071	P0DMV9	0	+	31777916	31779071	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31778216	31778564	P34931	0	-	31778216	31778564	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31778585	31779743	P34931	0	-	31778585	31779743	255,102,0	1	1158	0	.	Nucleotide-binding	domain	(NBD).
chr6	31779092	31779440	P0DMV8	0	+	31779092	31779440	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31779092	31779440	P0DMV9	0	+	31779092	31779440	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31783102	31784257	P0DMV8	0	+	31783102	31784257	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31783102	31784257	P0DMV9	0	+	31783102	31784257	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31783536	31784691	P0DMV8	0	+	31783536	31784691	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31783536	31784691	P0DMV9	0	+	31783536	31784691	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31784278	31784626	P0DMV8	0	+	31784278	31784626	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31784278	31784626	P0DMV9	0	+	31784278	31784626	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31784712	31785060	P0DMV8	0	+	31784712	31785060	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31784712	31785060	P0DMV9	0	+	31784712	31785060	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31785969	31787124	P0DMV8	0	+	31785969	31787124	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31785969	31787124	P0DMV9	0	+	31785969	31787124	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31787145	31787493	P0DMV8	0	+	31787145	31787493	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31787145	31787493	P0DMV9	0	+	31787145	31787493	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31795730	31796885	P0DMV8	0	+	31795730	31796885	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31795730	31796885	P0DMV9	0	+	31795730	31796885	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31796906	31797254	P0DMV8	0	+	31796906	31797254	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31796906	31797254	P0DMV9	0	+	31796906	31797254	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31830203	31830215	Q96KQ7	0	-	31830203	31830215	255,102,0	1	12	0	.	Interaction	with	histone	H3.
chr6	31830743	31830749	Q96KQ7	0	-	31830743	31830749	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	31830803	31831028	Q96KQ7	0	-	31830803	31831028	255,102,0	1	225	0	.	Interaction	with	histone	H3.
chr6	31832703	31832712	Q96KQ7	0	-	31832703	31832712	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr6	31834748	31834757	Q96KQ7	0	-	31834748	31834757	255,102,0	1	9	0	.	Histone	H3K9me	binding.
chr6	31835566	31835578	Q96KQ7	0	-	31835566	31835578	255,102,0	1	12	0	.	Interaction	with	histone	H3.
chr6	31836106	31836112	Q96KQ7	0	-	31836106	31836112	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	31836166	31836391	Q96KQ7	0	-	31836166	31836391	255,102,0	1	225	0	.	Interaction	with	histone	H3.
chr6	31838066	31838075	Q96KQ7	0	-	31838066	31838075	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr6	31838402	31838414	Q96KQ7	0	-	31838402	31838414	255,102,0	1	12	0	.	Interaction	with	histone	H3.
chr6	31838942	31838948	Q96KQ7	0	-	31838942	31838948	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	31839002	31839227	Q96KQ7	0	-	31839002	31839227	255,102,0	1	225	0	.	Interaction	with	histone	H3.
chr6	31840111	31840120	Q96KQ7	0	-	31840111	31840120	255,102,0	1	9	0	.	Histone	H3K9me	binding.
chr6	31840901	31840910	Q96KQ7	0	-	31840901	31840910	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr6	31842946	31842955	Q96KQ7	0	-	31842946	31842955	255,102,0	1	9	0	.	Histone	H3K9me	binding.
chr6	31848022	31848034	Q96KQ7	0	-	31848022	31848034	255,102,0	1	12	0	.	Interaction	with	histone	H3.
chr6	31848562	31848568	Q96KQ7	0	-	31848562	31848568	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	31848622	31848847	Q96KQ7	0	-	31848622	31848847	255,102,0	1	225	0	.	Interaction	with	histone	H3.
chr6	31850522	31850531	Q96KQ7	0	-	31850522	31850531	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr6	31850565	31851720	P0DMV8	0	+	31850565	31851720	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31850565	31851720	P0DMV9	0	+	31850565	31851720	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31851741	31852089	P0DMV8	0	+	31851741	31852089	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31851741	31852089	P0DMV9	0	+	31851741	31852089	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31852567	31852576	Q96KQ7	0	-	31852567	31852576	255,102,0	1	9	0	.	Histone	H3K9me	binding.
chr6	31862762	31863917	P0DMV8	0	+	31862762	31863917	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31862762	31863917	P0DMV9	0	+	31862762	31863917	255,102,0	1	1155	0	.	Nucleotide-binding	domain	(NBD).
chr6	31863938	31864286	P0DMV8	0	+	31863938	31864286	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31863938	31864286	P0DMV9	0	+	31863938	31864286	255,102,0	1	348	0	.	Substrate-binding	domain	(SBD).
chr6	31904531	31904711	P18615	0	-	31904531	31904711	255,102,0	1	180	0	.	30	X	2	AA	approximate	tandem	repeats	of	R-[DSNE].
chr6	31909890	31910070	P18615	0	-	31909890	31910070	255,102,0	1	180	0	.	30	X	2	AA	approximate	tandem	repeats	of	R-[DSNE].
chr6	31912726	31912906	P18615	0	-	31912726	31912906	255,102,0	1	180	0	.	30	X	2	AA	approximate	tandem	repeats	of	R-[DSNE].
chr6	31914998	31915178	P18615	0	-	31914998	31915178	255,102,0	1	180	0	.	30	X	2	AA	approximate	tandem	repeats	of	R-[DSNE].
chr6	31922344	31922524	P18615	0	-	31922344	31922524	255,102,0	1	180	0	.	30	X	2	AA	approximate	tandem	repeats	of	R-[DSNE].
chr6	31998787	31998967	P18615	0	-	31998787	31998967	255,102,0	1	180	0	.	30	X	2	AA	approximate	tandem	repeats	of	R-[DSNE].
chr6	32000921	32000972	P08686	0	+	32000921	32000972	255,102,0	1	51	0	.	Steroid-binding.
chr6	32035265	32035289	Q99941	0	-	32035265	32035289	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32035295	32035358	Q99941	0	-	32035295	32035358	255,102,0	1	63	0	.	Basic	motif.
chr6	32043413	32044431	Q99941	0	-	32043413	32044431	255,102,0	1	1018	0	.	Transcription	activation.
chr6	32062586	32062610	Q99941	0	-	32062586	32062610	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32062616	32062679	Q99941	0	-	32062616	32062679	255,102,0	1	63	0	.	Basic	motif.
chr6	32070734	32071752	Q99941	0	-	32070734	32071752	255,102,0	1	1018	0	.	Transcription	activation.
chr6	32084709	32084760	P08686	0	+	32084709	32084760	255,102,0	1	51	0	.	Steroid-binding.
chr6	32086813	32086837	Q99941	0	-	32086813	32086837	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32086843	32086906	Q99941	0	-	32086843	32086906	255,102,0	1	63	0	.	Basic	motif.
chr6	32094963	32095981	Q99941	0	-	32094963	32095981	255,102,0	1	1018	0	.	Transcription	activation.
chr6	32163240	32163264	Q99941	0	-	32163240	32163264	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32163270	32163333	Q99941	0	-	32163270	32163333	255,102,0	1	63	0	.	Basic	motif.
chr6	32171390	32172408	Q99941	0	-	32171390	32172408	255,102,0	1	1018	0	.	Transcription	activation.
chr6	32365258	32367923	P01903	0	+	32365258	32367923	255,102,0	1	2665	0	.	Alpha-1.
chr6	32368414	32368696	P01903	0	+	32368414	32368696	255,102,0	1	282	0	.	Alpha-2.
chr6	32368985	32369024	P01903	0	+	32368985	32369024	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32382514	32385179	P01903	0	+	32382514	32385179	255,102,0	1	2665	0	.	Alpha-1.
chr6	32385670	32385952	P01903	0	+	32385670	32385952	255,102,0	1	282	0	.	Alpha-2.
chr6	32386241	32386280	P01903	0	+	32386241	32386280	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32413625	32414618	P79483	0	-	32413625	32414618	255,102,0	1	993	0	.	Beta-2.
chr6	32414410	32417075	P01903	0	+	32414410	32417075	255,102,0	1	2665	0	.	Alpha-1.
chr6	32414618	32424858	P79483	0	-	32414618	32424858	255,102,0	1	10240	0	.	Beta-1.
chr6	32417566	32417848	P01903	0	+	32417566	32417848	255,102,0	1	282	0	.	Alpha-2.
chr6	32418137	32418176	P01903	0	+	32418137	32418176	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32446426	32449092	P01903	0	+	32446426	32449092	255,102,0	1	2666	0	.	Alpha-1.
chr6	32449583	32449865	P01903	0	+	32449583	32449865	255,102,0	1	282	0	.	Alpha-2.
chr6	32450154	32450193	P01903	0	+	32450154	32450193	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32477646	32477676	P01912	0	-	32477646	32477676	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32478374	32478656	P01912	0	-	32478374	32478656	255,102,0	1	282	0	.	Beta-2.
chr6	32480886	32489162	P01912	0	-	32480886	32489162	255,102,0	1	8276	0	.	Beta-1.
chr6	32482893	32482923	P01912	0	-	32482893	32482923	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32483175	32485840	P01903	0	+	32483175	32485840	255,102,0	1	2665	0	.	Alpha-1.
chr6	32483621	32483903	P01912	0	-	32483621	32483903	255,102,0	1	282	0	.	Beta-2.
chr6	32486143	32494419	P01912	0	-	32486143	32494419	255,102,0	1	8276	0	.	Beta-1.
chr6	32486331	32486613	P01903	0	+	32486331	32486613	255,102,0	1	282	0	.	Alpha-2.
chr6	32486414	32487426	Q30154	0	-	32486414	32487426	255,102,0	1	1012	0	.	Beta-2.
chr6	32486902	32486941	P01903	0	+	32486902	32486941	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32487426	32497914	Q30154	0	-	32487426	32497914	255,102,0	1	10488	0	.	Beta-1.
chr6	32511590	32512603	P13762	0	-	32511590	32512603	255,102,0	1	1013	0	.	Beta-2.
chr6	32512603	32525188	P13762	0	-	32512603	32525188	255,102,0	1	12585	0	.	Beta-1.
chr6	32518362	32519367	P13761	0	-	32518362	32519367	255,102,0	1	1005	0	.	Beta-2.
chr6	32519367	32532149	P13761	0	-	32519367	32532149	255,102,0	1	12782	0	.	Beta-1.
chr6	32533482	32538001	P01909	0	+	32533482	32538001	255,102,0	1	4519	0	.	Alpha-1.
chr6	32538001	32538253	P01909	0	+	32538001	32538253	255,102,0	1	252	0	.	Alpha-2.
chr6	32538616	32538655	P01909	0	+	32538616	32538655	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32538739	32543258	P01909	0	+	32538739	32543258	255,102,0	1	4519	0	.	Alpha-1.
chr6	32543258	32543510	P01909	0	+	32543258	32543510	255,102,0	1	252	0	.	Alpha-2.
chr6	32543873	32543912	P01909	0	+	32543873	32543912	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32548604	32549613	P01911	0	-	32548604	32549613	255,102,0	1	1009	0	.	Beta-2.
chr6	32549613	32557432	P01911	0	-	32549613	32557432	255,102,0	1	7819	0	.	Beta-1.
chr6	32580135	32581148	P13762	0	-	32580135	32581148	255,102,0	1	1013	0	.	Beta-2.
chr6	32581148	32593733	P13762	0	-	32581148	32593733	255,102,0	1	12585	0	.	Beta-1.
chr6	32632980	32636875	P01906	0	+	32632980	32636875	255,102,0	1	3895	0	.	Alpha-1.
chr6	32637258	32637540	P01906	0	+	32637258	32637540	255,102,0	1	282	0	.	Alpha-2.
chr6	32637707	32637746	P01906	0	+	32637707	32637746	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32660002	32660032	P01920	0	-	32660002	32660032	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32660549	32660831	P01920	0	-	32660549	32660831	255,102,0	1	282	0	.	Beta-2.
chr6	32663460	32665190	P01920	0	-	32663460	32665190	255,102,0	1	1730	0	.	Beta-1.
chr6	32688451	32692348	P01906	0	+	32688451	32692348	255,102,0	1	3897	0	.	Alpha-1.
chr6	32692731	32693013	P01906	0	+	32692731	32693013	255,102,0	1	282	0	.	Alpha-2.
chr6	32692762	32693767	P13761	0	-	32692762	32693767	255,102,0	1	1005	0	.	Beta-2.
chr6	32693180	32693219	P01906	0	+	32693180	32693219	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32693767	32706547	P13761	0	-	32693767	32706547	255,102,0	1	12780	0	.	Beta-1.
chr6	32703901	32703931	P13765	0	-	32703901	32703931	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32704417	32704699	P13765	0	-	32704417	32704699	255,102,0	1	282	0	.	Beta-2.
chr6	32705141	32706970	P13765	0	-	32705141	32706970	255,102,0	1	1829	0	.	Beta-1.
chr6	32709289	32713183	P01906	0	+	32709289	32713183	255,102,0	1	3894	0	.	Alpha-1.
chr6	32713566	32713848	P01906	0	+	32713566	32713848	255,102,0	1	282	0	.	Alpha-2.
chr6	32714015	32714054	P01906	0	+	32714015	32714054	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32720875	32722461	Q03519	0	-	32720875	32722461	255,102,0	1	1586	0	.	Involved	in	peptide-binding	site.
chr6	32722533	32725294	Q03519	0	-	32722533	32725294	255,102,0	1	2761	0	.	Involved	in	peptide-binding	site.
chr6	32727250	32728836	Q03519	0	-	32727250	32728836	255,102,0	1	1586	0	.	Involved	in	peptide-binding	site.
chr6	32728908	32731669	Q03519	0	-	32728908	32731669	255,102,0	1	2761	0	.	Involved	in	peptide-binding	site.
chr6	32738851	32739105	Q03518	0	-	32738851	32739105	255,102,0	1	254	0	.	Involved	in	peptide-binding	site.
chr6	32739201	32740540	Q03518	0	-	32739201	32740540	255,102,0	1	1339	0	.	Involved	in	peptide-binding	site.
chr6	32745228	32745482	Q03518	0	-	32745228	32745482	255,102,0	1	254	0	.	Involved	in	peptide-binding	site.
chr6	32745578	32746917	Q03518	0	-	32745578	32746917	255,102,0	1	1339	0	.	Involved	in	peptide-binding	site.
chr6	32749834	32753729	P01906	0	+	32749834	32753729	255,102,0	1	3895	0	.	Alpha-1.
chr6	32754112	32754394	P01906	0	+	32754112	32754394	255,102,0	1	282	0	.	Alpha-2.
chr6	32754561	32754600	P01906	0	+	32754561	32754600	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32781581	32781611	P13765	0	-	32781581	32781611	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32782097	32782379	P13765	0	-	32782097	32782379	255,102,0	1	282	0	.	Beta-2.
chr6	32782821	32784650	P13765	0	-	32782821	32784650	255,102,0	1	1829	0	.	Beta-1.
chr6	32794510	32794764	Q03518	0	-	32794510	32794764	255,102,0	1	254	0	.	Involved	in	peptide-binding	site.
chr6	32794860	32796197	Q03518	0	-	32794860	32796197	255,102,0	1	1337	0	.	Involved	in	peptide-binding	site.
chr6	32798556	32800142	Q03519	0	-	32798556	32800142	255,102,0	1	1586	0	.	Involved	in	peptide-binding	site.
chr6	32800214	32802975	Q03519	0	-	32800214	32802975	255,102,0	1	2761	0	.	Involved	in	peptide-binding	site.
chr6	32815081	32815111	P13765	0	-	32815081	32815111	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32815597	32815879	P13765	0	-	32815597	32815879	255,102,0	1	282	0	.	Beta-2.
chr6	32816321	32818150	P13765	0	-	32816321	32818150	255,102,0	1	1829	0	.	Beta-1.
chr6	32816533	32816787	Q03518	0	-	32816533	32816787	255,102,0	1	254	0	.	Involved	in	peptide-binding	site.
chr6	32816883	32818222	Q03518	0	-	32816883	32818222	255,102,0	1	1339	0	.	Involved	in	peptide-binding	site.
chr6	32821012	32821042	P13765	0	-	32821012	32821042	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32821528	32821810	P13765	0	-	32821528	32821810	255,102,0	1	282	0	.	Beta-2.
chr6	32822252	32824081	P13765	0	-	32822252	32824081	255,102,0	1	1829	0	.	Beta-1.
chr6	32832112	32832145	P28068	0	-	32832112	32832145	255,102,0	1	33	0	.	Connecting	peptide.
chr6	32833664	32833949	P28068	0	-	32833664	32833949	255,102,0	1	285	0	.	Beta-2.
chr6	32835176	32835458	P28068	0	-	32835176	32835458	255,102,0	1	282	0	.	Beta-1.
chr6	32850009	32850263	Q03518	0	-	32850009	32850263	255,102,0	1	254	0	.	Involved	in	peptide-binding	site.
chr6	32850359	32851696	Q03518	0	-	32850359	32851696	255,102,0	1	1337	0	.	Involved	in	peptide-binding	site.
chr6	32855805	32856059	Q03518	0	-	32855805	32856059	255,102,0	1	254	0	.	Involved	in	peptide-binding	site.
chr6	32856155	32857492	Q03518	0	-	32856155	32857492	255,102,0	1	1337	0	.	Involved	in	peptide-binding	site.
chr6	32872458	32872488	P13765	0	-	32872458	32872488	255,102,0	1	30	0	.	Connecting	peptide.
chr6	32872974	32873256	P13765	0	-	32872974	32873256	255,102,0	1	282	0	.	Beta-2.
chr6	32873698	32875527	P13765	0	-	32873698	32875527	255,102,0	1	1829	0	.	Beta-1.
chr6	32881333	32881366	P28068	0	-	32881333	32881366	255,102,0	1	33	0	.	Connecting	peptide.
chr6	32882885	32883170	P28068	0	-	32882885	32883170	255,102,0	1	285	0	.	Beta-2.
chr6	32884397	32884679	P28068	0	-	32884397	32884679	255,102,0	1	282	0	.	Beta-1.
chr6	32897241	32897280	P06340	0	-	32897241	32897280	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32897375	32897657	P06340	0	-	32897375	32897657	255,102,0	1	282	0	.	Alpha-2.
chr6	32898077	32899525	P06340	0	-	32898077	32899525	255,102,0	1	1448	0	.	Alpha-1.
chr6	32903635	32903674	P06340	0	-	32903635	32903674	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32903769	32904051	P06340	0	-	32903769	32904051	255,102,0	1	282	0	.	Alpha-2.
chr6	32904471	32905919	P06340	0	-	32904471	32905919	255,102,0	1	1448	0	.	Alpha-1.
chr6	32942649	32942682	P28068	0	-	32942649	32942682	255,102,0	1	33	0	.	Connecting	peptide.
chr6	32944201	32944486	P28068	0	-	32944201	32944486	255,102,0	1	285	0	.	Beta-2.
chr6	32945713	32945995	P28068	0	-	32945713	32945995	255,102,0	1	282	0	.	Beta-1.
chr6	32952315	32953901	Q03519	0	-	32952315	32953901	255,102,0	1	1586	0	.	Involved	in	peptide-binding	site.
chr6	32952901	32952940	P06340	0	-	32952901	32952940	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32953035	32953317	P06340	0	-	32953035	32953317	255,102,0	1	282	0	.	Alpha-2.
chr6	32953737	32955185	P06340	0	-	32953737	32955185	255,102,0	1	1448	0	.	Alpha-1.
chr6	32953973	32956734	Q03519	0	-	32953973	32956734	255,102,0	1	2761	0	.	Involved	in	peptide-binding	site.
chr6	32958513	32958552	P20036	0	-	32958513	32958552	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32958766	32959048	P20036	0	-	32958766	32959048	255,102,0	1	282	0	.	Alpha-2.
chr6	32959388	32963233	P20036	0	-	32959388	32963233	255,102,0	1	3845	0	.	Alpha-1.
chr6	32965582	32965621	P20036	0	-	32965582	32965621	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32965835	32966117	P20036	0	-	32965835	32966117	255,102,0	1	282	0	.	Alpha-2.
chr6	32966457	32970302	P20036	0	-	32966457	32970302	255,102,0	1	3845	0	.	Alpha-1.
chr6	32970293	32970547	Q03518	0	-	32970293	32970547	255,102,0	1	254	0	.	Involved	in	peptide-binding	site.
chr6	32970643	32971982	Q03518	0	-	32970643	32971982	255,102,0	1	1339	0	.	Involved	in	peptide-binding	site.
chr6	32974954	32974993	P06340	0	-	32974954	32974993	255,102,0	1	39	0	.	Connecting	peptide.
chr6	32975088	32975370	P06340	0	-	32975088	32975370	255,102,0	1	282	0	.	Alpha-2.
chr6	32975790	32977238	P06340	0	-	32975790	32977238	255,102,0	1	1448	0	.	Alpha-1.
chr6	33008416	33008455	P06340	0	-	33008416	33008455	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33008550	33008832	P06340	0	-	33008550	33008832	255,102,0	1	282	0	.	Alpha-2.
chr6	33009252	33010700	P06340	0	-	33009252	33010700	255,102,0	1	1448	0	.	Alpha-1.
chr6	33014481	33014520	P20036	0	-	33014481	33014520	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33014734	33015016	P20036	0	-	33014734	33015016	255,102,0	1	282	0	.	Alpha-2.
chr6	33015356	33019201	P20036	0	-	33015356	33019201	255,102,0	1	3845	0	.	Alpha-1.
chr6	33021843	33026649	P04440	0	+	33021843	33026649	255,102,0	1	4806	0	.	Beta-1.
chr6	33030655	33030937	P04440	0	+	33030655	33030937	255,102,0	1	282	0	.	Beta-2.
chr6	33031484	33031514	P04440	0	+	33031484	33031514	255,102,0	1	30	0	.	Connecting	peptide.
chr6	33036543	33036582	P20036	0	-	33036543	33036582	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33036796	33037078	P20036	0	-	33036796	33037078	255,102,0	1	282	0	.	Alpha-2.
chr6	33037418	33041263	P20036	0	-	33037418	33041263	255,102,0	1	3845	0	.	Alpha-1.
chr6	33043905	33048711	P04440	0	+	33043905	33048711	255,102,0	1	4806	0	.	Beta-1.
chr6	33052725	33053007	P04440	0	+	33052725	33053007	255,102,0	1	282	0	.	Beta-2.
chr6	33053554	33053584	P04440	0	+	33053554	33053584	255,102,0	1	30	0	.	Connecting	peptide.
chr6	33055202	33068878	P13942	0	-	33055202	33068878	255,102,0	1	13676	0	.	Triple-helical	region.
chr6	33057172	33057205	P28068	0	-	33057172	33057205	255,102,0	1	33	0	.	Connecting	peptide.
chr6	33058724	33059009	P28068	0	-	33058724	33059009	255,102,0	1	285	0	.	Beta-2.
chr6	33060236	33060518	P28068	0	-	33060236	33060518	255,102,0	1	282	0	.	Beta-1.
chr6	33068878	33076185	P13942	0	-	33068878	33076185	255,102,0	1	7307	0	.	Nonhelical	region.
chr6	33070015	33070054	P20036	0	-	33070015	33070054	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33070268	33070550	P20036	0	-	33070268	33070550	255,102,0	1	282	0	.	Alpha-2.
chr6	33070890	33074717	P20036	0	-	33070890	33074717	255,102,0	1	3827	0	.	Alpha-1.
chr6	33075630	33075669	P20036	0	-	33075630	33075669	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33075883	33076165	P20036	0	-	33075883	33076165	255,102,0	1	282	0	.	Alpha-2.
chr6	33076505	33080332	P20036	0	-	33076505	33080332	255,102,0	1	3827	0	.	Alpha-1.
chr6	33084087	33085839	P28702	0	-	33084087	33085839	255,102,0	1	1752	0	.	Ligand-binding.	Pubmed:11782480
chr6	33085839	33087174	P28702	0	-	33085839	33087174	255,102,0	1	1335	0	.	Hinge.
chr6	33087738	33089877	P28702	0	-	33087738	33089877	255,102,0	1	2139	0	.	Modulating.
chr6	33091272	33093024	P28702	0	-	33091272	33093024	255,102,0	1	1752	0	.	Ligand-binding.	Pubmed:11782480
chr6	33093024	33094359	P28702	0	-	33093024	33094359	255,102,0	1	1335	0	.	Hinge.
chr6	33094923	33097064	P28702	0	-	33094923	33097064	255,102,0	1	2141	0	.	Modulating.
chr6	33099031	33100801	Q06587	0	+	33099031	33100801	255,102,0	1	1770	0	.	Necessary	for	transcriptional	repression.
chr6	33100786	33101793	Q06587	0	+	33100786	33101793	255,102,0	1	1007	0	.	Necessary	for	interaction	with	CBX2.
chr6	33106226	33107996	Q06587	0	+	33106226	33107996	255,102,0	1	1770	0	.	Necessary	for	transcriptional	repression.
chr6	33107981	33108988	Q06587	0	+	33107981	33108988	255,102,0	1	1007	0	.	Necessary	for	interaction	with	CBX2.
chr6	33115613	33115652	P06340	0	-	33115613	33115652	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33115747	33116029	P06340	0	-	33115747	33116029	255,102,0	1	282	0	.	Alpha-2.
chr6	33116449	33117897	P06340	0	-	33116449	33117897	255,102,0	1	1448	0	.	Alpha-1.
chr6	33128709	33128748	P06340	0	-	33128709	33128748	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33128843	33129125	P06340	0	-	33128843	33129125	255,102,0	1	282	0	.	Alpha-2.
chr6	33129545	33130993	P06340	0	-	33129545	33130993	255,102,0	1	1448	0	.	Alpha-1.
chr6	33140367	33142119	P28702	0	-	33140367	33142119	255,102,0	1	1752	0	.	Ligand-binding.	Pubmed:11782480
chr6	33142119	33143454	P28702	0	-	33142119	33143454	255,102,0	1	1335	0	.	Hinge.
chr6	33144018	33146159	P28702	0	-	33144018	33146159	255,102,0	1	2141	0	.	Modulating.
chr6	33155317	33157087	Q06587	0	+	33155317	33157087	255,102,0	1	1770	0	.	Necessary	for	transcriptional	repression.
chr6	33157072	33158079	Q06587	0	+	33157072	33158079	255,102,0	1	1007	0	.	Necessary	for	interaction	with	CBX2.
chr6	33162461	33164213	P28702	0	-	33162461	33164213	255,102,0	1	1752	0	.	Ligand-binding.	Pubmed:11782480
chr6	33164213	33165548	P28702	0	-	33164213	33165548	255,102,0	1	1335	0	.	Hinge.
chr6	33166112	33168253	P28702	0	-	33166112	33168253	255,102,0	1	2141	0	.	Modulating.
chr6	33176991	33177030	P20036	0	-	33176991	33177030	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33177244	33177526	P20036	0	-	33177244	33177526	255,102,0	1	282	0	.	Alpha-2.
chr6	33177411	33179181	Q06587	0	+	33177411	33179181	255,102,0	1	1770	0	.	Necessary	for	transcriptional	repression.
chr6	33177866	33181711	P20036	0	-	33177866	33181711	255,102,0	1	3845	0	.	Alpha-1.
chr6	33179166	33180173	Q06587	0	+	33179166	33180173	255,102,0	1	1007	0	.	Necessary	for	interaction	with	CBX2.
chr6	33184353	33189159	P04440	0	+	33184353	33189159	255,102,0	1	4806	0	.	Beta-1.
chr6	33190647	33190686	P20036	0	-	33190647	33190686	255,102,0	1	39	0	.	Connecting	peptide.
chr6	33190900	33191182	P20036	0	-	33190900	33191182	255,102,0	1	282	0	.	Alpha-2.
chr6	33191522	33195367	P20036	0	-	33191522	33195367	255,102,0	1	3845	0	.	Alpha-1.
chr6	33193173	33193455	P04440	0	+	33193173	33193455	255,102,0	1	282	0	.	Beta-2.
chr6	33194002	33194032	P04440	0	+	33194002	33194032	255,102,0	1	30	0	.	Connecting	peptide.
chr6	33208128	33208152	Q9UER7	0	-	33208128	33208152	255,102,0	1	24	0	.	Sumo	interaction	motif	(SIM).
chr6	33208128	33208827	Q9UER7	0	-	33208128	33208827	255,102,0	1	699	0	.	Interaction	with	SPOP.	Pubmed:15240113
chr6	33208827	33209202	Q9UER7	0	-	33208827	33209202	255,102,0	1	375	0	.	Interaction	with	MAP3K5.
chr6	33208992	33209975	Q9UER7	0	-	33208992	33209975	255,102,0	1	983	0	.	Necessary	for	interaction	with	USP7.
chr6	33209762	33210611	Q9UER7	0	-	33209762	33210611	255,102,0	1	849	0	.	Interaction	with	histone	H3.3.
chr6	33210677	33211308	Q9UER7	0	-	33210677	33211308	255,102,0	1	631	0	.	Necessary	for	interaction	with	USP7	and	ATRX.
chr6	33215359	33215383	Q9UER7	0	-	33215359	33215383	255,102,0	1	24	0	.	Sumo	interaction	motif	(SIM).
chr6	33215359	33216058	Q9UER7	0	-	33215359	33216058	255,102,0	1	699	0	.	Interaction	with	SPOP.	Pubmed:15240113
chr6	33216058	33216433	Q9UER7	0	-	33216058	33216433	255,102,0	1	375	0	.	Interaction	with	MAP3K5.
chr6	33216223	33217206	Q9UER7	0	-	33216223	33217206	255,102,0	1	983	0	.	Necessary	for	interaction	with	USP7.
chr6	33216993	33217842	Q9UER7	0	-	33216993	33217842	255,102,0	1	849	0	.	Interaction	with	histone	H3.3.
chr6	33217908	33218539	Q9UER7	0	-	33217908	33218539	255,102,0	1	631	0	.	Necessary	for	interaction	with	USP7	and	ATRX.
chr6	33264446	33264470	Q9UER7	0	-	33264446	33264470	255,102,0	1	24	0	.	Sumo	interaction	motif	(SIM).
chr6	33264446	33265145	Q9UER7	0	-	33264446	33265145	255,102,0	1	699	0	.	Interaction	with	SPOP.	Pubmed:15240113
chr6	33265145	33265520	Q9UER7	0	-	33265145	33265520	255,102,0	1	375	0	.	Interaction	with	MAP3K5.
chr6	33265310	33266293	Q9UER7	0	-	33265310	33266293	255,102,0	1	983	0	.	Necessary	for	interaction	with	USP7.
chr6	33266080	33266929	Q9UER7	0	-	33266080	33266929	255,102,0	1	849	0	.	Interaction	with	histone	H3.3.
chr6	33266995	33267626	Q9UER7	0	-	33266995	33267626	255,102,0	1	631	0	.	Necessary	for	interaction	with	USP7	and	ATRX.
chr6	33286522	33286546	Q9UER7	0	-	33286522	33286546	255,102,0	1	24	0	.	Sumo	interaction	motif	(SIM).
chr6	33286522	33287221	Q9UER7	0	-	33286522	33287221	255,102,0	1	699	0	.	Interaction	with	SPOP.	Pubmed:15240113
chr6	33287221	33287596	Q9UER7	0	-	33287221	33287596	255,102,0	1	375	0	.	Interaction	with	MAP3K5.
chr6	33287386	33288369	Q9UER7	0	-	33287386	33288369	255,102,0	1	983	0	.	Necessary	for	interaction	with	USP7.
chr6	33288156	33289005	Q9UER7	0	-	33288156	33289005	255,102,0	1	849	0	.	Interaction	with	histone	H3.3.
chr6	33289071	33289702	Q9UER7	0	-	33289071	33289702	255,102,0	1	631	0	.	Necessary	for	interaction	with	USP7	and	ATRX.
chr6	33316341	33318093	P28702	0	-	33316341	33318093	255,102,0	1	1752	0	.	Ligand-binding.	Pubmed:11782480
chr6	33318093	33319428	P28702	0	-	33318093	33319428	255,102,0	1	1335	0	.	Hinge.
chr6	33319992	33322133	P28702	0	-	33319992	33322133	255,102,0	1	2141	0	.	Modulating.
chr6	33331295	33333065	Q06587	0	+	33331295	33333065	255,102,0	1	1770	0	.	Necessary	for	transcriptional	repression.
chr6	33332824	33334574	P28702	0	-	33332824	33334574	255,102,0	1	1750	0	.	Ligand-binding.	Pubmed:11782480
chr6	33333050	33334057	Q06587	0	+	33333050	33334057	255,102,0	1	1007	0	.	Necessary	for	interaction	with	CBX2.
chr6	33334574	33335909	P28702	0	-	33334574	33335909	255,102,0	1	1335	0	.	Hinge.
chr6	33336473	33338613	P28702	0	-	33336473	33338613	255,102,0	1	2140	0	.	Modulating.
chr6	33347771	33349541	Q06587	0	+	33347771	33349541	255,102,0	1	1770	0	.	Necessary	for	transcriptional	repression.
chr6	33349526	33350533	Q06587	0	+	33349526	33350533	255,102,0	1	1007	0	.	Necessary	for	interaction	with	CBX2.
chr6	33384438	33384465	O60888	0	-	33384438	33384465	255,102,0	1	27	0	.	O-glycosylated	at	one	site.
chr6	33456863	33456887	Q9UER7	0	-	33456863	33456887	255,102,0	1	24	0	.	Sumo	interaction	motif	(SIM).
chr6	33456863	33457562	Q9UER7	0	-	33456863	33457562	255,102,0	1	699	0	.	Interaction	with	SPOP.	Pubmed:15240113
chr6	33457562	33457937	Q9UER7	0	-	33457562	33457937	255,102,0	1	375	0	.	Interaction	with	MAP3K5.
chr6	33457727	33458710	Q9UER7	0	-	33457727	33458710	255,102,0	1	983	0	.	Necessary	for	interaction	with	USP7.
chr6	33458497	33459346	Q9UER7	0	-	33458497	33459346	255,102,0	1	849	0	.	Interaction	with	histone	H3.3.
chr6	33459412	33460043	Q9UER7	0	-	33459412	33460043	255,102,0	1	631	0	.	Necessary	for	interaction	with	USP7	and	ATRX.
chr6	33524628	33524655	O60888	0	-	33524628	33524655	255,102,0	1	27	0	.	O-glycosylated	at	one	site.
chr6	33630388	33630403	Q14573	0	+	33630388	33630403	255,102,0	1	15	0	.	Inositol	1,4,5-trisphosphate	binding.
chr6	33633720	33633732	Q14573	0	+	33633720	33633732	255,102,0	1	12	0	.	Inositol	1,4,5-trisphosphate	binding.
chr6	33635052	33635061	Q14573	0	+	33635052	33635061	255,102,0	1	9	0	.	Inositol	1,4,5-trisphosphate	binding.
chr6	33693325	33693352	Q96PC2	0	-	33693325	33693352	255,102,0	1	27	0	.	Substrate	binding.
chr6	33756584	33756674	Q8NC56	0	-	33756584	33756674	255,102,0	1	90	0	.	Interaction	with	lamin	A/C	complexes.
chr6	34059849	34059858	Q14833	0	-	34059849	34059858	255,102,0	1	9	0	.	Glutamate	binding.
chr6	34210509	34211256	P17096	0	+	34210509	34211256	255,102,0	1	747	0	.	Interaction	with	HIPK2.
chr6	34261294	34261303	O95989	0	-	34261294	34261303	255,102,0	1	9	0	.	Substrate	binding.
chr6	34360079	34360088	O95989	0	-	34360079	34360088	255,102,0	1	9	0	.	Substrate	binding.
chr6	35253930	35255487	P36508	0	+	35253930	35255487	255,102,0	1	1557	0	.	3	X	12	AA	approximate	repeats.
chr6	35392237	35393853	Q03181	0	+	35392237	35393853	255,102,0	1	1616	0	.	Ligand-binding.
chr6	35423722	35426217	Q9HB96	0	+	35423722	35426217	255,102,0	1	2495	0	.	Interaction	with	FANCC.	Pubmed:12649160
chr6	35911679	35923171	Q96RN1	0	-	35911679	35923171	255,102,0	1	11492	0	.	Interaction	with	RACGAP1.	Pubmed:11278976
chr6	36020566	36020572	Q16539	0	+	36020566	36020572	255,102,0	1	6	0	.	Inhibitor-binding.
chr6	36040659	36040674	Q16539	0	+	36040659	36040674	255,102,0	1	15	0	.	Inhibitor-binding.
chr6	36043630	36043636	Q16539	0	+	36043630	36043636	255,102,0	1	6	0	.	Inhibitor-binding.
chr6	36492162	36492240	Q15208	0	-	36492162	36492240	255,102,0	1	78	0	.	Interaction	with	S100B.	Pubmed:14661952
chr6	36564539	36566689	P84103	0	+	36564539	36566689	255,102,0	1	2150	0	.	Sufficient	for	interaction	with	NXF1.
chr6	36568941	36569763	P84103	0	+	36568941	36569763	255,102,0	1	822	0	.	2	X	approximate	repeats,	basic.
chr6	36651926	36651950	P38936	0	+	36651926	36651950	255,102,0	1	24	0	.	Required	for	binding	cyclins.
chr6	36652034	36652052	P38936	0	+	36652034	36652052	255,102,0	1	18	0	.	Required	for	binding	CDKs.
chr6	36823750	36823765	Q9Y3C6	0	-	36823750	36823765	255,102,0	1	15	0	.	Cyclosporin	A	binding.
chr6	36823777	36823795	Q9Y3C6	0	-	36823777	36823795	255,102,0	1	18	0	.	Cyclosporin	A	binding.
chr6	36824428	36839497	Q9Y3C6	0	-	36824428	36839497	255,102,0	1	15069	0	.	Cyclosporin	A	binding.
chr6	36839509	36839545	Q9Y3C6	0	-	36839509	36839545	255,102,0	1	36	0	.	Cyclosporin	A	binding.
chr6	36931273	36931303	Q6UXB8	0	+	36931273	36931303	255,102,0	1	30	0	.	O-glycosylated	at	one	site.
chr6	37419650	37420834	Q8N1G2	0	+	37419650	37420834	255,102,0	1	1184	0	.	Substrate	binding.	Pubmed:24402442
chr6	37426438	37426459	Q8N1G2	0	+	37426438	37426459	255,102,0	1	21	0	.	S-adenosyl-L-methionine	binding.	Pubmed:24402442
chr6	37427367	37427373	Q8N1G2	0	+	37427367	37427373	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:24402442
chr6	37429348	37429357	Q8N1G2	0	+	37429348	37429357	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:24402442
chr6	37446209	37447918	Q8N1G2	0	+	37446209	37447918	255,102,0	1	1709	0	.	Interaction	with	POLR2A.	Pubmed:18533109
chr6	38645151	38645157	Q04760	0	-	38645151	38645157	255,102,0	1	6	0	.	Substrate	binding.
chr6	38828346	38835885	Q96JB1	0	+	38828346	38835885	255,102,0	1	7539	0	.	AAA	1.
chr6	38838266	38841110	Q96JB1	0	+	38838266	38841110	255,102,0	1	2844	0	.	AAA	2.
chr6	38850723	38862551	Q96JB1	0	+	38850723	38862551	255,102,0	1	11828	0	.	AAA	3.
chr6	38866081	38879256	Q96JB1	0	+	38866081	38879256	255,102,0	1	13175	0	.	AAA	4.
chr6	38879298	38890860	Q96JB1	0	+	38879298	38890860	255,102,0	1	11562	0	.	Stalk.
chr6	38891920	38905823	Q96JB1	0	+	38891920	38905823	255,102,0	1	13903	0	.	AAA	5.
chr6	38919124	38950211	Q96JB1	0	+	38919124	38950211	255,102,0	1	31087	0	.	AAA	6.
chr6	39874135	39874804	Q9NZB8	0	-	39874135	39874804	255,102,0	1	669	0	.	Molybdenum	cofactor	biosynthesis	protein	C.
chr6	39880031	39880040	Q9NZB8	0	-	39880031	39880040	255,102,0	1	9	0	.	GTP	binding.
chr6	40998413	41001750	Q8IV45	0	-	40998413	41001750	255,102,0	1	3337	0	.	Interaction	with	RELA	and	NFKB1.	Pubmed:14769797
chr6	41035157	41036581	Q9Y530	0	-	41035157	41036581	255,102,0	1	1424	0	.	Substrate	binding.
chr6	41556448	41557553	Q8IVH2	0	+	41556448	41557553	255,102,0	1	1105	0	.	Leucine-zipper.
chr6	41652810	41653887	P19484	0	-	41652810	41653887	255,102,0	1	1077	0	.	Leucine-zipper.
chr6	41657522	41658403	P19484	0	-	41657522	41658403	255,102,0	1	881	0	.	Strong	transcription	activation	domain.
chr6	42196085	42236014	Q96PN7	0	-	42196085	42236014	255,102,0	1	39929	0	.	Interaction	with	CREBBP.	Pubmed:11349124
chr6	42930513	42930519	Q14749	0	+	42930513	42930519	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	42930513	42930519	V9HW60	0	+	42930513	42930519	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr6	42974203	42974251	Q14738	0	+	42974203	42974251	255,102,0	1	48	0	.	8	X	2	AA	approximate	tandem	repeats	of	Q-P.
chr6	43017889	43018861	Q14999	0	-	43017889	43018861	255,102,0	1	972	0	.	Interaction	with	TP53.
chr6	43112316	43128616	Q13308	0	+	43112316	43128616	255,102,0	1	16300	0	.	Interaction	with	CTNNB1.	Pubmed:21132015
chr6	43139895	43141737	P11831	0	+	43139895	43141737	255,102,0	1	1842	0	.	Involved	in	dimerization.
chr6	43193605	43193614	O43598	0	-	43193605	43193614	255,102,0	1	9	0	.	Substrate	binding;	shared	with	homodimeric	partner.
chr6	43197104	43197125	O43598	0	-	43197104	43197125	255,102,0	1	21	0	.	Substrate	binding.	Pubmed:25108359
chr6	43516137	43519166	Q9HAV4	0	-	43516137	43519166	255,102,0	1	3029	0	.	Necessary	for	interaction	with	ILF3.
chr6	43538707	43543598	Q9HAV4	0	-	43538707	43543598	255,102,0	1	4891	0	.	Necessary	for	interaction	with	Ran.
chr6	43604203	43604305	Q15013	0	+	43604203	43604305	255,102,0	1	102	0	.	Interaction	with	MAD2L1.
chr6	44144632	44148209	Q9UMQ6	0	+	44144632	44148209	255,102,0	1	3577	0	.	Domain	III.
chr6	44148209	44148354	Q9UMQ6	0	+	44148209	44148354	255,102,0	1	145	0	.	Linker.
chr6	44148354	44151663	Q9UMQ6	0	+	44148354	44151663	255,102,0	1	3309	0	.	Domain	IV.
chr6	44371603	44371624	Q99459	0	+	44371603	44371624	255,102,0	1	21	0	.	Required	for	interaction	with	CTNNBL1.	Pubmed:21385873
chr6	44374078	44394386	Q99459	0	+	44374078	44394386	255,102,0	1	20308	0	.	Interaction	with	PPP1R8.	Pubmed:10827081
chr6	44392251	44397533	Q99459	0	+	44392251	44397533	255,102,0	1	5282	0	.	Interaction	with	DAPK3.
chr6	44413415	44414439	Q99459	0	+	44413415	44414439	255,102,0	1	1024	0	.	Interaction	with	PLRG1.	Pubmed:11544257
chr6	45459715	45459766	Q13950	0	+	45459715	45459766	255,102,0	1	51	0	.	Required	for	interaction	with	FOXO1.
chr6	45480128	45514793	Q13950	0	+	45480128	45514793	255,102,0	1	34665	0	.	Interaction	with	KAT6A.
chr6	45514595	45514880	Q13950	0	+	45514595	45514880	255,102,0	1	285	0	.	Interaction	with	KAT6B.	Pubmed:11965546
chr6	46766851	46794101	Q16819	0	+	46766851	46794101	255,102,0	1	27250	0	.	Metalloprotease.
chr6	47445980	47522486	Q9Y5K6	0	+	47445980	47522486	255,102,0	1	76506	0	.	Interaction	with	ANLN	and	localization	to	the	midbody.	Pubmed:15800069
chr6	49754702	49754714	A0A140VJR3	0	-	49754702	49754714	255,102,0	1	12	0	.	Substrate	binding.
chr6	49754702	49754714	P07205	0	-	49754702	49754714	255,102,0	1	12	0	.	Substrate	binding.
chr6	49754822	49754831	A0A140VJR3	0	-	49754822	49754831	255,102,0	1	9	0	.	Substrate	binding.
chr6	49754822	49754831	P07205	0	-	49754822	49754831	255,102,0	1	9	0	.	Substrate	binding.
chr6	50696979	50740448	Q7Z6R9	0	+	50696979	50740448	255,102,0	1	43469	0	.	H-S-H	(helix-span-helix),	dimerization.
chr6	52619808	52619814	P09210	0	-	52619808	52619814	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:20083122
chr6	52619847	52619853	P09210	0	-	52619847	52619853	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:20083122
chr6	52661047	52661053	P08263	0	-	52661047	52661053	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:19618965,	Pubmed:16421451
chr6	52661086	52661092	P08263	0	-	52661086	52661092	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:19618965,	Pubmed:16421451
chr6	52701101	52701107	Q7RTV2	0	-	52701101	52701107	255,102,0	1	6	0	.	Glutathione	binding.
chr6	52701140	52701146	Q7RTV2	0	-	52701140	52701146	255,102,0	1	6	0	.	Glutathione	binding.
chr6	52767211	52767217	Q16772	0	-	52767211	52767217	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:20083122,	Pubmed:15595823
chr6	52767250	52767256	Q16772	0	-	52767250	52767256	255,102,0	1	6	0	.	Glutathione	binding.	Pubmed:20083122,	Pubmed:15595823
chr6	52850316	52850322	O15217	0	-	52850316	52850322	255,102,0	1	6	0	.	Glutathione	binding.
chr6	52850355	52850361	O15217	0	-	52850355	52850361	255,102,0	1	6	0	.	Glutathione	binding.
chr6	53883826	53986301	Q5VWP3	0	+	53883826	53986301	255,102,0	1	102475	0	.	Interaction	with	LMNA.	Pubmed:21498514
chr6	54735044	54804621	Q5T0W9	0	+	54735044	54804621	255,102,0	1	69577	0	.	Required	for	interaction	with	RAF1	and	for	the	function.	Pubmed:22886302
chr6	55039481	55039532	O43614	0	+	55039481	55039532	255,102,0	1	51	0	.	Required	for	response	to	orexin-A.	Pubmed:26950369
chr6	56911553	56917966	Q9HCI6	0	+	56911553	56917966	255,102,0	1	6413	0	.	Sufficient	for	E3	SUMO-protein	ligase	activity.
chr6	56912176	56915577	Q9HCI6	0	+	56912176	56915577	255,102,0	1	3401	0	.	Interaction	with	SUMO2	1.
chr6	56915589	56915616	Q9HCI6	0	+	56915589	56915616	255,102,0	1	27	0	.	Interaction	with	SUMO2	2.
chr6	56955051	57006135	Q9Y4E5	0	+	56955051	57006135	255,102,0	1	51084	0	.	Sufficient	for	E3	SUMO-protein	ligase	activity.	Pubmed:26524493
chr6	56955051	57011915	Q9Y4E5	0	+	56955051	57011915	255,102,0	1	56864	0	.	Important	for	interaction	with	SUMO1	and	SUMO2.	Pubmed:18656483
chr6	56955674	56963864	Q9Y4E5	0	+	56955674	56963864	255,102,0	1	8190	0	.	Interaction	with	SUMO2	1.	Pubmed:26524494
chr6	56963876	56963903	Q9Y4E5	0	+	56963876	56963903	255,102,0	1	27	0	.	Interaction	with	SUMO2	2.	Pubmed:26524494
chr6	56997916	57012458	Q9Y4E5	0	+	56997916	57012458	255,102,0	1	14542	0	.	Important	for	interaction	with	SMAD4.	Pubmed:24324267
chr6	57033228	57033264	Q9Y4E5	0	+	57033228	57033264	255,102,0	1	36	0	.	Important	for	ubiquitin	binding.	Pubmed:18656483
chr6	64288892	64289228	Q93096	0	+	64288892	64289228	255,102,0	1	336	0	.	Interaction	with	ATF5.
chr6	64288916	64288934	Q93096	0	+	64288916	64288934	255,102,0	1	18	0	.	Phosphate	binding.
chr6	70647929	70733545	Q14993	0	+	70647929	70733545	255,102,0	1	85616	0	.	Triple-helical	region	1	(COL1).
chr6	70744163	70831780	Q14993	0	+	70744163	70831780	255,102,0	1	87617	0	.	Triple-helical	region	2	(COL2).
chr6	70840073	70861315	Q14993	0	+	70840073	70861315	255,102,0	1	21242	0	.	Triple-helical	region	3	(COL3).
chr6	70866036	70877925	Q14993	0	+	70866036	70877925	255,102,0	1	11889	0	.	Triple-helical	region	4	(COL4).
chr6	70909376	70916882	Q14993	0	+	70909376	70916882	255,102,0	1	7506	0	.	Triple-helical	region	6	(COL6).
chr6	70926602	70926662	P20849	0	-	70926602	70926662	255,102,0	1	60	0	.	Nonhelical	region	(NC1).
chr6	70926662	70942430	P20849	0	-	70926662	70942430	255,102,0	1	15768	0	.	Triple-helical	region	(COL1).
chr6	70942430	70944287	P20849	0	-	70942430	70944287	255,102,0	1	1857	0	.	Nonhelical	region	(NC2).
chr6	70944287	70978542	P20849	0	-	70944287	70978542	255,102,0	1	34255	0	.	Triple-helical	region	(COL2).
chr6	70978542	70979350	P20849	0	-	70978542	70979350	255,102,0	1	808	0	.	Nonhelical	region	(NC3).
chr6	70979350	70991164	P20849	0	-	70979350	70991164	255,102,0	1	11814	0	.	Triple-helical	region	(COL3).
chr6	70991164	71011722	P20849	0	-	70991164	71011722	255,102,0	1	20558	0	.	Nonhelical	region	(NC4).
chr6	71603837	71603867	Q9NPZ5	0	-	71603837	71603867	255,102,0	1	30	0	.	Interaction	with	galactose	moiety	of	substrate	glycoprotein.
chr6	74135297	74138499	Q8N884	0	-	74135297	74138499	255,102,0	1	3202	0	.	DNA-binding.	Pubmed:23707061
chr6	74161259	74161388	Q8N884	0	-	74161259	74161388	255,102,0	1	129	0	.	DNA-binding.	Pubmed:23707061
chr6	74228687	74228696	P68104	0	-	74228687	74228696	255,102,0	1	9	0	.	G5.
chr6	74228807	74228819	P68104	0	-	74228807	74228819	255,102,0	1	12	0	.	G4.
chr6	74229101	74229113	P68104	0	-	74229101	74229113	255,102,0	1	12	0	.	G3.
chr6	74229161	74229176	P68104	0	-	74229161	74229176	255,102,0	1	15	0	.	G2.
chr6	74229686	74229710	P68104	0	-	74229686	74229710	255,102,0	1	24	0	.	G1.
chr6	74481253	74492479	Q6YHK3	0	+	74481253	74492479	255,102,0	1	11226	0	.	Bait	region	(approximate).
chr6	75796265	75797341	Q99715	0	-	75796265	75797341	255,102,0	1	1076	0	.	Nonhelical	region	(NC1).
chr6	75797341	75799943	Q99715	0	-	75797341	75799943	255,102,0	1	2602	0	.	Triple-helical	region	(COL1)	with	2	imperfections.
chr6	75799943	75801096	Q99715	0	-	75799943	75801096	255,102,0	1	1153	0	.	Nonhelical	region	(NC2).
chr6	75801096	75814948	Q99715	0	-	75801096	75814948	255,102,0	1	13852	0	.	Triple-helical	region	(COL2)	with	1	imperfection.
chr6	75814948	75828762	Q99715	0	-	75814948	75828762	255,102,0	1	13814	0	.	Nonhelical	region	(NC3).
chr6	76388563	76425307	Q9GZR1	0	+	76388563	76425307	255,102,0	1	36744	0	.	Protease.
chr6	78172127	78172142	P28222	0	-	78172127	78172142	255,102,0	1	15	0	.	Agonist	binding.
chr6	78172718	78172748	P28222	0	-	78172718	78172748	255,102,0	1	30	0	.	Agonist	binding.
chr6	79577293	79577566	Q5VVH5	0	+	79577293	79577566	255,102,0	1	273	0	.	Intrinsically	disordered.
chr6	79607985	79608048	Q5VVH5	0	+	79607985	79608048	255,102,0	1	63	0	.	Required	for	nuclear	localization	(NLS).
chr6	79672961	79688428	Q8WWQ0	0	-	79672961	79688428	255,102,0	1	15467	0	.	Mediates	interaction	with	IRS1.
chr6	83602743	83667123	Q7Z6J8	0	-	83602743	83667123	255,102,0	1	64380	0	.	HECT-like.
chr6	83732246	83733722	Q7Z6J8	0	-	83732246	83733722	255,102,0	1	1476	0	.	Interaction	with	UBE2C.	Pubmed:15749827
chr6	83880062	83880077	A0A087WT27	0	-	83880062	83880077	255,102,0	1	15	0	.	Substrate	binding.
chr6	83880062	83880077	J3KN95	0	-	83880062	83880077	255,102,0	1	15	0	.	Substrate	binding.
chr6	83880062	83880077	O95394	0	-	83880062	83880077	255,102,0	1	15	0	.	Substrate	binding.
chr6	83885692	83885701	A0A087WT27	0	-	83885692	83885701	255,102,0	1	9	0	.	Substrate	binding.
chr6	83885692	83885701	J3KN95	0	-	83885692	83885701	255,102,0	1	9	0	.	Substrate	binding.
chr6	83885692	83885701	O95394	0	-	83885692	83885701	255,102,0	1	9	0	.	Substrate	binding.
chr6	84563869	84567057	Q5TAB7	0	+	84563869	84567057	255,102,0	1	3188	0	.	Ripply	homology	domain.
chr6	86201831	86201852	P21589	0	+	86201831	86201852	255,102,0	1	21	0	.	Substrate	binding.
chr6	86324662	86328618	O60506	0	-	86324662	86328618	255,102,0	1	3956	0	.	Interaction	with	APOBEC1.
chr6	86324668	86325004	O60506	0	-	86324668	86325004	255,102,0	1	336	0	.	8	X	3	AA	repeats	of	R-G-G.
chr6	86324698	86324794	O60506	0	-	86324698	86324794	255,102,0	1	96	0	.	Interaction	with	SMN.	Pubmed:11574476
chr6	86324881	86324968	O60506	0	-	86324881	86324968	255,102,0	1	87	0	.	3	X	4	AA	repeats	of	Y-Y-G-Y.
chr6	87725343	87725373	P28566	0	+	87725343	87725373	255,102,0	1	30	0	.	Agonist	binding.
chr6	87725961	87725976	P28566	0	+	87725961	87725976	255,102,0	1	15	0	.	Agonist	binding.
chr6	89322440	89601634	O60942	0	-	89322440	89601634	255,102,0	1	279194	0	.	GTase.
chr6	89554186	89563392	O60942	0	-	89554186	89563392	255,102,0	1	9206	0	.	Interaction	with	POLR2A.
chr6	89614481	89673128	O60942	0	-	89614481	89673128	255,102,0	1	58647	0	.	TPase.
chr6	90647871	90647895	Q9BYV9	0	-	90647871	90647895	255,102,0	1	24	0	.	Leucine-zipper.
chr6	90647904	90647955	Q9BYV9	0	-	90647904	90647955	255,102,0	1	51	0	.	Basic	motif.
chr6	91260235	91296602	O43318	0	-	91260235	91296602	255,102,0	1	36367	0	.	Interaction	with	MAPK8IP1.
chr6	96034492	96054278	Q5SRI9	0	+	96034492	96054278	255,102,0	1	19786	0	.	Catalytic.
chr6	96969752	96982142	O94874	0	+	96969752	96982142	255,102,0	1	12390	0	.	Mediates	interaction	with	DDRGK1.	Pubmed:25219498
chr6	96969752	96982178	O94874	0	+	96969752	96982178	255,102,0	1	12426	0	.	Required	for	E3	UFM1-protein	ligase	activity.	Pubmed:20018847
chr6	96974206	96984214	O94874	0	+	96974206	96984214	255,102,0	1	10008	0	.	Involved	in	CDK5RAP3-binding.	Pubmed:20164180
chr6	96982139	96988452	O94874	0	+	96982139	96988452	255,102,0	1	6313	0	.	Mediates	interaction	with	TRIP4.	Pubmed:25219498
chr6	102337535	102337544	Q13002	0	+	102337535	102337544	255,102,0	1	9	0	.	Glutamate	binding.
chr6	102376486	102376492	Q13002	0	+	102376486	102376492	255,102,0	1	6	0	.	Glutamate	binding.
chr6	105572511	105573399	Q8NE79	0	-	105572511	105573399	255,102,0	1	888	0	.	Required	for	interaction	with	KCNK2.	Pubmed:26642364
chr6	105577259	105577328	Q8NE79	0	-	105577259	105577328	255,102,0	1	69	0	.	Required	for	interaction	with	CAV3.
chr6	106553613	106553757	O75626	0	+	106553613	106553757	255,102,0	1	144	0	.	Interaction	with	PIAS1.
chr6	108499361	108508571	Q9Y466	0	+	108499361	108508571	255,102,0	1	9210	0	.	Ligand-binding.
chr6	108508529	108508664	Q9Y466	0	+	108508529	108508664	255,102,0	1	135	0	.	Required	for	transcriptional	repression.
chr6	108533355	108533403	O60493	0	-	108533355	108533403	255,102,0	1	48	0	.	Binds	predominantly	to	PtdIns(P5)	and	weaker	to	PtdIns(P3)	abd	PtdIns(P4);	involved	in	neurite	outgrowth	regulation.
chr6	108984933	108986055	O43524	0	+	108984933	108986055	255,102,0	1	1122	0	.	Mediates	interaction	with	CHUK/IKKA	and	IKBKB/IKKB.	Pubmed:15084260
chr6	109308749	109314085	Q9Y6P5	0	-	109308749	109314085	255,102,0	1	5336	0	.	C-terminal	domain;	mediates	TORC1	regulation.
chr6	109311927	109311939	Q9Y6P5	0	-	109311927	109311939	255,102,0	1	12	0	.	Leucine-binding.
chr6	109319754	109322649	Q9Y6P5	0	-	109319754	109322649	255,102,0	1	2895	0	.	N-terminal	domain;	mediates	the	alkylhydroperoxide	reductase	activity.
chr6	109690056	109690077	Q04900	0	-	109690056	109690077	255,102,0	1	21	0	.	Required	for	endosomal	and	lysosomal	localization.
chr6	109765414	109766651	Q8TDZ2	0	-	109765414	109766651	255,102,0	1	1237	0	.	RAB-binding	domain	(RBD).	Pubmed:27552051
chr6	109770651	109775399	Q8TDZ2	0	-	109770651	109775399	255,102,0	1	4748	0	.	Monooxygenase	domain.
chr6	109827575	109835472	Q5TCS8	0	-	109827575	109835472	255,102,0	1	7897	0	.	Adenylate	kinase	3.
chr6	109827728	109827879	Q5TCS8	0	-	109827728	109827879	255,102,0	1	151	0	.	LID	3.
chr6	109830446	109830542	Q5TCS8	0	-	109830446	109830542	255,102,0	1	96	0	.	NMPbind	3.
chr6	109850237	109867321	Q5TCS8	0	-	109850237	109867321	255,102,0	1	17084	0	.	Adenylate	kinase	2.
chr6	109854591	109854654	Q5TCS8	0	-	109854591	109854654	255,102,0	1	63	0	.	LID	2.
chr6	109867138	109867234	Q5TCS8	0	-	109867138	109867234	255,102,0	1	96	0	.	NMPbind	2.
chr6	109962798	109996858	Q5TCS8	0	-	109962798	109996858	255,102,0	1	34060	0	.	Adenylate	kinase	1.
chr6	109980445	109980583	Q5TCS8	0	-	109980445	109980583	255,102,0	1	138	0	.	LID	1.
chr6	109993185	109995404	Q5TCS8	0	-	109993185	109995404	255,102,0	1	2219	0	.	NMPbind	1.
chr6	111693863	111694019	O60673	0	-	111693863	111694019	255,102,0	1	156	0	.	Mediates	interaction	with	MAD2L2.	Pubmed:10660610
chr6	111912548	111922417	O43734	0	-	111912548	111922417	255,102,0	1	9869	0	.	Mediates	interaction	with	TRAF6.	Pubmed:12459498
chr6	114181209	114181284	P29966	0	+	114181209	114181284	255,102,0	1	75	0	.	Calmodulin-binding	(PSD).
chr6	114267187	114292048	Q92769	0	-	114267187	114292048	255,102,0	1	24861	0	.	Histone	deacetylase.
chr6	114378780	114378786	Q8IZT8	0	-	114378780	114378786	255,102,0	1	6	0	.	Substrate	binding.
chr6	114378987	114378999	Q8IZT8	0	-	114378987	114378999	255,102,0	1	12	0	.	Substrate	binding.
chr6	114379077	114379098	Q8IZT8	0	-	114379077	114379098	255,102,0	1	21	0	.	Substrate	binding.
chr6	116441238	116441721	Q03692	0	-	116441238	116441721	255,102,0	1	483	0	.	Nonhelical	region	(NC1).
chr6	116441721	116443110	Q03692	0	-	116441721	116443110	255,102,0	1	1389	0	.	Triple-helical	region.
chr6	116443110	116446601	Q03692	0	-	116443110	116446601	255,102,0	1	3491	0	.	Nonhelical	region	(NC2).
chr6	116911443	116912094	Q9H446	0	+	116911443	116912094	255,102,0	1	651	0	.	Interaction	with	DRG2.
chr6	118880129	118880150	P26678	0	+	118880129	118880150	255,102,0	1	21	0	.	Involved	in	HAX1	binding.
chr6	119215577	119228632	Q9Y294	0	+	119215577	119228632	255,102,0	1	13054	0	.	Interaction	with	histone	H3,	CHAF1B,	and	HIRA.
chr6	119228626	119228776	Q9Y294	0	+	119228626	119228776	255,102,0	1	150	0	.	Required	for	interaction	with	HIRA.
chr6	121768722	121769139	P17302	0	+	121768722	121769139	255,102,0	1	417	0	.	Interaction	with	NOV.
chr6	121768782	121769139	P17302	0	+	121768782	121769139	255,102,0	1	357	0	.	Interaction	with	UBQLN4.
chr6	122734693	122740357	Q03933	0	+	122734693	122740357	255,102,0	1	5664	0	.	Hydrophobic	repeat	HR-A/B.
chr6	122744732	122744810	Q03933	0	+	122744732	122744810	255,102,0	1	78	0	.	Hydrophobic	repeat	HR-C.
chr6	123104891	123104900	O15540	0	+	123104891	123104900	255,102,0	1	9	0	.	Fatty	acid	binding.
chr6	126073001	126080282	Q9UBP5	0	+	126073001	126080282	255,102,0	1	7281	0	.	Transcriptional	repression	and	interaction	with	NCOR1	and	SIN3A.
chr6	128134231	128135008	Q8N1K5	0	-	128134231	128135008	255,102,0	1	777	0	.	CABIT	2.
chr6	128135008	128222077	Q8N1K5	0	-	128135008	128222077	255,102,0	1	87069	0	.	CABIT	1.
chr6	128304506	128306870	Q15262	0	-	128304506	128306870	255,102,0	1	2364	0	.	Substrate	binding.
chr6	129687365	129774135	P24043	0	+	129687365	129774135	255,102,0	1	86770	0	.	Domain	II	and	I.
chr6	131179278	131190747	O43491	0	-	131179278	131190747	255,102,0	1	11469	0	.	C-terminal	(CTD).
chr6	131199258	131206238	O43491	0	-	131199258	131206238	255,102,0	1	6980	0	.	Spectrin--actin-binding.
chr6	131206238	131211590	O43491	0	-	131206238	131211590	255,102,0	1	5352	0	.	Hydrophilic.
chr6	131571710	131571740	O43687	0	+	131571710	131571740	255,102,0	1	30	0	.	Required	for	membrane	localization.
chr6	131574178	131602671	O43687	0	+	131574178	131602671	255,102,0	1	28493	0	.	Required	for	apical	membrane	localization.
chr6	131602698	131602863	Q9P0M2	0	+	131602698	131602863	255,102,0	1	165	0	.	PKA-RII-alpha	subunit	binding	domain.
chr6	131602701	131602776	Q9P0M2	0	+	131602701	131602776	255,102,0	1	75	0	.	RI-alpha-binding.
chr6	131602704	131602746	O43687	0	+	131602704	131602746	255,102,0	1	42	0	.	RII-binding.
chr6	131602704	131602746	Q9P0M2	0	+	131602704	131602746	255,102,0	1	42	0	.	RII-binding.
chr6	131902428	131902443	P05089	0	+	131902428	131902443	255,102,0	1	15	0	.	Substrate	binding.
chr6	131902461	131902470	P05089	0	+	131902461	131902470	255,102,0	1	9	0	.	Substrate	binding.
chr6	131973984	132041482	O14638	0	+	131973984	132041482	255,102,0	1	67498	0	.	Phosphodiesterase.
chr6	132047199	132068093	O14638	0	+	132047199	132068093	255,102,0	1	20894	0	.	Nuclease.
chr6	132173328	132198181	P22413	0	+	132173328	132198181	255,102,0	1	24853	0	.	Phosphodiesterase.
chr6	132198196	132199729	P22413	0	+	132198196	132199729	255,102,0	1	1533	0	.	Linker.
chr6	132201033	132211648	P22413	0	+	132201033	132211648	255,102,0	1	10615	0	.	Nuclease.
chr6	132270406	132271103	P29279	0	-	132270406	132271103	255,102,0	1	697	0	.	Heparin-binding.
chr6	134495190	134495945	O00141	0	-	134495190	134495945	255,102,0	1	755	0	.	Necessary	for	localization	to	the	mitochondria.
chr6	135307285	135307294	Q9Y450	0	-	135307285	135307294	255,102,0	1	9	0	.	G5.
chr6	135308785	135308797	Q9Y450	0	-	135308785	135308797	255,102,0	1	12	0	.	G4.
chr6	135314937	135314949	Q9Y450	0	-	135314937	135314949	255,102,0	1	12	0	.	G3.
chr6	135314997	135315012	Q9Y450	0	-	135314997	135315012	255,102,0	1	15	0	.	G2.
chr6	135318057	135318081	Q9Y450	0	-	135318057	135318081	255,102,0	1	24	0	.	G1.
chr6	135510982	135513513	P10242	0	+	135510982	135513513	255,102,0	1	2531	0	.	Interaction	with	HIPK2	and	NLK.
chr6	135515035	135516918	P10242	0	+	135515035	135516918	255,102,0	1	1883	0	.	Transcription	activation	domain	(PubMed:2189102).	Pubmed:2189102
chr6	135516918	135521271	P10242	0	+	135516918	135521271	255,102,0	1	4353	0	.	Negative	regulatory	domain.
chr6	135517062	135517128	P10242	0	+	135517062	135517128	255,102,0	1	66	0	.	Leucine-zipper.
chr6	135776913	135787280	Q8N157	0	-	135776913	135787280	255,102,0	1	10367	0	.	Interaction	with	HAP1.	Pubmed:23532844
chr6	136475247	136512855	Q9NP56	0	+	136475247	136512855	255,102,0	1	37608	0	.	Catalytic.
chr6	138192535	138198307	P21580	0	+	138192535	138198307	255,102,0	1	5772	0	.	TRAF-binding.
chr6	138196154	138196163	P21580	0	+	138196154	138196163	255,102,0	1	9	0	.	Interaction	with	ubiquitin.
chr6	138196905	138196914	P21580	0	+	138196905	138196914	255,102,0	1	9	0	.	Interaction	with	ubiquitin.
chr6	138197167	138197179	P21580	0	+	138197167	138197179	255,102,0	1	12	0	.	Interaction	with	ubiquitin.
chr6	138198262	138199650	P21580	0	+	138198262	138199650	255,102,0	1	1388	0	.	2	X	approximate	repeats.
chr6	138199686	138202408	P21580	0	+	138199686	138202408	255,102,0	1	2722	0	.	Interaction	with	TNIP1.
chr6	138199737	138199941	P21580	0	+	138199737	138199941	255,102,0	1	204	0	.	Interaction	with	RIPK1.	Pubmed:19131965
chr6	138200394	138201266	P21580	0	+	138200394	138201266	255,102,0	1	872	0	.	Required	for	proteosomal	degradation	of	UBE2N	and	UBE2D3,	TRAF6	deubiquitination,	and	TAX1BP1	interaction	with	UBE2N.
chr6	138200397	138202453	P21580	0	+	138200397	138202453	255,102,0	1	2056	0	.	Sufficient	for	inhibitory	activity	of	TNF-induced	NF-kappa-B	activity.
chr6	138202171	138202453	P21580	0	+	138202171	138202453	255,102,0	1	282	0	.	Required	for	lysosomal	localization	and	for	TRAF2	lysosomal	degradation.
chr6	139226203	139233919	Q96D71	0	-	139226203	139233919	255,102,0	1	7716	0	.	Interaction	with	RALBP1.
chr6	142468427	142490704	Q9NP79	0	+	142468427	142490704	255,102,0	1	22277	0	.	Interaction	with	CHMP5.
chr6	142468427	142519613	Q9NP79	0	+	142468427	142519613	255,102,0	1	51186	0	.	Interaction	with	IST1.
chr6	142519646	142539777	Q9NP79	0	+	142519646	142539777	255,102,0	1	20131	0	.	Interaction	with	VPS4B.
chr6	142688722	142691926	Q86SQ4	0	+	142688722	142691926	255,102,0	1	3204	0	.	Mediates	interaction	with	type	IV	collagen.
chr6	142688722	142736120	Q86SQ4	0	+	142688722	142736120	255,102,0	1	47398	0	.	Inhibits	receptor	signaling	in	absence	of	type	IV	collagen.
chr6	142715087	142732518	Q86SQ4	0	+	142715087	142732518	255,102,0	1	17431	0	.	Mediates	interaction	with	laminin-2.
chr6	143080980	143081268	P31629	0	-	143080980	143081268	255,102,0	1	288	0	.	10	X	4	AA	tandem	repeats	of	S-P-[RGMKC]-[RK].
chr6	143772179	143780283	P56589	0	+	143772179	143780283	255,102,0	1	8104	0	.	Targeting	to	peroxisomes.
chr6	143792123	143792174	P56589	0	+	143792123	143792174	255,102,0	1	51	0	.	Interaction	with	PEX19.
chr6	144750823	144782340	P46939	0	+	144750823	144782340	255,102,0	1	31517	0	.	Interaction	with	SYNM.	Pubmed:16777071
chr6	144809841	144837424	P46939	0	+	144809841	144837424	255,102,0	1	27583	0	.	Interaction	with	SYNM.	Pubmed:16777071
chr6	145075891	145142155	P46939	0	+	145075891	145142155	255,102,0	1	66264	0	.	Interaction	with	SYNM.	Pubmed:16777071
chr6	146351208	146351217	Q13255	0	+	146351208	146351217	255,102,0	1	9	0	.	Glutamate	binding.
chr6	146875594	146875654	Q13637	0	+	146875594	146875654	255,102,0	1	60	0	.	PKA-RII	subunit	binding	domain.
chr6	149730795	149730828	Q9NYJ8	0	+	149730795	149730828	255,102,0	1	33	0	.	Interaction	with	polyubiquitin.
chr6	149772334	149773764	A2A288	0	-	149772334	149773764	255,102,0	1	1430	0	.	Necessary	for	interaction	with	ZC3H12A.	Pubmed:26134560
chr6	149925864	149959683	O75449	0	-	149925864	149959683	255,102,0	1	33819	0	.	Interaction	with	microtubules.
chr6	149953989	149959683	O75449	0	-	149953989	149959683	255,102,0	1	5694	0	.	Interaction	with	dynein	and	NDEL1.
chr6	149959596	149959683	O75449	0	-	149959596	149959683	255,102,0	1	87	0	.	Interaction	with	KATNB1.	Pubmed:10751153
chr6	150004259	150004649	O95835	0	-	150004259	150004649	255,102,0	1	390	0	.	Interaction	with	YAP1.	Pubmed:18158288
chr6	150210484	150210757	Q8TD07	0	-	150210484	150210757	255,102,0	1	273	0	.	MHC	class	I	alpha-2	like.
chr6	150210757	150211276	Q8TD07	0	-	150210757	150211276	255,102,0	1	519	0	.	MHC	class	I	alpha-1	like.
chr6	150240179	150240458	Q6H3X3	0	-	150240179	150240458	255,102,0	1	279	0	.	MHC	class	I	alpha-2	like.
chr6	150240458	150240953	Q6H3X3	0	-	150240458	150240953	255,102,0	1	495	0	.	MHC	class	I	alpha-1	like.
chr6	150266443	150267509	Q9BZM5	0	+	150266443	150267509	255,102,0	1	1066	0	.	MHC	class	I	alpha-1	like.
chr6	150267509	150267788	Q9BZM5	0	+	150267509	150267788	255,102,0	1	279	0	.	MHC	class	I	alpha-2	like.
chr6	150285260	150290222	Q9BZM6	0	+	150285260	150290222	255,102,0	1	4962	0	.	MHC	class	I	alpha-1	like.
chr6	150290222	150290495	Q9BZM6	0	+	150290222	150290495	255,102,0	1	273	0	.	MHC	class	I	alpha-2	like.
chr6	150342041	150342320	Q5VY80	0	-	150342041	150342320	255,102,0	1	279	0	.	MHC	class	I	alpha-2	like.
chr6	150342320	150343380	Q5VY80	0	-	150342320	150343380	255,102,0	1	1060	0	.	MHC	class	I	alpha-1	like.
chr6	150386534	150386807	Q9BZM4	0	-	150386534	150386807	255,102,0	1	273	0	.	MHC	class	I	alpha-2	like.
chr6	150386807	150387299	Q9BZM4	0	-	150386807	150387299	255,102,0	1	492	0	.	MHC	class	I	alpha-1	like.
chr6	151187048	151243400	Q6UB35	0	+	151187048	151243400	255,102,0	1	56352	0	.	Methylenetetrahydrofolate	dehydrogenase	and	cyclohydrolase.
chr6	151243400	151413689	Q6UB35	0	+	151243400	151413689	255,102,0	1	170289	0	.	Formyltetrahydrofolate	synthetase.
chr6	151670321	151671197	Q02952	0	+	151670321	151671197	255,102,0	1	876	0	.	Involved	in	PKC-binding.
chr6	151674146	151674188	Q02952	0	+	151674146	151674188	255,102,0	1	42	0	.	RII-binding.
chr6	152129047	152163831	P03372	0	+	152129047	152163831	255,102,0	1	34784	0	.	Modulating	(transactivation	AF-1);	mediates	interaction	with	MACROD1.	Pubmed:17914104
chr6	152129149	152129188	P03372	0	+	152129149	152129188	255,102,0	1	39	0	.	Required	for	interaction	with	NCOA1.
chr6	152129149	152163801	P03372	0	+	152129149	152163801	255,102,0	1	34652	0	.	Interaction	with	DDX5;	self-association.
chr6	152163831	152265477	P03372	0	+	152163831	152265477	255,102,0	1	101646	0	.	Mediates	interaction	with	DNTTIP2.	Pubmed:15047147
chr6	152201896	152265477	P03372	0	+	152201896	152265477	255,102,0	1	63581	0	.	Hinge.
chr6	152265330	152420098	P03372	0	+	152265330	152420098	255,102,0	1	154768	0	.	Interaction	with	AKAP13.	Pubmed:9627117
chr6	152265336	152420098	P03372	0	+	152265336	152420098	255,102,0	1	154762	0	.	Self-association.
chr6	152265477	152419966	P03372	0	+	152265477	152419966	255,102,0	1	154489	0	.	Steroid-binding.
chr6	152265477	152420098	P03372	0	+	152265477	152420098	255,102,0	1	154621	0	.	Transactivation	AF-2.
chr6	153296127	153296457	Q9UKT4	0	-	153296127	153296457	255,102,0	1	330	0	.	Interaction	with	EVI5.	Pubmed:16439210
chr6	155635448	155635460	Q8WVM0	0	-	155635448	155635460	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr6	158323057	158327178	Q9Y5X1	0	+	158323057	158327178	255,102,0	1	4121	0	.	Critical	for	tubulation	activity.
chr6	158925090	158927723	Q9NRJ4	0	+	158925090	158927723	255,102,0	1	2633	0	.	TUB.
chr6	159057861	159058875	P63172	0	-	159057861	159058875	255,102,0	1	1014	0	.	Interaction	with	GNB1.
chr6	159187948	159197505	P15311	0	-	159187948	159197505	255,102,0	1	9557	0	.	Interaction	with	SCYL3.	Pubmed:12651155
chr6	161781174	161807861	O60260	0	-	161781174	161807861	255,102,0	1	26687	0	.	REP.
chr6	161990440	162206906	O60260	0	-	161990440	162206906	255,102,0	1	216466	0	.	SYT11	binding	2.	Pubmed:12925569
chr6	162394353	162475131	O60260	0	-	162394353	162475131	255,102,0	1	80778	0	.	SYT11	binding	1.	Pubmed:12925569
chr6	163836255	163876414	Q96PU8	0	+	163836255	163876414	255,102,0	1	40159	0	.	Qua1	domain;	involved	in	homodimerization.
chr6	163956154	163984456	Q96PU8	0	+	163956154	163984456	255,102,0	1	28302	0	.	Qua2	domain;	involved	in	RNA	binding.	Pubmed:23630077
chr6	165829744	165829750	Q9Y233	0	-	165829744	165829750	255,102,0	1	6	0	.	Allosteric	effector	binding.
chr6	165832229	165832235	Q9Y233	0	-	165832229	165832235	255,102,0	1	6	0	.	Allosteric	effector	binding.
chr6	169642051	169649066	P35442	0	-	169642051	169649066	255,102,0	1	7015	0	.	Heparin-binding.
chr6	170110442	170112565	Q8WUB8	0	-	170110442	170112565	255,102,0	1	2123	0	.	Essential	to	induce	neural	progenitor	proliferation.
chr6	170112553	170118944	Q8WUB8	0	-	170112553	170118944	255,102,0	1	6391	0	.	SAY.
chr6	170115941	170118944	Q8WUB8	0	-	170115941	170118944	255,102,0	1	3003	0	.	Essential	to	induce	neural	progenitor	proliferation.
chr6	170591964	170592084	O00548	0	-	170591964	170592084	255,102,0	1	120	0	.	Interaction	with	MAGI1.
chr7	288383	299886	Q8IXL6	0	+	288383	299886	255,102,0	1	11503	0	.	Kinase	domain.	Pubmed:22582013
chr7	540846	540861	P04085	0	-	540846	540861	255,102,0	1	15	0	.	Receptor	binding	site.
chr7	716897	751139	P31321	0	-	716897	751139	255,102,0	1	34242	0	.	Dimerization	and	phosphorylation.
chr7	1474237	1477228	Q8IY33	0	-	1474237	1477228	255,102,0	1	2991	0	.	Mediates	interaction	with	RAB13	and	is	required	for	transition	from	the	closed	to	the	opened	conformation.
chr7	1477225	1478506	Q8IY33	0	-	1477225	1478506	255,102,0	1	1281	0	.	Forms	an	intramolecular	interaction	with	the	N-terminal	CH	and	LIM	zinc-binding	domains-containing	region	keeping	the	protein	in	a	closed	conformation.
chr7	1478506	1484925	Q8IY33	0	-	1478506	1484925	255,102,0	1	6419	0	.	Mediates	targeting	to	the	cell	plasma	membrane.
chr7	1484541	1484925	Q8IY33	0	-	1484541	1484925	255,102,0	1	384	0	.	Necessary	and	sufficient	for	interaction	with	actinins.
chr7	1484925	1498962	Q8IY33	0	-	1484925	1498962	255,102,0	1	14037	0	.	Forms	an	intramolecular	interaction	with	the	C-terminal	coiled	coil	domain	keeping	the	protein	in	a	closed	conformation.
chr7	1579690	1579768	O60675	0	+	1579690	1579768	255,102,0	1	78	0	.	Basic	motif.
chr7	1579774	1579819	O60675	0	+	1579774	1579819	255,102,0	1	45	0	.	Leucine-zipper.
chr7	1997263	2108909	Q9Y6D9	0	-	1997263	2108909	255,102,0	1	111646	0	.	Necessary	for	interaction	with	NEK2.	Pubmed:14978040
chr7	2275107	2275113	Q9UI43	0	-	2275107	2275113	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr7	2279092	2279104	Q9UI43	0	-	2279092	2279104	255,102,0	1	12	0	.	S-adenosyl-L-methionine	binding.
chr7	2394925	2406033	P55884	0	+	2394925	2406033	255,102,0	1	11108	0	.	Sufficient	for	interaction	with	EIF3E.
chr7	2400352	2402714	P55884	0	+	2400352	2402714	255,102,0	1	2362	0	.	Sufficient	for	interaction	with	EIF3J.
chr7	2583426	2584675	Q6PJG6	0	-	2583426	2584675	255,102,0	1	1249	0	.	Required	for	interaction	with	NDFIP1.	Pubmed:25631046
chr7	4721939	4722059	P85037	0	+	4721939	4722059	255,102,0	1	120	0	.	Interaction	with	SIN3A	and	SIN3B.
chr7	4722221	4798697	P85037	0	+	4722221	4798697	255,102,0	1	76476	0	.	Required	for	interaction	with	FOXO4	and	MEF2C.
chr7	5103597	5103867	Q9NYW8	0	+	5103597	5103867	255,102,0	1	270	0	.	Required	for	interaction	with	RB1.	Pubmed:10702291
chr7	5104335	5105229	Q9NYW8	0	+	5104335	5105229	255,102,0	1	894	0	.	Interaction	with	AR.	Pubmed:14664718
chr7	6054884	6057588	Q13155	0	+	6054884	6057588	255,102,0	1	2704	0	.	Interaction	with	PARK2.	Pubmed:16135753
chr7	6057585	6063034	Q13155	0	+	6057585	6063034	255,102,0	1	5449	0	.	Interaction	with	TP53.	Pubmed:18695251
chr7	6204577	6204604	O43739	0	-	6204577	6204604	255,102,0	1	27	0	.	C-terminal	autoinhibitory	region.
chr7	6205424	6210172	O43739	0	-	6205424	6210172	255,102,0	1	4748	0	.	Phosphatidylinositol	3,4,5-trisphosphate	binding.
chr7	8790646	8790874	P58417	0	+	8790646	8790874	255,102,0	1	228	0	.	II.
chr7	8790874	8791111	P58417	0	+	8790874	8791111	255,102,0	1	237	0	.	III.
chr7	8791111	8791138	P58417	0	+	8791111	8791138	255,102,0	1	27	0	.	IV	(linker	domain).
chr7	8791138	8791396	P58417	0	+	8791138	8791396	255,102,0	1	258	0	.	V	(Cys-rich).
chr7	12617822	12620687	Q9Y6U3	0	+	12617822	12620687	255,102,0	1	2865	0	.	Polyphosphoinositide	binding.
chr7	12620741	12620768	Q9Y6U3	0	+	12620741	12620768	255,102,0	1	27	0	.	Polyphosphoinositide	binding.
chr7	12666316	12692337	Q9Y6U3	0	+	12666316	12692337	255,102,0	1	26021	0	.	Ca(2+)-dependent	actin	binding.
chr7	16841300	16841360	O95994	0	-	16841300	16841360	255,102,0	1	60	0	.	Required	to	promote	cell	adhesion.	Pubmed:23274113
chr7	18624947	18624962	Q9UKV0	0	+	18624947	18624962	255,102,0	1	15	0	.	Interaction	with	CTBP1.
chr7	18631137	18631194	Q9UKV0	0	+	18631137	18631194	255,102,0	1	57	0	.	Interaction	with	MEF2.
chr7	18631254	18687410	Q9UKV0	0	+	18631254	18687410	255,102,0	1	56156	0	.	Interaction	with	MAPK10.
chr7	18633648	18669100	Q9UKV0	0	+	18633648	18669100	255,102,0	1	35452	0	.	Interaction	with	ETV6.	Pubmed:12590135
chr7	18767370	18993774	Q9UKV0	0	+	18767370	18993774	255,102,0	1	226404	0	.	Histone	deacetylase.
chr7	19154830	19154923	Q15672	0	-	19154830	19154923	255,102,0	1	93	0	.	Sufficient	for	transactivation	activity.
chr7	20441472	20444450	P26012	0	+	20441472	20444450	255,102,0	1	2978	0	.	Cysteine-rich	tandem	repeats.
chr7	21582863	21723503	Q96DT5	0	+	21582863	21723503	255,102,0	1	140640	0	.	Stem.
chr7	21723503	21742375	Q96DT5	0	+	21723503	21742375	255,102,0	1	18872	0	.	AAA	1.
chr7	21744183	21757507	Q96DT5	0	+	21744183	21757507	255,102,0	1	13324	0	.	AAA	2.
chr7	21765575	21784058	Q96DT5	0	+	21765575	21784058	255,102,0	1	18483	0	.	AAA	3.
chr7	21784619	21813479	Q96DT5	0	+	21784619	21813479	255,102,0	1	28860	0	.	AAA	4.
chr7	21813494	21847544	Q96DT5	0	+	21813494	21847544	255,102,0	1	34050	0	.	Stalk.
chr7	21856126	21892246	Q96DT5	0	+	21856126	21892246	255,102,0	1	36120	0	.	AAA	5.
chr7	21906276	21920490	Q96DT5	0	+	21906276	21920490	255,102,0	1	14214	0	.	AAA	6.
chr7	21946233	21947792	Q96GN5	0	-	21946233	21947792	255,102,0	1	1559	0	.	MYC-binding.
chr7	21948071	21951366	Q96GN5	0	-	21948071	21951366	255,102,0	1	3295	0	.	PSIP1-binding.
chr7	23224846	23235522	O15504	0	+	23224846	23235522	255,102,0	1	10676	0	.	Interaction	with	HIV-1	Vpr.
chr7	23240184	23240361	O15504	0	+	23240184	23240361	255,102,0	1	177	0	.	Interaction	with	GLE1.	Pubmed:16000379
chr7	23545851	23547088	Q13595	0	-	23545851	23547088	255,102,0	1	1237	0	.	Linker.
chr7	24749903	24789393	O60443	0	-	24749903	24789393	255,102,0	1	39490	0	.	Triggers	pyroptosis.	Pubmed:27281216
chr7	26225055	26225115	Q9Y4A8	0	+	26225055	26225115	255,102,0	1	60	0	.	Basic	motif.
chr7	26225133	26225178	Q9Y4A8	0	+	26225133	26225178	255,102,0	1	45	0	.	Leucine-zipper.
chr7	26232138	26236213	P22626	0	-	26232138	26236213	255,102,0	1	4075	0	.	Low	complexity	(LC)	region.	Pubmed:26544936
chr7	26232156	26232949	P22626	0	-	26232156	26232949	255,102,0	1	793	0	.	Nuclear	targeting	sequence.
chr7	26386083	26411504	Q9Y5X0	0	+	26386083	26411504	255,102,0	1	25421	0	.	Required	for	interaction	with	ATP6V1D.	Pubmed:21844891
chr7	26893762	26904009	O75563	0	-	26893762	26904009	255,102,0	1	10247	0	.	Homodimerization.
chr7	27827141	27831846	Q86VP1	0	+	27827141	27831846	255,102,0	1	4705	0	.	Oligomerization.
chr7	27934986	28031601	Q86VZ6	0	-	27934986	28031601	255,102,0	1	96615	0	.	Required	for	interaction	with	NR2C2.	Pubmed:15302918
chr7	28848905	28848968	Q02930	0	+	28848905	28848968	255,102,0	1	63	0	.	Basic	motif.
chr7	28848983	28857726	Q02930	0	+	28848983	28857726	255,102,0	1	8743	0	.	Leucine-zipper.
chr7	30094455	30118400	Q96JA3	0	+	30094455	30118400	255,102,0	1	23945	0	.	Glycolipid	transfer	protein	homology	domain.
chr7	30544253	30544271	O75223	0	-	30544253	30544271	255,102,0	1	18	0	.	Substrate	binding.	Pubmed:18515354
chr7	30655515	30655530	P41250	0	+	30655515	30655530	255,102,0	1	15	0	.	Substrate	binding.
chr7	30668201	30668216	P41250	0	+	30668201	30668216	255,102,0	1	15	0	.	Substrate	binding.
chr7	30793444	30793453	O95050	0	+	30793444	30793453	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr7	30795098	30795104	O95050	0	+	30795098	30795104	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr7	31123799	31123844	P41586	0	+	31123799	31123844	255,102,0	1	45	0	.	Important	for	ligand	binding	and	specificity.
chr7	33057146	33057152	Q9H0P0	0	-	33057146	33057152	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17405878
chr7	33136106	33148984	Q8TA86	0	-	33136106	33148984	255,102,0	1	12878	0	.	PIM1-binding.
chr7	33427693	33545254	Q3SYG4	0	+	33427693	33545254	255,102,0	1	117561	0	.	Interaction	with	LZTL1.	Pubmed:22072986
chr7	36429635	36435991	Q9NQW6	0	+	36429635	36435991	255,102,0	1	6356	0	.	Required	for	ubiquitination.
chr7	36429635	36438980	Q9NQW6	0	+	36429635	36438980	255,102,0	1	9345	0	.	Interaction	with	CD2AP.	Pubmed:15800069
chr7	36429635	36445992	Q9NQW6	0	+	36429635	36445992	255,102,0	1	16357	0	.	Nuclear	localization.
chr7	36445992	36460218	Q9NQW6	0	+	36445992	36460218	255,102,0	1	14226	0	.	Interaction	with	F-actin.
chr7	36461489	36492206	Q9NQW6	0	+	36461489	36492206	255,102,0	1	30717	0	.	Localization	to	the	cleavage	furrow.
chr7	37903963	37907453	Q8N427	0	+	37903963	37907453	255,102,0	1	3490	0	.	NDK	1.
chr7	37916557	37927996	Q8N427	0	+	37916557	37927996	255,102,0	1	11439	0	.	NDK	2.
chr7	37927996	37936691	Q8N427	0	+	37927996	37936691	255,102,0	1	8695	0	.	NDK	3.
chr7	38796512	38948774	P49754	0	-	38796512	38948774	255,102,0	1	152262	0	.	Interaction	with	ARL8B.	Pubmed:25908847
chr7	44104461	44104467	P15259	0	-	44104461	44104467	255,102,0	1	6	0	.	Substrate	binding.
chr7	44104777	44104783	P15259	0	-	44104777	44104783	255,102,0	1	6	0	.	Substrate	binding.
chr7	44104852	44104864	P15259	0	-	44104852	44104864	255,102,0	1	12	0	.	Substrate	binding.
chr7	44105056	44105062	P15259	0	-	44105056	44105062	255,102,0	1	6	0	.	Substrate	binding.
chr7	44105077	44105101	P15259	0	-	44105077	44105101	255,102,0	1	24	0	.	Substrate	binding.
chr7	44113804	44113998	Q9NP87	0	-	44113804	44113998	255,102,0	1	194	0	.	Involved	in	ssDNA	binding.
chr7	44149630	44150787	Q8IUX7	0	+	44149630	44150787	255,102,0	1	1157	0	.	Required	for	DNA-binding	and	interaction	with	NFKBIA.
chr7	44149805	44151484	Q8IUX7	0	+	44149805	44151484	255,102,0	1	1679	0	.	Interaction	with	MAPK1	and	MAPK3.
chr7	44150784	44153338	Q8IUX7	0	+	44150784	44153338	255,102,0	1	2554	0	.	Interaction	with	PTEN.
chr7	44153203	44153857	Q8IUX7	0	+	44153203	44153857	255,102,0	1	654	0	.	Required	for	transcriptional	repression.
chr7	44153398	44153857	Q8IUX7	0	+	44153398	44153857	255,102,0	1	459	0	.	Interaction	with	MAPK1	and	MAPK3.
chr7	44184803	44189428	P35557	0	-	44184803	44189428	255,102,0	1	4625	0	.	Hexokinase	large	subdomain.
chr7	44189422	44189428	P35557	0	-	44189422	44189428	255,102,0	1	6	0	.	Substrate	binding.
chr7	44189428	44192909	P35557	0	-	44189428	44192909	255,102,0	1	3481	0	.	Hexokinase	small	subdomain.
chr7	44189639	44189645	P35557	0	-	44189639	44189645	255,102,0	1	6	0	.	Substrate	binding.
chr7	44190581	44190587	P35557	0	-	44190581	44190587	255,102,0	1	6	0	.	Substrate	binding.
chr7	44281298	44281331	Q13554	0	-	44281298	44281331	255,102,0	1	33	0	.	Calmodulin-binding.
chr7	44281325	44281355	Q13554	0	-	44281325	44281355	255,102,0	1	30	0	.	Autoinhibitory	domain.
chr7	44801109	44801426	Q8NF64	0	+	44801109	44801426	255,102,0	1	317	0	.	Interaction	with	AR.	Pubmed:16051670
chr7	45113101	45115449	Q9BSQ5	0	+	45113101	45115449	255,102,0	1	2348	0	.	Harmonin	homology	domain.
chr7	45701684	45701768	Q08828	0	+	45701684	45701768	255,102,0	1	84	0	.	Interaction	with	calmodulin.
chr7	45753303	45753375	Q08828	0	+	45753303	45753375	255,102,0	1	72	0	.	Interaction	with	calmodulin.
chr7	45960337	45960658	P17936	0	-	45960337	45960658	255,102,0	1	321	0	.	IGF-binding.
chr7	48142983	48142995	Q16831	0	+	48142983	48142995	255,102,0	1	12	0	.	Phosphate	binding.	Pubmed:19291308
chr7	50450275	50450305	Q13422	0	+	50450275	50450305	255,102,0	1	30	0	.	Required	for	both	high-affinity	DNA	binding	and	pericentromeric	heterochromatin	localization.
chr7	50450353	50450401	Q13422	0	+	50450353	50450401	255,102,0	1	48	0	.	Required	for	both	high-affinity	DNA	binding	and	pericentromeric	heterochromatin	localization.
chr7	50468166	50468178	Q13422	0	+	50468166	50468178	255,102,0	1	12	0	.	Required	for	binding	PP1CC.
chr7	50513953	50514103	Q6PIW4	0	-	50513953	50514103	255,102,0	1	150	0	.	Necessary	and	sufficient	for	interaction	with	RAD51.	Pubmed:23754376
chr7	50596941	50611612	P20711	0	-	50596941	50611612	255,102,0	1	14671	0	.	2	X	approximate	tandem	repeats.
chr7	55241613	55241664	P00533	0	+	55241613	55241664	255,102,0	1	51	0	.	Important	for	dimerization,	phosphorylation	and	activation.
chr7	55433721	55433763	Q9NS86	0	+	55433721	55433763	255,102,0	1	42	0	.	Interaction	with	inositol	phospholipids.
chr7	56085017	56085023	P78330	0	-	56085017	56085023	255,102,0	1	6	0	.	Substrate	binding.
chr7	56148809	56148884	Q16816	0	-	56148809	56148884	255,102,0	1	75	0	.	Calmodulin-binding	(domain-C).
chr7	56148929	56149334	Q16816	0	-	56148929	56149334	255,102,0	1	405	0	.	Calmodulin-binding	(domain-N).
chr7	70853248	70885915	Q6IS24	0	+	70853248	70885915	255,102,0	1	32667	0	.	Catalytic	subdomain	A.
chr7	72395659	72395761	Q96HA1	0	+	72395659	72395761	255,102,0	1	102	0	.	Cisternal	side.
chr7	72395659	72397010	Q96HA1	0	+	72395659	72397010	255,102,0	1	1351	0	.	Required	for	targeting	to	the	nucleus	and	nuclear	pore	complex.
chr7	72395824	72416770	Q96HA1	0	+	72395824	72416770	255,102,0	1	20945	0	.	Pore	side.
chr7	72718778	72718799	Q96P11	0	-	72718778	72718799	255,102,0	1	21	0	.	S-adenosyl-L-methionine	binding.
chr7	72848508	72848853	O00144	0	+	72848508	72848853	255,102,0	1	345	0	.	Required	for	Wnt-activated	receptor	activity.
chr7	72849996	72850110	O00144	0	+	72849996	72850110	255,102,0	1	114	0	.	Required	for	CTNNB1	accumulation	and	TCF	transcription	factor	activity.
chr7	72892755	72936263	Q9UIG0	0	-	72892755	72936263	255,102,0	1	43508	0	.	Mediates	the	tyrosine-protein	kinase	activity.
chr7	73010185	73010251	Q9NP71	0	-	73010185	73010251	255,102,0	1	66	0	.	Leucine-zipper.
chr7	73183719	73183725	O15551	0	-	73183719	73183725	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2	and	TJP3.
chr7	73245531	73245840	O14493	0	+	73245531	73245840	255,102,0	1	309	0	.	Interaction	with	EPHA2.	Pubmed:16236711
chr7	73246152	73246158	O14493	0	+	73246152	73246158	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2	and	TJP3.
chr7	73604575	73609072	Q15056	0	+	73604575	73609072	255,102,0	1	4497	0	.	HHV-1	Vhs	binding	site.
chr7	75187065	75189183	O00291	0	-	75187065	75189183	255,102,0	1	2118	0	.	pDED.
chr7	75932236	75933487	P04792	0	+	75932236	75933487	255,102,0	1	1251	0	.	Interaction	with	TGFB1I1.
chr7	77200481	77200496	Q05209	0	+	77200481	77200496	255,102,0	1	15	0	.	Substrate	binding.	Pubmed:27134172
chr7	77230118	77236567	Q05209	0	+	77230118	77236567	255,102,0	1	6449	0	.	Substrate	binding.
chr7	77256028	77256310	Q05209	0	+	77256028	77256310	255,102,0	1	282	0	.	Interaction	with	TGFB1I1.
chr7	77975320	78130955	Q86UL8	0	-	77975320	78130955	255,102,0	1	155635	0	.	Interaction	with	DDN.	Pubmed:16464232
chr7	80286011	80290457	P16671	0	+	80286011	80290457	255,102,0	1	4446	0	.	Required	for	interaction	with	thrombospondins,	THBS1	and	THBS2.	Pubmed:1371676
chr7	80303421	80303460	P16671	0	+	80303421	80303460	255,102,0	1	39	0	.	Interaction	with	PTK2,	PXN	and	LYN.	Pubmed:20037584
chr7	86415621	86415630	Q14832	0	+	86415621	86415630	255,102,0	1	9	0	.	Glutamate	binding.
chr7	86794257	86810658	Q9Y222	0	+	86794257	86810658	255,102,0	1	16401	0	.	Interaction	with	CCND2.
chr7	86800336	86803976	Q9Y222	0	+	86800336	86803976	255,102,0	1	3640	0	.	Required	for	transcriptional	activation.
chr7	86800336	86817580	Q9Y222	0	+	86800336	86817580	255,102,0	1	17244	0	.	Required	for	DNA-binding.
chr7	86808866	86824453	Q9Y222	0	+	86808866	86824453	255,102,0	1	15587	0	.	Interaction	with	CCND1,	CCND2	and	CCND3.
chr7	86817580	86824453	Q9Y222	0	+	86817580	86824453	255,102,0	1	6873	0	.	Required	for	transcriptional	activation.
chr7	87011785	87011809	Q9UKG9	0	+	87011785	87011809	255,102,0	1	24	0	.	Coenzyme	A	binding.
chr7	87056188	87060740	P21439	0	-	87056188	87060740	255,102,0	1	4552	0	.	Interaction	with	HAX1.
chr7	91502934	91502958	Q99551	0	-	91502934	91502958	255,102,0	1	24	0	.	Interaction	with	DNA.
chr7	91503033	91503045	Q99551	0	-	91503033	91503045	255,102,0	1	12	0	.	Interaction	with	DNA.
chr7	91503114	91503138	Q99551	0	-	91503114	91503138	255,102,0	1	24	0	.	Interaction	with	DNA.
chr7	91503354	91503369	Q99551	0	-	91503354	91503369	255,102,0	1	15	0	.	Interaction	with	DNA.
chr7	91503597	91503603	Q99551	0	-	91503597	91503603	255,102,0	1	6	0	.	Interaction	with	DNA.
chr7	91852190	91852259	O00522	0	-	91852190	91852259	255,102,0	1	69	0	.	Interaction	with	RAP1B.	Pubmed:22577140
chr7	91864860	91864932	O00522	0	-	91864860	91864932	255,102,0	1	72	0	.	Interaction	with	ITGB1BP1.
chr7	91864935	91871449	O00522	0	-	91864935	91871449	255,102,0	1	6514	0	.	N-terminal	domain	similar	to	Nudix	hydrolase	domain.
chr7	92098243	92098303	Q9UQF0	0	-	92098243	92098303	255,102,0	1	60	0	.	Essential	for	the	fusiogenic	function.
chr7	92098507	92098558	Q9UQF0	0	-	92098507	92098558	255,102,0	1	51	0	.	Immunosuppression.
chr7	92098675	92098738	Q9UQF0	0	-	92098675	92098738	255,102,0	1	63	0	.	Fusion	peptide.
chr7	94539425	94539857	Q9ULJ8	0	+	94539425	94539857	255,102,0	1	432	0	.	Actin-binding.
chr7	94540697	94740681	Q9ULJ8	0	+	94540697	94740681	255,102,0	1	199984	0	.	Interaction	with	protein	phosphatase	1.
chr7	94827694	94919588	Q9ULJ8	0	+	94827694	94919588	255,102,0	1	91894	0	.	Interaction	with	TGN38.
chr7	95157348	95157354	Q9Y574	0	+	95157348	95157354	255,102,0	1	6	0	.	Essential	for	interaction	with	HIF1AN.
chr7	95157366	95157375	Q9Y574	0	+	95157366	95157375	255,102,0	1	9	0	.	Essential	for	interaction	with	HIF1AN.
chr7	95434041	95457372	O14576	0	+	95434041	95457372	255,102,0	1	23331	0	.	Interaction	with	DCTN1.
chr7	95499207	95499258	O14576	0	+	95499207	95499258	255,102,0	1	51	0	.	Interaction	with	DYNLT1.	Pubmed:27502274
chr7	97498237	97498246	P08243	0	-	97498237	97498246	255,102,0	1	9	0	.	Glutamine	binding.
chr7	97498309	97498324	P08243	0	-	97498309	97498324	255,102,0	1	15	0	.	Glutamine	binding.
chr7	97922835	97923399	Q9UHR4	0	-	97922835	97923399	255,102,0	1	564	0	.	Binds	F-actin.
chr7	98553879	98564672	Q9Y4A5	0	+	98553879	98564672	255,102,0	1	10793	0	.	Interaction	with	TP53.	Pubmed:12138177
chr7	99688756	99689409	Q7L5N1	0	+	99688756	99689409	255,102,0	1	653	0	.	Interaction	with	Vpr.
chr7	99690557	99691915	P33993	0	-	99690557	99691915	255,102,0	1	1358	0	.	Interaction	with	ATRIP.
chr7	99691951	99693431	P33993	0	-	99691951	99693431	255,102,0	1	1480	0	.	Interaction	with	RAD17.	Pubmed:15538388
chr7	100028991	100029000	Q7L2J0	0	+	100028991	100029000	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr7	100029060	100029066	Q7L2J0	0	+	100029060	100029066	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr7	100030544	100030550	Q7L2J0	0	+	100030544	100030550	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr7	100064674	100064740	Q9Y3Q8	0	-	100064674	100064740	255,102,0	1	66	0	.	Leucine-zipper.
chr7	100084600	100085902	Q6ZVC0	0	+	100084600	100085902	255,102,0	1	1302	0	.	Involved	in	CYFIP1-	and	NCKAP1-binding.
chr7	100253065	100253197	O94805	0	-	100253065	100253197	255,102,0	1	132	0	.	Essential	for	mediating	its	function	in	dendritic	development;	may	contribute	to	neuronal-specific	targeting.
chr7	100470898	100470922	Q15654	0	+	100470898	100470922	255,102,0	1	24	0	.	Interaction	with	MAGI1	and	PTPN13.	Pubmed:19017743
chr7	100491151	100491157	P22303	0	-	100491151	100491157	255,102,0	1	6	0	.	Galanthamine	binding.
chr7	100634078	100647698	Q9UKN1	0	+	100634078	100647698	255,102,0	1	13620	0	.	28	X	19	AA	approximate	tandem	repeats	of	E-E-S-X-X-X-H-X-X-P-X-X-T-X-T-X-X-X-P.
chr7	100675249	100685878	Q685J3	0	+	100675249	100685878	255,102,0	1	10629	0	.	59	X	approximate	tandem	repeats.
chr7	100866777	100867010	O43257	0	+	100866777	100867010	255,102,0	1	233	0	.	Interaction	with	NR1D2.	Pubmed:17892483
chr7	100876136	100876142	P56746	0	-	100876136	100876142	255,102,0	1	6	0	.	Important	for	the	formation	of	tight-junction	strand-like	structures.
chr7	102036858	102038090	Q9H875	0	+	102036858	102038090	255,102,0	1	1232	0	.	Interaction	with	EIF2AK2.
chr7	102038090	102047917	Q9H875	0	+	102038090	102047917	255,102,0	1	9827	0	.	Required	for	RNA-binding.
chr7	102045113	102047902	Q9H875	0	+	102045113	102047902	255,102,0	1	2789	0	.	Required	for	nuclear	localization.
chr7	102963210	102967084	Q99543	0	-	102963210	102967084	255,102,0	1	3874	0	.	ZRF1-UBD.
chr7	102982372	102982399	Q99543	0	-	102982372	102982399	255,102,0	1	27	0	.	Epitope	(recognized	by	CD8(+)	cytotoxic	T-lymphocytes).
chr7	105902060	105902066	A0A024R718	0	-	105902060	105902066	255,102,0	1	6	0	.	Nicotinamide	ribonucleotide	binding.
chr7	105902060	105902066	P43490	0	-	105902060	105902066	255,102,0	1	6	0	.	Nicotinamide	ribonucleotide	binding.
chr7	105903867	105903876	A0A024R718	0	-	105903867	105903876	255,102,0	1	9	0	.	Nicotinamide	ribonucleotide	binding.
chr7	105903867	105903876	P43490	0	-	105903867	105903876	255,102,0	1	9	0	.	Nicotinamide	ribonucleotide	binding.
chr7	106685355	106768719	P31323	0	+	106685355	106768719	255,102,0	1	83364	0	.	Dimerization	and	phosphorylation.
chr7	107398588	107398765	Q75N03	0	+	107398588	107398765	255,102,0	1	177	0	.	HYB	domain.
chr7	107564398	107572720	P07942	0	-	107564398	107572720	255,102,0	1	8322	0	.	Domain	I.
chr7	107572720	107572819	P07942	0	-	107572720	107572819	255,102,0	1	99	0	.	Domain	alpha.
chr7	107572819	107580660	P07942	0	-	107572819	107580660	255,102,0	1	7841	0	.	Domain	II.
chr7	107664486	107688454	A4D0S4	0	-	107664486	107688454	255,102,0	1	23968	0	.	Domain	I.
chr7	107688454	107688553	A4D0S4	0	-	107688454	107688553	255,102,0	1	99	0	.	Domain	alpha.
chr7	107688553	107696309	A4D0S4	0	-	107688553	107696309	255,102,0	1	7756	0	.	Domain	II.
chr7	114292324	114294025	O15409	0	+	114292324	114294025	255,102,0	1	1701	0	.	Leucine-zipper.
chr7	114294061	114298132	O15409	0	+	114294061	114298132	255,102,0	1	4071	0	.	CTBP1-binding.
chr7	115580607	115580838	O14948	0	-	115580607	115580838	255,102,0	1	231	0	.	Necessary	for	transcriptional	transactivation.
chr7	115596757	115624495	O14948	0	-	115596757	115624495	255,102,0	1	27738	0	.	Necessary	for	transcriptional	transactivation.
chr7	116423358	116436175	P08581	0	+	116423358	116436175	255,102,0	1	12817	0	.	Interaction	with	RANBP9.
chr7	116435962	116436082	P08581	0	+	116435962	116436082	255,102,0	1	120	0	.	Interaction	with	MUC20.	Pubmed:15314156
chr7	119914689	119914746	Q9NZV8	0	+	119914689	119914746	255,102,0	1	57	0	.	Interaction	with	KCNIP1,	KCNIP2,	and	other	family	members.
chr7	119914896	119914956	Q9NZV8	0	+	119914896	119914956	255,102,0	1	60	0	.	Interaction	with	KCNIP1.
chr7	119915607	119915649	Q9NZV8	0	+	119915607	119915649	255,102,0	1	42	0	.	S4-S5	linker.
chr7	120382608	120382656	Q9NZV8	0	+	120382608	120382656	255,102,0	1	48	0	.	Required	for	dendritic	targeting.
chr7	120382608	120387909	Q9NZV8	0	+	120382608	120387909	255,102,0	1	5301	0	.	Important	for	normal	channel	activation	and	inactivation,	for	interaction	with	KCNIP2,	and	probably	other	family	members	as	well.	Pubmed:16934482
chr7	121681028	121682677	P23471	0	+	121681028	121682677	255,102,0	1	1649	0	.	Substrate	binding.
chr7	121716545	121738898	Q9UDR5	0	-	121716545	121738898	255,102,0	1	22353	0	.	Saccharopine	dehydrogenase.
chr7	121741465	121773684	Q9UDR5	0	-	121741465	121773684	255,102,0	1	32219	0	.	Lysine-ketoglutarate	reductase.
chr7	122027169	122091453	Q86UW7	0	-	122027169	122091453	255,102,0	1	64284	0	.	Interaction	with	DRD2.	Pubmed:15857609
chr7	123296017	123296158	Q6P5Q4	0	+	123296017	123296158	255,102,0	1	141	0	.	Interaction	with	tropomyosin	alpha.	Pubmed:25250574
chr7	123296017	123302123	Q6P5Q4	0	+	123296017	123302123	255,102,0	1	6106	0	.	Interaction	with	actin	1.	Pubmed:26417072
chr7	123302123	123303131	Q6P5Q4	0	+	123302123	123303131	255,102,0	1	1008	0	.	Interaction	with	actin	2.	Pubmed:26417072
chr7	123303200	123303775	Q6P5Q4	0	+	123303200	123303775	255,102,0	1	575	0	.	Interaction	with	actin	3.	Pubmed:26417072
chr7	124493075	124493087	Q9NUX5	0	-	124493075	124493087	255,102,0	1	12	0	.	DNA	binding.
chr7	124511075	124532347	Q9NUX5	0	-	124511075	124532347	255,102,0	1	21272	0	.	DNA	binding.
chr7	126746739	126746748	O00222	0	-	126746739	126746748	255,102,0	1	9	0	.	Glutamate	binding.
chr7	128034992	128035007	C9J381	0	-	128034992	128035007	255,102,0	1	15	0	.	IMP	binding.
chr7	128035073	128035079	C9J381	0	-	128035073	128035079	255,102,0	1	6	0	.	IMP	binding.
chr7	128035236	128035245	C9J381	0	-	128035236	128035245	255,102,0	1	9	0	.	IMP	binding.
chr7	128097322	128097433	Q9Y5L2	0	+	128097322	128097433	255,102,0	1	111	0	.	Required	for	targeting	to	lipid	droplets.
chr7	128490032	128490104	Q14315	0	+	128490032	128490104	255,102,0	1	72	0	.	Hinge	1.
chr7	128494026	128494468	Q14315	0	+	128494026	128494468	255,102,0	1	442	0	.	Intradomain	insert;	mediate	targeting	to	Z	lines.
chr7	128495323	128498571	Q14315	0	+	128495323	128498571	255,102,0	1	3248	0	.	Interaction	with	INPPL1.	Pubmed:11739414
chr7	128497386	128498168	Q14315	0	+	128497386	128498168	255,102,0	1	782	0	.	Hinge	2.
chr7	128497386	128498574	Q14315	0	+	128497386	128498574	255,102,0	1	1188	0	.	Self-association	site,	tail.
chr7	128850348	128850860	Q99835	0	+	128850348	128850860	255,102,0	1	512	0	.	Interaction	with	BBS5	and	BBS7.	Pubmed:22072986
chr7	128864920	128865244	Q96HN2	0	+	128864920	128865244	255,102,0	1	324	0	.	LISN	domain,	inhibits	interaction	with	ITPR1.	Pubmed:19220705
chr7	129297191	129311279	Q16656	0	+	129297191	129311279	255,102,0	1	14088	0	.	Dimerization.
chr7	129350348	129394937	Q16656	0	+	129350348	129394937	255,102,0	1	44589	0	.	Required	for	transcriptional	activation.
chr7	129666143	129668855	Q86WB0	0	-	129666143	129668855	255,102,0	1	2712	0	.	F-box-like.
chr7	129770457	129770583	Q6PID8	0	+	129770457	129770583	255,102,0	1	126	0	.	Interaction	with	CUL2.	Pubmed:23102700
chr7	129915036	129915048	P48052	0	+	129915036	129915048	255,102,0	1	12	0	.	Substrate	binding.
chr7	129917728	129917734	P48052	0	+	129917728	129917734	255,102,0	1	6	0	.	Substrate	binding.
chr7	129919433	129919439	P48052	0	+	129919433	129919439	255,102,0	1	6	0	.	Substrate	binding.
chr7	129945709	129945721	Q9UI42	0	+	129945709	129945721	255,102,0	1	12	0	.	Substrate	binding.
chr7	129948209	129948215	Q9UI42	0	+	129948209	129948215	255,102,0	1	6	0	.	Substrate	binding.
chr7	129950655	129950661	Q9UI42	0	+	129950655	129950661	255,102,0	1	6	0	.	Substrate	binding.
chr7	129950757	129950763	Q9UI42	0	+	129950757	129950763	255,102,0	1	6	0	.	Substrate	binding.
chr7	130002329	130002341	Q8WXQ8	0	+	130002329	130002341	255,102,0	1	12	0	.	Substrate	binding.
chr7	130003322	130003328	Q8WXQ8	0	+	130003322	130003328	255,102,0	1	6	0	.	Substrate	binding.
chr7	130007343	130007349	Q8WXQ8	0	+	130007343	130007349	255,102,0	1	6	0	.	Substrate	binding.
chr7	130023282	130023294	P15085	0	+	130023282	130023294	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:18566513
chr7	130024439	130024445	P15085	0	+	130024439	130024445	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:18566513
chr7	130025117	130025123	P15085	0	+	130025117	130025123	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:18566513
chr7	134346286	134346310	P07738	0	+	134346286	134346310	255,102,0	1	24	0	.	Substrate	binding.	Pubmed:17052986
chr7	134346325	134346331	P07738	0	+	134346325	134346331	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17052986
chr7	134346523	134346535	P07738	0	+	134346523	134346535	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:17052986
chr7	134346604	134346610	P07738	0	+	134346604	134346610	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17052986
chr7	134346823	134346829	P07738	0	+	134346823	134346829	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17052986
chr7	134613508	134618141	Q05682	0	+	134613508	134618141	255,102,0	1	4633	0	.	Myosin	and	calmodulin-binding.
chr7	134618474	134618645	Q05682	0	+	134618474	134618645	255,102,0	1	171	0	.	3	X	14	AA	tandem	repeats	of	E-E-E-K-R-A-A-E-E-R-Q-R-I-K.
chr7	134632415	134635193	Q05682	0	+	134632415	134635193	255,102,0	1	2778	0	.	Tropomyosin-binding.
chr7	134642840	134643038	Q05682	0	+	134642840	134643038	255,102,0	1	198	0	.	Strong	actin-binding.
chr7	134642969	134643002	Q05682	0	+	134642969	134643002	255,102,0	1	33	0	.	Tropomyosin-binding.
chr7	134644808	134644829	Q05682	0	+	134644808	134644829	255,102,0	1	21	0	.	Calmodulin-binding.
chr7	134650062	134653093	Q05682	0	+	134650062	134653093	255,102,0	1	3031	0	.	Weak	actin-binding.
chr7	136699918	136699933	P08172	0	+	136699918	136699933	255,102,0	1	15	0	.	Agonist	binding.
chr7	136700818	136700824	P08172	0	+	136700818	136700824	255,102,0	1	6	0	.	Agonist	binding.
chr7	136700887	136700902	P08172	0	+	136700887	136700902	255,102,0	1	15	0	.	Agonist	binding.
chr7	136912769	136935989	P21246	0	-	136912769	136935989	255,102,0	1	23220	0	.	Chondroitin	sulfate	A	binding.	Pubmed:26896299
chr7	136936034	136936061	P21246	0	-	136936034	136936061	255,102,0	1	27	0	.	Chondroitin	sulfate	binding.	Pubmed:26896299
chr7	136936130	136938226	P21246	0	-	136936130	136938226	255,102,0	1	2096	0	.	Chondroitin	sulfate	binding.	Pubmed:26896299
chr7	137570220	137586137	Q70SY1	0	-	137570220	137586137	255,102,0	1	15917	0	.	Leucine-zipper.
chr7	137588703	137590477	Q70SY1	0	-	137588703	137590477	255,102,0	1	1774	0	.	Basic	motif.
chr7	138263951	138264029	O15164	0	+	138263951	138264029	255,102,0	1	78	0	.	Nuclear	receptor	binding	site	(NRBS).
chr7	138264191	138264212	O15164	0	+	138264191	138264212	255,102,0	1	21	0	.	Interaction	with	histone	H3	that	is	not	methylated	at	'Lys-4'	(H3K4me0).
chr7	138268735	138268741	O15164	0	+	138268735	138268741	255,102,0	1	6	0	.	Interaction	with	histone	H3	that	is	acetylated	at	'Lys-23'	(H3K23ac).
chr7	138764924	138768553	Q7Z2W4	0	-	138764924	138768553	255,102,0	1	3629	0	.	Binding	to	EXOSC5.
chr7	138764924	138794074	Q7Z2W4	0	-	138764924	138794074	255,102,0	1	29150	0	.	N-terminal	domain.
chr7	139257675	139268578	Q9H2X6	0	-	139257675	139268578	255,102,0	1	10903	0	.	Autoinhibitory	domain	(AID).
chr7	139258122	139268725	Q9H2X6	0	-	139258122	139268725	255,102,0	1	10603	0	.	Interaction	with	AXIN1.
chr7	139268587	139281563	Q9H2X6	0	-	139268587	139281563	255,102,0	1	12976	0	.	Required	for	localization	to	nuclear	speckles.
chr7	139268704	139281644	Q9H2X6	0	-	139268704	139281644	255,102,0	1	12940	0	.	Interaction	with	TP53	and	TP73.	Pubmed:11925430
chr7	139268803	139281530	Q9H2X6	0	-	139268803	139281530	255,102,0	1	12727	0	.	SUMO	interaction	motifs	(SIM);	required	for	nuclear	localization	and	kinase	activity.
chr7	139268806	139281563	Q9H2X6	0	-	139268806	139281563	255,102,0	1	12757	0	.	Interaction	with	UBE2I.
chr7	139281488	139285239	Q9H2X6	0	-	139281488	139285239	255,102,0	1	3751	0	.	Interaction	with	HMGA1.
chr7	139281488	139288828	Q9H2X6	0	-	139281488	139288828	255,102,0	1	7340	0	.	Interaction	with	POU4F1.
chr7	139281551	139285278	Q9H2X6	0	-	139281551	139285278	255,102,0	1	3727	0	.	Interaction	with	CTBP1.
chr7	139281647	139311351	Q9H2X6	0	-	139281647	139311351	255,102,0	1	29704	0	.	Interaction	with	SKI	and	SMAD1.	Pubmed:12874272
chr7	139416143	139416545	Q9H2X6	0	-	139416143	139416545	255,102,0	1	402	0	.	Transcriptional	corepression.
chr7	139833394	139833448	Q6ZMT4	0	-	139833394	139833448	255,102,0	1	54	0	.	Linker.
chr7	140156648	140158872	Q9UHC7	0	-	140156648	140158872	255,102,0	1	2224	0	.	Makorin-type	Cys-His.
chr7	141721418	141750604	O43451	0	+	141721418	141750604	255,102,0	1	29186	0	.	Maltase.
chr7	141754592	141803182	O43451	0	+	141754592	141803182	255,102,0	1	48590	0	.	Glucoamylase.
chr7	141831763	141864766	Q2M2H8	0	+	141831763	141864766	255,102,0	1	33003	0	.	Maltase.
chr7	141869913	141918271	Q2M2H8	0	+	141869913	141918271	255,102,0	1	48358	0	.	Glucoamylase.
chr7	142960651	142960660	Q9Y2Q3	0	+	142960651	142960660	255,102,0	1	9	0	.	Glutathione	binding.
chr7	142965243	142965249	Q9Y2Q3	0	+	142965243	142965249	255,102,0	1	6	0	.	Glutathione	binding.
chr7	148512096	148515209	Q15910	0	-	148512096	148515209	255,102,0	1	3113	0	.	Interaction	with	CDYL.	Pubmed:22009739
chr7	148515173	148544390	Q15910	0	-	148515173	148544390	255,102,0	1	29217	0	.	Interaction	with	DNMT1,	DNMT3A	and	DNMT3B.
chr7	148543603	148544276	Q15910	0	-	148543603	148544276	255,102,0	1	673	0	.	Interaction	with	EED.
chr7	150554668	150554701	P19801	0	+	150554668	150554701	255,102,0	1	33	0	.	Substrate	binding.	Pubmed:19764817
chr7	150554929	150554947	P19801	0	+	150554929	150554947	255,102,0	1	18	0	.	Substrate	binding.	Pubmed:19764817
chr7	150555981	150556005	P19801	0	+	150555981	150556005	255,102,0	1	24	0	.	Heparin-binding.
chr7	150768622	150773451	P04920	0	+	150768622	150773451	255,102,0	1	4829	0	.	Membrane	(anion	exchange).
chr7	150779560	150779647	Q9BVT8	0	-	150779560	150779647	255,102,0	1	87	0	.	Required	to	release	iHOPS	from	membranes.
chr7	150813905	150825678	Q96P47	0	+	150813905	150825678	255,102,0	1	11773	0	.	Small	GTPase-like.
chr7	151680098	151699869	Q7Z4T8	0	+	151680098	151699869	255,102,0	1	19771	0	.	Catalytic	subdomain	A.
chr7	151700040	151711791	Q7Z4T8	0	+	151700040	151711791	255,102,0	1	11751	0	.	Catalytic	subdomain	B.
chr7	151800224	151805193	Q8NCW6	0	+	151800224	151805193	255,102,0	1	4969	0	.	Catalytic	subdomain	A.
chr7	151805364	151810393	Q8NCW6	0	+	151805364	151810393	255,102,0	1	5029	0	.	Catalytic	subdomain	B.
chr7	151835976	151835982	Q8NEZ4	0	-	151835976	151835982	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr7	154735861	154760143	Q6ZW49	0	-	154735861	154760143	255,102,0	1	24282	0	.	Interaction	with	TP53BP1.
chr7	154767930	154782760	Q6ZW49	0	-	154767930	154782760	255,102,0	1	14830	0	.	Interaction	with	PAGR1.
chr7	156742431	156743238	Q5C9Z4	0	+	156742431	156743238	255,102,0	1	807	0	.	Necessary	for	nucleolar	localization	and	for	targeting	PPP1CA	to	the	nucleolus.
chr7	156931966	156961801	Q15386	0	+	156931966	156961801	255,102,0	1	29835	0	.	Cis-determinant	of	acceptor	ubiquitin-binding.
chr7	157151269	157175031	O75190	0	+	157151269	157175031	255,102,0	1	23762	0	.	Interaction	with	HSP70.	Pubmed:10954706
chr7	157174947	157202523	O75190	0	+	157174947	157202523	255,102,0	1	27576	0	.	Interaction	with	KRT18.	Pubmed:10954706
chr7	157361642	157364136	Q92932	0	-	157361642	157364136	255,102,0	1	2494	0	.	Substrate	binding.
chr7	157926661	158380361	Q92932	0	-	157926661	158380361	255,102,0	1	453700	0	.	Involved	in	localization	to	secretory	granules;	interaction	with	CPE.
chr8	363079	382896	Q8TCJ0	0	+	363079	382896	255,102,0	1	19817	0	.	Interaction	with	beta-actin.
chr8	10622913	10623138	Q96BK5	0	-	10622913	10623138	255,102,0	1	225	0	.	Telomerase	inhibitory	domain	(TID).
chr8	11994679	11995075	Q6R6M4	0	-	11994679	11995075	255,102,0	1	396	0	.	Mediates	interaction	with	SUDS3.	Pubmed:21239494
chr8	12044101	12044110	Q8N7N1	0	-	12044101	12044110	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr8	12286382	12286391	P0C5J1	0	-	12286382	12286391	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr8	12952702	12955924	Q96QB1	0	-	12952702	12955924	255,102,0	1	3222	0	.	Polybasic	cluster	(PBR).
chr8	12957193	12957718	Q96QB1	0	-	12957193	12957718	255,102,0	1	525	0	.	Focal	adhesion-targeting	(FAT).
chr8	16026269	16026368	P21757	0	-	16026269	16026368	255,102,0	1	99	0	.	Spacer.
chr8	17169088	17169109	Q9Y216	0	-	17169088	17169109	255,102,0	1	21	0	.	Substrate	binding.
chr8	17188695	17188701	Q9Y216	0	-	17188695	17188701	255,102,0	1	6	0	.	Substrate	binding.
chr8	17188764	17188776	Q9Y216	0	-	17188764	17188776	255,102,0	1	12	0	.	Substrate	binding.
chr8	18079871	18079877	P18440	0	+	18079871	18079877	255,102,0	1	6	0	.	Substrate	binding.
chr8	19816787	19818595	P06858	0	+	19816787	19818595	255,102,0	1	1808	0	.	Heparin-binding.
chr8	21891639	21891711	Q86SE8	0	+	21891639	21891711	255,102,0	1	72	0	.	Acidic	tract	A2.
chr8	21929901	21937946	Q08495	0	+	21929901	21937946	255,102,0	1	8045	0	.	Interaction	with	RASGRF2.	Pubmed:11856323
chr8	22033753	22037882	P13497	0	+	22033753	22037882	255,102,0	1	4129	0	.	Metalloprotease.
chr8	22424220	22428536	O60504	0	+	22424220	22428536	255,102,0	1	4316	0	.	Binds	to	vinculin.
chr8	22429320	22432238	O60504	0	+	22429320	22432238	255,102,0	1	2918	0	.	Binds	to	SOS.
chr8	22473743	22475228	Q8N163	0	+	22473743	22475228	255,102,0	1	1485	0	.	Interaction	with	MCC.	Pubmed:24824780
chr8	22475897	22477192	Q8N163	0	+	22475897	22477192	255,102,0	1	1295	0	.	Interaction	with	NR1D1.	Pubmed:23398316
chr8	22861947	22864388	Q9BYZ6	0	+	22861947	22864388	255,102,0	1	2441	0	.	Rho-like.
chr8	23155627	23167419	Q9Y4K0	0	-	23155627	23167419	255,102,0	1	11792	0	.	Lysyl-oxidase	like.
chr8	24771309	24771618	P07197	0	+	24771309	24771618	255,102,0	1	309	0	.	Head.
chr8	24771618	24771714	P07197	0	+	24771618	24771714	255,102,0	1	96	0	.	Coil	1A.
chr8	24771618	24774604	P07197	0	+	24771618	24774604	255,102,0	1	2986	0	.	Rod.
chr8	24771714	24771753	P07197	0	+	24771714	24771753	255,102,0	1	39	0	.	Linker	1.
chr8	24771753	24772050	P07197	0	+	24771753	24772050	255,102,0	1	297	0	.	Coil	1B.
chr8	24772050	24772101	P07197	0	+	24772050	24772101	255,102,0	1	51	0	.	Linker	12.
chr8	24772101	24772167	P07197	0	+	24772101	24772167	255,102,0	1	66	0	.	Coil	2A.
chr8	24772167	24772179	P07197	0	+	24772167	24772179	255,102,0	1	12	0	.	Linker	2.
chr8	24772179	24774604	P07197	0	+	24772179	24774604	255,102,0	1	2425	0	.	Coil	2B.
chr8	24774604	24776116	P07197	0	+	24774604	24776116	255,102,0	1	1512	0	.	Tail.
chr8	24775207	24775441	P07197	0	+	24775207	24775441	255,102,0	1	234	0	.	6	X	13	AA	approximate	tandem	repeats	of	K-S-P-V-[PS]-K-S-P-V-E-E-[KA]-[GAK].
chr8	24810325	24811149	P07196	0	-	24810325	24811149	255,102,0	1	823	0	.	Tail,	subdomain	B	(acidic).
chr8	24810325	24811290	P07196	0	-	24810325	24811290	255,102,0	1	964	0	.	Tail.
chr8	24811149	24811290	P07196	0	-	24811149	24811290	255,102,0	1	141	0	.	Tail,	subdomain	A.
chr8	24811290	24813189	P07196	0	-	24811290	24813189	255,102,0	1	1899	0	.	Coil	2B.
chr8	24811290	24813753	P07196	0	-	24811290	24813753	255,102,0	1	2463	0	.	Rod.
chr8	24811305	24811723	P07196	0	-	24811305	24811723	255,102,0	1	418	0	.	Epitope;	recognized	by	IF-specific	monoclonal	antibody.
chr8	24813189	24813216	P07196	0	-	24813189	24813216	255,102,0	1	27	0	.	Linker	2.
chr8	24813216	24813273	P07196	0	-	24813216	24813273	255,102,0	1	57	0	.	Coil	2A.
chr8	24813273	24813327	P07196	0	-	24813273	24813327	255,102,0	1	54	0	.	Linker	12.
chr8	24813327	24813618	P07196	0	-	24813327	24813618	255,102,0	1	291	0	.	Coil	1B.
chr8	24813618	24813657	P07196	0	-	24813618	24813657	255,102,0	1	39	0	.	Linker	1.
chr8	24813657	24813753	P07196	0	-	24813657	24813753	255,102,0	1	96	0	.	Coil	1A.
chr8	24813753	24814026	P07196	0	-	24813753	24814026	255,102,0	1	273	0	.	Head.
chr8	25747304	25747316	Q9HAK2	0	-	25747304	25747316	255,102,0	1	12	0	.	Interaction	with	DNA.
chr8	25766013	25766037	Q9HAK2	0	-	25766013	25766037	255,102,0	1	24	0	.	Interaction	with	DNA.
chr8	25899703	25899715	Q9HAK2	0	-	25899703	25899715	255,102,0	1	12	0	.	Interaction	with	DNA.
chr8	27308325	27316023	Q14289	0	+	27308325	27316023	255,102,0	1	7698	0	.	Interaction	with	TGFB1I1.
chr8	27311676	27316023	Q14289	0	+	27311676	27316023	255,102,0	1	4347	0	.	Focal	adhesion	targeting	(FAT).
chr8	27348725	27369364	P34913	0	+	27348725	27369364	255,102,0	1	20639	0	.	Phosphatase.
chr8	27362492	27362498	P34913	0	+	27362492	27362498	255,102,0	1	6	0	.	Phosphate	binding.
chr8	27369394	27402036	P34913	0	+	27369394	27402036	255,102,0	1	32642	0	.	Epoxide	hydrolase.
chr8	27667824	27667833	Q96KB5	0	-	27667824	27667833	255,102,0	1	9	0	.	PDZ-interaction.
chr8	28588757	28588775	O43909	0	+	28588757	28588775	255,102,0	1	18	0	.	Substrate	binding.
chr8	28588820	28588829	O43909	0	+	28588820	28588829	255,102,0	1	9	0	.	Substrate	binding.
chr8	28600665	28600680	O43909	0	+	28600665	28600680	255,102,0	1	15	0	.	Substrate	binding.
chr8	30361847	30361871	Q93062	0	+	30361847	30361871	255,102,0	1	24	0	.	Interaction	with	RNA.	Pubmed:26347403
chr8	30915966	30933795	Q14191	0	+	30915966	30933795	255,102,0	1	17829	0	.	Interaction	with	WRNIP1.
chr8	30941214	30942762	Q14191	0	+	30941214	30942762	255,102,0	1	1548	0	.	2	X	27	AA	tandem	repeats	of	H-L-S-P-N-D-N-E-N-D-T-S-Y-V-I-E-S-D-E-D-L-E-M-E-M-L-K.
chr8	30990013	30998957	Q14191	0	+	30990013	30998957	255,102,0	1	8944	0	.	Interaction	with	DNA.	Pubmed:20159463
chr8	35406976	35406985	Q6UXZ4	0	+	35406976	35406985	255,102,0	1	9	0	.	Important	for	interaction	with	FLRT2.
chr8	36694382	36694445	A8MYU2	0	+	36694382	36694445	255,102,0	1	63	0	.	Segment	S7.
chr8	36698070	36698489	A8MYU2	0	+	36698070	36698489	255,102,0	1	419	0	.	Segment	S8.
chr8	36766852	36766915	A8MYU2	0	+	36766852	36766915	255,102,0	1	63	0	.	Segment	S9.
chr8	36780093	36788477	A8MYU2	0	+	36780093	36788477	255,102,0	1	8384	0	.	Segment	S10.
chr8	37607341	37611540	O94905	0	+	37607341	37611540	255,102,0	1	4199	0	.	Interaction	with	ERLIN1.	Pubmed:19240031
chr8	37702010	37702175	Q9HAW0	0	-	37702010	37702175	255,102,0	1	165	0	.	Required	for	interaction	with	TBP	and	formation	of	a	ternary	complex	with	DNA	and	TBP.	Pubmed:26638071
chr8	37702178	37702199	Q9HAW0	0	-	37702178	37702199	255,102,0	1	21	0	.	Required	for	the	formation	of	a	ternary	complex	with	DNA	and	TBP;	not	required	for	interaction	with	TBP	in	the	absence	of	DNA.	Pubmed:26638071
chr8	37704565	37704586	Q9HAW0	0	-	37704565	37704586	255,102,0	1	21	0	.	Interaction	with	target	DNA.	Pubmed:26638071
chr8	37720415	37720610	Q6WKZ4	0	-	37720415	37720610	255,102,0	1	195	0	.	Necessary	for	interaction	with	RAB4A	and	RAB11A,	subcellular	location	and	endosomal	recycling.
chr8	37822979	37822994	P13945	0	-	37822979	37822994	255,102,0	1	15	0	.	Agonist	and	antagonist	binding.
chr8	37823051	37823075	P13945	0	-	37823051	37823075	255,102,0	1	24	0	.	Agonist	and	antagonist	binding.
chr8	37823351	37823396	P13945	0	-	37823351	37823396	255,102,0	1	45	0	.	Agonist	and	antagonist	binding.
chr8	37963905	37968297	Q9UBL3	0	+	37963905	37968297	255,102,0	1	4392	0	.	DNA-binding.
chr8	38123659	38123692	Q8NEB5	0	-	38123659	38123692	255,102,0	1	33	0	.	Phosphatase	sequence	motif	III.
chr8	38124791	38124803	Q8NEB5	0	-	38124791	38124803	255,102,0	1	12	0	.	Phosphatase	sequence	motif	II.
chr8	38124899	38125431	Q8NEB5	0	-	38124899	38125431	255,102,0	1	532	0	.	Phosphatase	sequence	motif	I.
chr8	38285528	38285582	P11362	0	-	38285528	38285582	255,102,0	1	54	0	.	Heparin-binding.
chr8	38645103	38646225	O75410	0	+	38645103	38646225	255,102,0	1	1122	0	.	Interaction	with	LSM7	and	SNRPG.	Pubmed:12165861
chr8	38677215	38677539	O75410	0	+	38677215	38677539	255,102,0	1	324	0	.	Interaction	with	TDRD7.	Pubmed:14603251
chr8	38677377	38678043	O75410	0	+	38677377	38678043	255,102,0	1	666	0	.	Interaction	with	YEATS4.	Pubmed:11903063
chr8	38699944	38705538	O75410	0	+	38699944	38705538	255,102,0	1	5594	0	.	Interaction	with	CH-TOG.
chr8	38834090	38839258	P83105	0	+	38834090	38839258	255,102,0	1	5168	0	.	Serine	protease.
chr8	41399338	41399603	Q9BRT9	0	+	41399338	41399603	255,102,0	1	265	0	.	Important	for	GINS	complex	assembly.
chr8	41547762	41550324	P16157	0	-	41547762	41550324	255,102,0	1	2562	0	.	UPA	domain.
chr8	41557046	41655056	P16157	0	-	41557046	41655056	255,102,0	1	98010	0	.	89	kDa	domain.
chr8	41789893	41790001	Q92794	0	-	41789893	41790001	255,102,0	1	108	0	.	Required	for	activation	of	RUNX1-2.
chr8	41790514	41791189	Q92794	0	-	41790514	41791189	255,102,0	1	675	0	.	Interaction	with	PML.	Pubmed:23431171
chr8	41790811	41791189	Q92794	0	-	41790811	41791189	255,102,0	1	378	0	.	Interaction	with	RUNX1-2.
chr8	41800316	41812893	Q92794	0	-	41800316	41812893	255,102,0	1	12577	0	.	Mediates	interaction	with	BRPF1,	required	for	histone	H3	acetyltransferase	activity.	Pubmed:18794358
chr8	41800412	41832242	Q92794	0	-	41800412	41832242	255,102,0	1	31830	0	.	Catalytic.
chr8	41804112	41836269	Q92794	0	-	41804112	41836269	255,102,0	1	32157	0	.	Interaction	with	RUNX1-1.
chr8	41804112	41906066	Q92794	0	-	41804112	41906066	255,102,0	1	101954	0	.	Interaction	with	PML.	Pubmed:23431171
chr8	41804124	41804145	Q92794	0	-	41804124	41804145	255,102,0	1	21	0	.	Acetyl-CoA	binding.
chr8	41804157	41804172	Q92794	0	-	41804157	41804172	255,102,0	1	15	0	.	Acetyl-CoA	binding.
chr8	41905997	41906342	Q92794	0	-	41905997	41906342	255,102,0	1	345	0	.	Required	for	nuclear	localization.
chr8	41906063	41906495	Q92794	0	-	41906063	41906495	255,102,0	1	432	0	.	Required	for	activation	of	RUNX1-1.
chr8	42046548	42046581	P00750	0	-	42046548	42046581	255,102,0	1	33	0	.	Important	for	binding	to	annexin	A2.
chr8	42176794	42176860	O14920	0	+	42176794	42176860	255,102,0	1	66	0	.	Leucine-zipper.
chr8	42188434	42188452	O14920	0	+	42188434	42188452	255,102,0	1	18	0	.	NEMO-binding.
chr8	42214906	42218838	P06746	0	+	42214906	42218838	255,102,0	1	3932	0	.	DNA	binding.
chr8	42231638	42231860	Q9UBT3	0	-	42231638	42231860	255,102,0	1	222	0	.	DKK-type	Cys-2.
chr8	42232423	42233339	Q9UBT3	0	-	42232423	42233339	255,102,0	1	916	0	.	DKK-type	Cys-1.
chr8	42752274	42812260	Q86VS8	0	+	42752274	42812260	255,102,0	1	59986	0	.	Sufficient	for	interaction	with	microtubules.
chr8	42862990	42873638	Q86VS8	0	+	42862990	42873638	255,102,0	1	10648	0	.	Required	for	association	with	Golgi.
chr8	42862999	42873638	Q86VS8	0	+	42862999	42873638	255,102,0	1	10639	0	.	Required	for	interaction	with	MSR1.	Pubmed:17237231
chr8	48649920	48650007	P49716	0	-	48649920	48650007	255,102,0	1	87	0	.	Leucine-zipper.
chr8	48650016	48650100	P49716	0	-	48650016	48650100	255,102,0	1	84	0	.	Basic	motif.
chr8	48719808	48752725	P78527	0	-	48719808	48752725	255,102,0	1	32917	0	.	KIP-binding.
chr8	48798666	48800173	P78527	0	-	48798666	48800173	255,102,0	1	1507	0	.	Interaction	with	C1D.	Pubmed:9679063
chr8	48798666	48800173	P78527	0	-	48798666	48800173	255,102,0	1	1507	0	.	Leucine-zipper.
chr8	49833764	49833824	O43623	0	-	49833764	49833824	255,102,0	1	60	0	.	SNAG	domain.
chr8	56715056	56737238	Q96RS0	0	+	56715056	56737238	255,102,0	1	22182	0	.	Sufficient	for	catalytic	activity.
chr8	57078804	57079152	Q6DJT9	0	-	57078804	57079152	255,102,0	1	348	0	.	Massively	activates	transcription.
chr8	57078804	57079578	Q6DJT9	0	-	57078804	57079578	255,102,0	1	774	0	.	Activates	transcription;	Inhibition	of	nuclear	import	due	to	lack	of	NLS	and	KPNA2	interaction.
chr8	57079152	57079578	Q6DJT9	0	-	57079152	57079578	255,102,0	1	426	0	.	Repression	domain;	contains	3	sumoylation	motifs	and	massively	decrease	transcription	activity.
chr8	57079578	57080708	Q6DJT9	0	-	57079578	57080708	255,102,0	1	1130	0	.	Decreased	nuclear	import	with	localization	in	the	nucleus	but	also	in	the	cytoplasm.
chr8	57080052	57080825	Q6DJT9	0	-	57080052	57080825	255,102,0	1	773	0	.	Interaction	with	KPNA2.	Pubmed:11882654
chr8	57892606	57892618	Q9NX62	0	-	57892606	57892618	255,102,0	1	12	0	.	Substrate	binding.
chr8	59477595	59484813	O00560	0	+	59477595	59484813	255,102,0	1	7218	0	.	Interaction	with	PDCD6IP.	Pubmed:22660413
chr8	59492350	59493078	O00560	0	+	59492350	59493078	255,102,0	1	728	0	.	phosphatidylinositol-4,5-bisphosphate-binding.	Pubmed:27386966
chr8	61429769	61471421	P61019	0	+	61429769	61471421	255,102,0	1	41652	0	.	Required	for	interaction	with	PRKCI.	Pubmed:14570876
chr8	62430142	62430151	Q12797	0	-	62430142	62430151	255,102,0	1	9	0	.	2-oxoglutarate	binding.
chr8	64099832	64099841	Q7Z739	0	+	64099832	64099841	255,102,0	1	9	0	.	N6-methyladenosine	binding.
chr8	64099880	64099886	Q7Z739	0	+	64099880	64099886	255,102,0	1	6	0	.	N6-methyladenosine	binding.
chr8	66619261	66620225	Q15390	0	+	66619261	66620225	255,102,0	1	964	0	.	Necessary	and	sufficient	to	promote	mitochondrial	fission.
chr8	66631620	66651773	Q13946	0	-	66631620	66651773	255,102,0	1	20153	0	.	Catalytic.
chr8	67484785	67492577	P10243	0	-	67484785	67492577	255,102,0	1	7792	0	.	Negative	regulatory	domain.
chr8	67492583	67505429	P10243	0	-	67492583	67505429	255,102,0	1	12846	0	.	Transcriptional	activation	domain.
chr8	68179406	68179581	Q9Y6D6	0	-	68179406	68179581	255,102,0	1	175	0	.	HUS;	DCB:HUS	domain	interaction.
chr8	68204325	68255519	Q9Y6D6	0	-	68204325	68255519	255,102,0	1	51194	0	.	DCB;	DCB:DCB	domain	and	DCB:HUS	domain	interaction.
chr8	68346335	68346341	Q8N4T0	0	-	68346335	68346341	255,102,0	1	6	0	.	Substrate	binding.
chr8	68396024	68396030	Q8N4T0	0	-	68396024	68396030	255,102,0	1	6	0	.	Substrate	binding.
chr8	68419060	68419072	Q8N4T0	0	-	68419060	68419072	255,102,0	1	12	0	.	Substrate	binding.
chr8	70978500	70981516	Q9GZV8	0	-	70978500	70981516	255,102,0	1	3016	0	.	Interaction	with	CBFA2T2.
chr8	71041176	71068412	Q15596	0	-	71041176	71068412	255,102,0	1	27236	0	.	Interaction	with	ARNTL.
chr8	71068370	71068529	Q15596	0	-	71068370	71068529	255,102,0	1	159	0	.	CASP8AP2-binding.
chr8	72935344	72936062	O75762	0	-	72935344	72936062	255,102,0	1	718	0	.	Inositolphosphate	binding.	Pubmed:25855297
chr8	73921292	73939204	P54274	0	+	73921292	73939204	255,102,0	1	17912	0	.	TRFH	dimerization.
chr8	73939192	73951445	P54274	0	+	73939192	73951445	255,102,0	1	12253	0	.	Interaction	with	RLIM.	Pubmed:19164295
chr8	74204601	74205028	P18124	0	-	74204601	74205028	255,102,0	1	427	0	.	4	X	12	AA	tandem	repeats.
chr8	74939046	74939061	Q9Y6Y9	0	+	74939046	74939061	255,102,0	1	15	0	.	Interaction	with	lipopolysaccharide.	Pubmed:17569869,	Pubmed:17803912
chr8	75276482	75276599	Q8TB36	0	+	75276482	75276599	255,102,0	1	117	0	.	Required	for	mitochondrial	localization.
chr8	80523430	80549095	Q93045	0	+	80523430	80549095	255,102,0	1	25665	0	.	Membrane	attachment.
chr8	80553611	80553785	Q93045	0	+	80553611	80553785	255,102,0	1	174	0	.	Regulatory/phosphorylation	domain.
chr8	80677986	80679477	Q9Y5J3	0	-	80677986	80679477	255,102,0	1	1491	0	.	Transcriptional	repression	and	interaction	with	NCOR1	and	SIN3A.
chr8	81888781	81888790	Q9NWQ8	0	-	81888781	81888790	255,102,0	1	9	0	.	Interaction	with	SLC9A3R1.	Pubmed:11684085
chr8	81889117	81889129	Q9NWQ8	0	-	81889117	81889129	255,102,0	1	12	0	.	Interaction	with	CSK.	Pubmed:10790433
chr8	82196778	82196787	Q01469	0	+	82196778	82196787	255,102,0	1	9	0	.	Fatty	acid	binding.
chr8	82355644	82355653	P02689	0	-	82355644	82355653	255,102,0	1	9	0	.	Fatty	acid	binding.
chr8	82391111	82391120	P15090	0	-	82391111	82391120	255,102,0	1	9	0	.	Fatty	acid	binding.
chr8	82437316	82437325	A6NFH5	0	-	82437316	82437325	255,102,0	1	9	0	.	Fatty	acid	binding.
chr8	82572880	82572889	P29218	0	-	82572880	82572889	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:8068620
chr8	82591377	82591389	P29218	0	-	82591377	82591389	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:8068620,	Pubmed:8068621
chr8	82644861	82667695	Q96CF2	0	+	82644861	82667695	255,102,0	1	22834	0	.	Intramolecular	interaction	with	C-terminus.
chr8	82667695	82670776	Q96CF2	0	+	82667695	82670776	255,102,0	1	3081	0	.	Intramolecular	interaction	with	N-terminus.
chr8	86089880	86114441	Q15329	0	+	86089880	86114441	255,102,0	1	24561	0	.	Leucine-zipper.
chr8	86115338	86121406	Q15329	0	+	86115338	86121406	255,102,0	1	6068	0	.	Dimerization.
chr8	86121619	86126094	Q15329	0	+	86121619	86126094	255,102,0	1	4475	0	.	Transactivation.
chr8	86126022	86126076	Q15329	0	+	86126022	86126076	255,102,0	1	54	0	.	RBL2	association.
chr8	86180784	86180790	Q8N1Q1	0	+	86180784	86180790	255,102,0	1	6	0	.	Substrate	binding.
chr8	86241983	86241989	P00915	0	-	86241983	86241989	255,102,0	1	6	0	.	Substrate	binding.
chr8	86352095	86352107	P07451	0	+	86352095	86352107	255,102,0	1	12	0	.	Involved	in	proton	transfer.
chr8	86358454	86358460	P07451	0	+	86358454	86358460	255,102,0	1	6	0	.	Substrate	binding.
chr8	86389432	86389438	P00918	0	+	86389432	86389438	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:10550681,	Pubmed:19520834
chr8	90967701	90983442	O60934	0	-	90967701	90983442	255,102,0	1	15741	0	.	Interaction	with	MTOR,	MAPKAP1	and	RICTOR.	Pubmed:23762398
chr8	90976647	90993111	O60934	0	-	90976647	90993111	255,102,0	1	16464	0	.	Mediates	interaction	with	SP100.
chr8	91094904	91094922	P05937	0	-	91094904	91094922	255,102,0	1	18	0	.	Interaction	with	RANBP9.	Pubmed:12684061
chr8	92090721	92090742	Q8N6M0	0	+	92090721	92090742	255,102,0	1	21	0	.	Cys-loop.
chr8	92092922	92092955	Q8N6M0	0	+	92092922	92092955	255,102,0	1	33	0	.	Variable-loop.
chr8	92097012	92097045	Q8N6M0	0	+	92097012	92097045	255,102,0	1	33	0	.	His-loop.
chr8	92406252	92407322	Q8TE54	0	+	92406252	92407322	255,102,0	1	1070	0	.	Membrane	targeting.	Pubmed:16524946
chr8	92982948	92988154	Q06455	0	-	92982948	92988154	255,102,0	1	5206	0	.	Nervy	homology	region	3	(NHR3).	Pubmed:12559562
chr8	92998481	92999183	Q06455	0	-	92998481	92999183	255,102,0	1	702	0	.	Important	for	oligomerization.
chr8	92998481	92999183	Q06455	0	-	92998481	92999183	255,102,0	1	702	0	.	Nervy	homology	region	2	(NHR2).	Pubmed:12559562
chr8	95262573	95262633	P55040	0	-	95262573	95262633	255,102,0	1	60	0	.	Calmodulin-binding.
chr8	98656734	98656947	Q86UE4	0	+	98656734	98656947	255,102,0	1	213	0	.	Activation	of	NF-kappa-B.
chr8	98656947	98698919	Q86UE4	0	+	98656947	98698919	255,102,0	1	41972	0	.	Interaction	with	BCCIP.	Pubmed:18440304
chr8	98657034	98699703	Q86UE4	0	+	98657034	98699703	255,102,0	1	42669	0	.	Interaction	with	RELA.	Pubmed:16452207
chr8	98712073	98725946	Q86UE4	0	+	98712073	98725946	255,102,0	1	13873	0	.	Lung-homing	for	mammary	tumors.
chr8	101270786	101271323	Q9NV58	0	-	101270786	101271323	255,102,0	1	537	0	.	Interaction	with	CASR.	Pubmed:16513638
chr8	101724888	101730008	P11940	0	-	101724888	101730008	255,102,0	1	5120	0	.	CSDE1-binding.
chr8	102504997	102565005	Q6ISB3	0	+	102504997	102565005	255,102,0	1	60008	0	.	Transcription	activation.
chr8	103564054	103564186	Q14990	0	+	103564054	103564186	255,102,0	1	132	0	.	2	X	5	AA	repeats	of	[RC]-C-L-C-D.
chr8	103572983	103573073	Q14990	0	+	103572983	103573073	255,102,0	1	90	0	.	C-X-P	repeat	region.
chr8	104153134	104153233	Q8WXS3	0	+	104153134	104153233	255,102,0	1	99	0	.	Interaction	with	CAMK2A.
chr8	106814794	106814815	Q8WW38	0	+	106814794	106814815	255,102,0	1	21	0	.	Interaction	with	CTBP2.
chr8	107722872	107722956	Q8N573	0	+	107722872	107722956	255,102,0	1	84	0	.	Mediates	oxidative	antimutator	activity.
chr8	107773267	107773357	Q8N0Z2	0	-	107773267	107773357	255,102,0	1	90	0	.	Interaction	with	actin.
chr8	107773267	107773513	Q8N0Z2	0	-	107773267	107773513	255,102,0	1	246	0	.	Actin-binding	2.
chr8	107773513	107781824	Q8N0Z2	0	-	107773513	107781824	255,102,0	1	8311	0	.	Actin-binding	1.
chr8	107773555	107773693	Q8N0Z2	0	-	107773555	107773693	255,102,0	1	138	0	.	Interaction	with	actin.
chr8	109214116	109226846	P60228	0	-	109214116	109226846	255,102,0	1	12730	0	.	Sufficient	for	interaction	with	MCM7.	Pubmed:17310990
chr8	109241310	109260907	P60228	0	-	109241310	109260907	255,102,0	1	19597	0	.	Sufficient	for	interaction	with	TRIM27.	Pubmed:10504338
chr8	109247313	109260922	P60228	0	-	109247313	109260922	255,102,0	1	13609	0	.	Sufficient	for	interaction	with	EPAS1.	Pubmed:17324924
chr8	110587875	110588199	Q9NX95	0	-	110587875	110588199	255,102,0	1	324	0	.	Sufficient	for	interaction	with	STX1A.	Pubmed:15459722
chr8	110587875	110656885	Q9NX95	0	-	110587875	110656885	255,102,0	1	69010	0	.	Sufficient	for	interaction	with	KIF5B.	Pubmed:15459722
chr8	116426253	116426610	Q9UHF7	0	-	116426253	116426610	255,102,0	1	357	0	.	Transcriptional	repressor	domain.
chr8	116426544	116427144	Q9UHF7	0	-	116426544	116427144	255,102,0	1	600	0	.	Mediates	interaction	with	RNF4.
chr8	116599431	116616254	Q9UHF7	0	-	116599431	116616254	255,102,0	1	16823	0	.	Mediates	interaction	with	GLI3.	Pubmed:19389374
chr8	117864899	117866561	O60216	0	-	117864899	117866561	255,102,0	1	1662	0	.	Interaction	with	STAG1.	Pubmed:19696148
chr8	117864899	117868483	O60216	0	-	117864899	117868483	255,102,0	1	3584	0	.	Interaction	with	WAPL	and	PDS5B.	Pubmed:19696148
chr8	118812088	118812130	Q16394	0	-	118812088	118812130	255,102,0	1	42	0	.	Substrate	binding.
chr8	118817053	118817068	Q16394	0	-	118817053	118817068	255,102,0	1	15	0	.	Substrate	binding.
chr8	118825131	118825140	Q16394	0	-	118825131	118825140	255,102,0	1	9	0	.	Substrate	binding.
chr8	118825185	118830676	Q16394	0	-	118825185	118830676	255,102,0	1	5491	0	.	Substrate	binding.
chr8	120569799	120569865	Q13822	0	-	120569799	120569865	255,102,0	1	66	0	.	Required	for	secretion.
chr8	120628516	120628552	Q13822	0	-	120628516	120628552	255,102,0	1	36	0	.	Substrate	binding.
chr8	120629418	120629430	Q13822	0	-	120629418	120629430	255,102,0	1	12	0	.	Substrate	binding.
chr8	121292951	121313030	Q05707	0	+	121292951	121313030	255,102,0	1	20079	0	.	Nonhelical	region	(NC4).
chr8	121313030	121354627	Q05707	0	+	121313030	121354627	255,102,0	1	41597	0	.	Triple-helical	region	1	(COL2).
chr8	121357684	121383416	Q05707	0	+	121357684	121383416	255,102,0	1	25732	0	.	Triple-helical	region	2	(COL1).
chr8	121509745	121535573	Q96DY7	0	+	121509745	121535573	255,102,0	1	25828	0	.	Interaction	with	MDM2.
chr8	121551119	121551182	Q13884	0	-	121551119	121551182	255,102,0	1	63	0	.	Calmodulin-binding.
chr8	123986282	123986774	Q9Y6X8	0	+	123986282	123986774	255,102,0	1	492	0	.	Required	for	homodimerization.
chr8	123986486	123987038	Q9Y6X8	0	+	123986486	123987038	255,102,0	1	552	0	.	Required	for	repressor	activity.
chr8	123986486	123987191	Q9Y6X8	0	+	123986486	123987191	255,102,0	1	705	0	.	Required	for	interaction	with	NFYA.	Pubmed:12741956
chr8	123986648	123987038	Q9Y6X8	0	+	123986648	123987038	255,102,0	1	390	0	.	Required	for	nuclear	localization.
chr8	124259716	124259845	Q9UKY1	0	-	124259716	124259845	255,102,0	1	129	0	.	Required	for	repressor	activity.
chr8	124260031	124260136	Q9UKY1	0	-	124260031	124260136	255,102,0	1	105	0	.	Required	for	nuclear	localization.
chr8	124260643	124261522	Q9UKY1	0	-	124260643	124261522	255,102,0	1	879	0	.	Required	for	interaction	with	NFYA.
chr8	124261039	124261522	Q9UKY1	0	-	124261039	124261522	255,102,0	1	483	0	.	Required	for	dimerization.
chr8	125464044	125464050	Q53H54	0	+	125464044	125464050	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr8	128753120	128753186	P01106	0	+	128753120	128753186	255,102,0	1	66	0	.	Leucine-zipper.
chr8	130764962	130789833	Q9BYG8	0	-	130764962	130789833	255,102,0	1	24871	0	.	Triggers	pyroptosis.	Pubmed:27281216
chr8	134050771	134050966	Q13239	0	-	134050771	134050966	255,102,0	1	195	0	.	SLA	C-terminal.
chr8	134251201	134251291	Q92597	0	-	134251201	134251291	255,102,0	1	90	0	.	3	X	10	AA	tandem	repeats	of	G-T-R-S-R-S-H-T-S-E.
chr8	136470109	136569699	O75525	0	+	136470109	136569699	255,102,0	1	99590	0	.	Involved	in	homodimerization.	Pubmed:26758068
chr8	136594142	136594262	O75525	0	+	136594142	136594262	255,102,0	1	120	0	.	Interaction	with	SIAH1.	Pubmed:15163637
chr8	141542549	141542618	Q9UKV8	0	-	141542549	141542618	255,102,0	1	69	0	.	Interaction	with	guide	RNA.
chr8	141542702	141545581	Q9UKV8	0	-	141542702	141545581	255,102,0	1	2879	0	.	Interaction	with	guide	RNA.
chr8	141549457	141549463	Q9UKV8	0	-	141549457	141549463	255,102,0	1	6	0	.	Interaction	with	guide	RNA.
chr8	141551316	141551349	Q9UKV8	0	-	141551316	141551349	255,102,0	1	33	0	.	Interaction	with	GW182	family	members.
chr8	141554380	141554392	Q9UKV8	0	-	141554380	141554392	255,102,0	1	12	0	.	Interaction	with	GW182	family	members.
chr8	141557616	141559231	Q9UKV8	0	-	141557616	141559231	255,102,0	1	1615	0	.	Interaction	with	guide	RNA.
chr8	141567265	141567283	Q9UKV8	0	-	141567265	141567283	255,102,0	1	18	0	.	Interaction	with	guide	RNA.
chr8	141669567	141678499	Q05397	0	-	141669567	141678499	255,102,0	1	8932	0	.	Interaction	with	ARHGEF28.
chr8	141669567	141727720	Q05397	0	-	141669567	141727720	255,102,0	1	58153	0	.	Interaction	with	TGFB1I1.
chr8	143623687	143625775	O14514	0	+	143623687	143625775	255,102,0	1	2088	0	.	Necessary	for	interaction	with	MAGI1.	Pubmed:9647739
chr8	143625763	143625775	O14514	0	+	143625763	143625775	255,102,0	1	12	0	.	Indispensable	for	interaction	with	MAGI1.	Pubmed:9647739
chr8	143692375	143692435	Q7LC44	0	-	143692375	143692435	255,102,0	1	60	0	.	Required	for	binding	DNM2.
chr8	143692717	143692753	Q7LC44	0	-	143692717	143692753	255,102,0	1	36	0	.	Binds	SH3GL1	or	SH3GL3.
chr8	144399953	144399962	Q969P6	0	-	144399953	144399962	255,102,0	1	9	0	.	Interaction	with	DNA.
chr8	144403529	144403547	Q969P6	0	-	144403529	144403547	255,102,0	1	18	0	.	Interaction	with	DNA.
chr8	144406684	144406690	Q969P6	0	-	144406684	144406690	255,102,0	1	6	0	.	Interaction	with	DNA.
chr8	144511667	144511733	Q8NHW3	0	-	144511667	144511733	255,102,0	1	66	0	.	Leucine-zipper.
chr8	144511739	144511817	Q8NHW3	0	-	144511739	144511817	255,102,0	1	78	0	.	Basic	motif.
chr8	144511754	144511799	Q8NHW3	0	-	144511754	144511799	255,102,0	1	45	0	.	Interaction	with	DNA.
chr8	144661964	144662771	P29692	0	-	144661964	144662771	255,102,0	1	807	0	.	Catalytic	(GEF).
chr8	144663268	144663450	P29692	0	-	144663268	144663450	255,102,0	1	182	0	.	Leucine-zipper.
chr8	144797779	144799759	Q6ZRV2	0	-	144797779	144799759	255,102,0	1	1980	0	.	Mediates	interaction	with	CSNK1A1	and	is	required	for	FAM83H	activity	in	keratin	cytoskeleton	organization.	Pubmed:23902688
chr8	144810772	144812752	Q6ZRV2	0	-	144810772	144812752	255,102,0	1	1980	0	.	Mediates	interaction	with	CSNK1A1	and	is	required	for	FAM83H	activity	in	keratin	cytoskeleton	organization.	Pubmed:23902688
chr8	144885699	144890842	Q9UHX1	0	-	144885699	144890842	255,102,0	1	5143	0	.	Inhibits	transcriptional	repression,	interaction	with	ERCC3	and	apoptosis	induction.
chr8	144885828	144898480	Q9UHX1	0	-	144885828	144898480	255,102,0	1	12652	0	.	Inhibits	homodimerization.
chr8	144898692	144903835	Q9UHX1	0	-	144898692	144903835	255,102,0	1	5143	0	.	Inhibits	transcriptional	repression,	interaction	with	ERCC3	and	apoptosis	induction.
chr8	144898821	144911473	Q9UHX1	0	-	144898821	144911473	255,102,0	1	12652	0	.	Inhibits	homodimerization.
chr8	144990347	144996134	Q15149	0	-	144990347	144996134	255,102,0	1	5787	0	.	Globular	2.
chr8	144990479	144990527	Q15149	0	-	144990479	144990527	255,102,0	1	48	0	.	4	X	4	AA	tandem	repeats	of	G-S-R-X.
chr8	144991499	144991652	Q15149	0	-	144991499	144991652	255,102,0	1	153	0	.	Binding	to	intermediate	filaments.
chr8	144996134	145000996	Q15149	0	-	144996134	145000996	255,102,0	1	4862	0	.	Central	fibrous	rod	domain.
chr8	145000996	145024874	Q15149	0	-	145000996	145024874	255,102,0	1	23878	0	.	Globular	1.
chr8	145052084	145057659	Q53GL7	0	-	145052084	145057659	255,102,0	1	5575	0	.	Myc	binding.
chr8	145154100	145154742	Q9H0F6	0	-	145154100	145154742	255,102,0	1	642	0	.	Interaction	with	SHANK1.
chr8	145154724	145158656	Q9H0F6	0	-	145154724	145158656	255,102,0	1	3932	0	.	Self-association.
chr8	145318604	145319313	Q14137	0	-	145318604	145319313	255,102,0	1	709	0	.	Sufficient	for	nucleolar	localization.
chr8	145533481	145535051	Q00613	0	+	145533481	145535051	255,102,0	1	1570	0	.	Hydrophobic	repeat	HR-A/B.	Pubmed:7935471
chr8	145535048	145535236	Q00613	0	+	145535048	145535236	255,102,0	1	188	0	.	D	domain.	Pubmed:10747973
chr8	145535224	145535718	Q00613	0	+	145535224	145535718	255,102,0	1	494	0	.	Regulatory	domain.	Pubmed:7760831
chr8	145537203	145537281	Q00613	0	+	145537203	145537281	255,102,0	1	78	0	.	Hydrophobic	repeat	HR-C.	Pubmed:7935471
chr8	145544998	145550299	O75907	0	-	145544998	145550299	255,102,0	1	5301	0	.	Involved	in	homomerization.
chr8	145699656	145699902	O75593	0	-	145699656	145699902	255,102,0	1	246	0	.	SMAD-interaction	domain	(SID).
chr8	146156663	146156756	P17020	0	-	146156663	146156756	255,102,0	1	93	0	.	Required	for	nuclear	localization.
chr8	146156993	146157371	P17020	0	-	146156993	146157371	255,102,0	1	378	0	.	Required	for	nuclear	localization.
chr8	146157053	146157152	P17020	0	-	146157053	146157152	255,102,0	1	99	0	.	Required	for	nuclear	localization.
chr8	146157542	146171409	P17020	0	-	146157542	146171409	255,102,0	1	13867	0	.	Necessary	for	transcription	activation.
chr9	14809	16059	A8K0Z3	0	-	14809	16059	255,102,0	1	1250	0	.	VCA.
chr9	17762	24999	A8K0Z3	0	-	17762	24999	255,102,0	1	7237	0	.	WHD1.
chr9	18479	24999	A8K0Z3	0	-	18479	24999	255,102,0	1	6520	0	.	Required	for	WASH	complex	assembly.
chr9	711636	712167	Q14678	0	+	711636	712167	255,102,0	1	531	0	.	Interaction	with	KIF21A.	Pubmed:19559006
chr9	738416	744517	Q14678	0	+	738416	744517	255,102,0	1	6101	0	.	Interaction	with	KIF21A.	Pubmed:19559006
chr9	2651413	2651908	P98155	0	+	2651413	2651908	255,102,0	1	495	0	.	Clustered	O-linked	oligosaccharides.
chr9	2828739	2828766	Q15397	0	-	2828739	2828766	255,102,0	1	27	0	.	HA-8.
chr9	4679770	4697100	Q7L3B6	0	+	4679770	4697100	255,102,0	1	17330	0	.	Self-association.
chr9	4688536	4701947	Q7L3B6	0	+	4688536	4701947	255,102,0	1	13411	0	.	Self-association	and	interaction	with	Hsp90.
chr9	4701914	4706109	Q7L3B6	0	+	4701914	4706109	255,102,0	1	4195	0	.	Interaction	with	Hsp70.
chr9	4701947	4706109	Q7L3B6	0	+	4701947	4706109	255,102,0	1	4162	0	.	Required	for	interaction	with	STIP1.
chr9	4718489	4719200	Q9UIJ7	0	-	4718489	4719200	255,102,0	1	711	0	.	LID.
chr9	4722578	4740979	Q9UIJ7	0	-	4722578	4740979	255,102,0	1	18401	0	.	NMPbind.
chr9	5021987	5054665	O60674	0	+	5021987	5054665	255,102,0	1	32678	0	.	Interaction	with	cytokine/interferon/growth	hormone	receptors.
chr9	6014458	6014611	O60518	0	-	6014458	6014611	255,102,0	1	153	0	.	Ran-GTP	binding.
chr9	6241694	6250577	O95760	0	+	6241694	6250577	255,102,0	1	8883	0	.	Homeodomain-like	HTH	domain.
chr9	6250577	6251255	O95760	0	+	6250577	6251255	255,102,0	1	678	0	.	Interaction	with	RELA.
chr9	6421106	6475460	Q96PU4	0	+	6421106	6475460	255,102,0	1	54354	0	.	Required	for	interaction	with	histone	H3.
chr9	6434108	6460792	Q96PU4	0	+	6434108	6460792	255,102,0	1	26684	0	.	Interaction	with	PCNP.
chr9	6481721	6499858	Q96PU4	0	+	6481721	6499858	255,102,0	1	18137	0	.	Methyl-CpG	binding	and	interaction	with	HDAC1.	Pubmed:15361834
chr9	8341962	8375940	P23468	0	-	8341962	8375940	255,102,0	1	33978	0	.	Substrate	binding.
chr9	8526627	8528594	P23468	0	-	8526627	8528594	255,102,0	1	1967	0	.	Interaction	with	IL1RAPL1.
chr9	17579240	17747081	Q99962	0	+	17579240	17747081	255,102,0	1	167841	0	.	Membrane-binding	amphipathic	helix.	Pubmed:16763557
chr9	17579240	17787421	Q99962	0	+	17579240	17787421	255,102,0	1	208181	0	.	Binds	and	tubulates	liposomes.
chr9	17761497	17786452	Q99962	0	+	17761497	17786452	255,102,0	1	24955	0	.	Required	for	dimerization	upon	membrane	association.
chr9	18928172	18928274	Q8IYX7	0	-	18928172	18928274	255,102,0	1	102	0	.	Mn	12.
chr9	18928274	18928376	Q8IYX7	0	-	18928274	18928376	255,102,0	1	102	0	.	Mn	12.
chr9	18928376	18928478	Q8IYX7	0	-	18928376	18928478	255,102,0	1	102	0	.	Mn	10.
chr9	18928478	18928577	Q8IYX7	0	-	18928478	18928577	255,102,0	1	99	0	.	Mn	9.
chr9	18928577	18928676	Q8IYX7	0	-	18928577	18928676	255,102,0	1	99	0	.	Mn	8.
chr9	18928676	18928778	Q8IYX7	0	-	18928676	18928778	255,102,0	1	102	0	.	Mn	7.
chr9	18928778	18928877	Q8IYX7	0	-	18928778	18928877	255,102,0	1	99	0	.	Mn	6.
chr9	18928877	18928979	Q8IYX7	0	-	18928877	18928979	255,102,0	1	102	0	.	Mn	5.
chr9	18928979	18941662	Q8IYX7	0	-	18928979	18941662	255,102,0	1	12683	0	.	Mn	4.
chr9	18941662	18941764	Q8IYX7	0	-	18941662	18941764	255,102,0	1	102	0	.	Mn	3.
chr9	18941764	18950781	Q8IYX7	0	-	18941764	18950781	255,102,0	1	9017	0	.	Mn	2.
chr9	18950781	18950886	Q8IYX7	0	-	18950781	18950886	255,102,0	1	105	0	.	Mn	1.
chr9	19409082	19409121	Q5QJU3	0	+	19409082	19409121	255,102,0	1	39	0	.	Essential	for	localization	in	the	Golgi	apparatus	and	for	activity.
chr9	21816769	21818037	B4DUC8	0	+	21816769	21818037	255,102,0	1	1268	0	.	Phosphate	binding.
chr9	21816769	21818037	J3QSB7	0	+	21816769	21818037	255,102,0	1	1268	0	.	Phosphate	binding.
chr9	21816769	21818037	Q13126	0	+	21816769	21818037	255,102,0	1	1268	0	.	Phosphate	binding.
chr9	21818130	21818136	B4DUC8	0	+	21818130	21818136	255,102,0	1	6	0	.	Phosphate	binding.
chr9	21818130	21818136	J3QSB7	0	+	21818130	21818136	255,102,0	1	6	0	.	Phosphate	binding.
chr9	21818130	21818136	Q13126	0	+	21818130	21818136	255,102,0	1	6	0	.	Phosphate	binding.
chr9	21854836	21854845	B4DUC8	0	+	21854836	21854845	255,102,0	1	9	0	.	Substrate	binding.
chr9	21854836	21854845	J3QSB7	0	+	21854836	21854845	255,102,0	1	9	0	.	Substrate	binding.
chr9	21854836	21854845	Q13126	0	+	21854836	21854845	255,102,0	1	9	0	.	Substrate	binding.
chr9	21994138	21994330	Q8N726	0	-	21994138	21994330	255,102,0	1	192	0	.	Interaction	with	CDK5RAP3	and	MDM2.	Pubmed:16173922
chr9	26961965	26980582	Q96LB3	0	+	26961965	26980582	255,102,0	1	18617	0	.	Basic	region.
chr9	32418463	32418472	P21399	0	+	32418463	32418472	255,102,0	1	9	0	.	Substrate	binding.
chr9	32440549	32440555	P21399	0	+	32440549	32440555	255,102,0	1	6	0	.	Substrate	binding.
chr9	32457122	32491338	O95786	0	-	32457122	32491338	255,102,0	1	34216	0	.	Interaction	with	ZC3HAV1.	Pubmed:21102435
chr9	32541771	32541963	Q9NS56	0	-	32541771	32541963	255,102,0	1	192	0	.	Interaction	with	UBE2I.	Pubmed:14516784
chr9	32541876	32543157	Q9NS56	0	-	32541876	32543157	255,102,0	1	1281	0	.	Interaction	with	TOP1.	Pubmed:10352183
chr9	32542329	32543157	Q9NS56	0	-	32542329	32543157	255,102,0	1	828	0	.	Interaction	with	p53/TP53.	Pubmed:10415337
chr9	32542560	32543214	Q9NS56	0	-	32542560	32543214	255,102,0	1	654	0	.	Interaction	with	SUMO1.	Pubmed:14516784
chr9	32542800	32543214	Q9NS56	0	-	32542800	32543214	255,102,0	1	414	0	.	Required	for	sumoylation	and	localization	to	discrete	nuclear	foci.
chr9	32543400	32550819	Q9NS56	0	-	32543400	32550819	255,102,0	1	7419	0	.	Required	for	DNA-binding.
chr9	32543937	32552434	Q9NS56	0	-	32543937	32552434	255,102,0	1	8497	0	.	E3	ubiquitin-protein	ligase	activity.
chr9	32987736	33001602	Q7Z2E3	0	-	32987736	33001602	255,102,0	1	13866	0	.	Interactions	with	ADPRT	and	NCL.
chr9	33113797	33113809	P15291	0	-	33113797	33113809	255,102,0	1	12	0	.	UDP-alpha-D-galactose	binding.
chr9	33116002	33116014	P15291	0	-	33116002	33116014	255,102,0	1	12	0	.	N-acetyl-D-glucosamine	binding.
chr9	33120502	33120508	P15291	0	-	33120502	33120508	255,102,0	1	6	0	.	UDP-alpha-D-galactose	binding.
chr9	33120580	33120589	P15291	0	-	33120580	33120589	255,102,0	1	9	0	.	UDP-alpha-D-galactose	binding.
chr9	33135273	33135288	P15291	0	-	33135273	33135288	255,102,0	1	15	0	.	UDP-alpha-D-galactose	binding.
chr9	33271194	33276540	Q9NZZ3	0	+	33271194	33276540	255,102,0	1	5346	0	.	Interaction	with	VTA1.
chr9	33294416	33294470	Q12986	0	+	33294416	33294470	255,102,0	1	54	0	.	Interaction	with	PABPC1	and	PABC4.	Pubmed:17267499
chr9	34635631	34635772	Q99720	0	-	34635631	34635772	255,102,0	1	141	0	.	C-terminal	hydrophobic	region.	Pubmed:27042935
chr9	34637250	34637274	Q99720	0	-	34637250	34637274	255,102,0	1	24	0	.	Important	for	ligand-binding.
chr9	34637670	34637691	Q99720	0	-	34637670	34637691	255,102,0	1	21	0	.	Targeting	to	endoplasmic	reticulum-associated	lipid	droplets.
chr9	34709393	34709576	O00585	0	-	34709393	34709576	255,102,0	1	183	0	.	C-terminal	basic	extension.
chr9	35057116	35057146	P55072	0	-	35057116	35057146	255,102,0	1	30	0	.	Interaction	with	UBXN6.	Pubmed:18656546
chr9	35649862	35649874	Q9Y3P8	0	-	35649862	35649874	255,102,0	1	12	0	.	Interaction	with	GRB2.	Pubmed:11433379
chr9	35649919	35649931	Q9Y3P8	0	-	35649919	35649931	255,102,0	1	12	0	.	Interaction	with	CSK.	Pubmed:11433379
chr9	35649982	35650000	Q9Y3P8	0	-	35649982	35650000	255,102,0	1	18	0	.	Interaction	with	PTPN11.
chr9	35650369	35650381	Q9Y3P8	0	-	35650369	35650381	255,102,0	1	12	0	.	Interaction	with	GRB2.	Pubmed:11433379
chr9	35674067	35674292	Q16790	0	+	35674067	35674292	255,102,0	1	225	0	.	Proteoglycan-like	(PG).
chr9	35674292	35680754	Q16790	0	+	35674292	35680754	255,102,0	1	6462	0	.	Catalytic.
chr9	35679267	35679273	Q16790	0	+	35679267	35679273	255,102,0	1	6	0	.	Substrate	binding.
chr9	35704701	35711292	Q9Y490	0	-	35704701	35711292	255,102,0	1	6591	0	.	Interaction	with	SYNM.	Pubmed:18342854
chr9	35720194	35722863	Q9Y490	0	-	35720194	35722863	255,102,0	1	2669	0	.	Interaction	with	LAYN.
chr9	36052269	36091269	O95980	0	+	36052269	36091269	255,102,0	1	39000	0	.	5	X	Knot	repeats.
chr9	36150912	36150936	Q9H4G4	0	+	36150912	36150936	255,102,0	1	24	0	.	Interaction	with	CAV1.	Pubmed:11865038
chr9	36199017	36204177	P09496	0	+	36199017	36204177	255,102,0	1	5160	0	.	Involved	in	binding	clathrin	heavy	chain.
chr9	36217364	36227310	Q9Y223	0	-	36217364	36227310	255,102,0	1	9946	0	.	N-acetylmannosamine	kinase.
chr9	36643002	36651784	Q14680	0	+	36643002	36651784	255,102,0	1	8782	0	.	UBA-like.
chr9	36651796	36677331	Q14680	0	+	36651796	36677331	255,102,0	1	25535	0	.	Autoinhibitory	region.
chr9	37425950	37425956	Q9UBQ7	0	+	37425950	37425956	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:16756993
chr9	37436668	37436680	Q9UBQ7	0	+	37436668	37436680	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:16756993
chr9	37744798	37744822	Q5SYB0	0	+	37744798	37744822	255,102,0	1	24	0	.	Important	for	interaction	with	GPSM2.	Pubmed:23318951
chr9	37948747	38068642	Q15464	0	-	37948747	38068642	255,102,0	1	119895	0	.	Mediates	interaction	with	LAT,	PTK2/FAK1,	JAK1	and	JAK3.	Pubmed:10488157,	Pubmed:12200137
chr9	70993216	70993222	Q15124	0	+	70993216	70993222	255,102,0	1	6	0	.	Substrate	binding.
chr9	71007234	71007240	Q15124	0	+	71007234	71007240	255,102,0	1	6	0	.	Substrate	binding.
chr9	71080105	71080114	Q15124	0	+	71080105	71080114	255,102,0	1	9	0	.	Substrate	binding.
chr9	71869278	71869287	Q9UDY2	0	+	71869278	71869287	255,102,0	1	9	0	.	Interaction	with	SCRIB.	Pubmed:15975580
chr9	72067082	72067130	Q02410	0	-	72067082	72067130	255,102,0	1	48	0	.	Autoinhibitory	helix	linker.
chr9	72086599	72131010	Q02410	0	-	72086599	72131010	255,102,0	1	44411	0	.	LIN-2/CASK	binding.
chr9	72131184	72131451	Q02410	0	-	72131184	72131451	255,102,0	1	267	0	.	Munc-18-1	binding.
chr9	72914987	72933561	Q8IY18	0	+	72914987	72933561	255,102,0	1	18574	0	.	Flexible	hinge.
chr9	77257340	77257724	Q92753	0	+	77257340	77257724	255,102,0	1	384	0	.	Hinge.
chr9	77257724	77300531	Q92753	0	+	77257724	77300531	255,102,0	1	42807	0	.	Ligand-binding.
chr9	77684002	77684008	Q9NWW6	0	-	77684002	77684008	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17698003,	Pubmed:17914902
chr9	77692075	77692081	Q9NWW6	0	-	77692075	77692081	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17698003,	Pubmed:17914902
chr9	77692408	77692420	Q9NWW6	0	-	77692408	77692420	255,102,0	1	12	0	.	Substrate	binding.	Pubmed:17698003,	Pubmed:17914902
chr9	78794516	78973436	Q92824	0	+	78794516	78973436	255,102,0	1	178920	0	.	CRM	(Cys-rich	motif).
chr9	78973673	78973733	Q92824	0	+	78973673	78973733	255,102,0	1	60	0	.	AC	1.
chr9	78973766	78973835	Q92824	0	+	78973766	78973835	255,102,0	1	69	0	.	AC	2.
chr9	79117309	79117324	Q02742	0	+	79117309	79117324	255,102,0	1	15	0	.	Mediates	interaction	with	GOLPH3	and	is	necessary	and	sufficient	for	localization	to	the	Golgi.	Pubmed:23027862
chr9	79117393	79117660	Q02742	0	+	79117393	79117660	255,102,0	1	267	0	.	Stem	region.
chr9	79117660	79118581	Q02742	0	+	79117660	79118581	255,102,0	1	921	0	.	Catalytic.
chr9	80919693	80919699	Q9Y617	0	+	80919693	80919699	255,102,0	1	6	0	.	Pyridoxal	phosphate	binding.
chr9	80923479	80923485	Q9Y617	0	+	80923479	80923485	255,102,0	1	6	0	.	Pyridoxal	phosphate	binding.
chr9	82187705	82267525	Q04727	0	+	82187705	82267525	255,102,0	1	79820	0	.	Q	domain.	Pubmed:21429299
chr9	82267525	82319700	Q04727	0	+	82267525	82319700	255,102,0	1	52175	0	.	GP	domain.	Pubmed:21429299
chr9	82319700	82321700	Q04727	0	+	82319700	82321700	255,102,0	1	2000	0	.	CcN	domain.	Pubmed:21429299
chr9	82321700	82333652	Q04727	0	+	82321700	82333652	255,102,0	1	11952	0	.	SP	domain.	Pubmed:21429299
chr9	84208170	84231010	Q04724	0	-	84208170	84231010	255,102,0	1	22840	0	.	SP	domain.	Pubmed:21429299
chr9	84231010	84235469	Q04724	0	-	84231010	84235469	255,102,0	1	4459	0	.	CcN	domain.	Pubmed:21429299
chr9	84235469	84249195	Q04724	0	-	84235469	84249195	255,102,0	1	13726	0	.	GP	domain.	Pubmed:21429299
chr9	84249195	84303155	Q04724	0	-	84249195	84303155	255,102,0	1	53960	0	.	Q	domain.	Pubmed:21429299
chr9	86281312	86294869	Q9UMX0	0	-	86281312	86294869	255,102,0	1	13557	0	.	Interaction	with	UBXN4.	Pubmed:19822669
chr9	86585174	86591963	P61978	0	-	86585174	86591963	255,102,0	1	6789	0	.	2	X	22	AA	approximate	repeats.
chr9	86585216	86591948	P61978	0	-	86585216	86591948	255,102,0	1	6732	0	.	5	X	4	AA	repeats	of	G-X-G-G.
chr9	86586268	86587779	P61978	0	-	86586268	86587779	255,102,0	1	1511	0	.	Interaction	with	ZIK1.
chr9	86586607	86587017	P61978	0	-	86586607	86587017	255,102,0	1	410	0	.	2	X	6	AA	approximate	repeats.
chr9	86586921	86593167	P61978	0	-	86586921	86593167	255,102,0	1	6246	0	.	Necessary	for	interaction	with	DDX1.	Pubmed:12183465
chr9	86586930	86587044	P61978	0	-	86586930	86587044	255,102,0	1	114	0	.	RNA-binding	RGG-box.
chr9	86587812	86592657	P61978	0	-	86587812	86592657	255,102,0	1	4845	0	.	Interaction	with	ASFV	p30.
chr9	90255732	90258374	P53355	0	+	90255732	90258374	255,102,0	1	2642	0	.	Calmodulin-binding.
chr9	90256928	90256958	P53355	0	+	90256928	90256958	255,102,0	1	30	0	.	Autoinhibitory	domain.
chr9	91077465	91077657	Q9Y657	0	+	91077465	91077657	255,102,0	1	192	0	.	Tudor-like	domain	1.
chr9	91077585	91077603	Q9Y657	0	+	91077585	91077603	255,102,0	1	18	0	.	Histone	H3K4me3	and	H3R8me2a	binding.
chr9	91083324	91083510	Q9Y657	0	+	91083324	91083510	255,102,0	1	186	0	.	Tudor-like	domain	2.
chr9	91083354	91083357	Q9Y657	0	+	91083354	91083357	255,102,0	1	3	0	.	Histone	H3K4me3	and	H3R8me2a	binding.
chr9	91090039	91090189	Q9Y657	0	+	91090039	91090189	255,102,0	1	150	0	.	Tudor-like	domain	3.
chr9	91090150	91090159	Q9Y657	0	+	91090150	91090159	255,102,0	1	9	0	.	Histone	H3K4me3	and	H3R8me2a	binding.
chr9	91653069	91661869	Q92529	0	-	91653069	91661869	255,102,0	1	8800	0	.	CH1.
chr9	91965670	91965736	Q96T21	0	+	91965670	91965736	255,102,0	1	66	0	.	RNA-binding.
chr9	92220419	92220684	O95257	0	+	92220419	92220684	255,102,0	1	265	0	.	Homodimerization.
chr9	93606501	93607799	P43405	0	+	93606501	93607799	255,102,0	1	1298	0	.	Interdomain	A.
chr9	93626930	93637060	P43405	0	+	93626930	93637060	255,102,0	1	10130	0	.	Interdomain	B.
chr9	94118225	94118387	Q13825	0	-	94118225	94118387	255,102,0	1	162	0	.	RNA-binding.
chr9	94171927	94172122	Q16649	0	-	94171927	94172122	255,102,0	1	195	0	.	Necessary	for	transcriptional	repression	and	sufficient	for	interaction	with	DR1.	Pubmed:8836190
chr9	94172698	94172722	Q16649	0	-	94172698	94172722	255,102,0	1	24	0	.	Leucine-zipper.
chr9	94172731	94172782	Q16649	0	-	94172731	94172782	255,102,0	1	51	0	.	Basic	motif.
chr9	95227276	95228745	Q9BXN1	0	-	95227276	95228745	255,102,0	1	1469	0	.	Interaction	with	TGFB1.
chr9	95475740	95481159	Q8TD16	0	-	95475740	95481159	255,102,0	1	5419	0	.	Interaction	with	RANBP2.
chr9	95477561	95480931	Q8TD16	0	-	95477561	95480931	255,102,0	1	3370	0	.	Interacts	with	RAB6A.
chr9	95481129	95482644	Q8TD16	0	-	95481129	95482644	255,102,0	1	1515	0	.	Interaction	with	KIF5A.
chr9	95481732	95526954	Q8TD16	0	-	95481732	95526954	255,102,0	1	45222	0	.	Interacts	with	DYNLL1,	DYNC1H1,	DYNC1I2,	DCTN1	and	DCTN2.
chr9	96261152	96278348	Q9NZB2	0	+	96261152	96278348	255,102,0	1	17196	0	.	Interaction	with	YES1,	SRC	and	FYN.	Pubmed:19015244
chr9	96320108	96326819	Q9NZB2	0	+	96320108	96326819	255,102,0	1	6711	0	.	RNA	binding.
chr9	97325701	97325716	O00757	0	-	97325701	97325716	255,102,0	1	15	0	.	Substrate	binding.
chr9	97329608	97329620	O00757	0	-	97329608	97329620	255,102,0	1	12	0	.	Substrate	binding.
chr9	97355978	97356002	O00757	0	-	97355978	97356002	255,102,0	1	24	0	.	Important	for	interaction	with	ALDOA.	Pubmed:18214967
chr9	97365848	97367741	P09467	0	-	97365848	97367741	255,102,0	1	1893	0	.	Substrate	binding.
chr9	97367816	97367834	P09467	0	-	97367816	97367834	255,102,0	1	18	0	.	Substrate	binding.
chr9	97369153	97369165	P09467	0	-	97369153	97369165	255,102,0	1	12	0	.	Substrate	binding.
chr9	97380100	97380112	P09467	0	-	97380100	97380112	255,102,0	1	12	0	.	Substrate	binding.
chr9	99285650	99296815	O60729	0	-	99285650	99296815	255,102,0	1	11165	0	.	B.
chr9	99296815	99301392	O60729	0	-	99296815	99301392	255,102,0	1	4577	0	.	Linker.
chr9	99301392	99381531	O60729	0	-	99301392	99381531	255,102,0	1	80139	0	.	A.
chr9	100245298	100258162	Q8NHU6	0	+	100245298	100258162	255,102,0	1	12864	0	.	Interaction	with	CDK17.
chr9	100245394	100258162	Q8NHU6	0	+	100245394	100258162	255,102,0	1	12768	0	.	Interaction	with	CABLES1.
chr9	100286584	100325030	P28289	0	+	100286584	100325030	255,102,0	1	38446	0	.	Tropomyosin-binding.
chr9	100451913	100459565	P23025	0	-	100451913	100459565	255,102,0	1	7652	0	.	Interaction	with	CEP164	and	required	for	UV	resistance.	Pubmed:19197159
chr9	100693415	100700400	Q9BXL5	0	-	100693415	100700400	255,102,0	1	6985	0	.	Necessary	for	nuclear	localization.
chr9	100983189	100991329	Q9BYX2	0	-	100983189	100991329	255,102,0	1	8140	0	.	Interaction	with	RAC1.	Pubmed:20116244
chr9	101014070	101017823	Q9BYX2	0	-	101014070	101017823	255,102,0	1	3753	0	.	Interaction	with	CADH1.
chr9	101585568	101589224	Q8IXK2	0	+	101585568	101589224	255,102,0	1	3656	0	.	Catalytic	subdomain	A.
chr9	101594231	101599316	Q8IXK2	0	+	101594231	101599316	255,102,0	1	5085	0	.	Catalytic	subdomain	B.
chr9	101749611	101782688	P39059	0	+	101749611	101782688	255,102,0	1	33077	0	.	Nonhelical	region	1	(NC1).
chr9	101765740	101782688	P39059	0	+	101765740	101782688	255,102,0	1	16948	0	.	4	X	tandem	repeats.
chr9	101782688	101784390	P39059	0	+	101782688	101784390	255,102,0	1	1702	0	.	Triple-helical	region	1	(COL1).
chr9	101784390	101785731	P39059	0	+	101784390	101785731	255,102,0	1	1341	0	.	Nonhelical	region	2	(NC2).
chr9	101787155	101797412	P39059	0	+	101787155	101797412	255,102,0	1	10257	0	.	Triple-helical	region	2	(COL2).
chr9	101797412	101797700	P39059	0	+	101797412	101797700	255,102,0	1	288	0	.	Nonhelical	region	3	(NC3).
chr9	101798451	101798663	P39059	0	+	101798451	101798663	255,102,0	1	212	0	.	Triple-helical	region	3	(COL3).
chr9	101798663	101801006	P39059	0	+	101798663	101801006	255,102,0	1	2343	0	.	Nonhelical	region	4	(NC4).
chr9	101801006	101806876	P39059	0	+	101801006	101806876	255,102,0	1	5870	0	.	Triple-helical	region	4	(COL4).
chr9	101806876	101806909	P39059	0	+	101806876	101806909	255,102,0	1	33	0	.	Nonhelical	region	5	(NC5).
chr9	101806909	101812025	P39059	0	+	101806909	101812025	255,102,0	1	5116	0	.	Triple-helical	region	5	(COL5).
chr9	101812025	101814714	P39059	0	+	101812025	101814714	255,102,0	1	2689	0	.	Nonhelical	region	6	(NC6).
chr9	101816856	101817391	P39059	0	+	101816856	101817391	255,102,0	1	535	0	.	Triple-helical	region	6	(COL6).
chr9	101817391	101817433	P39059	0	+	101817391	101817433	255,102,0	1	42	0	.	Nonhelical	region	7	(NC7).
chr9	101817543	101817597	P39059	0	+	101817543	101817597	255,102,0	1	54	0	.	Triple-helical	region	7	(COL7).
chr9	101817597	101817618	P39059	0	+	101817597	101817618	255,102,0	1	21	0	.	Nonhelical	region	8	(NC8).
chr9	101817618	101818670	P39059	0	+	101817618	101818670	255,102,0	1	1052	0	.	Triple-helical	region	8	(COL8).
chr9	101818670	101822184	P39059	0	+	101818670	101822184	255,102,0	1	3514	0	.	Nonhelical	region	9	(NC9).
chr9	101822184	101822229	P39059	0	+	101822184	101822229	255,102,0	1	45	0	.	Triple-helical	region	9	(COL9).
chr9	101822229	101832165	P39059	0	+	101822229	101832165	255,102,0	1	9936	0	.	Nonhelical	region	10	(NC10).
chr9	102590324	102590648	Q92570	0	+	102590324	102590648	255,102,0	1	324	0	.	Activation	function	(AF)-1	domain.
chr9	102590324	102590738	Q92570	0	+	102590324	102590738	255,102,0	1	414	0	.	Required	for	DNA-PK	heterotrimer.	Pubmed:25852083
chr9	102590324	102591197	Q92570	0	+	102590324	102591197	255,102,0	1	873	0	.	Interaction	with	NCOA1,	NCOA2,	NCOA3	and	KAT2B.
chr9	102595616	102626146	Q92570	0	+	102595616	102626146	255,102,0	1	30530	0	.	Interaction	with	KAT2B.
chr9	102606993	102609734	Q92570	0	+	102606993	102609734	255,102,0	1	2741	0	.	Ligand-binding.
chr9	102730730	102730871	P56962	0	+	102730730	102730871	255,102,0	1	141	0	.	Necessary	and	sufficient	for	localization	to	autophagosome.	Pubmed:23217709
chr9	102769878	102778660	Q9BS26	0	-	102769878	102778660	255,102,0	1	8782	0	.	Interaction	with	ITPR1.
chr9	104340096	104341558	Q8TCU5	0	-	104340096	104341558	255,102,0	1	1462	0	.	PPP2CB	binding	site.
chr9	105765437	105767954	Q14093	0	+	105765437	105767954	255,102,0	1	2517	0	.	31	X	3	AA	repeats	of	K-K-X.
chr9	105767381	105767633	Q14093	0	+	105767381	105767633	255,102,0	1	252	0	.	3	X	approximate	tandem	repeats.
chr9	106876351	106882324	O95347	0	+	106876351	106882324	255,102,0	1	5973	0	.	Flexible	hinge.
chr9	111624692	111624755	Q9Y615	0	+	111624692	111624755	255,102,0	1	63	0	.	Required	for	interaction	with	TES.
chr9	112144051	112144586	P26045	0	-	112144051	112144586	255,102,0	1	535	0	.	Substrate	binding.
chr9	112900212	112900254	Q9Y2D5	0	+	112900212	112900254	255,102,0	1	42	0	.	PKA-RII	subunit	binding	domain.
chr9	113234520	113234544	Q4LDE5	0	-	113234520	113234544	255,102,0	1	24	0	.	O-glycosylated	at	one	site.
chr9	113704106	113704124	Q92633	0	-	113704106	113704124	255,102,0	1	18	0	.	Lysophosphatidic	acid	binding.	Pubmed:26091040
chr9	115962234	115969532	Q5T1M5	0	-	115962234	115969532	255,102,0	1	7298	0	.	Important	for	function	in	growth	cone	organization.
chr9	116824963	116825026	P02760	0	-	116824963	116825026	255,102,0	1	63	0	.	Glycopeptide	(secretory	piece).
chr9	116931707	117064370	Q8IZC6	0	+	116931707	117064370	255,102,0	1	132663	0	.	Triple-helical	region.
chr9	117119192	117120209	Q7Z591	0	-	117119192	117120209	255,102,0	1	1017	0	.	PEST.
chr9	117121953	117122055	Q7Z591	0	-	117121953	117122055	255,102,0	1	102	0	.	PEST.
chr9	118949830	118974042	Q13219	0	+	118949830	118974042	255,102,0	1	24212	0	.	Metalloprotease.
chr9	123151516	123165215	Q96SN8	0	-	123151516	123165215	255,102,0	1	13699	0	.	Interaction	with	PCNT	and	AKAP9.	Pubmed:20466722
chr9	123152033	123152063	Q96SN8	0	-	123152033	123152063	255,102,0	1	30	0	.	Required	for	centrosomal	attachment,	Golgi	localization	and	CALM1	interaction.
chr9	123165086	123165215	Q96SN8	0	-	123165086	123165215	255,102,0	1	129	0	.	Interaction	with	CDK5R1.
chr9	123201774	123215751	Q96SN8	0	-	123201774	123215751	255,102,0	1	13977	0	.	Interaction	with	MAPRE1.	Pubmed:19553473
chr9	123298723	123330622	Q96SN8	0	-	123298723	123330622	255,102,0	1	31899	0	.	Interaction	with	NCKAP5L.	Pubmed:26485573
chr9	123636284	123636305	Q5T6S3	0	-	123636284	123636305	255,102,0	1	21	0	.	Histone	H3K36me3	binding.
chr9	123776244	123776334	P01031	0	-	123776244	123776334	255,102,0	1	90	0	.	Involved	in	C5AR1	binding.	Pubmed:9553099
chr9	123929952	123933763	Q7Z7A1	0	+	123929952	123933763	255,102,0	1	3811	0	.	Required	for	centrosome	localization.
chr9	123930481	123939461	Q7Z7A1	0	+	123930481	123939461	255,102,0	1	8980	0	.	Sufficient	for	interaction	with	HOOK2.	Pubmed:17140400
chr9	124064252	124072985	P06396	0	+	124064252	124072985	255,102,0	1	8733	0	.	Actin-severing.
chr9	124065205	124065217	P06396	0	+	124065205	124065217	255,102,0	1	12	0	.	Actin-actin	interfilament	contact	point.
chr9	124065322	124072964	P06396	0	+	124065322	124072964	255,102,0	1	7642	0	.	Polyphosphoinositide	binding.
chr9	124073018	124073045	P06396	0	+	124073018	124073045	255,102,0	1	27	0	.	Polyphosphoinositide	binding.
chr9	124081113	124094878	P06396	0	+	124081113	124094878	255,102,0	1	13765	0	.	Actin-binding,	Ca-sensitive.
chr9	124103485	124103530	P27105	0	-	124103485	124103530	255,102,0	1	45	0	.	Interaction	with	LANCL1.	Pubmed:9512664
chr9	124103527	124103554	P27105	0	-	124103527	124103554	255,102,0	1	27	0	.	Required	for	homooligomerization.
chr9	124103539	124103548	P27105	0	-	124103539	124103548	255,102,0	1	9	0	.	Required	for	lipid	raft	association.
chr9	124532860	124535636	Q5VWQ8	0	+	124532860	124535636	255,102,0	1	2776	0	.	Necessary	for	interaction	with	AKT1.	Pubmed:19903888
chr9	124632894	124736370	Q8NHH1	0	-	124632894	124736370	255,102,0	1	103476	0	.	c-MTBD	region.	Pubmed:25959773
chr9	124979359	124989216	Q9UPM6	0	-	124979359	124989216	255,102,0	1	9857	0	.	Required	for	interaction	with	LDB1.
chr9	125645554	125652642	Q9HBD1	0	-	125645554	125652642	255,102,0	1	7088	0	.	ROQ.
chr9	127064243	127074829	Q9HC98	0	+	127064243	127074829	255,102,0	1	10586	0	.	Interaction	with	ARHGAP33,	ANKRA2,	CDC42,	PRDX3,	RAD26L,	RBBP6,	RPS7	and	TRIP4.	Pubmed:20873783
chr9	127110068	127110080	Q9HC98	0	+	127110068	127110080	255,102,0	1	12	0	.	Interaction	with	APBB1.	Pubmed:17512906
chr9	127245039	127262551	Q13285	0	-	127245039	127262551	255,102,0	1	17512	0	.	Important	for	dimerization.
chr9	127253456	127262461	Q13285	0	-	127253456	127262461	255,102,0	1	9005	0	.	Ligand-binding.
chr9	127300435	127302394	Q15406	0	-	127300435	127302394	255,102,0	1	1959	0	.	Sufficient	for	interaction	with	UIMC1.
chr9	127781457	127905716	Q8N9R8	0	-	127781457	127905716	255,102,0	1	124259	0	.	Necessary	to	inhibit	MKL1-induced	SRF	transcriptional	activity.
chr9	127783041	127818174	Q8N9R8	0	-	127783041	127818174	255,102,0	1	35133	0	.	Required	for	interaction	with	MKL1.
chr9	128201168	128206821	Q9BPZ7	0	-	128201168	128206821	255,102,0	1	5653	0	.	Interaction	with	ATF2.	Pubmed:17054722
chr9	128321958	128434850	Q9BPZ7	0	-	128321958	128434850	255,102,0	1	112892	0	.	Interaction	with	NBN.	Pubmed:23762398
chr9	128347952	128434850	Q9BPZ7	0	-	128347952	128434850	255,102,0	1	86898	0	.	Interaction	with	MAP3K2.	Pubmed:15988011
chr9	129974458	129981045	Q5JS13	0	+	129974458	129981045	255,102,0	1	6587	0	.	Required	for	stimulation	of	nucleotide	exchange	by	RALA.
chr9	130166013	130166034	Q9NY64	0	+	130166013	130166034	255,102,0	1	21	0	.	Monosaccharide	binding.
chr9	130550555	130550633	P50750	0	+	130550555	130550633	255,102,0	1	78	0	.	T-loop.
chr9	130586705	130605516	P17813	0	-	130586705	130605516	255,102,0	1	18811	0	.	Required	for	interaction	with	EGL.
chr9	130630692	130630725	P00568	0	-	130630692	130630725	255,102,0	1	33	0	.	LID.
chr9	130630692	130630725	Q5T9B7	0	-	130630692	130630725	255,102,0	1	33	0	.	LID.
chr9	130630692	130630725	Q6FGX9	0	-	130630692	130630725	255,102,0	1	33	0	.	LID.
chr9	130634974	130635064	P00568	0	-	130634974	130635064	255,102,0	1	90	0	.	NMPbind.
chr9	130634974	130635064	Q5T9B7	0	-	130634974	130635064	255,102,0	1	90	0	.	NMPbind.
chr9	130634974	130635064	Q6FGX9	0	-	130634974	130635064	255,102,0	1	90	0	.	NMPbind.
chr9	130829170	130829380	Q69YI7	0	-	130829170	130829380	255,102,0	1	210	0	.	Required	for	nuclear	localization	and	apoptosis-inducing	activity.
chr9	130886811	130886817	Q9H7Z7	0	-	130886811	130886817	255,102,0	1	6	0	.	Glutathione	binding.
chr9	131019348	131019381	Q08379	0	-	131019348	131019381	255,102,0	1	33	0	.	Interaction	with	GORASP1/GRASP65.
chr9	131030758	131038255	Q08379	0	-	131030758	131038255	255,102,0	1	7497	0	.	Interaction	with	p115/USO1.
chr9	131267084	131267171	Q53GS7	0	+	131267084	131267171	255,102,0	1	87	0	.	Interaction	with	NUP155.
chr9	131295808	131295928	Q53GS7	0	+	131295808	131295928	255,102,0	1	120	0	.	Mediates	the	shuttling	between	the	nucleus	and	the	cytoplasm.
chr9	131302554	131303446	Q53GS7	0	+	131302554	131303446	255,102,0	1	892	0	.	Interaction	with	NUPL2.	Pubmed:16000379
chr9	131446264	131454200	Q01105	0	+	131446264	131454200	255,102,0	1	7936	0	.	Dimerization.
chr9	131454200	131456060	Q01105	0	+	131454200	131456060	255,102,0	1	1860	0	.	Earmuff	domain.
chr9	131702655	131702664	Q5SRE7	0	+	131702655	131702664	255,102,0	1	9	0	.	Alpha-ketoglutarate	binding.
chr9	131708160	131708208	Q9UPQ8	0	-	131708160	131708208	255,102,0	1	48	0	.	CTP-binding.
chr9	131784684	131790433	Q9NR46	0	-	131784684	131790433	255,102,0	1	5749	0	.	Membrane-binding	amphipathic	helix.
chr9	131860565	131860589	P43155	0	-	131860565	131860589	255,102,0	1	24	0	.	Coenzyme	A	binding.
chr9	132396440	132396449	A0A024R8E4	0	+	132396440	132396449	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr9	132396440	132396449	Q9BV86	0	+	132396440	132396449	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.	Pubmed:26543161,	Pubmed:26543159
chr9	132396524	132396530	A0A024R8E4	0	+	132396524	132396530	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr9	132396524	132396530	Q9BV86	0	+	132396524	132396530	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.	Pubmed:26543161,	Pubmed:26543159
chr9	132502009	132502021	O14684	0	-	132502009	132502021	255,102,0	1	12	0	.	Glutathione	binding.
chr9	132502117	132510935	O14684	0	-	132502117	132510935	255,102,0	1	8818	0	.	Glutathione	binding.
chr9	132515177	132515210	O14684	0	-	132515177	132515210	255,102,0	1	33	0	.	Glutathione	binding.
chr9	132576253	132576316	O14656	0	-	132576253	132576316	255,102,0	1	63	0	.	Interaction	with	SYNE3.	Pubmed:18827015
chr9	132576253	132576499	O14656	0	-	132576253	132576499	255,102,0	1	246	0	.	Interaction	with	KLC1.	Pubmed:14970196
chr9	132576496	132585033	O14656	0	-	132576496	132585033	255,102,0	1	8537	0	.	Interaction	with	SNAPIN.
chr9	132652820	132662283	Q96RU3	0	-	132652820	132662283	255,102,0	1	9463	0	.	Interaction	with	ARHGAP17,	DAAM1,	DIAPH1	and	DIAPH2.	Pubmed:11431473,	Pubmed:16630611
chr9	132652820	132662328	Q96RU3	0	-	132652820	132662328	255,102,0	1	9508	0	.	Interaction	with	DNM1	and	DNM3.	Pubmed:15252009
chr9	132652820	132662715	Q96RU3	0	-	132652820	132662715	255,102,0	1	9895	0	.	Required	for	interaction	with	TNKS.	Pubmed:14596906
chr9	132652820	132662772	Q96RU3	0	-	132652820	132662772	255,102,0	1	9952	0	.	Interaction	with	PDE6G.
chr9	132652820	132689512	Q96RU3	0	-	132652820	132689512	255,102,0	1	36692	0	.	Required	for	self-association	and	induction	of	membrane	tubulation.
chr9	132658132	132662274	Q96RU3	0	-	132658132	132662274	255,102,0	1	4142	0	.	Interaction	with	FASLG.
chr9	132658135	132662274	Q96RU3	0	-	132658135	132662274	255,102,0	1	4139	0	.	Interaction	with	DNM2	and	WASL.
chr9	132662274	132671266	Q96RU3	0	-	132662274	132671266	255,102,0	1	8992	0	.	Interaction	with	RND2.
chr9	132686287	132805254	Q96RU3	0	-	132686287	132805254	255,102,0	1	118967	0	.	Interaction	with	microtubules.
chr9	132740851	132805254	Q96RU3	0	-	132740851	132805254	255,102,0	1	64403	0	.	Required	for	self-association	and	induction	of	membrane	tubulation.
chr9	132988712	132988763	P62166	0	+	132988712	132988763	255,102,0	1	51	0	.	Interaction	with	IL1RAPL1.	Pubmed:12783849
chr9	133710836	133729551	P00519	0	+	133710836	133729551	255,102,0	1	18715	0	.	CAP.
chr9	133760281	133760581	P00519	0	+	133760281	133760581	255,102,0	1	300	0	.	DNA-binding.
chr9	133760533	133761067	P00519	0	+	133760533	133761067	255,102,0	1	534	0	.	F-actin-binding.
chr9	133945207	133967171	Q9Y6N6	0	+	133945207	133967171	255,102,0	1	21964	0	.	Domain	II	and	I.
chr9	134002985	134016015	P35658	0	+	134002985	134016015	255,102,0	1	13030	0	.	Seven-bladed	beta	propeller.
chr9	134019812	134107684	P35658	0	+	134019812	134107684	255,102,0	1	87872	0	.	11	X	5	AA	approximate	repeats.
chr9	134026092	134027149	P35658	0	+	134026092	134027149	255,102,0	1	1057	0	.	Leucine-zipper	1.
chr9	134038417	134038483	P35658	0	+	134038417	134038483	255,102,0	1	66	0	.	Leucine-zipper	2.
chr9	134073105	134108853	P35658	0	+	134073105	134108853	255,102,0	1	35748	0	.	18	X	4	AA	approximate	repeats.
chr9	134073159	134108856	P35658	0	+	134073159	134108856	255,102,0	1	35697	0	.	11	X	3	AA	approximate	repeats.
chr9	134165591	134165657	Q8NBV4	0	+	134165591	134165657	255,102,0	1	66	0	.	Interaction	with	MTOR.
chr9	135042422	135073403	Q96CW9	0	+	135042422	135073403	255,102,0	1	30981	0	.	NGL	discriminant	loop	I.
chr9	135073739	135073748	Q96CW9	0	+	135073739	135073748	255,102,0	1	9	0	.	NGL	discriminant	loop	II.
chr9	135073928	135073940	Q96CW9	0	+	135073928	135073940	255,102,0	1	12	0	.	NGL	discriminant	loop	III.
chr9	135139628	135139679	Q7Z333	0	-	135139628	135139679	255,102,0	1	51	0	.	Necessary	for	nuclear	localization.
chr9	135277539	135278208	Q15361	0	-	135277539	135278208	255,102,0	1	669	0	.	N-terminal	region	(NRD).
chr9	135601101	135698676	Q96MA6	0	-	135601101	135698676	255,102,0	1	97575	0	.	Adenylate	kinase	2.	Pubmed:21080915
chr9	135601242	135602872	Q96MA6	0	-	135601242	135602872	255,102,0	1	1630	0	.	LID	2.
chr9	135668160	135690112	Q96MA6	0	-	135668160	135690112	255,102,0	1	21952	0	.	NMPbind	2.
chr9	135698706	135742338	Q96MA6	0	-	135698706	135742338	255,102,0	1	43632	0	.	Adenylate	kinase	1.	Pubmed:21080915
chr9	135702379	135703427	Q96MA6	0	-	135702379	135703427	255,102,0	1	1048	0	.	LID	1.
chr9	135730306	135739126	Q96MA6	0	-	135730306	135739126	255,102,0	1	8820	0	.	NMPbind	1.
chr9	135862065	135862125	Q5VTD9	0	+	135862065	135862125	255,102,0	1	60	0	.	SNAG	domain.
chr9	135863615	135866434	Q5VTD9	0	+	135863615	135866434	255,102,0	1	2819	0	.	Interaction	with	ARIH2.	Pubmed:17646546
chr9	135863834	135866434	Q5VTD9	0	+	135863834	135866434	255,102,0	1	2600	0	.	Mediates	interaction	with	GATA1.
chr9	136029314	136029326	Q8N5D6	0	-	136029314	136029326	255,102,0	1	12	0	.	Substrate	binding.
chr9	136029383	136029392	Q8N5D6	0	-	136029383	136029392	255,102,0	1	9	0	.	Substrate	binding.
chr9	136029644	136030578	Q8N5D6	0	-	136029644	136030578	255,102,0	1	934	0	.	Substrate	binding.
chr9	136301957	136303449	Q76LX8	0	+	136301957	136303449	255,102,0	1	1492	0	.	Cysteine-rich.
chr9	136303446	136307606	Q76LX8	0	+	136303446	136307606	255,102,0	1	4159	0	.	Spacer.
chr9	136340133	136340154	Q9UGQ3	0	-	136340133	136340154	255,102,0	1	21	0	.	Monosaccharide	binding.
chr9	137218477	137300117	P19793	0	+	137218477	137300117	255,102,0	1	81640	0	.	Modulating.
chr9	137300955	137309065	P19793	0	+	137300955	137309065	255,102,0	1	8110	0	.	Hinge.
chr9	137309065	137328457	P19793	0	+	137309065	137328457	255,102,0	1	19392	0	.	Ligand-binding.
chr9	137619147	137623506	P20908	0	+	137619147	137623506	255,102,0	1	4359	0	.	Nonhelical	region.
chr9	137623506	137644446	P20908	0	+	137623506	137644446	255,102,0	1	20940	0	.	Interrupted	collagenous	region.
chr9	137644446	137716457	P20908	0	+	137644446	137716457	255,102,0	1	72011	0	.	Triple-helical	region.
chr9	137716457	137716562	P20908	0	+	137716457	137716562	255,102,0	1	105	0	.	Nonhelical	region.
chr9	137779039	137779045	Q15485	0	+	137779039	137779045	255,102,0	1	6	0	.	Carbohydrate	binding.	Pubmed:17215869
chr9	137801646	137801676	O00602	0	-	137801646	137801676	255,102,0	1	30	0	.	P	domain.	Pubmed:17148457
chr9	137801772	137801781	O00602	0	-	137801772	137801781	255,102,0	1	9	0	.	Carbohydrate-binding.	Pubmed:17897951
chr9	137802982	137804867	O00602	0	-	137802982	137804867	255,102,0	1	1885	0	.	B	domain;	contributes	to	trimerization.
chr9	137804867	137804987	O00602	0	-	137804867	137804987	255,102,0	1	120	0	.	A	domain;	contributes	to	trimerization.
chr9	138713740	138713800	Q5T5Y3	0	-	138713740	138713800	255,102,0	1	60	0	.	Sufficient	for	interaction	with	calmodulin.
chr9	138713830	138713896	Q5T5Y3	0	-	138713830	138713896	255,102,0	1	66	0	.	Sufficient	for	interaction	with	SPTBN1.	Pubmed:24117850
chr9	139272099	139272438	Q5SXM2	0	-	139272099	139272438	255,102,0	1	339	0	.	SNAPC2-binding.	Pubmed:11056176
chr9	139289821	139290150	Q5SXM2	0	-	139289821	139290150	255,102,0	1	329	0	.	SNAPC5-binding.	Pubmed:11056176
chr9	139301821	139301899	Q96C92	0	-	139301821	139301899	255,102,0	1	78	0	.	Required	for	interaction	with	PTPN13.	Pubmed:23108400
chr9	139333145	139333844	Q9NRR6	0	-	139333145	139333844	255,102,0	1	699	0	.	13	X	4	AA	repeats	of	P-X-X-P.
chr9	139393579	139393606	P46531	0	-	139393579	139393606	255,102,0	1	27	0	.	HIF1AN-binding.
chr9	139395072	139395099	P46531	0	-	139395072	139395099	255,102,0	1	27	0	.	HIF1AN-binding.
chr9	139412288	139412303	P46531	0	-	139412288	139412303	255,102,0	1	15	0	.	Interaction	with	DLL4.
chr9	139412381	139412387	P46531	0	-	139412381	139412387	255,102,0	1	6	0	.	Interaction	with	DLL4.
chr9	139702762	139731825	Q3YEC7	0	+	139702762	139731825	255,102,0	1	29063	0	.	Small	GTPase-like.
chr9	139734637	139734863	Q3YEC7	0	+	139734637	139734863	255,102,0	1	226	0	.	Interaction	with	CDKN2A.	Pubmed:16582619
chr9	139744583	139745209	Q9NRX4	0	+	139744583	139745209	255,102,0	1	626	0	.	Substrate	binding.	Pubmed:18991813
chr9	139757403	139758293	O60869	0	-	139757403	139758293	255,102,0	1	890	0	.	Interaction	with	NR5A2,	PPARG	and	NR1H3.	Pubmed:12040021
chr9	139757418	139757826	O60869	0	-	139757418	139757826	255,102,0	1	408	0	.	Interaction	with	TBP	and	NR5A1.	Pubmed:10567391
chr9	139814853	139814886	Q12933	0	+	139814853	139814886	255,102,0	1	33	0	.	Important	for	interaction	with	BIRC2	and	BIRC3.
chr9	139888051	139888254	Q9BUH6	0	+	139888051	139888254	255,102,0	1	203	0	.	Mediates	interaction	with	XRCC5/Ku80	and	XRCC6/Ku70	and	association	with	the	non-homologous	end	joining	core	complex.	Pubmed:25670504,	Pubmed:25574025
chr9	139889898	139890995	O95833	0	-	139889898	139890995	255,102,0	1	1097	0	.	Required	for	insertion	into	the	membrane.
chr9	139972542	139972554	Q3KQV9	0	+	139972542	139972554	255,102,0	1	12	0	.	UTP	binding.
chr9	140056453	140056462	Q05586	0	+	140056453	140056462	255,102,0	1	9	0	.	Glycine	binding.
chr9	140069844	140075346	Q9UJX6	0	-	140069844	140075346	255,102,0	1	5502	0	.	Cullin	homology.	Pubmed:9469815
chr9	140350867	140353551	Q6X4W1	0	-	140350867	140353551	255,102,0	1	2684	0	.	Necessary	and	sufficient	to	elicit	dendritic	processes	and	synaptic	contacts.
chr9	140705912	140705921	Q9H9B1	0	+	140705912	140705921	255,102,0	1	9	0	.	Histone	H3K9me	binding.
chr9	140711921	140711930	Q9H9B1	0	+	140711921	140711930	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chr9	140712533	140728803	Q9H9B1	0	+	140712533	140728803	255,102,0	1	16270	0	.	Interaction	with	histone	H3.
chr9	140728857	140728863	Q9H9B1	0	+	140728857	140728863	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chr9	140729231	140729243	Q9H9B1	0	+	140729231	140729243	255,102,0	1	12	0	.	Interaction	with	histone	H3.
chr9	140850213	140851224	Q00975	0	+	140850213	140851224	255,102,0	1	1011	0	.	Binding	to	the	beta	subunit.
chrX	1522164	1546695	O95671	0	-	1522164	1546695	255,102,0	1	24531	0	.	ASMT-like.
chrX	1531739	1531748	O95671	0	-	1531739	1531748	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chrX	1546854	1571703	O95671	0	-	1546854	1571703	255,102,0	1	24849	0	.	MAF-like.
chrX	1712601	1712691	Q02040	0	+	1712601	1712691	255,102,0	1	90	0	.	PKA-RI	and	PKA-RII	subunit	binding	domain.
chrX	1719671	1719761	Q02040	0	+	1719671	1719761	255,102,0	1	90	0	.	PKA-RI-alpha	subunit	binding	domain.
chrX	1755329	1755338	P46597	0	+	1755329	1755338	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chrX	5821626	5821644	Q8N0W4	0	-	5821626	5821644	255,102,0	1	18	0	.	Interaction	with	NRXN1.
chrX	6451797	6452037	Q9NNX9	0	-	6451797	6452037	255,102,0	1	240	0	.	8	X	10	AA	tandem	repeats	of	L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	7811745	7812045	Q9H320	0	+	7811745	7812045	255,102,0	1	300	0	.	10	X	10	AA	tandem	repeats	of	L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	8138123	8138183	Q9H322	0	-	8138123	8138183	255,102,0	1	60	0	.	2	X	10	AA	tandem	repeats	of	L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	8433992	8434412	Q9H321	0	+	8433992	8434412	255,102,0	1	420	0	.	14	X	10	AA	tandem	repeats	of	L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	9711657	9711711	P51810	0	-	9711657	9711711	255,102,0	1	54	0	.	Necessary	for	its	G	protein-activation	ability	and	normal	distribution	of	melanosomes.
chrX	10153111	10155599	P51793	0	+	10153111	10155599	255,102,0	1	2488	0	.	Required	for	localization	in	the	endoplasmic	reticulum.	Pubmed:17023393
chrX	11782016	11790313	Q8N5Y2	0	+	11782016	11790313	255,102,0	1	8297	0	.	Required	for	the	histone	acetyltransferase	activity	of	the	MSL	complex.
chrX	12837728	12837776	P11908	0	+	12837728	12837776	255,102,0	1	48	0	.	Binding	of	phosphoribosylpyrophosphate.
chrX	13778403	13778574	O75665	0	+	13778403	13778574	255,102,0	1	171	0	.	Mediates	homooligomerization.
chrX	13778421	13787224	O75665	0	+	13778421	13787224	255,102,0	1	8803	0	.	Mediates	the	interaction	with	SDCCAG8.	Pubmed:20835237
chrX	14625380	14627120	P23416	0	+	14625380	14627120	255,102,0	1	1740	0	.	Strychnine-binding.
chrX	15364365	15371268	O43915	0	-	15364365	15371268	255,102,0	1	6903	0	.	4	X	16	AA	repeats	of	C-X(10)-C-X-C-X(1,3)-C.
chrX	15582307	15584401	Q9BYF1	0	-	15582307	15584401	255,102,0	1	2094	0	.	Essential	for	cleavage	by	TMPRSS11D	and	TMPRSS2.
chrX	15585868	15585892	Q9BYF1	0	-	15585868	15585892	255,102,0	1	24	0	.	Essential	for	cleavage	by	ADAM17.
chrX	15599342	15599357	Q9BYF1	0	-	15599342	15599357	255,102,0	1	15	0	.	Interaction	with	SARS-CoV	spike	glycoprotein.
chrX	15613060	15613069	Q9BYF1	0	-	15613060	15613069	255,102,0	1	9	0	.	Interaction	with	SARS-CoV	spike	glycoprotein.
chrX	15618911	15618947	Q9BYF1	0	-	15618911	15618947	255,102,0	1	36	0	.	Interaction	with	SARS-CoV	spike	glycoprotein.
chrX	15794920	15794926	Q9Y2D0	0	+	15794920	15794926	255,102,0	1	6	0	.	Substrate	binding.
chrX	17121863	17165601	Q8NFH8	0	+	17121863	17165601	255,102,0	1	43738	0	.	Interaction	with	RALBP1.
chrX	17153401	17165601	Q8NFH8	0	+	17153401	17165601	255,102,0	1	12200	0	.	Interaction	with	ASAP1.
chrX	18768034	18824634	O14829	0	+	18768034	18824634	255,102,0	1	56600	0	.	Catalytic.
chrX	18913294	18915388	P46019	0	-	18913294	18915388	255,102,0	1	2094	0	.	Calmodulin-binding.
chrX	18926023	18926116	P46019	0	-	18926023	18926116	255,102,0	1	93	0	.	Calmodulin-binding.
chrX	21874695	21874908	O15391	0	+	21874695	21874908	255,102,0	1	213	0	.	Mediates	transcriptional	activation.
chrX	21875310	21875718	O15391	0	+	21875310	21875718	255,102,0	1	408	0	.	Mediates	transcriptional	repression.
chrX	22002433	22002439	P52788	0	+	22002433	22002439	255,102,0	1	6	0	.	S-adenosylmethioninamine	binding.
chrX	22291393	22291570	Q8N7E2	0	+	22291393	22291570	255,102,0	1	177	0	.	HYB	domain.
chrX	23801786	23801792	P21673	0	+	23801786	23801792	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:17516632
chrX	23803521	23803530	P21673	0	+	23803521	23803530	255,102,0	1	9	0	.	Acetyl-CoA	binding.	Pubmed:17516632
chrX	23803635	23803653	P21673	0	+	23803635	23803653	255,102,0	1	18	0	.	Acetyl-CoA	binding.	Pubmed:17516632
chrX	23803832	23803841	P21673	0	+	23803832	23803841	255,102,0	1	9	0	.	Substrate	binding.	Pubmed:17516632
chrX	23803853	23803865	P21673	0	+	23803853	23803865	255,102,0	1	12	0	.	Acetyl-CoA	binding.	Pubmed:17516632
chrX	23803874	23803886	P21673	0	+	23803874	23803886	255,102,0	1	12	0	.	Acetyl-CoA	binding.	Pubmed:17516632
chrX	24075545	24075569	P41091	0	+	24075545	24075569	255,102,0	1	24	0	.	G1.
chrX	24075629	24075644	P41091	0	+	24075629	24075644	255,102,0	1	15	0	.	G2.
chrX	24078220	24078232	P41091	0	+	24078220	24078232	255,102,0	1	12	0	.	G3.
chrX	24080621	24080633	P41091	0	+	24080621	24080633	255,102,0	1	12	0	.	G4.
chrX	24082352	24082361	P41091	0	+	24082352	24082361	255,102,0	1	9	0	.	G5.
chrX	24755783	24757614	P09884	0	+	24755783	24757614	255,102,0	1	1831	0	.	DNA-binding	region.
chrX	24859782	24906221	P09884	0	+	24859782	24906221	255,102,0	1	46439	0	.	DNA-binding	region.
chrX	26158655	26159387	Q96M61	0	+	26158655	26159387	255,102,0	1	732	0	.	Interaction	with	LNX1.	Pubmed:20864041
chrX	29973490	29973778	Q9NZN1	0	+	29973490	29973778	255,102,0	1	288	0	.	Interaction	with	NCS1.	Pubmed:12783849
chrX	30322698	30326721	P51843	0	-	30322698	30326721	255,102,0	1	4023	0	.	Ligand-binding.
chrX	30326721	30327480	P51843	0	-	30326721	30327480	255,102,0	1	759	0	.	4	X	67	AA	tandem	repeats.
chrX	38229099	38229114	P00480	0	+	38229099	38229114	255,102,0	1	15	0	.	Ornithine	and	carbamoyl	phosphate	binding.
chrX	38260642	38260654	P00480	0	+	38260642	38260654	255,102,0	1	12	0	.	Ornithine	and	carbamoyl	phosphate	binding.
chrX	38268197	38268212	P00480	0	+	38268197	38268212	255,102,0	1	15	0	.	Ornithine	binding.
chrX	38271150	38271162	P00480	0	+	38271150	38271162	255,102,0	1	12	0	.	Ornithine	binding.
chrX	39911385	39913215	Q6W2J9	0	-	39911385	39913215	255,102,0	1	1830	0	.	Necessary	and	sufficient	for	interaction	with	PCGF1.
chrX	39933056	39933107	Q6W2J9	0	-	39933056	39933107	255,102,0	1	51	0	.	Interaction	with	BCL6.
chrX	40540147	40556428	O60244	0	-	40540147	40556428	255,102,0	1	16281	0	.	Interaction	with	SREBF1.	Pubmed:15340088
chrX	40552106	40573120	O60244	0	-	40552106	40573120	255,102,0	1	21014	0	.	Interaction	with	STAT2.	Pubmed:12509459
chrX	41193508	41201763	O00571	0	+	41193508	41201763	255,102,0	1	8255	0	.	Interaction	with	EIF4E.
chrX	41193508	41201880	O00571	0	+	41193508	41201880	255,102,0	1	8372	0	.	Required	for	TBK1	and	IKBKE-dependent	IFN-beta	activation.
chrX	41200825	41200855	O00571	0	+	41200825	41200855	255,102,0	1	30	0	.	Required	for	interaction	with	VACV	protein	K7.
chrX	41201760	41201793	O00571	0	+	41201760	41201793	255,102,0	1	33	0	.	Required	for	interaction	with	IKBKE.
chrX	41201760	41206969	O00571	0	+	41201760	41206969	255,102,0	1	5209	0	.	Interaction	with	GSK3B.	Pubmed:18846110
chrX	41203057	41203294	O00571	0	+	41203057	41203294	255,102,0	1	237	0	.	Involved	in	stimulation	of	ATPase	activity	by	DNA	and	RNA,	nucleic	acid	binding	and	unwinding	and	HIV-1	replication.
chrX	41203294	41205811	O00571	0	+	41203294	41205811	255,102,0	1	2517	0	.	Necessary	for	interaction	with	XPO1.	Pubmed:15507209
chrX	41485926	41495833	O14936	0	-	41485926	41495833	255,102,0	1	9907	0	.	Calmodulin-binding.
chrX	42636889	42636901	O14990	0	-	42636889	42636901	255,102,0	1	12	0	.	Required	for	binding	PPP1CC	catalytic	center,	displacing	metal	ions	and	inhibition	of	PPP1CC	catyltic	activity.
chrX	42637165	42637204	O14990	0	-	42637165	42637204	255,102,0	1	39	0	.	Required	for	binding	PPP1CC.
chrX	42637279	42637297	O14990	0	-	42637279	42637297	255,102,0	1	18	0	.	Required	for	binding	PPP1CC.
chrX	43603733	43603742	P21397	0	+	43603733	43603742	255,102,0	1	9	0	.	Interaction	with	membrane	phospholipid	headgroups.
chrX	44703504	44703762	Q9H596	0	+	44703504	44703762	255,102,0	1	258	0	.	Sufficient	for	mitochondrial	localization.
chrX	47058617	47065738	P22314	0	+	47058617	47065738	255,102,0	1	7121	0	.	2	approximate	repeats.
chrX	47432265	47433417	P17600	0	-	47432265	47433417	255,102,0	1	1152	0	.	E.
chrX	47433417	47434571	P17600	0	-	47433417	47434571	255,102,0	1	1154	0	.	D;	Pro-rich	linker.
chrX	47434571	47478791	P17600	0	-	47434571	47478791	255,102,0	1	44220	0	.	C;	actin-binding	and	synaptic-vesicle	binding.
chrX	47442883	47442898	P01033	0	+	47442883	47442898	255,102,0	1	15	0	.	Involved	in	metalloproteinase-binding.
chrX	47444669	47444675	P01033	0	+	47444669	47444675	255,102,0	1	6	0	.	Involved	in	metalloproteinase-binding.
chrX	47478791	47479043	P17600	0	-	47478791	47479043	255,102,0	1	252	0	.	B;	linker.
chrX	47479043	47479127	P17600	0	-	47479043	47479127	255,102,0	1	84	0	.	A.
chrX	47496317	47497191	P19419	0	-	47496317	47497191	255,102,0	1	874	0	.	Sufficient	for	interaction	with	MAD2L2.	Pubmed:17296730
chrX	48555175	48558583	O43463	0	+	48555175	48558583	255,102,0	1	3408	0	.	Interaction	with	SIRT1.
chrX	48559075	48559084	O43463	0	+	48559075	48559084	255,102,0	1	9	0	.	S-adenosyl-L-methionine	binding.
chrX	48559078	48565853	O43463	0	+	48559078	48565853	255,102,0	1	6775	0	.	Mediates	interaction	with	MECOM.
chrX	48564793	48564799	O43463	0	+	48564793	48564799	255,102,0	1	6	0	.	S-adenosyl-L-methionine	binding.
chrX	48650728	48652319	P15976	0	+	48650728	48652319	255,102,0	1	1591	0	.	Interaction	with	MED1	and	CCAR1.	Pubmed:24245781
chrX	48650737	48650797	P15976	0	+	48650737	48650797	255,102,0	1	60	0	.	Required	for	interaction	with	ZFPM1.
chrX	48651578	48652274	P15976	0	+	48651578	48652274	255,102,0	1	696	0	.	Interaction	with	CALCOCO1.	Pubmed:24245781
chrX	48661570	48673853	Q9UBN7	0	+	48661570	48673853	255,102,0	1	12283	0	.	Histone	deacetylase	1.
chrX	48674409	48681092	Q9UBN7	0	+	48674409	48681092	255,102,0	1	6680	0	.	Histone	deacetylase	2.
chrX	48682584	48682593	Q9UBN7	0	+	48682584	48682593	255,102,0	1	9	0	.	Ubiquitin	binding.
chrX	48682668	48682692	Q9UBN7	0	+	48682668	48682692	255,102,0	1	24	0	.	Ubiquitin	binding.
chrX	48689672	48689792	Q9UHG2	0	-	48689672	48689792	255,102,0	1	120	0	.	C-terminal	inhibitory	domain;	interacts	with	PCSK1.
chrX	48759306	48760358	O60828	0	+	48759306	48760358	255,102,0	1	1052	0	.	Intrinsically	disordered.
chrX	48759526	48759631	O60828	0	+	48759526	48759631	255,102,0	1	105	0	.	5	X	7	AA	approximate	tandem	repeats	of	D-R-[SG]-H-D-K-S.
chrX	48759631	48759649	O60828	0	+	48759631	48759649	255,102,0	1	18	0	.	3	X	2	AA	tandem	repeats	of	[DE]-R.
chrX	48759664	48759706	O60828	0	+	48759664	48759706	255,102,0	1	42	0	.	7	X	2	AA	tandem	repeats	of	[DE]-R.
chrX	48760295	48760328	O60828	0	+	48760295	48760328	255,102,0	1	33	0	.	Important	for	interaction	with	TXNL4A.
chrX	48791808	48791826	Q96G74	0	-	48791808	48791826	255,102,0	1	18	0	.	His-loop.
chrX	48792044	48792077	Q96G74	0	-	48792044	48792077	255,102,0	1	33	0	.	Variable-loop.
chrX	48801466	48801487	Q96G74	0	-	48801466	48801487	255,102,0	1	21	0	.	Cys-loop.
chrX	48822984	48823032	Q9NSA2	0	-	48822984	48823032	255,102,0	1	48	0	.	Mediates	dendritic	targeting.
chrX	48826618	48826675	Q9NSA2	0	-	48826618	48826675	255,102,0	1	57	0	.	Interaction	with	KCNIP2.
chrX	48888106	48888971	P19532	0	-	48888106	48888971	255,102,0	1	861	0	.	Leucine-zipper.
chrX	48895606	48895724	P19532	0	-	48895606	48895724	255,102,0	1	118	0	.	Strong	transcription	activation	domain.
chrX	49047920	49048076	P08247	0	-	49047920	49048076	255,102,0	1	156	0	.	Repeats,	Gly-rich.
chrX	49067456	49067886	O60840	0	-	49067456	49067886	255,102,0	1	430	0	.	Dihydropyridine	binding.
chrX	49067489	49067850	O60840	0	-	49067489	49067850	255,102,0	1	361	0	.	Phenylalkylamine	binding.
chrX	49071822	49072933	O60840	0	-	49071822	49072933	255,102,0	1	1111	0	.	Dihydropyridine	binding.
chrX	49083471	49083525	O60840	0	-	49083471	49083525	255,102,0	1	54	0	.	Binding	to	the	beta	subunit.
chrX	49109622	49110513	Q9BZS1	0	-	49109622	49110513	255,102,0	1	891	0	.	Interaction	with	RUNX1.	Pubmed:17377532
chrX	49111925	49112196	Q9BZS1	0	-	49111925	49112196	255,102,0	1	271	0	.	Leucine-zipper.
chrX	49113257	49113893	Q9BZS1	0	-	49113257	49113893	255,102,0	1	636	0	.	Interaction	with	IKZF4.
chrX	49113260	49114022	Q9BZS1	0	-	49113260	49114022	255,102,0	1	762	0	.	Interaction	with	ZFP90.	Pubmed:23543754
chrX	49113284	49114022	Q9BZS1	0	-	49113284	49114022	255,102,0	1	738	0	.	Essential	for	transcriptional	repressor	activity	and	for	interaction	with	KAT5	and	HDAC7.	Pubmed:17360565
chrX	49958328	49958358	Q5JQC9	0	-	49958328	49958358	255,102,0	1	30	0	.	PKA-RI-alpha	subunit	binding	domain.
chrX	49958667	49958709	Q5JQC9	0	-	49958667	49958709	255,102,0	1	42	0	.	PKA-RI	and	PKA-RII	subunit	binding	domain.
chrX	50111950	50114740	Q5KSL6	0	-	50111950	50114740	255,102,0	1	2790	0	.	Required	for	localization	to	the	plasma	membrane.
chrX	50213140	50213536	Q5KSL6	0	-	50213140	50213536	255,102,0	1	396	0	.	33	X	4	AA	approximate	tandem	repeats	of	E-P-A-P.
chrX	51075865	51075874	Q8NFP7	0	+	51075865	51075874	255,102,0	1	9	0	.	Substrate	binding.
chrX	51076081	51076090	Q8NFP7	0	+	51076081	51076090	255,102,0	1	9	0	.	Substrate	binding.
chrX	51239023	51239032	Q96G61	0	-	51239023	51239032	255,102,0	1	9	0	.	Substrate	binding.
chrX	51239239	51239248	Q96G61	0	-	51239239	51239248	255,102,0	1	9	0	.	Substrate	binding.
chrX	51487349	51487373	Q8IYD1	0	+	51487349	51487373	255,102,0	1	24	0	.	G1.
chrX	51487517	51487532	Q8IYD1	0	+	51487517	51487532	255,102,0	1	15	0	.	G2.
chrX	51487580	51487592	Q8IYD1	0	+	51487580	51487592	255,102,0	1	12	0	.	G3.
chrX	51487766	51487778	Q8IYD1	0	+	51487766	51487778	255,102,0	1	12	0	.	G4.
chrX	51487892	51487901	Q8IYD1	0	+	51487892	51487901	255,102,0	1	9	0	.	G5.
chrX	51639636	51640083	Q9Y5V3	0	+	51639636	51640083	255,102,0	1	447	0	.	22	X	6	AA	tandem	repeats	of	W-[PQ]-X-P-X-X.
chrX	52733586	52734289	Q16385	0	-	52733586	52734289	255,102,0	1	703	0	.	Interaction	with	RAB3IP.	Pubmed:12007189
chrX	52733586	52734799	Q16385	0	-	52733586	52734799	255,102,0	1	1213	0	.	Interaction	with	SSX2IP.	Pubmed:12007189
chrX	52781757	52782970	Q16385	0	+	52781757	52782970	255,102,0	1	1213	0	.	Interaction	with	SSX2IP.	Pubmed:12007189
chrX	52782267	52782970	Q16385	0	+	52782267	52782970	255,102,0	1	703	0	.	Interaction	with	RAB3IP.	Pubmed:12007189
chrX	54048747	54048792	Q9UPP1	0	-	54048747	54048792	255,102,0	1	45	0	.	Linker.
chrX	54565477	54566591	Q9NVN8	0	+	54565477	54566591	255,102,0	1	1114	0	.	Required	for	nucleolar	localization.
chrX	54955407	54957447	Q12816	0	+	54955407	54957447	255,102,0	1	2040	0	.	62	X	10	AA	approximate	tandem	repeats.
chrX	54959838	54978433	P16118	0	-	54959838	54978433	255,102,0	1	18595	0	.	Fructose-2,6-bisphosphatase.
chrX	54978433	55020437	P16118	0	-	54978433	55020437	255,102,0	1	42004	0	.	6-phosphofructo-2-kinase.
chrX	55033478	55033502	Q9UBZ4	0	+	55033478	55033502	255,102,0	1	24	0	.	Required	for	the	colocalization	with	PCNA	in	nuclear	foci	in	presence	of	oxidative-induced	DNA	damaging	agents.
chrX	56591776	56591884	Q9UHD9	0	+	56591776	56591884	255,102,0	1	108	0	.	12	X	3	AA	tandem	repeats	of	P-X-X.
chrX	57619291	57620212	P98169	0	+	57619291	57620212	255,102,0	1	921	0	.	Required	for	interaction	with	ZXDC.
chrX	57620206	57620590	P98169	0	+	57620206	57620590	255,102,0	1	384	0	.	Required	for	transcriptional	activation.
chrX	57934757	57935141	P98168	0	-	57934757	57935141	255,102,0	1	384	0	.	Required	for	transcriptional	activation.
chrX	57935135	57936056	P98168	0	-	57935135	57936056	255,102,0	1	921	0	.	Required	for	interaction	with	ZXDC.	Pubmed:17493635
chrX	62926188	62926221	O43307	0	-	62926188	62926221	255,102,0	1	33	0	.	Interaction	with	GPHN.
chrX	63557216	63557237	Q96EF0	0	-	63557216	63557237	255,102,0	1	21	0	.	Substrate	binding.
chrX	63564961	63564967	Q96EF0	0	-	63564961	63564967	255,102,0	1	6	0	.	Substrate	binding.
chrX	63565030	63565042	Q96EF0	0	-	63565030	63565042	255,102,0	1	12	0	.	Substrate	binding.
chrX	66764988	66863158	P10275	0	+	66764988	66863158	255,102,0	1	98170	0	.	Modulating.
chrX	66863134	66943677	P10275	0	+	66863134	66943677	255,102,0	1	80543	0	.	Interaction	with	LPXN.	Pubmed:18451096
chrX	66863194	66931344	P10275	0	+	66863194	66931344	255,102,0	1	68150	0	.	Interaction	with	HIPK3.
chrX	66905856	66943677	P10275	0	+	66905856	66943677	255,102,0	1	37821	0	.	Interaction	with	CCAR1.	Pubmed:23887938
chrX	66905955	66943677	P10275	0	+	66905955	66943677	255,102,0	1	37722	0	.	Interaction	with	KAT7.	Pubmed:10930412
chrX	66931428	66943677	P10275	0	+	66931428	66943677	255,102,0	1	12249	0	.	Ligand-binding.
chrX	69282809	69282830	Q7L8S5	0	+	69282809	69282830	255,102,0	1	21	0	.	Cys-loop.
chrX	69283001	69283034	Q7L8S5	0	+	69283001	69283034	255,102,0	1	33	0	.	Variable-loop.
chrX	69283145	69283178	Q7L8S5	0	+	69283145	69283178	255,102,0	1	33	0	.	His-loop.
chrX	69354475	69366606	P78318	0	+	69354475	69366606	255,102,0	1	12131	0	.	Interaction	with	PPP2CA.
chrX	69366672	69370171	P78318	0	+	69366672	69370171	255,102,0	1	3499	0	.	Interaction	with	MID1.	Pubmed:11806752
chrX	69596012	69640112	O95239	0	+	69596012	69640112	255,102,0	1	44100	0	.	Interaction	with	PRC1.
chrX	69626129	69640112	O95239	0	+	69626129	69640112	255,102,0	1	13983	0	.	Globular.
chrX	70354680	70360593	Q93074	0	+	70354680	70360593	255,102,0	1	5913	0	.	Interaction	with	CTNNB1	and	GLI3.	Pubmed:17000779
chrX	70511633	70517776	Q15233	0	+	70511633	70517776	255,102,0	1	6143	0	.	DBHS.
chrX	70602399	70612568	P21675	0	+	70602399	70612568	255,102,0	1	10169	0	.	Histone	acetyltransferase	(HAT).
chrX	70626515	70674659	P21675	0	+	70626515	70674659	255,102,0	1	48144	0	.	Interaction	with	ASF1A	and	ASF1B.	Pubmed:12842904
chrX	70793473	70793533	O15294	0	+	70793473	70793533	255,102,0	1	60	0	.	Required	for	phosphatidylinositol	3,4,5-triphosphate	binding.
chrX	71681886	71792572	Q9BY41	0	-	71681886	71792572	255,102,0	1	110686	0	.	Histone	deacetylase.
chrX	71804137	71813061	P46020	0	-	71804137	71813061	255,102,0	1	8924	0	.	Calmodulin-binding.
chrX	71830883	71830976	P46020	0	-	71830883	71830976	255,102,0	1	93	0	.	Calmodulin-binding.
chrX	74519718	74520715	Q96BW1	0	+	74519718	74520715	255,102,0	1	997	0	.	5-phospho-alpha-D-ribose	1-diphosphate	binding.
chrX	74523310	74523319	Q96BW1	0	+	74523310	74523319	255,102,0	1	9	0	.	Uracil	binding.
chrX	75650549	75651194	Q9HCI5	0	+	75650549	75651194	255,102,0	1	645	0	.	Interaction	with	DTNA.
chrX	77224571	77224577	Q8N0Y7	0	-	77224571	77224577	255,102,0	1	6	0	.	Substrate	binding.
chrX	77224784	77224790	Q8N0Y7	0	-	77224784	77224790	255,102,0	1	6	0	.	Substrate	binding.
chrX	77224859	77224871	Q8N0Y7	0	-	77224859	77224871	255,102,0	1	12	0	.	Substrate	binding.
chrX	77225063	77225069	Q8N0Y7	0	-	77225063	77225069	255,102,0	1	6	0	.	Substrate	binding.
chrX	77225084	77225108	Q8N0Y7	0	-	77225084	77225108	255,102,0	1	24	0	.	Substrate	binding.
chrX	77365367	77365376	P00558	0	+	77365367	77365376	255,102,0	1	9	0	.	Substrate	binding.
chrX	77365367	77365376	V9HWF4	0	+	77365367	77365376	255,102,0	1	9	0	.	Substrate	binding.
chrX	77369310	77369322	P00558	0	+	77369310	77369322	255,102,0	1	12	0	.	Substrate	binding.
chrX	77369310	77369322	V9HWF4	0	+	77369310	77369322	255,102,0	1	12	0	.	Substrate	binding.
chrX	83129309	83129375	P35663	0	+	83129309	83129375	255,102,0	1	66	0	.	8	X	approximate	tandem	repeats.
chrX	84347528	84347537	Q86VE3	0	-	84347528	84347537	255,102,0	1	9	0	.	Substrate	binding.
chrX	84348214	84348232	Q86VE3	0	-	84348214	84348232	255,102,0	1	18	0	.	Acetyl-CoA	binding.
chrX	84349149	84349158	Q86VE3	0	-	84349149	84349158	255,102,0	1	9	0	.	Acetyl-CoA	binding.
chrX	84358903	84358909	Q86VE3	0	-	84358903	84358909	255,102,0	1	6	0	.	Substrate	binding.
chrX	85403828	85404089	Q96NX9	0	+	85403828	85404089	255,102,0	1	261	0	.	DACHbox-N.
chrX	86067974	86069752	Q96NX9	0	+	86067974	86069752	255,102,0	1	1778	0	.	DACHbox-C.
chrX	100078294	100081664	P33240	0	+	100078294	100081664	255,102,0	1	3370	0	.	Interactions	with	CSTF3	and	SYMPK.
chrX	100088188	100088368	P33240	0	+	100088188	100088368	255,102,0	1	180	0	.	12	X	5	AA	tandem	repeats	of	M-E-A-R-[AG].
chrX	100092366	100093347	P33240	0	+	100092366	100093347	255,102,0	1	981	0	.	Interaction	with	RPO2TC1.	Pubmed:11389848
chrX	100099027	100104868	Q9Y5S8	0	-	100099027	100104868	255,102,0	1	5841	0	.	Interaction	with	NOXO1.	Pubmed:16329988
chrX	100349567	100349603	Q53FP2	0	+	100349567	100349603	255,102,0	1	36	0	.	Interaction	with	NGFR.
chrX	100611168	100611186	Q06187	0	-	100611168	100611186	255,102,0	1	18	0	.	Inhibitor-binding.
chrX	100630200	100630239	Q06187	0	-	100630200	100630239	255,102,0	1	39	0	.	Inositol-(1,3,4,5)-tetrakisphosphate	1-binding.
chrX	100655671	100655686	P06280	0	-	100655671	100655686	255,102,0	1	15	0	.	Substrate	binding.
chrX	100667675	100668275	P55795	0	+	100667675	100668275	255,102,0	1	600	0	.	2	X	16	AA	Gly-rich	approximate	repeats.
chrX	100668035	100668152	P55795	0	+	100668035	100668152	255,102,0	1	117	0	.	2	X	19	AA	perfect	repeats.
chrX	101911535	101913026	Q5JY77	0	+	101911535	101913026	255,102,0	1	1491	0	.	OPRD1-binding.
chrX	102632620	102632698	Q00994	0	+	102632620	102632698	255,102,0	1	78	0	.	Interaction	with	p75NTR/NGFR.
chrX	102632620	102632752	Q00994	0	+	102632620	102632752	255,102,0	1	132	0	.	Interaction	with	14-3-3	epsilon.
chrX	102974191	102977089	Q5JXX5	0	-	102974191	102977089	255,102,0	1	2898	0	.	Strychnine-binding.
chrX	103494995	103495400	Q8N693	0	-	103494995	103495400	255,102,0	1	405	0	.	15	X	9	AA	tandem	repeats	of	P-P-x-x-P-x-P-P-x.
chrX	106144041	106144714	Q0D2K3	0	-	106144041	106144714	255,102,0	1	673	0	.	Ripply	homology	domain.
chrX	106172142	106172148	P57739	0	+	106172142	106172148	255,102,0	1	6	0	.	Interactions	with	TJP1,	TJP2	and	TJP3.
chrX	106888509	106888557	P60891	0	+	106888509	106888557	255,102,0	1	48	0	.	Binding	of	phosphoribosylpyrophosphate.
chrX	106957862	106957928	Q99576	0	-	106957862	106957928	255,102,0	1	66	0	.	Leucine-zipper.
chrX	106957973	106960041	Q99576	0	-	106957973	106960041	255,102,0	1	2068	0	.	AP1-binding.
chrX	107328206	107330932	O75832	0	-	107328206	107330932	255,102,0	1	2726	0	.	Interaction	with	RB1.	Pubmed:10613832
chrX	107328206	107332080	O75832	0	-	107328206	107332080	255,102,0	1	3874	0	.	Interaction	with	RELA.
chrX	107331981	107334750	O75832	0	-	107331981	107334750	255,102,0	1	2769	0	.	Interaction	with	RB1.	Pubmed:10613832
chrX	107334639	107334750	O75832	0	-	107334639	107334750	255,102,0	1	111	0	.	Required	for	nuclear	localization.
chrX	107403831	107553986	Q14031	0	-	107403831	107553986	255,102,0	1	150155	0	.	Triple-helical	region.
chrX	107553986	107554058	Q14031	0	-	107553986	107554058	255,102,0	1	72	0	.	7S	domain.
chrX	107683433	107783017	P29400	0	+	107683433	107783017	255,102,0	1	99584	0	.	Nonhelical	region	(NC2).
chrX	107783017	107930782	P29400	0	+	107783017	107930782	255,102,0	1	147765	0	.	Triple-helical	region.
chrX	107976883	107976892	O14654	0	-	107976883	107976892	255,102,0	1	9	0	.	GRB2-binding.
chrX	107977174	107977543	O14654	0	-	107977174	107977543	255,102,0	1	369	0	.	CRK-binding.
chrX	110385340	110391012	O75914	0	+	110385340	110391012	255,102,0	1	5672	0	.	GTPase-binding.
chrX	110385340	110391093	O75914	0	+	110385340	110391093	255,102,0	1	5753	0	.	Autoregulatory	region.
chrX	110385397	110416280	O75914	0	+	110385397	110416280	255,102,0	1	30883	0	.	Linker.
chrX	110491795	110494273	Q9Y6Q1	0	-	110491795	110494273	255,102,0	1	2478	0	.	Domain	III.
chrX	110924446	110928323	Q9NP73	0	+	110924446	110928323	255,102,0	1	3877	0	.	Glycosyltransferase	activity.
chrX	110928323	110961452	Q9NP73	0	+	110928323	110961452	255,102,0	1	33129	0	.	Deubiquitinase	activity.
chrX	111019543	111019552	Q9UL62	0	-	111019543	111019552	255,102,0	1	9	0	.	Essential	for	binding	to	NHERF	PDZ	domain.
chrX	114536615	114537881	Q9P127	0	+	114536615	114537881	255,102,0	1	1266	0	.	Arg-rich;	required	for	RNA-binding.	Pubmed:25662211
chrX	114540958	114541135	Q9P127	0	+	114540958	114541135	255,102,0	1	177	0	.	RS-containing	His-rich	(RS-H);	necessary	for	nuclear	localization.	Pubmed:25662211
chrX	114541138	114541288	Q9P127	0	+	114541138	114541288	255,102,0	1	150	0	.	Leucine-zipper;	required	for	RNA-binding	and	for	its	relocalization	to	the	cytoplasm	during	cell	division.	Pubmed:25662211
chrX	114541147	114541366	Q9P127	0	+	114541147	114541366	255,102,0	1	219	0	.	Interaction	with	NXF1.	Pubmed:25662211
chrX	117480469	117526918	Q5JSH3	0	+	117480469	117526918	255,102,0	1	46449	0	.	Binding	activity.
chrX	117676780	117677542	Q5JSL3	0	+	117676780	117677542	255,102,0	1	762	0	.	Interaction	with	activated	CDC42.
chrX	118724499	118726460	O15226	0	-	118724499	118726460	255,102,0	1	1961	0	.	Active	repression	domain.
chrX	118968843	118985548	Q9BZI7	0	-	118968843	118985548	255,102,0	1	16705	0	.	Sufficient	for	association	with	EJC	core.
chrX	118968951	118971734	Q9BZI7	0	-	118968951	118971734	255,102,0	1	2783	0	.	Necessary	for	interaction	with	RBM8A	and	for	activating	NMD.
chrX	118975080	118986804	Q9BZI7	0	-	118975080	118986804	255,102,0	1	11724	0	.	Necessary	for	interaction	with	UPF2.
chrX	118985821	118986738	Q9BZI7	0	-	118985821	118986738	255,102,0	1	917	0	.	Binds	to	UPF2.
chrX	119037288	119037342	Q86UN6	0	+	119037288	119037342	255,102,0	1	54	0	.	RII-binding.
chrX	119059185	119066100	Q8N5F7	0	-	119059185	119066100	255,102,0	1	6915	0	.	Necessary	for	interaction	with	HDAC3	and	transcriptional	repression.	Pubmed:19409814
chrX	119066100	119070578	Q8N5F7	0	-	119066100	119070578	255,102,0	1	4478	0	.	Necessary	for	interaction	with	CIR1.	Pubmed:19409814
chrX	119387270	119387579	Q86T24	0	+	119387270	119387579	255,102,0	1	309	0	.	Interaction	with	NCOR1.	Pubmed:14527417
chrX	119387270	119387678	Q86T24	0	+	119387270	119387678	255,102,0	1	408	0	.	Self-association.
chrX	119388161	119388989	Q86T24	0	+	119388161	119388989	255,102,0	1	828	0	.	Interaction	with	CBFA2T3.	Pubmed:23251453
chrX	119388629	119389286	Q86T24	0	+	119388629	119389286	255,102,0	1	657	0	.	Interaction	with	CTNND1.
chrX	119388809	119389184	Q86T24	0	+	119388809	119389184	255,102,0	1	375	0	.	Required	for	DNA-binding.
chrX	119565198	119565210	P13473	0	-	119565198	119565210	255,102,0	1	12	0	.	Important	for	binding	and	subsequent	lysosomal	degradation	of	target	proteins.	Pubmed:11082038
chrX	119565285	119581752	P13473	0	-	119565285	119581752	255,102,0	1	16467	0	.	Second	lumenal	domain.
chrX	119581752	119581860	P13473	0	-	119581752	119581860	255,102,0	1	108	0	.	Hinge.
chrX	119581860	119590604	P13473	0	-	119581860	119590604	255,102,0	1	8744	0	.	First	lumenal	domain.
chrX	122551273	122551282	P42263	0	+	122551273	122551282	255,102,0	1	9	0	.	Glutamate	binding.
chrX	122561969	122561975	P42263	0	+	122561969	122561975	255,102,0	1	6	0	.	Glutamate	binding.
chrX	123019932	123019959	P98170	0	+	123019932	123019959	255,102,0	1	27	0	.	Interaction	with	caspase-7.
chrX	123499671	123504100	O60880	0	+	123499671	123504100	255,102,0	1	4429	0	.	Interaction	with	FYN	SH3	domain.
chrX	128692964	128709203	Q01968	0	+	128692964	128709203	255,102,0	1	16239	0	.	5-phosphatase.
chrX	128709203	128710448	Q01968	0	+	128709203	128710448	255,102,0	1	1245	0	.	ASH.
chrX	129205205	129208105	Q99607	0	-	129205205	129208105	255,102,0	1	2900	0	.	RUNX1-binding.	Pubmed:10207087
chrX	129267286	129281801	O95831	0	-	129267286	129281801	255,102,0	1	14515	0	.	FAD-dependent	oxidoreductase.
chrX	131763069	131763096	Q96MM7	0	-	131763069	131763096	255,102,0	1	27	0	.	3'-phosphate	binding.
chrX	132091056	132091077	Q96MM7	0	-	132091056	132091077	255,102,0	1	21	0	.	5'-phosphosulfate-binding.
chrX	132351357	132351528	Q5H9I0	0	-	132351357	132351528	255,102,0	1	171	0	.	DCB2.
chrX	132351369	132351765	Q5H9I0	0	-	132351369	132351765	255,102,0	1	396	0	.	Involved	in	negatively	regulating	E2F	activity.
chrX	132351564	132351663	Q5H9I0	0	-	132351564	132351663	255,102,0	1	99	0	.	DCB1.
chrX	133511686	133527960	Q8IWS0	0	+	133511686	133527960	255,102,0	1	16274	0	.	Extended	PHD1	domain	(ePHD1).
chrX	133547891	133559252	Q8IWS0	0	+	133547891	133559252	255,102,0	1	11361	0	.	Extended	PHD2	domain	(ePHD2).
chrX	135593044	135594169	O43719	0	+	135593044	135594169	255,102,0	1	1125	0	.	Mediates	interaction	with	the	P-TEFb	complex.
chrX	135956303	135956480	P38159	0	-	135956303	135956480	255,102,0	1	177	0	.	Necessary	for	RNA-binding.
chrX	135957490	135957730	P38159	0	-	135957490	135957730	255,102,0	1	240	0	.	Necessary	for	the	association	to	nascent	RNAPII	transcripts	and	nuclear	localization.
chrX	137715145	137791079	Q92913	0	-	137715145	137791079	255,102,0	1	75933	0	.	Mediates	interaction	with	sodium	channels.
chrX	137792979	137793165	Q92913	0	-	137792979	137793165	255,102,0	1	186	0	.	Mediates	targeting	to	the	nucleus.
chrX	139865913	139866003	P51861	0	-	139865913	139866003	255,102,0	1	90	0	.	5	X	6	AA	approximate	repeats.
chrX	139866003	139866111	P51861	0	-	139866003	139866111	255,102,0	1	108	0	.	6	X	6	AA	approximate	repeats.
chrX	139866111	139866525	P51861	0	-	139866111	139866525	255,102,0	1	414	0	.	23	X	6	AA	approximate	repeats.
chrX	141290654	141291371	Q9UBF1	0	-	141290654	141291371	255,102,0	1	717	0	.	Interaction	with	TRIM28.
chrX	146993697	147011685	Q06787	0	+	146993697	147011685	255,102,0	1	17987	0	.	Required	for	nuclear	localization.
chrX	147011646	147013946	Q06787	0	+	147011646	147013946	255,102,0	1	2300	0	.	Necessary	for	interaction	with	CYFIP1,	CYFIP2,	FXR1	and	FXR2.	Pubmed:14532325,	Pubmed:8668200
chrX	147022094	147026390	Q06787	0	+	147022094	147026390	255,102,0	1	4295	0	.	Required	for	nuclear	export.	Pubmed:8789445,	Pubmed:18936162
chrX	147022160	147030361	Q06787	0	+	147022160	147030361	255,102,0	1	8200	0	.	Interaction	with	RANBP9.	Pubmed:15381419
chrX	147026516	147026561	Q06787	0	+	147026516	147026561	255,102,0	1	45	0	.	RNA-binding	RGG-box.
chrX	149901196	149905072	Q13613	0	+	149901196	149905072	255,102,0	1	3876	0	.	Substrate	binding.	Pubmed:27018598
chrX	149905135	149905141	Q13613	0	+	149905135	149905141	255,102,0	1	6	0	.	Substrate	binding.	Pubmed:27018598
chrX	149905782	149905803	Q13613	0	+	149905782	149905803	255,102,0	1	21	0	.	Substrate	binding.	Pubmed:27018598
chrX	149924325	149931199	Q13613	0	+	149924325	149931199	255,102,0	1	6873	0	.	Required	for	dimerization.	Pubmed:27018598
chrX	150839530	150840050	Q8IV76	0	+	150839530	150840050	255,102,0	1	520	0	.	Necessary	for	transcriptional	repression.	Pubmed:25936801
chrX	151998232	151998304	P41208	0	-	151998232	151998304	255,102,0	1	72	0	.	Required	for	self-assembly.
chrX	152710837	152710843	Q9BQ50	0	-	152710837	152710843	255,102,0	1	6	0	.	Substrate	binding.
chrX	152830507	152830561	Q16720	0	+	152830507	152830561	255,102,0	1	54	0	.	Calmodulin-binding	subdomain	A.
chrX	152845435	152845465	Q16720	0	+	152845435	152845465	255,102,0	1	30	0	.	Calmodulin-binding	subdomain	B.
chrX	152936010	152936225	Q6P2M8	0	-	152936010	152936225	255,102,0	1	215	0	.	Calmodulin-binding.
chrX	152990919	152991279	P33897	0	+	152990919	152991279	255,102,0	1	360	0	.	Interaction	with	PEX19.
chrX	153199400	153200357	P41227	0	-	153199400	153200357	255,102,0	1	957	0	.	Interaction	with	NAA15.	Pubmed:15496142
chrX	153208345	153208411	P51606	0	-	153208345	153208411	255,102,0	1	66	0	.	Leucine-zipper.
chrX	153221761	153222428	P51610	0	-	153221761	153222428	255,102,0	1	667	0	.	Interaction	with	GABP2.	Pubmed:10675337
chrX	153221791	153222870	P51610	0	-	153221791	153222870	255,102,0	1	1079	0	.	Interaction	with	ZBTB17.	Pubmed:12244100
chrX	153222951	153223676	P51610	0	-	153222951	153223676	255,102,0	1	725	0	.	Interaction	with	SIN3A.	Pubmed:12670868
chrX	153224172	153224889	P51610	0	-	153224172	153224889	255,102,0	1	717	0	.	Required	for	interaction	with	OGT.
chrX	153284145	153284756	P51617	0	-	153284145	153284756	255,102,0	1	611	0	.	ProST	region.
chrX	153296351	153296474	P51608	0	-	153296351	153296474	255,102,0	1	123	0	.	Interaction	with	NCOR2.
chrX	153577219	153578020	P21333	0	-	153577219	153578020	255,102,0	1	801	0	.	Self-association	site,	tail.
chrX	153577832	153578020	P21333	0	-	153577832	153578020	255,102,0	1	188	0	.	Hinge	2.
chrX	153582830	153583076	P21333	0	-	153582830	153583076	255,102,0	1	246	0	.	Hinge	1.
chrX	153585925	153587358	P21333	0	-	153585925	153587358	255,102,0	1	1433	0	.	Interaction	with	furin.
chrX	153608102	153609458	P50402	0	+	153608102	153609458	255,102,0	1	1356	0	.	Interaction	with	F-actin.
chrX	153609293	153609350	P50402	0	+	153609293	153609350	255,102,0	1	57	0	.	Interaction	with	CTNNB1.	Pubmed:16858403
chrX	153762581	153762596	P11413	0	-	153762581	153762596	255,102,0	1	15	0	.	Substrate	binding.
chrX	153780346	153784525	Q9Y6K9	0	+	153780346	153784525	255,102,0	1	4179	0	.	Interaction	with	CHUK/IKBKB.
chrX	153786794	153791027	Q9Y6K9	0	+	153786794	153791027	255,102,0	1	4233	0	.	Interaction	with	TANK.
chrX	153789954	153791911	Q9Y6K9	0	+	153789954	153791911	255,102,0	1	1957	0	.	Ubiquitin-binding	(UBD).
chrX	153789966	153792213	Q9Y6K9	0	+	153789966	153792213	255,102,0	1	2247	0	.	Self-association.
chrX	153789981	153792673	Q9Y6K9	0	+	153789981	153792673	255,102,0	1	2692	0	.	Required	for	interaction	with	TNFAIP3.
chrX	153791824	153791890	Q9Y6K9	0	+	153791824	153791890	255,102,0	1	66	0	.	Leucine-zipper.
chrX	153792559	153792673	Q9Y6K9	0	+	153792559	153792673	255,102,0	1	114	0	.	Interaction	with	CYLD.	Pubmed:12917691
chrX	153991243	153993220	O60832	0	+	153991243	153993220	255,102,0	1	1977	0	.	Nucleolar	localization.
chrX	154003545	154005139	O60832	0	+	154003545	154005139	255,102,0	1	1594	0	.	Nuclear	and	nucleolar	localization.
chrX	154007454	154012366	Q00013	0	-	154007454	154012366	255,102,0	1	4912	0	.	Interaction	with	MPP5.	Pubmed:17584769
chrX	154113582	154113669	P0C5Y9	0	+	154113582	154113669	255,102,0	1	87	0	.	Docking	domain.
chrX	154157063	154159787	P00451	0	-	154157063	154159787	255,102,0	1	2724	0	.	B.
chrX	154507194	154509332	O15247	0	-	154507194	154509332	255,102,0	1	2138	0	.	C-terminal.
chrX	154508506	154508569	O15247	0	-	154508506	154508569	255,102,0	1	63	0	.	Foot	loop.
chrX	154610693	154610780	P0C5Z0	0	+	154610693	154610780	255,102,0	1	87	0	.	Docking	domain.
chrX	154689243	154689330	P0C5Z0	0	-	154689243	154689330	255,102,0	1	87	0	.	Docking	domain.
chrY	2655032	2655053	Q05066	0	-	2655032	2655053	255,102,0	1	21	0	.	Necessary	for	interaction	with	SLC9A3R2.	Pubmed:9054412
chrY	2655179	2655233	Q05066	0	-	2655179	2655233	255,102,0	1	54	0	.	Necessary	for	interaction	with	ZNF208	isoform	KRAB-O.
chrY	2655227	2655326	Q05066	0	-	2655227	2655326	255,102,0	1	99	0	.	Sufficient	for	interaction	with	EP300.	Pubmed:15297880
chrY	2655236	2655257	Q05066	0	-	2655236	2655257	255,102,0	1	21	0	.	Required	for	nuclear	localization.
chrY	2655236	2655470	Q05066	0	-	2655236	2655470	255,102,0	1	234	0	.	Sufficient	for	interaction	with	KPNB1.
chrY	2655413	2655464	Q05066	0	-	2655413	2655464	255,102,0	1	51	0	.	Required	for	nuclear	localization.
chrY	16941872	16941890	Q8NFZ3	0	+	16941872	16941890	255,102,0	1	18	0	.	Interaction	with	NRXN1.
